PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lyons, JR; Lewis, RS; Clayton, RN				Lyons, James R.; Lewis, Roy S.; Clayton, Robert N.			Comment on "Experimental Test of Self-Shielding in Vacuum Ultraviolet Photodissociation of CO"	SCIENCE			English	Editorial Material							ORIGIN	Chakraborty et al. (Reports, 5 September 2008, p. 1328) demonstrated very large, wavelength-dependent mass-independent isotopic effects during carbon monoxide ( CO) photodissociation and argued that self-shielding in CO was not responsible. We suggest that variations in band oscillator strengths and linewidths among CO isotopologs are responsible for most of the wavelength dependence observed and that the reported experiments confirm the importance of self-shielding during CO photodissociation.	[Lyons, James R.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Lewis, Roy S.; Clayton, Robert N.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Lewis, Roy S.] Univ Chicago, Chicago Ctr Cosmochem, Chicago, IL 60637 USA; [Clayton, Robert N.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Clayton, Robert N.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of California System; University of California Los Angeles; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Lyons, JR (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	jimlyons@ucla.edu	Yin, Qing-Zhu/B-8198-2009; Shi, Xiaoyu/D-4682-2017	Yin, Qing-Zhu/0000-0002-4445-5096; Shi, Xiaoyu/0000-0002-9634-2659; Young, Edward/0000-0002-1299-0801				Chakraborty S, 2008, SCIENCE, V321, P1328, DOI 10.1126/science.1159178; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Eidelsberg M, 2006, ASTROPHYS J, V647, P1543, DOI 10.1086/505486; EIDELSBERG M, 1991, ASTRON ASTROPHYS SUP, V90, P231; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; LYONS JR, 2009, 40 LUN PLAN SCI C LU; STARK G, 1991, ASTROPHYS J, V369, P574, DOI 10.1086/169788; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	9	16	16	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934								10.1126/science.1167717	http://dx.doi.org/10.1126/science.1167717			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541978				2022-12-28	WOS:000267130600020
J	Yin, QZ; Shi, XY; Chang, C; Ng, CY				Yin, Qing-Zhu; Shi, Xiaoyu; Chang, Chao; Ng, Cheuk-Yiu			Comment on "Experimental Test of Self-Shielding in Vacuum Ultraviolet Photodissociation of CO"	SCIENCE			English	Editorial Material							SOLAR-SYSTEM; OXYGEN; NEBULA; METEORITES; ANOMALIES; ORIGIN; NM	Chakraborty et al. (Reports, 5 September 2008, p. 1328) concluded that an anomalously enriched atomic oxygen reservoir can be generated through carbon monoxide photodissociation without self-shielding. We show that this conclusion is based on the incorrect assumption that the spectral shifts of the 97.03-nanometers and 107.61-nanometers vibrational bands for (CO)-O-16, (CO)-O-17, and (CO)-O-18 are negligible and point out shortcomings of the low-resolution light source used in their experiments.	[Yin, Qing-Zhu] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Shi, Xiaoyu; Chang, Chao; Ng, Cheuk-Yiu] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Yin, QZ (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	qyin@ucdavis.edu	Yin, Qing-Zhu/B-8198-2009; Shi, Xiaoyu/D-4682-2017	Yin, Qing-Zhu/0000-0002-4445-5096; Shi, Xiaoyu/0000-0002-9634-2659; Young, Edward/0000-0002-1299-0801				BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; Cacciani P, 2004, J MOL SPECTROSC, V225, P62, DOI 10.1016/j.jms.2004.02.009; Chakraborty S, 2008, SCIENCE, V321, P1328, DOI 10.1126/science.1159178; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Hashizume K, 2005, NATURE, V434, P619, DOI 10.1038/nature03432; LETZELTER C, 1987, CHEM PHYS, V114, P273, DOI 10.1016/0301-0104(87)80117-9; LEVELT PF, 1992, J CHEM PHYS, V97, P7160, DOI 10.1063/1.463540; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; MCKEEGAN KD, 2008, LUNAR PLANET, V39, pA2020; NAVON O, 1985, EARTH PLANET SC LETT, V73, P1, DOI 10.1016/0012-821X(85)90030-5; Pandey A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206584; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021; SHI XY, 2009, LUN PLAN SCI C, V40, pA2251; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Ubachs W, 2000, J CHEM PHYS, V113, P547, DOI 10.1063/1.481830; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	18	16	16	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934								10.1126/science.1170488	http://dx.doi.org/10.1126/science.1170488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541978				2022-12-28	WOS:000267130600022
J	Federman, SR; Young, ED				Federman, S. R.; Young, E. D.			Comment on "Experimental Test of Self-Shielding in Vacuum Ultraviolet Photodissociation of CO"	SCIENCE			English	Editorial Material							OSCILLATOR-STRENGTHS; PREDISSOCIATION; (CO)-C-12-O-16; (CO)-C-13-O-18; TRANSITIONS	Chakraborty et al. (Reports, 5 September 2008, p. 1328) suggested that experimental results provide support for CO photodissociation having caused the oxygen isotope ratio associated with the early solar nebula. We point out that further analysis is required before other mechanisms, such as self-shielding, are shown to be of little importance.	[Federman, S. R.] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Young, E. D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University System of Ohio; University of Toledo; University of California System; University of California Los Angeles	Federman, SR (corresponding author), Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA.	steven.federman@utoledo.edu	Yin, Qing-Zhu/B-8198-2009; Shi, Xiaoyu/D-4682-2017	Yin, Qing-Zhu/0000-0002-4445-5096; Shi, Xiaoyu/0000-0002-9634-2659; Young, Edward/0000-0002-1299-0801				Chakraborty S, 2008, SCIENCE, V321, P1328, DOI 10.1126/science.1159178; Eidelsberg M, 2006, ASTROPHYS J, V647, P1543, DOI 10.1086/505486; Eidelsberg M, 2004, ASTRON ASTROPHYS, V424, P355, DOI 10.1051/0004-6361:20041017; Federman SR, 2003, ASTROPHYS J, V591, P986, DOI 10.1086/375483; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Sheffer Y, 2002, ASTROPHYS J, V574, pL171, DOI 10.1086/342501; Ubachs W, 2000, J CHEM PHYS, V113, P547, DOI 10.1063/1.481830; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877	9	16	16	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934								10.1126/science.1169923	http://dx.doi.org/10.1126/science.1169923			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541978				2022-12-28	WOS:000267130600021
J	Zimmer, SM; Burke, DS				Zimmer, Shanta M.; Burke, Donald S.			Historical Perspective - Emergence of Influenza A (H1N1) Viruses	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SWINE INFLUENZA; GENETIC RELATEDNESS; UNITED-STATES; NEUTRALIZING ANTIBODIES; NORTH-AMERICA; NEW-JERSEY; FORT-DIX; PIGS; TRANSMISSION; EPIDEMIC		[Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Zimmer, Shanta M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Burke, DS (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, 130 Desoto St,Rm 624, Pittsburgh, PA 15261 USA.	donburke@pitt.edu		/0000-0002-5704-8094	National Institute of General Medical Sciences [1U01-GM070708]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a grant (1U01-GM070708) from the National Institute of General Medical Sciences and by the Bill and Melinda Gates Foundation.	[Anonymous], MMWR MORB MORTAL WKL; Campitelli L, 1997, VIROLOGY, V232, P310, DOI 10.1006/viro.1997.8514; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DIMOCK WW, 1919, J AM VET MED ASSOC, V54, P321; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; GARTEN RJ, 2009, SCIENCE         0522; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; KANEGAE Y, 1994, ARCH VIROL, V134, P17, DOI 10.1007/BF01379103; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; KENDAL AP, 1978, VIROLOGY, V89, P632, DOI 10.1016/0042-6822(78)90207-6; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kilbourne ED, 2003, P NATL ACAD SCI USA, V100, P764, DOI 10.1073/pnas.162366899; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; KLUSKA V, 1961, Cesk Pediatr, V16, P408; Koen J.S., 1919, AM J VET MED ASSOC, V14, P468; Laidlaw PP, 1935, LANCET, V1, P1118; Lessler J, 2007, J R SOC INTERFACE, V4, P755, DOI 10.1098/rsif.2007.0228; MARKS JS, 1980, JAMA-J AM MED ASSOC, V243, P2490, DOI 10.1001/jama.243.24.2490; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; NAKAJIMA K, 1984, VIROLOGY, V139, P194, DOI 10.1016/0042-6822(84)90341-6; NARDELLI L, 1978, ZBL VET MED B, V25, P853; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; SALK JE, 1949, AM J PUBLIC HEALTH, V39, P345; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1931, SCIENCE, V73, P214, DOI 10.1126/science.73.1886.214; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; SHU LL, 1994, VIROLOGY, V202, P825, DOI 10.1006/viro.1994.1404; SMITH TF, 1976, NEW ENGL J MED, V294, P708, DOI 10.1056/NEJM197603252941308; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Vincent AL, 2006, VET MICROBIOL, V118, P212, DOI 10.1016/j.vetmic.2006.07.017; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WELLS DL, 1991, JAMA-J AM MED ASSOC, V265, P478, DOI 10.1001/jama.265.4.478; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; 2009, MMWR MORB MORTAL WKL, V58, P435	49	234	269	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					279	285		10.1056/NEJMra0904322	http://dx.doi.org/10.1056/NEJMra0904322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470LL	19564632	Bronze			2022-12-28	WOS:000267976100009
J	Kagansky, A; Folco, HD; Almeida, R; Pidoux, AL; Boukaba, A; Simmer, F; Urano, T; Hamilton, GL; Allshire, RC				Kagansky, Alexander; Folco, Hernan Diego; Almeida, Ricardo; Pidoux, Alison L.; Boukaba, Abdelhalim; Simmer, Femke; Urano, Takeshi; Hamilton, Georgina L.; Allshire, Robin C.			Synthetic Heterochromatin Bypasses RNAi and Centromeric Repeats to Establish Functional Centromeres	SCIENCE			English	Article							FISSION YEAST; CHROMATIN; RECRUITMENT; REQUIREMENT; DISTINCT; PROTEIN	In the central domain of fission yeast centromeres, the kinetochore is assembled on CENP-A(Cnp1) nucleosomes. Normally, small interfering RNAs generated from flanking outer repeat transcripts direct histone H3 lysine 9 methyltransferase Clr4 to homologous loci to form heterochromatin. Outer repeats, RNA interference (RNAi), and centromeric heterochromatin are required to establish CENP-AC(np1) chromatin. We demonstrated that tethering Clr4 via DNA-binding sites at euchromatic loci induces heterochromatin assembly, with or without active RNAi. This synthetic heterochromatin completely substitutes for outer repeats on plasmid-based minichromosomes, promoting de novo CENP-A(Cnp1) and kinetochore assembly, to allow their mitotic segregation, even with RNAi inactive. Thus, the role of outer repeats in centromere establishment is simply the provision of RNAi substrates to direct heterochromatin formation; H3K9 methylation-dependent heterochromatin is alone sufficient to form functional centromeres.	[Kagansky, Alexander; Folco, Hernan Diego; Almeida, Ricardo; Pidoux, Alison L.; Boukaba, Abdelhalim; Simmer, Femke; Hamilton, Georgina L.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6938501, Japan	University of Edinburgh; Shimane University	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Kagansky, Alexander/B-3137-2011; Simmer, Femke/N-2150-2015	Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625; Urano, Takeshi/0000-0003-3383-3554	European Molecular Biology Organization Long Term Fellowship; Medical Research Council [G0301153]; Wellcome Trust Programme [065061/Z]; MRC [G0301153] Funding Source: UKRI	European Molecular Biology Organization Long Term Fellowship(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the following colleagues for strains and reagents, M. Baum, L. Clarke, K. Scott, J. Partridge, J. Ma, S. Grewal, D. Moazed, K. Takahashi, M. Yanagida, and S. A. White. This research was supported by a European Molecular Biology Organization Long Term Fellowship (to F.S.), a Medical Research Council Strategic Grant (G0301153 to R.C.A.), and a Wellcome Trust Programme grant (065061/Z to R.C.A.). R.C.A. is a Wellcome Trust Principal Research Fellow.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	16	122	123	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1716	1719		10.1126/science.1172026	http://dx.doi.org/10.1126/science.1172026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556509	Green Accepted			2022-12-28	WOS:000267338200042
J	Stappenbeck, TS; Miyoshi, H				Stappenbeck, Thaddeus S.; Miyoshi, Hiroyuki			The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair	SCIENCE			English	Review							LIMB REGENERATION; GENE-EXPRESSION; SKIN; MODELS; MOUSE; TRANSDIFFERENTIATION; DIFFERENTIATION; SPECIFICATION; MACROPHAGES; IDENTITY	The process of wound repair in epithelium-lined organs of mammals is complex and is influenced by numerous secreted factors including cytokines, growth factors, and chemokines. However, the cellular organizers of this process are still not understood. Recent studies of tissue regeneration in organisms with simpler development have uncovered details about the activity of stem cells in the mesenchyme (the blastema) during this process. These blastemal cells are well positioned to interpret cues from the environment and to execute decisions about the direction of wound repair. In mammalian wounds, stromal stem cells appear to be positioned to perform functions similar to those of blastemal cells, including communication with both the overlying epithelium and the inflammatory cells in the mesenchyme.	[Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	stappenb@pathology.wustl.edu		Miyoshi, Hiroyuki/0000-0001-7400-0714				Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Carlson B. M., 2007, PRINCIPLES REGENERAT; CELSUS AC, 1935, MEDICINE, V1, P219; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Doherty JM, 2008, STEM CELLS, V26, P2124, DOI 10.1634/stemcells.2008-0380; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kumar V, 2008, ROBBINS COTRAN PATHO; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; ORMEROD LD, 1989, INVEST OPHTH VIS SCI, V30, P2148; PARK HS, 1995, AM J PATHOL, V147, P1416; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; RANDOLPH H, 1892, J MORPHOL, V7, P317, DOI DOI 10.1002/JMOR.1050070304; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Wilson SE, 2003, METH MOLEC MED, V78, P67; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Zhang SH, 2006, J CELL BIOCHEM, V99, P1132, DOI 10.1002/jcb.20949	61	245	271	7	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1666	1669		10.1126/science.1172687	http://dx.doi.org/10.1126/science.1172687			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556498				2022-12-28	WOS:000267338200027
J	Iglehart, JK				Iglehart, John K.			A New Era of For-Profit Hospice Care - The Medicare Benefit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Back AL, 2009, ARCH INTERN MED, V169, P474, DOI 10.1001/archinternmed.2008.583; Medicare Payment Advisory Commission, 2009, REP C MED PAYM POL; *NAT HOSP PALL CAR, NAT END OF LIF ORG R	3	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2701	2703		10.1056/NEJMp0902437	http://dx.doi.org/10.1056/NEJMp0902437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461RC	19553645				2022-12-28	WOS:000267286600004
J	de Koning-Ward, TF; Gilson, PR; Boddey, JA; Rug, M; Smith, BJ; Papenfuss, AT; Sanders, PR; Lundie, RJ; Maier, AG; Cowman, AF; Crabb, BS				de Koning-Ward, Tania F.; Gilson, Paul R.; Boddey, Justin A.; Rug, Melanie; Smith, Brian J.; Papenfuss, Anthony T.; Sanders, Paul R.; Lundie, Rachel J.; Maier, Alexander G.; Cowman, Alan F.; Crabb, Brendan S.			A newly discovered protein export machine in malaria parasites	NATURE			English	Article							PLASMODIUM-FALCIPARUM; TARGETING SIGNAL; BINDING PROTEIN; VIRULENCE; SURFACE; TRAFFICKING; COMPLEXES; INVASION; ANTIGEN; CYTOADHERENCE	Several hundred malaria parasite proteins are exported beyond an encasing vacuole and into the cytosol of the host erythrocyte, a process that is central to the virulence and viability of the causative Plasmodium species. The trafficking machinery responsible for this export is unknown. Here we identify in Plasmodium falciparum a translocon of exported proteins (PTEX), which is located in the vacuole membrane. The PTEX complex is ATP-powered, and comprises heat shock protein 101 (HSP101; a ClpA/B-like ATPase from the AAA+ superfamily, of a type commonly associated with protein translocons), a novel protein termed PTEX150 and a known parasite protein, exported protein 2 (EXP2). EXP2 is the potential channel, as it is the membrane-associated component of the core PTEX complex. Two other proteins, a new protein PTEX88 and thioredoxin 2 (TRX2), were also identified as PTEX components. As a common portal for numerous crucial processes, this translocon offers a new avenue for therapeutic intervention.	[de Koning-Ward, Tania F.; Gilson, Paul R.; Boddey, Justin A.; Rug, Melanie; Smith, Brian J.; Papenfuss, Anthony T.; Sanders, Paul R.; Lundie, Rachel J.; Maier, Alexander G.; Cowman, Alan F.; Crabb, Brendan S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds, Vic 3217, Australia; [Gilson, Paul R.; Crabb, Brendan S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia	Walter & Eliza Hall Institute; Deakin University; Burnet Institute	Crabb, BS (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	crabb@burnet.edu.au	Crabb, Brendan/F-5287-2013; Smith, Brian J/F-8282-2011; de Koning-Ward, Tania F/N-3572-2017; Cowman, Alan F/C-7642-2013; Rug, Melanie/A-9504-2011; Maier, Alex G/A-6499-2009; Rug, Melanie/B-5417-2015; Papenfuss, Anthony T/C-6297-2008	Smith, Brian J/0000-0003-0498-1910; de Koning-Ward, Tania F/0000-0001-5810-8063; Cowman, Alan F/0000-0001-5145-9004; Maier, Alex G/0000-0001-7369-1058; Papenfuss, Anthony T/0000-0002-1102-8506; Boddey, Justin/0000-0001-7322-2040	NHMRC IRIISS [361646, 361637]; NIH [RO1 AI44008]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044008] Funding Source: NIH RePORTER	NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Australian Red Cross Blood Bank for the provision of human blood and serum. We thank J. McBride, A. Lupas, A. Diemand, M. T. O'Neill, M. Brown, P. Cannon, S. Charnaud, R. Moritz, S. Haase, R. Waller, G. McFadden, G. Cantin and J. Yates for provision of reagents and/or other assistance with some aspects of this study. We are especially grateful to S. Muller for sharing unpublished images and data. This work was supported by NHMRC, by a grant from the NIH (RO1 AI44008) and by infrastructure support from NHMRC IRIISS (361646 and 361637) and Victorian State Government OIS grants. J. A. B. is an NHMRC Peter Doherty postdoctoral fellow, A. G. M. is an ARC Research fellow and A. F. C. is an International Research Scholar of the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Banumathy G, 2002, J BIOL CHEM, V277, P3902, DOI 10.1074/jbc.M110513200; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fischer K, 1998, MOL BIOCHEM PARASIT, V92, P47, DOI 10.1016/S0166-6851(97)00224-7; Freyer B, 1998, PARASITOL RES, V84, P583, DOI 10.1007/s004360050453; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutensohn M, 2006, J PLANT PHYSIOL, V163, P333, DOI 10.1016/j.jplph.2005.11.009; HALL R, 1983, MOL BIOCHEM PARASIT, V7, P247, DOI 10.1016/0166-6851(83)90025-7; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	45	325	330	1	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					945	U66		10.1038/nature08104	http://dx.doi.org/10.1038/nature08104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536257	Green Accepted			2022-12-28	WOS:000267063500034
J	Waters, DJ				Waters, Daniel J.			Heart, Attacked	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dwaters@mcclinic.com							0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2423	2423		10.1001/jama.2009.808	http://dx.doi.org/10.1001/jama.2009.808			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531772				2022-12-28	WOS:000267028100001
J	Rehm, J; Mathers, C; Popova, S; Thavorncharoensap, M; Teerawattananon, Y; Patra, J				Rehm, Juergen; Mathers, Colin; Popova, Svetlana; Thavorncharoensap, Montarat; Teerawattananon, Yot; Patra, Jayadeep			Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders	LANCET			English	Article							RISK-FACTORS; DRINKING; CONSUMPTION; POPULATION; NUTRITION; PATTERNS; TOBACCO; DRUGS	Alcohol consumption has been identified as an important risk factor for chronic disease and injury. in the first paper in this Series, we quantify the burden of mortality and disease attributable to alcohol, both globally and for ten large countries. We assess alcohol exposure and prevalence of alcohol-use disorders on the basis of reviews of published work. After identification of other major disease categories causally linked to alcohol, we estimate attributable fractions by sex, age, and WHO region. Additionally, we compare social costs of alcohol in selected countries. The net effect of alcohol consumption on health is detrimental, with an estimated 3.8% of all global deaths and 4.6% of global disability-adjusted life-years attributable to alcohol. Disease burden is closely related to average volume of alcohol consumption, and, for every unit of exposure, is strongest in poor people and in those who are marginalised from society. The costs associated with alcohol amount to more than 1% of the gross national product in high-income and middle-income countries, with the costs of social harm constituting a major proportion in addition to health costs. Overall, we conclude that alcohol consumption is one of the major avoidable risk factors, and actions to reduce burden and costs associated with alcohol should be urgently increased.	[Rehm, Juergen; Popova, Svetlana; Patra, Jayadeep] Ctr Addict & Mental Hlth, Publ Hlth & Regulatory Policies, Toronto, ON M5S 2S1, Canada; [Rehm, Juergen; Popova, Svetlana] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] WHO, Collaborat Ctr Subst Abuse, Zurich, Switzerland; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, Klin Psychol & Psychotherapie, Dresden, Germany; [Mathers, Colin] WHO, Dept Hlth Stat, CH-1211 Geneva, Switzerland; [Popova, Svetlana] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Thavorncharoensap, Montarat; Teerawattananon, Yot] Minist Publ Hlth, Nonthaburi, Thailand; [Thavorncharoensap, Montarat] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10700, Thailand	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; World Health Organization; Technische Universitat Dresden; World Health Organization; University of Toronto; Ministry of Public Health - Thailand; Mahidol University	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Publ Hlth & Regulatory Policies, 33 Russell St,Room 2035B, Toronto, ON M5S 2S1, Canada.	jtrehm@aol.com	Rem, Jürgen/H-1309-2011; Rehm, Jürgen/K-2147-2012; Rao, Rahul/P-7158-2014	Rehm, Jürgen/0000-0001-5665-0385; Teerawattananon, Yot/0000-0003-2217-2930; Mathers, Colin/0000-0002-0617-6731	WHO; Swiss Federal Office of Public Health; Centre for Addiction and Mental Health, Toronto, Canada	WHO(World Health Organization); Swiss Federal Office of Public Health; Centre for Addiction and Mental Health, Toronto, Canada	The comparative risk assessments for alcohol for 2000 and 2002 underlying this study have been Supported by WHO and by the Swiss Federal Office of Public Health to the first author. The specific work for this study has been supported by the Centre for Addiction and Mental Health, Toronto, Canada. We thank Robert Beaglehole for his sustained support and comments throughout the whole process of preparing the paper; Sally Casswell, Fotis Kanteres, Dan Chisholm, Peter Anderson, and Robin Room for their detailed comments during various stages of the preparation of the paper; and six anonymous reviewers for their very helpful and constructive comments in the review process.	ANDERSEN P, 2006, ALCOHOL EUROPE; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Babor Thomas F., 2003, ALCOHOL ORDINARY COM; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Begg S., 2007, BURDEN DIS INJURY AU; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chung Woo-Jin, 2006, J Prev Med Public Health, V39, P21; Collins D., 2002, COUNTING COST ESTIMA; COLLINS D, 1996, SOCIAL COSTS DRUG AB; DELVIN NJ, 1997, ADDICTION, V92, P1491; English D.R., 1995, QUANTIFICATION DRUG; Ezzati M, 2004, COMP QUANTIFICATION; Fenoglio P, 2003, EUR ADDICT RES, V9, P18, DOI 10.1159/000067730; Frentzel-Beyme R, 2001, INT J HYG ENVIR HEAL, V204, P81, DOI 10.1078/1438-4639-00077; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Hanson DJ., 1995, PREVENTING ALCOHOL A; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Harwood H., 1998, NIH PUBLICATION; International Monetary Fund, WORLD EC OUTL DAT 20; Johansson P., 2006, SOCIAL COSTS ALCOHOL; KEHOE T, 2007, GLOBAL BURDEN ALCOHO; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mathers C, 2003, GLOBAL BURDEN ALCOHO; MEZEY E, 1991, SEMIN LIVER DIS, V11, P340, DOI 10.1055/s-2008-1040451; Mill J. S., 1967, SYSTEM LOGIC RATIOCI; Murray, 2002, SUMMARY MEASURES POP, P205; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Prasad R, 2009, LANCET, V373, P17, DOI 10.1016/S0140-6736(08)61939-X; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; REHM J, 1995, ADDICTION, V90, P471, DOI 10.1046/j.1360-0443.1995.9044712.x; Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731; Rehm J., 2006, COSTS SUBSTANCE ABUS; REHM J, 2008, INT ENCY PUBLIC HLTH, P135; REHM J, INT J METHO IN PRESS; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J., 2006, ALCOHOL CONSUMPTION; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Rehm J, 2007, J STUD ALCOHOL DRUGS, V68, P886, DOI 10.15288/jsad.2007.68.886; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rumpf HJ, 2002, ALCOHOL ALCOHOLISM, V37, P261, DOI 10.1093/alcalc/37.3.261; Rush B., 1785, INQUIRY EFFECTS ARDE; SCHMIDT LA, PRIORITY PU IN PRESS; Single E., 2003, INT GUIDELINES ESTIM, V2nd ed.; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P39; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; THAVORNCHAROENS.M, 2008, EC COSTS ALC CONS TH; The United Nations Population Division, 2007, WORLD POP PROSP 2006; Ustun TB., 2003, HLTH SYSTEMS PERFORM; Varney SJ, 2002, PHARMACOECONOMICS, V20, P891, DOI 10.2165/00019053-200220130-00003; WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; WHO, 2004, GLOB STAT REP ALC 20; *WHO, 2006, 2 WHO EXP COMM PROBL; *WHO REG OFFF S E, 2006, PUBL HLTH PROBL CAUS; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2007, INT CLASS DIS REL HL; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	65	2293	2350	8	326	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2223	2233		10.1016/S0140-6736(09)60746-7	http://dx.doi.org/10.1016/S0140-6736(09)60746-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560604				2022-12-28	WOS:000267444500035
J	Maji, SK; Perrin, MH; Sawaya, MR; Jessberger, S; Vadodaria, K; Rissman, RA; Singru, PS; Nilsson, KPR; Simon, R; Schubert, D; Eisenberg, D; Rivier, J; Sawchenko, P; Vale, W; Riek, R				Maji, Samir K.; Perrin, Marilyn H.; Sawaya, Michael R.; Jessberger, Sebastian; Vadodaria, Krishna; Rissman, Robert A.; Singru, Praful S.; Nilsson, K. Peter R.; Simon, Rozalyn; Schubert, David; Eisenberg, David; Rivier, Jean; Sawchenko, Paul; Vale, Wylie; Riek, Roland			Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules	SCIENCE			English	Article							MOLECULAR-ORGANIZATION; PROLACTIN GRANULES; PROTEIN; BIOGENESIS; GLYCOSAMINOGLYCANS; SYNUCLEIN; PATHWAYS; FIBRILS; HEPARIN; ATT-20	Amyloids are highly organized cross-beta-sheet-rich protein or peptide aggregates that are associated with pathological conditions including Alzheimer's disease and type II diabetes. However, amyloids may also have a normal biological function, as demonstrated by fungal prions, which are involved in prion replication, and the amyloid protein Pmel17, which is involved in mammalian skin pigmentation. We found that peptide and protein hormones in secretory granules of the endocrine system are stored in an amyloid-like cross-beta-sheet-rich conformation. Thus, functional amyloids in the pituitary and other organs can contribute to normal cell and tissue physiology.	[Maji, Samir K.; Riek, Roland] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Perrin, Marilyn H.; Rivier, Jean; Sawchenko, Paul; Vale, Wylie] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Jessberger, Sebastian; Vadodaria, Krishna] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Rissman, Robert A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Singru, Praful S.] Tufts Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02111 USA; [Nilsson, K. Peter R.; Simon, Rozalyn] Linkoping Univ, IFM, Dept Chem, SE-58183 Linkoping, Sweden; [Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California San Diego; Tufts Medical Center; Linkoping University; Salk Institute	Riek, R (corresponding author), ETH, Phys Chem Lab, Wolfgang Paulistr 10, CH-8093 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Maji, Samir K. K./B-9640-2019; Vadodaria, Krishna C./H-1711-2017; Jessberger, Sebastian/AAJ-4032-2020	Maji, Samir K. K./0000-0002-9110-1565; Vadodaria, Krishna C./0000-0002-3455-0209; Riek, Roland/0000-0002-6333-066X; Jessberger, Sebastian/0000-0002-0056-8275	Swiss National Foundation; Clayton Medical Research Foundation Inc.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [PO1 DK026741-29]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Clayton Medical Research Foundation Inc.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Swiss National Foundation, Clayton Medical Research Foundation Inc., and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant PO1 DK026741-29	Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Arvan P, 2002, CURR OPIN CELL BIOL, V14, P448, DOI 10.1016/S0955-0674(02)00344-7; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; CARLSON SS, 1983, J BIOL CHEM, V258, P1082; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dannies PS, 2001, MOL CELL ENDOCRINOL, V177, P87, DOI 10.1016/S0303-7207(01)00437-3; FARQUHAR MG, 1971, SUBCELLULAR ORG FUNC, P79; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; GIANNATTASIO G, 1975, J CELL BIOL, V64, P246, DOI 10.1083/jcb.64.1.246; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GUMBINER B, 1981, P NATL ACAD SCI-BIOL, V78, P318, DOI 10.1073/pnas.78.1.318; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hook V, 2008, BIOL CHEM, V389, P993, DOI 10.1515/BC.2008.124; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Keeler C, 2004, J MOL NEUROSCI, V22, P43, DOI 10.1385/JMN:22:1-2:43; KELLY RB, 1987, NATURE, V326, P14, DOI 10.1038/326014a0; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Liu YB, 1998, J NEUROCHEM, V71, P2322; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2008, PLOS BIOL, V6, P240, DOI 10.1371/journal.pbio.0060017; MILLER F, 1966, J CELL BIOL, V31, P349, DOI 10.1083/jcb.31.2.349; Miller M, 2008, ENDOCRINOLOGY, V149, P4158, DOI 10.1210/en.2007-1760; MOORE HP, 1983, NATURE, V302, P434, DOI 10.1038/302434a0; Onoue S, 2004, PHARM RES, V21, P1274, DOI 10.1023/B:PHAM.0000033016.36825.2c; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; ROSA P, 1983, EUR J CELL BIOL, V31, P94; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yonemoto IT, 2008, BIOCHEMISTRY-US, V47, P9900, DOI 10.1021/bi800828u; ZANINI A, 1980, J CELL BIOL, V86, P260, DOI 10.1083/jcb.86.1.260	37	720	736	1	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					328	332		10.1126/science.1173155	http://dx.doi.org/10.1126/science.1173155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19541956	Green Accepted			2022-12-28	WOS:000268036600048
J	Opigo, J; Woodrow, C				Opigo, Jimmy; Woodrow, Charles			NECT trial: more than a small victory over sleeping sickness	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; COMBINATION THERAPY; EFLORNITHINE; MELARSOPROL; UGANDA; CONGO		[Woodrow, Charles] Univ London, Ctr Infect, Dept Cellular & Mol Med, London SW17 0RE, England; [Opigo, Jimmy] Moyo Dist Local Govt, Directorate Dist Hlth Serv, Moyo, Uganda; [Woodrow, Charles] Mahidol Univ, Fac Trop Med, MORU, Bangkok, Thailand	University of London; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Woodrow, C (corresponding author), Univ London, Ctr Infect, Dept Cellular & Mol Med, London SW17 0RE, England.	charlie@tropmedres.ac		Woodrow, Charles/0000-0002-5134-7165				Balasegaram M, 2009, T ROY SOC TROP MED H, V103, P280, DOI 10.1016/j.trstmh.2008.09.005; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Checchi F, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000064; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Priotto G, 2007, CLIN INFECT DIS, V45, P1435, DOI 10.1086/522982; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Robays J, 2008, EMERG INFECT DIS, V14, P966, DOI 10.3201/eid1406.071266; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; 2008, BBC WORLD NEWS  1011	12	17	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					7	9		10.1016/S0140-6736(09)61163-6	http://dx.doi.org/10.1016/S0140-6736(09)61163-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19559477				2022-12-28	WOS:000267768800007
J	Agarwal, N; Lamichhane, G; Gupta, R; Nolan, S; Bishai, WR				Agarwal, Nisheeth; Lamichhane, Gyanu; Gupta, Radhika; Nolan, Scott; Bishai, William R.			Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; PHAGOSOME MATURATION; INFECTION; TRANSCRIPTION; MURINE; GENES; LUNGS; GRANULOMAS; EXPANSION; ARREST	With 8.9 million new cases and 1.7 million deaths per year, tuberculosis is a leading global killer that has not been effectively controlled(1,2). The causative agent, Mycobacterium tuberculosis, proliferates within host macrophages where it modifies both its intracellular and local tissue environment, resulting in caseous granulomas with incomplete bacterial sterilization(3,4). Although infection by various mycobacterial species produces a cyclic AMP burst within macrophages that influences cell signalling, the underlying mechanism for the cAMP burst remains unclear(5-7). Here we show that among the 17 adenylate cyclase genes present in M. tuberculosis, at least one (Rv0386) is required for virulence. Furthermore, we demonstrate that the Rv0386 adenylate cyclase facilitates delivery of bacterial-derived cAMP into the macrophage cytoplasm. Loss of Rv0386 and the intramacrophage cAMP it delivers results in reductions in TNF-alpha production via the protein kinase A and cAMP response-element-binding protein pathway, decreased immunopathology in animal tissues, and diminished bacterial survival. Direct intoxication of host cells by bacterial-derived cAMP may enable M. tuberculosis to modify both its intracellular and tissue environments to facilitate its long-term survival.	[Agarwal, Nisheeth; Lamichhane, Gyanu; Gupta, Radhika; Nolan, Scott; Bishai, William R.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Bishai, WR (corresponding author), Johns Hopkins Sch Med, Dept Med, CRB2,Room 1-08,1550 Orleans St, Baltimore, MD 21231 USA.	wbishai@jhmi.edu		Gupta, Radhika/0000-0002-0445-0194; Lamichhane, Gyanu/0000-0002-2214-0114	National Institutes of Health (NIH) [AI30036, AI36973, AI37856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI036973, R01AI030036, R01AI036973, R01AI037856] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The support of National Institutes of Health (NIH) awards AI30036, AI36973 and AI37856 is gratefully acknowledged.	Agarwal N, 2007, INFECT IMMUN, V75, P452, DOI 10.1128/IAI.01395-06; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Bohme E, 1974, Methods Enzymol, V38, P27; Chakravarty SD, 2008, INFECT IMMUN, V76, P916, DOI 10.1128/IAI.01011-07; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Higashida H, 2002, ANAL BIOCHEM, V308, P106, DOI 10.1016/S0003-2697(02)00237-3; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Roach SK, 2005, INFECT IMMUN, V73, P514, DOI 10.1128/IAI.73.1.514-522.2005; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; von Knethen A, 2000, MOL CELL BIOCHEM, V212, P35, DOI 10.1023/A:1007124203607; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; WRIGHT A, LANCET IN PRESS, DOI DOI 10.1016/S0140-6736(09)60331-7	34	161	168	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					98	U112		10.1038/nature08123	http://dx.doi.org/10.1038/nature08123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19516256				2022-12-28	WOS:000267545200037
J	Dagan, T; Martin, W				Dagan, Tal; Martin, William			Seeing Green and Red in Diatom Genomes	SCIENCE			English	Editorial Material							EVOLUTION; SEQUENCE		[Dagan, Tal; Martin, William] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Dagan, T (corresponding author), Univ Dusseldorf, Inst Bot 3, Univ Str 1, D-40225 Dusseldorf, Germany.	w.martin@uni-duesseldorf.de	Martin, William/C-5680-2008; Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449; Dagan, Tal/0000-0002-9042-192X				Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; ROGOZIN IB, 2009, GENOME BIOL EVOL, P99, DOI DOI 10.1093/GBE/EVP011; Sanchez-Puerta MV, 2008, J PHYCOL, V44, P1097, DOI 10.1111/j.1529-8817.2008.00559.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796	15	22	24	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1651	1652		10.1126/science.1175765	http://dx.doi.org/10.1126/science.1175765			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556490				2022-12-28	WOS:000267338200019
J	Postberg, F; Kempf, S; Schmidt, J; Brilliantov, N; Beinsen, A; Abel, B; Buck, U; Srama, R				Postberg, F.; Kempf, S.; Schmidt, J.; Brilliantov, N.; Beinsen, A.; Abel, B.; Buck, U.; Srama, R.			Sodium salts in E-ring ice grains from an ocean below the surface of Enceladus	NATURE			English	Article							WATER; ORIGIN; DUST; VICINITY; PLUME; LIFE	Saturn's moon Enceladus emits plumes of water vapour and ice particles from fractures near its south pole(1-5), suggesting the possibility of a subsurface ocean(5-7). These plume particles are the dominant source of Saturn's E ring(7,8). A previous in situ analysis(9) of these particles concluded that the minor organic or siliceous components, identified in many ice grains, could be evidence for interaction between Enceladus' rocky core and liquid water(9,10). It was not clear, however, whether the liquid is still present today or whether it has frozen. Here we report the identification of a population of E-ring grains that are rich in sodium salts (similar to 0.5-2% by mass), which can arise only if the plumes originate from liquid water. The abundance of various salt components in these particles, as well as the inferred basic pH, exhibit a compelling similarity to the predicted composition of a subsurface Enceladus ocean in contact with its rock core(11). The plume vapour is expected to be free of atomic sodium. Thus, the absence of sodium from optical spectra(12) is in good agreement with our results. In the E ring the upper limit for spectroscopy(12) is insufficiently sensitive to detect the concentrations we found.	[Postberg, F.] Heidelberg Univ, Inst Geowissensch, D-69120 Heidelberg, Germany; [Postberg, F.; Kempf, S.; Srama, R.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Kempf, S.] Tech Univ Carolo Wilhelmina Braunschweig, IGEP, D-38106 Braunschweig, Germany; [Schmidt, J.] Univ Potsdam, D-14476 Potsdam, Germany; [Brilliantov, N.] Univ Leicester, Dept Math, Leicester LE1 7RH, Leics, England; [Brilliantov, N.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119991, Russia; [Beinsen, A.; Abel, B.] Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany; [Abel, B.] Univ Leipzig, Wilhelm Oswald Inst Phys & Theoret Chem, D-04103 Leipzig, Germany; [Buck, U.] Max Planck Inst Dynam & Selbstorg, D-37073 Gottingen, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Braunschweig University of Technology; University of Potsdam; University of Leicester; Lomonosov Moscow State University; University of Gottingen; Leipzig University; Max Planck Society	Postberg, F (corresponding author), Heidelberg Univ, Inst Geowissensch, D-69120 Heidelberg, Germany.	frank.postberg@mpi-hd.mpg.de	Brilliantov, Nikolay V./A-7423-2014; Beinsen, Alexander/E-6188-2011; Postberg, Frank/AAE-6295-2019	Brilliantov, Nikolay V./0000-0002-7107-0693; Postberg, Frank/0000-0002-5862-4276; KEMPF, SASCHA/0000-0001-5236-3004	DLR; DFG; Frontier programme of the University of Heidelberg.	DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); DFG(German Research Foundation (DFG)); Frontier programme of the University of Heidelberg.	We thank U. Beckmann, M. Burger, M. Burton, M. Gellert, E. Grun, J. K. Hillier, N. Schneider, F. Spahn, and M. Zolotov for discussions. We acknowledge the efforts of the Cassini team and JPL. The work has been supported by the DLR, the DFG and the Frontier programme of the University of Heidelberg.	Buck U, 1998, J PHYS CHEM A, V102, P7333, DOI 10.1021/jp982357j; Charvat A, 2007, PHYS CHEM CHEM PHYS, V9, P3335, DOI 10.1039/b615114k; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; DZIDIC I, 1970, J PHYS CHEM-US, V74, P1466, DOI 10.1021/j100702a013; Frohn A., 2000, EXP FLUID MECH, DOI 10.1007/978-3-662-04040-9; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; HARDER H, 1967, NATURWISSENSCHAFTEN, V54, P613, DOI 10.1007/BF00591420; Hillier JK, 2007, MON NOT R ASTRON SOC, V377, P1588, DOI 10.1111/j.1365-2966.2007.11710.x; Kempe S, 2002, ASTROBIOLOGY, V2, P123, DOI 10.1089/153110702753621394; Kempf S, 2008, ICARUS, V193, P420, DOI 10.1016/j.icarus.2007.06.027; KEMPF S, ICARUS UNPUB; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Matson DL, 2007, ICARUS, V187, P569, DOI 10.1016/j.icarus.2006.10.016; McKay CP, 2008, ASTROBIOLOGY, V8, P909, DOI 10.1089/ast.2008.0265; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2008, ICARUS, V193, P438, DOI 10.1016/j.icarus.2007.09.001; POSTBERG F, PLANET SPAC IN PRESS; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; SCHULZ CP, 1986, PHYS REV LETT, V57, P1703, DOI 10.1103/PhysRevLett.57.1703; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Steinbach C, 2005, PHYS CHEM CHEM PHYS, V7, P986, DOI 10.1039/b419325n; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Zolotov MY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031234	27	303	309	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1098	1101		10.1038/nature08046	http://dx.doi.org/10.1038/nature08046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553992				2022-12-28	WOS:000267636700036
J	Santner, A; Estelle, M				Santner, Aaron; Estelle, Mark			Recent advances and emerging trends in plant hormone signalling	NATURE			English	Review							F-BOX PROTEINS; EARLY SEEDLING DEVELOPMENT; ABSCISIC-ACID RECEPTOR; AUXIN RESPONSE FACTORS; CHELATASE H-SUBUNIT; AUX/IAA PROTEINS; GENE FAMILY; TRANSCRIPTIONAL REPRESSION; GIBBERELLIN RECEPTORS; ARABIDOPSIS-THALIANA	Plant growth and development is regulated by a structurally unrelated collection of small molecules called plant hormones. During the last 15 years the number of known plant hormones has grown from five to at least ten. Furthermore, many of the proteins involved in plant hormone signalling pathways have been identified, including receptors for many of the major hormones. Strikingly, the ubiquitin-proteasome pathway plays a central part in most hormone-signalling pathways. In addition, recent studies confirm that hormone signalling is integrated at several levels during plant growth and development.	[Estelle, Mark] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Santner, Aaron] Mol Kinet Inc, Indianapolis, IN 46268 USA	University of California System; University of California San Diego	Estelle, M (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mestelle@ucsd.edu	Estelle, Mark/ABD-6742-2021		NIH [GM43644]; NSF [IOS 0744800]; DOE [DE-FG02-02ER15312]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	Work in M. E.'s laboratory was supported by grants from the NIH (GM43644), the NSF (IOS 0744800), and the DOE ( DOE DE-FG02-02ER15312) to M. E.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Browse J, 2005, VITAM HORM, V72, P431, DOI 10.1016/S0083-6729(05)72012-4; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chow B, 2006, GENE DEV, V20, P1998, DOI 10.1101/gad.1432806; Davies Peter J., 1995, P1; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dharmasiri S, 2002, PLANT MOL BIOL, V49, P401, DOI 10.1023/A:1015203013208; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Feraru E, 2008, PLANT PHYSIOL, V147, P1553, DOI 10.1104/pp.108.121756; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Grun S, 2006, J EXP BOT, V57, P507, DOI 10.1093/jxb/erj053; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Hayashi K, 2008, P NATL ACAD SCI USA, V105, P5632, DOI 10.1073/pnas.0711146105; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Jun JH, 2008, CELL MOL LIFE SCI, V65, P743, DOI 10.1007/s00018-007-7411-5; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Mouchel CF, 2006, NATURE, V443, P458, DOI 10.1038/nature05130; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Ongaro V, 2008, J EXP BOT, V59, P67, DOI 10.1093/jxb/erm134; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Risk JM, 2009, PLANT PHYSIOL, V150, P6, DOI 10.1104/pp.109.135749; ROMAN G, 1995, GENETICS, V139, P1393; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Schwechheimer C, 2009, CURR OPIN PLANT BIOL, V12, P57, DOI 10.1016/j.pbi.2008.09.004; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Symons GM, 2008, J EXP BOT, V59, P17, DOI 10.1093/jxb/erm098; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tan X, 2009, AM J PHYSIOL-ENDOC M, V296, pE223, DOI 10.1152/ajpendo.90807.2008; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Tsuchisaka A, 2004, P NATL ACAD SCI USA, V101, P2275, DOI 10.1073/pnas.0308515101; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vandenbussche F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-65; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Vert G, 2008, P NATL ACAD SCI USA, V105, P9829, DOI 10.1073/pnas.0803996105; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhao YD, 2008, CURR OPIN PLANT BIOL, V11, P16, DOI 10.1016/j.pbi.2007.10.008	95	644	702	20	316	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1071	1078		10.1038/nature08122	http://dx.doi.org/10.1038/nature08122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553990				2022-12-28	WOS:000267636700032
J	Silverman, EK; Sandhaus, RA				Silverman, Edwin K.; Sandhaus, Robert A.			Alpha(1)-Antitrypsin Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VOLUME-REDUCTION SURGERY; AIR-FLOW OBSTRUCTION; ALPHA-1-ANTITRYPSIN DEFICIENCY; LIVER-DISEASE; AUGMENTATION THERAPY; LUNG TRANSPLANTATION; MZ HETEROZYGOTES; SINGLE-LUNG; DIAGNOSIS	A 60-year-old white man presents for evaluation of progressive dyspnea. He is a former smoker with a 20-pack-year smoking history and a 10-year history of diagnosed chronic obstructive pulmonary disease (COPD). There is no family history of COPD. Severe airflow obstruction is seen on spirometry, with a forced expiratory volume in 1 second (FEV1) that is 40% of the predicted value. Should the patient be evaluated for alpha(1)-antitrypsin (AAT) deficiency? If AAT deficiency is documented, how should his case be managed?	[Silverman, Edwin K.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Silverman, Edwin K.] Harvard Univ, Sch Med, Boston, MA USA; [Sandhaus, Robert A.] Natl Jewish Hlth, Div Pulm, Denver, CO USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Jewish Health	Silverman, EK (corresponding author), Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA.	ed.silverman@channing.harvard.edu	Shawcross, Debbie Lindsay/H-9669-2012; McElvaney, Noel/A-6809-2010	Shawcross, Debbie Lindsay/0000-0001-6133-4619; 	GlaxoSmithKline; AstraZeneca and serving on advisory boards for the Alpha-1 Foundation; Kamada; Biotherapeutics; CSL Behring	GlaxoSmithKline(GlaxoSmithKline); AstraZeneca and serving on advisory boards for the Alpha-1 Foundation; Kamada; Biotherapeutics; CSL Behring	Dr. Silverman reports receiving grant support, consulting fees, and honoraria from GlaxoSmithKline and consulting fees and honoraria from AstraZeneca and serving on advisory boards for the Alpha-1 Foundation; and Dr. Sandhaus, receiving grant support from Kamada, Talecris Biotherapeutics, and CSL Behring and honoraria for consulting or lectures from Kamada, Dey, Talecris Biotherapeutics, and CSL Behring, with all fees and honoraria donated to AlphaNet, and receiving compensation for his part-time position as medical director of the Alpha-1 Foundation and AlphaNet and for serving on an advisory board at AlphaNet. The Alpha-1 Foundation and AlphaNet are not-forprofit organizations that receive funding from donors that include companies making products for the treatment of AAT deficiency.; We thank Drs. Dawn DeMeo, Michael Krowka, Ronald Sokol, Francine Jacobson, Robert Senior, Jeffrey Teckman, Charlie Strange, John Pierce, and James Stoller for their helpful discussions.	Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Bernspang E, 2007, RESP MED, V101, P1971, DOI 10.1016/j.rmed.2007.04.003; Borawski J, 2003, RENAL FAILURE, V25, P589, DOI 10.1081/JDI-120022550; Brantly M, 2006, CLIN CHEM, V52, P2180, DOI 10.1373/clinchem.2006.078907; Burton CM, 2005, J HEART LUNG TRANSPL, V24, P1834, DOI 10.1016/j.healun.2005.03.001; Campos MA, 2005, CHEST, V128, P1179, DOI 10.1378/chest.128.3.1179; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Cassivi SD, 2002, ANN THORAC SURG, V74, P1663, DOI 10.1016/S0003-4975(02)04064-X; Coakley RJ, 2001, AM J MED SCI, V321, P33, DOI 10.1097/00000441-200101000-00006; de Serres FJ, 2002, CHEST, V122, P1818, DOI 10.1378/chest.122.5.1818; Demeo DL, 2009, HUM HERED, V67, P38, DOI 10.1159/000164397; DeMeo DL, 2007, THORAX, V62, P806, DOI 10.1136/thx.2006.075846; Demeo DL, 2008, AM J RESP CELL MOL, V38, P114, DOI 10.1165/rcmb.2007-0107OC; DeMeo DL, 2004, THORAX, V59, P259, DOI 10.1136/thx.2003.006502; Dirksen A, 1999, AM J RESP CRIT CARE, V160, P1468, DOI 10.1164/ajrccm.160.5.9901055; DIRKSEN A, 2009, EUR RESP J      0205; ERIKKSON SG, 1985, SCAND J GASTROENTERO, V20, P907, DOI 10.3109/00365528509088844; ERIKSSON S, 1987, ACTA MED SCAND, V221, P461; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Hashimoto A, 2005, J HIGH ENERGY PHYS; HERBETH B, 1981, CLIN CHIM ACTA, V112, P293, DOI 10.1016/0009-8981(81)90452-6; Hersh CP, 2004, THORAX, V59, P843, DOI 10.1136/thx.2004.022541; Ioachimescu Octavian C, 2005, COPD, V2, P263; JANOFF A, 1977, AM REV RESPIR DIS, V116, P65; Kohnlein T, 2008, AM J MED, V121, P3, DOI 10.1016/j.amjmed.2007.07.025; Mayer Annyce S, 2006, Int J Chron Obstruct Pulmon Dis, V1, P485, DOI 10.2147/copd.2006.1.4.485; Mazodier P, 1996, QJM-INT J MED, V89, P599; McElvaney NG, 1997, CHEST, V111, P394, DOI 10.1378/chest.111.2.394; OBRIEN ML, 1978, J PEDIATR-US, V92, P1006, DOI 10.1016/S0022-3476(78)80388-6; Parfrey H, 2003, INT J BIOCHEM CELL B, V35, P1009, DOI 10.1016/S1357-2725(02)00250-9; Parr DG, 2007, AM J RESP CRIT CARE, V176, P1215, DOI 10.1164/rccm.200703-489OC; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Regev A, 2006, J PEDIATR GASTR NUTR, V43, pS30, DOI 10.1097/01.mpg.0000226387.56612.1e; Requena L, 2001, J AM ACAD DERMATOL, V45, P325, DOI 10.1067/mjd.2001.114735; Sandhaus RA, 2008, CHEST, V134, P831, DOI 10.1378/chest.08-0868; Schenkein JG, 2008, CHEST, V133, P767, DOI 10.1378/chest.07-0996; Seersholm N, 1997, EUR RESPIR J, V10, P2260, DOI 10.1183/09031936.97.10102260; SILVERMAN EK, 1989, AM REV RESPIR DIS, V140, P961, DOI 10.1164/ajrccm/140.4.961; SMITH KC, 1987, ARCH DERMATOL, V123, P1655, DOI 10.1001/archderm.123.12.1655; STERNBERG JC, 1977, CLIN CHEM, V23, P1456; Stoller JK, 2005, CHEST, V128, P1989, DOI 10.1378/chest.128.4.1989; Stoller JK, 2003, CHEST, V123, P1425, DOI 10.1378/chest.123.5.1425; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Turino GM, 1996, AM J RESP CRIT CARE, V154, P1718, DOI 10.1164/ajrccm.154.6.8970361; Tutic M, 2004, J THORAC CARDIOV SUR, V128, P408, DOI 10.1016/j.jtcvs.2004.03.040; Vreim CE, 1998, AM J RESP CRIT CARE, V158, P49; Wencker M, 2001, CHEST, V119, P737, DOI 10.1378/chest.119.3.737; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704	52	272	280	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2749	2757		10.1056/NEJMcp0900449	http://dx.doi.org/10.1056/NEJMcp0900449			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553648				2022-12-28	WOS:000267286600009
J	Xu, XD; Yao, W; Sun, B; Steel, DG; Bracker, AS; Gammon, D; Sham, LJ				Xu, Xiaodong; Yao, Wang; Sun, Bo; Steel, Duncan G.; Bracker, Allan S.; Gammon, Daniel; Sham, L. J.			Optically controlled locking of the nuclear field via coherent dark-state spectroscopy	NATURE			English	Article							SINGLE QUANTUM DOTS; ELECTRON-SPIN; MAGNETIC-RESONANCE; MANIPULATION	A single electron or hole spin trapped inside a semiconductor quantum dot forms the foundation for many proposed quantum logic devices(1-6). In group III-V materials, the resonance and coherence between two ground states of the single spin are inevitably affected by the lattice nuclear spins through the hyperfine interaction(7-9), while the dynamics of the single spin also influence the nuclear environment(10-15). Recent efforts(12,16) have been made to protect the coherence of spins in quantum dots by suppressing the nuclear spin fluctuations. However, coherent control of a single spin in a single dot with simultaneous suppression of the nuclear fluctuations has yet to be achieved. Here we report the suppression of nuclear field fluctuations in a singly charged quantum dot to well below the thermal value, as shown by an enhancement of the single electron spin dephasing time T-2*, which we measure using coherent dark-state spectroscopy. The suppression of nuclear fluctuations is found to result from a hole-spin assisted dynamic nuclear spin polarization feedback process, where the stable value of the nuclear field is determined only by the laser frequencies at fixed laser powers. This nuclear field locking is further demonstrated in a three-laser measurement, indicating a possible enhancement of the electron spin T-2* by a factor of several hundred. This is a simple and powerful method of enhancing the electron spin coherence time without use of 'spin echo'-type techniques(8,12). We expect that our results will enable the reproducible preparation of the nuclear spin environment for repetitive control and measurement of a single spin with minimal statistical broadening.	[Xu, Xiaodong; Sun, Bo; Steel, Duncan G.] Univ Michigan, Harrison M Randall Lab Phys, Ann Arbor, MI 48109 USA; [Bracker, Allan S.; Gammon, Daniel] USN, Res Lab, Washington, DC 20375 USA; [Sham, L. J.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Yao, Wang] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China	University of Michigan System; University of Michigan; United States Department of Defense; United States Navy; Naval Research Laboratory; University of California System; University of California San Diego; University of Hong Kong	Steel, DG (corresponding author), Univ Michigan, Harrison M Randall Lab Phys, Ann Arbor, MI 48109 USA.	dst@umich.edu	Yao, Wang/C-1353-2008	Yao, Wang/0000-0003-2883-4528; Sham, Lu/0000-0001-5718-2077	US ARO; AFOSR; ONR; NSA/LPS; FOCUS-NSF	US ARO; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR(Office of Naval Research); NSA/LPS(National Security Agency); FOCUS-NSF	We thank P. L. McEuen, L.- M. Duan, and D. Kim for discussions. This work is supported by US ARO, AFOSR, ONR, NSA/LPS, and FOCUS-NSF.	Alen B, 2003, APPL PHYS LETT, V83, P2235, DOI 10.1063/1.1609243; Baugh J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.096804; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Braun PF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.116601; Eble B, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.081306; Eble B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146601; Fischer J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.155329; Gammon D, 1997, SCIENCE, V277, P85, DOI 10.1126/science.277.5322.85; Gammon D, 2002, PHYS TODAY, V55, P36, DOI 10.1063/1.1522165; Gerardot BD, 2008, NATURE, V451, P441, DOI 10.1038/nature06472; Greilich A, 2007, SCIENCE, V317, P1896, DOI 10.1126/science.1146850; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Kikkawa JM, 2000, SCIENCE, V287, P473, DOI 10.1126/science.287.5452.473; Kim D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.236804; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Koudinov AV, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241305; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Maletinsky P, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035409; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Scheibner M, 2008, NAT PHYS, V4, P291, DOI 10.1038/nphys882; Stepanenko D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136401; Tartakovskii AI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026806; VINK IT, 2009, LOCKING ELECT SPINS; Ware ME, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177403; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401; Xu XD, 2007, SCIENCE, V317, P929, DOI 10.1126/science.1142979	30	186	186	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1105	1109		10.1038/nature08120	http://dx.doi.org/10.1038/nature08120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553994				2022-12-28	WOS:000267636700038
J	Munthe-Fog, L; Hummelshoj, T; Honore, C; Madsen, HO; Permin, H; Garred, P				Munthe-Fog, Lea; Hummelshoj, Tina; Honore, Christian; Madsen, Hans O.; Permin, Henrik; Garred, Peter			Immunodeficiency Associated with FCN3 Mutation and Ficolin-3 Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HAKATA ANTIGEN; H-FICOLIN; BINDING; POLYMORPHISMS; DISEASE; FAMILY	Ficolin-3, encoded by the FCN3 gene and expressed in the lung and liver, is a recognition molecule in the lectin pathway of the complement system. Heterozygosity for an FCN3 frameshift mutation (rs28357092), leading to a distortion of the C-terminal end of the molecule, occurs in people without disease (allele frequency among whites, 0.01). We describe a patient with recurrent infections who was homozygous for this mutation, who had undetectable serum levels of ficolin-3, and who had a deficiency in ficolin-3-dependent complement activation.	[Munthe-Fog, Lea; Hummelshoj, Tina; Honore, Christian; Madsen, Hans O.; Garred, Peter] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol,Sect 7631, DK-2100 Copenhagen O, Denmark; [Permin, Henrik] Bispebjerg Hosp, Dept Lung Dis L, DK-2400 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Garred, P (corresponding author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol,Sect 7631, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	garred@post5.tele.dk	Madsen, Hans O/Q-2035-2015	Madsen, Hans O/0000-0001-5551-4787; Munthe-Fog, Lea/0000-0003-1345-176X; Garred, Peter/0000-0002-2876-8586; Honore, Christian/0000-0003-4846-1319	University of Copenhagen, Capital Region of Denmark; Alfred Benzon Foundation; Lundbeck Foundation; Carlsberg Foundation; John and Birthe Meyer Foundation	University of Copenhagen, Capital Region of Denmark; Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); John and Birthe Meyer Foundation	Supported by grants from the University of Copenhagen, Capital Region of Denmark, the Alfred Benzon Foundation, the Lundbeck Foundation, the Carlsberg Foundation, and the John and Birthe Meyer Foundation.	Akaiwa M, 1999, J HISTOCHEM CYTOCHEM, V47, P777, DOI 10.1177/002215549904700607; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; INABA S, 1990, Fukuoka Acta Medica, V81, P284; Jonsson G, 2005, MEDICINE, V84, P23, DOI 10.1097/01.md.0000152371.22747.1e; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2003, INT IMMUNOL, V15, P109, DOI 10.1093/intimm/dxg008; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Marquart HV, 2007, CLIN IMMUNOL, V124, P33, DOI 10.1016/j.clim.2007.03.547; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang CC, 2007, CLIN CHEM, V53, P42, DOI 10.1373/clinchem.2007.074401	23	125	131	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2637	2644		10.1056/NEJMoa0900381	http://dx.doi.org/10.1056/NEJMoa0900381			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535802	Bronze			2022-12-28	WOS:000267060000008
J	Cho, Y; Challa, S; Moquin, D; Genga, R; Ray, TD; Guildford, M; Chan, FKM				Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Ray, Tathagat Dutta; Guildford, Melissa; Chan, Francis Ka-Ming			Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation	CELL			English	Article							NF-KAPPA-B; RECEPTOR-INTERACTING PROTEIN; DEATH DOMAIN KINASE; NONAPOPTOTIC CELL-DEATH; RIP-LIKE KINASE; TNF; APOPTOSIS; ACTIVATION; IDENTIFICATION; INDUCTION	Programmed necrosis is a form of caspase-independent cell death whose molecular regulation is poorly understood. The kinase RIP1 is crucial for programmed necrosis, but also mediates activation of the prosurvival transcription factor NF-kappa B. We postulated that additional molecules are required to specifically activate programmed necrosis. Using a RNA interference screen, we identified the kinase RIP3 as a crucial activator for programmed necrosis induced by TNF and during virus infection. RIP3 regulates necrosis-specific RIP1 phosphorylation. The phosphorylation of RIP1 and RIP3 stabilizes their association within the pronecrotic complex, activates the pronecrotic kinase activity, and triggers downstream reactive oxygen species production. The pronecrotic RIP1-RIP3 complex is induced during vaccinia virus infection. Consequently, RIP3(-/-) mice exhibited severely impaired virus-induced tissue necrosis, inflammation, and control of viral replication. Our findings suggest that RIP3 controls programmed necrosis by initiating the pronecrotic kinase cascade, and that this is necessary for the inflammatory response against virus infections.	[Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Ray, Tathagat Dutta; Guildford, Melissa; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Cho, YoungSik; Challa, Sreerupa; Moquin, David; Ray, Tathagat Dutta; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Immunol & Virol Program, Worcester, MA 01655 USA; [Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Ctr AIDS Res, Worcester, MA 01655 USA; [Cho, YoungSik] Korea Res Inst Chem Technol, Ctr Metab Syndrome Therapeut, Bioorgan Sci Div, Taejon 305600, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Korea Research Institute of Chemical Technology (KRICT)	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, 55 Lake Ave N, Worcester, MA 01655 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; 	National Institutes of Health [AI065877, AI17672]; Diabetes Endocrinology Research Center [DK32520]; Smith Family Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017672, R01AI017672, R21AI065877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Smith Family Foundation; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI065877 (F. K. C.) and AI17672 (R. Welsh) and departmental startup fund (to F. K. C.). Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were also used. F. K. C. was a recipient of investigator awards from the Smith Family Foundation and the Cancer Research Institute. Wethank M. Wu and M. Harrington for the RIP3 cDNAs, V. Dixit for the RIP3<SUP>-/-</SUP> mice, and members of the Pathology Department, E. Baehrecke, and A. Winoto for discussion and critical reading of the manuscript.	Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; Ruby J, 1997, J EXP MED, V186, P1591, DOI 10.1084/jem.186.9.1591; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	40	1593	1672	4	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1112	1123		10.1016/j.cell.2009.05.037	http://dx.doi.org/10.1016/j.cell.2009.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524513	Bronze, Green Accepted			2022-12-28	WOS:000266916400022
J	Cocco, G; Chu, D				Cocco, Giuseppe; Chu, David			Drug Points Rimonabant may induce atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOMETABOLIC RISK-FACTORS; RANDOMIZED CONTROLLED-TRIAL; FATTY-ACIDS; OVERWEIGHT; OBESITY; BLOCKER		[Cocco, Giuseppe; Chu, David] Cardiol Off, CH-4310 Rheinfelden 1, Switzerland		Cocco, G (corresponding author), Cardiol Off, POB 119,Marktgasse 10A, CH-4310 Rheinfelden 1, Switzerland.	praxis@cocco.ch						Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; CHISTENSEN R, 2007, LANCET, V370, P1706; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; *FDA, 2007, FDA BRIEF DOC; Gelfand EV, 2006, J AM COLL CARDIOL, V47, P1919, DOI 10.1016/j.jacc.2005.12.067; GESCH B, 2000, BR J PSYCH, V181, P22; MacLean F, 1999, PHARM J, V262, P113; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Sakabe M, 2007, CIRCULATION, V116, P2101, DOI 10.1161/CIRCULATIONAHA.107.704759; Schellekens Stefanie, 2004, Eur Heart J, V25, P2164, DOI 10.1016/j.ehj.2004.09.031; Stockli R, 2008, SWISS MED FORUM, V8, P356	15	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2009	338								b1061	10.1136/bmj.b1061	http://dx.doi.org/10.1136/bmj.b1061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LK	19525304				2022-12-28	WOS:000267022200004
J	Kramer, M				Kramer, Michael			Extreme Spinning Tops	SCIENCE			English	Editorial Material							MILLISECOND PULSAR; RADIO PULSARS; BINARY-SYSTEM		[Kramer, Michael] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Kramer, Michael] Univ Manchester, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England	Max Planck Society; University of Manchester; Jodrell Bank Centre for Astrophysics	Kramer, M (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	mkramer@mpifr-bonn.mpg.de		Kramer, Michael/0000-0002-4175-2271				ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Archibald AM, 2009, SCIENCE, V324, P1411, DOI 10.1126/science.1172740; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Bisnovatyi-Kogan G. S., 1974, Soviet Astronomy, V18, P217; Chakrabarty D, 1998, NATURE, V394, P346, DOI 10.1038/28561; Chakrabarty D, 2003, NATURE, V424, P42, DOI 10.1038/nature01732; Hessels JWT, 2006, SCIENCE, V311, P1901, DOI 10.1126/science.1123430; HULSE RA, 1975, ASTROPHYS J, V195, pL51, DOI 10.1086/181708; SMARR LL, 1976, ASTROPHYS J, V207, P574, DOI 10.1086/154524; Stairs IH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.141101; van der Klis M, 2000, ANNU REV ASTRON ASTR, V38, P717, DOI 10.1146/annurev.astro.38.1.717; Wijnands R, 1998, NATURE, V394, P344, DOI 10.1038/28557	13	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1396	1397		10.1126/science.1175012	http://dx.doi.org/10.1126/science.1175012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520945				2022-12-28	WOS:000266878700028
J	Rogowski, K; Juge, F; van Dijk, J; Wloga, D; Strub, JM; Levilliers, N; Thomas, D; Bre, MH; Van Dorsselaer, A; Gaertig, J; Janke, C				Rogowski, Krzysztof; Juge, Francois; van Dijk, Juliette; Wloga, Dorota; Strub, Jean-Marc; Levilliers, Nicolette; Thomas, Daniel; Bre, Marie-Helene; Van Dorsselaer, Alain; Gaertig, Jacek; Janke, Carsten			Evolutionary Divergence of Enzymatic Mechanisms for Posttranslational Polyglycylation	CELL			English	Article							NUCLEOSOME ASSEMBLY PROTEIN; ALPHA-TUBULIN; AXONEMAL TUBULIN; BETA-TUBULIN; TETRAHYMENA-THERMOPHILA; MONOCLONAL-ANTIBODIES; MICROTUBULES; POLYGLUTAMYLATION; DIFFERENTIATION; GLYCYLATION	Polyglycylation is a posttranslational modification that generates glycine side chains on proteins. Here we identify a family of evolutionarily conserved glycine ligases that modify tubulin using different enzymatic mechanisms. In mammals, two distinct enzyme types catalyze the initiation and elongation steps of polyglycylation, whereas Drosophila glycylases are bifunctional. We further show that the human elongating glycylase has lost enzymatic activity due to two amino acid changes, suggesting that the functions of protein glycylation could be sufficiently fulfilled by monoglycylation. Depletion of a glycylase in Drosophila using RNA interference results in adult flies with strongly decreased total glycylation levels and male sterility associated with defects in sperm individualization and axonemal maintenance. A more severe RNAi depletion is lethal at early developmental stages, indicating that protein glycylation is essential. Together with the observation that multiple proteins are glycylated, our functional data point towards a general role of glycylation in protein functions.	[Rogowski, Krzysztof; van Dijk, Juliette; Janke, Carsten] Univ Montpellier 2, CRBM, CNRS, F-34293 Montpellier, France; [Rogowski, Krzysztof; van Dijk, Juliette; Janke, Carsten] Univ Montpellier I, CRBM, CNRS, F-34293 Montpellier, France; [Juge, Francois] Univ Montpellier 2, IGMM, CNRS, F-34293 Montpellier, France; [Wloga, Dorota; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Strub, Jean-Marc; Van Dorsselaer, Alain] Univ Strasbourg, LSMBO, CNRS, F-67087 Strasbourg, France; [Levilliers, Nicolette; Bre, Marie-Helene] Univ Paris 11, Lab Biol Cellulaire 4, CNRS, F-91405 Orsay, France; [Thomas, Daniel] Univ Rennes 1, CNRS, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Janke, C (corresponding author), Univ Montpellier 2, CRBM, CNRS, F-34293 Montpellier, France.	carsten.janke@crbm.cnrs.fr	Juge, François/P-2371-2017; THOMAS, Danniel/AAJ-5033-2020; Janke, Carsten/A-7279-2011; Włoga, Dorota/R-4078-2016; Gaertig, Jacek/F-1553-2010	THOMAS, Danniel/0000-0002-9650-0434; Janke, Carsten/0000-0001-7053-2000; Włoga, Dorota/0000-0003-3314-7773; Juge, Francois/0000-0001-5015-2019; Strub, Jean-Marc/0000-0001-6224-3428; Rogowski, Krzysztof/0000-0002-0206-3289	CNRS; Universities Montpellier 2 and 1; Association pour la Recherche sur le Cancer (ARC) [CR504/7817, CR504/3140, CR504/4894]; French National Research Agency (ANR) [05-JCJC-0035, 08-JCJC-0007]; Ligue contre le Cancer fellowship [JG/VP-5454]; EMBO long-term fellowship ALTF [5462006]; NSF [MBC-033965]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universities Montpellier 2 and 1; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); French National Research Agency (ANR)(French National Research Agency (ANR)); Ligue contre le Cancer fellowship; EMBO long-term fellowship ALTF; NSF(National Science Foundation (NSF))	This work was supported by the CNRS; the Universities Montpellier 2 and 1; the Association pour la Recherche sur le Cancer (ARC) awards CR504/7817 and 3140 (to C.J.) and 4894 (to F.J.); the French National Research Agency (ANR) awards 05-JCJC-0035 and 08-JCJC-0007 to C. J.; and the Ligue contre le Cancer fellowship JG/VP-5454, the EMBO long-term fellowship ALTF 5462006 to K. R. and NSF grant MBC-033965 to J. G. We thank J.-M. Donnay, G. Herrada-Aldrian, B. Lacroix, L. Linares, J.-C. Mazur, J. Miro, D. Moustapha Abba Moussa, Y. Thomas (CRBM, Montpellier, France), V. Backer, J. Cau, S. DeRossi, P. Travo (RIO Imaging facility at the CRBM), and U. Rothbauer (ChromoTek GmbH, Martinsried, Germany) for technical assistance and C. Cazevieille (CRIC, Montpellier, France) for technical assistance and helping us to interpret the ultrastructural data. We are grateful to M. Bosch-Grau, A. Burgess, B. Edde, B. Lacroix, M. M. Magiera, J. Miro, A. C. Seixas (CRBM), M. Bettencourt-Dias (Instituto Gulbenkian de Ciencia, Oeiras, Portugal), M. Knop, I. Mattaj (EMBL, Heidelberg, Germany), and C. Sardet (IGMM, Montpellier, France) for instructive discussions. The authors want to thank the following researchers for providing essential reagents: C. Dehay (Institute of Brain and Stem Cell Research, INSERM, Bron, France) for proving us with rhesus sperm samples, M. Gorovsky (University of Rochester, Rochester, NY, USA) for his generous gift of the polyG and polyE antibodies, and Y. Ishimi (MitsubishiKasei Institute of Life Sciences, Tokyo, Japan) for kindly providing mAb 4A8. The monoclonal antibody 12G10 developed by J. Frankel and M. Nelson was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa.	BELL PB, 1995, SCANNING MICROSCOPY, V9, P843; Bre MH, 1996, J CELL SCI, V109, P727; Bre MH, 1998, MOL BIOL CELL, V9, P2655, DOI 10.1091/mbc.9.9.2655; BRESSAC C, 1995, EUR J CELL BIOL, V67, P346; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; EDDE B, 1987, DEV BIOL, V123, P549, DOI 10.1016/0012-1606(87)90413-1; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; ISHIMI Y, 1985, CELL STRUCT FUNCT, V10, P373, DOI 10.1247/csf.10.373; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kann ML, 1998, CELL MOTIL CYTOSKEL, V41, P341; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; LEVILLIERS N, 1995, J CELL SCI, V108, P3013; Mans DA, 2008, BBA-REV CANCER, V1786, P114, DOI 10.1016/j.bbcan.2008.02.002; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; Schneider A, 1997, J CELL SCI, V110, P431; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vinh J, 1999, BIOCHEMISTRY-US, V38, P3133, DOI 10.1021/bi982304s; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097; Xie R, 2007, EUKARYOT CELL, V6, P388, DOI 10.1128/EC.00366-06	37	93	142	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1076	1087		10.1016/j.cell.2009.05.020	http://dx.doi.org/10.1016/j.cell.2009.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524510	Green Submitted, Bronze			2022-12-28	WOS:000266916400019
J	Palmer, A; Tomkinson, J; Phung, C; Ford, N; Joffres, M; Fernandes, KA; Zeng, LL; Lima, V; Montaner, JSG; Guyatt, GH; Mills, EJ				Palmer, Alexis; Tomkinson, Jocelyn; Phung, Charlene; Ford, Nathan; Joffres, Michel; Fernandes, Kimberly A.; Zeng, Leilei; Lima, Viviane; Montaner, Julio S. G.; Guyatt, Gordon H.; Mills, Edward J.			Does ratification of human-rights treaties have effects on population health?	LANCET			English	Article							ESSENTIAL MEDICINES; ACCESS	Human-rights treaties indicate a country's commitment to human rights. Here, we assess whether ratification of human-rights treaties is associated with improved health and social indicators. Data for health (including HIV prevalence, and maternal, infant, and child [<5 years] mortalities) and social indicators (child labour, human development index, sex gap, and corruption index), gathered from 170 countries, showed no consistent associations between ratification of human-rights treaties and health or social outcomes. Established market economy states had consistently improved health compared with less wealthy settings, but this was not associated with treaty ratification. The status of treaty ratification alone is not a good indicator of the realisation of the right to health. We suggest the need for stringent requirements for ratification of treaties, improved accountability mechanisms to monitor compliance of states with treaty obligations, and financial assistance to support the realisation of the right to health.	[Palmer, Alexis; Tomkinson, Jocelyn; Phung, Charlene; Ford, Nathan; Joffres, Michel; Zeng, Leilei] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Mills, Edward J.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Guyatt, Gordon H.; Mills, Edward J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; McMaster University	Mills, EJ (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	emills@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; *AMN INT, AMN INT REP 2008 STA; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; Attaran A, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.3.155; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Burris S, 2001, LANCET, V358, P1901; CHIRWA DM, OVERVIEW IMPACT INT; Erikson SL, 2008, LANCET, V371, P1229, DOI 10.1016/S0140-6736(08)60539-5; *FREED HOUS, 2006, FREED WORLD REP; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Hathaway OA, 2002, YALE LAW J, V111, P1935, DOI 10.2307/797642; Hathaway OA, 2007, J CONFLICT RESOLUT, V51, P588, DOI 10.1177/0022002707303046; Heyns C, 2001, HUM RIGHTS QUART, V23, P483, DOI 10.1353/hrq.2001.0036; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hunt P, 2006, T ROY SOC TROP MED H, V100, P603, DOI 10.1016/j.trstmh.2006.03.001; Hunt Paul, 2007, EC SOCIAL CULTURAL R; Lachin J. M., 2000, WILEY SER PROB STAT; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Neumayer E, 2005, J CONFLICT RESOLUT, V49, P43, DOI 10.1177/0022002704271057; *OFF UN HIGH COMM, 2004, STAT RAT PRINC HUM R; Ooms G, 2006, PLOS MED, V3, P2171, DOI 10.1371/journal.pmed.0030530; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Shao J, 1997, STAT SINICA, V7, P221; Singh JA, 2007, LANCET, V370, P521, DOI 10.1016/S0140-6736(07)61236-7; Tarantola Daniel, 2006, Health Hum Rights, V9, P297, DOI 10.2307/4065412; *TRANSP INT, 2006, 2006 GLOB CORR REP; *UN DEP PUBL INF, 1996, DPI1774HR UN DEP PUB; UNHCHR, 1966, INT COV EC SOC CULT; UNICEF, 2006, STAT WORLDS CHILDR 2; WHO, 2006, WHO STAT INF SYST WH; *WORLD EC FOR, 112006 WORLD EC FOR	32	44	44	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1987	1992		10.1016/S0140-6736(09)60231-2	http://dx.doi.org/10.1016/S0140-6736(09)60231-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19501746	Green Submitted			2022-12-28	WOS:000266832500034
J	Koh, J; Lim, C; Poh, A				Koh, Jansen; Lim, Cynthia; Poh, Angeline			Recurrent pneumothoraces, rash, and polyuria	LANCET			English	Editorial Material							LANGERHANS-CELL HISTIOCYTOSIS		[Koh, Jansen; Lim, Cynthia] Changi Gen Hosp, Dept Med, Singapore 529889, Singapore; [Poh, Angeline] Changi Gen Hosp, Dept Radiol, Singapore 529889, Singapore	Changi General Hospital; Changi General Hospital	Koh, J (corresponding author), Changi Gen Hosp, Dept Med, 2 Simei St 3, Singapore 529889, Singapore.	jansenkoh@gmail.com						Arico M, 2003, EUR J CANCER, V39, P2341, DOI 10.1016/S0959-8049(03)00672-5; Mogulkoc N, 1999, CHEST, V115, P1452, DOI 10.1378/chest.115.5.1452; Stockschlaeder M, 2006, EUR J HAEMATOL, V76, P363, DOI 10.1111/j.1600-0609.2006.00648.x; Tazi A, 2006, EUR RESPIR J, V27, P1272, DOI 10.1183/09031936.06.00024004; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2009	373	9682					2258	2258		10.1016/S0140-6736(09)60863-1	http://dx.doi.org/10.1016/S0140-6736(09)60863-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463PQ	19560607				2022-12-28	WOS:000267444500038
J	Charbonnel, B				Charbonnel, Bernard			PPAR-alpha and PPAR-gamma agonists for type 2 diabetes	LANCET			English	Editorial Material							EVENTS; FENOFIBRATE; MELLITUS; GLUCOSE; DEATH		Univ Nantes, Inst Thorax, Dept Endocrinol & Diabet, F-44000 Nantes, France	Nantes Universite; CHU de Nantes	Charbonnel, B (corresponding author), Univ Nantes, Inst Thorax, Dept Endocrinol & Diabet, F-44000 Nantes, France.	Bernard.Charbonnel@univ-nantes.fr						Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Fievet C, 2006, CURR OPIN PHARMACOL, V6, P606, DOI 10.1016/j.coph.2006.06.009; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gelman L, 2007, BBA-MOL CELL BIOL L, V1771, P1094, DOI 10.1016/j.bbalip.2007.03.004; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Kahn SE, 2009, JAMA-J AM MED ASSOC, V301, P1590, DOI 10.1001/jama.2009.511; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Rajamani K, 2009, LANCET, V373, P1780, DOI 10.1016/S0140-6736(09)60698-X; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460	15	24	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					96	98		10.1016/S0140-6736(09)61040-0	http://dx.doi.org/10.1016/S0140-6736(09)61040-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19515412				2022-12-28	WOS:000268111600006
J	Cahill, KS; Chi, JH; Day, A; Claus, EB				Cahill, Kevin S.; Chi, John H.; Day, Arthur; Claus, Elizabeth B.			Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTERIOR CERVICAL DISKECTOMY; LUMBAR INTERBODY FUSION; ILIAC-CREST AUTOGRAFT; LENGTH-OF-STAY; UNITED-STATES; SURGERY; ICD-9-CM; IMPACT; SAFETY; GRAFT	Context No national data exist to examine use of bone-morphogenetic proteins (BMPs) in spinal fusion surgery. Objective To determine the patterns of use and rates of complications and financial charges associated with BMP use in spinal fusion nationally. Design, Setting, and Patients Retrospective cohort study of 328 468 patients undergoing spinal fusion procedures from 2002-2006 identified from the Nationwide Inpatient Sample database, a 20% sample of US community hospitals. Main Outcome Measures The rates of use of BMP among patients undergoing spinal fusion procedures are examined along with complications, length of stay, and hospital charges associated with use of this fusion adjunct. Results The nationwide usage of BMP has increased from 0.69% of all fusions in 2002 to 24.89% of all fusions in 2006. Use of BMP varied by patient sex, race, and primary payer with increased use seen in women (56.26% with BMP vs 53.35% without BMP; odds ratio [OR], 1.12; 95% confidence interval, [CI], 1.09-1.16) and Medicare patients (29.62% with BMP vs 27.16% without BMP; OR, 1.43; 95% CI, 1.311.56) and decreased use in nonwhite patients (8.69% with BMP vs 10.23% without BMP; OR, 0.80; 95% CI, 0.75-0.85). When comparing immediate postoperative, in-hospital rates of complications for the year 2006 among patients undergoing spinal fusion by BMP use status, no differences were seen for lumbar, thoracic, or posterior cervical procedures. On univariate analysis and after multivariable adjustment, the use of BMP in anterior cervical fusion procedures was associated with a higher rate of complication occurrence (7.09% with BMP vs 4.68% without BMP; adjusted OR, 1.43; 95% CI, 1.12-1.70) with the primary increases seen in wound-related complications (1.22% with BMP vs 0.65% without BMP; adjusted OR, 1.67; 95% CI, 1.10-2.53) and dysphagia or hoarseness (4.35% with BMP vs 2.45% without BMP; adjusted OR, 1.63; 95% CI, 1.30-2.05). Bone-morphogenetic protein use was associated with greater inpatient hospital charges across all categories of fusion. Increases between 11% and 41% of total hospital charges were reported, with the greatest percentage increase seen for anterior cervical fusion. Conclusion Bone-morphogenetic protein was used in approximately 25% of all spinal fusions nationally in 2006, with use associated with more frequent complications for anterior cervical fusions and with greater hospital charges for all categories of fusions. JAMA. 2009;302(1):58-66	[Cahill, Kevin S.; Chi, John H.; Day, Arthur; Claus, Elizabeth B.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Claus, Elizabeth B.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Harvard University; Brigham & Women's Hospital; Yale University	Cahill, KS (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, PBB 3,75 Francis St, Boston, MA 02115 USA.	kcahill3@partners.org			Brain Science Foundation	Brain Science Foundation	This work was supported by the Brain Science Foundation.	Ackerman SJ, 2002, SPINE, V27, pS94, DOI 10.1097/00007632-200208151-00017; Agency for Healthcare Research and Quality, HEALTHC UT PROJ OV N; Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; Brasel KJ, 2007, ARCH SURG-CHICAGO, V142, P461, DOI 10.1001/archsurg.142.5.461; Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CYPRESS BK, 1983, AM J PUBLIC HEALTH, V73, P389, DOI 10.2105/AJPH.73.4.389; DAVIS H, 1994, SPINE, V19, P1117, DOI 10.1097/00007632-199405001-00003; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Dickerman RD, 2007, SPINE J, V7, P508, DOI 10.1016/j.spinee.2007.03.003; Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81; Friedman Bernard, 2002, J Health Care Finance, V29, P1; Glassman SD, 2008, SPINE J, V8, P443, DOI 10.1016/j.spinee.2007.03.004; Lipson SJ, 2004, NEW ENGL J MED, V350, P643, DOI 10.1056/NEJMp038162; Liu JH, 2006, JAMA-J AM MED ASSOC, V296, P1973, DOI 10.1001/jama.296.16.1973; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; McClellan JW, 2006, J SPINAL DISORD TECH, V19, P483, DOI 10.1097/01.bsd.0000211231.83716.4b; Patil PG, 2005, NEUROSURGERY, V57, P753, DOI 10.1227/01.NEU.0000175729.79119.1d; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Romano PS, 2002, MED CARE, V40, P856, DOI 10.1097/00005650-200210000-00004; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Schmidt WP, 2003, CEREBROVASC DIS, V16, P247, DOI 10.1159/000071123; Shamji MF, 2008, J NEUROSURG-SPINE, V9, P10, DOI 10.3171/SPI/2008/9/7/010; Shamji MF, 2009, SPINE J, V9, P31, DOI 10.1016/j.spinee.2008.07.005; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Tumialan LM, 2008, J NEUROSURG-SPINE, V8, P529, DOI 10.3171/SPI/2008/8/6/529; URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371; *US FDA PUBL HLTH, 2008, LIF THREAT COMPL ASS; US Food and Drug Administration, INFUSE BON GRAFT LT; US Food and Drug Administration, OP 1 PUTT H020008; Vaccaro AR, 2008, SPINE J, V8, P457, DOI 10.1016/j.spinee.2007.03.012; Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9; Wang MC, 2007, SPINE, V32, P342, DOI 10.1097/01.brs.0000254120.25411.ae; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	42	354	362	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					58	66		10.1001/jama.2009.956	http://dx.doi.org/10.1001/jama.2009.956			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567440	Bronze			2022-12-28	WOS:000267492800022
J	Lee, LM; Gostin, LO				Lee, Lisa M.; Gostin, Lawrence O.			Ethical Collection, Storage, and Use of Public Health Data A Proposal for a National Privacy Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFORMATION		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Lee, Lisa M.] Ctr Dis Control & Prevent, Atlanta, GA USA	Georgetown University; Centers for Disease Control & Prevention - USA	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044; Lee, Lisa M/0000-0002-3397-3269				*COMM HLTH RES PRI, 2009, HIPAA PRIV RUL I MED; Fairchild AL, 2007, PUBLIC HEALTH REP, V122, P7, DOI 10.1177/00333549071220S103; Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P1373, DOI 10.1001/jama.2009.424; Gostin LO, 2005, AM J PUBLIC HEALTH, V95, P576, DOI 10.2105/AJPH.2004.055152; Gostin LO, 1996, JAMA-J AM MED ASSOC, V275, P1921, DOI 10.1001/jama.275.24.1921; Hodge J.G., 2004, PUBLIC HLTH PRACTICE; Public Health Leadership Society, 2002, PRINC ETH PRACT PUBL; *WHIT HOUS, MEM HEADS EX DEP AG	8	52	52	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					82	84		10.1001/jama.2009.958	http://dx.doi.org/10.1001/jama.2009.958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567443				2022-12-28	WOS:000267492800026
J	Nash, KL; Bentley, I; Hirschfield, GM				Nash, Kathryn L.; Bentley, Ian; Hirschfield, Gideon M.			Managing hepatitis C virus infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RIBAVIRIN COMBINATION THERAPY; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; VIROLOGICAL RESPONSE; TREATMENT DURATION; HCV GENOTYPE-2; LIVER-DISEASE; INTERFERON; FIBROSIS; TRIAL		[Hirschfield, Gideon M.] Univ Toronto, Toronto Western Hosp, Dept Med, Liver Ctr, Toronto, ON M5T 2S8, Canada; [Nash, Kathryn L.] Southampton Univ Hosp, NHS Trust, Southampton, Hants, England; [Bentley, Ian] Sotuhampton Univ Hosp, Hill Lane Surg, Southampton, Hants, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Southampton	Hirschfield, GM (corresponding author), Univ Toronto, Toronto Western Hosp, Dept Med, Liver Ctr, Toronto, ON M5T 2S8, Canada.	gideon.hirschfield@uhn.on.ca	Hirschfield, Gideon M/M-2143-2015; Cummings, Mike/J-7108-2019	Hirschfield, Gideon M/0000-0002-6736-2255; Cummings, Mike/0000-0003-2224-8835				Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Ferenci P, 2008, GASTROENTEROLOGY, V135, P451, DOI 10.1053/j.gastro.2008.04.015; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2008, HEPATOLOGY, V47, P43, DOI 10.1002/hep.22061; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 2009, LIVER INT, V29, P1, DOI 10.1111/j.1478-3231.2008.01947.x; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Schaefer M, 2007, HEPATOLOGY, V46, P991, DOI 10.1002/hep.21791; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Shiffman ML, 2006, CLIN GASTROENTEROL H, V4, P645, DOI 10.1016/j.cgh.2006.02.002; Shutt James D, 2008, Br J Nurs, V17, P572; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003	30	9	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2009	339								b2366	10.1136/bmj.b2366	http://dx.doi.org/10.1136/bmj.b2366			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QW	19561051				2022-12-28	WOS:000267678400021
J	Meek, SA; Conrad, H; Meijer, G				Meek, Samuel A.; Conrad, Horst; Meijer, Gerard			Trapping Molecules on a Chip	SCIENCE			English	Article							ATOMS; TRAPS	Magnetic trapping of atoms on chips has recently become straightforward, but analogous trapping of molecules has proved to be challenging. We demonstrated trapping of carbon monoxide molecules above a chip using direct loading from a supersonic beam. Upon arrival above the chip, the molecules are confined in tubular electric field traps similar to 20 micrometers in diameter, centered 25 micrometers above the chip, that move with the molecular beam at a velocity of several hundred meters per second. An array of these miniaturized moving traps is brought to a standstill over a distance of only a few centimeters. After a certain holding time, the molecules are accelerated off the chip again for detection. This loading and detection methodology is applicable to a wide variety of polar molecules, enabling the creation of a gas-phase molecular laboratory on a chip.	[Meek, Samuel A.; Conrad, Horst; Meijer, Gerard] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Meijer, G (corresponding author), Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.	meijer@fhi-berlin.mpg.de	Meijer, Gerard/D-2141-2009	Meijer, Gerard/0000-0001-9669-8340; Meek, Samuel/0000-0003-0011-8634	European Communitys Seventh Framework Program [FP7/2007-2013, 216 774]	European Communitys Seventh Framework Program(European Commission)	We acknowledge the help of B. G. Sartakov in the calculation of the hyperfine structure of 13CO and the design of the electronics by G. Heyne, V. Platschkowski, and T. Vetter. This work has been funded by the European Communitys Seventh Framework Program FP7/2007-2013 under grant agreement 216 774.	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Campbell WC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.083003; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; GAMMON RH, 1971, J CHEM PHYS, V54, P2136, DOI 10.1063/1.1675146; Gilijamse JJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2813888; Hansel W, 2001, NATURE, V413, P498, DOI 10.1038/35097032; Hinds EA, 1999, J PHYS D APPL PHYS, V32, pR119, DOI 10.1088/0022-3727/32/18/201; Kirste M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.051401; Lara M, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033433; Meek SA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.153003; Meek SA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055024; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; Van De Meerakker SYT, 2008, NAT PHYS, V4, P595, DOI 10.1038/nphys1031; van de Meerakker SYT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.013003; WEINSTEIN JD, 1995, PHYS REV A, V52, P4004, DOI 10.1103/PhysRevA.52.4004	16	77	80	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1699	1702		10.1126/science.1175975	http://dx.doi.org/10.1126/science.1175975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556505	Green Published			2022-12-28	WOS:000267338200036
J	Tabor, JJ; Salis, HM; Simpson, ZB; Chevalier, AA; Levskaya, A; Marcotte, EM; Voigt, CA; Ellington, AD				Tabor, Jeffrey J.; Salis, Howard M.; Simpson, Zachary Booth; Chevalier, Aaron A.; Levskaya, Anselm; Marcotte, Edward M.; Voigt, Christopher A.; Ellington, Andrew D.			A Synthetic Genetic Edge Detection Program	CELL			English	Article							MYCOPLASMA-GENITALIUM GENOME; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; BACTERIOPHAGE-LAMBDA; DIRECTED EVOLUTION; CHEMICAL-SYNTHESIS; PATTERN-FORMATION; TOGGLE SWITCH; EXPRESSION; NETWORKS	Edge detection is a signal processing algorithm common in artificial intelligence and image recognition programs. We have constructed a genetically encoded edge detection algorithm that programs an isogenic community of E. coli to sense an image of light, communicate to identify the light-dark edges, and visually present the result of the computation. The algorithm is implemented using multiple genetic circuits. An engineered light sensor enables cells to distinguish between light and dark regions. In the dark, cells produce a diffusible chemical signal that diffuses into light regions. Genetic logic gates are used so that only cells that sense light and the diffusible signal produce a positive output. A mathematical model constructed from first principles and parameterized with experimental measurements of the component circuits predicts the performance of the complete program. Quantitatively accurate models will facilitate the engineering of more complex biological behaviors and inform bottom-up studies of natural genetic regulatory networks.	[Tabor, Jeffrey J.; Salis, Howard M.; Levskaya, Anselm; Voigt, Christopher A.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94158 USA; [Simpson, Zachary Booth; Chevalier, Aaron A.; Marcotte, Edward M.; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Simpson, Zachary Booth; Chevalier, Aaron A.; Marcotte, Edward M.; Ellington, Andrew D.] Univ Texas Austin, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Marcotte, Edward M.; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Voigt, CA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94158 USA.	cavoigt@picasso.ucsf.edu	Tabor, Jeffrey/A-7022-2008; Salis, Howard M/A-2495-2008	Tabor, Jeffrey/0000-0001-7316-0361; Salis, Howard/0000-0003-0411-4390; Marcotte, Edward/0000-0001-8808-180X	National Science Foundation (SynBERC) [NSF-BES0547637,]; Office of Naval Research; Pew and Packard Foundations; Kirschstein National Research Service Award;  [NIH EY016546];  [NIH AI067699];  [NIH R01GM077040]; NATIONAL EYE INSTITUTE [PN2EY016546, PN1EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067699, R56AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077040, R01GM067779, F32GM082106, R01GM076536] Funding Source: NIH RePORTER	National Science Foundation (SynBERC)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Pew and Packard Foundations; Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. A. Davidson, L. A. Lavery, M. Levy, K. McGary, and A. Scouras for helpful discussions; A. Nishimura for the JW3367 E. coli strain; and L. A. Lavery, C. Conboy, and D. Endy for assistance with Biobrick construction. This work was supported by the National Science Foundation (SynBERC), NSF-BES0547637, NIH EY016546, NIH AI067699, NIH R01GM077040, Office of Naval Research, and the Pew and Packard Foundations. J.J.T. is supported by a Kirschstein National Research Service Award.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; CHAN L, 2005, MOL SYST BIOL, V26, P787; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Endy D, 2008, SCIENCE, V319, P1196, DOI 10.1126/science.1155749; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Flagan S, 2003, APPL ENVIRON MICROB, V69, P909, DOI 10.1128/AEM.69.2.909-916.2003; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2007, BIOPHYS J, V93, pL55, DOI 10.1529/biophysj.107.118687; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; Kim JH, 2001, EXP MOL MED, V33, P83, DOI 10.1038/emm.2001.15; Kim PM, 2003, GENOME RES, V13, P2391, DOI 10.1101/gr.1207003; Knight T, 2002, IDEMPOTENT VECTOR DE; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; KOBLAN KS, 1991, BIOCHEMISTRY-US, V30, P7817, DOI 10.1021/bi00245a022; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Materna SC, 2007, CURR OPIN BIOTECH, V18, P351, DOI 10.1016/j.copbio.2007.07.008; MATURANA HUMBERTO R., 1963, SCIENCE, V142, P977, DOI 10.1126/science.142.3594.977; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rackham O, 2005, J AM CHEM SOC, V127, P17584, DOI 10.1021/ja055338d; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; SUEL M, 2000, PRACTICAL ALGORITHMS; Tabor JJ, 2008, MOL BIOSYST, V4, P754, DOI 10.1039/b801245h; Tabor JJ, 2009, SYSTEMS BIOLOGY AND BIOTECHNOLOGY OF ESCHERICHIA COLI, P401, DOI 10.1007/978-1-4020-9394-4_19; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Urbanowski AL, 2004, J BACTERIOL, V186, P631, DOI 10.1128/JB.186.3.631-637.2004; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; WEISS R, 2001, LECT NOTES COMPUTER, P1; WEISS R, 1999, DIMACS WORKSH EV COM, V1, P1; Weiss R, 2001, CELLULAR COMPUTATION; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	73	340	359	6	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1272	1281		10.1016/j.cell.2009.04.048	http://dx.doi.org/10.1016/j.cell.2009.04.048			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563759	Green Accepted, Bronze			2022-12-28	WOS:000267373400020
J	Veatch, JR; McMurray, MA; Nelson, ZW; Gottschling, DE				Veatch, Joshua R.; McMurray, Michael A.; Nelson, Zara W.; Gottschling, Daniel E.			Mitochondrial Dysfunction Leads to Nuclear Genome Instability via an Iron-Sulfur Cluster Defect	CELL			English	Article							OXIDATIVE DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; PROTEIN BIOGENESIS; BUDDING YEAST; CYTOCHROME-C; EXPRESSION; PHENOTYPE; MEMBRANE; IMPORT; GENES	Mutations and deletions in the mitochondrial genome (mtDNA), as well as instability of the nuclear genome, are involved in multiple human diseases. Here, we report that in Saccharomyces cerevisiae, loss of mtDNA leads to nuclear genome instability, through a process of cell-cycle arrest and selection we define as a cellular crisis. This crisis is not mediated by the absence of respiration, but instead correlates with a reduction in the mitochondrial membrane potential. Analysis of cells undergoing this crisis identified a defect in iron-sulfur cluster (ISC) biogenesis, which requires normal mitochondrial function. We found that downregulation of nonmitochondrial ISC protein biogenesis was sufficient to cause increased genomic instability in cells with intact mitochondrial function. These results suggest mitochondrial dysfunction stimulates nuclear genome instability by inhibiting the production of ISC-containing protein(s), which are required for maintenance of nuclear genome integrity. For a video summary of this article, see the Paper-Flick file available with the online Supplemental Data.	[Veatch, Joshua R.; McMurray, Michael A.; Nelson, Zara W.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Veatch, Joshua R.; McMurray, Michael A.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Gottschling, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	dgottsch@fhcrc.org			Aging Training [T32 AG00057]; ARCS foundation; FHCRC; National Institutes of Health [AG023779, GM43893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023779, T32AG000057, R01AG023779] Funding Source: NIH RePORTER	Aging Training; ARCS foundation; FHCRC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Foury, P. Thorsness, J. Pinkham, R. Lill, R. Tsien, and the Yeast Resource Center for reagents. We thank R. Lill and P. Thorsness for experimental advice; J. Vazquez for help with microscopy; and J. Delrow and R. Basom for help with expression array analysis. Thanks to members of the Gottschling lab for critical reading of this manuscript. This work was supported by fellowships to J. R. V. from a Genetic Approaches to Aging Training Grant (T32 AG00057) and the ARCS foundation, and FHCRC pilot project and National Institutes of Health grants (AG023779 and GM43893) to D. E. G.	Alseth I, 1999, MOL CELL BIOL, V19, P3779; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brown MA, 1997, ADV GENET, V36, P45, DOI 10.1016/S0065-2660(08)60307-7; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Church C, 1998, J EXP BIOL, V201, P1729; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.0.CO;2-L; Dagsgaard C, 2001, J BIOL CHEM, V276, P7593, DOI 10.1074/jbc.M009180200; DERISI JL, 1997, ANN MED, V37, P222; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Dunn CD, 2003, GENETICS, V165, P35; DUPONT CH, 1985, BIOCHEM BIOPH RES CO, V132, P1116, DOI 10.1016/0006-291X(85)91922-9; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0; EPHRUSSI B, 1949, ANN I PASTEUR PARIS, V76, P419; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z; FLURY F, 1976, GENETICS, V83, P645; FOURY F, 1989, J BIOL CHEM, V264, P20552; Francis BR, 2007, J BIOENERG BIOMEMBR, V39, P127, DOI 10.1007/s10863-007-9071-4; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GASSER SM, 1983, J BIOL CHEM, V258, P3427; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; JAMES AP, 1958, GENETICS, V43, P317; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KOERNER TJ, 1985, J BIOL CHEM, V260, P5871; Kominsky DJ, 2002, GENETICS, V162, P1595; KOTYLAK Z, 1977, MITOCHONDRIA 1977, P83; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; NAGLEY P, 1970, BIOCHEM BIOPH RES CO, V39, P989, DOI 10.1016/0006-291X(70)90422-5; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stevens B., 1981, MOL BIOL YEAST SACCH, V11, P471; Swayne TC, 2007, METHOD CELL BIOL, V80, P591, DOI 10.1016/S0091-679X(06)80029-4; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Zhang XT, 2001, J BIOL CHEM, V276, P47844, DOI 10.1074/jbc.M106285200	71	290	298	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1247	1258		10.1016/j.cell.2009.04.014	http://dx.doi.org/10.1016/j.cell.2009.04.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563757	Bronze, Green Accepted			2022-12-28	WOS:000267373400018
J	Loytynoja, A; Goldman, N				Loeytynoja, Ari; Goldman, Nick			Uniting Alignments and Trees	SCIENCE			English	Editorial Material							SEQUENCE ALIGNMENT; PHYLOGENY; CONFIDENCE; BOOTSTRAP; PROTEINS; SEARCH		[Loeytynoja, Ari; Goldman, Nick] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, England	European Molecular Biology Laboratory (EMBL)	Loytynoja, A (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton CB10 1SD, England.	ari@ebi.ac.uk; goldman@ebi.ac.uk		Loytynoja, Ari/0000-0001-5389-6611; Goldman, Nick/0000-0001-8486-2211	Wellcome Trust [GR078968] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; [Anonymous], 2007, TREE LIFE WEB PROJEC; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HOGEWEG P, 1984, J MOL EVOL, V20, P175, DOI 10.1007/BF02257378; Liu K, 2009, SCIENCE, V324, P1561, DOI 10.1126/science.1171243; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Whelan S, 2007, SYSTEMATIC BIOL, V56, P727, DOI 10.1080/10635150701611134; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	17	21	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1528	1529		10.1126/science.1175949	http://dx.doi.org/10.1126/science.1175949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541988				2022-12-28	WOS:000267130600033
J	Dublin, S; Jackson, ML; Nelson, JC; Weiss, NS; Larson, EB; Jackson, LA				Dublin, Sascha; Jackson, Michael L.; Nelson, Jennifer C.; Weiss, Noel S.; Larson, Eric B.; Jackson, Lisa A.			Statin use and risk of community acquired pneumonia in older people: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVES SURVIVAL; MURINE MODEL; MORTALITY; SEPSIS; INFLUENZA; THERAPY; IMPACT; HOSPITALIZATION; INFLAMMATION; INHIBITION	Objective To test the hypothesis that hydroxymethyl glutaryl coenzyme A reductase inhibitors (statin s) may decrease the risk of community acquired pneumonia. Design Population based case-control study. Setting Group Health, a large integrated healthcare delivery system. Population Immunocompetent, community dwelling Group Health members aged 65 to 94; two matched controls for each case with pneumonia. Information on comorbid illnesses and functional and cognitive status, potential confounders of the association between statin use and risk of pneumonia, came from medical record review and computerised pharmacy data. Main outcome measure Adjusted estimates of risk of pneumonia in relation to current statin use. Results 1125 validated cases of pneumonia and 2235 matched controls were identified. Compared with controls, cases were more likely to have chronic lung and heart disease, especially severe disease, and functional or cognitive impairment. Current statin use was present in 16.1% (181/1125) of cases and 14.6% (327/2235) of controls (adjusted odds ratio 1.26, 95% confidence interval 1.01 to 1.56). Among cases admitted to hospital and matched controls, current statin use was present in 17.2% (68/395) of cases and 14.2% (112/788) of controls (adjusted odds ratio 1.61, 1.08 to 2.39, compared with non-use). In people in whom statins were indicated for secondary prevention, the adjusted odds ratio for risk of pneumonia in relation to current statin use was 1.25 (0.94 to 1.67); in those with no such indication, it was 0.81 (0.46 to 1.42). Conclusions Statin use was not associated with decreased risk of pneumonia among immunocompetent, community dwelling older people. Findings of previous studies may reflect "healthy user" bias.	[Dublin, Sascha; Jackson, Michael L.; Nelson, Jennifer C.; Larson, Eric B.; Jackson, Lisa A.] Grp Hlth Ctr Hlth Studies, Seattle, WA 98101 USA; [Dublin, Sascha; Weiss, Noel S.; Jackson, Lisa A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nelson, Jennifer C.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dublin, S (corresponding author), Grp Hlth Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	dublin.s@ghc.org			National Institute on Aging [K23AG028954]; Hartford and Starr Foundations; Atlantic Philanthropies; Group Health Center for Health Studies; NATIONAL INSTITUTE ON AGING [K23AG028954] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hartford and Starr Foundations; Atlantic Philanthropies; Group Health Center for Health Studies; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SD was funded by a Paul Beeson Career Development Award from the National Institute on Aging ( grant K23AG028954). The Beeson award is also supported by the Hartford and Starr Foundations and Atlantic Philanthropies. Group Health Center for Health Studies internal funds covered the data collection and analysis. The sponsors played no role in study design; the collection, analysis or interpretation of data; the writing of the report; or in the decision to submit the manuscript for publication.	Ahmed F, 2005, J CLIN EPIDEMIOL, V58, P624, DOI 10.1016/j.jclinepi.2004.11.020; Almog Y, 2003, CHEST, V124, P740, DOI 10.1378/chest.124.2.740; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chaudhry MZ, 2008, SURG INFECT, V9, P183, DOI 10.1089/sur.2006.077; CLAUSELL N, STATIN IMMUNOMUDULAT; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DONNINO MW, STATIN THERAPY TREAT; Dunzendorfer S, 1997, CIRC RES, V81, P963; Farr BM, 2000, RESP MED, V94, P422, DOI 10.1053/rmed.1999.0743; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fessler MB, 2005, AM J RESP CRIT CARE, V171, P606, DOI 10.1164/rccm.200406-729OC; Gambassi G, 1998, ARCH INTERN MED, V158, P2377, DOI 10.1001/archinte.158.21.2377; Ganguli M, 2005, ARCH NEUROL-CHICAGO, V62, P779, DOI 10.1001/archneur.62.5.779; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; JACOBSON J, STATINS EARLY TREATM; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; LACROIX AZ, 1989, PUBLIC HEALTH REP, V104, P350; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mancini GBJ, 2007, CHEST, V131, P950, DOI 10.1378/chest.06-2838; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Novack V, 2006, CRIT CARE, V10, DOI 10.1186/cc3972; ORTIZCASTILLO F, EFFECT ROSUVASTATIN; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; SCHENK P, SIMVASTATIN PATIENTS; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; *US FDA, 2008, SENT SYST MON MED PR; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; ZAKYNTHINOS E, PRAVASTATIN VENTILAT	51	58	58	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2009	338								b2137	10.1136/bmj.b2137	http://dx.doi.org/10.1136/bmj.b2137			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UQ	19531550	hybrid, Green Published			2022-12-28	WOS:000267216600002
J	Phillips, MR; Zhang, JX; Shi, QC; Song, ZQ; Ding, ZJ; Pang, ST; Li, XY; Zhang, YL; Wang, ZQ				Phillips, Michael R.; Zhang, Jingxuan; Shi, Qichang; Song, Zhiqiang; Ding, Zhijie; Pang, Shutao; Li, Xianyun; Zhang, Yali; Wang, Zhiqing			Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey	LANCET			English	Article							HEALTH-SERVICES; SEVERITY; SCALE	Background In China and other middle-income countries, neuropsychiatric conditions are the most important cause of ill health in men and women, but efforts to scale up mental health services have been hampered by the absence of high-quality, country-specific data for the prevalence, treatment, and associated disability of different types of mental disorders. We therefore estimated these variables from a series of epidemiological studies that were done in four provinces in China. Methods We used multistage stratified random sampling methods to identify 96 urban and 267 rural primary sampling sites in four provinces of China; the sampling frame of 113 million individuals aged 18 years or older included 12% of the adult population in China. 63 004 individuals, identified with simple random selection methods at the sampling sites, were screened with an expanded version of the General Health Questionnaire and 16 577 were administered a Chinese version of the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-IV axis I disorders by a psychiatrist. Findings The adjusted 1-month prevalence of any mental disorder was 17.5% (95% CI 16.6-18.5). The prevalence of mood disorders was 6.1% (5.7-6.6), anxiety disorders was 5.6% (5.0-6.3), substance abuse disorders was 5.9% (5.3-6.5), and psychotic disorders was 1.0% (0.8-1.1). Mood disorders and anxiety disorders were more prevalent in women than in men, and in individuals 40 years and older than in those younger than 40 years. Alcohol use disorders were 48 times more prevalent in men than in women. Rural residents were more likely to have depressive disorders and alcohol dependence than were urban residents. Among individuals with a diagnosable mental illness, 24% were moderately or severely disabled by their illness, 8% had ever sought professional help, and 5% had ever seen a mental health professional. Interpretation Substantial differences between our results and prevalence, disability, and treatment rate estimates used in the analysis of global burden of disease for China draw attention to the need for low-income and middle-income countries to do detailed, country-specific situation analyses before they scale up mental health services.	[Phillips, Michael R.; Li, Xianyun; Zhang, Yali; Wang, Zhiqing] Beijing Hui Long Guan Hosp, WHO, Collaborating Ctr Res & Training Suicide Prevent, Beijing 100096, Peoples R China; [Phillips, Michael R.] Columbia Univ, Dept Psychiat, New York, NY USA; [Phillips, Michael R.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Zhang, Jingxuan] Shandong Prov Mental Hlth Ctr, Jinan, Shandong, Peoples R China; [Shi, Qichang] Li Tong De Hosp, Hangzhou, Zhejiang, Peoples R China; [Song, Zhiqiang] Peoples Hosp 3, Xining, Qinghai, Peoples R China; [Ding, Zhijie] Tianshui City Psychiat Hosp, Tianshui City, Gansu, Peoples R China; [Pang, Shutao] Qingdao Mental Hlth Ctr, Qingdao, Shandong, Peoples R China	World Health Organization; Columbia University; Columbia University	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, WHO, Collaborating Ctr Res & Training Suicide Prevent, Beijing 100096, Peoples R China.	phillipschina@yahoo.com	Phillips, Michael Robert/AAE-7585-2021; Zhang, Xiao/V-9027-2017	Phillips, Michael Robert/0000-0002-5973-2439; Zhang, Xiao/0000-0002-2932-5875	China Medical Board of New York [02-777]; Chinese Ministry of Health Mental Health Project; WHO [GL/GLO/MNH/343/XE/00.J.999.00]	China Medical Board of New York; Chinese Ministry of Health Mental Health Project; WHO(World Health Organization)	This study was done under the auspices of the Small Grants Program to Improve the Quality and Implementation of Mental Health Research in China, which was coordinated by Xue Zhang at Peking Union Medical College and MRP at Beijing Hui Long Guan Hospital, and supported by the China Medical Board of New York (grant number 02-777). The Zhejiang survey was part of the WHO and Chinese Ministry of Health Mental Health Project, and was supported by a WHO grant (GL/GLO/MNH/343/XE/00.J.999.00). The Shandong Provincial Bureau of Health also provided additional support for the survey in Shandong. We thank the participating institutions, clinicians, and individuals in Shandong, Zhejiang, Qinghai, and Gansu for their active support; and Kenneth Kendler, Colin Mathers, Darrel Regier, Norman Sartorius, and Ulrich Wittchen for their comments about the report.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; [Anonymous], 2008, LANCET, V372, P1274; [Anonymous], 1988, USERS GUIDE GEN HLTH; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [陈贺龙 Chen Helong], 2004, [中华精神科杂志, Chinese Journal of Psychiatry], V37, P172; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Cooper JE, 1996, MENTAL DISORDERS CHI; CUIPERS P, 2008, AM J PSYCHIAT, V165, P1272; CUIPERS P, 2005, J NERV MENT DIS, V193, P119; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; First MB, 2002, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hao W, 2004, ALCOHOL ALCOHOLISM, V39, P43, DOI 10.1093/alcalc/agh018; Hao W, 1999, ADDICTION, V94, P1467, DOI 10.1046/j.1360-0443.1999.941014673.x; [栗克清 LI Keqing], 2007, [中华精神科杂志, Chinese Journal of Psychiatry], V40, P36; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Pan G., 2006, CHIN J PUBLIC HLTH, V22, P1505; Phillips M.R., 2004, CHIN J NERV MENT DIS, V30, P1; Phillips MR, 2007, J AFFECT DISORDERS, V98, P73, DOI 10.1016/j.jad.2006.07.020; Phillips MR, 1998, CHINA J, V39, P1, DOI 10.2307/2667691; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; WHO, 2008, MENT HLTH GAP ACT PR; *WHO DEP MEAS HLTH, DEATH DALY EST 2004; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Health Organization, 2005, MENT HLTH ATL; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang Ting-zhong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P769; Zhang W.X., 1998, CHINESE J PSYCHIAT, V31, P69; Zhou R.Y., 1997, CHIN J PSYCHIAT, V30, P45	36	758	977	9	152	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2041	2053		10.1016/S0140-6736(09)60660-7	http://dx.doi.org/10.1016/S0140-6736(09)60660-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19524780				2022-12-28	WOS:000267080100031
J	Dieffenbach, CW; Fauci, AS				Dieffenbach, Carl W.; Fauci, Anthony S.			Universal Voluntary Testing and Treatment for Prevention of HIV Transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; VIRAL LOAD		[Dieffenbach, Carl W.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dieffenbach, CW (corresponding author), NIAID, NIH, 6700-B Rockledge Dr, Bethesda, MD 20892 USA.	cdieffenba@niaid.nih.gov						Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza P, 2008, B MED SUISSES, V89, P165; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0	13	203	207	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2380	2382		10.1001/jama.2009.828	http://dx.doi.org/10.1001/jama.2009.828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509386				2022-12-28	WOS:000266773400032
J	Kamstrup, PR; Tybjaerg-Hansen, A; Steffensen, R; Nordestgaard, BG				Kamstrup, Pia R.; Tybjaerg-Hansen, Anne; Steffensen, Rolf; Nordestgaard, Borge G.			Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; PENTANUCLEOTIDE REPEAT POLYMORPHISM; MENDELIAN RANDOMIZATION; APOLIPOPROTEIN(A) SIZE; IN-VIVO; CARDIOVASCULAR EVENTS; LP(A) LIPOPROTEIN; AORTIC INTIMA; RABBIT AORTA; APO(A) SIZE	Context High levels of lipoprotein(a) are associated with increased risk of myocardial infarction (MI). Objective To assess whether genetic data are consistent with this association being causal. Design, Setting, and Participants Three studies of white individuals from Copenhagen, Denmark, were used: the Copenhagen City Heart Study (CCHS), a prospective general population study with 16 years of follow-up (1991-2007, n=8637, 599 MI events); the Copenhagen General Population Study (CGPS), a cross-sectional general population study (2003-2006, n=29 388, 994 MI events); and the Copenhagen Ischemic Heart Disease Study (CIHDS), a case-control study (1991-2004, n=2461, 1231 MI events). Main Outcome Measures Plasma lipoprotein(a) levels, lipoprotein(a) kringle IV type 2 (KIV-2) size polymorphism genotype, and MIs recorded from 1976 through July 2007 for all participants. Results In the CCHS, multivariable-adjusted hazard ratios (HRs) for MI for elevated lipoprotein( a) levels were 1.2 (95% confidence interval [CI], 0.9-1.6; events/10 000 person-years, 59) for levels between the 22nd and 66th percentile, 1.6 (95% CI, 1.1-2.2; events/10 000 person-years, 75) for the 67th to 89th percentile, 1.9 ( 95% CI, 1.2-3.0; events/10 000 person-years, 84) for the 90th to 95th percentile, and 2.6 ( 95% CI, 1.6-4.1; events/10 000 person-years, 108) for levels greater than the 95th percentile, respectively, vs levels less than the 22nd percentile (events/10 000 person-years, 55) (trend P<.001). Numbers of KIV-2 repeats (sum of repeats on both alleles) ranged from 6 to 99 and on analysis of variance explained 21% and 27% of all variation in plasma lipoprotein(a) levels in the CCHS and CGPS, respectively. Mean lipoprotein(a) levels were 56, 31, 20, and 15 mg/dL for the first, second, third, and fourth quartiles of KIV-2 repeats in the CCHS, respectively (trend P<.001); corresponding values in the CGPS were 60, 34, 22, and 19 mg/dL (trend P<.001). In the CCHS, multivariable-adjusted HRs for MI were 1.5 (95% CI, 1.2-1.9; events/10 000 person-years, 75), 1.3 (95% CI, 1.0-1.6; events/10 000 person-years, 66), and 1.1 (95% CI, 0.9-1.4; events/10 000 person-years, 57) for individuals in the first, second, and third quartiles, respectively, as compared with individuals in the fourth quartile of KIV-2 repeats (events/10 000 person-years, 51) (trend P<.001). Corresponding odds ratios were 1.3 (95% CI, 1.1-1.5), 1.1 (95% CI, 0.9-1.3), and 0.9 (95% CI, 0.8-1.1) in the CGPS (trend P=.005), and 1.4 (95% CI, 1.1-1.7), 1.2 ( 95% CI, 1.0-1.6), and 1.3 (95% CI, 1.0-1.6) in the CIHDS (trend P=.01). Genetically elevated lipoprotein(a) was associated with an HR of 1.22 (95% CI, 1.09-1.37) per doubling of lipoprotein(a) level on instrumental variable analysis, while the corresponding value for plasma lipoprotein(a) levels on Cox regression was 1.08 (95% CI, 1.03-1.12). Conclusion These data are consistent with a causal association between elevated lipoprotein(a) levels and increased risk of MI. JAMA. 2009; 301(22):2331-2339 www.jama.com	[Kamstrup, Pia R.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Kamstrup, Pia R.; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Steffensen, Rolf] Nordsjaellands Hosp Hillerod, Dept Internal Med, Hillerod, Denmark; [Kamstrup, Pia R.; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Girelli, Domenico/B-1183-2008; Nordestgaard, Borge Gronne/ABF-1310-2020	Girelli, Domenico/0000-0001-9684-1899; Nordestgaard, Borge/0000-0002-1954-7220	Danish Heart Foundation; IMK Almene Fund; Carl-Bertil Laurell's Nordic Fund for Clinical Chemistry; Johan and Lise Boserup's Fund	Danish Heart Foundation; IMK Almene Fund; Carl-Bertil Laurell's Nordic Fund for Clinical Chemistry; Johan and Lise Boserup's Fund	The present study was supported by the Danish Heart Foundation, IMK Almene Fund, Carl-Bertil Laurell's Nordic Fund for Clinical Chemistry, and Johan and Lise Boserup's Fund.	Amemiya H, 1996, ATHEROSCLEROSIS, V123, P181, DOI 10.1016/0021-9150(96)05806-6; Ariyo AA, 2003, NEW ENGL J MED, V349, P2108, DOI 10.1056/NEJMoa001066; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Chimienti G, 2002, EXP MOL PATHOL, V73, P28, DOI 10.1006/exmp.2002.2445; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; Deb A, 2004, CLIN CARDIOL, V27, P258, DOI 10.1002/clc.4960270503; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gazzaruso C, 1999, J AM COLL CARDIOL, V33, P157, DOI 10.1016/S0735-1097(98)00541-5; Geethanjali FS, 2003, ATHEROSCLEROSIS, V169, P121, DOI 10.1016/S0021-9150(03)00143-6; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Kamstrup PR, 2008, J CLIN ENDOCR METAB, V93, P3769, DOI 10.1210/jc.2008-0830; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; KARK JD, 1993, ATHEROSCLEROSIS, V98, P139, DOI 10.1016/0021-9150(93)90124-D; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; Kraft HG, 1996, ARTERIOSCL THROM VAS, V16, P713, DOI 10.1161/01.ATV.16.6.713; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Nielsen LB, 1996, CIRC RES, V78, P615, DOI 10.1161/01.RES.78.4.615; NIELSEN LB, 1995, ARTERIOSCL THROM VAS, V15, P1492, DOI 10.1161/01.ATV.15.9.1492; Nielsen LB, 1996, J CLIN INVEST, V98, P563, DOI 10.1172/JCI118824; Nielsen LB, 1997, ARTERIOSCL THROM VAS, V17, P905, DOI 10.1161/01.ATV.17.5.905; Nielsen LB, 1998, ARTERIOSCL THROM VAS, V18, P641, DOI 10.1161/01.ATV.18.4.641; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Paultre F, 2000, ARTERIOSCL THROM VAS, V20, P2619, DOI 10.1161/01.ATV.20.12.2619; Rifai N, 2004, CLIN CHEM, V50, P1364, DOI 10.1373/clinchem.2003.030031; Rosby O, 2000, J INTERN MED, V247, P139, DOI 10.1046/j.1365-2796.2000.00628.x; SANDHOLZER C, 1992, ARTERIOSCLER THROMB, V12, P1214, DOI 10.1161/01.ATV.12.10.1214; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tate JR, 1998, CLIN CHEM, V44, P1629; Utermann G., 2001, METABOLIC MOL BASES, V8th, P2753; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239	40	786	809	3	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2331	2339		10.1001/jama.2009.801	http://dx.doi.org/10.1001/jama.2009.801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509380	Bronze			2022-12-28	WOS:000266773400026
J	Scott, IA				Scott, Ian A.			Errors in clinical reasoning: causes and remedial strategies	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; DIAGNOSTIC ERRORS; DECISION-MAKING; HEALTH-CARE; PHYSICIANS; QUALITY; CERTAINTY; AUTOPSIES; BIAS		Princess Alexandra Hosp, Dept Internal Med & Clin Epidemiol, Brisbane, Qld 4102, Australia		Scott, IA (corresponding author), Princess Alexandra Hosp, Dept Internal Med & Clin Epidemiol, Ipswich Rd, Brisbane, Qld 4102, Australia.	ian_scott@health.qld.gov.au	Scott, Ian/Z-4577-2019; Scott, Ian A/F-1482-2011	Scott, Ian/0000-0002-7596-0837				Aalten CM, 2006, NETH J MED, V64, P186; Aberegg SK, 2006, MED DECIS MAKING, V26, P575, DOI 10.1177/0272989X06295362; BAUMANN AO, 1991, SOC SCI MED, V32, P167, DOI 10.1016/0277-9536(91)90057-J; Brownlee S., 2007, OVERTREATED WHY TOO; Chellis RI, 2001, ACAD EMERG MED, V8, P125, DOI 10.1111/j.1553-2712.2001.tb01276.x; Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1111/j.1553-2712.2002.tb01574.x; Croskerry P., 2008, PATIENT SAFETY EMERG, P219; ELY JW, 1995, J FAM PRACTICE, V40, P337; Epstein RM, 2004, JAMA-J AM MED ASSOC, V291, P2359, DOI 10.1001/jama.291.19.2359; Friedman CP, 2005, J GEN INTERN MED, V20, P334, DOI 10.1111/j.1525-1497.2005.30145.x; Groves M, 2002, MED TEACH, V24, P507, DOI 10.1080/01421590220145743; KASSIRER JP, 1983, NEW ENGL J MED, V309, P921, DOI 10.1056/NEJM198310133091511; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Neale G, 2001, J ROY SOC MED, V94, P322, DOI 10.1177/014107680109400702; Podbregar M, 2001, INTENS CARE MED, V27, P1750, DOI 10.1007/s00134-001-1129-x; Scott I, 2000, CLINICAL REASONING IN THE HEALTH PROFESSIONS, 2ND EDITION, P290; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Steinman MA, 2004, AM J MED, V117, P747, DOI 10.1016/j.amjmed.2004.03.035; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x	20	75	75	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2009	338								b1860	10.1136/bmj.b1860	http://dx.doi.org/10.1136/bmj.b1860			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LF	19505957				2022-12-28	WOS:000267021700001
J	Wang, YG; Vera, L; Fischer, WH; Montminy, M				Wang, Yiguo; Vera, Liliana; Fischer, Wolfgang H.; Montminy, Marc			The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR; INSULIN; ATF6; TORC2; PROTEOLYSIS; OBESITY; CELLS; IRE1	In fasted mammals, circulating pancreatic glucagon stimulates hepatic gluconeogenesis in part through the CREB regulated transcription coactivator 2 (CRTC2, also referred to as TORC2)(1,2). Hepatic glucose production is increased in obesity, reflecting chronic increases in endoplasmic reticulum (ER) stress that promote insulin resistance(3). Whether ER stress also modulates the gluconeogenic program directly, however, is unclear. Here we show that CRTC2 functions as a dual sensor for ER stress and fasting signals. Acute increases in ER stress triggered the dephosphorylation and nuclear entry of CRTC2, which in turn promoted the expression of ER quality control genes through an association with activating transcription factor 6 alpha (ATF6 alpha, also known as ATF6)-an integral branch of the unfolded protein response(4-9). In addition to mediating CRTC2 recruitment to ER stress inducible promoters, ATF6 alpha also reduced hepatic glucose output by disrupting the CREB-CRTC2 interaction and thereby inhibiting CRTC2 occupancy over gluconeogenic genes. Conversely, hepatic glucose output was upregulated when hepatic ATF6 alpha protein amounts were reduced, either by RNA interference (RNAi)-mediated knockdown or as a result of persistent stress in obesity. Because ATF6 alpha overexpression in the livers of obese mice reversed CRTC2 effects on the gluconeogenic program and lowered hepatic glucose output, our results demonstrate how cross-talk between ER stress and fasting pathways at the level of a transcriptional coactivator contributes to glucose homeostasis.	[Wang, Yiguo; Vera, Liliana; Fischer, Wolfgang H.; Montminy, Marc] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu			National Institutes of Health; Clayton Foundation for Medical Research; Keickhefer Foundation; Vincent J. Coates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064142, R37DK083834, R01DK083834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Medical Research; Keickhefer Foundation; Vincent J. Coates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health, by the Clayton Foundation for Medical Research, by the Keickhefer Foundation, and by the Vincent J. Coates Foundation. We thank N. Miller, S. Hedrick, and Y. Liu for technical assistance and helpful discussions.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	18	211	225	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					534	U116		10.1038/nature08111	http://dx.doi.org/10.1038/nature08111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19543265	Green Accepted			2022-12-28	WOS:000268257000043
J	Steinbrook, R				Steinbrook, Robert			A Higher Bar -- Vermont's New Law on Marketing Prescribed Products.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*COMM MASS, 105CMR970000 COMM MA; SORRELL WH, 2009, PHARM MARKETING DISC; *STAT VERM, ACT REL MARK PRESCR; Steinbrook R, 2008, NEW ENGL J MED, V359, P559, DOI 10.1056/NEJMp0805309	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					8	9		10.1056/NEJMp0904719	http://dx.doi.org/10.1056/NEJMp0904719			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464UK	19516028				2022-12-28	WOS:000267533100004
J	Kurth, T; de Jong, PE; Cook, NR; Buring, JE; Ridker, PM				Kurth, Tobias; de Jong, Paul E.; Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.			Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION-RATE; LOW-DOSE ASPIRIN; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; ASSOCIATION; EVENTS; DEATH; CLASSIFICATION; DYSFUNCTION	Objective To evaluate the association of kidney function with cardiovascular disease and mortality among apparently healthy women. Design Prospective cohort study. Setting Women's Health Study, United States. Participants 27 939 female health professionals aged >= 45 who were free of cardiovascular disease and other major disease and who provided a blood sample at study entry. Main outcome measures Time to cardiovascular disease (non-fatal stroke, non-fatal myocardial infarction, coronary revascularisation procedures, or death from cardiovascular cause), specific cardiovascular disease events, and all-cause mortality. End points were confirmed after review of medical records and death certificates. Results Glomerular filtration rate (GFR) was estimated with the abbreviated Modification of Diet in Renal Disease Study equation. At baseline, 1315 (4.7%) women had GFR <60 ml/min/1.73 m(2). During 12 years of follow-up, 1199 incident cardiovascular disease events and 856 deaths (179 from cardiovascular disease) occurred. Compared with women with GFR >= 90 ml/min/1.73 m(2), the multivariable adjusted hazard ratios for any first cardiovascular disease were 0.95 (95% CI 0.83 to 1.08), 0.84 (0.70 to 1.00), and 1.00 (0.79 to 1.27) among women with GFR of 75-89.9, 60-74.9, and <60 ml/min/1.73 m(2), respectively; the equivalent hazard ratios for all cause mortality were 0.93 (0.79 to 1.09), 1.03 (0.85 to 1.26), and 1.09 (0.83 to 1.45). Similar null findings were observed for myocardial infarction, stroke, coronary revascularisation, and non-cardiovascular death. However, an increased risk of death from cardiovascular disease was found among women with GFR <60 ml/min/1.73 m(2) (hazard ratio 1.68 (1.02 to 2.79)). Conclusions In this large cohort of women, a glomerular filtration rate <60 ml/min/1.73 m(2) was associated with increased risk of cardiovascular disease death but not other cardiovascular disease events or non-cardiovascular disease mortality. We observed no increase in risk of any of the outcomes among women with less severe impairment of kidney function.	[Kurth, Tobias] Hop La Pitie Salpetriere, INSERM, U708, F-75651 Paris 13, France; [Kurth, Tobias; Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Kurth, Tobias; Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kurth, Tobias] Univ Paris 06, Fac Med, Paris, France; [de Jong, Paul E.; Ridker, Paul M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Buring, Julie E.] Brigham & Womens Hosp, Dept Med, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Cambridge, MA 02138 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Sorbonne Universite; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University	Kurth, T (corresponding author), Hop La Pitie Salpetriere, INSERM, U708, 47 Blvd Hop, F-75651 Paris 13, France.	tkurth@rics.bwh.harvard.edu	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood Institute [HL-043851, HL-080467]; National Cancer Institute [CA-047988]; Donald W Reynolds Foundation; Leducq Foundation; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Leducq Foundation(Leducq Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Health Study is supported by grants and from the National Heart, Lung, and Blood Institute (HL-043851 and HL-080467), and the National Cancer Institute (CA-047988). The research for this work was supported by grants from the Donald W Reynolds Foundation, the Leducq Foundation, and the Doris Duke Charitable Foundation. The funding sources played no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; *M, 2016, USRDS ANN DAT REP EP; McCullough PA, 2007, ARCH INTERN MED, V167, P1122, DOI 10.1001/archinte.167.11.1122; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Schaeffner ES, 2003, J AM SOC NEPHROL, V14, P2084, DOI 10.1681/ASN.V1482084; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tokmakova MP, 2004, CIRCULATION, V110, P3667, DOI 10.1161/01.CIR.0000149806.01354.BF; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	32	43	47	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2009	339								b2392	10.1136/bmj.b2392	http://dx.doi.org/10.1136/bmj.b2392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QV	19564178	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000267678300002
J	Bodenheimer, T; Grumbach, K; Berenson, RA				Bodenheimer, Thomas; Grumbach, Kevin; Berenson, Robert A.			HEALTH CARE 2009 A Lifeline for Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bodenheimer, Thomas] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.		Grumbach, Kevin/L-9222-2016					Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Council on Graduate Medical Education, 2007, 19 COUNC GRAD MED ED; *MED PAYM ADV COMM, 2009, REP C MED PAYM POL, P77; *NAT RES MATCH PRO, ADV DAT TABL 2009 MA; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	5	85	85	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2693	2696		10.1056/NEJMp0902909	http://dx.doi.org/10.1056/NEJMp0902909			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461RC	19553643				2022-12-28	WOS:000267286600001
J	Curran, SP; Wu, XY; Riedel, CG; Ruvkun, G				Curran, Sean P.; Wu, Xiaoyun; Riedel, Christian G.; Ruvkun, Gary			A soma-to-germline transformation in long-lived Caenorhabditis elegans mutants	NATURE			English	Article							LIFE-SPAN; RNA INTERFERENCE; GENE-EXPRESSION; FACTOR SKN-1; DNA-DAMAGE; DAF-16; IDENTIFICATION; LONGEVITY; CHROMATIN; TARGETS	Unlike the soma, which ages during the lifespan of multicellular organisms, the germ line traces an essentially immortal lineage. Genomic instability in somatic cells increases with age, and this decline in somatic maintenance might be regulated to facilitate resource reallocation towards reproduction at the expense of cellular senescence. Here we show that Caenorhabditis elegans mutants with increased longevity exhibit a soma-to-germline transformation of gene expression programs normally limited to the germ line. Decreased insulin-like signalling causes the somatic misexpression of the germline-limited pie-1 and pgl family of genes in intestinal and ectodermal tissues. The forkhead boxO1A (FOXO) transcription factor DAF-16, the major transcriptional effector of insulin-like signalling, regulates pie-1 expression by directly binding to the pie-1 promoter. The somatic tissues of insulin-like mutants are more germline-like and protected from genotoxic stress. Gene inactivation of components of the cytosolic chaperonin complex that induce increased longevity also causes somatic misexpression of PGL-1. These results indicate that the acquisition of germline characteristics by the somatic cells of C. elegans mutants with increased longevity contributes to their increased health and survival.	[Curran, Sean P.; Wu, Xiaoyun; Riedel, Christian G.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Curran, Sean P.; Wu, Xiaoyun; Riedel, Christian G.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Riedel, Christian/0000-0002-3689-8022	National Institutes of Health; National Institute on Aging [F32-AG026207, R01-AG016636]; European Molecular Biology Organization; Human Frontier Science Program; NATIONAL INSTITUTE ON AGING [F32AG026207, R00AG032308, R01AG016636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We thank A. Conery, H. Gabel, J. Melo, E. O'Rourke, D. Simon, A. Soukas and M. Wang for reagents, discussion and reading of the manuscript; G. Seydoux and members of the Ruvkun, Ausubel and Kaplan laboratories for discussion; S. Strome for the pie-1p::gfp::pgl-1 strain and C. Mello for monoclonal antisera against PGL-1, S. S. Lee, S. Ercan and the Kingston laboratory for technical advice on ChIP. This work was supported by grants from the National Institutes of Health and the National Institute on Aging F32-AG026207 to S. P. C. and R01-AG016636 to G. R. and the European Molecular Biology Organization and the Human Frontier Science Program to C. G. R.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BRENNER S, 1974, GENETICS, V77, P71; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Houthoofd Koen, 2007, V35, P98; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kim SH, 2007, J CELL BIOL, V179, P41, DOI 10.1083/jcb.200705182; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; O'Neil Nigel, 2006, WormBook, P1; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang D, 2004, COLD SPRING HARB SYM, V69, P429, DOI 10.1101/sqb.2004.69.429; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	49	87	108	2	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1079	U60		10.1038/nature08106	http://dx.doi.org/10.1038/nature08106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19506556	Green Accepted			2022-12-28	WOS:000267636700033
J	Cheng, S; Keyes, MJ; Larson, MG; McCabe, EL; Newton-Cheh, C; Levy, D; Benjamin, EJ; Vasan, RS; Wang, TJ				Cheng, Susan; Keyes, Michelle J.; Larson, Martin G.; McCabe, Elizabeth L.; Newton-Cheh, Christopher; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Wang, Thomas J.			Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; ATRIAL-FIBRILLATION; RISK-FACTORS; NATURAL-HISTORY; WAVE DURATION; CONDUCTION; REGURGITATION; POPULATION; PROGNOSIS; FEATURES	Context Prolongation of the electrocardiographic PR interval, known as first-degree atrioventricular block when the PR interval exceeds 200 milliseconds, is frequently encountered in clinical practice. Objective To determine the clinical significance of PR prolongation in ambulatory individuals. Design, Setting, and Participants Prospective, community-based cohort including 7575 individuals from the Framingham Heart Study (mean age, 47 years; 54% women) who underwent routine 12-lead electrocardiography. The study cohort underwent prospective follow-up through 2007 from baseline examinations in 1968-1974. Multivariable-adjusted Cox proportional hazards models were used to examine the associations of PR interval with the incidence of arrhythmic events and death. Main Outcome Measures Incident atrial fibrillation (AF), pacemaker implantation, and all-cause mortality. Results During follow-up, 481 participants developed AF, 124 required pacemaker implantation, and 1739 died. At the baseline examination, 124 individuals had PR intervals longer than 200 milliseconds. For those with PR intervals longer than 200 milliseconds compared with those with PR intervals of 200 milliseconds or shorter, incidence rates per 10 000 person-years were 140 (95% confidence interval [CI], 95-208) vs 36 (95% CI, 32-39) for AF, 59 (95% CI, 40-87) vs 6 (95% CI, 5-7) for pacemaker implantation, and 334 (95% CI, 260-428) vs 129 (95% CI, 123-135) for all-cause mortality. Corresponding absolute risk increases were 1.04% (AF), 0.53% (pacemaker implantation), and 2.05% (all-cause mortality) per year. In multivariable analyses, each 20-millisecond increment in PR was associated with an adjusted hazard ratio (HR) of 1.11 (95% CI, 1.02-1.22; P = .02) for AF, 1.22 (95% CI, 1.14-1.30; P < .001) for pacemaker implantation, and 1.08 (95% CI, 1.02-1.13; P = .005) for all-cause mortality. Individuals with first-degree atrioventricular block had a 2-fold adjusted risk of AF (HR, 2.06; 95% CI, 1.36-3.12; P < .001), 3-fold adjusted risk of pacemaker implantation (HR, 2.89; 95% CI, 1.83-4.57; P < .001), and 1.4-fold adjusted risk of all-cause mortality (HR, 1.44, 95% CI, 1.09-1.91; P = .01). Conclusion Prolongation of the PR interval is associated with increased risks of AF, pacemaker implantation, and all-cause mortality. JAMA. 2009; 301(24):2571-2577	[Cheng, Susan; McCabe, Elizabeth L.; Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cheng, Susan; Keyes, Michelle J.; Larson, Martin G.; McCabe, Elizabeth L.; Newton-Cheh, Christopher; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Wang, Thomas J.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Newton-Cheh, Christopher] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cheng, Susan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02114 USA; [Cheng, Susan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Clin Investigator Training Program, Boston, MA 02114 USA; [Keyes, Michelle J.; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; [Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University	Wang, TJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Cardiol, GRB 800,55 Fruit St, Boston, MA 02114 USA.	tjwang@partners.org	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Cheng, Susan/0000-0002-4977-036X; Wang, Thomas/0000-0003-4063-6508; Larson, Martin/0000-0002-9631-1254; Benjamin, Emelia/0000-0003-4076-2336	National Institutes of Health [N01-HC-25195];  [K24-HL-04334]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001, K24HL004334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: The Framingham Heart Study is funded by National Institutes of Health contract N01-HC-25195. Dr Vasan was supported in part by grant K24-HL-04334.	Agarwal YK, 2003, AM J CARDIOL, V91, P882, DOI 10.1016/S0002-9149(03)00027-4; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bjornstad HH, 2009, CARDIOLOGY, V112, P234, DOI 10.1159/000151435; BLACKBURN H, 1970, Circulation Research Supplement, V41, P154; Crouse SF, 2009, CLIN CARDIOL, V32, P37, DOI 10.1002/clc.20452; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Dilaveris PE, 2001, ANN NONINVAS ELECTRO, V6, P92, DOI 10.1111/j.1542-474X.2001.tb00092.x; ERIKSSEN J, 1984, CLIN CARDIOL, V7, P6, DOI 10.1002/clc.4960070104; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; Freed LA, 2002, J AM COLL CARDIOL, V40, P1298, DOI 10.1016/S0735-1097(02)02161-7; ISHIKAWA T, 1992, PACE, V15, P1927, DOI 10.1111/j.1540-8159.1992.tb02996.x; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KINOSHITA S, 1987, J ELECTROCARDIOL, V20, P272, DOI 10.1016/S0022-0736(87)80026-2; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LAKATTA EG, 1975, CIRC RES, V36, P262, DOI 10.1161/01.RES.36.2.262; LEIER CV, 1978, CIRCULATION, V57, P213, DOI 10.1161/01.CIR.57.2.213; LEV M, 1964, AM J MED, V37, P742, DOI 10.1016/0002-9343(64)90022-1; LINDSAY J, 1974, CHEST, V66, P114, DOI 10.1378/chest.66.2.114; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; MYMIN D, 1986, NEW ENGL J MED, V315, P1183, DOI 10.1056/NEJM198611063151902; PACKARD JM, 1954, CIRCULATION, V10, P384, DOI 10.1161/01.CIR.10.3.384; PERLAMN LV, 1971, CHEST, V59, P40, DOI 10.1378/chest.59.1.40; Psaty BM, 1997, CIRCULATION, V96, P2455; ROSE G, 1978, BRIT HEART J, V40, P636; *SAS I INC, 2004, SAS R ODBC DRIV 9 1; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; SCHNITTGER I, 1988, J AM COLL CARDIOL, V11, P83, DOI 10.1016/0735-1097(88)90170-2; Schwartzmann D, 2004, CARDIAC ELECTROPHYSI, P485; SIMPSON RJ, 1982, AM J CARDIOL, V50, P1331, DOI 10.1016/0002-9149(82)90471-4; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281; YIN FCP, 1979, MECH AGEING DEV, V10, P17, DOI 10.1016/0047-6374(79)90067-8	37	369	412	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2571	2577		10.1001/jama.2009.888	http://dx.doi.org/10.1001/jama.2009.888			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549974	Bronze, Green Accepted			2022-12-28	WOS:000267266500022
J	Butler, CC; Hood, K; Verheij, T; Little, P; Melbye, H; Nuttall, J; Statistician, MJK; Molstad, S; Godycki-Cwirko, M; Almirall, J; Torres, A; Gillespie, D; Rautakorpi, U; Coenen, S; Goossens, H				Butler, C. C.; Hood, K.; Verheij, T.; Little, P.; Melbye, H.; Nuttall, J.; Statistician, M. J. Kelly; Molstad, S.; Godycki-Cwirko, M.; Almirall, J.; Torres, A.; Gillespie, D.; Rautakorpi, U.; Coenen, S.; Goossens, H.			Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries	BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; GENERAL-PRACTICE; COMMUNICATION; INTERVENTION; MANAGEMENT; RESISTANCE; COMMUNITY; DATABASE; ILLNESS	Objective To describe variation in antibiotic prescribing for acute cough in contrasting European settings and impact on recovery. Design Cross sectional observational study with clinicians from 14 primary care research networks in 13 European countries who recorded symptoms on presentation and management. Patients followed up for 28 days with patient diaries. Setting Primary care. Participants Adults with a new or worsening cough or clinical presentation suggestive of lower respiratory infection. Main outcome measures Prescribing of antibiotics by clinicians and total symptom severity scores over time. Results 3402 patients were recruited (clinicians completed a case report form for 99% (3368) of participants and 80% (2714) returned a symptom Mean symptom severity scores at presentation ranged from 19 (scale range 0 to 100) in networks based in and Italy to 38 in the network based in Sweden. prescribing by networks ranged from 20% to nearly 90% (53% overall), with wide variation in classes of prescribed. Amoxicillin was overall the most common antibiotic prescribed, but this ranged from 3% of antibiotics prescribed in the Norwegian network to 83% the English network. While fluoroquinolones were not prescribed at all in three networks, they were prescribed for 18% in the Milan network. After adjustment for presentation and demographics, considerable differences remained in antibiotic prescribing, ranging from Norway (odds ratio 0.18, 95% confidence interval 0.11 to 0.30) to Slovakia (11.2, 6.20 to 20.27) with the overall mean (proportion prescribed: 0.53). The rate of recovery was similar for patients who were and were not prescribed antibiotics (coefficient -0.01, P<0.01) once clinical presentation was taken into account. Conclusions Variation in clinical presentation does not explain the considerable variation in antibiotic prescribing for acute cough in Europe. Variation in antibiotic prescribing is not associated with clinically important differences in recovery.	[Butler, C. C.] Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff CF14 4XN, Wales; [Hood, K.; Nuttall, J.; Statistician, M. J. Kelly; Gillespie, D.] Cardiff Univ, Sch Med, SEWTU, Dept Primary Care & Publ Hlth, Cardiff CF14 4XN, Wales; [Verheij, T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Little, P.] Univ Southampton, Southampton SO16 5ST, Hants, England; [Melbye, H.] Univ Tromso, Inst Community Med, Gen Practice Res Unit, N-9037 Tromso, Norway; [Molstad, S.] Linkoping Univ, Dept Med & Hlth Sci, S-55185 Jonkoping, Sweden; [Molstad, S.] Unit Res & Dev Primary Care, S-55185 Jonkoping, Sweden; [Godycki-Cwirko, M.] Med Univ Lodz, Dept Family & Community Med, U190 153, Lodz Kopcinskiego 20, Poland; [Almirall, J.] Hosp Mataro, Unitat Cures Intens, Barcelona 08304, Spain; [Torres, A.] Univ Barcelona, Serv Pneumol & Al Lergia Resp, Inst Clin Torax, Hosp Clin Barcelona,CIBERES 06 06 0028, E-08007 Barcelona, Spain; [Rautakorpi, U.] FinOHTA, Stakes Tampere Satellite Off, Tampere 33520, Finland; [Goossens, H.] Univ Antwerp, Vaccine & Infect Dis Inst, Lab Med Microbiol, B-2020 Antwerp, Belgium	Cardiff University; Cardiff University; Utrecht University; Utrecht University Medical Center; University of Southampton; UiT The Arctic University of Tromso; Linkoping University; Medical University Lodz; University of Barcelona; Hospital Clinic de Barcelona; University of Antwerp	Butler, CC (corresponding author), Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff CF14 4XN, Wales.	ButlerCC@cardiff.ac.uk	Almirall, Jordi/H-6850-2013; Torres, Antoni/H-6128-2017; Hood, Kerenza/C-2528-2008; Kelly, Mark J/G-5035-2012; Coenen, Samuel JA/A-6410-2011; Kelson, Mark J/E-6753-2016	Almirall, Jordi/0000-0002-3821-4341; Torres, Antoni/0000-0002-8643-2167; Hood, Kerenza/0000-0002-5268-8631; Coenen, Samuel JA/0000-0002-1238-8052; Kelson, Mark J/0000-0001-7744-3780; Gillespie, David/0000-0002-6934-2928; Butler, Christopher/0000-0002-0102-3453; Melbye, Hasse/0000-0002-9773-3141; Little, Paul/0000-0003-3664-1873	ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Akkerman AE, 2005, BRIT J GEN PRACT, V55, P114; Akkerman AE, 2008, PHARMACOEPIDEM DR S, V17, P378, DOI 10.1002/pds.1501; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bates D. M., 2007, LME4 LINEAR MIXED EF; Bjerrum L, 2004, EUR J CLIN PHARMACOL, V60, P23, DOI 10.1007/s00228-003-0706-z; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Coenen S, 2004, J ANTIMICROB CHEMOTH, V54, P661, DOI 10.1093/jac/dkh374; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; GRUNDMANN H, 2007, EARSS ANN REPORT 200, P40; Huchon GJ, 1996, EUR RESPIR J, V9, P1590, DOI 10.1183/09031936.96.09081590; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Macfarlane J, 1997, RESP MED, V91, P427, DOI 10.1016/S0954-6111(97)90258-4; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Pinheiro J.C., 2007, R CORE TEAM NLME LIN; R Development Core Team, 2007, R LANG ENV STAT COMP; SMUCNY J, 2000, COCHRANE DB SYST REV, P245; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB	22	174	174	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2009	338								b2242	10.1136/bmj.b2242	http://dx.doi.org/10.1136/bmj.b2242			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MM	19549995				2022-12-28	WOS:000267436300003
J	Boetius, A; Joye, S				Boetius, Antje; Joye, Samantha			Thriving in Salt	SCIENCE			English	Editorial Material							SEA; LIFE; DEEP; ANTARCTICA; DIVERSITY; BRINES; OCEAN; WATER; LAKES		[Boetius, Antje] Alfred Wegener Inst Polar & Marine Res, HGF MPG Joint Res Grp Deep Sea Ecol & Technol, D-27515 Bremerhaven, Germany; [Boetius, Antje] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Joye, Samantha] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; University System of Georgia; University of Georgia	Boetius, A (corresponding author), Alfred Wegener Inst Polar & Marine Res, HGF MPG Joint Res Grp Deep Sea Ecol & Technol, D-27515 Bremerhaven, Germany.	aboetius@mpi-bremen.de; mjoye@uga.edu	Boetius, Antje/D-5459-2013	Boetius, Antje/0000-0003-2117-4176; Joye, Samantha/0000-0003-1610-451X				Arahal DR, 1996, APPL ENVIRON MICROB, V62, P3779, DOI 10.1128/AEM.62.10.3779-3786.1996; Baas-Becking LGM, 1931, J GEN PHYSIOL, V14, P765, DOI 10.1085/jgp.14.6.765; Biddanda B. A., 2009, EOS T AM GEOPHYS UN, V90, P61, DOI [10.1029/2009EO080001, DOI 10.1029/2009EO080001]; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Green WJ, 2009, AQUAT GEOCHEM, V15, P321, DOI 10.1007/s10498-008-9052-1; Joye SB, 2009, NAT GEOSCI, V2, P349, DOI 10.1038/NGEO475; Mancinelli RL, 2004, ADV SPACE RES, V33, P1244, DOI 10.1016/j.asr.2003.08.034; Mikucki JA, 2007, APPL ENVIRON MICROB, V73, P4029, DOI 10.1128/AEM.01396-06; Mikucki JA, 2009, SCIENCE, V324, P397, DOI 10.1126/science.1167350; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Siegert MJ, 2001, NATURE, V414, P603, DOI 10.1038/414603a; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Wilkansky B, 1936, NATURE, V138, P467, DOI [10.1038/138467a0, DOI 10.1038/138467A0]	17	29	31	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1523	1525		10.1126/science.1172979	http://dx.doi.org/10.1126/science.1172979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541984				2022-12-28	WOS:000267130600029
J	Hajdenberg, J				Hajdenberg, Julio			Adding radiotherapy to endocrine therapy improved survival in locally advanced prostate cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Orlando, FL USA	University of Texas System; UTMD Anderson Cancer Center	Hajdenberg, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Orlando, FL USA.			Hajdenberg, Julio/0000-0001-6346-1638				Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-6	10.7326/0003-4819-150-12-200906160-02006	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528551				2022-12-28	WOS:000267164800018
J	Bremner, R				Bremner, Rod			Retinoblastoma, an Inside Job	CELL			English	Editorial Material							RB	Why are some cell types more prone to transformation than others? In this issue, Xu et al. (2009) show that retinoblastoma cells co-opt several intrinsic features of cone photoreceptors for their survival and growth.	[Bremner, Rod] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON M5Y 2S8, Canada; [Bremner, Rod] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON M5T 2S8, Canada; [Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Bremner, R (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON M5Y 2S8, Canada.	rbremner@uhnres.utoronto.ca	Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212				Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Guigon CJ, 2009, IUBMB LIFE, V61, P528, DOI 10.1002/iub.180; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829	8	13	14	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6					992	994		10.1016/j.cell.2009.05.034	http://dx.doi.org/10.1016/j.cell.2009.05.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524501	Bronze			2022-12-28	WOS:000266916400010
J	Liu, CC; Linde, AT; Sacks, IS				Liu, ChiChing; Linde, Alan T.; Sacks, I. Selwyn			Slow earthquakes triggered by typhoons	NATURE			English	Article							EPISODIC TREMOR; JAPAN; SLIP; SEISMICITY; SUBDUCTION; TAIWAN; ALASKA; FAULT	The first reports(1,2) on a slow earthquake were for an event in the Izu peninsula, Japan, on an intraplate, seismically active fault. Since then, many slow earthquakes have been detected(3-8). It has been suggested(9) that the slow events may trigger ordinary earthquakes (in a context supported by numerical modelling(10)), but their broader significance in terms of earthquake occurrence remains unclear. Triggering of earthquakes has received much attention: strain diffusion from large regional earthquakes has been shown to influence large earthquake activity(11,12), and earthquakes may be triggered during the passage of teleseismic waves(13), a phenomenon now recognized as being common(14-17). Here we show that, in eastern Taiwan, slow earthquakes can be triggered by typhoons. We model the largest of these earthquakes as repeated episodes of slow slip on a reverse fault just under land and dipping to the west; the characteristics of all events are sufficiently similar that they can be modelled with minor variations of the model parameters. Lower pressure results in a very small unclamping of the fault that must be close to the failure condition for the typhoon to act as a trigger. This area experiences very high compressional deformation but has a paucity of large earthquakes; repeating slow events may be segmenting the stressed area and thus inhibiting large earthquakes, which require a long, continuous seismic rupture.	[Liu, ChiChing] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan; [Linde, Alan T.; Sacks, I. Selwyn] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Academia Sinica - Taiwan; Carnegie Institution for Science	Liu, CC (corresponding author), Acad Sinica, Inst Earth Sci, 128 Sinica Rd,Sec 2, Taipei 115, Taiwan.	liucc@sinica.edu.tw						Brodsky EE, 2000, GEOPHYS RES LETT, V27, P2741, DOI 10.1029/2000GL011534; CHI WR, 1981, GEOL SOC CHINA MEM, V4, P155; Crescentini L, 1999, SCIENCE, V286, P2132, DOI 10.1126/science.286.5447.2132; Dragert H, 2004, EARTH PLANETS SPACE, V56, P1143, DOI 10.1186/BF03353333; Gao SS, 2000, NATURE, V406, P500, DOI 10.1038/35020045; GLADWIN MT, 1994, J GEOPHYS RES-SOL EA, V99, P4559, DOI 10.1029/93JB02877; Gomberg J, 2004, NATURE, V427, P621, DOI 10.1038/nature02335; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Ho C. S., 1986, INTRO GEOLOGY TAIWAN; HSEIH ML, 2004, QUATERN INT, V115, P47; ITO Y, 2006, SCIENCE, V26, P503; Kato N, 2003, EARTH PLANET SC LETT, V216, P17, DOI 10.1016/S0012-821X(03)00483-7; Kim KH, 2005, GEOPHYS J INT, V162, P204, DOI [10.1111/j.1365-246X.2005.02657.x, 10.1111/j.1365-246X.2005.02650.x]; Lee JC, 2001, TECTONOPHYSICS, V333, P219, DOI 10.1016/S0040-1951(00)00276-6; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; Linde AT, 2002, EARTH PLANET SC LETT, V203, P265, DOI 10.1016/S0012-821X(02)00849-X; LIU CC, 1990, TECTONOPHYSICS, V183, P111, DOI 10.1016/0040-1951(90)90191-A; Miyazawa M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022539; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; POLLITZ FF, 1995, B SEISMOL SOC AM, V85, P796; RYDELEK PA, 1988, NATURE, V336, P234, DOI 10.1038/336234a0; SACKS IS, 1982, TECTONOPHYSICS, V81, P311, DOI 10.1016/0040-1951(82)90135-4; SACKS IS, 1971, P JPN ACAD, V47, P707, DOI 10.2183/pjab1945.47.707; SACKS IS, 1978, NATURE, V275, P599, DOI 10.1038/275599a0; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Suppe J., 1984, MEMOIR GEOL SOC CHIN, V6, P21; TSAI YB, 1986, TECTONOPHYSICS, V125, P17; West M, 2005, SCIENCE, V308, P1144, DOI 10.1126/science.1112462; Yu S.B., 1989, P GEOL SOC CHINA, V32, P209	30	85	97	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					833	836		10.1038/nature08042	http://dx.doi.org/10.1038/nature08042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516339				2022-12-28	WOS:000267084500037
J	Okabe, Y; Sano, T; Nagata, S				Okabe, Yasutaka; Sano, Teruyuki; Nagata, Shigekazu			Regulation of the innate immune response by threonine-phosphatase of Eyes absent	NATURE			English	Article							PATTERN-RECOGNITION RECEPTORS; PROTEIN-TYROSINE-PHOSPHATASE; NF-KAPPA-B; BRANCHIOOTORENAL SYNDROME; ANTIVIRAL PATHWAY; VIRUS-INFECTION; MAMMALIAN DNA; GENE; TRANSCRIPTION; ACTIVATION	Innate immunity is stimulated not only by viral or bacterial components, but also by non-microbial danger signals (damage-associated molecular patterns)(1). One of the damage-associated molecular patterns is chromosomal DNA that escapes degradation. In programmed cell death and erythropoiesis, DNA from dead cells or nuclei expelled from erythroblasts is digested by DNase II in the macrophages after they are engulfed. DNase II-/- (also known as Dnase2a(-/-)) mice suffer from severe anaemia or chronic arthritis due to interferon-beta (IFN-beta) and tumour necrosis factor-alpha (TNF-alpha) produced from the macrophages carrying undigested DNA(2,3) in a Toll-like receptor (TLR)-independent mechanism(4). Here we show that Eyes absent 4 (EYA4), originally identified as a co-transcription factor, stimulates the expression of IFN-beta and CXCL10 in response to the undigested DNA of apoptotic cells. EYA4 enhanced the innate immune response against viruses (Newcastle disease virus and vesicular stomatitis virus), and could associate with signalling molecules (IPS-1 (also known as MAVS), STING (TMEM173) and NLRX1). Three groups have previously shown that EYA has phosphatase activity(5-7). We found that mouse EYA family members act as a phosphatase for both phosphotyrosine and phosphothreonine. The haloacid dehalogenase domain at the carboxy terminus contained the tyrosine-phosphatase, and the amino-terminal half carried the threonine-phosphatase. Mutations of the threonine-phosphatase, but not the tyrosine-phosphatase, abolished the ability of EYA4 to enhance the innate immune response, suggesting that EYA regulates the innate immune response by modulating the phosphorylation state of signal transducers for the intracellular pathogens.	[Okabe, Yasutaka; Sano, Teruyuki; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Okabe, Yasutaka; Nagata, Shigekazu] Japan Sci & Technol Corp, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426; Okabe, Yasutaka/0000-0002-1913-7280	Ministry of Education, Science, Sports, and Culture in Japan	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Fujita and M. Yoneyama for the NDV, A. Sehara-Fujisawa for the myogenin promoter, and M. Fujii and M. Harayama for secretarial assistance. This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture in Japan. T. S. is a Research Assistant for Kyoto University Global COE program (Center for Frontier Medicine).	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; FUJISAWASEHARA A, 1993, BIOCHEM BIOPH RES CO, V191, P351, DOI 10.1006/bbrc.1993.1224; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawane K, 1999, CELL DEATH DIFFER, V6, P745, DOI 10.1038/sj.cdd.4400547; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; LAM KM, 1987, VET MICROBIOL, V15, P49, DOI 10.1016/0378-1135(87)90128-3; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Umeda IO, 2004, EXP EYE RES, V79, P385, DOI 10.1016/j.exer.2004.06.013; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	47	118	124	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					520	U99		10.1038/nature08138	http://dx.doi.org/10.1038/nature08138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19561593				2022-12-28	WOS:000268257000040
J	Beck, LH; Bonegio, RGB; Lambeau, G; Beck, DM; Powell, DW; Cummins, TD; Klein, JB; Salant, DJ				Beck, Laurence H., Jr.; Bonegio, Ramon G. B.; Lambeau, Gerard; Beck, David M.; Powell, David W.; Cummins, Timothy D.; Klein, Jon B.; Salant, David J.			M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEYMANN NEPHRITIS; EXPERIMENTAL GLOMERULONEPHRITIS; 180-KDA RECEPTOR; A(2); FAMILY; EXPRESSION; CLONING; IDENTIFICATION; LOCALIZATION; GLYCOPROTEIN	Background: Idiopathic membranous nephropathy, a common form of the nephrotic syndrome, is an antibody-mediated autoimmune glomerular disease. Serologic diagnosis has been elusive because the target antigen is unknown. Methods: We performed Western blotting of protein extracts from normal human glomeruli with serum samples from patients with idiopathic or secondary membranous nephropathy or other proteinuric or autoimmune diseases and from normal controls. We used mass spectrometry to analyze the reactive protein bands and confirmed the identity and location of the target antigen with a monospecific antibody. Results: Serum samples from 26 of 37 patients (70%) with idiopathic but not secondary membranous nephropathy specifically identified a 185-kD glycoprotein in nonreduced glomerular extract. Mass spectrometry of the reactive protein band detected the M-type phospholipase A(sub 2) receptor (PLA(sub 2)R). Reactive serum specimens recognized recombinant PLA(sub 2)R and bound the same 185-kD glomerular protein as did the monospecific anti-PLA(sub 2)R antibody. Anti-PLA(sub 2)R autoantibodies in serum samples from patients with membranous nephropathy were mainly IgG4, the predominant immunoglobulin subclass in glomerular deposits. PLA(sub 2)R was expressed in podocytes in normal human glomeruli and colocalized with IgG4 in immune deposits in glomeruli of patients with membranous nephropathy. IgG eluted from such deposits in patients with idiopathic membranous nephropathy, but not in those with lupus membranous or IgA nephropathy, recognized PLA(sub 2)R. Conclusions: A majority of patients with idiopathic membranous nephropathy have antibodies against a conformation-dependent epitope in PLA(sub 2)R. PLA(sub 2)R is present in normal podocytes and in immune deposits in patients with idiopathic membranous nephropathy, indicating that PLA(sub 2)R is a major antigen in this disease. N Engl J Med 2009;361:11-21.	[Beck, Laurence H., Jr.; Bonegio, Ramon G. B.; Beck, David M.; Salant, David J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lambeau, Gerard] Univ Nice Sophia Antipolis, Valbonne, France; [Lambeau, Gerard] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Powell, David W.; Cummins, Timothy D.; Klein, Jon B.] Univ Louisville, Sch Med, Louisville, KY 40292 USA	Boston University; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Louisville	Salant, DJ (corresponding author), Evans Biomed Res Ctr, Rm 504,650 Albany St, Boston, MA 02118 USA.	djsalant@bu.edu	Klein, Jon/B-9833-2013; Lambeau, Gerard/GRJ-5624-2022; Powell, David W/E-9288-2013; Cummins, Timothy D./C-9120-2013	Beck, Laurence/0000-0003-1482-4089; Lambeau, Gerard/0000-0002-9239-518X; Bonegio, Ramon/0000-0002-1286-141X; Salant, David/0000-0002-3866-3120; Cummins, Timothy/0000-0001-9648-5441	National Institute of Diabetes and Digestive and Kidney Diseases [DK067658, DK30932, DK076743]; Amgen; Halpin Foundation; Centre National de la Recherche Scientifique and Association pour la Recherche sur le Cancer; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030932, R56DK030932, R21DK067658, K01DK076743, T32DK007053] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amgen(Amgen); Halpin Foundation; Centre National de la Recherche Scientifique and Association pour la Recherche sur le Cancer(Centre National de la Recherche Scientifique (CNRS)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK067658 and DK30932, to Dr. Salant, and DK076743, to Dr. Powell), Amgen (to Dr. Beck), the Halpin Foundation (to Dr. Beck), Centre National de la Recherche Scientifique and Association pour la Recherche sur le Cancer (to Dr. Lambeau), and the Department of Veterans Affairs (to Dr. Klein).	ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; Beck S, 2006, KIDNEY INT, V70, P1251, DOI 10.1038/sj.ki.5001664; Brandslund I, 1981, Methods Enzymol, V74 Pt C, P551; COUSER WG, 1980, KIDNEY INT, V17, P1, DOI 10.1038/ki.1980.1; COUSER WG, 1978, J CLIN INVEST, V62, P1275, DOI 10.1172/JCI109248; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; DOI T, 1984, CLIN EXP IMMUNOL, V58, P57; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; HAAS M, 1994, AM J KIDNEY DIS, V23, P358, DOI 10.1016/S0272-6386(12)80997-8; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; MAKKER SP, 1984, LAB INVEST, V50, P287; MAKKER SP, 1989, J IMMUNOL, V142, P3406; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Silliman CC, 2002, AM J PHYSIOL-CELL PH, V283, pC1102, DOI 10.1152/ajpcell.00608.2001; VANDAMME BJC, 1978, LAB INVEST, V38, P502; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	33	1345	1448	11	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					11	21		10.1056/NEJMoa0810457	http://dx.doi.org/10.1056/NEJMoa0810457			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571279	Green Accepted			2022-12-28	WOS:000267533100005
J	Avolio, L; Martucciello, G				Avolio, Luigi; Martucciello, Giuseppe			Ingested Magnets	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avolio, Luigi; Martucciello, Giuseppe] Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo	Avolio, L (corresponding author), Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy.		Avolio, Luigi/H-8598-2014; Martucciello, Giuseppe/J-6543-2018	Avolio, Luigi/0000-0002-3703-6969; Martucciello, Giuseppe/0000-0002-7709-8937					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2770	2770		10.1056/NEJMicm0801917	http://dx.doi.org/10.1056/NEJMicm0801917			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553650				2022-12-28	WOS:000267286600011
J	Royer, JR; Evans, DJ; Oyarte, L; Guo, Q; Kapit, E; Mobius, ME; Waitukaitis, SR; Jaeger, HM				Royer, John R.; Evans, Daniel J.; Oyarte, Loreto; Guo, Qiti; Kapit, Eliot; Moebius, Matthias E.; Waitukaitis, Scott R.; Jaeger, Heinrich M.			High-speed tracking of rupture and clustering in freely falling granular streams	NATURE			English	Article							MOLECULAR-DYNAMICS; COLLISION; BREAKUP; SPHERES	Thin streams of liquid commonly break up into characteristic droplet patterns owing to the surface-tension-driven Plateau Rayleigh instability(1-3). Very similar patterns are observed when initially uniform streams of dry granular material break up into clusters of grains(4-6), even though flows of macroscopic particles are considered to lack surface tension(7,8). Recent studies on freely falling granular streams tracked fluctuations in the stream profile(9), but the clustering mechanism remained unresolved because the full evolution of the instability could not be observed. Here we demonstrate that the cluster formation is driven by minute, nanoNewton cohesive forces that arise from a combination of van der Waals interactions and capillary bridges between nanometre-scale surface asperities. Our experiments involve high-speed video imaging of the granular stream in the co-moving frame, control over the properties of the grain surfaces and the use of atomic force microscopy to measure grain-grain interactions. The cohesive forces that we measure correspond to an equivalent surface tension five orders of magnitude below that of ordinary liquids. We find that the shapes of these weakly cohesive, non-thermal clusters of macroscopic particles closely resemble droplets resulting from thermally induced rupture of liquid nanojets(10-12).	[Royer, John R.; Evans, Daniel J.; Oyarte, Loreto; Guo, Qiti; Kapit, Eliot; Moebius, Matthias E.; Waitukaitis, Scott R.; Jaeger, Heinrich M.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Royer, John R.; Evans, Daniel J.; Oyarte, Loreto; Guo, Qiti; Kapit, Eliot; Moebius, Matthias E.; Waitukaitis, Scott R.; Jaeger, Heinrich M.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Royer, JR (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	jroyer@uchicago.edu	Möbius, Matthias/D-3140-2013; Mobius, Matthias/HDM-3517-2022; Royer, John/E-8056-2016	Möbius, Matthias/0000-0002-5509-8725; Royer, John/0000-0002-8368-7252; Waitukaitis, Scott/0000-0002-2299-3176; Oyarte Galvez, Loreto/0000-0001-7570-8431	NSF through its MRSEC programme; Inter-American Materials Collaboration Chicago-Chile; Keck Initiative for Ultrafast Imaging at the University of Chicago	NSF through its MRSEC programme(National Science Foundation (NSF)); Inter-American Materials Collaboration Chicago-Chile; Keck Initiative for Ultrafast Imaging at the University of Chicago(University of Chicago)	We thank X. Cheng, R. Cocco, E. Corwin, R. Karri, N. Keim, T. Knowlton, S. Nagel, T. Witten and W. Zhang for discussions and J. Jureller for AFM training and assistance. This work was supported by NSF through its MRSEC programme and the Inter-American Materials Collaboration Chicago-Chile, and by the Keck Initiative for Ultrafast Imaging at the University of Chicago.	Amarouchene Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218001; [Anonymous], 1992, INTERMOLECULAR SURFA; Bocquet L, 1998, NATURE, V396, P735, DOI 10.1038/25492; Brilliantov N. V, 2004, KINETIC THEORY GRANU; Brilliantov NV, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051302; Cheng X, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188001; Cheng X, 2008, NAT PHYS, V4, P234, DOI 10.1038/nphys834; Doshi P, 2003, SCIENCE, V302, P1185, DOI 10.1126/science.1089272; Efrati E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.088001; Eggers J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.084502; Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601; FOERSTER SF, 1994, PHYS FLUIDS, V6, P1108, DOI 10.1063/1.868282; Goldhirsch I, 2003, ANNU REV FLUID MECH, V35, P267, DOI 10.1146/annurev.fluid.35.101101.161114; Halsey TC, 1998, PHYS REV LETT, V80, P3141, DOI 10.1103/PhysRevLett.80.3141; Hennequin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.244502; Jones R, 2003, GRANUL MATTER, V4, P191, DOI 10.1007/s10035-002-0122-6; Kawano S, 1998, PHYS REV E, V58, P4468, DOI 10.1103/PhysRevE.58.4468; Khamontoff N, 1890, J RUSS PHYS CHEM SOC, V22, P281; KOPLIK J, 1993, PHYS FLUIDS A-FLUID, V5, P521, DOI 10.1063/1.858879; Lohse D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198003; Mobius ME, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051304; Moseler M, 2000, SCIENCE, V289, P1165, DOI 10.1126/science.289.5482.1165; Podczeck F., 1998, PHARM CAPSULES; Rowlinson J. S., 1982, MOL THEORY CAPILLARI; Royer JR, 2005, NAT PHYS, V1, P164, DOI 10.1038/nphys175; SCHAEFER DM, 1995, FUNDAMENTALS ADHESIO, P35; SHI XD, 1994, SCIENCE, V265, P219, DOI 10.1126/science.265.5169.219; Sorace CM, 2009, MECH RES COMMUN, V36, P364, DOI 10.1016/j.mechrescom.2008.10.009; VISSER J, 1989, POWDER TECHNOL, V58, P1, DOI 10.1016/0032-5910(89)80001-4	30	153	157	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1110	1113		10.1038/nature08115	http://dx.doi.org/10.1038/nature08115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553995				2022-12-28	WOS:000267636700039
J	Balan, A; Kessel, D				Balan, Anu; Kessel, David			Picture quiz A woman with tuberous sclerosis and acute onset right sided abdominal pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							RENAL ANGIOMYOLIPOMA; EMBOLIZATION		[Balan, Anu; Kessel, David] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Balan, A (corresponding author), Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England.	balan.anu@gmail.com						Han YM, 1997, RADIOLOGY, V204, P65, DOI 10.1148/radiology.204.1.9205224; Kessel D, 2008, BRIT MED J, V336, P1205, DOI 10.1136/bmj.a168; Lee DJ, 2005, RENEW AGR FOOD SYST, V20, P3; Lenton J, 2008, CLIN RADIOL, V63, P864, DOI 10.1016/j.crad.2008.02.005; Rimon U, 2006, AM J ROENTGENOL, V187, P762, DOI 10.2214/AJR.05.0629; Wagner BJ, 1997, RADIOGRAPHICS, V17, P155, DOI 10.1148/radiographics.17.1.9017806	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2009	338								b987	10.1136/bmj.b987	http://dx.doi.org/10.1136/bmj.b987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MO	19553272				2022-12-28	WOS:000267436500002
J	Bell, KJL; Hayen, A; Macaskill, P; Irwig, L; Craig, JC; Ensrud, K; Bauer, DC				Bell, Katy J. L.; Hayen, Andrew; Macaskill, Petra; Irwig, Les; Craig, Jonathan C.; Ensrud, Kristine; Bauer, Douglas C.			Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VERTEBRAL FRACTURES; OSTEOPOROSIS; RISK; ALENDRONATE; WOMEN; MANAGEMENT; DETECT	Objective: To assess the value of monitoring response to bisphosphonate treatment by means of measuring bone mineral density. Design Secondary analysis of trial data using mixed models. Data source The Fracture Intervention Trial, a randomised controlled trial that compared the effects of alendronate and placebo in 6459 postmenopausal women with low bone mineral density recruited between May 1992 and May 1993. Bone density measurements of hip and spine were obtained at baseline and at one, two, and three years after randomisation. Main outcome measures Between-person (treatment related) variation and within-person (measurement related) variation in hip and spine bone mineral density. Results The mean effect of three years' treatment with alendronate was to increase hip bone mineral density by 0.030 g/cm(2). There was some between-person variation in the effects of alendronate, but this was small in size compared with within-person variation. Alendronate treatment is estimated to result in increases in hip bone density >= 0.019 g/cm(2) in 97.5% of patients. Conclusions: Monitoring bone mineral density in postmenopausal women in the first three years after starting treatment with a potent bisphosphonate is unnecessary and may be misleading. Routine monitoring should be avoided in this early period after bisphosphonate treatment is commenced.	[Hayen, Andrew; Macaskill, Petra; Irwig, Les; Craig, Jonathan C.] Univ Sydney, Screening & Test Evaluat Program, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Ensrud, Kristine] Univ Minnesota, Sch Med, Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; [Bauer, Douglas C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Sydney; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California San Francisco		katyb@health.usyd.edu.au	Craig, Jonathan/E-2813-2013; Bell, Katy/B-9650-2013	Craig, Jonathan/0000-0002-2548-4035; Bell, Katy/0000-0002-0137-3218; Hayen, Andrew/0000-0003-4046-8030; Ensrud, Kristine/0000-0002-9069-3036; Macaskill, Petra/0000-0001-5879-6193	Australian National Health and Medical Research Council [457212, 402764]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian National Health and Medical Research Council (Public Health Postgraduate Research Scholarship No 457212 and Program Grant No 402764). The Fracture Intervention Trial was sponsored by Merck Research Laboratories. The sponsors did not influence the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation and approval of the manuscript; or decision to submit the article for publication. All of the researchers involved in this project are independent of the funding bodies.	Bell KJL, 2008, BMJ-BRIT MED J, V336, P361, DOI 10.1136/bmj.39476.623611.25; Bell KJL, 2009, J CLIN EPIDEMIOL, V62, P650, DOI 10.1016/j.jclinepi.2008.07.018; BLACK DM, 1993, OSTEOPOROSIS INT, V3, pS29; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bland JM, 1996, BRIT MED J, V313, P744; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Chapurlat RD, 2005, OSTEOPOROSIS INT, V16, P842, DOI 10.1007/s00198-004-1770-7; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; HAYNES RB, 1980, GERIATRICS, V35, P91; HAYNES RB, 1980, HYPERTENSION, V2, P757, DOI 10.1161/01.HYP.2.6.757; Hochberg MC, 2002, J CLIN ENDOCR METAB, V87, P1586, DOI 10.1210/jc.87.4.1586; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Lu Y, 2001, J BONE MINER RES, V16, P901, DOI 10.1359/jbmr.2001.16.5.901; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; *NOGG, 2008, OST CLIN GUID PREV T; Pavlic M, 2001, STAT MED, V20, P1739, DOI 10.1002/sim.787; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Wasnich RD, 2000, J CLIN ENDOCR METAB, V85, P231, DOI 10.1210/jc.85.1.231; Willett JB, 2003, APPL LONGITUDINAL DA, P75, DOI DOI 10.1093/ACPROF:OSO/9780195152968.003.0004; *WRIT GROUP BON TO, 2000, OST CLIN GUID PREV T	28	62	63	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2009	338								b2266	10.1136/bmj.b2266	http://dx.doi.org/10.1136/bmj.b2266			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MM	19549996	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000267436300004
J	Honisch, B; Hemming, NG; Archer, D; Siddall, M; McManus, JF				Hoenisch, Baerbel; Hemming, N. Gary; Archer, David; Siddall, Mark; McManus, Jerry F.			Atmospheric Carbon Dioxide Concentration Across the Mid-Pleistocene Transition	SCIENCE			English	Article							PLEISTOCENE CLIMATE; EVOLUTION; PACIFIC; ONSET; PH	The dominant period of Pleistocene glacial cycles changed during the mid-Pleistocene from 40,000 years to 100,000 years, for as yet unknown reasons. Here we present a 2.1-million-year record of sea surface partial pressure of CO2 (Pco(2)), based on boron isotopes in planktic foraminifer shells, which suggests that the atmospheric partial pressure of CO2 (pco(2)) was relatively stable before the mid-Pleistocene climate transition. Glacial Pco(2) was similar to 31 microatmospheres higher before the transition (more than 1 million years ago), but interglacial Pco(2) was similar to that of late Pleistocene interglacial cycles (<450,000 years ago). These estimates are consistent with a close linkage between atmospheric CO2 concentration and global climate, but the lack of a gradual decrease in interglacial Pco(2) does not support the suggestion that a long-term drawdown of atmospheric CO2 was the main cause of the climate transition.	[Hoenisch, Baerbel; Hemming, N. Gary; McManus, Jerry F.] Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Hemming, N. Gary] CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA; [Archer, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Siddall, Mark] Univ Bristol, Dept Earth Sci, Bristol, Avon, England	Columbia University; City University of New York (CUNY) System; Queens College NY (CUNY); University of Chicago; University of Bristol	Honisch, B (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisades, NY 10964 USA.		Archer, David/K-7371-2012; Hoenisch, Baerbel/ABF-4968-2021; Hoenisch, Baerbel/C-7530-2013	Archer, David/0000-0002-4523-7912; Hoenisch, Baerbel/0000-0001-5844-3398; Hoenisch, Baerbel/0000-0001-5844-3398	NSF [OCE 06-23621]	NSF(National Science Foundation (NSF))	We thank ODP for sediment samples and NSF (grant OCE 06-23621) for financial support. The idea for this study was seeded through conversations with S. Hemming. L. Leon is gratefully acknowledged for laboratory assistance, P. deMenocal for Mg/Ca analyses at the Lamont-Doherty Earth Observatory (LDEO), and M. Segl for isotope analyses at Bremen University. We also thank C. Pelejero and two anonymous reviewers for valuable comments. Discussions with P. Kohler and R. Bintanja improved the manuscript. The oxygen isotope data are available in the National Oceanic and Atmospheric Administration Paleoclimatology database (www.ngdc.noaa.gov/paleo/data.html). This is LDEO contribution number 7261.	Archer D., 2006, GLOBAL WARMING UNDER; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kisakurek B, 2008, EARTH PLANET SC LETT, V273, P260, DOI 10.1016/j.epsl.2008.06.026; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Marlow JR, 2000, SCIENCE, V290, P2288; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; McClymont EL, 2005, GEOLOGY, V33, P389, DOI 10.1130/G21292.1; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Sanyal A, 2001, PALEOCEANOGRAPHY, V16, P515, DOI 10.1029/2000PA000547; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596	24	316	326	4	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1551	1554		10.1126/science.1171477	http://dx.doi.org/10.1126/science.1171477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541994				2022-12-28	WOS:000267130600041
J	Risch, N; Herrell, R; Lehner, T; Liang, KY; Eaves, L; Hoh, J; Griem, A; Kovacs, M; Ott, J; Merikangas, KR				Risch, Neil; Herrell, Richard; Lehner, Thomas; Liang, Kung-Yee; Eaves, Lindon; Hoh, Josephine; Griem, Andrea; Kovacs, Maria; Ott, Jurg; Merikangas, Kathleen Ries			Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of Depression A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ENVIRONMENT INTERACTIONS; THREATENING EXPERIENCES; PROMOTER POLYMORPHISM; PSYCHIATRIC-DISORDERS; SOCIAL SUPPORTS; ASSOCIATION; ADVERSITY; SYMPTOMS; GENOTYPE; MODERATION	Context Substantial resources are being devoted to identify candidate genes for complex mental and behavioral disorders through inclusion of environmental exposures following the report of an interaction between the serotonin transporter linked polymorphic region (5-HTTLPR) and stressful life events on an increased risk of major depression. Objective To conduct a meta-analysis of the interaction between the serotonin transporter gene and stressful life events on depression using both published data and individual-level original data. Data Sources Search of PubMed, EMBASE, and PsycINFO databases through March 2009 yielded 26 studies of which 14 met criteria for the meta-analysis. Study Selection Criteria for studies for the meta-analyses included published data on the association between 5-HTTLPR genotype (SS, SL, or LL), number of stressful life events (0, 1, 2, >= 3) or equivalent, and a categorical measure of depression defined by the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) or the International Statistical Classification of Diseases, 10th Revision (ICD-10) or use of a cut point to define depression from standardized rating scales. To maximize our ability to use a common framework for variable definition, we also requested original data from all studies published prior to 2008 that met inclusion criteria. Of the 14 studies included in the meta-analysis, 10 were also included in a second sex-specific meta-analysis of original individual-level data. Data Extraction Logistic regression was used to estimate the effects of the number of short alleles at 5-HTTLPR, the number of stressful life events, and their interaction on depression. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated separately for each study and then weighted averages of the individual estimates were obtained using random-effects meta-analysis. Both sex-combined and sex-specific meta-analyses were conducted. Of a total of 14 250 participants, 1769 were classified as having depression; 12 481 as not having depression. Results In the meta-analysis of published data, the number of stressful life events was significantly associated with depression (OR, 1.41; 95% CI, 1.25-1.57). No association was found between 5-HTTLPR genotype and depression in any of the individual studies nor in the weighted average (OR, 1.05; 95% CI, 0.98-1.13) and no interaction effect between genotype and stressful life events on depression was observed (OR, 1.01; 95% CI, 0.94-1.10). Comparable results were found in the sex-specific meta-analysis of individual-level data. Conclusion This meta-analysis yielded no evidence that the serotonin transporter genotype alone or in interaction with stressful life events is associated with an elevated risk of depression in men alone, women alone, or in both sexes combined. JAMA. 2009; 301(23):2462-2471	[Merikangas, Kathleen Ries] NIMH, Genet Epidemiol Res Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Risch, Neil] Univ Calif San Francisco, Inst Human Genet, Oakland, CA USA; [Risch, Neil] Kaiser Permanente No Calif Div Res, Oakland, CA USA; [Liang, Kung-Yee] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Eaves, Lindon] Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23284 USA; [Eaves, Lindon] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA; [Hoh, Josephine] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Kovacs, Maria] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Ott, Jurg] Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California San Francisco; Kaiser Permanente; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Virginia Commonwealth University; Virginia Commonwealth University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rockefeller University	Merikangas, KR (corresponding author), NIMH, Genet Epidemiol Res Branch, Intramural Res Program, 35 Convent Dr,MSC 3720, Bethesda, MD 20892 USA.	kathleen.merikangas@nih.gov	Liang, Kung-Yee/F-8299-2011	Merikangas, Kathkeen/0000-0002-4667-2414	National Institutes of Health; National Institute of Mental Health; Intramural Research Program; Division of Developmental Translational Research; Division of Neuroscience and Basic Behavioral Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program; Division of Developmental Translational Research; Division of Neuroscience and Basic Behavioral Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding/Support: This work was supported in part by the National Institutes of Health, National Institute of Mental Health, Intramural Research Program, Division of Developmental Translational Research, and Division of Neuroscience and Basic Behavioral Science. Disclaimer: The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organizations or agencies or the US government. Additional Information: Online tables are available at http://www.jama.com.	AGUILERA M, 2009, PSYCHOL MED, V39, P1425, DOI DOI 10.1017/S0033291709005248; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Anguelova M, 2003, MOL PSYCHIATR, V8, P646, DOI 10.1038/sj.mp.4001336; [Anonymous], 2003, SCIENCE, V302, P2039; Araya R, 2009, AM J MED GENET B, V150B, P670, DOI 10.1002/ajmg.b.30888; BAZELONI E, 2006, NY TIMES MAGAZI 0430; Bearden CE, 2004, CURR OPIN GENET DEV, V14, P280, DOI 10.1016/j.gde.2004.04.005; BEGLEY S, 2008, NEWSWEEK        0425, P40; Bernet W, 2007, J FORENSIC SCI, V52, P1362, DOI 10.1111/j.1556-4029.2007.00562.x; BROWN GW, 1973, PSYCHOL MED, V3, P159, DOI 10.1017/S0033291700048492; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Cervilla JA, 2007, MOL PSYCHIATR, V12, P748, DOI 10.1038/sj.mp.4001981; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chipman P, 2007, AM J MED GENET B, V144B, P561, DOI 10.1002/ajmg.b.30480; Chorbov VM, 2007, AM J MED GENET B, V144B, P830, DOI 10.1002/ajmg.b.30534; Dean M, 1996, SCIENCE, V274, P1069; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DOHRENWEND BP, 1974, ANNU REV PSYCHOL, V25, P417, DOI 10.1146/annurev.ps.25.020174.002221; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; EATON WW, 1978, J HEALTH SOC BEHAV, V19, P230, DOI 10.2307/2136537; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Guo G, 2007, EUR J HUM GENET, V15, P279, DOI 10.1038/sj.ejhg.5201763; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Holden C, 2003, SCIENCE, V301, P291; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Joober R, 2007, AM J PSYCHIAT, V164, P829, DOI 10.1176/appi.ajp.164.5.829-b; Katsuyama H, 2008, INT J MOL MED, V21, P499; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; LAUCHT M, 2009, INT J NEUROPSYCHOPH, P1, DOI DOI 10.1017/S1461145708009875; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Mather K, 1982, BIOMETRICAL GENETICS; Merikangas KR, 2003, AM J PSYCHIAT, V160, P625, DOI 10.1176/appi.ajp.160.4.625; Middeldorp CM, 2008, PSYCHOL MED, V38, P1557, DOI 10.1017/S0033291708002985; Middeldorp CM, 2007, BEHAV GENET, V37, P294, DOI 10.1007/s10519-006-9139-7; Monroe SM, 2008, PSYCHOL SCI, V19, P947, DOI 10.1111/j.1467-9280.2008.02181.x; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; *NAT I MENT HLTH, 2006, NAT I MENT HLTH WORK; OLFSON M, 1993, AM J PSYCHIAT, V150, P571; Ottman R, 1996, PREV MED, V25, P764, DOI 10.1006/pmed.1996.0117; Power T, 2010, NEUROBIOL AGING, V31, P886, DOI 10.1016/j.neurobiolaging.2008.06.006; QUEST DIAGNOSTICS, Patent No. 11010244; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Scheid JM, 2007, GENES BRAIN BEHAV, V6, P453, DOI 10.1111/j.1601-183X.2006.00272.x; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Veletza S, 2009, SYNAPSE, V63, P193, DOI 10.1002/syn.20598; Wichers M, 2008, AM J MED GENET B, V147B, P120, DOI 10.1002/ajmg.b.30576; Wilhelm K, 2006, BRIT J PSYCHIAT, V188, P210, DOI 10.1192/bjp.bp.105.009522; Wilhelm K, 2009, BRIT J PSYCHIAT, V194, P404, DOI 10.1192/bjp.bp.107.047514; Wray N. R., 2008, NOVART FDN SYMP, V293, P59; Wray Naomi R, 2008, Novartis Found Symp, V293, P48; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588; Zammit S, 2006, BRIT J PSYCHIAT, V188, P199, DOI 10.1192/bjp.bp.105.020644	71	1208	1226	3	304	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2462	2471		10.1001/jama.2009.878	http://dx.doi.org/10.1001/jama.2009.878			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531786	Green Accepted, Green Submitted			2022-12-28	WOS:000267028100024
J	Warren, JL; Klabunde, CN; Mariotto, AB; Meekins, A; Topor, M; Brown, ML; Ransohoff, DF				Warren, Joan L.; Klabunde, Carrie N.; Mariotto, Angela B.; Meekins, Angela; Topor, Marie; Brown, Martin L.; Ransohoff, David F.			Adverse Events After Outpatient Colonoscopy in the Medicare Population	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; COLORECTAL-CANCER; SCREENING COLONOSCOPY; DIAGNOSTIC YIELD; UNITED-STATES; LOW-RISK; COMPLICATIONS; GUIDELINES; SURVEILLANCE; PERFORATION	Background: Although use of colonoscopy has increased substantially among elderly Medicare beneficiaries, no one has described colonoscopy-related adverse events in a representative sample of Medicare patients. Objective: To determine risk for adverse events after outpatient colonoscopy in elderly patients. Design: Population-based, matched cohort study. Setting: Surveillance, Epidemiology, and End Results cancer registry areas. Patients: Random 5% sample of Medicare beneficiaries, age 66 to 95 years, who underwent outpatient colonoscopy between 1 July 2001 and 31 October 2005 (n = 53 220), matched with beneficiaries who did not have colonoscopy. Measurements: Medicare claims were used to measure the rate of serious gastrointestinal events (bleeding and perforation), other gastrointestinal events, and cardiovascular events resulting in a hospitalization or emergency department visit within 30 days after colonoscopy compared with matched beneficiaries who did not have colonoscopy. Logistic regression was used to estimate adjusted predictive risks for adverse events and to assess whether these events varied by age, comorbid conditions, or type of colonoscopy. Results: Persons undergoing colonoscopy had a higher risk for adverse gastrointestinal events than their matched group. Rates of adverse events after colonoscopy increased with age. Patients having polypectomy had higher risk for all adverse events compared with their matched group and with the screening and diagnostic colonoscopy groups. Comorbid conditions increased the risk for adverse events. Patients with a history of stroke, chronic obstructive pulmonary disease, atrial fibrillation, or congestive heart failure had significantly higher risk for serious gastrointestinal events. Limitation: The analysis relied on the diagnosis and procedure codes recorded on the Medicare claims. Conclusion: Risks for adverse events after outpatient colonoscopy among elderly Medicare beneficiaries were low; however, they increased with age with specific comorbid conditions and depending on whether polypectomy was done. These data may inform decisions on whether to perform colonoscopy in persons of advanced age or those with comorbid conditions.	[Warren, Joan L.] NCI, Hlth Serv & Econ Branch, Appl Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; Informat Management Serv Inc, Silver Spring, MD USA; Univ N Carolina, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; University of North Carolina; University of North Carolina Chapel Hill	Warren, JL (corresponding author), NCI, Hlth Serv & Econ Branch, Appl Res Program, Div Canc Control & Populat Sci, Execut Plaza N,Room 4005,6130 Execut Blvd,MSC 734, Bethesda, MD 20892 USA.	joan_warren@nih.gov						American Medical Association, 2004, CPT 2005 CURR PROC T; Arora A, 2004, GASTROINTEST ENDOSC, V60, P408, DOI 10.1016/S0016-5107(04)01715-8; Beloosesky Y, 2003, ARCH INTERN MED, V163, P803, DOI 10.1001/archinte.163.7.803; Brawarsky P, 2004, CANCER DETECT PREV, V28, P260, DOI 10.1016/j.cdp.2004.04.006; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Canada Robin E, 2007, J Fam Pract, V56, pE1; Centers for Medicare and Medicaid Services, HEALTHC COMM PROC CO; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper GS, 2006, AM J GASTROENTEROL, V101, P1715; Duncan JE, 2006, DIS COLON RECTUM, V49, P646, DOI 10.1007/s10350-005-0306-3; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Janz NK, 2003, PREV MED, V37, P627, DOI 10.1016/j.ypmed.2003.09.016; JAVITT JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P605, DOI 10.1001/archopht.1993.01090050039024; Karajeh MA, 2006, ENDOSCOPY, V38, P226, DOI 10.1055/s-2005-921209; Katz JN, 1997, ARTHRITIS RHEUM, V40, P1594, DOI 10.1002/art.1780400908; Ko CW, 2007, GASTROINTEST ENDOSC, V65, P648, DOI 10.1016/j.gie.2006.06.020; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Lichtenstein GR, 2007, ALIMENT PHARM THER, V26, P633, DOI 10.1111/j.1365-2036.2007.03406.x; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sardinha TC, 1999, INT J COLORECTAL DIS, V14, P172, DOI 10.1007/s003840050205; Schenck AP, 2007, CANCER EPIDEM BIOMAR, V16, P2118, DOI 10.1158/1055-9965.EPI-07-0123; Sharma VK, 2007, GASTROINTEST ENDOSC, V66, P27, DOI 10.1016/j.gie.2006.12.040; Shih YCT, 2006, HEALTH AFFAIR, V25, P1153, DOI 10.1377/hlthaff.25.4.1153; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; Subramanian S, 2004, PREV MED, V38, P536, DOI 10.1016/j.ypmed.2003.12.011; URE T, 1995, SURG ENDOSC-ULTRAS, V9, P505; *US DEP HHS, 2006, AR RES FIL ARF; *US PHS, 2003, INT CLASS DIS 9 REV; Warren JL, 2002, MED CARE, V40, P3; Wexner SD, 1998, SURG ENDOSC-ULTRAS, V12, P1410, DOI 10.1007/s004649900870; Wexner SD, 2006, SURG ENDOSC, V20, P1147, DOI 10.1007/s00464-006-0152-y; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Wolf MS, 2007, J GEN INTERN MED, V22, P1493, DOI 10.1007/s11606-007-0289-y; Yabroff KR, 2007, J NATL CANCER I, V99, P14, DOI 10.1093/jnci/djk001; Zubarik R, 1999, GASTROINTEST ENDOSC, V50, P322, DOI 10.1053/ge.1999.v50.97111; YIELD SAFTEY COLONSC	49	304	314	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					849	U51		10.7326/0003-4819-150-12-200906160-00008	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528563				2022-12-28	WOS:000267164800004
J							Bari D Study Grp	A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; CLINICAL-OUTCOMES; GLYCEMIC CONTROL; RISK-FACTORS; REVASCULARIZATION; PIOGLITAZONE; GLIMEPIRIDE; RATIONALE	BACKGROUND Optimal treatment for patients with both type 2 diabetes mellitus and stable ischemic heart disease has not been established. METHODS We randomly assigned 2368 patients with both type 2 diabetes and heart disease to undergo either prompt revascularization with intensive medical therapy or intensive medical therapy alone and to undergo either insulin-sensitization or insulin-provision therapy. Primary end points were the rate of death and a composite of death, myocardial infarction, or stroke (major cardiovascular events). Randomization was stratified according to the choice of percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) as the more appropriate intervention. RESULTS At 5 years, rates of survival did not differ significantly between the revascularization group (88.3%) and the medical-therapy group (87.8%, P = 0.97) or between the insulin-sensitization group (88.2%) and the insulin-provision group (87.9%, P = 0.89). The rates of freedom from major cardiovascular events also did not differ significantly among the groups: 77.2% in the revascularization group and 75.9% in the medical-treatment group (P = 0.70) and 77.7% in the insulin-sensitization group and 75.4% in the insulin-provision group (P = 0.13). In the PCI stratum, there was no significant difference in primary end points between the revascularization group and the medical-therapy group. In the CABG stratum, the rate of major cardiovascular events was significantly lower in the revascularization group (22.4%) than in the medical-therapy group (30.5%, P = 0.01; P = 0.002 for interaction between stratum and study group). Adverse events and serious adverse events were generally similar among the groups, although severe hypoglycemia was more frequent in the insulin-provision group (9.2%) than in the insulin-sensitization group (5.9%, P = 0.003). CONCLUSIONS Overall, there was no significant difference in the rates of death and major cardiovascular events between patients undergoing prompt revascularization and those undergoing medical therapy or between strategies of insulin sensitization and insulin provision. (ClinicalTrials.gov number, NCT00006305.)					Marroquin, Oscar C/F-2214-2015	Marroquin, Oscar C/0000-0002-0909-0319; IKENO, FUMIAKI/0000-0003-2905-0311	National Heart, Lung and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases [U01-HL061744, U01-HL061746, U01-HL061748, U01-HL063804]; GlaxoSmithKline; Lantheus Medical Imaging; Astellas Pharma; Merck; Abbott Laboratories; Pfizer; MediSense; Baye; Becton Dickinson; J. R. Carlson Labs; Centocor; Eli Lilly; LipoScience; Novartis; Novo Nordisk; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL061744, U01HL063804, U01HL061746, U01HL061748] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); Lantheus Medical Imaging; Astellas Pharma(Astellas Pharmaceuticals); Merck(Merck & Company); Abbott Laboratories(Abbott Laboratories); Pfizer(Pfizer); MediSense; Baye; Becton Dickinson; J. R. Carlson Labs; Centocor; Eli Lilly(Eli Lilly); LipoScience; Novartis(Novartis); Novo Nordisk(Novo Nordisk); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01-HL061744, U01-HL061746, U01-HL061748, and U01-HL063804) from the National Heart, Lung and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases; and by GlaxoSmithKline, Lantheus Medical Imaging, Astellas Pharma, Merck, Abbott Laboratories, Pfizer, MediSense, Bayer, Becton Dickinson, J. R. Carlson Labs, Centocor, Eli Lilly, LipoScience, Novartis, and Novo Nordisk.	Abizaid A, 1998, J AM COLL CARDIOL, V32, P584, DOI 10.1016/S0735-1097(98)00286-1; Albu J, 2006, AM J CARDIOL, V97, p41G, DOI 10.1016/j.amjcard.2006.03.012; Alderman EL, 1996, NEW ENGL J MED, V335, P217; [Anonymous], 1995, DIABETES AM; Barsness GW, 2006, AM J CARDIOL, V97, p31G, DOI 10.1016/j.amjcard.2006.03.011; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brooks MM, 2008, AM HEART J, V156, P528, DOI [10.1016/j.ahj.2008.05.015, 10.1016/j.ajh.2008.05.015]; Brooks MM, 2006, AM J CARDIOL, V97, p9G, DOI 10.1016/j.amjcard.2006.02.023; Chamberlain DA, 1997, LANCET, V350, P461; DETRE K, 1977, LANCET, V2, P1243; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; George PB, 2001, AM HEART J, V142, P857, DOI 10.1067/mhj.2001.119132; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Kim LJ, 2009, JACC-CARDIOVASC INTE, V2, P384, DOI 10.1016/j.jcin.2009.01.009; Kronmal RA, 2004, J CLIN ENDOCR METAB, V89, P2852, DOI 10.1210/jc.2003-031822; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Lakkis Nasser, 2002, Crit Pathw Cardiol, V1, P232, DOI 10.1097/00132577-200212000-00005; Magee MF, 2006, AM J CARDIOL, V97, p20G, DOI 10.1016/j.amjcard.2006.02.024; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; McFarlane SI, 2002, DIABETES CARE, V25, P718, DOI 10.2337/diacare.25.4.718; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pepine CJ, 1999, J CARDIAC SURG, V14, P1, DOI 10.1111/j.1540-8191.1999.tb00943.x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; The Bypass Angioplasty Revascularization Investigation (BARI) Investigators, 1997, NEW ENGL J MED, V336, P147; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; YUSUF, 1994, LANCET, V344, P1446; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	37	582	600	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2503	2515		10.1056/NEJMoa0805796	http://dx.doi.org/10.1056/NEJMoa0805796			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19502645	Green Accepted			2022-12-28	WOS:000266813800005
J	Gostin, LO				Gostin, Lawrence O.			Influenza A(H1N1) and Pandemic Preparedness Under the Rule of International Law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PUBLIC-HEALTH		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2005, FED REGISTER, V70, p[71, 892]; [Anonymous], 2009, BBC NEWS        0505; Beitsch LM, 2006, HEALTH AFFAIR, V25, P911, DOI 10.1377/hlthaff.25.4.911; CAMPBELL C, 2005, SARS COMMISSION 2 IN; CHAN M, 2009, SWINE INFLUENZA STAT; CHAN M, 2009, INFLUENZA A H1N1 STA; CHENG J, 2009, WALL STREET J   0505, pA1; Fidler DP, 2006, J LAW MED ETHICS, V34, P85, DOI 10.1111/j.1748-720X.2006.00011.x; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Oster S., 2009, WALL STREET J, pA10; *US DEP ED, H1N1 FLU US SCH ANSW; WHO, EP PAND AL RESP EPR; 2009, LOS ANGELES TIM 0502; 2009, ECONOMIST       0430	14	38	39	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2376	2378		10.1001/jama.2009.849	http://dx.doi.org/10.1001/jama.2009.849			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	455OT	19509384	Green Published			2022-12-28	WOS:000266773400030
J	Brown, J; Pengas, G; Dawson, K; Brown, LA; Clatworthy, P				Brown, Jeremy; Pengas, George; Dawson, Kate; Brown, Lucy A.; Clatworthy, Philip			Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MINI-MENTAL-STATE; MEDICAL-PRACTICE; EARLY-DIAGNOSIS; TEST BATTERY; IMPAIRMENT; DEMENTIA; CONSORTIUM; CONSENSUS; ACE	Objective To evaluate a cognitive test, the TYM ("test your memory"), in the detection of Alzheimer's disease. Design Cross sectional study. Setting Outpatient departments in three hospitals, including a memory clinic. Participants 540 control participants aged 18-95 and 139 patients attending a memory clinic with dementia/amnestic mild cognitive impairment. Intervention Cognitive test designed to use minimal operator time and to be suitable for non-specialist use. Main outcome measures Performance of normal controls on the TYM. Performance of patients with Alzheimer's disease on the TYM compared with age matched controls. Validation of the TYM with two standard tests (the mini-mental state examination (MMSE) and the Addenbrooke's cognitive examination-revised (ACE-R)). Sensitivity and specificity of the TYM in the detection of Alzheimer's disease. Results Control participants completed the TYM with an average score of 47/50. Patients with Alzheimer's disease scored an average of 33/50. The TYM score shows excellent correlation with the two standard tests. A score of <= 42/50 had a sensitivity of 93% and specificity of 86% in the diagnosis of Alzheimer's disease. The TYM was more sensitive in detection of Alzheimer's disease than the mini-mental examination, detecting 93% of patients compared with 52% for the mini-mental state exxamination. The negative and positive predictive values of the TYM with the cut off of <= 42 were 99% and 42% with a prevalence of Alzheimer's disease of 10%. Thirty one patients with non-Alzheimer dementias scored an average of 39/50. Conclusions The TYM can be completed quickly and accurately by normal controls. It is a powerful and valid screening test for the detection of Alzheimer's disease.	[Brown, Jeremy; Dawson, Kate; Brown, Lucy A.] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Brown, J (corresponding author), Addenbrookes Hosp, Dept Neurol, Hills Rd, Cambridge CB2 2QQ, England.	jmb75@medschl.cam.ac.uk	Clatworthy, Phil/E-5288-2010	Clatworthy, Phil/0000-0002-1206-3573	Alzheimer's Research Trust (UK); Cambridge Commonwealth Trust; Stroke Association; MRC [G84/6735] Funding Source: UKRI; Alzheimers Research UK [ART-CRF2007-1] Funding Source: researchfish; Medical Research Council [G84/6735] Funding Source: researchfish	Alzheimer's Research Trust (UK); Cambridge Commonwealth Trust; Stroke Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GP was supported by Alzheimer's Research Trust (UK) and the Cambridge Commonwealth Trust. PC was supported by the Stroke Association. The authors are independent of any funders for this work. All authors had access to all data in this study.	Bier JC, 2005, DEMENT GERIATR COGN, V19, P15, DOI 10.1159/000080965; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALASKO D, 1990, ARCH NEUROL-CHICAGO, V47, P49, DOI 10.1001/archneur.1990.00530010061020; Galton CJ, 2005, COGN BEHAV NEUROL, V18, P144, DOI 10.1097/01.wnn.0000182831.47073.e9; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Holmes J, 1996, BRIT MED J, V313, P465; JITAPUNKUL S, 1991, AGE AGEING, V20, P332, DOI 10.1093/ageing/20.5.332; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; MacKenzie DM, 1996, PSYCHOL MED, V26, P427, DOI 10.1017/S0033291700034826; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; NAUGLE RI, 1989, CLEV CLIN J MED, V56, P277, DOI 10.3949/ccjm.56.3.277; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; *NICE, 2007, NICE TECHN GUID, V111; NICHONCHUBHAIR A, 1995, BRIT J ANAESTH, V75, P481, DOI 10.1093/bja/75.4.481; Philpot M, 2004, INT PSYCHOGERIATR, V16, P251, DOI 10.1017/S1041610204000419; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Tangalos EG, 1996, MAYO CLIN PROC, V71, P829, DOI 10.4065/71.9.829; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Woodford HJ, 2007, QJM-INT J MED, V100, P469, DOI 10.1093/qjmed/hcm051	30	133	136	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2009	338								b2030	10.1136/bmj.b2030	http://dx.doi.org/10.1136/bmj.b2030			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458LG	19509424	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000267021800003
J	Schattner, A				Schattner, Ami			As sharp as Occam?	LANCET			English	Editorial Material							SPINAL SUBDURAL-HEMATOMA		[Schattner, Ami] Kaplan Med Ctr, Dept Med, Rehovot, Israel; [Schattner, Ami] Hebrew Univ Jerusalem, Hadassah Med Sch, Fac Med, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem	Schattner, A (corresponding author), Kaplan Med Ctr, Dept Med, Rehovot, Israel.	amiMD@clalit.org.il	Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Domenicucci M, 1999, J NEUROSURG, V91, P65, DOI 10.3171/spi.1999.91.1.0065; Kyriakides AE, 2007, SPINE, V32, pE619, DOI 10.1097/BRS.0b013e318154c618; Lo Re V III, 2002, ANN INTERN MED, V136, P634, DOI 10.7326/0003-4819-136-8-200204160-00022	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1996	1996		10.1016/S0140-6736(09)60696-6	http://dx.doi.org/10.1016/S0140-6736(09)60696-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19501747				2022-12-28	WOS:000266832500036
J	[Anonymous]				[Anonymous]			Alcohol and harm reduction in Russia	LANCET			English	Editorial Material																			0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2171	2171						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560580				2022-12-28	WOS:000267444500001
J	Carrano, AC; Liu, Z; Dillin, A; Hunter, T				Carrano, Andrea C.; Liu, Zheng; Dillin, Andrew; Hunter, Tony			A conserved ubiquitination pathway determines longevity in response to diet restriction	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; LIFE-SPAN; PHARYNGEAL DEVELOPMENT; TRANSCRIPTION FACTOR; GENETICS; DAF-16; LIGASE; INSULIN/IGF-1; DEGRADATION	Dietary restriction extends longevity in diverse species, suggesting that there is a conserved mechanism for nutrient regulation and prosurvival responses(1). Here we show a role for the HECT (homologous to E6AP carboxy terminus) E3 ubiquitin ligase WWP-1 as a positive regulator of lifespan in Caenorhabditis elegans in response to dietary restriction. We find that overexpression of wwp-1 in worms extends lifespan by up to 20% under conditions of ad libitum feeding. This extension is dependent on the FOXA transcription factor pha-4, and independent of the FOXO transcription factor daf-16. Reduction of wwp-1 completely suppresses the extended longevity of diet-restricted animals. However, the loss of wwp-1 does not affect the long lifespan of animals with compromised mitochondrial function or reduced insulin/IGF-1 signalling. Overexpression of a mutant form of WWP-1 lacking catalytic activity suppresses the increased lifespan of diet-restricted animals, indicating that WWP-1 ubiquitin ligase activity is essential for longevity. Furthermore, we find that the E2 ubiquitin conjugating enzyme, UBC-18, is essential and specific for diet-restriction-induced longevity. UBC-18 interacts with WWP-1 and is required for the ubiquitin ligase activity of WWP-1 and the extended longevity of worms overexpressing wwp-1. Taken together, our results indicate that WWP-1 and UBC-18 function to ubiquitinate substrates that regulate diet-restriction-induced longevity.	[Carrano, Andrea C.; Liu, Zheng; Dillin, Andrew; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Liu, Zheng; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Liu, Zheng; Dillin, Andrew] Glenn Ctr Aging Res, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Dillin@salk.edu	Liu, Zheng/E-6302-2012	Liu, Zheng/0000-0002-7968-3849	National Institutes of Health (NIH) National Center for Research Resources (NCRR); National Cancer Institute [CA 14195, CA 54418, CA 82683]; National Institute of Diabetes and Digestive and Kidney Diseases [DK 070696]; National Institute on Aging [AG 027463, AG 032560]; Ellison Medical and Glenn Medical Foundations; American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA082683, P01CA054418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463, R21AG032560] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical and Glenn Medical Foundations; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Dillin laboratory for discussion, and P. Marks and H. Sun for their help. We thank A. Brunet for the solid-plate diet-restriction protocol. wwp-1(ok1102) was generated by the C. elegans Gene Knockout Consortium, and some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) National Center for Research Resources (NCRR). This work was supported by grants from the National Cancer Institute (CA 14195, CA 54418 and CA 82683) to T. H., and grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK 070696) and the National Institute on Aging (AG 027463 and AG 032560), and the Ellison Medical and Glenn Medical Foundations to A. D. A. C. C. was supported by an American Cancer Society Postdoctoral Fellowship and The Rossi Endowment. T. H. is a Frank and Else Schilling American Cancer Society Professor.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Astin JW, 2008, DNA REPAIR, V7, P267, DOI 10.1016/j.dnarep.2007.10.004; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; Fay DS, 2004, DEV BIOL, V271, P11, DOI 10.1016/j.ydbio.2004.03.022; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; HOPE IA, 1999, C ELEGANS PRACTICAL, P62; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huang K, 2000, GENE, V252, P137, DOI 10.1016/S0378-1119(00)00216-X; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Qiu XH, 2006, DEV BIOL, V291, P239, DOI 10.1016/j.ydbio.2005.11.045; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200	38	91	103	1	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					396	U113		10.1038/nature08130	http://dx.doi.org/10.1038/nature08130			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19553937	Green Accepted			2022-12-28	WOS:000267979000039
J	Mitchell, A; Romano, GH; Groisman, B; Yona, A; Dekel, E; Kupiec, M; Dahan, O; Pilpel, Y				Mitchell, Amir; Romano, Gal H.; Groisman, Bella; Yona, Avihu; Dekel, Erez; Kupiec, Martin; Dahan, Orna; Pilpel, Yitzhak			Adaptive prediction of environmental changes by microorganisms	NATURE			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; FLUCTUATING ENVIRONMENTS; GENE-EXPRESSION; STRESS-RESPONSE; YEAST; GENOME; RESISTANCE; EVOLUTION; GROWTH	Natural habitats of some microorganisms may fluctuate erratically, whereas others, which are more predictable, offer the opportunity to prepare in advance for the next environmental change. In analogy to classical Pavlovian conditioning, microorganisms may have evolved to anticipate environmental stimuli by adapting to their temporal order of appearance. Here we present evidence for environmental change anticipation in two model microorganisms, Escherichia coli and Saccharomyces cerevisiae. We show that anticipation is an adaptive trait, because pre-exposure to the stimulus that typically appears early in the ecology improves the organism's fitness when encountered with a second stimulus. Additionally, we observe loss of the conditioned response in E. coli strains that were repeatedly exposed in a laboratory evolution experiment only to the first stimulus. Focusing on the molecular level reveals that the natural temporal order of stimuli is embedded in the wiring of the regulatory network-early stimuli pre-induce genes that would be needed for later ones, yet later stimuli only induce genes needed to cope with them. Our work indicates that environmental anticipation is an adaptive trait that was repeatedly selected for during evolution and thus may be ubiquitous in biology.	[Mitchell, Amir; Groisman, Bella; Yona, Avihu; Dahan, Orna; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Romano, Gal H.; Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Dekel, Erez] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Pilpel, Yitzhak] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Weizmann Institute of Science; Tel Aviv University; Weizmann Institute of Science; Harvard University; Harvard Medical School	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il	Mitchell, Amir/AAS-1148-2020	Mitchell, Amir/0000-0001-9376-3987; Yona, Avihu H./0000-0002-3923-4897	Tauber Foundation; Minerva Foundation; Israel Science Foundation; European Research Council; Ben May Foundation; Israeli Ministry of Science and Technology	Tauber Foundation; Minerva Foundation; Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Ben May Foundation; Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	We thank S. Trattner-Frenkel and Z. Bloom for their help and support in the yeast microarray experiments. We thank members of the Pilpel laboratory for many discussions. We thank E. Schneidman, E. Ben-Jacob, M. Springer, A. Tanay, U. Alon and D. Cavalieri for discussions and advice. We thank U. Alon for providing the promoter-GFP fused plasmids. We thank the Tauber Foundation, the Minerva Foundation, the Israel Science Foundation 'Bikura program', the European Research Council 'Ideas Program' and the Ben May Foundation for grant support. M. K. was supported from grants from the Israel Science Foundation and the Israeli Ministry of Science and Technology.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bauer F. F., 2000, South African Journal of Enology and Viticulture, V21, P27; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Braun E, 2004, PHYS BIOL, V1, P67, DOI 10.1088/1478-3967/1/2/003; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Johnston M., 1992, MOL CELLULAR BIOL YE, P193; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Maris AF, 2001, CURR GENET, V39, P137, DOI 10.1007/s002940100194; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; SABLAYROLLES JM, 1993, AM J ENOL VITICULT, V44, P127; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Savageau MA, 1998, GENETICS, V149, P1677; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	29	353	366	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					220	U80		10.1038/nature08112	http://dx.doi.org/10.1038/nature08112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19536156				2022-12-28	WOS:000267761000033
J	Nelson, MR				Nelson, Michael R.			Building an Open Cloud	SCIENCE			English	Editorial Material									Georgetown Univ, Commun Culture & Technol Program, Washington, DC 20057 USA	Georgetown University	Nelson, MR (corresponding author), Georgetown Univ, Commun Culture & Technol Program, Washington, DC 20057 USA.	mnelson@pobox.com	Nelson, Michael Shawn/GXF-4934-2022					ARMBRUST M, 2009, UBSEECS200928; Atkins D.E., 2003, REVOLUTIONIZING SCI; Bell G, 2009, SCIENCE, V323, P1297, DOI 10.1126/science.1170411; BORGMAN CL, 2007, SCHOLARSHIP DIGITAL, P3; Gilder G, 2008, ESTIMATING EXAFLOOD; Jonathan Zittrain, 2009, FUTURE INTERNET STOP; NELSON MR, 2005, TEL POL RES C; Rogers JD, 1998, INFORM SOC, V14, P213, DOI 10.1080/019722498128836; SCHMIDT E, 2006, ECONOMIST       1116; 2008, ECONOMIST       1023	10	17	20	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1656	1657		10.1126/science.1174225	http://dx.doi.org/10.1126/science.1174225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462GE	19556494				2022-12-28	WOS:000267338200023
J	Pelupessy, P; Rennella, E; Bodenhausen, G				Pelupessy, Philippe; Rennella, Enrico; Bodenhausen, Geoffrey			High-Resolution NMR in Magnetic Fields with Unknown Spatiotemporal Variations	SCIENCE			English	Article							SINGLE-SCAN; INHOMOGENEOUS FIELDS; SPECTROSCOPY; SPECTRA; ACQUISITION	Nuclear magnetic resonance (NMR) experiments are usually carried out in homogeneous magnetic fields. In many cases, however, high-resolution spectra are virtually impossible to obtain because of the inherent heterogeneity of the samples or living organisms under investigation, as well as the poor homogeneity of the magnets (particularly when bulky samples must be placed outside their bores). Unstable power supplies and vibrations arising from cooling can lead to field fluctuations in time as well as space. We show how high-resolution NMR spectra can be obtained in inhomogeneous fields with unknown spatiotemporal variations. Our method, based on coherence transfer between spins, can accommodate spatial inhomogeneities of at least 11 gauss per centimeter and temporal fluctuations slower than 2 hertz.	[Pelupessy, Philippe; Bodenhausen, Geoffrey] Ecole Normale Super, Dept Chim, CNRS, F-75231 Paris 05, France; [Rennella, Enrico] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Bodenhausen, Geoffrey] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Udine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pelupessy, P (corresponding author), Ecole Normale Super, Dept Chim, CNRS, 24 Rue Lhomond, F-75231 Paris 05, France.	philippe.pelupessy@ens.fr	Bodenhausen, Geoffrey/AAS-7726-2020		CNRS; Agence Nationale pour la Recherche; Integrated Infrastructure Initiative (I3) of the 6th Framework Program of the EC [RII3-026145]; Fonds National de la Recherche Scientifique (Switzerland); Commission pour la Technologie et l Innovation (Switzerland)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Integrated Infrastructure Initiative (I3) of the 6th Framework Program of the EC(European Commission); Fonds National de la Recherche Scientifique (Switzerland); Commission pour la Technologie et l Innovation (Switzerland)	Supported by CNRS, the Agence Nationale pour la Recherche, the Integrated Infrastructure Initiative (I3) of the 6th Framework Program of the EC (contract RII3-026145, EU-NMR), the Fonds National de la Recherche Scientifique (Switzerland), and the Commission pour la Technologie et l Innovation (Switzerland).	Blumich B, 2008, PROG NUCL MAG RES SP, V52, P197, DOI 10.1016/j.pnmrs.2007.10.002; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; COX IJ, 1986, J MAGN RESON, V70, P163, DOI 10.1016/0022-2364(86)90373-2; Demas V, 2006, CONCEPT MAGN RESON B, V29B, P137, DOI 10.1002/cmr.b.20069; Eidmann G, 1996, J MAGN RESON SER A, V122, P104, DOI 10.1006/jmra.1996.0185; FREEMAN R, 1971, J CHEM PHYS, V54, P301, DOI 10.1063/1.1674608; Frydman L, 2002, P NATL ACAD SCI USA, V99, P15858, DOI 10.1073/pnas.252644399; Frydman L, 2003, J AM CHEM SOC, V125, P9204, DOI 10.1021/ja030055b; Galiana G, 2005, J AM CHEM SOC, V127, P17574, DOI 10.1021/ja054463m; Giraudeau P, 2008, J MAGN RESON, V195, P9, DOI 10.1016/j.jmr.2008.08.001; Giraudeau P, 2007, J MAGN RESON, V186, P352, DOI 10.1016/j.jmr.2007.03.007; HAHN EL, 1952, PHYS REV, V88, P1070, DOI 10.1103/PhysRev.88.1070; KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; McDonald PJ, 1997, PROG NUCL MAG RES SP, V30, P69, DOI 10.1016/S0079-6565(96)01035-7; Meriles CA, 2001, SCIENCE, V293, P82, DOI 10.1126/science.1061498; Mountford CE, 2004, CHEM REV, V104, P3677, DOI 10.1021/cr030410g; NAGAYAMA K, 1979, BIOCHEM BIOPH RES CO, V90, P305, DOI 10.1016/0006-291X(79)91625-5; Pelupessy P, 2003, J AM CHEM SOC, V125, P12345, DOI 10.1021/ja034958g; Pelupessy P, 2008, J MAGN RESON, V194, P169, DOI 10.1016/j.jmr.2008.06.023; Perlo J, 2005, SCIENCE, V308, P1279, DOI 10.1126/science.1108944; Shapira B, 2004, J AM CHEM SOC, V126, P7184, DOI 10.1021/ja048859u; Shapira B, 2007, CHEM PHYS LETT, V442, P478, DOI 10.1016/j.cplett.2007.06.016; Shapira B, 2006, J MAGN RESON, V182, P12, DOI 10.1016/j.jmr.2006.04.012; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; VOLD RL, 1970, J CHEM PHYS, V53, P449, DOI 10.1063/1.1673804; WOKAUN A, 1977, CHEM PHYS LETT, V52, P407, DOI 10.1016/0009-2614(77)80476-4	27	66	70	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1693	1697		10.1126/science.1175102	http://dx.doi.org/10.1126/science.1175102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556503	Green Published			2022-12-28	WOS:000267338200034
J	Heath, I				Heath, Iona			Life and Death It is not wrong to say no	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 23	2009	338								b2529	10.1136/bmj.b2529	http://dx.doi.org/10.1136/bmj.b2529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MM	19549650				2022-12-28	WOS:000267436300017
J	Chatterjee, A				Chatterjee, Anjan			Is it acceptable for people to take methylphenidate to enhance performance? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							COSMETIC NEUROLOGY; CONTROVERSY; MENTATION; MOVEMENT; MOOD		[Chatterjee, Anjan] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Chatterjee, Anjan] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Chatterjee, A (corresponding author), Univ Penn, Dept Neurol, 3 W Gates,3400 Spruce St, Philadelphia, PA 19104 USA.	anjan@mail.med.upenn.edu						Chatterjee A, 2006, J MED ETHICS, V32, P110, DOI 10.1136/jme.2005.013599; Chatterjee A, 2004, NEUROLOGY, V63, P968, DOI 10.1212/01.WNL.0000138438.88589.7C; Chatterjee A, 2007, CAMB Q HEALTHC ETHIC, V16, P129, DOI 10.1017/S0963180107070156; Chatterjee A, 2009, NATURE, V457, P532, DOI 10.1038/457532c; Cuttler L, 1996, JAMA-J AM MED ASSOC, V276, P531, DOI 10.1001/jama.276.7.531; Daniels N, 2000, CAMB Q HEALTHC ETHIC, V9, P309, DOI 10.1017/S0963180100903037; FRANK R, 1995, WINNER TAKE ALL STRA; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hall SS, 2003, SCI AM, V289, P54, DOI 10.1038/scientificamerican0903-54; Heilman K., 2005, CREATIVITY BRAIN; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Russo M, 2005, NEUROLOGY, V64, P1320, DOI 10.1212/WNL.64.7.1320-a; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schachter HA, 2001, CAN MED ASSOC J, V165, P1475; *THOMS REUT, 2009, PHYS DESK REF	15	9	9	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 18	2009	338								b1956	10.1136/bmj.b1956	http://dx.doi.org/10.1136/bmj.b1956			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460US	19541706	Green Published			2022-12-28	WOS:000267216800002
J	Jefferson, T				Jefferson, Tom			Pneumococcal vaccines: confronting the confounders	LANCET			English	Editorial Material							POLYSACCHARIDE VACCINE; CLINICAL EFFECTIVENESS; EFFICACY; ADULTS; METAANALYSIS		Cochrane Vaccines Field, I-00061 Rome, Italy		Jefferson, T (corresponding author), Cochrane Vaccines Field, I-00061 Rome, Italy.	jefferson.tom@gmail.com						*ACIP PNEUM VACC W, 2008, US PNEUM POL VACC PP; *CDCP NAT IMM PROG, PNEUM DIS PNEUM VACC; CHANG CC, 2007, COCHRANE DB SYST REV, V2; Conaty S, 2004, VACCINE, V22, P3214, DOI 10.1016/j.vaccine.2003.08.050; Cornu C, 2001, VACCINE, V19, P4780, DOI 10.1016/S0264-410X(01)00217-1; Davies EG, 2004, COCHRANE DB SYST REV, V1; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; FINE MJ, 1994, ARCH INTERN MED, V154, P2666, DOI 10.1001/archinte.1994.00420230051007; GRANGER R, 2006, COCHRANE DB SYST REV, V4; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Hutchison BG, 1999, CAN FAM PHYSICIAN, V45, P2381; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Moore R A, 2000, BMC Fam Pract, V1, P1, DOI 10.1186/1471-2296-1-1; Puig-Barbera J, 2002, Aten Primaria, V30, P269; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sheikh A, 2002, COCHRANE DB SYST REV, V1; Watson L, 2002, VACCINE, V20, P2166, DOI 10.1016/S0264-410X(02)00112-3; WHO, 2008, 23 VAL PNEUM POL VAC	20	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2008	2009		10.1016/S0140-6736(09)61093-X	http://dx.doi.org/10.1016/S0140-6736(09)61093-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19524765				2022-12-28	WOS:000267080100009
J	Hanage, WP; Fraser, C; Tang, J; Connor, TR; Corander, J				Hanage, William Paul; Fraser, Christophe; Tang, Jing; Connor, Thomas Richard; Corander, Jukka			Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus	SCIENCE			English	Article							BINDING PROTEIN GENES; STREPTOCOCCUS-PNEUMONIAE; PENICILLIN RESISTANCE; POPULATION-STRUCTURE; HORIZONTAL TRANSFER; CONJUGATE VACCINE; BAYESIAN-ANALYSIS; SEROTYPES; EVOLUTION; STRAINS	Streptococcus pneumoniae is a pathogen of global importance that frequently transfers genetic material between strains and on occasion across species boundaries. In an analysis of 1930 pneumococcal genotypes from six housekeeping genes and 94 genotypes from related species, we identified mosaic genotypes representing admixture between populations and found that these were significantly associated with resistance to several classes of antibiotics. We hypothesize that these observations result from a history of hyper-recombination, which means that these strains are more likely to acquire both divergent genetic material and resistance determinants. This could have consequences for the reemergence of drug resistance after pneumococcal vaccination and also for our understanding of diversification and speciation in recombinogenic bacteria.	[Hanage, William Paul; Fraser, Christophe; Connor, Thomas Richard] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Tang, Jing; Corander, Jukka] Abo Akad Univ, Dept Math, FI-20500 Turku, Finland	Imperial College London; Abo Akademi University	Hanage, WP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	w.hanage@imperial.ac.uk	Connor, Thomas/ABD-6533-2021; tang, jing/HHR-9815-2022; Tang, Jing/W-1764-2019; Connor, Thomas/E-7135-2011; Hanage, Bill/CAF-1813-2022; Connor, Thomas/ABE-5989-2020; Tang, Jing/H-4084-2012; Fraser, Christophe/A-8109-2008	Tang, Jing/0000-0001-7480-7710; Connor, Thomas/0000-0003-2394-6504; Tang, Jing/0000-0001-7480-7710; Fraser, Christophe/0000-0003-2399-9657	Royal Society; Computational Biology, Bioinformatics, and Biometry graduate school; UK Biotechnology and Biological Sciences Research Council; Academy of Finland [121301]; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish	Royal Society(Royal Society of London); Computational Biology, Bioinformatics, and Biometry graduate school; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the support of the Royal Society (W.P.H. and C.F.); the Computational Biology, Bioinformatics, and Biometry graduate school (J.T.); a UK Biotechnology and Biological Sciences Research Council studentship (to T.R.C.); and the Academy of Finland (J.C., grant no. 121301). We thank B. Spratt for helpful discussions.	Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; del Campo R, 2005, J CLIN MICROBIOL, V43, P2207, DOI 10.1128/JCM.43.5.2207-2214.2005; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DOWSON CG, 1990, P NATL ACAD SCI USA, V87, P5858, DOI 10.1073/pnas.87.15.5858; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; Enright MC, 1999, MOL BIOL EVOL, V16, P1687, DOI 10.1093/oxfordjournals.molbev.a026082; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Hakenbeck R, 1998, ELECTROPHORESIS, V19, P597, DOI 10.1002/elps.1150190423; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; Negri MC, 2002, ANTIMICROB AGENTS CH, V46, P528, DOI 10.1128/AAC.46.2.528-530.2002; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	25	127	127	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1454	1457		10.1126/science.1171908	http://dx.doi.org/10.1126/science.1171908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520963				2022-12-28	WOS:000266878700049
J	Symon, A; Winter, C; Inkster, M; Donnan, PT				Symon, Andrew; Winter, Clare; Inkster, Melanie; Donnan, Peter T.			Outcomes for births booked under an independent midwife and births in NHS maternity units: matched comparison study	BRITISH MEDICAL JOURNAL			English	Article							HOME BIRTHS; PERINATAL-MORTALITY; LITIGATION; AUSTRALIA; ENGLAND; PLACE; WALES; RATES	Objective To compare clinical outcomes between women employing an independent midwife and comparable pregnant women using NHS services. Design Anonymised matched cohort analysis. Cases from the database of the Independent Midwives' Association (IMA) matched up to 1: 5 with Scottish National Health Service (NHS) records for age, parity, year of birth, and socioeconomic status. Multivariable logistic regression models used to explore the relation between explanatory variables and outcomes; analyses controlled for potential confounding factors and adjusted for stratification. Setting UK databases 2002-5. Participants Anonymised records for 8676 women (7214 NHS; 1462 IMA). Main outcome measures Unassisted vertex delivery, live birth, perinatal death, onset of labour, gestation, use of analgesia, duration of labour, perineal trauma, Apgar scores, admission to neonatal intensive care, infant feeding. Results IMA cohort mothers were significantly more likely to achieve an unassisted vertex delivery than NHS cohort mothers (77.9% (1139) v 54.3% (3918); odds ratio 3.49, 95% confidence interval 2.99 to 4.07) but also significantly more likely to experience a stillbirth or a neonatal death (1.7% (25) v 0.6% (46); 5.91, 3.27 to 10.7). All odds ratios are adjusted for confounding factors. Exclusion of "high risk" cases from both cohorts showed a non-significant difference (0.5% (5) v 0.3% (18); 2.73, 0.87 to 8.55); the "low risk" IMA perinatal mortality rate is comparable with other studies of low risk births. Women in the IMA cohort had a higher incidence of pre-existing medical conditions (1.5% (22) v 1.0% (72) in the NHS cohort) and previous obstetric complications (21.0% (307) v 17.8% (1284)). The incidence of twin pregnancy was also higher (3.4% (50) v 3.1% (224)). In the IMA cohort, 66.0% of mothers (965/1462) had home births, compared with only 0.4% of NHS cohort mothers (27/7214). Spontaneous onset of labour was more common in the IMA group (96.6% (1405) v 74.5% (5365); 10.43, 7.74 to 14.0), and fewer mothers used pharmacological analgesia (40.2% (588) v 60.6% (4370); 0.42, 0.38 to 0.47). Mothers in the IMA cohort were much more likely to breast feed (88.0% (1286) v 64.0% (2759); 3.46, 2.84 to 4.20). Prematurity (4.3% (63) v 6.9% (498); 0.49, 0.35 to 0.69), low birth weight (4.0% (60) v 7.1%) (523); 0.93, 0.62 to 1.38), and rate of admission to neonatal intensive care (4.4% (65) v 9.3% (667); 0.43, 0.32 to 0.59) were all higher in the NHS dataset. Conclusions Healthcare policy tries to direct patient choice towards clinically appropriate and practicable options; nevertheless, pregnant women are free to make decisions about birth preferences, including place of delivery and staff in attendance. While clinical outcomes across a range of variables were significantly better for women accessing an independent midwife, the significantly higher perinatal mortality rates for high risk cases in this group indicate an urgent need for a review of these cases. The significantly higher prematurity and admission rates to intensive care in the NHS cohort also indicate an urgent need for review.	[Symon, Andrew; Winter, Clare] Univ Dundee, Sch Nursing & Midwifery, Dundee DD1 4HJ, Scotland; [Inkster, Melanie; Donnan, Peter T.] Univ Dundee, Community Hlth Sci, Dundee DD2 4BF, Scotland	University of Dundee; University of Dundee	Symon, A (corresponding author), Univ Dundee, Sch Nursing & Midwifery, Dundee DD1 4HJ, Scotland.	a.g.symon@dundee.ac.uk		Donnan, Peter/0000-0001-7828-0610; Symon, Andrew/0000-0001-9269-940X	East of Scotland Research Network; University of Dundee	East of Scotland Research Network; University of Dundee	This project was fully funded by a grant from the East of Scotland Research Network. All members of the research team are independent of the funder. The University of Dundee sponsored the study.	ANDERSON T, 2002, MIDIRS MIDWIFERY DIG, V12, P405; [Anonymous], 2008, CONF ENQ MAT CHILD H; [Anonymous], [No title captured]; Bastian H, 1998, BRIT MED J, V317, P384; BENNETT R, 2008, TIMES           0525; CAMPBELL R, 1984, BRIT MED J, V289, P721, DOI 10.1136/bmj.289.6447.721; Capstick B, 2004, BMJ-BRIT MED J, V328, P457, DOI 10.1136/bmj.328.7437.457; CAPSTICK B, 1991, BRIT MED J, V302, P230, DOI 10.1136/bmj.302.6770.230; *CEMACH, 2005, STILLB NEON POSTN MO; *CEMACH, 2006, PER MORT SURV REP 20; *CLIN NEGL SCHEM T, 2007, MAT CLIN RISK MAN ST; Confidential Enquiry into Maternal and Child Health, 2007, PER MORT 2005; *DEP HLTH, 2007, BREASTF NHS PRIOR PL; *DEP HLTH, 2006, MUCH IS TOO MUCH YOU; Department of Health, 1993, CHANGING CHILDBIRTH; Department of Health, 2007, CM7013; Department of Health, 2007, MAT MATT CHOIC ACC C; Department of Health (2007c), 2007, CHOIC MATT 2007 08 P; Edwards N., 2006, RISK CHOICE MATERNIT; FROHLICH J, 2007, MIDIRS MIDWIFERY DIG, V17, P313; GASKIN IM, 2003, MIDWIFERY TODAY INT, V66, P38; Grady MA, 2004, J MIDWIFERY WOM HEAL, V49, P412, DOI 10.1016/j.jmwh.2004.05.009; Healthcare Commission, 2007, WOM EXP MAT CAR NHS; HOSMER DW, 1989, APPL LOGISTIC REGRES; *HUM FERT EMBR AUT, FACTS FIG 2006; *ISD, 2006, SCOTT PER INF MORT M; Johnson KC, 2005, BRIT MED J, V330, P1416, DOI 10.1136/bmj.330.7505.1416; LINDGREN HE, 2008, MIDWIFERY, DOI DOI 10.1016/JMIDW.2008.04.010; Milan M., 2005, MIDIRS MIDWIFERY DIG, V15, P439; Mori R, 2008, BJOG-INT J OBSTET GY, V115, P554, DOI 10.1111/j.1471-0528.2008.01669.x; Murphy PA, 1998, OBSTET GYNECOL, V92, P461, DOI 10.1016/S0029-7844(98)00182-3; NHS Scotland, 2007, BETT HLTH BETT CAR; O'Neill, 2008, SAFE BIRTHS EVERYBOD; OLSEN O, 2000, COCHRANE DB SYST REV; Roberts CL, 2000, BRIT MED J, V321, P137, DOI 10.1136/bmj.321.7254.137; ROOKS JP, 1989, NEW ENGL J MED, V321, P1804, DOI 10.1056/NEJM198912283212606; Rothman K., 1998, MODERN EPIDEMIOLOGY; *ROYAL COLL OBST G, HOM BIRTHS JOINT STA, V2; SACN, 2008, INF FEED SURV 2005 C; *SCOTT EX, 2001, FRAM MAT SERV SCOTL; Shanley Laura, 1994, UNASSISTED CHILDBIRT; Shorten Allison, 2007, Women Birth, V20, P49, DOI 10.1016/j.wombi.2007.02.001; Symon AG, 2002, MIDWIFERY, V18, P35, DOI 10.1054/midw.2002.0297; Tayal Upasana, 2003, BMJ, V327, P249, DOI 10.1136/bmj.327.7409.249; Tew, 1998, SAFER CHILDBIRTH CRI; *WELSH ASS, 2004, ALL WAL CLIN PATHW N; WINTER C, 2002, THESIS S BANK U LOND; Zander L, 1999, BRIT MED J, V318, P721	48	20	20	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 11	2009	338								b2060	10.1136/bmj.b2060	http://dx.doi.org/10.1136/bmj.b2060			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LJ	19520729	Green Published, hybrid			2022-12-28	WOS:000267022100004
J	Zhang, YB; Tang, TT; Girit, C; Hao, Z; Martin, MC; Zettl, A; Crommie, MF; Shen, YR; Wang, F				Zhang, Yuanbo; Tang, Tsung-Ta; Girit, Caglar; Hao, Zhao; Martin, Michael C.; Zettl, Alex; Crommie, Michael F.; Shen, Y. Ron; Wang, Feng			Direct observation of a widely tunable bandgap in bilayer graphene	NATURE			English	Article							BERRYS PHASE	The electronic bandgap is an intrinsic property of semiconductors and insulators that largely determines their transport and optical properties. As such, it has a central role in modern device physics and technology and governs the operation of semiconductor devices such as p-n junctions, transistors, photodiodes and lasers(1). A tunable bandgap would be highly desirable because it would allow great flexibility in design and optimization of such devices, in particular if it could be tuned by applying a variable external electric field. However, in conventional materials, the bandgap is fixed by their crystalline structure, preventing such bandgap control. Here we demonstrate the realization of a widely tunable electronic bandgap in electrically gated bilayer graphene. Using a dual-gate bilayer graphene field-effect transistor (FET)(2) and infrared microspectroscopy(3-5), we demonstrate a gate-controlled, continuously tunable bandgap of up to 250 meV. Our technique avoids uncontrolled chemical doping(6-8) and provides direct evidence of a widely tunable bandgap-spanning a spectral range from zero to mid-infrared-that has eluded previous attempts(2,9). Combined with the remarkable electrical transport properties of such systems, this electrostatic bandgap control suggests novel nanoelectronic and nanophotonic device applications based on graphene.	[Zhang, Yuanbo; Tang, Tsung-Ta; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Shen, Y. Ron; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Hao, Zhao; Martin, Michael C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source Div, Berkeley, CA 94720 USA; [Zettl, Alex; Crommie, Michael F.; Shen, Y. Ron; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Hao, Zhao] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	wang, Feng/I-5727-2015; Hao, Zhao/G-2391-2015; Zettl, Alex K/O-4925-2016; 1.4, ALS Beamline/I-1886-2014; Girit, Çağlar/D-4845-2014; Girit, Çağlar/AFT-1507-2022; Martin, Michael C./ABH-9841-2020	wang, Feng/0000-0001-8369-6194; Hao, Zhao/0000-0003-0677-8529; Zettl, Alex K/0000-0001-6330-136X; Girit, Çağlar/0000-0001-8953-9261; Girit, Çağlar/0000-0001-8953-9261; Martin, Michael C./0000-0002-6611-070X	Office of Basic Energy Sciences, US Department of Energy [DE-AC03-76SF0098, DE-AC02-05CH11231]; Sloan fellowship; Miller fellowship; National Science Council of Taiwan	Office of Basic Energy Sciences, US Department of Energy(United States Department of Energy (DOE)); Sloan fellowship(Alfred P. Sloan Foundation); Miller fellowship; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Office of Basic Energy Sciences, US Department of Energy under contract DE-AC03-76SF0098 (Materials Science Division) and contract DE-AC02-05CH11231 (Advanced Light Source). F. W., Y. Z. and T.-T. T. acknowledge support from a Sloan fellowship, a Miller fellowship and a fellowship from the National Science Council of Taiwan, respectively.	Abergel DSL, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155430; ADAM S, 2007, PHYS REV B, V77, P5436; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Guinea F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245426; Huard B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.236803; HYBERTSEN MS, 1986, PHYS REV B, V34, P5390, DOI 10.1103/PhysRevB.34.5390; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; KUZMENKO AB, 2008, INFRARED SPECTROSCOP; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Li ZQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037403; Lu CL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144427; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; McCann E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161403; Min HK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155115; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Sze S.M., 2006, PHYS SEMICONDUCTOR D, DOI DOI 10.1002/0470068329; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Zhang LM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.235408; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003	26	2747	2819	58	1859	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					820	823		10.1038/nature08105	http://dx.doi.org/10.1038/nature08105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516337	Green Submitted			2022-12-28	WOS:000267084500034
J	McGirk, J				McGirk, Jan			Gazan patients targeted for interrogation	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1833	1833		10.1016/S0140-6736(09)61006-0	http://dx.doi.org/10.1016/S0140-6736(09)61006-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19504664				2022-12-28	WOS:000266616400011
J	Cronin, SJF; Nehme, NT; Limmer, S; Liegeois, S; Pospisilik, JA; Schramek, D; Leibbrandt, A; Simoes, RD; Gruber, S; Puc, U; Ebersberger, I; Zoranovic, T; Neely, GG; von Haeseler, A; Ferrandon, D; Penninger, JM				Cronin, Shane J. F.; Nehme, Nadine T.; Limmer, Stefanie; Liegeois, Samuel; Pospisilik, J. Andrew; Schramek, Daniel; Leibbrandt, Andreas; Simoes, Ricardo de Matos; Gruber, Susanne; Puc, Urszula; Ebersberger, Ingo; Zoranovic, Tamara; Neely, G. Gregory; von Haeseler, Arndt; Ferrandon, Dominique; Penninger, Josef M.			Genome-Wide RNAi Screen Identifies Genes Involved in Intestinal Pathogenic Bacterial Infection	SCIENCE			English	Article							IMMUNE-RESPONSE; HOST-DEFENSE; STEM-CELLS; SERRATIA-MARCESCENS; IN-VIVO; DROSOPHILA; INTERFERENCE; ACTIVATION; AUTOPHAGY; VIRULENCE	Innate immunity represents the first line of defense in animals. We report a genome-wide in vivo Drosophila RNA interference screen to uncover genes involved in susceptibility or resistance to intestinal infection with the bacterium Serratia marcescens. We first employed whole-organism gene suppression, followed by tissue-specific silencing in gut epithelium or hemocytes to identify several hundred genes involved in intestinal antibacterial immunity. Among the pathways identified, we showed that the JAK-STAT signaling pathway controls host defense in the gut by regulating stem cell proliferation and thus epithelial cell homeostasis. Therefore, we revealed multiple genes involved in antibacterial defense and the regulation of innate immunity.	[Nehme, Nadine T.; Limmer, Stefanie; Liegeois, Samuel; Ferrandon, Dominique] CNRS, Inst Biol Mol & Cellulaire, Equipe Fdn Rech Med, UPR 9022, F-67084 Strasbourg, France; [Cronin, Shane J. F.; Pospisilik, J. Andrew; Schramek, Daniel; Leibbrandt, Andreas; Gruber, Susanne; Puc, Urszula; Zoranovic, Tamara; Neely, G. Gregory; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Simoes, Ricardo de Matos; Ebersberger, Ingo; von Haeseler, Arndt] Univ Vet Med, Univ Vienna, Ctr Integrat Bioinformat CIBIV, Med Univ Vienna, A-1030 Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Equipe Fdn Rech Med, UPR 9022, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr	Schirmeier, Stefanie SM/V-9721-2017; neely, graham/A-6511-2011; Pryjda, Tamara/O-5714-2019; Penninger, Josef M/I-6860-2013; Schramek, Daniel/J-5792-2014; Schramek, Daniel/AAL-1470-2020; LIEGEOIS, Samuel/AGG-0452-2022; Cronin, Shane/AAC-9964-2020; Neely, Greg/AAB-4642-2020; von Haeseler, Arndt/HCI-9958-2022	Schirmeier, Stefanie SM/0000-0001-8431-9593; Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; LIEGEOIS, Samuel/0000-0003-3228-7678; Neely, Greg/0000-0002-1957-9732; von Haeseler, Arndt/0000-0002-3366-4458; de Matos Simoes, Ricardo/0000-0002-1700-5276; FERRANDON, Dominique/0000-0001-7680-7773; zoranovic, tamara/0000-0002-5369-6385	CNRS; NIH [P01 AI44220]; Agence Nationale de la Recherche [DROSELEGANS]; Fondation pour la Recherche Medicale; IMBA; EuroThymaide; Austrian Science Fund Science Research Program (FWF-SFB); European Research Council; Austrian Ministry of Science; Vienna Science and Technology Fund (WWTF); German Research Foundation [Ha-1628/8-1]; Boehringer Ingelheim; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); IMBA; EuroThymaide(European Commission); Austrian Science Fund Science Research Program (FWF-SFB)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Austrian Ministry of Science; Vienna Science and Technology Fund (WWTF); German Research Foundation(German Research Foundation (DFG)); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported financially by the CNRS, an NIH Program grant P01 AI44220, and a DROSELEGANS grant from the Programme Microbiologie, Immunologie, et Maladies Emergentes (MIME) of the Agence Nationale de la Recherche. The D.F. laboratory is an Equipe FRM, awarded by the Fondation pour la Recherche Medicale. J.M.P. is supported by IMBA, EuroThymaide, an Austrian Science Fund Science Research Program (FWF SFB) grant, an advanced European Research Council grant, and the Austrian Ministry of Science. R.M.S. and A.v.H. are supported by the Vienna Science and Technology Fund (WWTF) and the German Research Foundation (DFG) (Ha-1628/8-1). The screen was supported by Boehringer Ingelheim.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200	34	240	248	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2009	325	5938					340	343		10.1126/science.1173164	http://dx.doi.org/10.1126/science.1173164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471DZ	19520911	Green Accepted			2022-12-28	WOS:000268036600051
J	Ura, Y; Beierle, JM; Leman, LJ; Orgel, LE; Ghadiri, MR				Ura, Yasuyuki; Beierle, John M.; Leman, Luke J.; Orgel, Leslie E.; Ghadiri, M. Reza			Self-Assembling Sequence-Adaptive Peptide Nucleic Acids	SCIENCE			English	Article							DYNAMIC COMBINATORIAL LIBRARIES; TEMPLATE-DIRECTED SYNTHESIS; BACKBONE; AMPLIFICATION; POLYMERIZATION; CHEMISTRY; EXCHANGE; POLYMERS; BINDING; ANALOGS	Several classes of nucleic acid analogs have been reported, but no synthetic informational polymer has yet proven responsive to selection pressures under enzyme-free conditions. Here, we introduce an oligomer family that efficiently self-assembles by means of reversible covalent anchoring of nucleobase recognition units onto simple oligo-dipeptide backbones [thioester peptide nucleic acids (tPNAs)] and undergoes dynamic sequence modification in response to changing templates in solution. The oligomers specifically self-pair with complementary tPNA strands and cross-pair with RNA and DNA in Watson-Crick fashion. Thus, tPNA combines base-pairing interactions with the side-chain functionalities of typical peptides and proteins. These characteristics might prove advantageous for the design or selection of catalytic constructs or biomaterials that are capable of dynamic sequence repair and adaptation.	[Ura, Yasuyuki; Beierle, John M.; Leman, Luke J.; Ghadiri, M. Reza] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Ura, Yasuyuki; Beierle, John M.; Leman, Luke J.; Ghadiri, M. Reza] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Orgel, Leslie E.] Salk Inst Biol Studies, San Diego, CA 92186 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu		Leman, Luke/0000-0002-1879-5900; Ura, Yasuyuki/0000-0003-0484-1299	Skaggs Institute for Chemical Biology; NASA Earth and Space Science Fellowship Program [NNX07AR35H]; NASA Science Mission Directorates Planetary Science Division [NRA NNH07ZDA001N]	Skaggs Institute for Chemical Biology; NASA Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); NASA Science Mission Directorates Planetary Science Division	Support was provided in part by the Skaggs Institute for Chemical Biology, the NASA Earth and Space Science Fellowship Program (grant NNX07AR35H to J.M.B.), and the NASA Science Mission Directorates Planetary Science Division (NRA NNH07ZDA001N).	Bean HD, 2006, ORIGINS LIFE EVOL B, V36, P39, DOI 10.1007/s11084-005-2082-4; BECK F, 2003, ARTIFICIAL DNA METHO, P91; Biron JP, 2005, ANGEW CHEM INT EDIT, V44, P6731, DOI 10.1002/anie.200501591; Corbett PT, 2008, CHEM-EUR J, V14, P2153, DOI 10.1002/chem.200701413; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Corbett PT, 2004, CHEM-EUR J, V10, P3139, DOI 10.1002/chem.200400300; De Duve Christian, 1998, P219; Diederichsen U, 1996, ANGEW CHEM INT EDIT, V35, P445, DOI 10.1002/anie.199604451; Eschenmoser A, 2005, CHIMIA, V59, P836, DOI 10.2533/000942905777675552; Fulton DA, 2008, ORG LETT, V10, P3291, DOI 10.1021/ol8011309; GOODWIN JT, 1992, J AM CHEM SOC, V114, P9197, DOI 10.1021/ja00049a067; Grote Z, 2003, ANGEW CHEM INT EDIT, V42, P3821, DOI 10.1002/anie.200351623; Hickman DT, 2008, HELV CHIM ACTA, V91, P1, DOI 10.1002/hlca.200890022; Higaki Y, 2004, MACROMOLECULES, V37, P1696, DOI 10.1021/ma035518c; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kleiner RE, 2008, J AM CHEM SOC, V130, P4646, DOI 10.1021/ja0753997; Ladame S, 2008, ORG BIOMOL CHEM, V6, P219, DOI 10.1039/b714599c; Larsson R, 2004, ANGEW CHEM INT EDIT, V43, P3716, DOI 10.1002/anie.200454165; Leclaire J, 2005, CHEM COMMUN, P1959, DOI 10.1039/b500638d; Li XY, 2002, ANGEW CHEM INT EDIT, V41, P4567, DOI 10.1002/1521-3773(20021202)41:23<4567::AID-ANIE4567>3.0.CO;2-6; Mittapalli GK, 2007, ANGEW CHEM INT EDIT, V46, P2478, DOI 10.1002/anie.200603209; Oh K, 2001, NATURE, V414, P889, DOI 10.1038/414889a; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Pascal R, 2005, TOP CURR CHEM, V259, P69, DOI 10.1007/b136707; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Severin K, 2004, CHEM-EUR J, V10, P2565, DOI 10.1002/chem.200305660; Skene WG, 2004, P NATL ACAD SCI USA, V101, P8270, DOI 10.1073/pnas.0401885101; Sreenivasachary N, 2006, CHEM-EUR J, V12, P8581, DOI 10.1002/chem.200600625; Woll MG, 2004, J AM CHEM SOC, V126, P11172, DOI 10.1021/ja046891i; Zhan ZYJ, 1997, J AM CHEM SOC, V119, P12420, DOI 10.1021/ja972870v; Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z	32	147	150	3	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					73	77		10.1126/science.1174577	http://dx.doi.org/10.1126/science.1174577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	465NL	19520909				2022-12-28	WOS:000267594000037
J	Donohoe, ME; Silva, SS; Pinter, SF; Xu, N; Lee, JT				Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.			The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting	NATURE			English	Article							EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; INACTIVATION; TRANSCRIPTION; CHOICE; TSIX; IDENTIFICATION; INITIATION; ACTIVATOR; PROTEIN	Pluripotency of embryonic stem (ES) cells is controlled by defined transcription factors(1,2). During differentiation, mouse ES cells undergo global epigenetic reprogramming, as exemplified by X-chromosome inactivation (XCI) in which one female X chromosome is silenced to achieve gene dosage parity between the sexes(3-5). Somatic XCI is regulated by homologous X-chromosome pairing(6,7) and counting(8-10), and by the random choice of future active and inactive X chromosomes. XCI and cell differentiation are tightly coupled(11), as blocking one process compromises the other(8,12) and dedifferentiation of somatic cells to induced pluripotent stem cells is accompanied by X chromosome reactivation(2). Recent evidence suggests coupling of Xist expression to pluripotency factors occurs(13), but how the two are interconnected remains unknown. Here we show that Oct4 (also known as Pou5f1)(14) lies at the top of the XCI hierarchy, and regulates XCI by triggering X-chromosome pairing and counting. Oct4 directly binds Tsix and Xite, two regulatory noncoding RNA genes of the X-inactivation centre(15,16), and also complexes with XCI trans-factors, Ctcf and Yy1 (ref. 17), through protein-protein interactions. Depletion of Oct4 blocks homologous X-chromosome pairing and results in the inactivation of both X chromosomes in female cells. Thus, we have identified the first trans-factor that regulates counting, and ascribed new functions to Oct4 during X-chromosome reprogramming.	[Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Donohoe, Mary E.; Silva, Susana S.; Pinter, Stefan F.; Xu, Na; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Pinter, Stefan/O-9228-2019	Pinter, Stefan/0000-0003-4750-1403	National Institutes of Health [GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058839, R01GM058839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Stavropoulos and J. Lopilato for their contributions to the early phase of this work. We also thank J. Zhao, J. A. Erwin and J. Ahn for critical reading of the manuscript and all laboratory members for stimulating discussion. This work was funded by a National Institutes of Health grant to J. T. L. (GM58839). J. T. L. is an Investigator of the Howard Hughes Medical Institute.	Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5	30	216	222	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					128	U147		10.1038/nature08098	http://dx.doi.org/10.1038/nature08098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19536159	Green Accepted			2022-12-28	WOS:000267545200043
J	Bilde, T; Foged, A; Schilling, N; Arnqvist, G				Bilde, Trine; Foged, Anne; Schilling, Nadia; Arnqvist, Goran			Postmating Sexual Selection Favors Males That Sire Offspring with Low Fitness	SCIENCE			English	Article							SPERM COMPETITION; GENETIC COMPATIBILITY; POLYANDROUS FEMALES; SEED BEETLES; EVOLUTION; BENEFITS; CONFLICT; BEHAVIOR	Despite the costs of mating, females of most taxa mate with multiple males. Polyandrous females are hypothesized to gain genetic benefits for their offspring, but this assumes paternity bias favoring male genotypes that enhance offspring viability. We determined net male genetic effects on female and offspring fitness in a seed beetle and then tested whether fertilization success was biased in favor of high-quality male genotypes in double mating experiments. Contrary to expectations, high-quality male genotypes consistently had a lower postmating fertilization success in two independent assays. Our results imply that sexually antagonistic adaptations have a major and unappreciated influence on male postmating fertilization success. Such genetic variation renders indirect genetic benefits an unlikely driver of the evolution of polyandry.	[Bilde, Trine; Arnqvist, Goran] Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Bilde, Trine; Foged, Anne; Schilling, Nadia] Univ Aarhus, Dept Biol Sci, DK-8000 Aarhus C, Denmark	Uppsala University; Aarhus University	Bilde, T (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	trine.bilde@biology.au.dk	Bilde, Trine/J-2872-2013; Arnqvist, Göran/E-6782-2015; Bilde, Trine/AAS-2098-2020	Bilde, Trine/0000-0002-0341-161X; Arnqvist, Göran/0000-0002-3501-3376; Bilde, Trine/0000-0002-0341-161X	Marie Curie fellowship [MC MEIF-CT-2006-023645]; Carlsberg Foundation; Swedish Research Council	Marie Curie fellowship(European Commission); Carlsberg Foundation(Carlsberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank E. B. Rasmussen for assistance; C. W. Fox for providing the beetle population used; and I. M. Horsman, D. Grand, and P. Schjerbeck at Aarhus University Hospital for their extensive help and flexibility with irradiating males. U. Friberg, T. Tregenza, M. Olsson, and J. Schneider provided valuable comments. Funded by a Marie Curie fellowship (MC MEIF-CT-2006-023645) (T.B.), the Carlsberg Foundation (T.B.), and the Swedish Research Council (G.A.).	Arnqvist G, 2005, BEHAV ECOL, V16, P123, DOI 10.1093/beheco/arh119; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 2005, MONOGRAPHS BEHAV ECO, P330; Bilde T, 2007, J EVOLUTION BIOL, V20, P1237, DOI 10.1111/j.1420-9101.2006.01280.x; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Birkhead TR, 1998, SPERM COMPETITION SE; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Dowling DK, 2007, J EVOLUTION BIOL, V20, P2113, DOI 10.1111/j.1420-9101.2007.01433.x; Dziminski MA, 2008, EVOLUTION, V62, P879, DOI 10.1111/j.1558-5646.2008.00328.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Evans JP, 2007, EVOLUTION, V61, P2832, DOI 10.1111/j.1558-5646.2007.00227.x; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Fox Charles W., 2007, P88; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Puurtinen M, 2005, TRENDS ECOL EVOL, V20, P157, DOI 10.1016/j.tree.2005.02.005; Roenn JL, 2008, J EVOLUTION BIOL, V21, P461, DOI 10.1111/j.1420-9101.2007.01493.x; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; Savalli UM, 1999, ETHOL ECOL EVOL, V11, P49, DOI 10.1080/08927014.1999.9522841; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wade MJ, 2003, AM NAT, V162, P403, DOI 10.1086/378211; Wilson N, 1997, P ROY SOC B-BIOL SCI, V264, P1491, DOI 10.1098/rspb.1997.0206; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260	30	44	44	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1705	1706		10.1126/science.1171675	http://dx.doi.org/10.1126/science.1171675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556506				2022-12-28	WOS:000267338200038
J	Mal, P; Breiner, B; Rissanen, K; Nitschke, JR				Mal, Prasenjit; Breiner, Boris; Rissanen, Kari; Nitschke, Jonathan R.			White Phosphorus Is Air-Stable Within a Self-Assembled Tetrahedral Capsule	SCIENCE			English	Article							DIELS-ALDER; TETRAPHOSPHORUS COMPLEXES; MOLECULAR CONTAINER; COORDINATION CAGE; STABILIZATION; CATALYSIS; TRIMERS; RHODIUM; WATER	The air-sensitive nature of white phosphorus underlies its destructive effect as a munition: Tetrahedral P-4 molecules readily react with atmospheric dioxygen, leading this form of the element to spontaneously combust upon exposure to air. Here, we show that hydrophobic P-4 molecules are rendered air-stable and water-soluble within the hydrophobic hollows of self-assembled tetrahedral container molecules, which form in water from simple organic subcomponents and iron(II) ions. This stabilization is not achieved through hermetic exclusion of O-2 but rather by constriction of individual P-4 molecules; the addition of oxygen atoms to P-4 would result in the formation of oxidized species too large for their containers. The phosphorus can be released in controlled fashion without disrupting the cage by adding the competing guest benzene.	[Mal, Prasenjit; Breiner, Boris; Nitschke, Jonathan R.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Rissanen, Kari] Univ Jyvaskyla, Dept Chem, Nanosci Ctr, Jyu 40014, Finland	University of Cambridge; University of Jyvaskyla	Nitschke, JR (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jrn34@cam.ac.uk	Rissanen, Kari T/B-5688-2008; Nitschke, Jonathan R/A-1664-2010	Rissanen, Kari T/0000-0002-7282-8419; Nitschke, Jonathan R/0000-0002-4060-5122; Mal, Prasenjit/0000-0002-7830-9812	Walters-Kundert Charitable Trust; Royal Society; Marie Curie IIF scheme of the 7th European Union Framework Program; Academy of Finland [212588]	Walters-Kundert Charitable Trust; Royal Society(Royal Society of London); Marie Curie IIF scheme of the 7th European Union Framework Program(European Commission); Academy of Finland(Academy of Finland)	This work was supported by the Walters-Kundert Charitable Trust, the Royal Society, the Marie Curie IIF scheme of the 7th European Union Framework Program (to P.M.), and the Academy of Finland (project 212588, to K.R.). The authors also thank D. S. Wright for helpful discussions and a gift of white phosphorus and J. K. M. Sanders for useful comments on the manuscript. Mass spectra were provided by the Engineering and Physical Sciences Research Council National Mass Spectrometry facility at Swansea. CCDC-727817 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.	Ajami D, 2008, ANGEW CHEM INT EDIT, V47, P6059, DOI 10.1002/anie.200802023; BENSON DR, 1990, ANGEW CHEM INT EDIT, V29, P191, DOI 10.1002/anie.199001911; Botana E, 2007, ANGEW CHEM INT EDIT, V46, P198, DOI 10.1002/anie.200603180; CORBRIDGE DEC, 1952, NATURE, V170, P629, DOI 10.1038/170629a0; CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; CRAM DJ, 1992, NATURE, V356, P29, DOI 10.1038/356029a0; DAINTON FS, 1947, T FARADAY SOC, V43, P244, DOI 10.1039/tf9474300244; Dong VM, 2006, J AM CHEM SOC, V128, P14464, DOI 10.1021/ja0657915; Gibb CLD, 2004, J AM CHEM SOC, V126, P11408, DOI 10.1021/ja0475611; GINSBERG AP, 1986, J AM CHEM SOC, V108, P403, DOI 10.1021/ja00263a010; Hastings CJ, 2008, J AM CHEM SOC, V130, P10977, DOI 10.1021/ja8013055; Iwasawa T, 2007, SCIENCE, V317, P493, DOI 10.1126/science.1143272; Kang JM, 1998, J AM CHEM SOC, V120, P3650, DOI 10.1021/ja973898+; Krossing I, 2002, CHEM-EUR J, V8, P700, DOI 10.1002/1521-3765(20020201)8:3<700::AID-CHEM700>3.0.CO;2-C; Kuil M, 2006, J AM CHEM SOC, V128, P11344, DOI 10.1021/ja063294i; LEWIS PR, 1971, POLYMER, V12, P258, DOI 10.1016/0032-3861(71)90050-4; MacGillivray LR, 1999, ANGEW CHEM INT EDIT, V38, P1019, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1018::AID-ANIE1018>3.0.CO;2-G; Mal P, 2008, ANGEW CHEM INT EDIT, V47, P8297, DOI 10.1002/anie.200803066; Marty M, 1998, CHEM COMMUN, P2265, DOI 10.1039/a806070c; Peruzzini M, 1999, EUR J INORG CHEM, P931; Pluth MD, 2007, SCIENCE, V316, P85, DOI 10.1126/science.1138748; Trembleau L, 2003, SCIENCE, V301, P1219, DOI 10.1126/science.1086644; Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688; Warmuth R, 1997, ANGEW CHEM INT EDIT, V36, P1347, DOI 10.1002/anie.199713471; Warmuth R, 2000, ANGEW CHEM INT EDIT, V39, P1117, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1117::AID-ANIE1117>3.0.CO;2-E; Yoshizawa M, 2000, J AM CHEM SOC, V122, P6311, DOI 10.1021/ja000779c; Yoshizawa M, 2006, SCIENCE, V312, P251, DOI 10.1126/science.1124985; Yoshizawa M, 2003, J AM CHEM SOC, V125, P3243, DOI 10.1021/ja020718+	28	793	796	11	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1697	1699		10.1126/science.1175313	http://dx.doi.org/10.1126/science.1175313			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556504				2022-12-28	WOS:000267338200035
J	Norskov, JK; Bligaard, T; Kleis, J				Norskov, J. K.; Bligaard, T.; Kleis, J.			Rate Control and Reaction Engineering	SCIENCE			English	Editorial Material									[Norskov, J. K.; Bligaard, T.; Kleis, J.] Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design, DK-2800 Lyngby, Denmark	Technical University of Denmark	Norskov, JK (corresponding author), Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design, DK-2800 Lyngby, Denmark.	norskov@fysik.dtu.dk; bligaard@fysik.dtu.dk; kleis@fysik.dtu.dk	Norskov, Jens K/D-2539-2017; Bligaard, Thomas/A-6161-2011; Bligaard, Thomas/A-6161-2011	Norskov, Jens K/0000-0002-4427-7728; Bligaard, Thomas/0000-0003-0386-0201; Bligaard, Thomas/0000-0001-9834-9179				Abild-Pedersen F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016105; Alcala R, 2003, J CATAL, V218, P178, DOI 10.1016/S0021-9517(03)00090-3; Dumesic JA, 2008, HDB HETEROGENEOUS CA, P1445; Jones G, 2008, J CATAL, V259, P147, DOI 10.1016/j.jcat.2008.08.003; Liu ZP, 2003, J AM CHEM SOC, V125, P1958, DOI 10.1021/ja0207551; Meskine H, 2009, SURF SCI, V603, P1724, DOI 10.1016/j.susc.2008.08.036; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Norskov JK, 2002, J CATAL, V209, P275, DOI 10.1006/jcat.2002.3615; Pallassana V, 2000, J CATAL, V191, P301, DOI 10.1006/jcat.1999.2724; Stegelmann C, 2009, J AM CHEM SOC, V131, P8077, DOI 10.1021/ja9000097	10	54	54	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1655	1656		10.1126/science.1174885	http://dx.doi.org/10.1126/science.1174885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556493				2022-12-28	WOS:000267338200022
J	Grumbach, K; Mold, JW				Grumbach, Kevin; Mold, James W.			A Health Care Cooperative Extension Service Transforming Primary Care and Community Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NETWORKS		[Grumbach, Kevin] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco Dept Family & Community Med, San Francisco, CA 94110 USA; [Mold, James W.] Univ Oklahoma, Coll Med, San Francisco Dept Family & Community Med, Oklahoma Phys Resource Res Network, Oklahoma City, OK 73190 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Oklahoma System; University of Oklahoma Health Sciences Center	Grumbach, K (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco Dept Family & Community Med, Ward 83,1001 Potrero Ave, San Francisco, CA 94110 USA.	kgrumbach@fcm.ucsf.edu	Grumbach, Kevin/L-9222-2016		PHS HHS [1-U54-R023566] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Academy of Family Physicians (AAFP) American Academy of Pediatrics (AAP) American College of Physicians (ACP) American Osteopathic Association (AOA), 2007, JOINT PRINC PAT CTR; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Bodenheimer T, 2007, ANN FAM MED, V5, P457, DOI 10.1370/afm.731; Medicare Payment Advisory Commission, 2008, PROM US PRIM CAR REP, P23; Meyers DS, 2009, ANN INTERN MED, V150, P272, DOI 10.7326/0003-4819-150-4-200902170-00009; Mold JW, 2008, J AM BOARD FAM MED, V21, P334, DOI 10.3122/jabfm.2008.04.080006; Nagykaldi Z, 2006, J AM BOARD FAM MED, V19, P506, DOI 10.3122/jabfm.19.5.506; *NAT CTR HLTH STAT, 2006, TABL 90 VIS PRIM CAR; PHILLIPS RL, 2007, LEARNING HEALTHCARE; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Steiner BD, 2008, ANN FAM MED, V6, P361, DOI 10.1370/afm.866; *USDA, 2009, FY 2010 BUDGET SUMMA	12	76	76	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2589	2591		10.1001/jama.2009.923	http://dx.doi.org/10.1001/jama.2009.923			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549977				2022-12-28	WOS:000267266500025
J	Kovacs, JA; Masur, H				Kovacs, Joseph A.; Masur, Henry			Evolving Health Effects of Pneumocystis One Hundred Years of Progress in Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CARINII DIHYDROPTEROATE SYNTHASE; TRIMETHOPRIM-SULFAMETHOXAZOLE; UNITED-STATES; S-ADENOSYLMETHIONINE; SULFONE PROPHYLAXIS; PNEUMONIA PROPHYLAXIS; RANDOMIZED-TRIAL; AIDS PATIENTS; MUTATIONS	2009 marks the 100th anniversary of the first description of Pneumocystis, an organism that was ignored for much of its first 50 years but that has subsequently been recognized as an important pathogen of immunocompromised patients, especially patients infected with human immunodeficiency virus (HIV). We present a patient with chronic lymphocytic leukemia who died from Pneumocystis pneumonia (PCP) despite appropriate anti-Pneumocystis therapy. Although substantial advances in diagnosis, treatment, and prevention of PCP have decreased its frequency and improved prognosis, PCP continues to be seen in both HIV-infected patients and patients receiving immunosuppressive medications. Pneumocystis species comprise a family of fungi, each of which appears to be able to infect only 1 host species. Pneumocystis has a worldwide distribution. Immunocompetent hosts clear infection without obvious clinical consequences. Pneumocystis has been identified in patients with other diseases such as chronic obstructive pulmonary disease, although its clinical impact is uncertain. Immunocompromised patients develop disease as a consequence of reinfection and possibly reactivation of latent infection. In patients with HIV infection, the CD4 count is predictive of the risk for developing PCP, but such reliable markers are not available for other immunocompromised populations. In the majority of patients with PCP, multiple Pneumocystis strains can be identified using recently developed typing techniques. Because Pneumocystis cannot be cultured, diagnosis relies on detection of the organism by colorimetric or immunofluorescent stains or by polymerase chain reaction. Trimethoprim-sulfamethoxazole is the preferred drug regimen for both treatment and prevention of PCP, although a number of alternatives are also available. Corticosteroids are an important adjunct for hypoxemic patients. JAMA. 2009; 301(24):2578-2585	[Kovacs, Joseph A.; Masur, Henry] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kovacs, JA (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, Bldg 10,Room 2C145,MSC 1662, Bethesda, MD 20892 USA.	jkovacs@mail.nih.gov	Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880	NIH Clinical Center, National Institutes of Health; CLINICAL CENTER [Z01CL000192, ZIACL000192] Funding Source: NIH RePORTER	NIH Clinical Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	Funding/Support: This research was supported by the Intramural Research Program of the NIH Clinical Center, National Institutes of Health.	Beard CB, 2005, J INFECT DIS, V192, P1815, DOI 10.1086/497381; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; BLACK JR, 1994, CLIN INFECT DIS, V18, P905, DOI 10.1093/clinids/18.6.905; BOZZETTE SA, 1990, NEW ENGL J MED, V323, P1451, DOI 10.1056/NEJM199011223232104; BYRD JC, 1995, AM J HEMATOL, V49, P135, DOI 10.1002/ajh.2830490207; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Chagas Carlos, 1911, Memorias do Instituto Oswaldo Cruz, V3; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Delanoe P, 1912, CR HEBD ACAD SCI, V155, P658; DOHN MN, 1994, ANN INTERN MED, V121, P174, DOI 10.7326/0003-4819-121-3-199408010-00003; EDMAN JC, 1988, NATURE, V334, P519, DOI 10.1038/334519a0; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; El-Sadr WM, 1998, NEW ENGL J MED, V339, P1889, DOI 10.1056/NEJM199812243392604; Gigliotti F, 2005, CLIN INFECT DIS, V41, P1752, DOI 10.1086/498150; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Gruden JF, 1997, AM J ROENTGENOL, V169, P967, DOI 10.2214/ajr.169.4.9308446; Helweg-Larsen J, 1999, LANCET, V354, P1347, DOI 10.1016/S0140-6736(99)03320-6; Helweg-Larsen J, 2001, AIDS, V15, P451, DOI 10.1097/00002030-200103090-00003; Huang L, 2000, J INFECT DIS, V182, P1192, DOI 10.1086/315824; HUGHES W, 1993, NEW ENGL J MED, V328, P1521, DOI 10.1056/NEJM199305273282103; HUGHES WT, 1982, J INFECT DIS, V145, P842, DOI 10.1093/infdis/145.6.842; HUGHES WT, 1973, J PEDIATR-US, V82, P404, DOI 10.1016/S0022-3476(73)80113-1; IMRIE KR, 1995, BONE MARROW TRANSPL, V15, P267; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kazanjian P, 1998, AIDS, V12, P873, DOI 10.1097/00002030-199808000-00009; Kazanjian P, 2000, J INFECT DIS, V182, P551, DOI 10.1086/315719; KLEIN NC, 1992, AIDS, V6, P301, DOI 10.1097/00002030-199203000-00007; Kolstad A, 2007, HAEMATOL-HEMATOL J, V92, P139, DOI 10.3324/haematol.10564; KOVACS JA, 1984, ANN INTERN MED, V100, P663, DOI 10.7326/0003-4819-100-5-663; KOVACS JA, 1988, J IMMUNOL, V140, P2023; KOVACS JA, 1988, NEW ENGL J MED, V318, P589, DOI 10.1056/NEJM198803103181001; Kutty G, 2008, EUKARYOT CELL, V7, P258, DOI 10.1128/EC.00345-07; Larsen HH, 2004, J INFECT DIS, V189, P1679, DOI 10.1086/383322; Leoung GS, 2001, J INFECT DIS, V184, P992, DOI 10.1086/323353; Ma L, 2002, J INFECT DIS, V186, P1647, DOI 10.1086/345721; Ma L, 1999, J INFECT DIS, V180, P1969, DOI 10.1086/315148; Mansharamani NG, 2000, CHEST, V118, P712, DOI 10.1378/chest.118.3.712; MASUR H, 1990, NEW ENGL J MED, V323, P1500, DOI 10.1056/NEJM199011223232131; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MEUWISSEN JHET, 1977, J INFECT DIS, V136, P43, DOI 10.1093/infdis/136.1.43; Morris A, 2004, AM J RESP CRIT CARE, V170, P408, DOI 10.1164/rccm.200401-094OC; Nahimana A, 2000, J MED MICROBIOL, V49, P753, DOI 10.1099/0022-1317-49-8-753; Ng VL, 1997, CLIN MICROBIOL REV, V10, P401, DOI 10.1128/CMR.10.3.401; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Safrin S, 1996, ANN INTERN MED, V124, P792, DOI 10.7326/0003-4819-124-9-199605010-00003; SATTLER FR, 1988, ANN INTERN MED, V109, P280, DOI 10.7326/0003-4819-109-4-280; Schmoldt S, 2008, J CLIN MICROBIOL, V46, P966, DOI 10.1128/JCM.02016-07; Sepkowitz KA, 1996, MAYO CLIN PROC, V71, P102, DOI 10.4065/71.1.102; SHELHAMER JH, 1984, AM REV RESPIR DIS, V130, P1161; SIEGEL SE, 1984, AM J DIS CHILD, V138, P1051, DOI 10.1001/archpedi.1984.02140490051012; SIMONDS RJ, 1993, JAMA-J AM MED ASSOC, V270, P470, DOI 10.1001/jama.270.4.470; Skelly M, 2003, LANCET, V361, P1267, DOI 10.1016/S0140-6736(03)12984-4; Stein CR, 2004, EMERG INFECT DIS, V10, P1760, DOI 10.3201/eid1010.040362; Stringer JR, 2002, EMERG INFECT DIS, V8, P891, DOI 10.3201/eid0809.020096; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Teshale EH, 2007, CLIN INFECT DIS, V44, P879, DOI 10.1086/511862; Van de Meer G., 1942, ANN SOC BELG MED TR, V22, P301; VANEK J., 1952, ZENTRALBL BAKT ABT I ORIG, V158, P120; Vargas SL, 2007, PEDIATR INFECT DIS J, V26, P81, DOI 10.1097/01.inf.0000247071.40739.fd; Vargas SL, 1999, CLIN INFECT DIS, V29, P1489, DOI 10.1086/313521; Vestereng VH, 2004, J INFECT DIS, V189, P1540, DOI 10.1086/382486; Walker DJ, 1998, J INFECT DIS, V178, P1767, DOI 10.1086/314509; WALZER PD, 1974, ANN INTERN MED, V80, P83, DOI 10.7326/0003-4819-80-1-83; Wang P, 2008, CLIN CHIM ACTA, V396, P86, DOI 10.1016/j.cca.2008.06.014; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; 2008, GUIDELINES PREVENTIO	67	115	124	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2578	2585		10.1001/jama.2009.880	http://dx.doi.org/10.1001/jama.2009.880			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549975				2022-12-28	WOS:000267266500023
J	Heller, PS				Heller, Peter S.			What can be learned from data for financing of global health?	LANCET			English	Editorial Material									Johns Hopkins Univ, Paul H Nitze Sch Adv Int Studies, Washington, DC 20016 USA	Johns Hopkins University	Heller, PS (corresponding author), Johns Hopkins Univ, Paul H Nitze Sch Adv Int Studies, Washington, DC 20016 USA.	phellerdc@gmail.com						Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3	1	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2087	2088		10.1016/S0140-6736(09)61132-6	http://dx.doi.org/10.1016/S0140-6736(09)61132-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541023	Green Submitted			2022-12-28	WOS:000267229700005
J	Tran, TH; Ruiz-Palacios, GM; Hayden, FG; Farrar, J				Tran Tinh Hien; Ruiz-Palacios, Guillermo M.; Hayden, Frederick G.; Farrar, Jeremy			Patient-oriented pandemic influenza research	LANCET			English	Editorial Material									[Tran Tinh Hien; Farrar, Jeremy] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tran Tinh Hien; Hayden, Frederick G.; Farrar, Jeremy] SE Asia Infect Dis Clin Res Network, Ho Chi Minh City, Vietnam; [Ruiz-Palacios, Guillermo M.] Mexico Emerging Infect Dis Clin Res Network, Mexico City, DF, Mexico; [Ruiz-Palacios, Guillermo M.] Natl Inst Med Sci & Nutr, Dept Infect Dis, Mexico City, DF, Mexico; [Hayden, Frederick G.] Univ Virginia, Charlottesville, VA USA; [Farrar, Jeremy] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	University of Virginia; University of Oxford	Farrar, J (corresponding author), Hosp Trop Dis, 190 Ben Ham Tu,Quan 5, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Ruiz-Palacios, Guillermo/GYQ-5462-2022; Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; WHO, CLIN MAN HUM INF AV; World Health Organisation, WEEKL EP REC; World Health Organization, INFL A H1N1 UPD 49	6	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2009	373	9681					2085	2086						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541022				2022-12-28	WOS:000267229700004
J	Powell, A; Shennan, S; Thomas, MG				Powell, Adam; Shennan, Stephen; Thomas, Mark G.			Late Pleistocene Demography and the Appearance of Modern Human Behavior	SCIENCE			English	Article							MIDDLE STONE-AGE; SOUTH-AFRICA; EMERGENCE; LANGUAGE; PERSPECTIVE; REVOLUTION; EVOLUTION; COGNITION; ETHIOPIA; ORIGINS	The origins of modern human behavior are marked by increased symbolic and technological complexity in the archaeological record. In western Eurasia this transition, the Upper Paleolithic, occurred about 45,000 years ago, but many of its features appear transiently in southern Africa about 45,000 years earlier. We show that demography is a major determinant in the maintenance of cultural complexity and that variation in regional subpopulation density and/or migratory activity results in spatial structuring of cultural skill accumulation. Genetic estimates of regional population size over time show that densities in early Upper Paleolithic Europe were similar to those in sub-Saharan Africa when modern behavior first appeared. Demographic factors can thus explain geographic variation in the timing of the first appearance of modern behavior without invoking increased cognitive capacity.	[Powell, Adam; Thomas, Mark G.] UCL, Res Dept Genet Evolut & Environm, London NW1 2HE, England; [Powell, Adam; Shennan, Stephen; Thomas, Mark G.] UCL, Inst Archaeol, AHRC, Ctr Evolut Cultural Div, London WC1H 0PY, England	University of London; University College London; UK Research & Innovation (UKRI); Arts & Humanities Research Council (AHRC); University of London; University College London	Thomas, MG (corresponding author), UCL, Res Dept Genet Evolut & Environm, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	m.thomas@ucl.ac.uk	Thomas, Mark G/A-2219-2012	Thomas, Mark G/0000-0002-2452-981X; Shennan, Stephen/0000-0001-6605-064X	AHRC Centre for the Evolution of Cultural Diversity; Wissenschaftskolleg zu Berlin fellowship	AHRC Centre for the Evolution of Cultural Diversity; Wissenschaftskolleg zu Berlin fellowship	We thank J. Henrich, P. Richerson, K. Laland, A. Bentley, T. Kivisild, T. Sumner, F. d Errico, and C. Stringer for discussion, and Q. Atkinson for making data available. This work was supported by an AHRC Centre for the Evolution of Cultural Diversity studentship awarded to A.P. and a Wissenschaftskolleg zu Berlin fellowship awarded to M.G.T.	Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bolender J, 2007, BIOL PHILOS, V22, P383, DOI 10.1007/s10539-006-9058-2; Brantingham G., 2004, ENTERING AM NE ASIA, P255; Brantingham PJ, 2001, CURR ANTHROPOL, V42, P735, DOI 10.1086/323817; Brumm A, 2005, CAMB ARCHAEOL J, V15, P157, DOI 10.1017/S0959774305000089; Chomsky N, 2005, LINGUIST INQ, V36, P1, DOI 10.1162/0024389052993655; d'Errico F, 2003, J WORLD PREHIST, V17, P1, DOI 10.1023/A:1023980201043; DRUMMOND AJ, 2008, RECONSTRUCTING EVOLU; Everett DL, 2005, CURR ANTHROPOL, V46, P621, DOI 10.1086/431525; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2006, AM ANTIQUITY, V71, P771, DOI 10.2307/40035890; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; James HVA, 2005, CURR ANTHROPOL, V46, pS3, DOI 10.1086/444365; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mithen S., 1996, PREHISTORY MIND; OCONNELL JF, 2007, RETHINKING HUMAN REV, P395; PETRAGLIA MD, 2007, RETHINKING HUMAN REV, P383; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Read D, 2006, AM ANTIQUITY, V71, P164, DOI 10.2307/40035327; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Stiner MC, 2006, HUM ECOL, V34, P693, DOI 10.1007/s10745-006-9041-1; Stringer C.B., 2007, RETHINKING HUMAN REV, P15; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Vanhaeren M., 2005, TOOLS SYMBOLS EARLY, P525; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1	37	601	612	7	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1298	1301		10.1126/science.1170165	http://dx.doi.org/10.1126/science.1170165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	453TF	19498164	Green Published, Green Submitted			2022-12-28	WOS:000266635100037
J	Beaglehole, R; Bonita, R				Beaglehole, Robert; Bonita, Ruth			Alcohol: a global health priority	LANCET			English	Editorial Material							DISEASE		[Beaglehole, Robert; Bonita, Ruth] Devonport, N Shore City 0624, New Zealand		Beaglehole, R (corresponding author), Devonport, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz						Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2007, LANCET, V370, P1102; BETTCHER D, OXFORD TXB IN PRESS; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; ENDAL D, 2008, DRINKS IND SUPPLANTI; Jackson R, 2005, LANCET, V366, P1911, DOI 10.1016/S0140-6736(05)67770-7; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Toumbourou JW, 2007, LANCET, V369, P1391, DOI 10.1016/S0140-6736(07)60369-9; WHO, 2009, GLOB STRAT RED HARMF; 2009, LANCET, V373, P1312	12	46	46	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2173	2174		10.1016/S0140-6736(09)61168-5	http://dx.doi.org/10.1016/S0140-6736(09)61168-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560583				2022-12-28	WOS:000267444500004
J	Conway, PH; Clancy, C				Conway, Patrick H.; Clancy, Carolyn			Comparative-Effectiveness Research - Implications of the Federal Coordinating Council's Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		[Conway, Patrick H.; Clancy, Carolyn] Dept Hlth & Human Serv, Washington, DC USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Clancy, Carolyn] Agcy Healthcare Res & Qual, Rockville, MD USA	Cincinnati Children's Hospital Medical Center; Agency for Healthcare Research & Quality	Conway, PH (corresponding author), Dept Hlth & Human Serv, Washington, DC USA.							Conway PH, 2009, JAMA-J AM MED ASSOC, V301, P763, DOI 10.1001/jama.2009.103; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333	4	127	133	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					328	330		10.1056/NEJMp0905631	http://dx.doi.org/10.1056/NEJMp0905631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DC	19567829				2022-12-28	WOS:000268184500002
J	Hammoud, SS; Nix, DA; Zhang, HY; Purwar, J; Carrell, DT; Cairns, BR				Hammoud, Saher Sue; Nix, David A.; Zhang, Haiying; Purwar, Jahnvi; Carrell, Douglas T.; Cairns, Bradley R.			Distinctive chromatin in human sperm packages genes for embryo development	NATURE			English	Article							STEM-CELLS; DNA METHYLATION; HISTONE H3; POLYCOMB TARGETS; GENOME; ORGANIZATION; FIBROBLASTS; EXPRESSION; DROSOPHILA; COMPLEX	Because nucleosomes are widely replaced by protamine in mature human sperm, the epigenetic contributions of sperm chromatin to embryo development have been considered highly limited. Here we show that the retained nucleosomes are significantly enriched at loci of developmental importance, including imprinted gene clusters, microRNA clusters, HOX gene clusters, and the promoters of stand-alone developmental transcription and signalling factors. Notably, histone modifications localize to particular developmental loci. Dimethylated lysine 4 on histone H3 (H3K4me2) is enriched at certain developmental promoters, whereas large blocks of H3K4me3 localize to a subset of developmental promoters, regions in HOX clusters, certain noncoding RNAs, and generally to paternally expressed imprinted loci, but not paternally repressed loci. Notably, trimethylated H3K27 (H3K27me3) is significantly enriched at developmental promoters that are repressed in early embryos, including many bivalent (H3K4me3/H3K27me3) promoters in embryonic stem cells. Furthermore, developmental promoters are generally DNA hypomethylated in sperm, but acquire methylation during differentiation. Taken together, epigenetic marking in sperm is extensive, and correlated with developmental regulators.	[Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, IVF & Androl Labs, Dept Surg, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, IVF & Androl Labs, Dept Obstet & Gynecol, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Carrell, Douglas T.] Univ Utah, Sch Med, IVF & Androl Labs, Dept Physiol, Salt Lake City, UT 84112 USA; [Hammoud, Saher Sue; Zhang, Haiying; Purwar, Jahnvi; Cairns, Bradley R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Nix, David A.] Univ Utah, Sch Med, Huntsman Canc Inst, Res Informat & Bioinformat Core Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Carrell, DT (corresponding author), Univ Utah, Sch Med, IVF & Androl Labs, Dept Surg, Salt Lake City, UT 84112 USA.	douglas.carrell@hsc.utah.edu; brad.cairns@hci.utah.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA24014, CA16056, P30 CA016056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Dudoit S, 2008, BIOMETRICAL J, V50, P716, DOI 10.1002/bimj.200710473; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Gordon M, 2007, MOL CELL BIOL, V27, P4058, DOI 10.1128/MCB.02044-06; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li SSL, 2006, BIOCHEM BIOPH RES CO, V340, P48, DOI 10.1016/j.bbrc.2005.11.149; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Reik W, 2003, THERIOGENOLOGY, V59, P21, DOI 10.1016/S0093-691X(02)01269-4; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917	39	909	941	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					473	U47		10.1038/nature08162	http://dx.doi.org/10.1038/nature08162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19525931	Green Accepted			2022-12-28	WOS:000268257000030
J	Galloway, JL; Delgado, I; Ros, MA; Tabin, CJ				Galloway, Jenna L.; Delgado, Irene; Ros, Maria A.; Tabin, Clifford J.			A reevaluation of X-irradiation-induced phocomelia and proximodistal limb patterning	NATURE			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; CHICK LIMB; NITROGEN-MUSTARD; SONIC-HEDGEHOG; FEEDBACK LOOP; THALIDOMIDE; BUD; EXPRESSION; OUTGROWTH	Phocomelia is a devastating, rare congenital limb malformation in which the long bones are shorter than normal, with the upper portion of the limb being most severely affected. In extreme cases, the hands or fingers are attached directly to the shoulder and the most proximal elements (those closest to the shoulder) are entirely missing. This disorder, previously known in both autosomal recessive and sporadic forms, showed a marked increase in incidence in the early 1960s due to the tragic toxicological effects of the drug thalidomide, which had been prescribed as a mild sedative(1,2). This human birth defect is mimicked in developing chick limb buds exposed to X-irradiation(3-5). Both X-irradiation(5) and thalidomide-induced phocomelia(5,6) have been interpreted as patterning defects in the context of the progress zone model, which states that a cell's proximodistal identity is determined by the length of time spent in a distal limb region termed the 'progress zone'(7). Indeed, studies of X-irradiation-induced phocomelia have served as one of the two major experimental lines of evidence supporting the validity of the progress zone model. Here, using a combination of molecular analysis and lineage tracing in chick, we show that X-irradiation-induced phocomelia is fundamentally not a patterning defect, but rather results from a time-dependent loss of skeletal progenitors. Because skeletal condensation proceeds from the shoulder to fingers (in a proximal to distal direction), the proximal elements are differentially affected in limb buds exposed to radiation at early stages. This conclusion changes the framework for considering the effect of thalidomide and other forms of phocomelia, suggesting the possibility that the aetiology lies not in a defect in the patterning process, but rather in progenitor cell survival and differentiation. Moreover, molecular evidence that proximodistal patterning is unaffected after X-irradiation does not support the predictions of the progress zone model.	[Galloway, Jenna L.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Delgado, Irene] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain; [Ros, Maria A.] CSIC UC IDICAN, Inst Biomed & Biotecnol Cantabria, Santander 39005, Spain	Harvard University; Harvard Medical School; Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@receptor.med.harvard.edu	Ros, Maria A./K-8160-2014; Delgado, Irene/L-9424-2014	Ros, Maria A./0000-0002-1224-7671; Delgado, Irene/0000-0002-0493-8261	NIH [R37 HD032443]; National Institute of Child Health and Human Development [F32HD057701]; Spanish Ministry of Science and Innovation [BFU2008-00397]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD057701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We would like to thank J. G. Arozamena and D. Connor for help with the irradiation machine and members of the Tabin-Cepko and Ros laboratories for discussions and ideas. Work in the laboratory of C. J. T. is supported by a grant, R37 HD032443, from the NIH. J. L. G. is supported by grant F32HD057701 from the National Institute of Child Health and Human Development. I. D. and M. A. R. are supported by BFU2008-00397 from the Spanish Ministry of Science and Innovation.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; BIGGERS JD, 1964, NATURE, V202, P152, DOI 10.1038/202152a0; Choudhury A, 2006, SEMIN RADIAT ONCOL, V16, P51, DOI 10.1016/j.semradonc.2005.08.007; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; GOFF RA, 1962, J EXP ZOOL, V151, P177, DOI 10.1002/jez.1401510208; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Knobloch J, 2008, MOL CELL BIOL, V28, P529, DOI 10.1128/MCB.00533-07; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LENZ W, 1962, LANCET, V1, P45; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mercader N, 2000, DEVELOPMENT, V127, P3961; Nelson CE, 1996, DEVELOPMENT, V122, P1449; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; PINOT M, 1970, Annales d'Embryologie et de Morphogenese, V3, P215; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; SALZGEBER B, 1975, DEV GROWTH DIFFER, V17, P295; SALZGEBER B, 1969, J EMBRYOL EXP MORPH, V22, P373; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; TOMS D, 1962, LANCET, V280, P400; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175	30	45	46	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					400	U119		10.1038/nature08117	http://dx.doi.org/10.1038/nature08117			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19553938	Green Submitted, Green Accepted			2022-12-28	WOS:000267979000040
J	Buse, JB; Rosenstock, J; Sesti, G; Schmidt, WE; Montanya, E; Brett, JH; Zychma, M; Blonde, L				Buse, John B.; Rosenstock, Julio; Sesti, Giorgio; Schmidt, Wolfgang E.; Montanya, Eduard; Brett, Jason H.; Zychma, Marcin; Blonde, Lawrence		LEAD-6 Study Grp	Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; HUMAN GLP-1 ANALOG; BETA-CELL MASS; GLYCEMIC CONTROL; ACUTE-PANCREATITIS; TREATED PATIENTS; METFORMIN; SULFONYLUREA; EXENDIN-4; WEIGHT	Background Unlike most antihyperglycaemic drugs, glucagon-like peptide-1 (GLP-1) receptor agonists have a glucose-dependent action and promote weight loss. We compared the efficacy and safety of liraglutide, a human GLP-1 analogue, with exenatide, an exendin-based GLP-1 receptor agonist. Methods Adults with inadequately controlled type 2 diabetes on maximally tolerated doses of metformin, sulphon urea, or both, were stratified by previous oral antidiabetic therapy and randomly assigned to receive additional liraglutide 1.8 mg once a day (n=233) or exenatide 10 mu g twice a day (n=231) in a 26-week open-label, parallel-group, multinational (15 countries) study. The primary outcome was change in glycosylated haemoglobin (HbA(1c)). Efficacy analyses were by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00518882. Findings Mean baseline HbA(1c) for the study population was 8.2%. Liraglutide reduced mean HbA(1c) significantly more than did exenatide (-1.12% [SE 0.08] vs -0.79% [0.08]; estimated treatment difference -0.33; 95% CI -0.47 to -0.18; p<0.0001) and more patients achieved a HbA(1c) value of less than 7% (54% vs 43%, respectively; odds ratio 2.02; 95% CI 1.31 to 3.11; p=0.0015). Liraglutide reduced mean fasting plasma glucose more than did exenatide (-1.61 mmol/L [S E 0.20] vs -0.60 mmol/L [0.20]; estimated treatment difference -1.01 mmol/L; 95% CI -1.37 to -0.65; p<0.0001) but postprandial glucose control was less effective after breakfast and dinner. Both drugs promoted similar weight losses (liraglutide -3.24 kg vs exenatide -2.87 kg). Both drugs were well tolerated, but nausea was less persistent (estimated treatment rate ratio 0.448, p<0.0001) and minor hypoglycaemia less frequent with liraglutide than with exenatide (1.93 vs 2.60 events per patient per year; rate ratio 0.55; 95% CI 0.34 to 0.88; p=0.0131; 25.5% vs 33.6% had minor hypoglycaemia). Two patients taking both exenatide and a sulphonylurea had a major hypoglycaemic episode. Interpretation Liraglutide once a day provided significantly greater improvements in glycaemic control than did exenatide twice a day, and was generally better tolerated. The results suggest that liraglutide might be a treatment option for type 2 diabetes, especially when weight loss and risk of hypoglycaemia are major considerations.	[Buse, John B.] Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC 27515 USA; [Rosenstock, Julio] Dallas Diabet & Endocrine Ctr Med City, Dallas, TX USA; [Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Schmidt, Wolfgang E.] Ruhr Univ Bochum, Fac Med, St Josef Hosp, Dept Med, Bochum, Germany; [Montanya, Eduard] Univ Barcelona, CIBERDEM, Hosp Univ Bellivtge IDIBELL, Barcelona, Spain; [Brett, Jason H.] Novo Nordisk AS, Princeton, NJ USA; [Zychma, Marcin] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; [Blonde, Lawrence] Ochsner Med Ctr, Ochsner Diabet Clin Res Unit, Dept Endocrinol, New Orleans, LA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Diabetes & Endocrine Center; Magna Graecia University of Catanzaro; Ruhr University Bochum; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Novo Nordisk; Novo Nordisk; Ochsner Health System	Buse, JB (corresponding author), Univ N Carolina, Sch Med, Div Endocrinol, Chapel Hill, NC 27515 USA.	jbuse@med.unc.edu	Buse, John Bernard/J-9742-2019; Byrne, Maria/A-8310-2017; Sesti, Giorgio/B-1509-2012; Torre, Edelmiro Menéndez/G-1547-2013; Christ, Emanuel/F-1196-2015	Buse, John Bernard/0000-0002-9723-3876; Byrne, Maria/0000-0002-9394-8698; Torre, Edelmiro Menéndez/0000-0002-9548-7821; Madsbad, Sten/0000-0002-5017-1815; Christ, Emanuel/0000-0002-5604-4606; Montanya, Eduard/0000-0003-2518-9076; Milenkovic, Tatjana/0000-0001-5762-9596; Sesti, Giorgio/0000-0002-1618-7688	Novo-Nordisk	Novo-Nordisk(Novo Nordisk)	We thank the LEA D-6 investigators and their staff for the conduct of this study; research volunteers for their participation; John Smith and Ann Olling for writing assistance; Maria Diking for statistical assistance; Watermeadow Medical UK (supported by Novo-Nordisk) for additional writing support and assistance with the collation of author comments.	Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; Amylin Pharmaceuticals Inc, 2008, PAT INF BYETT EX INJ; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Bjornsdottir I, 2008, DIABETOLOGIA, V51, pS356; Bradley C., 1994, HDB PSYCHOL DIABETES, P111; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; Russell-Jones D, 2008, DIABETES, V57, pA159; Tourrel C, 2001, DIABETES, V50, P1562, DOI 10.2337/diabetes.50.7.1562; ZINMAN B, 2009, DIABETES CARE, DOI DOI 10.2337/DC08-21240; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003; [No title captured]	28	1096	1211	8	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					39	47		10.1016/S0140-6736(09)60659-0	http://dx.doi.org/10.1016/S0140-6736(09)60659-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19515413				2022-12-28	WOS:000267768800032
J	Thomas, JA; Simcox, DJ; Clarke, RT				Thomas, J. A.; Simcox, D. J.; Clarke, R. T.			Successful Conservation of a Threatened Maculinea Butterfly	SCIENCE			English	Article							SOCIAL PARASITE; NICHE SELECTION; ANT NESTS; HOST; CRISIS; ARION	Globally threatened butterflies have prompted research-based approaches to insect conservation. Here, we describe the reversal of the decline of Maculinea arion (Large Blue), a charismatic specialist whose larvae parasitize Myrmica ant societies. M. arion larvae were more specialized than had previously been recognized, being adapted to a single host-ant species that inhabits a narrow niche in grassland. Inconspicuous changes in grazing and vegetation structure caused host ants to be replaced by similar but unsuitable congeners, explaining the extinction of European Maculinea populations. Once this problem was identified, UK ecosystems were perturbed appropriately, validating models predicting the recovery and subsequent dynamics of the butterfly and ants at 78 sites. The successful identification and reversal of the problem provide a paradigm for other insect conservation projects.	[Thomas, J. A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Thomas, J. A.; Simcox, D. J.; Clarke, R. T.] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Clarke, R. T.] Bournemouth Univ, Sch Conservat Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England	University of Oxford; UK Centre for Ecology & Hydrology (UKCEH); Bournemouth University	Thomas, JA (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	jeremy.thomas@zoo.ox.ac.uk	Clarke, Ralph T/B-3859-2009; Thomas, Jeremy/A-9619-2013		European Union Macman and Biodiversa (CLIMIT) programs; Natural England; Centre for Ecology and Hydrology; National Trust; Somerset Wildlife Trust; Network Rail; J and F Clark Trust; Butterfly Conservation; Gloucester Wildlife Trust; Millfield School; Defra; World Wildlife Fund; Holland and Barrett; Hydrex; ICI; Natural Environment Research Council [CEH010021] Funding Source: researchfish	European Union Macman and Biodiversa (CLIMIT) programs; Natural England; Centre for Ecology and Hydrology; National Trust; Somerset Wildlife Trust; Network Rail; J and F Clark Trust; Butterfly Conservation; Gloucester Wildlife Trust; Millfield School; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); World Wildlife Fund; Holland and Barrett; Hydrex; ICI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding, experimental sites and other resources were generously provided by the European Union Macman and Biodiversa (CLIMIT) programs, Natural England, Centre for Ecology and Hydrology, the National Trust, the Somerset Wildlife Trust, Network Rail, J and F Clark Trust, Butterfly Conservation, Gloucester Wildlife Trust, Millfield School, Defra, the World Wildlife Fund, Sir Terence Conran, Holland and Barrett, Hydrex, ICI, and R. Mattoni.	CLARKE RT, 2005, STUDIES ECOLOGY CONS, V2, P115; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; Dempster J.P., 1991, CONSERVATION INSECTS, P143; Ehrlich PR, 2004, WINGS CHECKERSPOTS M; Elmes GW, 1998, J INSECT CONSERV, V2, P67, DOI 10.1023/A:1009696823965; ELMES GW, 1992, BIODIVERS CONSERV, V1, P155, DOI 10.1007/BF00695913; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; ERHARDT A, 1985, J APPL ECOL, V22, P849, DOI 10.2307/2403234; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Mouquet N, 2005, ECOL MONOGR, V75, P525, DOI 10.1890/05-0319; NEW TR, 1995, ANNU REV ENTOMOL, V40, P57, DOI 10.1146/annurev.en.40.010195.000421; Schonrogge K, 2006, ECOL LETT, V9, P1032, DOI 10.1111/j.1461-0248.2006.00957.x; SPOONER G. M., 1963, ENTOMOLOGIST, V96, P199; Stewart A.J., 2007, INSECT CONSERVATION; Thomas J., 1980, Oryx, V15, P243; THOMAS J A, 1991, P149; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P471, DOI 10.1098/rspb.2000.1398; THOMAS JA, 1992, OECOLOGIA, V91, P101, DOI 10.1007/BF00317247; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 2004, SCIENCE, V305, P1563; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; THOMAS JA, 1989, OECOLOGIA, V79, P452, DOI 10.1007/BF00378660; Thomas JA, 2002, OECOLOGIA, V132, P531, DOI 10.1007/s00442-002-1002-9; WARREN MJ, COMMUNICATION; Wells S.M., 1983, IUCN INVERTEBRATE RE, P97	26	185	189	3	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					80	83		10.1126/science.1175726	http://dx.doi.org/10.1126/science.1175726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19541953				2022-12-28	WOS:000267594000039
J	Kilo, CM; Larson, EB				Kilo, Charles M.; Larson, Eric B.			Exploring the Harmful Effects of Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIAL; LIFE		[Kilo, Charles M.] Trust Healthcare Excellence & GreenField Hlth, Portland, OR 97225 USA; [Larson, Eric B.] Grp Hlth Ctr Hlth Studies, Seattle, WA USA		Kilo, CM (corresponding author), Trust Healthcare Excellence & GreenField Hlth, 9427 SW Barnes Rd,Ste 590, Portland, OR 97225 USA.	chuck.kilo@greenfieldhealth.com						Banthin JS, 2008, HEALTH AFFAIR, V27, P188, DOI 10.1377/hlthaff.27.1.188; Dalen JE, 2001, JAMA-J AM MED ASSOC, V286, P348, DOI 10.1001/jama.286.3.348; EPSTEIN AE, 1993, JAMA-J AM MED ASSOC, V270, P2451, DOI 10.1001/jama.270.20.2451; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; FISHER ES, 2003, NY TIMES        1201; Hartman M, 2009, HEALTH AFFAIR, V28, P246, DOI 10.1377/hlthaff.28.1.246; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Muennig P, 2007, AM J PUBLIC HEALTH, V97, P2020, DOI 10.2105/AJPH.2006.105478; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Somogyi-Zalud E, 2002, J AM GERIATR SOC, V50, P930, DOI 10.1046/j.1532-5415.2002.50222.x; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607	15	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					89	91		10.1001/jama.2009.957	http://dx.doi.org/10.1001/jama.2009.957			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567446				2022-12-28	WOS:000267492800029
J	Mattson-DiCecca, AA; Reynolds, E				Mattson-DiCecca, Anna A.; Reynolds, Eileen			Update: A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Zimetbaum PJ, 2007, JAMA-J AM MED ASSOC, V297, P1909, DOI 10.1001/jama.297.17.1909	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					81	81		10.1001/jama.2009.941	http://dx.doi.org/10.1001/jama.2009.941			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567442				2022-12-28	WOS:000267492800025
J	Schneider, NM; Burger, MH; Schaller, EL; Brown, ME; Johnson, RE; Kargel, JS; Dougherty, MK; Achilleos, NA				Schneider, Nicholas M.; Burger, Matthew H.; Schaller, Emily L.; Brown, Michael E.; Johnson, Robert E.; Kargel, Jeffrey S.; Dougherty, Michele K.; Achilleos, Nicholas A.			No sodium in the vapour plumes of Enceladus	NATURE			English	Article							DISCOVERY; ATMOSPHERE; SPECTROMETER; ORIGIN	The discovery of water vapour and ice particles erupting from Saturn's moon Enceladus fuelled speculation that an internal ocean was the source(1-3). Alternatively, the source might be ice warmed, melted or crushed by tectonic motions(4). Sodium chloride (that is, salt) is expected to be present in a long-lived ocean in contact with a rocky core. Here we report a ground-based spectroscopic search for atomic sodium near Enceladus that places an upper limit on the mixing ratio in the vapour plumes orders of magnitude below the expected ocean salinity(5). The low sodium content of escaping vapour, together with the small fraction of salt-bearing particles(6), argues against a situation in which a near-surface geyser is fuelled by a salty ocean through cracks in the crust(1). The lack of observable sodium in the vapour is consistent with a wide variety of alternative eruption sources, including a deep ocean(6), a freshwater reservoir, or ice. The existing data may be insufficient to distinguish between these hypotheses.	[Schneider, Nicholas M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; [Burger, Matthew H.] Univ Maryland Baltimore Cty, Greenbelt, MD 20771 USA; [Burger, Matthew H.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Schaller, Emily L.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Brown, Michael E.] CALTECH, Pasadena, CA 91125 USA; [Johnson, Robert E.] Univ Virginia, Charlottesville, VA 22904 USA; [Kargel, Jeffrey S.] Univ Arizona, Tucson, AZ 85721 USA; [Dougherty, Michele K.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Achilleos, Nicholas A.] UCL, London WC1E 6BT, England	University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Hawaii System; California Institute of Technology; University of Virginia; University of Arizona; Imperial College London; University of London; University College London	Schneider, NM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	nick.schneider@lasp.colorado.edu	Burger, Matthew/C-1310-2011	Achilleos, Nicholas/0000-0002-5886-3509; Brown, Michael E./0000-0002-8255-0545; Schaller, Emily/0000-0001-8967-5423; SCHNEIDER, NICHOLAS/0000-0001-6720-5519	W. M. Keck Foundation; National Science Foundation's Planetary Astronomy Program; NASA Postdoctoral Program; STFC [PP/D000912/1, PP/E001076/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000912/1, PP/E001076/1] Funding Source: researchfish	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation's Planetary Astronomy Program; NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the financial support of the W. M. Keck Foundation. We also acknowledge the Anglo-Australian Telescope and its staff. This work was supported by the National Science Foundation's Planetary Astronomy Program and the NASA Postdoctoral Program. This paper has benefited from discussions with M. Zolotov, J. Spencer, C. Porco, T. Johnson, A. Ingersoll, W. McKinnon, C. Mackay, F. Postberg, J. Schmidt, S. Kempf and R. Pappalardo.	Brown ME, 1996, NATURE, V380, P229, DOI 10.1038/380229a0; BROWN RA, 1974, IAU S, V65, P527; Burger MH, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012086; Burger MH, 2004, ICARUS, V171, P557, DOI 10.1016/j.icarus.2004.06.014; BURGER MH, 2003, THESIS U COLORADO; DIEGO F, 1990, P SOC PHOTO-OPT INS, V1235, P562, DOI 10.1117/12.19119; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Jurac S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015855; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Lellouch E, 2003, NATURE, V421, P45, DOI 10.1038/nature01292; LEVIN BJ, 1964, ICARUS, V4, P497; McKay CP, 2008, ASTROBIOLOGY, V8, P909, DOI 10.1089/ast.2008.0265; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Osterbrock DE, 1996, PUBL ASTRON SOC PAC, V108, P277, DOI 10.1086/133722; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; POTTER AE, 1988, SCIENCE, V241, P675, DOI 10.1126/science.241.4866.675; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tian F, 2007, ICARUS, V188, P154, DOI 10.1016/j.icarus.2006.11.010; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Zolotov MY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031234	23	31	31	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1102	1104		10.1038/nature08070	http://dx.doi.org/10.1038/nature08070			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553993				2022-12-28	WOS:000267636700037
J	Ravishankar, N; Gubbins, P; Cooley, R; Leach-Kemon, K; Michaud, CM; Jamison, DT; Murray, CJL				Ravishankar, Nirmala; Gubbins, Paul; Cooley, Rebecca; Leach-Kemon, Katherine; Michaud, Catherine M.; Jamison, Dean T.; Murray, Christopher J. L.			Financing of global health: tracking development assistance for health from 1990 to 2007	LANCET			English	Article								Background The need for timely and reliable information about global health resource flows to low-income and middle-income countries is widely recognised. We aimed to provide a comprehensive assessment of development assistance for health (DAH) from 1990 to 2007. Methods We defined DAH as all flows for health from public and private institutions whose primary purpose is to provide development assistance to low-income and middle-income countries. We used several data sources to measure the yearly volume of DAH in 2007 US$, and created an integrated project database to examine the composition of this assistance by recipient country. Findings DAH grew from $5.6 billion in 1990 to $21.8 billion in 2007. The proportion of DAH channelled via UN agencies and development banks decreased from 1990 to 2007, whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Global Alliance for Vaccines and Immunization (GAVI), and non-governmental organisations became the conduit for an increasing share of DAH. DAH has risen sharply since 2002 because of increases in public funding, especially from the USA, and on the private side, from increased philanthropic donations and in-kind contributions from corporate donors. Of the $14.5 billion DAH in 2007 for which project-level information was available, $5.1 billion was for HIV/AIDS, compared with $0.7 billion for tuberculosis, $0.8 billion for malaria, and $0.9 billion for health-sector support. Total DAH received by low-income and middle-income countries was positively correlated with burden of disease, whereas per head DAH was negatively correlated with per head gross domestic product. Interpretation This study documents the substantial rise of resources for global health in recent years. Although the rise in DAH has resulted in increased funds for HIV/AIDS, other areas of global health have also expanded. The influx of funds has been accompanied by major changes in the institutional landscape of global health, with global health initiatives such as the Global Fund and GAVI having a central role in mobilising and channelling global health funds. Funding Bill & Melinda Gates Foundation.	[Ravishankar, Nirmala; Gubbins, Paul; Cooley, Rebecca; Leach-Kemon, Katherine; Jamison, Dean T.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Michaud, Catherine M.] Harvard Univ, Harvard Initiat Global Hlth, Cambridge, MA 02138 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	[Anonymous], 2008, KAISER DAILY HIV AID; Eiseman E, 2005, CHALLENGES CREATING; ETHELSTON S, 2004, PROGR PROMISES TREND; Farmer P, 2007, FOREIGN AFF, V86, P155; Farrar J, 2007, NAT IMMUNOL, V8, P1277, DOI 10.1038/ni1532; Garrett L, 2007, FOREIGN AFF, V86, P14; *GLOB HLTH RES TRA, 2005, FOLL MON GLOB HLTH; *HUDS I, 2008, IND GLOB PHIL 2008; *INT MON FUND, 2008, WORLD EC OUTL DAT; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; Kates J, 2006, LANCET, V368, P187, DOI 10.1016/S0140-6736(06)69018-1; LEVINE R, 2004, FOR 8 MEX CIT NOV; MCNEIL DG, 2009, NY TIMES NEW YO 0202; MICHAUD C, 1994, B WORLD HEALTH ORGAN, V72, P639; Michaud C., 2003, DEV ASSISTANCE HLTH; Moyo Dambisa., 2009, DEAD AID WHY AID IS; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; *ORG EC COOP DEV, PURP AID CHARTS FOC; *ORG EC COOP DEV, 2008, MEAS AID HLTH; Powell-Jackson T, 2007, HEALTH POLICY PLANN, V22, P353, DOI 10.1093/heapol/czm024; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Reich MR, 1999, B WORLD HEALTH ORGAN, V77, P675; Schleber GJ, 2007, HEALTH AFFAIR, V26, P921, DOI 10.1377/hlthaff.26.4.921; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; UN Statistics Division, 2008, NAT ACC MAIN AGGR DA; United Nations Population Division, 2008, WORLD POP PROSP 2008; Waddington C, 2005, TRENDS INT FUNDING M; *WHO, 2009, WHO NAT HLTH ACC; *WHO, 2004, WHO BURD DIS DAT PRE; World Bank, 2008, WORLD DEV IND ONL; 2008, UN NEWS CTR	31	335	340	0	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2009	373	9681					2113	2124		10.1016/S0140-6736(09)60881-3	http://dx.doi.org/10.1016/S0140-6736(09)60881-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541038				2022-12-28	WOS:000267229700028
J	Matzke-Karasz, R; Smith, RJ; Symonova, R; Miller, CG; Tafforeau, P				Matzke-Karasz, R.; Smith, R. J.; Symonova, R.; Miller, C. G.; Tafforeau, P.			Sexual Intercourse Involving Giant Sperm in Cretaceous Ostracode	SCIENCE			English	Article									[Matzke-Karasz, R.] Univ Munich, Dept Environm & Geosci, D-80333 Munich, Germany; [Matzke-Karasz, R.] Univ Munich, GeoBioCtr, D-80333 Munich, Germany; [Smith, R. J.] Lake Biwa Museum, Shiga 5250001, Japan; [Symonova, R.] Charles Univ Prague, Dept Zool, CR-12844 Prague, Czech Republic; [Miller, C. G.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Tafforeau, P.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Munich; University of Munich; Charles University Prague; Natural History Museum London; European Synchrotron Radiation Facility (ESRF)	Matzke-Karasz, R (corresponding author), Univ Munich, Dept Environm & Geosci, D-80333 Munich, Germany.	r.matzke@lrz.uni-muenchen.de	Miller, Giles/C-5160-2012	Miller, Giles/0000-0001-9111-2136; Smith, Robin/0000-0002-9888-5323; Matzke-Karasz, Renate/0000-0002-8010-2028; Tafforeau, Paul/0000-0002-5962-1683	ESRF [ec-274]; European Union Marie Curie RTN SexAsex [FP6-512492]; LMU Palaeontology; Lake Biwa Museum (Japan)	ESRF; European Union Marie Curie RTN SexAsex(European Commission); LMU Palaeontology; Lake Biwa Museum (Japan)	Supported by the ESRF (proposal ec-274), the European Union Marie Curie RTN SexAsex (FP6-512492), LMU Palaeontology, the Lake Biwa Museum (Japan), and the Natural History Museum (by loan of fossil specimens).	Bjork A, 2006, NATURE, V441, P742, DOI 10.1038/nature04683; Do Carmo DA, 2008, J PALEONTOL, V82, P790, DOI 10.1666/07-008.1; Matzke-Karasz R, 2001, NATURWISSENSCHAFTEN, V88, P268, DOI 10.1007/s001140100234; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Smith RJ, 2000, PALAEONTOLOGY, V43, P63, DOI 10.1111/1475-4983.00119; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Williams Mark, 2008, Senckenbergiana Lethaea, V88, P11	8	33	34	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1535	1535		10.1126/science.1173898	http://dx.doi.org/10.1126/science.1173898			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541990				2022-12-28	WOS:000267130600035
J	Heilman, CB; Zerris, VA				Heilman, Carl B.; Zerris, Vasilios A.			Combined-System Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heilman, Carl B.; Zerris, Vasilios A.] Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Heilman, CB (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2655	2655		10.1056/NEJMicm020292	http://dx.doi.org/10.1056/NEJMicm020292			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535804				2022-12-28	WOS:000267060000010
J	Jain, RK				Jain, Rakesh K.			A New Target for Tumor Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTI-ANGIOGENIC THERAPY; NORMALIZATION; OXYGENATION		[Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.		Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548	NCI NIH HHS [P01 CA080124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Jain RK, 2008, NAT REV CANCER, V8, P309, DOI 10.1038/nrc2346; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011	5	51	57	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2669	2671		10.1056/NEJMcibr0902054	http://dx.doi.org/10.1056/NEJMcibr0902054			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535806	Green Accepted			2022-12-28	WOS:000267060000015
J	Becker, DJ; Gordon, RY; Halbert, SC; French, B; Morris, PB; Rader, DJ				Becker, David J.; Gordon, Ram Y.; Halbert, Steven C.; French, Benjamin; Morris, Patti B.; Rader, Daniel J.			Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PURPUREUS WENT RICE; MEDITERRANEAN DIET; MONASCUS-PURPUREUS; PRIMARY PREVENTION; CORONARY EVENTS; RISK PATIENTS; EFFICACY; ROSUVASTATIN; MYOPATHY; SAFETY	Background: Red yeast rice is an herbal supplement that decreases low-density lipoprotein (LDL) cholesterol level. Objective: To evaluate the effectiveness and tolerability of red yeast rice and therapeutic lifestyle change to treat dyslipidemia in patients who cannot tolerate statin therapy. Design: Randomized, controlled trial. Setting: Community-based cardiology practice. Patients: 62 patients with dyslipidemia and history of discontinuation of statin therapy due to myalgias. Intervention: Patients were assigned by random allocation software to receive red yeast rice, 1800 mg (31 patients), or placebo (31 patients) twice daily for 24 weeks. All patients were concomitantly enrolled in a 12-week therapeutic lifestyle change program. Measurements: Primary outcome was LDL cholesterol level, measured at baseline, week 12, and week 24. Secondary outcomes included total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, liver enzyme, and creatinine phosphokinase (CPK) levels; weight; and Brief Pain Inventory score. Results: In the red yeast rice group, LDL cholesterol decreased by 1.11 mmol/L (43 mg/dL) from baseline at week 12 and by 0.90 mmol/L (35 mg/dL) at week 24. In the placebo group, LDL cholesterol decreased by 0.28 mmol/L (11 mg/dL) at week 12 and by 0.39 mmol/L (15 mg/dL) at week 24. Low-density lipoprotein cholesterol level was significantly lower in the red yeast rice group than in the placebo group at both weeks 12 (P < 0.001) and 24 (P = 0.011). Significant treatment effects were also observed for total cholesterol level at weeks 12 (P < 0.001) and 24 (P = 0.016). Levels of HDL cholesterol, triglyceride, liver enzyme, or CPK; weight loss; and pain severity scores did not significantly differ between groups at either week 12 or week 24. Limitation: The study was small, was single-site, was of short duration, and focused on laboratory measures. Conclusion: Red yeast rice and therapeutic lifestyle change decrease LDL cholesterol level without increasing CPK or pain levels and may be a treatment option for dyslipidemic patients who cannot tolerate statin therapy.	Univ Penn, Sch Med, Chestnut Hill Hosp, Philadelphia, PA 19104 USA; Jefferson Myrna Brind Ctr Integrat Med, Philadelphia, PA USA	University of Pennsylvania	Becker, DJ (corresponding author), 1722 Bethlehem Pike, Flourtown, PA 19031 USA.	dbeckerchcardiology@hotmail.com			National Center for Complementary and Alternative Medicine [T32AT000600]; Commonwealth of Pennsylvania; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [T32AT000600] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Commonwealth of Pennsylvania; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	By grant T32AT000600 from the National Center for Complementary and Alternative Medicine (Dr. Halbert) and an unrestricted grant from the Commonwealth of Pennsylvania.	*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; Backes JM, 2008, ANN PHARMACOTHER, V42, P341, DOI 10.1345/aph.1K604; Backes JM, 2007, AM J CARDIOL, V100, P554, DOI 10.1016/j.amjcard.2007.03.059; Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006; Becker DJ, 2008, MAYO CLIN PROC, V83, P758, DOI 10.4065/83.7.758; BRADFORD RH, 1994, AM J CARDIOL, V74, P667, DOI 10.1016/0002-9149(94)90307-7; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cartin-Ceba R, 2007, AM J MED, V120, pE3, DOI 10.1016/j.amjmed.2007.04.018; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Gadarla M, 2008, AM J CARDIOL, V101, P1747, DOI 10.1016/j.amjcard.2008.02.061; Gazi IF, 2007, CURR MED RES OPIN, V23, P2183, DOI 10.1185/030079907X226267; Glueck CJ, 2006, CLIN THER, V28, P933, DOI 10.1016/j.clinthera.2006.06.004; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; HARDING A, 2008, CONTAMINATION COMMON; Heber D, 1999, AM J CLIN NUTR, V69, P231; Heber D, 2001, J ALTERN COMPLEM MED, V7, P133, DOI 10.1089/107555301750164181; Huang CF, 2007, EUR J CARDIOV PREV R, V14, P438, DOI 10.1097/HJR.0b013e32801da137; Jacobson TA, 2008, MAYO CLIN PROC, V83, P687, DOI 10.4065/83.6.687; Juszczyk Monika A, 2005, Prev Cardiol, V8, P197, DOI 10.1111/j.0197-3118.2005.04404.x; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Lapi F, 2008, BRIT J CLIN PHARMACO, V66, P572, DOI 10.1111/j.1365-2125.2008.03224.x; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lin CC, 2005, EUR J ENDOCRINOL, V153, P679, DOI 10.1530/eje.1.02012; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049; Mitka M, 2003, JAMA-J AM MED ASSOC, V290, P2243, DOI 10.1001/jama.290.17.2243; Mueller PS, 2006, ANN INTERN MED, V145, P474, DOI 10.7326/0003-4819-145-6-200609190-00021; *NBJ, 2008, NBJS SUPPPL BUS REP, P240; Prasad GVR, 2002, TRANSPLANTATION, V74, P1200, DOI 10.1097/01.TP.0000031950.34040.79; Rivers Shannon M, 2007, Endocr Pract, V13, P11; Roselle H, 2008, ANN INTERN MED, V149, P516, DOI 10.7326/0003-4819-149-7-200810070-00021; Schmidt-Trucksass A, 2003, NEW ENGL J MED, V348, P1494; Siddiqi SA, 2009, CURR ATHEROSCLER REP, V11, P9, DOI 10.1007/s11883-009-0002-1; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Smith DJ, 2003, SOUTH MED J, V96, P1265, DOI 10.1097/01.SMJ.0000100117.79718.DC; Snow G., 2006, BLOCKRAND PACKAGE RA; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099; Team RC., 2022, LANG ENV STAT COMP; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vercelli L, 2006, J AM GERIATR SOC, V54, P718, DOI 10.1111/j.1532-5415.2006.00668_7.x; Vogel RA, 2005, J AM COLL CARDIOL, V46, P184, DOI 10.1016/j.jacc.2005.05.031	51	198	206	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					830	U30		10.7326/0003-4819-150-12-200906160-00006	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528562				2022-12-28	WOS:000267164800002
J	Hirsch, C				Hirsch, Calvin			Continued use of antipsychotic drugs increased long-term mortality in patients with Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Rochon PA, 2007, ARCH INTERN MED, V167, P676, DOI 10.1001/archinte.167.7.676; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Selbaek G, 2008, AM J GERIAT PSYCHIAT, V16, P528, DOI 10.1097/JGP.0b013e318167ae76	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-8	10.7326/0003-4819-150-12-200906160-02008	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528553				2022-12-28	WOS:000267164800020
J	Yang, LH; Link, BG				Yang, Lawrence H.; Link, Bruce G.			Comparing diagnostic methods for mental disorders in China	LANCET			English	Editorial Material							WORLD-HEALTH-ORGANIZATION; NATIONAL-COMORBIDITY-SURVEY; PSYCHIATRIC-DISORDERS; DSM-IV; INTERVIEW; PREVALENCE; VERSION; CIDI; LIFETIME; VALIDITY		[Yang, Lawrence H.; Link, Bruce G.] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA	Columbia University	Yang, LH (corresponding author), Columbia Univ, Dept Epidemiol, 722 W 168th St,Room 1610, New York, NY 10032 USA.	lhy2001@columbia.edu	Link, Bruce/AAO-9094-2021; Link, Bruce G/N-9087-2013; Yang, Lawrence H/A-6386-2012	Link, Bruce/0000-0001-9980-7450				Booth BM, 1998, J PSYCHIAT RES, V32, P353, DOI 10.1016/S0022-3956(98)00031-4; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; First MB, 2002, STRUCTURED CLIN INTE; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Lee S, 2002, PSYCHOPATHOLOGY, V35, P152, DOI 10.1159/000065136; Mezzich JE, 1999, J NERV MENT DIS, V187, P457, DOI 10.1097/00005053-199908000-00001; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Xu MQ, 2009, SCHIZOPHRENIA BULL, V35, P568, DOI 10.1093/schbul/sbn168	14	17	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2002	2004		10.1016/S0140-6736(09)61091-6	http://dx.doi.org/10.1016/S0140-6736(09)61091-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19524763				2022-12-28	WOS:000267080100006
J	He, SD; Wang, L; Miao, L; Wang, T; Du, FH; Zhao, LP; Wang, XD				He, Sudan; Wang, Lai; Miao, Lin; Wang, Tao; Du, Fenghe; Zhao, Liping; Wang, Xiaodong			Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-alpha	CELL			English	Article							TUMOR-NECROSIS-FACTOR; CYTOCHROME-C; DEATH; RIP; IDENTIFICATION; ACTIVATION; APOPTOSIS; CASPASES; INDUCE; INHIBITION	Smac mimetics induce apoptosis synergistically with TNF-alpha by triggering the formation of a caspase-8-activating complex containing receptor interacting protein kinase-1 (RIPK1). Caspase inhibitors block this form of apoptosis in many types of cells. However, in several other cell lines, caspase inhibitors switch the apoptotic response to necrosis. A genome wide siRNA screen revealed another member of the RIP kinase family, RIP3, to be required for necrosis. The expression of RIP3 in different cell lines correlates with their responsiveness to necrosis induction. The kinase activity of RIP3 is essential for necrosis execution. Upon induction of necrosis, RIP3 is recruited to RIPK1 to form a necrosis-inducing complex. Embryonic fibroblasts from RIP3 knockout mice are resistant to necrosis and RIP3 knockout animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model. These data indicate RIP3 as the determinant for cellular necrosis in response to TNF-alpha family of death-inducing cytokines.	[Wang, Lai; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA; [He, Sudan] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [He, Sudan] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [He, Sudan; Miao, Lin; Wang, Tao; Zhao, Liping] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; National Institute of Biological Sciences, Beijing	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA.	xiaodong.wang@utsouthwestern.edu		He, Sudan/0000-0002-0846-1210; Wang, Xiaodong/0000-0001-9885-356X	National Cancer Institute (NCI) [PO1 CA 95471]; Chinese Ministry of Science and Technology [2008AA022318]; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to express our gratitude to the High-throughput Screening Facility at the University of Texas Southwestern Medical Center for help with siRNA screening. We also thank Yinan Gong, Hui Li, and Cai Zhang for technical assistance and Greg Kunkel for help with setting up siRNA screening and he and Sean Petersen for critical reading of the manuscript. This work is also supported by a grant from the National Cancer Institute (NCI) (PO1 CA 95471) and the National High Technology Projects 863 (2008AA022318) from Chinese Ministry of Science and Technology.	Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; LASTER SM, 1988, J IMMUNOL, V141, P2629; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lockshin RA, 2007, J CELL MOL MED, V11, P1214, DOI 10.1111/j.1582-4934.2007.00150.x; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5	35	1543	1632	7	208	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1100	1111		10.1016/j.cell.2009.05.021	http://dx.doi.org/10.1016/j.cell.2009.05.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524512	Bronze			2022-12-28	WOS:000266916400021
J	Dang, WW; Steffen, KK; Perry, R; Dorsey, JA; Johnson, FB; Shilatifard, A; Kaeberlein, M; Kennedy, BK; Berger, SL				Dang, Weiwei; Steffen, Kristan K.; Perry, Rocco; Dorsey, Jean A.; Johnson, F. Brad; Shilatifard, Ali; Kaeberlein, Matt; Kennedy, Brian K.; Berger, Shelley L.			Histone H4 lysine 16 acetylation regulates cellular lifespan	NATURE			English	Article							BLOCK PROTEIN FOB1; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; GENOMIC INSTABILITY; MOTHER CELLS; YEAST; SIR2; REPLICATION; CHROMATIN; SIRTUINS	Cells undergoing developmental processes are characterized by persistent non-genetic alterations in chromatin, termed epigenetic changes, represented by distinct patterns of DNA methylation and histone post-translational modifications. Sirtuins, a group of conserved NAD(+)-dependent deacetylases or ADP-ribosyltransferases, promote longevity in diverse organisms; however, their molecular mechanisms in ageing regulation remain poorly understood. Yeast Sir2, the first member of the family to be found, establishes and maintains chromatin silencing by removing histone H4 lysine 16 acetylation and bringing in other silencing proteins. Here we report an age-associated decrease in Sir2 protein abundance accompanied by an increase in H4 lysine 16 acetylation and loss of histones at specific subtelomeric regions in replicatively old yeast cells, which results in compromised transcriptional silencing at these loci. Antagonizing activities of Sir2 and Sas2, a histone acetyltransferase, regulate the replicative lifespan through histone H4 lysine 16 at subtelomeric regions. This pathway, distinct from existing ageing models for yeast, may represent an evolutionarily conserved function of sirtuins in regulation of replicative ageing by maintenance of intact telomeric chromatin.	[Dang, Weiwei; Perry, Rocco; Dorsey, Jean A.; Berger, Shelley L.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Steffen, Kristan K.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Cell & Mol Biol Grp,Biomed Grad Studies, Philadelphia, PA 19104 USA; [Johnson, F. Brad] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; [Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Berger, Shelley L.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	The Wistar Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; Stowers Institute for Medical Research; University of Pennsylvania	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA.	sberger@mail.med.upenn.edu		Berger, Shelley/0000-0001-5398-4400; Kaeberlein, Matt/0000-0002-1311-3421; Kennedy, Brian/0000-0002-5754-1874; Dang, Weiwei/0000-0002-6931-4636	US National Institutes of Health; American Federation for Aging Research Julie Martin Mid-Career Award in Aging Research; NATIONAL CANCER INSTITUTE [R01CA089455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025549] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research Julie Martin Mid-Career Award in Aging Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Louis for providing strains for the telomere silencing assay, and members of the Kennedy and Kaeberlein labs who participated in lifespan-determination studies. This work was funded by US National Institutes of Health grants (S. L. B. and B. K. K.), and an American Federation for Aging Research Julie Martin Mid-Career Award in Aging Research (B. K. K.). M. K. is an Ellison Medical Foundation New Scholar in Aging.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Johzuka K, 2002, GENES CELLS, V7, P99, DOI 10.1046/j.1356-9597.2001.00508.x; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; Laun P, 2007, NUCLEIC ACIDS RES, V35, P7514, DOI 10.1093/nar/gkm919; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Park PU, 2002, METHOD ENZYMOL, V351, P468; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021	45	442	461	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					802	U2		10.1038/nature08085	http://dx.doi.org/10.1038/nature08085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516333	Green Accepted			2022-12-28	WOS:000267084500030
J	Matok, I; Gorodischer, R; Koren, G; Sheiner, E; Wiznitzer, A; Levy, A				Matok, Ilan; Gorodischer, Rafael; Koren, Gideon; Sheiner, Eyal; Wiznitzer, Arnon; Levy, Amalia			The Safety of Metoclopramide Use in the First Trimester of Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-DEFECTS; NAUSEA; MEDICATIONS; POPULATION; PREVENTION; DELIVERY; THERAPY	BACKGROUND In various countries, metoclopramide is the antiemetic drug of choice in pregnant women, but insufficient information exists regarding its safety in pregnancy. METHODS We investigated the safety of metoclopramide use during the first trimester of pregnancy by linking a computerized database of medications dispensed between January 1, 1998, and March 31, 2007, to all women registered in the Clalit Health Services, southern district of Israel, with computerized databases containing maternal and infant hospital records from the district hospital during the same period. We assessed associations between the use of metoclopramide in pregnancy and adverse outcomes for the fetus, adjusting for parity, maternal age, ethnic group, presence or absence of maternal diabetes, smoking status, and presence or absence of peripartum fever. RESULTS There were 113,612 singleton births during the study period. A total of 81,703 of the infants (71.9%) were born to women registered in Clalit Health Services; 3458 of them (4.2%) were exposed to metoclopramide during the first trimester of pregnancy. Exposure to metoclopramide, as compared with no exposure to the drug, was not associated with significantly increased risks of major congenital malformations (5.3% and 4.9%, respectively; odds ratio, 1.04; 95% confidence interval [CI], 0.89 to 1.21), low birth weight (8.5% and 8.3%; odds ratio, 1.01; 95% CI, 0.89 to 1.14), pre-term delivery (6.3% and 5.9%; odds ratio, 1.15; 95% CI, 0.99 to 1.34), or perinatal death (1.5% and 2.2%; odds ratio, 0.87; 95% CI, 0.55 to 1.38). The results were materially unchanged when therapeutic abortions of exposed and unexposed fetuses were included in the analysis. CONCLUSIONS In this large cohort of infants, exposure to metoclopramide in the first trimester was not associated with significantly increased risks of any of several adverse outcomes. These findings provide reassurance regarding the safety of metoclopramide for the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy.	[Gorodischer, Rafael; Sheiner, Eyal; Wiznitzer, Arnon] Soroka Med Ctr, IL-84101 Beer Sheva, Israel; [Matok, Ilan; Levy, Amalia] Ben Gurion Univ Negev, Dept Epidemiol & Hlth Serv Evaluat, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Gorodischer, Rafael] Ben Gurion Univ Negev, Dept Pediat, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Sheiner, Eyal; Wiznitzer, Arnon] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Gorodischer, Rafael; Wiznitzer, Arnon] Clalit Hlth Serv So District, Beer Sheva, Israel; [Gorodischer, Rafael; Levy, Amalia] BeMORE Collaborat, Beer Sheva, Israel; [Koren, Gideon] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol, Motherisk Program, Toronto, ON M5G 1X8, Canada; [Koren, Gideon] BeMORE Collaborat, Toronto, ON, Canada; [Koren, Gideon] Univ Western Ontario, Dept Med, London, ON, Canada	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Clalit Health Services; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario)	Gorodischer, R (corresponding author), Soroka Med Ctr, POB 151, IL-84101 Beer Sheva, Israel.	rafaelg@bgu.ac.il	Gorodischer, Rafael/AAQ-8132-2020; Matok, Ilan/H-1562-2016; Koren, Gideon/AAG-7726-2019; SHEINER, EYAL/F-1488-2012	Matok, Ilan/0000-0003-1559-9258; Koren, Gideon/0000-0002-9234-0875; Gorodischer, Rafael/0000-0002-7649-3353	Duchesnay	Duchesnay	Dr. Koren reports receiving consulting and lecture fees and grant support from Duchesnay. No other potential conflict of interest relevant to this article was reported.	American College of Obstetrics and Gynecology, 2004, Obstet Gynecol, V103, P803; BENJOSEPH R, 2008, J MATERN-FETAL NEO M, P1; Berkovitch M, 2000, NEW ENGL J MED, V343, P445, DOI 10.1056/NEJM200008103430616; Berkovitch M, 2002, AM J PERINAT, V19, P311, DOI 10.1055/s-2002-34469; Boneva RS, 1999, AM J EPIDEMIOL, V149, P717; Centers for Disease Control and Prevention, METR ATL CONG DEF PR; *CENTR BUR STAT, STAT ISR HOD LAIT; *CENTR BUR STAT, 59 CENTR BUR STAT; Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P617, DOI 10.1002/bdra.10111; DEUCHAR N, 1995, BRIT J OBSTET GYNAEC, V102, P6, DOI 10.1111/j.1471-0528.1995.tb09017.x; Einarson A, 1998, EUR J OBSTET GYN R B, V76, P1, DOI 10.1016/S0301-2115(97)00129-2; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gadsby R, 1993, BR J GEN PRACT, V43, P325; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KALLEN B, 1987, EUR J OBSTET GYN R B, V26, P291; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Louik C, 2006, PAEDIATR PERINAT EP, V20, P270, DOI 10.1111/j.1365-3016.2006.00723.x; Magee LA, 2002, AM J OBSTET GYNECOL, V186, pS256, DOI 10.1067/mob.2002.122596; Meyerovitch J, 2006, PEDIATRICS, V118, pE1055, DOI 10.1542/peds.2006-0024; Misset B, 2008, CRIT CARE, V12, DOI 10.1186/cc6969; Ofir D, 2008, EUR J OBSTET GYN R B, V141, P115, DOI 10.1016/j.ejogrb.2008.07.025; Pradalier A, 1999, HEADACHE, V39, P125, DOI 10.1046/j.1526-4610.1999.3902125.x; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; ROSA F, 2005, DRUGS PREGNANCY LACT, P1057; Sheiner E, 1998, EUR J OBSTET GYN R B, V76, P141, DOI 10.1016/S0301-2115(97)00178-4; Sheiner E, 1999, INT J GYNECOL OBSTET, V64, P227, DOI 10.1016/S0020-7292(98)00166-0; SIDHU MS, 1970, P OBSTET GYNAECOL SO, V1, P43; Sorensen HT, 2000, BRIT J CLIN PHARMACO, V49, P264, DOI 10.1046/j.1365-2125.2000.00127.x; Tricco AC, 2008, J CLIN EPIDEMIOL, V61, P192, DOI 10.1016/j.jclinepi.2007.03.009; Van den Berg LTWDJ, 1999, TERATOLOGY, V60, P33; VELLACOTT ID, 1988, INT J GYNECOL OBSTET, V27, P57, DOI 10.1016/0020-7292(88)90088-4; WEIGEL RM, 1989, BRIT J OBSTET GYNAEC, V96, P1312, DOI 10.1111/j.1471-0528.1989.tb03229.x; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; *WHO, WHO COLL CTR DURG ST	35	104	107	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2528	2535		10.1056/NEJMoa0807154	http://dx.doi.org/10.1056/NEJMoa0807154			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516033				2022-12-28	WOS:000266813800007
J	Duncan, JR; Evens, RG				Duncan, James R.; Evens, Ronald G.			Using Information to Optimize Medical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Duncan, James R.; Evens, Ronald G.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Duncan, JR (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, 510 S Kingshighway Blvd, St Louis, MO 63110 USA.	duncanj@mir.wustl.edu		Duncan, James/0000-0002-0337-8805				[Anonymous], 2000, NEW EC IND GOVT ED; Argote L, 2013, ORG LEARNING CREATIN, DOI 10.1111/j.1552-6909.1999.tb01970.x; BOX G, 2006, IMPROVING ANYTHING I; Christensen C, 2009, INNOVATORS PRESCRIPT; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Embretson S, 2000, MULTIVARIATE APPL BO; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Kane M. T., 2006, ED MEASUREMENT, V4th, P17, DOI DOI 10.1037/0033-2909.114.3.533; Klein G., 1999, SOURCES POWER; Liker J., 2003, TOYOTA WAY; MOLDINOW L, 2008, DRUNKARDS WALK RANDO; Montgomery DC., 2019, INTRO STAT QUALITY C; Pierce J.R., 1980, INTRO INFORM THEORY; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Taguchi G., 1986, INTRO QUALITY ENG	15	17	17	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2383	2385		10.1001/jama.2009.827	http://dx.doi.org/10.1001/jama.2009.827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509387				2022-12-28	WOS:000266773400033
J	Kaufman, DS; Shipley, WU; Feldman, AS				Kaufman, Donald S.; Shipley, William U.; Feldman, Adam S.			Bladder cancer	LANCET			English	Review							TRANSITIONAL-CELL-CARCINOMA; PHASE-II TRIAL; BACILLUS-CALMETTE-GUERIN; INVASIVE UROTHELIAL CARCINOMA; 2ND TRANSURETHRAL RESECTION; GEMCITABINE PLUS CISPLATIN; MOLECULAR TARGETED THERAPY; LYMPH-NODE METASTASES; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY	Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial tumours, which tend to recur but are generally not life threatening, and 30% presenting as muscle-invasive disease associated with a high risk of death from distant metastases. The main presenting symptom of all bladder cancers is painless haematuria, and the diagnosis is established by urinary cytology and transurethral tumour resection. Intravesical treatment is used for carcinoma in situ and other high grade non-muscle-invasive tumours. The standard of care for muscle-invasive disease is radical cystoprostatectomy, and several types of urinary diversions are offered to patients, with quality of life as an important consideration. Bladder preservation with transurethral tumour resection, radiation, and chemotherapy can in some cases be equally curative. Several chemotherapeutic agents have proven to tie useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease. We discuss bladder preserving approaches, combination chemotherapy including new agents, targeted therapies, and advances in molecular biology.	[Kaufman, Donald S.] Massachusetts Gen Hosp, Claire & John Bertucci Ctr Genitourinary Canc, Dept Med, Boston, MA 02114 USA; [Shipley, William U.] Massachusetts Gen Hosp, Claire & John Bertucci Ctr Genitourinary Canc, Dept Radiat Oncol, Boston, MA 02114 USA; [Feldman, Adam S.] Massachusetts Gen Hosp, Claire & John Bertucci Ctr Genitourinary Canc, Dept Urol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kaufman, DS (corresponding author), Massachusetts Gen Hosp, Claire & John Bertucci Ctr Genitourinary Canc, Dept Med, Yawkey Bldg,Fruit St, Boston, MA 02114 USA.	dskaufman@partners.org						Abol-Enein H, 2005, EUR UROL, V48, P202, DOI 10.1016/j.eururo.2005.04.006; Al-Sukhun S, 2003, CANCER, V97, P2064, DOI 10.1002/cncr.11289; AliElDein B, 1997, BRIT J UROL, V79, P731, DOI 10.1046/j.1464-410X.1997.00142.x; ALTHAUSEN AF, 1976, J UROLOGY, V116, P575, DOI 10.1016/S0022-5347(17)58916-8; American Joint Committee on Cancer (AJCC), 2002, AM JOINT COMM CANC A; Bellmunt J, 2000, J CLIN ONCOL, V18, P3247, DOI 10.1200/JCO.2000.18.18.3247; Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011; Black PC, 2006, WORLD J UROL, V24, P531, DOI 10.1007/s00345-006-0113-z; Bohle A, 2003, J UROLOGY, V169, P90, DOI 10.1016/S0022-5347(05)64043-8; Bono A V, 1989, Prog Clin Biol Res, V303, P533; Bono AV, 2005, EUR UROL, V48, P189, DOI 10.1016/j.eururo.2005.04.005; Brauers A, 2001, J UROLOGY, V165, P808, DOI 10.1016/S0022-5347(05)66532-9; Chakravarti A, 2005, INT J RADIAT ONCOL, V62, P309, DOI 10.1016/j.ijrobp.2004.09.047; Chow NH, 2001, CLIN CANCER RES, V7, P1957; Chyle V, 1996, INT J RADIAT ONCOL, V35, P281, DOI 10.1016/0360-3016(96)00089-2; Davis JW, 2002, J UROLOGY, V167, P494, DOI 10.1016/S0022-5347(01)69072-4; de Wit R, 2003, CANCER-AM CANCER SOC, V97, P2120, DOI 10.1002/cncr.11288; del Muro XG, 2002, BRIT J CANCER, V86, P326, DOI 10.1038/sj.bjc.6600121; Deserno WMLLG, 2004, RADIOLOGY, V233, P449, DOI 10.1148/radiol.2332031111; Dhar NB, 2008, J UROLOGY, V179, P873, DOI 10.1016/j.juro.2007.10.076; Dimopoulos MA, 1999, ANN ONCOL, V10, P1385, DOI 10.1023/A:1008379500436; Dreicer R, 2000, J CLIN ONCOL, V18, P1058, DOI 10.1200/JCO.2000.18.5.1058; DROZ JP, 2005, EUR UROL, V48, P205; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Feldman AS, 2007, J UROLOGY, V177, P295, DOI 10.1016/S0022-5347(18)31115-7; Feldman AS, 2003, J UROLOGY, V169, P188; Freiha F, 1996, J UROLOGY, V155, P495, DOI 10.1016/S0022-5347(01)66430-9; Gburek BM, 1998, J UROLOGY, V160, P721, DOI 10.1016/S0022-5347(01)62767-8; Grimm MO, 2003, J UROLOGY, V170, P433, DOI 10.1097/01.ju.0000070437.14275.e0; Grossman HB, 2005, JAMA-J AM MED ASSOC, V293, P810, DOI 10.1001/jama.293.7.810; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Habuchi T, 2005, UROLOGY, V66, P64, DOI 10.1016/j.urology.2005.08.065; Hainsworth JD, 2005, CANCER-AM CANCER SOC, V103, P2298, DOI 10.1002/cncr.21078; HALL RR, 2002, P AN M AM SOC CLIN, V21, P178; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; HENEY NM, 1983, J UROLOGY, V130, P1083, DOI 10.1016/S0022-5347(17)51695-X; Herr HW, 2007, J UROLOGY, V177, P75, DOI 10.1016/j.juro.2006.08.070; Herr HW, 1999, J UROLOGY, V162, P74, DOI 10.1097/00005392-199907000-00018; Herr HW, 2000, J UROLOGY, V163, P60, DOI 10.1016/S0022-5347(05)67972-4; HUSSAIN M, 2001, J UROLOGY, V165, P65; Hussain MHA, 2007, J CLIN ONCOL, V25, P2218, DOI 10.1200/JCO.2006.08.0994; Hussain SA, 2004, BRIT J CANCER, V90, P2106, DOI 10.1038/sj.bjc.6601852; Irani J, 1999, EUR UROL, V35, P89, DOI 10.1159/000019824; Jalali Nadoushan Mohammad Reza, 2007, Urol J, V4, P151; James N, 2005, SIGHT SOUND, V15, P19, DOI 10.1016/j.semradonc.2004.07.006; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jimenez RE, 2001, CLIN CANCER RES, V7, P2440; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kamai T, 2001, BRIT J CANCER, V84, P1242, DOI 10.1054/bjoc.2000.1736; Kaufman D, 2000, J CLIN ONCOL, V18, P1921, DOI 10.1200/JCO.2000.18.9.1921; Kaufman DS, 2009, UROLOGY, V73, P833, DOI 10.1016/j.urology.2008.09.036; Kaufman DS, 2004, UROL ONCOL-SEMIN ORI, V22, P393, DOI 10.1016/j.urolonc.2004.01.002; Knowles MA, 2000, MOL PATHOL, V54, P215; Kolla SB, 2008, INT UROL NEPHROL, V40, P321, DOI 10.1007/s11255-007-9283-x; Korkolopoulou P, 2000, HUM PATHOL, V31, P751, DOI 10.1053/hupa.2000.8227; Kruger S, 2002, INT J CANCER, V102, P514, DOI 10.1002/ijc.10731; KURTH KH, 1995, EUR J CANCER, V31A, P1840, DOI 10.1016/0959-8049(95)00287-S; LAMM DL, 1991, NEW ENGL J MED, V325, P1205, DOI 10.1056/NEJM199110243251703; Lamm SH, 2006, ENVIRON HEALTH PERSP, V114, P1077, DOI 10.1289/ehp.8704; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Liukkonen T, 1999, EUR UROL, V36, P393, DOI 10.1159/000020039; Lokeshwar VB, 2001, J UROLOGY, V165, P1067, DOI 10.1016/S0022-5347(05)66428-2; Matsubara H, 2008, ONCOL REP, V19, P57; MCDOUGAL WS, 1983, ROB SMITHS OPERATIVE, P526; MCDOUGAL WS, 2008, PRINCIPLES PRACTICE, P1358; McDougal WS, 2008, CANC PRINCIPLES PRAC, P1358; Meluch AA, 2001, J CLIN ONCOL, V19, P3018, DOI 10.1200/JCO.2001.19.12.3018; Mersdorf A, 1998, J UROLOGY, V159, P143; Messing EM, 2004, CAMBELLS UROLOGY, P2737; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Moore MJ, 1999, J CLIN ONCOL, V17, P2876, DOI 10.1200/JCO.1999.17.9.2876; MOSTOFI FK, 1973, INT HISTOLOGICAL CLA, V10, P15; *MRC, 1999, LANCET, V354, P533; *NCI, 2008, NAT CANC I SEER CANC; Nieuwenhuijzen JA, 2008, EUR UROL, V53, P834, DOI 10.1016/j.eururo.2007.09.008; OOSTERLINCK W, 1993, J UROLOGY, V149, P749, DOI 10.1016/S0022-5347(17)36198-0; Osai WE, 2008, ANTI-CANCER DRUG, V19, P427, DOI 10.1097/CAD.0b013e3282f52bef; Parekh DJ, 2007, SEMIN ONCOL, V34, P98, DOI 10.1053/j.seminoncol.2006.12.010; Parekh DJ, 2000, UROLOGY, V55, P852, DOI 10.1016/S0090-4295(99)00619-6; Pollack A, 1997, CLIN CANCER RES, V3, P1823; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Primdahl H, 2002, J CANCER RES CLIN, V128, P295, DOI 10.1007/s00432-002-0344-3; Raghavan D, 2002, SURG ONCOL, V11, P55, DOI 10.1016/S0960-7404(02)00007-5; Rodel C, 2000, INT J RADIAT ONCOL, V46, P1213, DOI 10.1016/S0360-3016(99)00544-1; ROTH BJ, 1995, SEMIN ONCOL, V22, P33; ROTH BJ, 1995, SEMIN ONCOL, V22, P1; ROTH BJ, 1994, J CLIN ONCOL, V12, P2264, DOI 10.1200/JCO.1994.12.11.2264; RUBBEN H, 1988, J UROLOGY, V139, P283, DOI 10.1016/S0022-5347(17)42387-1; Santos LL, 2003, EUR J SURG ONCOL, V29, P74, DOI 10.1053/ejso.2002.1371; Schwaibold HE, 2006, BJU INT, V97, P1199, DOI 10.1111/j.1464-410X.2006.06144.x; Sengelov L, 1998, J CLIN ONCOL, V16, P3392, DOI 10.1200/JCO.1998.16.10.3392; Sgambato A, 2002, INT J CANCER, V97, P671, DOI 10.1002/ijc.10055; Shahin O, 2003, J UROLOGY, V169, P96, DOI 10.1016/S0022-5347(05)64044-X; Shariat SF, 2005, J UROLOGY, V173, P1518, DOI 10.1097/01.ju.0000154696.48217.75; Sharma R, 2003, IEEE T IND APPL, V39, P87, DOI 10.1109/TIA.2002.807234; Shinohara N, 2002, UROL RES, V30, P273, DOI 10.1007/s00240-002-0275-0; Shipley G, 2004, NETW COMPUT, V15, P36; Shipley WU, 1998, J CLIN ONCOL, V16, P3576, DOI 10.1200/JCO.1998.16.11.3576; SMITH H, 1989, UROLOGY, V34, P193, DOI 10.1016/0090-4295(89)90370-1; Solsona E, 1999, J UROLOGY, V161, P1120, DOI 10.1016/S0022-5347(01)61606-9; Stein JP, 2003, J UROLOGY, V170, P35, DOI 10.1097/01.ju.0000072422.69286.0e; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sternberg CN, 2001, CANCER, V92, P2993, DOI 10.1002/1097-0142(20011215)92:12<2993::AID-CNCR10108>3.0.CO;2-2; Sternberg CN, 2001, J CLIN ONCOL, V19, p21S; Steven K, 2007, J UROLOGY, V178, P1218, DOI 10.1016/j.juro.2007.05.160; STUDER UE, 1994, J UROLOGY, V152, P81, DOI 10.1016/S0022-5347(17)32822-7; Sweeney CJ, 2006, J CLIN ONCOL, V24, P3451, DOI 10.1200/JCO.2005.03.6699; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Sylvester RJ, 2004, J UROLOGY, V171, P2186, DOI 10.1097/01.ju.0000125486.92260.b2; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; TANRIKUT C, 2005, URINARY DIVERSION SC; Tetu B, 2005, MODERN PATHOL, V18, P83, DOI 10.1038/modpathol.3800262; Tolley DA, 1996, J UROLOGY, V155, P1233, DOI 10.1016/S0022-5347(01)66226-8; Turkolmez K, 2003, EUR UROL, V44, P682, DOI 10.1016/S0302-2838(03)00385-3; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Vallancien G, 2002, J UROLOGY, V168, P2413, DOI 10.1016/S0022-5347(05)64157-2; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; Vecchione A, 2004, CLIN CANCER RES, V10, P7607, DOI 10.1158/1078-0432.CCR-04-0341; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Vriesema JLJ, 2001, UROLOGY, V58, P367, DOI 10.1016/S0090-4295(01)01217-1; WIJKSTROM H, 1998, BR J UROL, V81, P786; Winquist E, 2004, J UROLOGY, V171, P561, DOI 10.1097/01.ju.0000090967.08622.33; WRIGHT JL, 2008, CANCER, V112, P2332; Yamada Y, 2007, ONCOL REP, V18, P1183; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yiou R, 2002, BJU INT, V89, P374, DOI 10.1046/j.1464-4096.2001.001020.x; Zietman AL, 2001, UROLOGY, V58, P380, DOI 10.1016/S0090-4295(01)01219-5; 2007, COCHRANE DATABASE SY, V1	129	830	869	0	139	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					239	249		10.1016/S0140-6736(09)60491-8	http://dx.doi.org/10.1016/S0140-6736(09)60491-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19520422				2022-12-28	WOS:000268263000033
J	Solon, J; Kaya-Copur, A; Colombelli, J; Brunner, D				Solon, Jerome; Kaya-Copur, Aynur; Colombelli, Julien; Brunner, Damian			Pulsed Forces Timed by a Ratchet-like Mechanism Drive Directed Tissue Movement during Dorsal Closure	CELL			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DROSOPHILA EMBRYOGENESIS; SHAPE OSCILLATIONS; TERMINAL KINASE; DISTINCT ROLES; MORPHOGENESIS; JUN; CELLS; NANOSURGERY; AMNIOSEROSA	Dorsal closure is a tissue-modeling process in the developing Drosophila embryo during which an epidermal opening is closed. It begins with the appearance of a supracellular actin cable that surrounds the opening and provides a contractile force. Amnioserosa cells that fill the opening produce an additional critical force pulling on the surrounding epidermal tissue. We show that this force is not gradual but pulsed and occurs long before dorsal closure starts. Quantitative analysis, combined with laser cutting experiments and simulations, reveals that tension-based dynamics and cell coupling control the force pulses. These constitutively pull the surrounding epidermal tissue dorsally, but the displacement is initially transient. It is translated into dorsal-ward movement only with the help of the actin cable, which acts like a ratchet, counteracting ventral-ward epidermis relaxation after force pulses. Our work uncovers a sophisticated mechanism of cooperative force generation between two major forces driving morphogenesis.	[Solon, Jerome; Kaya-Copur, Aynur; Brunner, Damian] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Colombelli, Julien] Inst Biomed Res, Barcelona 08028, Spain	European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Brunner, D (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	damian.brunner@embl.de	Brunner, Damian/F-2024-2011; Solon, Jerome/H-2039-2015	Kaya Copur, Aynur/0000-0002-3161-9442; Brunner, Damian/0000-0001-5250-492X; Colombelli, Julien/0000-0002-2784-4276; Solon, jerome/0000-0001-9967-9794	HFSP [RGP11/2005]	HFSP(Human Frontier Science Program)	We thank Ferenc Jankovics, Lars Hufnagel, Francois Nedelec, Darren Gilmour, Philippe Girard, Chaitanya Athale, Sonia Ferreira Furtado, and Nadia Dube for discussion and/or for critical reading of the manuscript. We are grateful to the EMBL ALMF team for providing help with the microscopy. We also like to thank Juan Riesgo-Escovar for fly strains. A. K. was supported by HFSP research grant RGP11/2005 and J.S. by a BioMS postdoctoral grant.	Bittig T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063001; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Colombelli J, 2005, TRAFFIC, V6, P1093, DOI 10.1111/j.1600-0854.2005.00334.x; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Marygold SJ, 2003, MECH DEVELOP, V120, P157, DOI 10.1016/S0925-4773(02)00439-2; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Peralta XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015004; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Ricos MG, 1999, J CELL SCI, V112, P1225; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; RiesgoEscovar JR, 1997, GENE DEV, V11, P1717, DOI 10.1101/gad.11.13.1717; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Sluss HK, 1997, J CELL BIOCHEM, V67, P1; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	38	373	376	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 26	2009	137	7					1331	1342		10.1016/j.cell.2009.03.050	http://dx.doi.org/10.1016/j.cell.2009.03.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563762	Bronze			2022-12-28	WOS:000267373400025
J	Van Horn, WD; Kim, HJ; Ellis, CD; Hadziselimovic, A; Sulistijo, ES; Karra, MD; Tian, CL; Sonnichsen, FD; Sanders, CR				Van Horn, Wade D.; Kim, Hak-Jun; Ellis, Charles D.; Hadziselimovic, Arina; Sulistijo, Endah S.; Karra, Murthy D.; Tian, Changlin; Soennichsen, Frank D.; Sanders, Charles R.			Solution Nuclear Magnetic Resonance Structure of Membrane-Integral Diacylglycerol Kinase	SCIENCE			English	Article							KCSA POTASSIUM CHANNEL; ESCHERICHIA-COLI; DETERGENT MICELLES; OUTER-MEMBRANE; DGK GENE; PROTEIN; MECHANISM; OLIGOSACCHARIDES; DYNAMICS; REVEALS	Escherichia coli diacylglycerol kinase (DAGK) represents a family of integral membrane enzymes that is unrelated to all other phosphotransferases. We have determined the three-dimensional structure of the DAGK homotrimer with the use of solution nuclear magnetic resonance. The third transmembrane helix from each subunit is domain-swapped with the first and second transmembrane segments from an adjacent subunit. Each of DAGK's three active sites resembles a portico. The cornice of the portico appears to be the determinant of DAGK's lipid substrate specificity and overhangs the site of phosphoryl transfer near the water-membrane interface. Mutations to cysteine that caused severe misfolding were located in or near the active site, indicating a high degree of overlap between sites responsible for folding and for catalysis.	[Van Horn, Wade D.; Kim, Hak-Jun; Ellis, Charles D.; Hadziselimovic, Arina; Sulistijo, Endah S.; Karra, Murthy D.; Tian, Changlin; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Van Horn, Wade D.; Kim, Hak-Jun; Ellis, Charles D.; Hadziselimovic, Arina; Sulistijo, Endah S.; Karra, Murthy D.; Tian, Changlin; Sanders, Charles R.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Kim, Hak-Jun] Korea Polar Res Inst, Inchon 406840, South Korea; [Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany	Vanderbilt University; Vanderbilt University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Kiel	Sanders, CR (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	chuck.sanders@vanderbilt.edu	Tian, Changlin/P-1469-2014; Sönnichsen, Frank D/D-8408-2011; Van Horn, Wade/GSN-2667-2022	Sönnichsen, Frank D/0000-0002-4539-3755; Van Horn, Wade/0000-0002-2493-5578	NIH [T32 NS007491]; National Institute of General Medical Sciences [RO1 GM47485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Bowie for providing the DAGK expression system, many of the mutants used in this work, and much discussion; M. Voehler, B. Gorzelle, P. Power, C. Kang, and J. Jacob for technical assistance; and K. Oxenoid, L. Kay, S. Prosser, M.-D. Tsai, T. Iverson, J. Meiler, A. Forster, J. Battiste, W. Chazin, and members of the Sanders lab for discussion. Supported by NIH training grant T32 NS007491 (W.V.H.) and National Institute of General Medical Sciences grant RO1 GM47485. C.R.S. is a consultant for Anatrace Inc. (now owned by Affymetrix), a company that markets high-purity biological detergents, including some of the detergents used in sample preparation in this work. The coordinates for DAGK have been deposited as PDB entry 2kdc in the Protein Data Bank. This work is dedicated to the fond memory of Anne Karpay.	Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Bishop RE, 2008, BBA-BIOMEMBRANES, V1778, P1881, DOI 10.1016/j.bbamem.2007.07.021; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Kumar S, 1999, CELL BIOCHEM BIOPHYS, V31, P141, DOI 10.1007/BF02738169; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Lorch M, 2004, J MOL BIOL, V344, P1109, DOI 10.1016/j.jmb.2004.09.090; Ma DJ, 2008, P NATL ACAD SCI USA, V105, P16537, DOI 10.1073/pnas.0805501105; Miller DJ, 2008, STRUCTURE, V16, P1036, DOI 10.1016/j.str.2008.03.019; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Nagy JK, 2004, BIOCHEMISTRY-US, V43, P19, DOI 10.1021/bi035918s; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Oxenoid K, 2004, J AM CHEM SOC, V126, P5048, DOI 10.1021/ja049916m; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; RAETZ CRH, 1979, J BACTERIOL, V137, P860, DOI 10.1128/JB.137.2.860-868.1979; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Shibata Y, 2009, MICROBIOL-SGM, V155, P557, DOI 10.1099/mic.0.023812-0; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; WALSH JP, 1990, J BIOL CHEM, V265, P4374; WALSH JP, 1992, METHOD ENZYMOL, V209, P153; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141; Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	34	182	182	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1726	1729		10.1126/science.1171716	http://dx.doi.org/10.1126/science.1171716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556511	Green Accepted			2022-12-28	WOS:000267338200045
J	Shah, SP; Kobel, M; Senz, J; Morin, RD; Clarke, BA; Wiegand, KC; Leung, G; Zayed, A; Mehl, E; Kalloger, SE; Sun, M; Giuliany, R; Yorida, E; Jones, S; Varhol, R; Swenerton, KD; Miller, D; Clement, PB; Crane, C; Madore, J; Provencher, D; Leung, P; DeFazio, A; Khattra, J; Turashvili, G; Zhao, YJ; Zeng, T; Glover, JNM; Vanderhyden, B; Zhao, CQ; Parkinson, CA; Jimenez-Linan, M; Bowtell, DDL; Mes-Masson, AM; Brenton, JD; Aparicio, SA; Boyd, N; Hirst, M; Gilks, CB; Marra, M; Huntsman, DG				Shah, Sohrab P.; Koebel, Martin; Senz, Janine; Morin, Ryan D.; Clarke, Blaise A.; Wiegand, Kimberly C.; Leung, Gillian; Zayed, Abdalnasser; Mehl, Erika; Kalloger, Steve E.; Sun, Mark; Giuliany, Ryan; Yorida, Erika; Jones, Steven; Varhol, Richard; Swenerton, Kenneth D.; Miller, Dianne; Clement, Philip B.; Crane, Colleen; Madore, Jason; Provencher, Diane; Leung, Peter; DeFazio, Anna; Khattra, Jaswinder; Turashvili, Gulisa; Zhao, Yongjun; Zeng, Thomas; Glover, J. N. Mark; Vanderhyden, Barbara; Zhao, Chengquan; Parkinson, Christine A.; Jimenez-Linan, Mercedes; Bowtell, David D. L.; Mes-Masson, Anne-Marie; Brenton, James D.; Aparicio, Samuel A.; Boyd, Niki; Hirst, Martin; Gilks, C. Blake; Marra, Marco; Huntsman, David G.			Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXL2; CORD-STROMAL TUMORS; GENOME; GENE; P53; IDENTIFICATION; EXPRESSION; BREAST	Background Granulosa-cell tumors (GCTs) are the most common type of malignant ovarian sex cord-stromal tumor (SCST). The pathogenesis of these tumors is unknown. Moreover, their histopathological diagnosis can be challenging, and there is no curative treatment beyond surgery. Methods We analyzed four adult-type GCTs using whole-transcriptome paired-end RNA sequencing. We identified putative GCT-specific mutations that were present in at least three of these samples but were absent from the transcriptomes of 11 epithelial ovarian tumors, published human genomes, and databases of single-nucleotide polymorphisms. We confirmed these variants by direct sequencing of complementary DNA and genomic DNA. We then analyzed additional tumors and matched normal genomic DNA, using a combination of direct sequencing, analyses of restriction-fragment-length polymorphisms, and TaqMan assays. Results All four index GCTs had a missense point mutation, 402C -> G (C134W), in FOXL2, a gene encoding a transcription factor known to be critical for granulosa-cell development. The FOXL2 mutation was present in 86 of 89 additional adult-type GCTs (97%), in 3 of 14 thecomas (21%), and in 1 of 10 juvenile-type GCTs (10%). The mutation was absent in 49 SCSTs of other types and in 329 unrelated ovarian or breast tumors. Conclusions Whole-transcriptome sequencing of four GCTs identified a single, recurrent somatic mutation (402C -> G) in FOXL2 that was present in almost all morphologically identified adult-type GCTs. Mutant FOXL2 is a potential driver in the pathogenesis of adult-type GCTs.	[Shah, Sohrab P.; Senz, Janine; Wiegand, Kimberly C.; Leung, Gillian; Zayed, Abdalnasser; Kalloger, Steve E.; Sun, Mark; Giuliany, Ryan; Yorida, Erika; Boyd, Niki; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Koebel, Martin; Mehl, Erika; Clement, Philip B.; Gilks, C. Blake; Huntsman, David G.] British Columbia Canc Agcy, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 4E6, Canada; [Morin, Ryan D.; Jones, Steven; Varhol, Richard; Zhao, Yongjun; Zeng, Thomas; Hirst, Martin; Marra, Marco] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Swenerton, Kenneth D.] British Columbia Canc Agcy, Cheryl Brown Ovarian Canc Outcomes Unit, Vancouver, BC V5Z 4E6, Canada; [Miller, Dianne] British Columbia Canc Agcy, Dept Gynecol, Vancouver, BC V5Z 4E6, Canada; [Khattra, Jaswinder; Turashvili, Gulisa; Aparicio, Samuel A.] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 4E6, Canada; [Koebel, Martin; Mehl, Erika; Miller, Dianne; Clement, Philip B.; Gilks, C. Blake; Huntsman, David G.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Koebel, Martin; Mehl, Erika; Clement, Philip B.; Leung, Peter; Gilks, C. Blake; Huntsman, David G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Clarke, Blaise A.] Univ Toronto, Dept Pathol, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Hlth Network, Toronto, ON, Canada; [Crane, Colleen] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Vanderhyden, Barbara] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Madore, Jason; Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [DeFazio, Anna; Bowtell, David D. L.] Univ Sydney, Westmead Hosp, Dept Gynaecol Oncol, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [DeFazio, Anna; Bowtell, David D. L.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Bowtell, David D. L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bowtell, David D. L.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Bowtell, David D. L.] Victorian Cerv Cytol Registry, Melbourne, Vic, Australia; [Zhao, Chengquan] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Parkinson, Christine A.; Jimenez-Linan, Mercedes; Brenton, James D.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Funct Genom Ovarian Canc Lab, Cambridge, England	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; University of Ottawa; Universite de Montreal; University of Alberta; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cancer Research UK; CRUK Cambridge Institute	Huntsman, DG (corresponding author), British Columbia Canc Agcy, Ctr Translat & Appl Genom, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	dhuntsma@bccancer.bc.ca	Jones, Steven J/C-3621-2009; Hirst, Martin/B-7684-2016; Köbel, Martin/A-7373-2011; Turashvili, Gulisa/A-6056-2008; DeFazio, Anna/O-2385-2019; Marra, Marco A/B-5987-2008; Hirst, Martin/C-3619-2009; Huntsman, David/ABE-6082-2020; Bowtell, David/H-1007-2016; Morin, Ryan/AAE-7824-2019; Brenton, James D/B-3174-2008; deFazio, Anna/D-3939-2013	Jones, Steven J/0000-0003-3394-2208; DeFazio, Anna/0000-0003-0057-4744; Marra, Marco A/0000-0001-7146-7175; Bowtell, David/0000-0001-9089-7525; Morin, Ryan/0000-0003-2932-7800; Brenton, James D/0000-0002-5738-6683; deFazio, Anna/0000-0003-0057-4744; Kobel, Martin/0000-0002-6615-2037; Clarke, Blaise/0000-0002-2585-8391; Aparicio, Samuel/0000-0002-0487-9599; Madore, Jason/0000-0002-3499-474X; Leung, Peter/0000-0003-3152-3800; Mes-Masson, Anne-Marie/0000-0002-6498-266X; Turashvili, Gulisa/0000-0001-6125-5865	British Columbia Cancer Foundation; Vancouver General Hospital Foundation; Genome Canada; Michael Smith Foundation for Health Research; Eli Lilly Canada; Canadian Institutes of Health Research's Training Program on Clinician-Scientists in Molecular Oncologic Pathology; Sanofi-Aventis; OvCaRe and Ovarian Cancer Canada; Fonds de la Recherche en Sante du Quebec (Montreal); Ovarian Cancer Canada (Ottawa); Australian National Health and Medical Research Council; Cancer Research UK; University of Cambridge, Hutchinson Whampoa; Experimental Cancer Medicine Centre; National Institute for Health Research's Cambridge Biomedical Research Centre; U. S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia	British Columbia Cancer Foundation; Vancouver General Hospital Foundation; Genome Canada(Genome Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Eli Lilly Canada(Eli Lilly); Canadian Institutes of Health Research's Training Program on Clinician-Scientists in Molecular Oncologic Pathology(Canadian Institutes of Health Research (CIHR)); Sanofi-Aventis(Sanofi-Aventis); OvCaRe and Ovarian Cancer Canada; Fonds de la Recherche en Sante du Quebec (Montreal)(Fonds de la Recherche en Sante du Quebec); Ovarian Cancer Canada (Ottawa); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); University of Cambridge, Hutchinson Whampoa(University of Cambridge); Experimental Cancer Medicine Centre; National Institute for Health Research's Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); U. S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by grants from the British Columbia Cancer Foundation and the Vancouver General Hospital Foundation (to OvCaRe in British Columbia), Genome Canada (to the Genome Sciences Centre), the Michael Smith Foundation for Health Research (to OvCaRe and the Genome Sciences Centre and to Drs. Shah, Marra, and Huntsman), Eli Lilly Canada (to Dr. Kobel), and the Canadian Institutes of Health Research's Training Program on Clinician-Scientists in Molecular Oncologic Pathology (to Dr. Turashvili); nondirected research funds from Sanofi-Aventis (to the Genetic Pathology Evaluation Centre); and funding for a Canada Research Chair in Molecular Oncology (to Dr. Aparicio). The contributing tumor banks were supported by OvCaRe and Ovarian Cancer Canada (Vancouver General Hospital), Fonds de la Recherche en Sante du Quebec (Montreal), and Ovarian Cancer Canada (Ottawa). The Westmead Gynaecological Oncology Tissue Bank is a member of the Australasian Biospecimens Network-Oncology group, which is funded by the Australian National Health and Medical Research Council; by Cancer Research UK, the University of Cambridge, Hutchinson Whampoa, the Experimental Cancer Medicine Centre, and the National Institute for Health Research's Cambridge Biomedical Research Centre; by a grant (DAMD17-01-1-0729) from the U. S. Army Medical Research and Materiel Command; and by grants from the Cancer Council Tasmania, the Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia to the Australian Ovarian Cancer Study. Dr. Kobel reports receiving grant support from Eli Lilly; and Dr. Huntsman, receiving grant support from Sanofi-Aventis and Novartis and being listed as an inventor on a provisional patent application filed by the British Columbia Cancer Agency on the diagnostic use of the FOXL2 402C -> G mutation and its development as a therapeutic target. No other potential conflict of interest relevant to this article was reported. We thank Ying Ng and Katie Chow for performing the array comparative-genomic-hybridization experiments; Krista Marcon for performing the immunohistochemical analysis and preparing tissue sections for DNA extraction; Samuel Leung for establishing the online image archive; Mona Mazgani and Salvador Saldivar for helping in the acquisition of informed consent and specimens for the gynecologic tumor bank at Vancouver General Hospital; Catherine Kennedy for helping in the acquisition of specimens from the Westmead Gynaecological Oncology Tissue Bank; Julie Irving for helping with accessing specimens for the secondary validation; the members of the Australian Ovarian Cancer Study (AOCS) management group: D. Bowtell, G. Chenevix-Trench, A. Green, P. Webb, A. deFazio, and D. Gertig; the AOCS study nurses and research assistants; and all the patients who participated in the AOCS study.	Beysen D, 2004, HUM MUTAT, V24, P189, DOI 10.1002/humu.20079; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Colombo N, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.1005; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; Dorward AM, 2005, CANCER RES, V65, P1259, DOI 10.1158/0008-5472.CAN-04-2992; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Fletcher C., 1995, DIAGNOSTIC HISTOPATH; FLETCHER JA, 1991, AM J PATHOL, V138, P515; Fuller PJ, 2004, TRENDS ENDOCRIN MET, V15, P122, DOI 10.1016/j.tem.2004.02.005; KAPPES S, 1995, INT J CANCER, V64, P52, DOI 10.1002/ijc.2910640111; King LA, 1996, GYNECOL ONCOL, V61, P227, DOI 10.1006/gyno.1996.0130; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Ligtenberg MJ, 1999, J CLIN ENDOCR METAB, V84, P2233, DOI 10.1210/jc.84.6.2233; Liu FS, 1996, GYNECOL ONCOL, V61, P50, DOI 10.1006/gyno.1996.0095; Mayr D, 2008, PATHOL RES PRACT, V204, P823, DOI 10.1016/j.prp.2008.07.009; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; Zhao CQ, 2009, AM J SURG PATHOL, V33, P354, DOI 10.1097/PAS.0b013e318188373d	31	507	535	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2719	2729		10.1056/NEJMoa0902542	http://dx.doi.org/10.1056/NEJMoa0902542			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19516027	Bronze			2022-12-28	WOS:000267286600006
J	Cheung, J; Shaw, R				Cheung, J.; Shaw, R.			Case report A case of secondary amenorrhoea	BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE ASHERMANS-SYNDROME; INTRA-UTERINE ADHESIONS; INTRAUTERINE ADHESIONS; HYSTEROSCOPIC ADHESIOLYSIS; FEMALE INFERTILITY; HYSTEROSALPINGOGRAPHY; MANAGEMENT; FERTILITY; ABORTION; SYNECHIAE		[Cheung, J.; Shaw, R.] Derby City Gen Hosp, Derby DE22 3NE, England	University of Nottingham	Cheung, J (corresponding author), Derby City Gen Hosp, Derby DE22 3NE, England.	robert.shaw@nottingham.ac.uk						Abbott J, 2004, J Obstet Gynaecol, V24, P710; Acunzo G, 2003, HUM REPROD, V18, P1918, DOI 10.1093/humrep/deg368; Al-Inany H, 2001, ACTA OBSTET GYN SCAN, V80, P986, DOI 10.1034/j.1600-0412.2001.801103.x; Amer MI, 2006, J OBSTET GYNAECOL RE, V32, P559, DOI 10.1111/j.1447-0756.2006.00454.x; Brown SE, 2000, FERTIL STERIL, V74, P1029, DOI 10.1016/S0015-0282(00)01541-7; BUTTRAM VC, 1977, INT J FERTIL, V22, P98; Capella-Allouc S, 1999, HUM REPROD, V14, P1230, DOI 10.1093/humrep/14.5.1230; CHAPMAN K, 1990, J ROY SOC MED, V83, P576, DOI 10.1177/014107689008300915; Chapman R, 1996, BRIT J OBSTET GYNAEC, V103, P1256, DOI 10.1111/j.1471-0528.1996.tb09641.x; Dalfo AR, 2004, AM J ROENTGENOL, V183, P1405, DOI 10.2214/ajr.183.5.1831405; Davies C, 2002, CLIN RADIOL, V57, P317, DOI 10.1053/crad.2001.0846; DEATON JL, 1989, AM J OBSTET GYNECOL, V160, P1053, DOI 10.1016/0002-9378(89)90159-2; FARHI J, 1993, HUM REPROD, V8, P1143, DOI 10.1093/oxfordjournals.humrep.a138208; FRIEDLER S, 1993, HUM REPROD, V8, P442, DOI 10.1093/oxfordjournals.humrep.a138068; ISMAJOVICH B, 1985, J REPROD MED, V30, P769; JEWELEWICZ R, 1976, OBSTET GYNECOL, V47, P701; KLEIN SM, 1973, FERTIL STERIL, V24, P722; KROLIKOWSKI A, 1995, OBSTET GYNECOL, V85, P898, DOI 10.1016/0029-7844(94)00371-J; MARCH CM, 1976, OBSTET GYNECOL, V48, P422; MARCH CM, 1978, AM J OBSTET GYNECOL, V130, P653, DOI 10.1016/0002-9378(78)90322-8; MARCH CM, 1995, OBSTET GYN CLIN N AM, V22, P491; McComb PF, 1997, FERTIL STERIL, V68, P1047, DOI 10.1016/S0015-0282(97)00413-5; Metwally M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001298.pub3; Orhue AAE, 2003, INT J GYNECOL OBSTET, V82, P49, DOI 10.1016/S0020-7292(03)00030-4; Pabuccu R, 1997, FERTIL STERIL, V68, P1141, DOI 10.1016/S0015-0282(97)00375-0; PREVEDOURAKIS C, 1994, HUM REPROD, V9, P2353, DOI 10.1093/oxfordjournals.humrep.a138451; Protopapas A, 1998, FERTIL STERIL, V69, P860, DOI 10.1016/S0015-0282(98)00036-3; RISBERG B, 1997, EUR J SURG S, V577, P32; SCHENKER JG, 1982, FERTIL STERIL, V37, P593; Schenker JG, 1996, EUR J OBSTET GYN R B, V65, P109, DOI 10.1016/0028-2243(95)02315-J; Sharma JB, 2008, ARCH GYNECOL OBSTET, V277, P37, DOI 10.1007/s00404-007-0419-0; SUGIMOTO O, 1978, AM J OBSTET GYNECOL, V131, P539, DOI 10.1016/0002-9378(78)90116-3; Thomson AJM, 2007, FERTIL STERIL, V87, P405, DOI 10.1016/j.fertnstert.2006.06.035; VALLE RF, 1988, AM J OBSTET GYNECOL, V158, P1459, DOI 10.1016/0002-9378(88)90382-1; Wang CW, 1996, J AM ASSOC GYN LAP, V3, P581, DOI 10.1016/S1074-3804(05)80170-7; Westendorp ICD, 1998, HUM REPROD, V13, P3347, DOI 10.1093/humrep/13.12.3347; Yasmin H, 2004, J Obstet Gynaecol, V24, P312; Zikopoulos KA, 2004, REPROD BIOMED ONLINE, V8, P720, DOI 10.1016/S1472-6483(10)61654-9	38	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 24	2009	338								b2282	10.1136/bmj.b2282	http://dx.doi.org/10.1136/bmj.b2282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MO	19553268				2022-12-28	WOS:000267436500001
J	Scher, AI; Gudmundsson, LS; Sigurdsson, S; Ghambaryan, A; Aspelund, T; Eiriksdottir, G; van Buchem, MA; Gudnason, V; Launer, LJ				Scher, Ann I.; Gudmundsson, Larus S.; Sigurdsson, Sigurdur; Ghambaryan, Anna; Aspelund, Thor; Eiriksdottir, Gudny; van Buchem, Mark A.; Gudnason, Vilmundur; Launer, Lenore J.			Migraine Headache in Middle Age and Late-Life Brain Infarcts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE/ENVIRONMENT SUSCEPTIBILITY-REYKJAVIK; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; GLOBAL BURDEN; RISK; WOMEN; EPIDEMIOLOGY; PATTERNS	Context Migraine is considered to be an episodic condition with no long-term consequences. However, recent studies suggest that migraine attacks may be associated with pathologic changes in the brain, particularly in the cerebellum. Objective To determine whether individuals not reporting headache compared with individuals reporting migraine symptoms, particularly aura, in midlife are at increased risk of late-life infarct-like lesions found on magnetic resonance imaging (MRI) without consideration of clinical symptoms. Design, Setting, and Participants A population-based study of men and women in Reykjavik, Iceland (cohort born 1907-1935; n = 4689; 57% women) were followed up since 1967, examined, and interviewed about migraine symptoms in midlife (mean age, 51 years; range, 33-65 years). Between 2002 and 2006, more than 26 years later, brain MRIs were performed. Participants reporting headaches once or more per month were asked about migraine symptoms including nausea, unilateral location, photophobia, visual disturbance, and numbness. These individuals with headache were classified as having migraine without aura, migraine with aura, or nonmigraine headache. A comprehensive cardiovascular risk assessment was performed at both examinations. Main Outcome Measure Presence of infarct-like lesions (total) and specifically located in the cortical, subcortical, and cerebellar regions. Results Infarct-like lesions were present in 39.3% of men and 24.6% of women. After adjusting for age, sex, and follow-up time, compared with those not reporting headaches once or more per month (n = 3243), those with midlife migraine with aura (n = 361) had an increased risk of late-life infarct-like lesions (adjusted odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8) that specifically reflected an association with cerebellar lesions in women (prevalence of infarcts 23.0% for women with migraine with aura vs 14.5% for women not reporting headaches; adjusted OR, 1.9; 95% CI, 1.4-2.6 vs a 19.3% prevalence of infarcts for men with migraine with aura vs 21.3% for men not reporting headaches; adjusted OR, 1.0; 95% CI, 0.6-1.8; P < .04 for interaction by sex). Migraine without aura and nonmigraine headache were not associated with an increased risk. Conclusions Migraine with aura in midlife was associated with late-life prevalence of cerebellar infarct-like lesions on MRI. This association was statistically significant only for women. This is consistent with the hypothesis that migraine with aura in midlife is associated with late-life vascular disease in the cerebellum and in women. JAMA. 2009; 301(24):2563-2570	[Launer, Lenore J.] NIA, LEDB, NIH, Bethesda, MD 20892 USA; [Scher, Ann I.; Ghambaryan, Anna] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gudmundsson, Larus S.] Univ Iceland, Dept Pharmacol & Toxicol, Reykjavik, Iceland; [Sigurdsson, Sigurdur; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uniformed Services University of the Health Sciences - USA; University of Iceland; Icelandic Heart Association; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Launer, LJ (corresponding author), NIA, LEDB, NIH, 7201 Wisconsin Ave,Ste 3C-309, Bethesda, MD 20892 USA.	launerl@nia.nih.gov	van Buchem, Mark/AAC-9843-2022; Aspelund, Thor/K-7022-2019; Gudmundsson, Larus S/K-2854-2019; Gudnason, Vilmundur/AAE-7126-2019; Launer, Lenore J/A-8218-2010; Gudnason, Vilmundur/K-6885-2015; Aspelund, Thor/F-4826-2011; Aspelund, Thor/C-5983-2008	van Buchem, Mark/0000-0003-1881-1998; Aspelund, Thor/0000-0002-7998-5433; Gudmundsson, Larus S/0000-0003-4660-1111; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Scher, Ann/0000-0003-4599-9834	National Institutes of Health [N01-AG-12100]; National Institute on Aging Intramural Research Program, Hjartavernd; Althingi; National Eye Institute; National Institute on Deafness and Other Communication Disorders; National Heart, Lung, and Blood Institute; NATIONAL INSTITUTE ON AGING [Z01AG007380, N01AG012100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Intramural Research Program, Hjartavernd(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: This study was funded by National Institutes of Health contract N01-AG-12100, the National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). Components of the study were also supported by the National Eye Institute, the National Institute on Deafness and Other Communication Disorders, and the National Heart, Lung, and Blood Institute. Funding in support of this analysis was provided by the Migraine Research Foundation.	Bousser MG, 2005, LANCET NEUROL, V4, P533, DOI 10.1016/S1474-4422(05)70164-2; Burns R J, 1979, Clin Exp Neurol, V16, P69; Del Zotto E, 2008, J CEREBR BLOOD F MET, V28, P1399, DOI 10.1038/jcbfm.2008.36; Diener HC, 2007, CURR OPIN NEUROL, V20, P310, DOI 10.1097/WCO.0b013e328136c22d; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Elkind MSV, 2008, NEUROLOGY, V70, P1506, DOI 10.1212/01.wnl.0000310647.04081.3c; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; Gudmundsson LS, 2006, CEPHALALGIA, V26, P436, DOI 10.1111/j.1468-2982.2005.01057.x; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 2003, INT PSYCHOGERIATR, V15, P99, DOI 10.1017/S1041610203009037; Lee SM, 2008, HORM RES, V70, P17; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Milhaud D, 2001, NEUROLOGY, V57, P1805, DOI 10.1212/WNL.57.10.1805; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; OPEENHEIM H, 1900, DIS NERVOUS SYSTEM T; Pezzini A, 2007, STROKE, V38, P3145, DOI 10.1161/STROKEAHA.107.491506; Qiu CX, 2008, DIABETES, V57, P1645, DOI 10.2337/db07-1455; Reid J, 2006, CEPHALALGIA, V26, P1247, DOI 10.1111/j.1468-2982.2006.01199.x; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schurks M, 2008, NEUROLOGY, V71, P505, DOI 10.1212/01.wnl.0000316198.34558.e5; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stang PE, 2005, NEUROLOGY, V64, P1573, DOI 10.1212/01.WNL.0000158326.31368.04; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tietjen GE, 2007, CEPHALALGIA, V27, P981; Vincent M, 2007, HEADACHE, V47, P820, DOI 10.1111/j.1526-4610.2006.00715.x; Welch KMA, 2003, FUNCT NEUROL, V18, P121	34	138	146	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2563	2570		10.1001/jama.2009.932	http://dx.doi.org/10.1001/jama.2009.932			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549973	Green Accepted, Bronze			2022-12-28	WOS:000267266500021
J	Siva, N				Siva, Nayanah			Raw deal for refused asylum seekers in the UK	LANCET			English	Editorial Material																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2099	2100		10.1016/S0140-6736(09)61135-1	http://dx.doi.org/10.1016/S0140-6736(09)61135-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19551914	Bronze			2022-12-28	WOS:000267229700012
J	Vitousek, PM; Naylor, R; Crews, T; David, MB; Drinkwater, LE; Holland, E; Johnes, PJ; Katzenberger, J; Martinelli, LA; Matson, PA; Nziguheba, G; Ojima, D; Palm, CA; Robertson, GP; Sanchez, PA; Townsend, AR; Zhang, FS				Vitousek, P. M.; Naylor, R.; Crews, T.; David, M. B.; Drinkwater, L. E.; Holland, E.; Johnes, P. J.; Katzenberger, J.; Martinelli, L. A.; Matson, P. A.; Nziguheba, G.; Ojima, D.; Palm, C. A.; Robertson, G. P.; Sanchez, P. A.; Townsend, A. R.; Zhang, F. S.			Nutrient Imbalances in Agricultural Development	SCIENCE			English	Editorial Material							MAIZE PRODUCTIVITY; NITROGEN-CYCLE; MANAGEMENT; PHOSPHORUS; ROTATIONS; SYSTEMS; TRENDS; INPUT; RIVER; SOIL		[Vitousek, P. M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Naylor, R.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Naylor, R.] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Crews, T.] Prescott Coll, Prescott, AZ USA; [David, M. B.] Univ Illinois, Dept Nat Resource & Environm Sci, Urbana, IL 61801 USA; [Drinkwater, L. E.] Cornell Univ, Dept Hort, Ithaca, NY 14853 USA; [Holland, E.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Johnes, P. J.] Univ Reading, Sch Human & Environm Sci, Aquat Environm Res Ctr, Reading RG6 6AB, Berks, England; [Katzenberger, J.] Aspen Global Change Inst, Aspen, CO 81611 USA; [Martinelli, L. A.] Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13416000 Piracicaba, SP, Brazil; [Matson, P. A.] Stanford Univ, Sch Earth Sci, Stanford, CA 94305 USA; [Nziguheba, G.; Palm, C. A.; Sanchez, P. A.] Columbia Univ, Earth Inst, Palisades, NY 10027 USA; [Ojima, D.] Heinz Ctr Sci Econ & Environm, Washington, DC 20009 USA; [Robertson, G. P.] Michigan State Univ, Dept Crop & Soil Sci, Hickory Corners, MI 49060 USA; [Townsend, A. R.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Townsend, A. R.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA; [Zhang, F. S.] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China	Stanford University; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; National Center Atmospheric Research (NCAR) - USA; University of Reading; Universidade de Sao Paulo; Stanford University; Columbia University; Michigan State University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; China Agricultural University	Vitousek, PM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	vitousek@stanford.edu	Johnes, Penny J/D-1381-2009; Ojima, Dennis/C-5272-2016; Johnes, Penny/AAV-8395-2021; Townsend, Alan/AAE-9602-2019; Martinelli, Luiz Antonio/F-7870-2011; Zhang, Fusuo/AAV-4517-2021; Robertson, G Philip/H-3885-2011	Johnes, Penny J/0000-0003-1605-6896; Johnes, Penny/0000-0003-1605-6896; Martinelli, Luiz Antonio/0000-0002-7103-7551; Robertson, G Philip/0000-0001-9771-9895; zhang, fusuo/0000-0001-8971-0129; Drinkwater, Laurie/0000-0002-0746-6765; Crews, Timothy/0000-0003-4764-341X; Holland, Elisabeth Ann/0000-0002-3570-621X; Nziguheba, Generose/0000-0003-4227-2242				Beaudoin N, 2005, AGR ECOSYST ENVIRON, V111, P292, DOI 10.1016/j.agee.2005.06.006; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Billen G, 2007, SCI TOTAL ENVIRON, V375, P80, DOI 10.1016/j.scitotenv.2006.12.005; Bunemann EK, 2004, PLANT SOIL, V264, P195, DOI 10.1023/B:PLSO.0000047749.43017.fd; Cherry KA, 2008, SCI TOTAL ENVIRON, V406, P1, DOI 10.1016/j.scitotenv.2008.07.015; Denning G, 2009, PLOS BIOL, V7, P2, DOI 10.1371/journal.pbio.1000023; Egli DB, 2008, AGRON J, V100, pS79, DOI 10.2134/agronj2006.0286c; Erisman JW, 2008, ATMOS ENVIRON, V42, P3209, DOI 10.1016/j.atmosenv.2007.04.004; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Johnes P. J., 2007, Redesigning animal agriculture: the challenge of the 21st Century, P185, DOI 10.1079/9781845932237.0185; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KLOPFENSTEIN TJ, 2002, 21 COUNC AGR SCI TEC; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; McIsaac GF, 2002, J ENVIRON QUAL, V31, P1610, DOI 10.2134/jeq2002.1610; PALM CA, 1997, SPECIAL PUBL SOIL SC, V5, P193; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; Sheldrick WF, 2002, NUTR CYCL AGROECOSYS, V62, P61, DOI 10.1023/A:1015124930280; Tang X, 2008, FIELD CROP RES, V108, P231, DOI 10.1016/j.fcr.2008.05.007; *US EPA, 2007, EPSAB08003; [李秋梅 Li Qiumei], 2002, [植物营养与肥料学报, Plant nutrition and fertitizer science], V8, P152; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	22	869	964	43	735	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1519	1520		10.1126/science.1170261	http://dx.doi.org/10.1126/science.1170261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541981				2022-12-28	WOS:000267130600026
J	Segal, JB; Brotman, DJ; Necochea, AJ; Emadi, A; Samal, L; Wilson, LM; Crim, MT; Bass, EB				Segal, Jodi B.; Brotman, Daniel J.; Necochea, Alejandro J.; Emadi, Ashkan; Samal, Lipika; Wilson, Lisa M.; Crim, Matthew T.; Bass, Eric B.			Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							THROMBOPHILIC RISK-FACTORS; ACTIVATED PROTEIN-C; THROMBOTIC RISK; 1ST EPISODE; LONG-TERM; CARRIERS; GENE; RECURRENCE; RELATIVES; THERAPY	Context Testing for genetic risks for venous thromboembolism (VTE) is common, but the safety and utility of such testing need review. Objectives To define rates of recurrent VTE among adults with VTE with a factor V Leiden (FVL) or prothrombin G20210A mutation compared with those without such mutations; to define rates of VTE among family members of adults with a FVL or prothrombin G20210A mutation according to presence or absence of a mutation; and to assess whether testing adults with VTE for FVL or prothrombin G20210A improves outcomes. Data Sources We searched MEDLINE, EMBASE, the Cochrane Library, the Cumulative Index to Nursing and Allied Health Literature, and PsycInfo through December 2008. Study Selection Studies were included if they assessed rates of VTE in individuals with a history of VTE who were tested for FVL or prothrombin G20210A or in family members of individuals with these mutations. Studies assessing the harms and benefits associated with testing were also included. Data Extraction Two investigators abstracted data and assessed study quality. We pooled the odds of VTE associated with the mutations using random-effects models. We assessed the strength of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Results We reviewed 7777 titles and included 46 articles. Heterozygosity (odds ratio [OR], 1.56; 95% confidence interval [CI], 1.14-2.12) and homozygosity (OR, 2.65; 95% CI, 1.2-6.0) for FVL in probands are predictive of recurrent VTE compared with individuals without FVL. Heterozygosity for FVL predicts VTE in family members (OR, 3.5; 95% CI, 2.5-5.0), as does homozygosity for FVL (OR, 18; 95% CI, 7.8-40) compared with family members of adults without FVL. Heterozygosity for prothrombin G20210A is not predictive of recurrent VTE in probands compared with individuals without prothrombin G20210A (OR, 1.45; 95% CI, 0.96-2.2). Evidence is insufficient regarding the predictive value of prothrombin G20210A homozygosity for recurrent VTE and the risk of VTE in family members of individuals with prothrombin G20210A. High-grade evidence supports that anticoagulation reduces recurrent VTE events in probands with either mutation. Low-grade evidence supports that this risk reduction is similar to that in individuals with a history of VTE and without mutations. Conclusions Patients with FVL are at increased risk of recurrent VTE compared with patients with VTE without this mutation. However, it is unknown whether testing for FVL or prothrombin G20210A improves outcomes in adults with VTE or in family members of those with a mutation. JAMA. 2009; 301(23):2472-2485	[Segal, Jodi B.; Brotman, Daniel J.; Emadi, Ashkan; Samal, Lipika; Wilson, Lisa M.; Crim, Matthew T.; Bass, Eric B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Segal, Jodi B.; Wilson, Lisa M.; Bass, Eric B.] Johns Hopkins Evidence Based Practice Ctr, Baltimore, MD USA; [Necochea, Alejandro J.] Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Segal, JB (corresponding author), 1830 E Monument St,Room 8047, Baltimore, MD 21287 USA.	jsegal@jhmi.edu		Bass, Eric/0000-0001-9106-527X	Agency for Healthcare Research and Quality (AHRQ) [HHSSA 290-2007-10061-I]; Centers for Disease Control and Prevention	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding/Support: This article was prepared under contract HHSSA 290-2007-10061-I Task Order No. 4 for the Agency for Healthcare Research and Quality (AHRQ). The report on which this article is based was requested and funded by the Centers for Disease Control and Prevention for the EGAPP working group.	Aillaud MF, 2003, BLOOD COAGUL FIBRIN, V14, P523, DOI 10.1097/01.mbc.0000061337.72909.c7; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baarslag Henk J, 2004, Eur J Intern Med, V15, P503, DOI 10.1016/j.ejim.2004.07.012; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Bank I, 2004, THROMB RES, V113, P7, DOI 10.1016/j.thromres.2004.02.002; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Castaman G, 2000, BLOOD COAGUL FIBRIN, V11, P321, DOI 10.1097/00001721-200006000-00002; Chang MH, 2009, AM J EPIDEMIOL, V169, P54, DOI 10.1093/aje/kwn286; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Couturaud F, 2006, THROMB HAEMOSTASIS, V96, P744, DOI 10.1160/TH06-06-0328; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 2002, ARCH INTERN MED, V162, P2357, DOI 10.1001/archinte.162.20.2357; Gonzalez-Porras JR, 2006, BLOOD COAGUL FIBRIN, V17, P23, DOI 10.1097/01.mbc.0000201488.33143.09; Heshka J, 2008, J Genet Couns, V17, P288, DOI 10.1007/s10897-008-9148-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoibraaten E, 2001, BRIT J HAEMATOL, V115, P415, DOI 10.1046/j.1365-2141.2001.03111.x; Hron G, 2006, AM J MED, V119, P50, DOI 10.1016/j.amjmed.2005.04.043; *JOANN BRIGGS I, APPR EXTR POOL EV AR; Kaptein AA, 2007, HEALTH PSYCHOL, V26, P807, DOI 10.1037/0278-6133.26.6.807; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2008, BLOOD, V112, P4432, DOI 10.1182/blood-2008-06-163279; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Le Cam-Duchez V, 1999, BRIT J HAEMATOL, V106, P889, DOI 10.1046/j.1365-2141.1999.01661.x; Lensen R, 2000, BRIT J HAEMATOL, V110, P939, DOI 10.1046/j.1365-2141.2000.02236.x; Lensen R, 2001, BRIT J HAEMATOL, V114, P380, DOI 10.1046/j.1365-2141.2001.02946.x; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Mansilha A, 2005, EUR J VASC ENDOVASC, V30, P545, DOI 10.1016/j.ejvs.2005.05.038; Martinelli I, 2000, BRIT J HAEMATOL, V111, P1223, DOI 10.1046/j.1365-2141.2000.02502.x; Meinardi JR, 2002, BRIT J HAEMATOL, V116, P625, DOI 10.1046/j.0007-1048.2001.03303.x; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Middeldorp S, 2001, ANN INTERN MED, V135, P322, DOI 10.7326/0003-4819-135-5-200109040-00008; Miles JS, 2001, J AM COLL CARDIOL, V37, P215, DOI 10.1016/S0735-1097(00)01080-9; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; RIDKER PM, 1995, CIRCULATION, V92, P2800, DOI 10.1161/01.CIR.92.10.2800; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rintelen C, 2001, EUR J HAEMATOL, V67, P165, DOI 10.1034/j.1600-0609.2001.5790460.x; Samama MM, 1996, HAEMOSTASIS, V26, P315; Santamaria MG, 2005, THROMB RES, V116, P301, DOI 10.1016/j.thromres.2004.12.012; Saukko PM, 2006, SOC SCI MED, V63, P1947, DOI 10.1016/j.socscimed.2006.04.012; Saukko PM, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-82; SEGAL JB, IMPACT TEST IN PRESS; Simioni P, 1999, ANN INTERN MED, V130, P538, DOI 10.7326/0003-4819-130-6-199903160-00012; Simioni P, 2000, BLOOD COAGUL FIBRIN, V11, P379, DOI 10.1097/00001721-200006000-00010; Simioni P, 2002, BLOOD, V99, P1938, DOI 10.1182/blood.V99.6.1938; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Simioni P, 2000, BLOOD, V96, P3329; Strandberg K, 2007, THROMB RES, V121, P145, DOI 10.1016/j.thromres.2007.03.020; Vossen CY, 2005, ARTERIOSCL THROM VAS, V25, P1992, DOI 10.1161/01.ATV.0000174806.76629.7b; Vossen CY, 2005, J THROMB HAEMOST, V3, P459, DOI 10.1111/j.1538-7836.2005.01197.x; Vossen CY, 2004, J THROMB HAEMOST, V2, P1526, DOI 10.1111/j.1538-7836.2004.00852.x; Wahlander K, 2006, BRIT J HAEMATOL, V133, P68, DOI 10.1111/j.1365-2141.2006.05960.x	56	168	175	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2472	2485		10.1001/jama.2009.853	http://dx.doi.org/10.1001/jama.2009.853			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458MO	19531787	Bronze			2022-12-28	WOS:000267028100025
J	Saint, S; Meddings, JA; Calfee, D; Kowalski, CP; Krein, SL				Saint, Sanjay; Meddings, Jennifer A.; Calfee, David; Kowalski, Christine P.; Krein, Sarah L.			Catheter-Associated Urinary Tract Infection and the Medicare Rule Changes	ANNALS OF INTERNAL MEDICINE			English	Article							INTERMITTENT SELF-CATHETERIZATION; NURSING-HOME PATIENTS; ASYMPTOMATIC BACTERIURIA; NOSOCOMIAL INFECTIONS; HOSPITALIZED-PATIENTS; UNITED-STATES; CARE; INTERVENTION; COMPLICATIONS; PREVENTION	Catheter-associated urinary tract infection, a common and potentially preventable complication of hospitalization, is 1 of the hospital-acquired complications chosen by the Centers for Medicare & Medicaid Services (CMS) for which hospitals no longer receive additional payment. To help readers understand the potential consequences of the recent CMS rule changes, the authors examine the preventability of catheter-associated infection, review the CMS rule changes regarding catheter-associated urinary tract infection, offer an assessment of the possible consequences of these changes, and provide guidance for hospital-based administrators and clinicians. Although the CMS rule changes related to catheter-associated urinary tract infection are controversial, they may do more good than harm, because hospitals are likely to redouble their efforts to prevent catheter-associated urinary tract infection, which may minimize unnecessary placement of indwelling catheters and facilitate prompt removal. However, even if forcing hospitals to increase efforts to prevent complications stemming from hospital-acquired infection is commendable, these efforts will have opportunity costs and may have unintended consequences. Therefore, how hospitals and physicians respond to the CMS rule changes must be monitored closely.	Univ Michigan, Sch Med, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Vet Affairs Univ Michigan, Patient Safety Enhancement Program, Ann Arbor, MI USA; Mt Sinai Sch Med, New York, NY USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Icahn School of Medicine at Mount Sinai	Saint, S (corresponding author), Univ Michigan Hlth Syst, Div Gen Med, 300 N Ingalls,Room 7E08,Campus Box 0429, Ann Arbor, MI 48109 USA.	saint@med.umich.edu	Krein, Sarah L/E-2742-2014; Saint, Sanjay/AAF-5126-2019	Krein, Sarah L/0000-0003-2111-8131; Kowalski, Christine/0000-0001-6258-0221; Meddings, Jennifer/0000-0001-9503-0293	National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK078717]; National Institute of Nursing Research [R01-NR010700]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010700] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	By the National Institute of Diabetes and Digestive and Kidney Diseases (R21-DK078717; Dr. Saint) and the National Institute of Nursing Research (R01-NR010700; Drs. Saint and Krein). Salary support for Dr. Saint was also provided through an Advanced Career Development Award from the Health Services Research & Development Program of the Department of Veterans Affairs.	Apisarnthanarak A, 2007, INFECT CONT HOSP EP, V28, P791, DOI 10.1086/518453; Centers for Medicare and Medicaid Services (CMS), 2008, FED REGISTER, V73, P48433; Centers for Medicare & Medicaid Services, AC INP PROSP PAYM SY; Centers of Medicare and Medicaid Services (CMS), 2007, FED REGISTER, V72, P47129; *CMS HHS, 2008, FED REGISTER, V73, P23547; Cornia PB, 2003, AM J MED, V114, P404, DOI 10.1016/S0002-9343(02)01568-1; Crouzet J, 2007, J HOSP INFECT, V67, P253, DOI 10.1016/j.jhin.2007.08.014; *CTR MED MED SERV, HOSP ACQ COND IN SUM; DIOKNO AC, 1983, J UROLOGY, V129, P1120, DOI 10.1016/S0022-5347(17)52599-9; Doyle B, 2001, Lippincotts Case Manag, V6, P127, DOI 10.1097/00129234-200105000-00007; Dumigan D G, 1998, Clin Perform Qual Health Care, V6, P172; Forster AJ, 2004, CAN MED ASSOC J, V170, P1235, DOI 10.1503/cmaj.1030683; Foxman B, 2002, AM J MED, V113, p5S; Goetz AM, 1999, AM J INFECT CONTROL, V27, P402, DOI 10.1016/S0196-6553(99)70005-2; Graves N, 2008, JAMA-J AM MED ASSOC, V300, P1577, DOI 10.1001/jama.300.13.1577; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; HIRSH DD, 1979, JAMA-J AM MED ASSOC, V242, P340, DOI 10.1001/jama.242.4.340; Huang WC, 2004, INFECT CONT HOSP EP, V25, P974, DOI 10.1086/502329; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; KUHN W, 1991, PARAPLEGIA, V29, P222, DOI 10.1038/sc.1991.33; LAPIDES J, 1972, Journal of Urology, V107, P458; Lin K, 2008, ANN INTERN MED, V149, pW20, DOI 10.7326/0003-4819-149-1-200807010-00009-w1; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Loeb M, 2008, J GEN INTERN MED, V23, P816, DOI 10.1007/s11606-008-0620-2; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; OUSLANDER JG, 1987, J UROLOGY, V138, P1191, DOI 10.1016/S0022-5347(17)43546-4; OUSLANDER JG, 1987, J AM GERIATR SOC, V35, P1063, DOI 10.1111/j.1532-5415.1987.tb04922.x; PEAR R, 2007, NY TIMES        0819; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Saint S, 2000, ARCH INTERN MED, V160, P2670, DOI 10.1001/archinte.160.17.2670; Saint S, 1999, J AM GERIATR SOC, V47, P1453, DOI 10.1111/j.1532-5415.1999.tb01567.x; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Saint S, 2008, INFECT CONT HOSP EP, V29, P333, DOI 10.1086/529589; Saint S, 2008, CLIN INFECT DIS, V46, P243, DOI 10.1086/524662; Saint S, 2006, J AM GERIATR SOC, V54, P1055, DOI 10.1111/j.1532-5415.2006.00785.x; SIMMONS BP, 1983, AM J INFECT CONTROL, V11, P183, DOI 10.1016/0196-6553(83)90079-2; Stephan F, 2006, CLIN INFECT DIS, V42, P1544, DOI 10.1086/503837; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Topal J, 2005, AM J MED QUAL, V20, P121, DOI 10.1177/1062860605276074; Wagenlehner FME, 2000, J HOSP INFECT, V46, P171, DOI 10.1016/S0195-6701(00)90821-1; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060; Zhan CL, 2007, MED CARE, V45, P288, DOI 10.1097/01.mlr.0000256969.34461.cf; Zhan CL, 2009, MED CARE, V47, P364, DOI 10.1097/MLR.0b013e31818af83d; [No title captured]	50	166	171	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					877	U82		10.7326/0003-4819-150-12-200906160-00013	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528567	Green Accepted			2022-12-28	WOS:000267164800008
J	Boguski, MS; Mandl, KD; Sukhatme, VP				Boguski, Mark S.; Mandl, Kenneth D.; Sukhatme, Vikas P.			Repurposing with a Difference	SCIENCE			English	Editorial Material							JANUARY-1 FEBRUARY 2005; DRUG DEVELOPMENT; ABANDONED DRUGS; PHARMACOVIGILANCE; COMMERCIALIZE; PHILADELPHIA; IDENTIFY; DEVELOP; USA; PA		[Boguski, Mark S.] Harvard Univ, Sch Med, Dept Pathobiol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Boguski, Mark S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Childrens Hosp Informat Program Harvard MIT, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Sukhatme, Vikas P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Boguski, MS (corresponding author), Harvard Univ, Sch Med, Dept Pathobiol, Beth Israel Deaconess Med Ctr, 10 Shattuck St, Boston, MA 02115 USA.	mark_boguski@hms.harvard.edu	Sukhatme, Vikas/W-2776-2019					Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bernoff, 2008, GROUNDSWELL WINNING; Boguski MS, 2009, GENOMIC AND PERSONALIZED MEDICINE, VOL 1, P252; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Brownstein JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000840; Carley DW, 2005, IDRUGS, V8, P310; Carley DW, 2005, IDRUGS, V8, P306; Christensen C, 2009, INNOVATORS PRESCRIPT; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eisenberg Rebecca S, 2005, Yale J Health Policy Law Ethics, V5, P717; Ferguson T., 2007, E PATIENTS THEY CAN; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Grabowski H, 2004, PHARMACOECONOMICS, V22, P15, DOI 10.2165/00019053-200422002-00003; Harmark L, 2008, EUR J CLIN PHARMACOL, V64, P743, DOI 10.1007/s00228-008-0475-9; Hauben M, 2009, DRUG DISCOV TODAY, V14, P343, DOI 10.1016/j.drudis.2008.12.012; Howe J., 2008, CROWDSOURCING WHY PO; Kaitin KI, 2008, CLIN PHARMACOL THER, V83, P210, DOI 10.1038/sj.clpt.6100462; Loughlin K.R., 2006, GUIDE OFF LABEL PRES; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; MCBRIDE WG, 1961, LANCET, V2, P1358; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; POLLACK A, 2009, NY TIMES        0312; Rehan HS, 2009, EUR J INTERN MED, V20, P3, DOI 10.1016/j.ejim.2008.04.019; Roin BN, 2009, TEX LAW REV, V87, P503; Slater R, 2003, MAGIC CANC BULLET TI; Weaver J, 2008, AAPS J, V10, P35, DOI 10.1208/s12248-007-9004-5; WHO, 2002, IMP PHARM SAF MON ME	28	147	151	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1394	1395		10.1126/science.1169920	http://dx.doi.org/10.1126/science.1169920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520944				2022-12-28	WOS:000266878700027
J	Bonn, D; Denn, MM				Bonn, Daniel; Denn, Morton M.			Yield Stress Fluids Slowly Yield to Analysis	SCIENCE			English	Editorial Material							FLOW; SPHERE		[Bonn, Daniel] Univ Amsterdam, WZI, NL-1018 XE Amsterdam, Netherlands; [Bonn, Daniel] LPS ENS, F-75231 Paris 05, France; [Denn, Morton M.] CUNY City Coll, Benjamin Levich Inst, New York, NY 10031 USA	University of Amsterdam; UDICE-French Research Universities; Universite Paris Cite; City University of New York (CUNY) System; City College of New York (CUNY)	Bonn, D (corresponding author), Univ Amsterdam, WZI, Valckenierstr 65, NL-1018 XE Amsterdam, Netherlands.	bonn@science.uva.nl; denn@ccny.cuny.edu	Bonn, Daniel/F-9928-2011					Barnes HA, 1999, J NON-NEWTON FLUID, V81, P133, DOI 10.1016/S0377-0257(98)00094-9; Barnes HA, 2001, J NON-NEWTON FLUID, V98, P1, DOI 10.1016/S0377-0257(01)00095-7; BERIS AN, 1985, J FLUID MECH, V158, P219, DOI 10.1017/S0022112085002622; Coussot P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.175501; Frigaard IA, 2005, J NON-NEWTON FLUID, V127, P1, DOI 10.1016/j.jnnfm.2005.01.003; Gueslin B, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2358090; LIPSCOMB GG, 1984, J NON-NEWTON FLUID, V14, P337, DOI 10.1016/0377-0257(84)80052-X; Liu BT, 2002, J NON-NEWTON FLUID, V102, P179, DOI 10.1016/S0377-0257(01)00177-X; MITSOULIS E, 2008, RHEOLOGY REV 2007, P135; Moller PCF, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041507; NGUYEN QD, 1992, ANNU REV FLUID MECH, V24, P47, DOI 10.1146/annurev.fl.24.010192.000403; Singh JP, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2912501; Tsamopoulos J, 2008, J FLUID MECH, V601, P123, DOI 10.1017/S0022112008000517	13	173	175	4	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1401	1402		10.1126/science.1174217	http://dx.doi.org/10.1126/science.1174217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520949				2022-12-28	WOS:000266878700032
J	Kapur, V; Chauhan, S; D'Cruz, S; Sachdev, A				Kapur, Vinay; Chauhan, Sandeep; D'Cruz, Sanjay; Sachdev, Atul			Kartagener's syndrome	LANCET			English	Editorial Material									[Kapur, Vinay; Chauhan, Sandeep; D'Cruz, Sanjay; Sachdev, Atul] Govt Med Coll & Hosp, Dept Med, Chandigarh 160030, India		Kapur, V (corresponding author), Govt Med Coll & Hosp, Dept Med, Sector 32, Chandigarh 160030, India.	vinay.kapur@yahoo.co.in	Sachdev, Atul/AAE-4831-2020; Papafaklis, Michail/E-9547-2013; Madhu, S/AAH-7431-2019	Papafaklis, Michail/0000-0002-5646-0378; Madhu, S/0000-0003-0018-5984					0	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1973	1973		10.1016/S0140-6736(09)60306-8	http://dx.doi.org/10.1016/S0140-6736(09)60306-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19501745				2022-12-28	WOS:000266832500032
J	Raab, MS; Podar, K; Breitkreutz, I; Richardson, PG; Anderson, KC				Raab, Marc S.; Podar, Klaus; Breitkreutz, Iris; Richardson, Paul G.; Anderson, Kenneth C.			Multiple myeloma	LANCET			English	Review							STEM-CELL TRANSPLANTATION; THALIDOMIDE PLUS DEXAMETHASONE; HIGH-DOSE THERAPY; PEGYLATED LIPOSOMAL DOXORUBICIN; PROTEASOME INHIBITOR BORTEZOMIB; BONE-MARROW-TRANSPLANTATION; PREVIOUSLY TREATED PATIENTS; MONOCLONAL GAMMOPATHY; HIGH-RISK; ELDERLY-PATIENTS	Multiple myeloma is characterised by clonal proliferation of malignant plasma cells, and mounting evidence indicates that the bone marrow microenvironment of tumour cells has a pivotal role in myeloma pathogenesis. This knowledge has already expanded treatment options for patients with multiple myeloma. Prototypic drugs thalidomide, bortezomib, and lenalidomide have each been approved for the treatment of this disease by targeting both multiple myeloma cells and the bone marrow microenvironment. Although benefit was first shown in relapsed and refractory disease, improved overall response, duration of response, and progression-free and overall survival can be achieved when these drugs are part of first-line regimens. This treatment framework promises to improve outcome not only for patients with multiple myeloma, but also with other haematological malignancies and solid tumours.	[Raab, Marc S.; Podar, Klaus; Breitkreutz, Iris; Richardson, Paul G.; Anderson, Kenneth C.] Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA; [Raab, Marc S.; Podar, Klaus; Breitkreutz, Iris; Richardson, Paul G.; Anderson, Kenneth C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Ctr Multiple Myeloma Res, Boston, MA 02115 USA; [Raab, Marc S.] Heidelberg Univ, Med Ctr, Dept Med 5, Heidelberg, Germany; [Raab, Marc S.; Breitkreutz, Iris] Natl Ctr Tumor Dis, Heidelberg, Germany; [Raab, Marc S.; Breitkreutz, Iris] German Canc Res Ctr, D-6900 Heidelberg, Germany	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Anderson, KC (corresponding author), Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, 44 Binney St, Boston, MA 02115 USA.	Kenneth_Anderson@dfci.harvard.edu	Podar, Klaus/ABD-1112-2020	Podar, Klaus/0000-0002-7414-3632				ALEXANIAN R, 1994, BLOOD, V84, P4278, DOI 10.1182/blood.V84.12.4278.bloodjournal84124278; ALEXANIAN R, 1986, ANN INTERN MED, V105, P8, DOI 10.7326/0003-4819-105-1-8; Anderson KC, 1999, SEMIN HEMATOL, V36, P3; Anderson KC, 2005, SEMIN HEMATOL, V42, pS3, DOI 10.1053/j.seminhematol.2005.10.001; ANDERSON KC, 2008, P AN M AM SOC CLIN, V26, P8545; [Anonymous], ASH ANN M; Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Avet-Loiseau H, 1999, CANCER RES, V59, P4546; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Bahlis NJ, 2006, BLOOD, V108, p1016A, DOI 10.1182/blood.V108.11.3557.3557; BARLOGIE B, 1987, BLOOD, V70, P869; Barlogie B, 1999, BLOOD, V93, P55, DOI 10.1182/blood.V93.1.55.401k04_55_65; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2001, BLOOD, V98, P492, DOI 10.1182/blood.V98.2.492; BARLOGIE B, 1984, NEW ENGL J MED, V310, P1353, DOI 10.1056/NEJM198405243102104; BARLOGIE B, 2008, P AN M AM SOC CLIN, V26, P8516; Berenson JR, 2005, BEST PRACT RES CL HA, V18, P653, DOI 10.1016/j.beha.2005.03.001; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; Blade J, 2007, BLOOD, V110, p127A, DOI 10.1182/blood.V110.11.410.410; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Breitkreutz I, 2008, LEUKEMIA, V22, P1925, DOI 10.1038/leu.2008.174; Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Casassus P, 2001, BRIT J HAEMATOL, V113, P1020; CAVO M, 2007, ASH ANN M ABSTR, V110, P73; Celegene Corporation, 2006, THALOMID THAL PROD I; Chanan-Khan AA, 2007, BLOOD, V109, P2604, DOI 10.1182/blood-2006-09-046409; Chanan-Khan AA, 2006, BLOOD, V108, p1014A, DOI 10.1182/blood.V108.11.3551.3551; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Cohen HJ, 1998, AM J MED, V104, P439, DOI 10.1016/S0002-9343(98)00080-1; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; de Bont ESJM, 2001, CANCER RES, V61, P7654; Dimopoulos MA, 2001, ANN ONCOL, V12, P991, DOI 10.1023/A:1011132808904; Dimopoulos MA, 2004, HEMATOL J, V5, P112, DOI 10.1038/sj.thj.6200326; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Echart C, 2007, BLOOD, V110, p741A; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Fermand JP, 1998, BLOOD, V92, P3131, DOI 10.1182/blood.V92.9.3131.421k30_3131_3136; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Georges GE, 2007, BIOL BLOOD MARROW TR, V13, P423, DOI 10.1016/j.bbmt.2006.11.011; Gerull S, 2005, BONE MARROW TRANSPL, V36, P963, DOI 10.1038/sj.bmt.1705161; Giles FJ, 2000, AM J HEMATOL, V63, P125, DOI 10.1002/(SICI)1096-8652(200003)63:3<125::AID-AJH3>3.3.CO;2-J; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Glasmacher A, 2006, BRIT J HAEMATOL, V132, P584, DOI 10.1111/j.1365-2141.2005.05914.x; Glasmacher A, 2005, BLOOD, V106, p364B; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau J.L., 2007, BLOOD, V110, P450; Harousseau JL, 2006, HAEMATOLOGICA, V91, P1498; Hazlehurst LA, 2000, ONCOGENE, V19, P4319, DOI 10.1038/sj.onc.1203782; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2007, HEMATOL ONCOL CLIN N, V21, P1071, DOI 10.1016/j.hoc.2007.08.013; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hussein MA, 2006, THROMB HAEMOSTASIS, V95, P924, DOI 10.1160/TH06-02-0080; Jagannath S, 2007, BLOOD, V110, p798A, DOI 10.1182/blood.V110.11.2717.2717; Jakob C, 2006, EUR J CANCER, V42, P1581, DOI 10.1016/j.ejca.2006.02.017; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keats JJ, 2006, LEUKEMIA LYMPHOMA, V47, P2289, DOI 10.1080/10428190600822128; Kroger N, 2004, BIOL BLOOD MARROW TR, V10, P698, DOI 10.1016/j.bbmt.2004.06.002; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kumar S, 2007, LEUKEMIA, V21, P2035, DOI 10.1038/sj.leu.2404801; Kumar S, 2004, BONE MARROW TRANSPL, V34, P161, DOI 10.1038/sj.bmt.1704545; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Lagarce L, 2007, FUND CLIN PHARMACOL, V21, P57; Lee CK, 2003, J CLIN ONCOL, V21, P2732, DOI 10.1200/JCO.2003.01.055; Lee CK, 2002, BONE MARROW TRANSPL, V30, P873, DOI 10.1038/sj.bmt.1703715; Lokhorst HM, 2007, HAEMATOLOGICA, V93, P124, DOI 10.3324/haematol.11644; LUDWIG H, 2007, ASH ANN M ABSTR, V110, P529; MACLENNAN ICM, 1992, LANCET, V339, P200, DOI 10.1016/0140-6736(92)90004-M; Macro M, 2006, BLOOD, V108, P57; Maloney DG, 2003, BLOOD, V102, P3447, DOI 10.1182/blood-2002-09-2955; Malpas JS, 1998, MULTIPLE MYELOMA BIO; Mateos MV, 2006, BLOOD, V108, P2165, DOI 10.1182/blood-2006-04-019778; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Miguel J. F. S., 2005, BLOOD, V106, P366; Mileshkin L, 2006, J CLIN ONCOL, V24, P4507, DOI 10.1200/JCO.2006.05.6689; Mitsiades CS, 2007, BEST PRACT RES CL HA, V20, P797, DOI 10.1016/j.beha.2007.09.008; Mitsiades CS, 2006, BLOOD, V108, p1005A, DOI 10.1182/blood.V108.11.3523.3523; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Moehler TM, 2001, BLOOD, V98, P3846, DOI 10.1182/blood.V98.13.3846; Moreau P, 2006, BLOOD, V107, P397, DOI 10.1182/blood-2005-06-2573; Moreau P, 2007, BLOOD, V110, p353A; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Munshi Nikhil C, 2008, Hematology Am Soc Hematol Educ Program, P298, DOI 10.1182/asheducation-2008.1.298; Munshi Nikhil C, 2008, Hematology Am Soc Hematol Educ Program, P297, DOI 10.1182/asheducation-2008.1.297; Naina HVK, 2005, BLOOD, V106, p970A; Neben K, 2002, CLIN CANCER RES, V8, P3377; Niesvizky R, 2007, BRIT J HAEMATOL, V138, P640, DOI 10.1111/j.1365-2141.2007.06698.x; Oakervee HE, 2005, BRIT J HAEMATOL, V129, P755, DOI 10.1111/j.1365-2141.2005.05519.x; Offidani M, 2006, HAEMATOLOGICA, V91, P133; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Orlowski RZ, 2005, BLOOD, V105, P3058, DOI 10.1182/blood-2004-07-2911; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Palumbo A, 2005, EUR J HAEMATOL, V75, P391, DOI 10.1111/j.1600-0609.2005.00533.x; Palumbo A, 2004, HEMATOL J, V5, P318, DOI 10.1038/sj.thj.6200403; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; Palumbo A, 2006, BLOOD, V108, p1016A, DOI 10.1182/blood.V108.11.3560.3560; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Podar K, 2005, EXPERT OPIN THER TAR, V9, P359, DOI 10.1517/14728222.9.2.359; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Podar K, 2007, BEST PRACT RES CL HA, V20, P597, DOI 10.1016/j.beha.2007.08.002; Podar K, 2007, CELL CYCLE, V6, P538, DOI 10.4161/cc.6.5.3922; Raab MS, 2007, BONE MARROW TRANSPL, V40, P1129, DOI 10.1038/sj.bmt.1705829; Rajkumar SV, 2008, J CLIN ONCOL, V26, P2171, DOI 10.1200/JCO.2007.14.1853; Rajkumar SV, 2007, BLOOD, V110, p31A, DOI 10.1182/blood.V110.11.74.74; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Richardson P, 2004, MAYO CLIN PROC, V79, P875, DOI 10.4065/79.7.875; Richardson Paul G, 2007, J Natl Compr Canc Netw, V5, P149; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Richardson PG, 2007, BRIT J HAEMATOL, V137, P429, DOI 10.1111/j.1365-2141.2007.06585.x; Richardson PG, 2006, BLOOD, V108, P3458, DOI 10.1182/blood-2006-04-015909; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; RICHARDSON PG, 2008, P AN M AM SOC CLIN, V26, P8520; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; San-Miguel J, 2008, J CLIN ONCOL, V26, P2761, DOI 10.1200/JCO.2007.15.2546; Scavelli C, 2008, ONCOGENE, V27, P663, DOI 10.1038/sj.onc.1210691; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Sirohi B, 2004, LANCET, V363, P875, DOI 10.1016/S0140-6736(04)15736-X; SONNEVELD P, 2007, P AN M AM SOC CLIN, V25, P8023; Tosi P, 2004, EUR J HAEMATOL, V73, P98, DOI 10.1111/j.1600-0609.2004.00272.x; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Vacca A, 2001, EXP HEMATOL, V29, P993, DOI 10.1016/S0301-472X(01)00674-9; Vesole DH, 1999, J CLIN ONCOL, V17, P2173, DOI 10.1200/JCO.1999.17.7.2173; Vesole DH, 1996, BLOOD, V88, P838; von Metzler I, 2007, LEUKEMIA, V21, P2025, DOI 10.1038/sj.leu.2404806; Weber D, 2007, BLOOD, V110, p128A, DOI 10.1182/blood.V110.11.412.412; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Whittenberger BF, 2007, ASH ANN M ABSTR, V110, P77; ZANGARI M, 2003, BLOOD, V102, P410; Zervas K, 2007, ANN ONCOL, V18, P1369, DOI 10.1093/annonc/mdm178; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang H, 2005, BLOOD, V105, P3286, DOI 10.1182/blood-2004-06-2101	148	573	637	3	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					324	339		10.1016/S0140-6736(09)60221-X	http://dx.doi.org/10.1016/S0140-6736(09)60221-X			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19541364				2022-12-28	WOS:000268508200030
J	Chalmers, I; Glasziou, P				Chalmers, Iain; Glasziou, Paul			Avoidable waste in the production and reporting of research evidence	LANCET			English	Editorial Material							TRIALS		[Chalmers, Iain] James Lind Lib, James Lind Initiat, Oxford OX2 7LG, England; [Glasziou, Paul] Univ Oxford, Ctr Evidence Based Med, Dept Primary Care, Oxford, England	University of Oxford	Chalmers, I (corresponding author), James Lind Lib, James Lind Initiat, Summertown Pavil,Middle Way, Oxford OX2 7LG, England.	ichalmers@jameslindlibrary.org	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; Cooksey D., 2006, REV UK HLTH RES FUND; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; GROSS CP, 1999, NEW ENGL J MED, V340, P1914; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Hewlett S, 2006, ARTHRIT RHEUM-ARTHR, V55, P676, DOI 10.1002/art.22091; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000010.pub3; HOPEWELL S, 2008, COCHRANE DB SYST REV, V2; Liberati A, 2004, BMJ-BRIT MED J, V328, P531, DOI 10.1136/bmj.328.7438.531; Mallett Susan, 2003, ACP J Club, V139, pA11; *NAT I HLTH RES, TRANSF HLTH RES 1 2; Oliver S, 2006, BIBLIO RES REPORTS P; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	23	1090	1115	3	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					86	89		10.1016/S0140-6736(09)60329-9	http://dx.doi.org/10.1016/S0140-6736(09)60329-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467UO	19525005	Green Submitted			2022-12-28	WOS:000267768800037
J	Gurm, HS; Eagle, K				Gurm, Hitinder S.; Eagle, Kim			Rivaroxaban in acute coronary syndromes: too soon to know?	LANCET			English	Editorial Material							METAANALYSIS; ENOXAPARIN; WARFARIN; ASPIRIN; DISEASE		[Gurm, Hitinder S.; Eagle, Kim] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eagle, K (corresponding author), Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	keagle@umich.edu		Gurm, Hitinder/0000-0002-1646-0218				Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Testa L, 2007, AM J CARDIOL, V99, P1637, DOI 10.1016/j.amjcard.2007.01.052	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					3	4		10.1016/S0140-6736(09)60952-1	http://dx.doi.org/10.1016/S0140-6736(09)60952-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19539362				2022-12-28	WOS:000267768800004
J	Mega, JL; Braunwald, E; Mohanavelu, S; Burton, P; Poulter, R; Misselwitz, F; Hricak, V; Barnathan, ES; Bordes, P; Witkowski, A; Markov, V; Oppenheimer, L; Gibson, CM				Mega, J. L.; Braunwald, E.; Mohanavelu, S.; Burton, P.; Poulter, R.; Misselwitz, F.; Hricak, V.; Barnathan, E. S.; Bordes, P.; Witkowski, A.; Markov, V.; Oppenheimer, L.; Gibson, C. M.		ATLAS ACS-TIMI 46 Study Grp	Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ANTITHROMBOTIC THERAPY; ASPIRIN; WARFARIN; ENOXAPARIN; THROMBOPROPHYLAXIS; PREVENTION; ANGINA; ARTHROPLASTY; COMBINATION	Background Rivaroxaban is an oral direct factor Xa inhibitor that has been effective in prevention of venous thromboembolism in patients undergoing elective orthopaedic surgery. However, its use after acute coronary syndromes has not been investigated. In this setting, we assessed the safety and efficacy of rivaroxaban and aimed to select the most favourable dose and dosing regimen. Methods In this double-blind, dose-escalation, phase II study, undertaken at 297 sites in 27 countries, 3491 patients stabilised after an acute coronary syndrome were stratified on the basis of investigator decision to use aspirin only (stratum 1, n=761) or aspirin plus a thienopyridine (stratum 2, n=2730). Participants were randomised within each strata and dose tier with a block randomisation method at 1:1:1 to receive either placebo or rivaroxaban (at doses 5-20 mg) given once daily or the same total daily dose given twice daily. The primary safety endpoint was clinically significant bleeding (TIMI major, TIMI minor, or requiring medical attention); the primary efficacy endpoint was death, myocardial infarction, stroke, or severe recurrent ischaemia requiring revascularisation during 6 months. Safety analyses included all participants who received at least one dose of study drug; efficacy analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00402597. Findings Three patients in stratum 1 and 26 in stratum 2 never received the study drug. The risk of clinically significant bleeding with rivaroxaban versus placebo increased in a dose-dependent manner (hazard ratios [HRs] 2.21 [95% Cl 1.25-3.91] for 5 mg, 3.35 [2.31-4.87] for 10 mg, 3.60 [2.32-5.58] for 15 mg, and 5.06 [3.45-7.42] for 20 mg doses; p<0.0001). Rates of the primary efficacy endpoint were 5.6% (126/2331) for rivaroxaban versus 7.0% (79/1160) for placebo (HR 0.79 [0.60-1.05], p=0.10). Rivaroxaban reduced the main secondary efficacy endpoint of death, myocardial infarction, or stroke compared with placebo (87/2331 [3.9%] vs 62/1160 [5.5%]; HR 0.69, [95% CI 0.50-0.96], p=0.0270). The most common adverse event in both groups was chest pain (248/2309 [10.7%] vs 118/1153 [10.2%]). Interpretation The use of an oral factor Xa inhibitor in patients stabilised after an acute coronary syndrome increases bleeding in a dose-dependent manner and might reduce major ischaemic outcomes. On the basis of these observations, a phase III study of low-dose rivaroxaban as adjunctive therapy in these patients is underway.	[Mega, J. L.; Braunwald, E.] Harvard Univ, Div Cardiovasc, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Mega, J. L.; Braunwald, E.; Mohanavelu, S.] TIMI Study Grp, Boston, MA USA; [Burton, P.; Barnathan, E. S.; Oppenheimer, L.] Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA; [Poulter, R.] Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia; [Misselwitz, F.] Bayer HealthCare, Wuppertal, Germany; [Hricak, V.] Natl Heart Inst, Bratislava, Slovakia; [Bordes, P.] Hosp Gen Univ Alicante, Alicante, Spain; [Witkowski, A.] Inst Cardiol, Warsaw, Poland; [Markov, V.] State Inst Res Cardiol Inst, Tomsk, Russia; [Gibson, C. M.] Harvard Univ, Sch Med, Beth Israel Hosp, Div Cardiovasc, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Johnson & Johnson; Johnson & Johnson USA; Royal Brisbane & Women's Hospital; University of Queensland; Bayer AG; Bayer Healthcare Pharmaceuticals; General University Hospital of Alicante; Institute of Cardiology - Poland; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mega, JL (corresponding author), Harvard Univ, Div Cardiovasc, Brigham & Womens Hosp, Sch Med, 75 Francis St, Boston, MA 02115 USA.	jmega@partners.org	Ponikowski, Piotr/O-6454-2015; Marchev, Sotir/AAH-6529-2020; Walters, Darren/A-7069-2011; Arkhipov, Mikhail V/Q-2316-2015; sharma, kamal/AAG-7271-2019; Sinkiewicz, Wladyslaw/G-5169-2014; Gibson, C. Michael/AAE-8212-2019; Boldueva, Svetlana/AAH-3862-2019; Markov, Valentin A/F-6359-2014; Markov, Valentin A/O-4459-2016; Shpektor, Alexander V/B-1083-2016	Ponikowski, Piotr/0000-0002-3391-7064; Marchev, Sotir/0000-0001-9250-510X; Arkhipov, Mikhail V/0000-0002-7924-7668; sharma, kamal/0000-0001-5866-2566; Boldueva, Svetlana/0000-0002-1898-084X; Markov, Valentin A/0000-0002-5959-2771; Markov, Valentin A/0000-0002-5959-2771; Naslund, Ulf/0000-0003-4100-8298; Sinnaeve, Peter/0000-0003-4716-5892; Poulter, Rohan/0000-0002-9875-4374	Johnson & Johnson Pharmaceutical Research Development; Bayer Healthcare AG	Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA); Bayer Healthcare AG(Bayer AGBayer Healthcare Pharmaceuticals)	This study is supported by research grants from Johnson & Johnson Pharmaceutical Research & Development and Bayer Healthcare AG.	Anand SS, 1998, CIRCULATION, V98, P1064, DOI 10.1161/01.CIR.98.11.1064; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Brouwer MA, 2002, CIRCULATION, V106, P659, DOI 10.1161/01.CIR.0000024408.81821.32; COHEN M, 1994, CIRCULATION, V89, P81, DOI 10.1161/01.CIR.89.1.81; COHEN M, 1990, AM J CARDIOL, V66, P1287, DOI 10.1016/0002-9149(90)91155-Y; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Huynh T, 2001, CIRCULATION, V103, P3069, DOI 10.1161/01.CIR.103.25.3069; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Kubitza D, 2005, EUR J CLIN PHARMACOL, V61, P873, DOI 10.1007/s00228-005-0043-5; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Wallentin L, 2003, LANCET, V362, P789, DOI 10.1016/S0140-6736(03)14287-0; Williams MJA, 1997, J AM COLL CARDIOL, V30, P364, DOI 10.1016/S0735-1097(97)00153-8; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, J AM COLL CARDIOL, V37, P475; Zibaeenezhad MJ, 2004, ANGIOLOGY, V55, P17, DOI 10.1177/000331970405500103	22	531	560	1	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					29	38		10.1016/S0140-6736(09)60738-8	http://dx.doi.org/10.1016/S0140-6736(09)60738-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19539361				2022-12-28	WOS:000267768800031
J	Priotto, G; Kasparion, S; Mutombo, W; Ngouama, D; Ghorashian, S; Arnold, U; Ghabri, S; Baudin, E; Buard, V; Kazadi-Kyanza, S; Ilunga, M; Mutangala, W; Pohlig, G; Schmid, C; Karunakara, U; Torreele, E; Kande, V				Priotto, Gerardo; Kasparion, Serena; Mutombo, Wilfried; Ngouama, Daniel; Ghorashian, Sara; Arnold, Ute; Ghabri, Salah; Baudin, Elisabeth; Buard, Vincent; Kazadi-Kyanza, Serge; Ilunga, Medard; Mutangala, Willy; Pohlig, Gabriele; Schmid, Caecilia; Karunakara, Unni; Torreele, Els; Kande, Victor			Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial	LANCET			English	Article							10-DAY MELARSOPROL SCHEDULE; SLEEPING SICKNESS; CLINICAL-TRIAL; I TRIAL; DIFLUOROMETHYLORNITHINE; METABOLISM; EFFICACY; FAILURE; ANGOLA	Background Human African trypanosomiasis (HAT, sleeping sickness) caused by Trypanosoma brucei gambiense is a fatal disease. Current treatment options for patients with second-stage disease are toxic, ineffective, or impractical. We assessed the efficacy and safety of nifurtimox-eflornithine combination therapy (NECT) for second-stage disease compared with the standard eflornithine regimen. Methods A multicentre, randomised, open-label, active control, phase III, non-inferiority trial was done at four HAT treatment centres in the Republic of the Congo and the Democratic Republic of the Congo. Patients aged 15 years or older with confirmed second-stage T b gambiense infection were randomly assigned by computer-generated randomisation sequence to receive intravenous eflornithine (400 mg/kg per day, every 6 h; n=144) for 14 days or intravenous eflornithine (400 mg/kg per day, every 12 h) for 7 days with oral nifurtimox (15 mg/kg per day, every 8 h) for 10 days (NECT, n=143). The primary endpoint was cure (defined as absence of trypanosomes in body fluids and a leucocyte count <= 20 cells per mu L) 18 months after treatment. Efficacy analyses were done in the intention-to-treat (ITT), modified ITT, and per-protocol (PP) populations. The non-inferiority margin for the difference in cure rates was defined as 10%. This study is registered with ClinicalTrials.gov, number NCT00146627. Findings One patient from the eflornithine group absconded after receiving the first dose, without any type of assessment done, and was excluded from all analyses. In the ITT population, 131 (91.6%) of 143 patients assigned to eflornithine and 138 (96.5%) of 143 patients assigned to NECT were cured at 18 months (difference -4.9%, one-sided 95% CI -0.3; p<0.0001). In the PP population, 122 (91.7%) of 133 patients in the eflornithine group and 129 (97.7%) of 132 in the NECT group were cured at 18 months (difference -6.0%, one-sided 95% CI -1.5; p<0.0001). Drug-related adverse events were frequent in both groups; 41 (28.7%) patients in the eflornithine group and 20 (14.0%) in the NECT group had major (grade 3 or 4) reactions, which resulted in temporary treatment interruption in nine and one patients, respectively. The most common major adverse events were fever (n=18), seizures (n=6), and infections (n=5) in the eflornithine group, and fever (n=7), seizures (n=6), and confusion (n=2) in the NECT group. There were four deaths, which were regarded as related to study drug (eflornithine, n=3; NECT, n=1). Interpretation The efficacy of NECT is non-inferior to that of eflornithine monotherapy. Since this combination treatment also presents safety advantages, is easier to administer (ie, infusion every 12 h for 7 days vs every 6 h for 14 days), and potentially protective against the emergence of resistant parasites, it is suitable for first-line use in HAT control programmes.	[Priotto, Gerardo; Kasparion, Serena; Ghabri, Salah; Baudin, Elisabeth] Epictr, F-75011 Paris, France; [Ghorashian, Sara; Arnold, Ute; Karunakara, Unni] Med Sans Frontieres, Amsterdam, Netherlands; [Buard, Vincent; Kazadi-Kyanza, Serge] Med Sans Frontieres, Brussels, Belgium; [Pohlig, Gabriele; Schmid, Caecilia] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Torreele, Els] Drugs Neglected Dis Initiat, Geneva, Switzerland	Doctors Without Borders; Doctors Without Borders; University of Basel; Swiss Tropical & Public Health Institute	Priotto, G (corresponding author), Epictr, 8 Rue St Sabin, F-75011 Paris, France.	gpriotto@epicentre.msf.org	Priotto, Gerardo/AAS-9027-2021	Baudin, Elisabeth/0000-0002-6575-6971	Dutch section of Medecins Sans Frontieres; Drugs for Neglected Diseases Initiative (DNDi); Medecins Sans Frontieres International; Department for International Development (DFID; UK); Medicor Foundation; Ministry of Foreign and European Affairs (France); Spanish Agency of International Cooperation for Development	Dutch section of Medecins Sans Frontieres; Drugs for Neglected Diseases Initiative (DNDi); Medecins Sans Frontieres International; Department for International Development (DFID; UK); Medicor Foundation; Ministry of Foreign and European Affairs (France); Spanish Agency of International Cooperation for Development	The study was funded by the Dutch section of Medecins Sans Frontieres and the Drugs for Neglected Diseases Initiative (DNDi). Medecins Sans Frontieres International funded the original protocol development through the Nobel Prize Fund. DNDi would like to acknowledge the following donors for their support of DNDi's NECT-related activities: the Department for International Development (DFID; UK), Medecins Sans Frontieres International, the Medicor Foundation, the Ministry of Foreign and European Affairs (France), and the Spanish Agency of International Cooperation for Development. The Medecins Sans Frontieres Tritryps Working Group provided strategic and technical support throughout the entire project. We thank the ministries of health of the Republic of the Congo and the Democratic Republic of the Congo, whose cooperation in setting up the study was invaluable. We acknowledge the clinical and laboratory field team members, international and local, whose hard work allowed this research to be undertaken.	ABELOFF MD, 1984, J CLIN ONCOL, V2, P124, DOI 10.1200/JCO.1984.2.2.124; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; BAILEY JW, 1992, T ROY SOC TROP MED H, V86, P630, DOI 10.1016/0035-9203(92)90160-E; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; Burri C, 2001, TROP MED INT HEALTH, V6, P412, DOI 10.1046/j.1365-3156.2001.00725.x; Checchi F, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000064; GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; JANSSENS PG, 1977, ANN SOC BELG MED TR, V57, P475; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; MOENS F, 1984, ANN SOC BELG MED TR, V64, P37; Moore AC, 2005, J INFECT DIS, V191, P1793, DOI 10.1086/429935; *NCI CTEP NIH, 1999, COMM TOX CRIT VERS 2; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; PEPIN J, 1992, T ROY SOC TROP MED H, V86, P254, DOI 10.1016/0035-9203(92)90298-Q; Priotto G, 2007, CLIN INFECT DIS, V45, P1435, DOI 10.1086/522982; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Robays J, 2008, EMERG INFECT DIS, V14, P966, DOI 10.3201/eid1406.071266; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; VANNIEUWENHOVE S, 1992, ANN SOC BELG MED TR, V72, P39; WEGNER DHG, 1972, ARZNEI-FORSCHUNG, V22, P1624; *WHO, 2007, WHOCDCNTDIDM20071; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1	30	350	353	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					56	64		10.1016/S0140-6736(09)61117-X	http://dx.doi.org/10.1016/S0140-6736(09)61117-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19559476				2022-12-28	WOS:000267768800034
J	Brugts, JJ; Yetgin, T; Hoeks, SE; Gotto, AM; Shepherd, J; Westendorp, RGJ; de Craen, AJM; Knopp, RH; Nakamura, H; Ridker, P; van Domburg, R; Deckers, JW				Brugts, J. J.; Yetgin, T.; Hoeks, S. E.; Gotto, A. M.; Shepherd, J.; Westendorp, R. G. J.; de Craen, A. J. M.; Knopp, R. H.; Nakamura, H.; Ridker, P.; van Domburg, R.; Deckers, J. W.			The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTIMA-MEDIA THICKNESS; CAROTID ATHEROSCLEROSIS; PRIMARY PREVENTION; CARDIAC OUTCOMES; CLINICAL-TRIALS; HEART-DISEASE; FOLLOW-UP; CHOLESTEROL; PROGRESSION; CORONARY	Objectives To investigate whether statins reduce all cause mortality and major coronary and cerebrovascular events in people without established cardiovascular disease but with cardiovascular risk factors, and whether these effects are similar in men and women, in young and older (>65 years) people, and in people with diabetes mellitus. Design Meta-analysis of randomised trials. Data sources Cochrane controlled trials register, Embase, and Medline. Data abstraction Two independent investigators identified studies on the clinical effects of statins compared with a placebo or control group and with follow-up of at least one year, at least 80% or more participants without established cardiovascular disease, and outcome data on mortality and major cardiovascular disease events. Heterogeneity was assessed using the Q and I-2 statistics. Publication bias was assessed by visual examination of funnel plots and the Egger regression test. Results 10 trials enrolled a total of 70 388 people, of whom 23 681 (34%) were women and 16 078 (23%) had diabetes mellitus. Mean follow-up was 4.1 years. Treatment with statins significantly reduced the risk of all cause mortality (odds ratio 0.88, 95% confidence interval 0.81 to 0.96), major coronary events (0.70, 0.61 to 0.81), and major cerebrovascular events (0.81, 0.71 to 0.93). No evidence of an increased risk of cancer was observed. There was no significant heterogeneity of the treatment effect in clinical subgroups. Conclusion In patients without established cardiovascular disease but with cardiovascular risk factors, statin use was associated with significantly improved survival and large reductions in the risk of major cardiovascular events.	[Brugts, J. J.; Yetgin, T.; Hoeks, S. E.; van Domburg, R.; Deckers, J. W.] Erasmus MC Thoraxctr, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands; [Gotto, A. M.] Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA; [Shepherd, J.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Westendorp, R. G. J.; de Craen, A. J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 RA Leiden, Netherlands; [Nakamura, H.] Mitsukoshi Hlth & Welf Fdn, Tokyo, Japan; [Ridker, P.] Brigham & Womens Hosp, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Cornell University; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital	Brugts, JJ (corresponding author), Erasmus MC Thoraxctr, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands.	j.brugts@erasmusmc.nl	Hoeks, Sanne/AAM-3313-2020	Venkatasubramanian, Siddharth/0000-0002-5860-0768				Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; American Heart Association, 2008, HEART DIS STROK STAT; Anderssen SA, 2005, ATHEROSCLEROSIS, V178, P387, DOI 10.1016/j.atherosclerosis.2004.08.033; [Anonymous], 2000, J Atheroscler Thromb, V7, P110; [Anonymous], 1993, Am J Cardiol, V72, P1031; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford I, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-8; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Fox KM, 1998, EUR HEART J, V19, pJ52; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; PEDERSEN TR, 1994, LANCET, V344, P1383; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Sawayama Y, 2002, J AM COLL CARDIOL, V39, P610, DOI 10.1016/S0735-1097(01)01783-1; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243; Wei L, 2005, BMJ-BRIT MED J, V330, P821, DOI 10.1136/bmj.38398.408032.8F; Zanchetti A, 2004, STROKE, V35, P2807, DOI 10.1161/01.STR.0000147041.00840.59	37	444	458	0	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2009	339								b2376	10.1136/bmj.b2376	http://dx.doi.org/10.1136/bmj.b2376			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	466QW	19567909	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000267678400001
J	Dong, J; MacAlister, CA; Bergmann, DC				Dong, Juan; MacAlister, Cora A.; Bergmann, Dominique C.			BASL Controls Asymmetric Cell Division in Arabidopsis	CELL			English	Article							STOMATAL DEVELOPMENT; TRANSCRIPTION FACTOR; AUXIN TRANSPORT; PLASMA-MEMBRANE; MAPKK KINASE; DIFFERENTIATION; MORPHOGENESIS; CYTOSKELETON; POLARITY; ELEGANS	Development in multicellular organisms requires the organized generation of differences. A universal mechanism for creating such differences is asymmetric cell division. In plants, as in animals, asymmetric divisions are correlated with the production of cellular diversity and pattern; however, structural constraints imposed by plant cell walls and the absence of homologs of known animal or fungal cell polarity regulators necessitates that plants utilize new molecules and mechanisms to create asymmetries. Here, we identify BASL, a novel regulator of asymmetric divisions in Arabidopsis. In asymmetrically dividing stomatal-lineage cells, BASL accumulates in a polarized crescent at the cell periphery before division, and then localizes differentially to the nucleus and a peripheral crescent in self-renewing cells and their sisters after division. BASL presence at the cell periphery is critical for its function, and we propose that BASL represents a plant-specific solution to the challenge of asymmetric cell division.	[Dong, Juan; MacAlister, Cora A.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dbergmann@stanford.edu		MacAlister, Cora/0000-0003-1470-0596; Bergmann, Dominique/0000-0003-0873-3543	national Science Foundation [IOS-0544895, IOS-0844521]; Stanford Genome Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	national Science Foundation(National Science Foundation (NSF)); Stanford Genome Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by national Science Foundation grants IOS-0544895 and IOS-0844521 and a Terman award ( to D. C. B.). C. A. M. was supported in part by the Stanford Genome Training Program ( National Human Genome Research Institute). We thank Marcus Heisler ( Caltech) for the gift of PIN1::PIN1-GFP, Jiri Friml (Ghent) for the gift of PIN2::PIN2-GFP, and Zhenbiao Yang (University of California, Riverside) for ROP reagents. We are indebted to Ryan Gutierrez, Sylvie Lalonde, David Ehrhardt, and other members of the Carnegie Institution Department of Plant Biology for expertise and for the use of microscopy facilities and to members of the lab for discussion and comments on the manuscript.	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dhonukshe P, 2005, PROTOPLASMA, V226, P67, DOI 10.1007/s00709-005-0104-8; Feraru E, 2008, PLANT PHYSIOL, V147, P1553, DOI 10.1104/pp.108.121756; Fleming AJ, 2006, J EXP BOT, V57, P25, DOI 10.1093/jxb/eri268; Fowler JE, 1997, ANNU REV CELL DEV BI, V13, P697, DOI 10.1146/annurev.cellbio.13.1.697; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Mizumoto K, 2007, DEV CELL, V12, P287, DOI 10.1016/j.devcel.2007.01.004; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2003, TRENDS PLANT SCI, V8, P294, DOI 10.1016/S1360-1385(03)00102-X; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; TEN H, 2008, CURR OPIN PLANT BIOL, V11, P34; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	47	194	209	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1320	1330		10.1016/j.cell.2009.04.018	http://dx.doi.org/10.1016/j.cell.2009.04.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19523675	Green Accepted, Bronze			2022-12-28	WOS:000267373400024
J	Jiang, HQ; Patel, PH; Kohlmaier, A; Grenley, MO; McEwen, DG; Edgar, BA				Jiang, Huaqi; Patel, Parthive H.; Kohlmaier, Alexander; Grenley, Marc O.; McEwen, Donald G.; Edgar, Bruce A.			Cytokine/Jak/Stat Signaling Mediates Regeneration and Homeostasis in the Drosophila Midgut	CELL			English	Article							INTESTINAL-STEM-CELLS; COLORECTAL-CANCER; JAK/STAT PATHWAY; HOST-DEFENSE; JNK ACTIVITY; IN-VIVO; ACTIVATION; GROWTH; PROLIFERATION; INFECTION	Cells in intestinal epithelia turn over rapidly due to damage from digestion and toxins produced by the enteric microbiota. Gut homeostasis is maintained by intestinal stem cells (ISCs) that divide to replenish the intestinal epithelium, but little is known about how ISC division and differentiation are coordinated with epithelial cell loss. We show here that when enterocytes (ECs) in the Drosophila midgut are subjected to apoptosis, enteric infection, or JNK-mediated stress signaling, they produce cytokines (Upd, Upd2, and Upd3) that activate Jak/Stat signaling in ISCs, promoting their rapid division. Upd/Jak/Stat activity also promotes progenitor cell differentiation, in part by stimulating Delta/Notch signaling, and is required for differentiation in both normal and regenerating midguts. Hence, cytokine-mediated feedback enables stem cells to replace spent progeny as they are lost, thereby establishing gut homeostasis.	[Jiang, Huaqi; Patel, Parthive H.; Kohlmaier, Alexander; Grenley, Marc O.; Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [McEwen, Donald G.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bedgar@fhcrc.org	Patel, Parthive H./ABC-8505-2021	Patel, Parthive/0000-0002-9288-8056	UW/FHCRC Cancer Consortium; National Institutes of Health [R01 GM51186]; American Cancer Society [PF-08-040-01-DDC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051186] Funding Source: NIH RePORTER	UW/FHCRC Cancer Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Schubiger, C. O'Cane, N. Reich, P. Hagan, D. Montell, G. Baeg, P. O'Farrell, M. Van Doren, E. Bach, K. Choi, S. Hou, H. Sun, K. Smith, VDRC, NIG, and the Bloomington DSC for reagents. We thank C. M. Ulrich for comments on the manuscript. This work was supported by the UW/FHCRC Cancer Consortium and National Institutes of Health grant R01 GM51186 to B. A. E. P. H. P. was an American Cancer Society Fellow (PF- 08-040-01-DDC). A. K. was a Human Frontiers in Science Program Fellow.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Becker C, 2005, CELL CYCLE, V4, P217; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1810, DOI 10.3748/wjg.14.1810; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gilbert MM, 2005, MECH DEVELOP, V122, P939, DOI 10.1016/j.mod.2005.03.004; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hakim RS, 2001, IN VITRO CELL DEV-AN, V37, P338; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kanda H, 2004, J BIOCHEM, V136, P1, DOI 10.1093/jb/mvh098; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Loeb MJ, 2001, IN VITRO CELL DEV-AN, V37, P348; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; MCGUIRE SE, 2004, SCI STKE, pPL6; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; MORGAN NS, 1994, J MOL BIOL, V239, P347, DOI 10.1006/jmbi.1994.1376; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Prieto Jesus, 2008, J Hepatol, V48, P380, DOI 10.1016/j.jhep.2007.11.007; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2	44	673	686	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1343	1355		10.1016/j.cell.2009.05.014	http://dx.doi.org/10.1016/j.cell.2009.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563763	Green Accepted, Bronze			2022-12-28	WOS:000267373400026
J	Pornillos, O; Ganser-Pornillos, BK; Kelly, BN; Hua, YZ; Whitby, FG; Stout, CD; Sundquist, WI; Hill, CP; Yeager, M				Pornillos, Owen; Ganser-Pornillos, Barbie K.; Kelly, Brian N.; Hua, Yuanzi; Whitby, Frank G.; Stout, C. David; Sundquist, Wesley I.; Hill, Christopher P.; Yeager, Mark			X-Ray Structures of the Hexameric Building Block of the HIV Capsid	CELL			English	Article							ROUS-SARCOMA-VIRUS; C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; ASSEMBLY PROPERTIES; PEPTIDE INHIBITOR; IN-VITRO; PROTEIN; CORE; HIV-1CA; COMPLEX	The mature capsids of HIV and other retroviruses organize and package the viral genome and its associated enzymes for delivery into host cells. The HIV capsid is a fullerene cone: a variably curved, closed shell composed of approximately 250 hexamers and exactly 12 pentamers of the viral CA protein. We devised methods for isolating soluble, assembly-competent CA hexamers and derived four crystallographically independent models that define the structure of this capsid assembly unit at atomic resolution. A ring of six CA N-terminal domains form an apparently rigid core, surrounded by an outer ring of C-terminal domains. Mobility of the outer ring appears to be an underlying mechanism for generating the variably curved lattice in authentic capsids. Hexamer-stabilizing interfaces are highly hydrated, and this property may be key to the formation of quasi-equivalent interactions within hexamers and pentamers. The structures also clarify the molecular basis for capsid assembly inhibition and should facilitate structure-based drug design strategies.	[Pornillos, Owen; Ganser-Pornillos, Barbie K.; Hua, Yuanzi; Yeager, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kelly, Brian N.; Whitby, Frank G.; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Dept Biochem, Sch Med, Salt Lake City, UT 84112 USA; [Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Yeager, Mark] Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA; [Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Univ Virginia Hlth Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Scripps Research Institute; Utah System of Higher Education; University of Utah; Scripps Research Institute; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	yeager@scripps.edu			NIH [R01-GM066087, P50-GM082545]; George E. Hewitt Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066087, P50GM082545] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George E. Hewitt Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH grants R01-GM066087 (M.Y.) and P50-GM082545 (M.Y., C.P.H., and W.I.S.). B.G.-P. was supported by a postdoctoral fellowship from the George E. Hewitt Foundation for Medical Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Mortuza GB, 2009, J MOL BIOL, V386, P1179, DOI 10.1016/j.jmb.2008.10.066; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051	49	391	408	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1282	1292		10.1016/j.cell.2009.04.063	http://dx.doi.org/10.1016/j.cell.2009.04.063			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19523676	Green Accepted, Bronze			2022-12-28	WOS:000267373400021
J	Hope, WW				Hope, William W.			Rational Testing Assessing candiduria in a critically ill patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE-UNIT PATIENTS; CANDIDIASIS; CANDIDEMIA; INFECTION; DIAGNOSIS; URINE		Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England	University of Manchester	Hope, WW (corresponding author), Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England.	william.hope@manchester.ac.uk		Hope, William/0000-0001-6187-878X				Alvarez-Lerma F, 2003, INTENS CARE MED, V29, P1069, DOI 10.1007/s00134-003-1807-y; BERENGUER J, 1993, DIAGN MICR INFEC DIS, V17, P103, DOI 10.1016/0732-8893(93)90020-8; Bougnoux ME, 2008, INTENS CARE MED, V34, P292, DOI 10.1007/s00134-007-0865-y; Chen SCA, 2008, EUR J CLIN MICROBIOL, V27, P201, DOI 10.1007/s10096-007-0427-9; Digby J, 2003, CLIN DIAGN LAB IMMUN, V10, P882, DOI 10.1128/CDLI.10.5.882-885.2003; Febre N, 1999, J CLIN MICROBIOL, V37, P1584; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Kauffman CA, 2005, CLIN INFECT DIS, V41, pS371, DOI 10.1086/430918; Lundstrom T, 2001, CLIN INFECT DIS, V32, P1602, DOI 10.1086/320531; NAVARRO EE, 1994, J MED VET MYCOL, V32, P415; Passos XS, 2005, MEM I OSWALDO CRUZ, V100, P925, DOI 10.1590/S0074-02762005000800016; Sendid B, 1999, J CLIN MICROBIOL, V37, P1510, DOI 10.1128/JCM.37.5.1510-1517.1999; Sobel JD, 2000, CLIN INFECT DIS, V30, P19, DOI 10.1086/313580	13	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 19	2009	338								b2289	10.1136/bmj.b2289	http://dx.doi.org/10.1136/bmj.b2289			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UT	19542107				2022-12-28	WOS:000267216900003
J	Laybourn-Parry, J				Laybourn-Parry, Johanna			No Place Too Cold	SCIENCE			English	Editorial Material									Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas 7001, Australia	University of Tasmania	Laybourn-Parry, J (corresponding author), Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas 7001, Australia.	Jo.Laybourn-Parry@utas.edu.au						Foreman CM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000358; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Laybourn-Parry J, 2005, FRESHWATER BIOL, V50, P830, DOI 10.1111/j.1365-2427.2005.01369.x; Mikucki JA, 2009, SCIENCE, V324, P397, DOI 10.1126/science.1167350; PEARCE DA, 2008, POLAR LAKES RIVERS, P231; Priscu J. C, 2008, POLAR LAKES RIVERS, P119, DOI DOI 10.1093/ACPROF:OSO/9780199213887.003.0007; Sawstrom C, 2008, EXTREMOPHILES, V12, P167, DOI 10.1007/s00792-007-0134-6; Skidmore ML, 2000, APPL ENVIRON MICROB, V66, P3214, DOI 10.1128/AEM.66.8.3214-3220.2000; Stackebrandt E, 2004, CELL MOL BIOL, V50, P517; Stibal M, 2008, BIOGEOCHEMISTRY, V90, P1, DOI 10.1007/s10533-008-9226-3; TRANVIK LJ, 1989, OECOLOGIA, V78, P473, DOI 10.1007/BF00378736	11	34	34	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1521	1522		10.1126/science.1173645	http://dx.doi.org/10.1126/science.1173645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541982				2022-12-28	WOS:000267130600027
J	Celniker, SE; Dillon, LAL; Gerstein, MB; Gunsalus, KC; Henikoff, S; Karpen, GH; Kellis, M; Lai, EC; Lieb, JD; MacAlpine, DM; Micklem, G; Piano, F; Snyder, M; Stein, L; White, KP; Waterston, RH				Celniker, Susan E.; Dillon, Laura A. L.; Gerstein, Mark B.; Gunsalus, Kristin C.; Henikoff, Steven; Karpen, Gary H.; Kellis, Manolis; Lai, Eric C.; Lieb, Jason D.; MacAlpine, David M.; Micklem, Gos; Piano, Fabio; Snyder, Michael; Stein, Lincoln; White, Kevin P.; Waterston, Robert H.		modENCODE Consortium	Unlocking the secrets of the genome	NATURE			English	Article							GENE-EXPRESSION MAP; FUNCTIONAL ELEMENTS; DROSOPHILA; DISCOVERY; IDENTIFICATION; TRANSCRIPTION; EVOLUTION; PROFILES; NETWORKS		[Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Biol, Berkeley, CA 94720 USA; [Dillon, Laura A. L.] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gunsalus, Kristin C.; Piano, Fabio] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Dept Genome & Computat Biol, Berkeley, CA 94720 USA; [Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02140 USA; [Kellis, Manolis] Harvard Univ, Cambridge, MA 02140 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [MacAlpine, David M.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Micklem, Gos] Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06824 USA; [Stein, Lincoln] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11542 USA; [White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [White, Kevin P.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Waterston, Robert H.] Dept Genome Sci, Seattle, WA 98195 USA; [Waterston, Robert H.] Univ Washington, Sch Med, Seattle, WA 98195 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yale University; Yale University; Yale University; New York University; Fred Hutchinson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Cambridge; University of Cambridge; Yale University; Cold Spring Harbor Laboratory; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Washington; University of Washington Seattle	Celniker, SE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Biol, Berkeley, CA 94720 USA.	celniker@fruitfly.org	Lai, Eric C/A-3412-2008; Brenner, Steven E/A-8729-2008; Lai, Eric/AAO-1143-2021; Kellis, Manolis/ABE-7385-2020	Brenner, Steven E/0000-0001-7559-6185; Lai, Eric/0000-0002-8432-5851; Kellis, Manolis/0000-0001-7113-9630; Gingeras, Thomas/0000-0001-9106-3573; Snyder, Michael/0000-0003-0784-7987; Russell, Steven/0000-0003-0546-3031; Brown, Christopher/0000-0002-3785-5008; Henikoff, Steven/0000-0002-7621-8685; Edsall, Lee Elizabeth/0000-0002-0326-2829; Perrimon, Norbert/0000-0001-7542-472X; manoharan, arun prasad/0000-0002-7030-7353; Micklem, Gos/0000-0002-6883-6168; Riddle, Nicole/0000-0003-1827-9145; Lieb, Jason/0000-0001-7601-8061	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U01HG004258, U01HG004279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG004258, U01 HG004258-03, R01 HG004037-02, R01 HG004037, U01 HG004279] Funding Source: Medline; NIGMS NIH HHS [R01 GM066272] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nichols CD, 2006, PHARMACOL THERAPEUT, V112, P677, DOI 10.1016/j.pharmthera.2006.05.012; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102	35	597	604	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					927	930		10.1038/459927a	http://dx.doi.org/10.1038/459927a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536255	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000267063500031
J	Harris, J				Harris, John			Is it acceptable for people to take methylphenidate to enhance performance? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRAIN		Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England	University of Manchester	Harris, J (corresponding author), Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England.	john.harris@manchester.ac.uk						Almeida SS, 2002, NUTR NEUROSCI, V5, P311, DOI 10.1080/1028415021000033776; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Greely H., 2008, NATURE, V456, P18, DOI DOI 10.1196/ANNALS.1382.021; Harris J., 2007, ENHANCING EVOLUTION; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645	8	15	15	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2009	338								b1955	10.1136/bmj.b1955	http://dx.doi.org/10.1136/bmj.b1955			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460US	19541705				2022-12-28	WOS:000267216800001
J	Neumann, G; Noda, T; Kawaoka, Y				Neumann, Gabriele; Noda, Takeshi; Kawaoka, Yoshihiro			Emergence and pandemic potential of swine-origin H1N1 influenza virus	NATURE			English	Review							LOWER RESPIRATORY-TRACT; A H5N1 VIRUS; MEDIATED ANTIVIRAL RESPONSES; POLYMERASE SUBUNIT PB2; SINGLE-AMINO-ACID; MOLECULAR-BASIS; HOST-RANGE; IMMUNOCOMPROMISED CHILD; RECEPTOR SPECIFICITY; BACTERIAL PNEUMONIA	Influenza viruses cause annual epidemics and occasional pandemics that have claimed the lives of millions. The emergence of new strains will continue to pose challenges to public health and the scientific communities. A prime example is the recent emergence of swine-origin H1N1 viruses that have transmitted to and spread among humans, resulting in outbreaks internationally. Efforts to control these outbreaks and real-time monitoring of the evolution of this virus should provide us with invaluable information to direct infectious disease control programmes and to improve understanding of the factors that determine viral pathogenicity and/or transmissibility.	[Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu			National Institute of Allergy and Infectious Diseases Public Health Service; National Institute of Allergy and Infectious Diseases [HHSN266200700010C]; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health; Japan Science and Technology Agency	National Institute of Allergy and Infectious Diseases Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We apologize to our colleagues whose critical contributions to influenza virus research could not be cited owing to the number of references permitted. We thank K. Wells for editing the manuscript. We also thank M. Ozawa and others in our laboratories who contributed to the data cited in this review. Our original research was supported by National Institute of Allergy and Infectious Diseases Public Health Service research grants; by the Center for Research on Influenza Pathogenesis (CRIP) funded by the National Institute of Allergy and Infectious Diseases (Contract HHSN266200700010C), Grant-in-Aid for Specially Promoted Research, by a contract research fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, by grants-in-aid from the Ministry of Health and by ERATO (Japan Science and Technology Agency). G. N. is named as co-inventor on several patents about influenza virus reverse genetics and/or the development of influenza virus vaccines or antivirals. Y. K. is named as inventor/co-inventor on several patents about influenza virus reverse genetics and/or the development of influenza virus vaccines or antivirals. Figures 1 and 2 were modified from Orthomyxoviruses: influenza, in Topley and Wilson's Microbiology and Microbial Infections: Virology (Hodder Arnold, 2005); Fig. 3 was modified from Orthomyxoviruses, in Fields Virology (Lippincott Williams & Wilkins, 2007).	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	100	1135	1235	7	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					931	939		10.1038/nature08157	http://dx.doi.org/10.1038/nature08157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19525932	Green Accepted, Bronze			2022-12-28	WOS:000267063500032
J	Cheung, A				Cheung, Amy			Review: SSRIs are associated with increased risk for attempted or completed suicide in adolescents but not in adults or the elderly	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTIDEPRESSANTS		Univ Toronto, Toronto, ON, Canada	University of Toronto	Cheung, A (corresponding author), Univ Toronto, Toronto, ON, Canada.							Bridge JA, 2009, AM J PSYCHIAT, V166, P42, DOI 10.1176/appi.ajp.2008.08020247; Cheung AH, 2005, J CHILD PSYCHOL PSYC, V46, P735, DOI 10.1111/j.1469-7610.2005.01467.x; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-13	10.7326/0003-4819-150-12-200906160-02013	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460CX	19528558				2022-12-28	WOS:000267164800025
J	Doyle, LW				Doyle, Lex W.			Antenatal progesterone to prevent preterm birth	LANCET			English	Editorial Material							17-ALPHA-HYDROXYPROGESTERONE CAPROATE; MAGNESIUM-SULFATE		Royal Hosp Women, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia		Doyle, LW (corresponding author), Royal Hosp Women, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	lwd@unimelb.edu.au	Doyle, Lex/AAJ-5205-2021	Doyle, Lex/0000-0002-7667-7312				Crowther CA, 2003, JAMA-J AM MED ASSOC, V290, P2669, DOI 10.1001/jama.290.20.2669; Crowther CA, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001060; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3; Doyle LW, 2009, OBSTET GYNECOL, V113, P1327, DOI 10.1097/AOG.0b013e3181a60495; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Northen AT, 2007, OBSTET GYNECOL, V110, P865, DOI 10.1097/01.AOG.0000281348.51499.bc; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; WHO, INT CLIN TRIALS REG	12	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2000	2002		10.1016/S0140-6736(09)61077-1	http://dx.doi.org/10.1016/S0140-6736(09)61077-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19523682				2022-12-28	WOS:000267080100005
J	Lees, AJ; Hardy, J; Revesz, T				Lees, Andrew J.; Hardy, John; Revesz, Tamas			Parkinson's disease	LANCET			English	Review							ALPHA-SYNUCLEIN PATHOLOGY; DEEP-BRAIN-STIMULATION; LEWY BODY DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; MITOCHONDRIAL DYSFUNCTION; SUBCUTANEOUS APOMORPHINE; PYRAMIDAL DEGENERATION; VASCULAR PARKINSONISM; VISUAL HALLUCINATIONS; NEUROTROPHIC FACTOR	Parkinson's disease is a common progressive bradykinetic disorder that can be accurately diagnosed. It is characterised by the presence of severe pars-compacta nigral-cell loss, and accumulation of aggregated alpha-synuclein in specific brain stem, spinal cord, and cortical regions. The main known risk factor is age. Susceptibility genes including a-synuclein, leucine rich repeat kinase 2 (LRRK-2), and glucocerebrosidase (GBA) have shown that genetic predisposition is another important causal factor. Dopamine replacement therapy considerably reduces motor handicap, and effective treatment of associated depression, pain, constipation, and nocturnal difficulties can improve quality of life. Embryonic stem cells and gene therapy are promising research therapeutic approaches.	[Lees, Andrew J.] UCL, Dept Mol Neurosci, London WC1N 3BG, England; UCL, Reta Lila Weston Inst Neurol Studies, Inst Neurol, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Lees, AJ (corresponding author), UCL, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	alees@ion.ucl.ac.uk	Lees, Andrew J/A-6605-2009; Revesz, Tamas/A-8732-2010; Hardy, John/C-2451-2009	Lees, Andrew J/0000-0002-2476-4385; Revesz, Tamas/0000-0003-2501-0259; Hardy, John/0000-0002-3122-0423	MRC [G0701075] Funding Source: UKRI; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; Medical Research Council [G0701075] Funding Source: Medline; Parkinson&apos;s UK [G-0907] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&quot;s UK(Parkinson&apos;s UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK)		Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029; Apaydin H, 2002, ARCH NEUROL-CHICAGO, V59, P102, DOI 10.1001/archneur.59.1.102; Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312; Ascherio A, 2003, NEUROLOGY, V60, P790, DOI 10.1212/01.WNL.0000046523.05125.87; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Burn D, 2006, MOVEMENT DISORD, V21, P1899, DOI 10.1002/mds.21077; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clarke CE, 2008, MOVEMENT DISORD, V23, P784, DOI 10.1002/mds.21918; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Cortes X, 1998, MED CLIN-BARCELONA, V111, P573; Cosentino C, 2000, NEUROLOGY, V55, P598, DOI 10.1212/WNL.55.4.598; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; de la Fuente-Fernandez- R, 2002, TRENDS NEUROSCI, V25, P302, DOI 10.1016/S0166-2236(02)02181-1; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; DelleDonne A, 2008, ARCH NEUROL-CHICAGO, V65, P1074, DOI 10.1001/archneur.65.8.1074; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Dickson DW, 2008, ACTA NEUROPATHOL, V115, P437, DOI 10.1007/s00401-008-0345-7; DOTY RL, 1995, NEURODEGENERATION, V4, P93, DOI 10.1006/neur.1995.0011; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Eggert K, 2008, CLIN NEUROPHARMACOL, V31, P151, DOI [10.1097/WNF.0b013e31814b113e, 10.1097/wnf.0b013e31814b113e]; Elbaz A, 2008, CURR OPIN NEUROL, V21, P454, DOI 10.1097/WCO.0b013e3283050461; Elbaz A, 2007, J NEUROL SCI, V262, P37, DOI 10.1016/j.jns.2007.06.024; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Evans AH, 2006, J NEUROL NEUROSUR PS, V77, P317, DOI 10.1136/jnnp.2005.065417; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fowler JS, 1996, P NATL ACAD SCI USA, V93, P14065, DOI 10.1073/pnas.93.24.14065; FRANKEL JP, 1990, J NEUROL NEUROSUR PS, V53, P96, DOI 10.1136/jnnp.53.2.96; FRANKEL JP, 1989, J NEUROL NEUROSUR PS, V52, P1063, DOI 10.1136/jnnp.52.9.1063; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Goya RL, 2008, J NEUROL SCI, V265, P32, DOI 10.1016/j.jns.2007.09.006; Greffard S, 2010, NEUROBIOL AGING, V31, P99, DOI 10.1016/j.neurobiolaging.2008.03.015; Grosset DG, 2005, J NEUROL NEUROSUR PS, V76, P9, DOI 10.1136/jnnp.2004.053116; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Hawkes C, 2004, LANCET NEUROL, V3, P393, DOI 10.1016/S1474-4422(04)00801-4; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hernan MA, 2001, ANN NEUROL, V50, P780, DOI 10.1002/ana.10028; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; INCE P, 2008, NEUROPATHOLOGY, P889; Iranzo A, 2005, NEUROLOGY, V65, P247, DOI 10.1212/01.wnl.0000168864.97813.e0; Jankovic J, 2008, ANN NEUROL, V63, P267, DOI 10.1002/ana.21348; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Kalaitzakis ME, 2008, ACTA NEUROPATHOL, V116, P125, DOI 10.1007/s00401-008-0381-3; Kalaitzakis ME, 2008, J NEUROPATH EXP NEUR, V67, P155, DOI 10.1097/NEN.0b013e31816362aa; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Katzenschlager R, 2008, NEUROLOGY, V71, P474, DOI 10.1212/01.wnl.0000310812.43352.66; Katzenschlager R, 2005, MOVEMENT DISORD, V20, P151, DOI 10.1002/mds.20276; Katzenschlager R, 2003, MOVEMENT DISORD, V18, P1123, DOI 10.1002/mds.10523; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kempster PA, 2007, BRAIN, V130, P2123, DOI 10.1093/brain/awm142; Kempster PA, 2007, NEUROLOGY, V69, P482, DOI 10.1212/01.wnl.0000266639.50620.d1; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lashley T, 2008, ACTA NEUROPATHOL, V115, P417, DOI 10.1007/s00401-007-0336-0; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Lozano AM, 2008, J NEUROL, V255, P30, DOI 10.1007/s00415-008-4005-6; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; Meseguer E, 2002, MOVEMENT DISORD, V17, P195, DOI 10.1002/mds.1268; Miyasaki JM, 2006, NAT CLIN PRACT NEURO, V2, P638, DOI 10.1038/ncpneuro0348; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Parkinson J, 1817, ESSAY SHAKING PALSY; Parkkinen L, 2005, NEUROPATHOLOGY, V25, P304, DOI 10.1111/j.1440-1789.2005.00644.x; Parkkinen L, 2005, ANN NEUROL, V57, P82, DOI 10.1002/ana.20321; Parkkinen L, 2008, ACTA NEUROPATHOL, V115, P399, DOI 10.1007/s00401-008-0346-6; Paul G, 2006, ADV EXP MED BIOL, V557, P221; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; POEWE WH, 1988, ANN NEUROL, V23, P73, DOI 10.1002/ana.410230112; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; Quik M, 2000, EUR J PHARMACOL, V393, P223, DOI 10.1016/S0014-2999(99)00888-2; Quinn NP, 2005, MOVEMENT DISORD, V20, pS5, DOI 10.1002/mds.20534; Rascol O, 2002, LANCET, V359, P1589, DOI 10.1016/S0140-6736(02)08520-3; SCHAPIRA AHV, 1994, MOVEMENT DISORD, V9, P125, DOI 10.1002/mds.870090202; Scherfler C, 2006, BRAIN, V129, P538, DOI 10.1093/brain/awh674; Scherfler C, 2007, MOVEMENT DISORD, V22, P1229, DOI 10.1002/mds.21505; Schneider SA, 2007, MOVEMENT DISORD, V22, P2210, DOI 10.1002/mds.21685; SEIBYL J, 2004, J NEUROL S7, V251, pV119; Shoulson I, 1998, ANN NEUROL, V44, pS160, DOI 10.1002/ana.410440724; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sourkes TL, 1999, CAN J PHYSIOL PHARM, V77, P375, DOI 10.1139/cjpp-77-6-375; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; STERN G, 1989, J NEUROL NEUROSUR PS, P11; Tanner Caroline M., 2000, Current Opinion in Neurology, V13, P427, DOI 10.1097/00019052-200008000-00010; Tanner CM, 2003, ADV NEUROL, V91, P133; Tanner CM, 2002, NEUROLOGY, V58, P581, DOI 10.1212/WNL.58.4.581; Taylor KSM, 2005, AGE AGEING, V34, P501, DOI 10.1093/ageing/afi123; Thacker EL, 2008, MOVEMENT DISORD, V23, P69, DOI 10.1002/mds.21772; Theuns J, 2008, NEUROLOGY, V70, P7, DOI 10.1212/01.wnl.0000295508.10258.6b; Tsuboi Y, 2005, PARKINSONISM RELAT D, V11, pS47, DOI 10.1016/j.parkreldis.2004.10.014; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; van de Warrenburg BPC, 2001, NEUROLOGY, V56, P555, DOI 10.1212/WNL.56.4.555; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488; Williams DR, 2005, LANCET NEUROL, V4, P605, DOI 10.1016/S1474-4422(05)70146-0; WILSON S, 1947, NEUROLOGY, P787; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Zijlmans J, 2007, MOVEMENT DISORD, V22, P1278, DOI 10.1002/mds.21479; Zijlmans JCM, 2004, MOVEMENT DISORD, V19, P630, DOI 10.1002/mds.20083	132	1485	1553	13	606	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2055	2066		10.1016/S0140-6736(09)60492-X	http://dx.doi.org/10.1016/S0140-6736(09)60492-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19524782				2022-12-28	WOS:000267080100033
J	Gehring, M; Bubb, KL; Henikoff, S				Gehring, Mary; Bubb, Kerry L.; Henikoff, Steven			Extensive Demethylation of Repetitive Elements During Seed Development Underlies Gene Imprinting	SCIENCE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; ARABIDOPSIS ENDOSPERM; GENOME; THALIANA	DNA methylation is an epigenetic mark associated with transposable element silencing and gene imprinting in flowering plants and mammals. In plants, imprinting occurs in the endosperm, which nourishes the embryo during seed development. We have profiled Arabidopsis DNA methylation genome-wide in the embryo and endosperm and found that large-scale methylation changes accompany endosperm development and endosperm-specific gene expression. Transposable element fragments are extensively demethylated in the endosperm. We discovered new imprinted genes by the identification of candidates associated with regions of reduced endosperm methylation and preferential expression in endosperm relative to other parts of the plant. These data suggest that imprinting in plants evolved from targeted methylation of transposable element insertions near genic regulatory elements followed by positive selection when the resulting expression change was advantageous.	[Gehring, Mary; Bubb, Kerry L.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685	HHMI Fellow of the Life Sciences Research Foundation	HHMI Fellow of the Life Sciences Research Foundation(Howard Hughes Medical Institute)	We thank the FHCRC Genomics Shared Resources for performing microarray hybridizations and Illumina sequencing, J. Henikoff for assistance with computational analyses, R. Deal and J. Cooper for comments on the manuscript, and D. Zilberman and R. Fischer for sharing unpublished data. M.G. is a HHMI Fellow of the Life Sciences Research Foundation. Illumina and NimbleGen data are deposited in the Genome Expression Omnibus (GEO) (accession number GSE14570 [NCBI GEO] ).	BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	18	412	441	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1447	1451		10.1126/science.1171609	http://dx.doi.org/10.1126/science.1171609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520961	Green Submitted, Green Accepted			2022-12-28	WOS:000266878700047
J	Kota, J; Chivukula, RR; O'Donnell, KA; Wentzel, EA; Montgomery, CL; Hwang, HW; Chang, TC; Vivekanandan, P; Torbenson, M; Clark, KR; Mendell, JR; Mendell, JT				Kota, Janaiah; Chivukula, Raghu R.; O'Donnell, Kathryn A.; Wentzel, Erik A.; Montgomery, Chrystal L.; Hwang, Hun-Way; Chang, Tsung-Cheng; Vivekanandan, Perumal; Torbenson, Michael; Clark, K. Reed; Mendell, Jerry R.; Mendell, Joshua T.			Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model	CELL			English	Article							ADENOASSOCIATED VIRUS VECTORS; IN-VIVO; HEPATOCELLULAR-CARCINOMA; GENE-THERAPY; AAV VECTORS; EXPRESSION; P53; MYC; TRANSDUCTION; APOPTOSIS	Therapeutic strategies based on modulation of microRNA (miRNA) activity hold great promise due to the ability of these small RNAs to potently influence cellular behavior. In this study, we investigated the efficacy of a miRNA replacement therapy for liver cancer. We demonstrate that hepatocellular carcinoma (HCC) cells exhibit reduced expression of miR-26a, a miRNA that is normally expressed at high levels in diverse tissues. Expression of this miRNA in liver cancer cells in vitro induces cell-cycle arrest associated with direct targeting of cyclins D2 and E2. Systemic administration of this miRNA in a mouse model of HCC using adeno-associated virus (AAV) results in inhibition of cancer cell proliferation, induction of tumor-specific apoptosis, and dramatic protection from disease progression without toxicity. These findings suggest that delivery of miRNAs that are highly expressed and therefore tolerated in normal tissues but lost in disease cells may provide a general strategy for miRNA replacement therapies.	[Kota, Janaiah; Montgomery, Chrystal L.; Clark, K. Reed; Mendell, Jerry R.] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH 43205 USA; [Chivukula, Raghu R.; Wentzel, Erik A.; Hwang, Hun-Way; Chang, Tsung-Cheng; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [O'Donnell, Kathryn A.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [O'Donnell, Kathryn A.; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Vivekanandan, Perumal; Torbenson, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Clark, K. Reed; Mendell, Jerry R.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Mendell, Jerry R.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mendell, JR (corresponding author), Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH 43205 USA.	jerry.mendell@nationwidechildrens.org; jmendell@jhmi.edu	Chang, Tsung-Cheng/C-2761-2008; Clark, Kelly/E-2900-2011	Chang, Tsung-Cheng/0000-0003-4706-0468; Hwang, Hun-Way/0000-0003-0522-1577	US National Institutes of Health [R01CA120185]; Sol Goldman Center for Pancreatic Cancer Research; Research Institute at Nationwide Children's Hospital; Damon Runyon Cancer Research Foundation [DRG-1918-06]; Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [R01CA120185] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sol Goldman Center for Pancreatic Cancer Research; Research Institute at Nationwide Children's Hospital(Ohio State University); Damon Runyon Cancer Research Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Michael Bishop for tet-o-MYC mice, Terri Shaffer and Lucia Rosas for help with virus administration, and the staff at Nationwide Children's Hospital Viral Vector Core facility. This work was supported by US National Institutes of Health grant R01CA120185 (to J.T.M.),the Sol Goldman Center for Pancreatic Cancer Research ( J.T.M.), and the Research Institute at Nationwide Children's Hospital (J.R.M.). J.T.M. is a Rita Allen Foundation Scholar and a Leukemia and Lymphoma Society Scholar. K.A.O. is a fellow of the Damon Runyon Cancer Research Foundation (DRG-1918-06). R. R. C. is supported by the Medical Scientist Training Program.	Alexander IE, 2008, GENE THER, V15, P831, DOI 10.1038/gt.2008.64; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carter BJ, 2005, HUM GENE THER, V16, P541, DOI 10.1089/hum.2005.16.541; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm Dirk, 2007, Hematology Am Soc Hematol Educ Program, P473; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Love TM, 2008, J ALLERGY CLIN IMMUN, V121, P309, DOI 10.1016/j.jaci.2007.12.1167; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2007, CELL CYCLE, V6, P1455; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Park K, 2008, FRONT BIOSCI-LANDMRK, V13, P2653, DOI 10.2741/2872; Pathak A, 2008, INT J NANOMED, V3, P31; Peng DC, 2000, J HEPATOL, V32, P975, DOI 10.1016/S0168-8278(00)80102-6; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roberts LR, 2008, NEW ENGL J MED, V359, P420, DOI 10.1056/NEJMe0802241; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shen Z, 2008, CANCER LETT, V272, P268, DOI 10.1016/j.canlet.2008.03.064; Stenvang J, 2008, SEMIN CANCER BIOL, V18, P89, DOI 10.1016/j.semcancer.2008.01.004; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	65	1376	1513	5	307	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1005	1017		10.1016/j.cell.2009.04.021	http://dx.doi.org/10.1016/j.cell.2009.04.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524505	Green Accepted, Bronze			2022-12-28	WOS:000266916400014
J	Olson, P; Hanahan, D				Olson, Peter; Hanahan, Douglas			Breaching the Cancer Fortress	SCIENCE			English	Editorial Material							PANCREATIC-CANCER; COMBINATION THERAPY; STEM-CELLS; FIBROBLASTS; PARADIGM		[Olson, Peter] Univ Calif San Francisco, Ctr Comprehens Canc, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Olson, P (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Ctr Diabet, San Francisco, CA 94143 USA.	polson@diabetes.ucsf.edu; dh@ucsf.edu						Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	16	52	52	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1400	1401		10.1126/science.1175940	http://dx.doi.org/10.1126/science.1175940			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520948				2022-12-28	WOS:000266878700031
J	Rossi, JJ				Rossi, John J.			New Hope for a MicroRNA Therapy for Liver Cancer	CELL			English	Editorial Material								The loss of expression of particular microRNAs can contribute to tumorigenesis. Kota et al. (2009) now explore in a mouse model a promising new approach for the treatment of liver cancer-re-establishing the expression of an miRNA using a viral vector.	City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Rossi, JJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA.	jrossi@coh.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029329] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228	6	98	101	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6					990	992		10.1016/j.cell.2009.05.038	http://dx.doi.org/10.1016/j.cell.2009.05.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524500	Bronze			2022-12-28	WOS:000266916400009
J	Skaar, JR; Pagan, JK; Pagano, M				Skaar, Jeffrey R.; Pagan, Julia K.; Pagano, Michele			SnapShot: F Box Proteins I	CELL			English	Editorial Material							SCF UBIQUITIN-LIGASE; COMPLEX; PROTEOLYSIS; INSIGHTS; SKP1		[Skaar, Jeffrey R.; Pagan, Julia K.; Pagano, Michele] NYU, Sch Med, New York, NY 10016 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute	Skaar, JR (corresponding author), NYU, Sch Med, New York, NY 10016 USA.		Pagan, Julia/O-1929-2016	Pagan, Julia/0000-0002-7079-6388; pagano, michele/0000-0003-3210-2442	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA076584] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1	10	69	71	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6								10.1016/j.cell.2009.05.039	http://dx.doi.org/10.1016/j.cell.2009.05.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524517	Bronze			2022-12-28	WOS:000266916400026
J	John, JL				John, Jeremy Leighton			The future of saving our past	NATURE			English	Editorial Material									[John, Jeremy Leighton] British Lib, London W1V 4BH, England		John, JL (corresponding author), British Lib, London W1V 4BH, England.	jeremy.john@bl.uk						GANTZ JF, 2007, EXPANDING DIGITAL UN; Garfinkel SL, 2009, INT J DIGIT CRIME FO, V1, P1, DOI 10.4018/jdcf.2009010101; JOHN JL, 2008, ADAPTING EXISTING TE; Williams P., 2008, DIGITAL LIVES REPORT	4	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 11	2009	459	7248					775	776		10.1038/459775a	http://dx.doi.org/10.1038/459775a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	459EV	19516320	Bronze			2022-12-28	WOS:000267084500017
J	Tubbs, JL; Latypov, V; Kanugula, S; Butt, A; Melikishvili, M; Kraehenbuehl, R; Fleck, O; Marriott, A; Watson, AJ; Verbeek, B; McGown, G; Thorncroft, M; Santibanez-Koref, MF; Millington, C; Arvai, AS; Kroeger, MD; Peterson, LA; Williams, DM; Fried, MG; Margison, GP; Pegg, AE; Tainer, JA				Tubbs, Julie L.; Latypov, Vitaly; Kanugula, Sreenivas; Butt, Amna; Melikishvili, Manana; Kraehenbuehl, Rolf; Fleck, Oliver; Marriott, Andrew; Watson, Amanda J.; Verbeek, Barbara; McGown, Gail; Thorncroft, Mary; Santibanez-Koref, Mauro F.; Millington, Christopher; Arvai, Andrew S.; Kroeger, Matthew D.; Peterson, Lisa A.; Williams, David M.; Fried, Michael G.; Margison, Geoffrey P.; Pegg, Anthony E.; Tainer, John A.			Flipping of alkylated DNA damage bridges base and nucleotide excision repair	NATURE			English	Article							O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ESCHERICHIA-COLI; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; STRUCTURAL BASIS; ENDONUCLEASE-V; PROTEIN; RECOGNITION; BINDING; GENOME; SUBSTRATE	Alkyltransferase-like proteins (ATLs) share functional motifs with the cancer chemotherapy target O-6-alkylguanine-DNA alkyltransferase (AGT) and paradoxically protect cells from the biological effects of DNA alkylation damage, despite lacking the reactive cysteine and alkyltransferase activity of AGT. Here we determine Schizosaccharomyces pombe ATL structures without and with damaged DNA containing the endogenous lesion O-6-methylguanine or cigarette-smoke-derived O-6-4-(3-pyridyl)-4-oxobutylguanine. These results reveal non-enzymatic DNA nucleotide flipping plus increased DNA distortion and binding pocket size compared to AGT. Our analysis of lesion-binding site conservation identifies new ATLs in sea anemone and ancestral archaea, indicating that ATL interactions are ancestral to present-day repair pathways in all domains of life. Genetic connections to mammalian XPG (also known as ERCC5) and ERCC1 in S. pombe homologues Rad13 and Swi10 and biochemical interactions with Escherichia coli UvrA and UvrC combined with structural results reveal that ATLs sculpt alkylated DNA to create a genetic and structural intersection of base damage processing with nucleotide excision repair.	[Tubbs, Julie L.; Arvai, Andrew S.; Kroeger, Matthew D.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tubbs, Julie L.; Arvai, Andrew S.; Kroeger, Matthew D.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Latypov, Vitaly; Butt, Amna; Marriott, Andrew; Watson, Amanda J.; Verbeek, Barbara; McGown, Gail; Thorncroft, Mary; Margison, Geoffrey P.] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Carcinogenesis Grp, Manchester M20 4BX, Lancs, England; [Kanugula, Sreenivas; Pegg, Anthony E.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Melikishvili, Manana; Fried, Michael G.] Univ Kentucky, Dept Mol & Cellular Biochem, Struct Biol Ctr, Lexington, KY 40536 USA; [Kraehenbuehl, Rolf; Fleck, Oliver] Bangor Univ, NWCRF Inst, Bangor LL57 2UW, Gwynedd, Wales; [Santibanez-Koref, Mauro F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Millington, Christopher; Williams, David M.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; [Peterson, Lisa A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Peterson, Lisa A.] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; Paterson Institute for Cancer Research; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kentucky; Bangor University; Newcastle University - UK; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tainer, JA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	aep1@psu.edu; jat@scripps.edu	Tainer, John/GWQ-4878-2022; Margison, Geoff/E-4146-2019; Williams, David M/J-9627-2013	Tainer, John/0000-0003-1659-2429; Kraehenbuehl, Rolf/0000-0003-2578-5601; Peterson, Lisa/0000-0001-8715-4480; Fleck, Oliver/0000-0003-0550-6513; Williams, David/0000-0002-5618-182X	US Department of Energy; NIH [CA097209, CA018137, GM070662, CA59887]; Skaggs Institute for Chemical Biology; North West Cancer Research Fund [CR675]; Cancer Research-UK; CHEMORES; NATIONAL CANCER INSTITUTE [R37CA018137, R01CA059887, R01CA097209, R01CA018137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070662] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; North West Cancer Research Fund; Cancer Research-UK(Cancer Research UK); CHEMORES; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. C. Vu and J. Gong for aiding in the synthesis of O<SUP>6</SUP>-pobG oligomers, M. N. Boddy, J. Prudden and A. Sarker for performing genetics and biochemical experiments, G. Guenther, S. Pebernard, R. S. Williams, J. J. Perry, B. R. Chapados, M. Bjora s, D. S. Shin, K. Hitomi, C. Hitomi, E. D. Getzoff, G. Williams, S. Tsutakawa and P. K. Cooper for suggestions, and the staff at the Advanced Light Source (ALS) SIBYLS beamline and the Stanford Synchrotron Radiation Laboratory (SSRL). Operations at SSRL and ALS are supported by the US Department of Energy and NIH. This work was supported by National Institutes of Health grants CA097209 (J. A. T., A. E. P.), CA018137 (A. E. P.), GM070662 (M. G. F.), and CA59887 (L. A. P.), The Skaggs Institute for Chemical Biology (J. L. T.), North West Cancer Research Fund grant CR675 (O. F.), Cancer Research-UK (G. P. M.) and CHEMORES (G. P. M.).	Branum ME, 2001, J BIOL CHEM, V276, P25421, DOI 10.1074/jbc.M101032200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Daniels DS, 2000, MUTAT RES-DNA REPAIR, V460, P151, DOI 10.1016/S0921-8777(00)00024-0; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Edara S, 1999, CARCINOGENESIS, V20, P103, DOI 10.1093/carcin/20.1.103; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; Kanugula S, 2005, P NATL ACAD SCI USA, V102, P3617, DOI 10.1073/pnas.0408719102; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; MAZON G, 2006, DNA REPAIR IN PRESS; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; MITRA S, 1993, PROG NUCLEIC ACID RE, V44, P109, DOI 10.1016/S0079-6603(08)60218-4; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Pauly GT, 1998, CARCINOGENESIS, V19, P457, DOI 10.1093/carcin/19.3.457; Pearson SJ, 2005, NUCLEIC ACIDS RES, V33, P3837, DOI 10.1093/nar/gki696; Pearson SJ, 2006, NUCLEIC ACIDS RES, V34, P2347, DOI 10.1093/nar/gkl270; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; Scharer OD, 2009, NAT STRUCT MOL BIOL, V16, P102, DOI 10.1038/nsmb0209-102; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; VOIGT JM, 1989, J BIOL CHEM, V264, P5172; Wang LJ, 1997, CHEM RES TOXICOL, V10, P562, DOI 10.1021/tx9602067; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553	50	99	101	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					808	813		10.1038/nature08076	http://dx.doi.org/10.1038/nature08076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516334	Green Accepted			2022-12-28	WOS:000267084500031
J	Dioum, EM; Chen, R; Alexander, MS; Zhang, QY; Hogg, RT; Gerard, RD; Garcia, JA				Dioum, Elhadji M.; Chen, Rui; Alexander, Matthew S.; Zhang, Quiyang; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.			Regulation of Hypoxia-Inducible Factor 2 alpha Signaling by the Stress-Responsive Deacetylase Sirtuin 1	SCIENCE			English	Article							CALORIE RESTRICTION; CELL-SURVIVAL; LIFE-SPAN; SIR2; TRANSCRIPTION; FAMILY; P53; ERYTHROPOIETIN; HOMEOSTASIS; EXPRESSION	To survive in hostile environments, organisms activate stress-responsive transcriptional regulators that coordinately increase production of protective factors. Hypoxia changes cellular metabolism and thus activates redox-sensitive as well as oxygen-dependent signal transducers. We demonstrate that Sirtuin 1 (Sirt1), a redox-sensing deacetylase, selectively stimulates activity of the transcription factor hypoxia-inducible factor 2 alpha (HIF-2 alpha) during hypoxia. The effect of Sirt1 on HIF-2 alpha required direct interaction of the proteins and intact deacetylase activity of Sirt1. Select lysine residues in HIF-2 alpha that are acetylated during hypoxia confer repression of Sirt1 augmentation by small-molecule inhibitors. In cultured cells and mice, decreasing or increasing Sirt1 activity or levels affected expression of the HIF-2 alpha target gene erythropoietin accordingly. Thus, Sirt1 promotes HIF-2 signaling during hypoxia and likely other environmental stresses.	[Dioum, Elhadji M.; Chen, Rui; Garcia, Joseph A.] Vet Affairs N Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Dioum, Elhadji M.; Chen, Rui; Alexander, Matthew S.; Zhang, Quiyang; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, JA (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Med, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Alexander, Matthew/0000-0001-7406-5171; Garcia, Joseph/0000-0002-5621-7538	Amgen; American Heart Association; Department of Veterans Affairs; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	Amgen(Amgen); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge A. Das, N. Wang, and K. Ding for technical assistance. We thank members of the laboratory of F. Alt for generously providing Sirt1 knockout mice, R. Hammer for assistance with mouse husbandry, Y. Li and H. Ball in the University of Texas Southwestern Medical Center Protein Chemistry Technology Center for mass spectrometry, and C. Xing for suggestions for statistical analyses. These studies were supported by funds provided by Amgen, American Heart Association, and Department of Veterans Affairs.	Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; GAROFALO O, 1988, J NEUROCHEM, V51, P172, DOI 10.1111/j.1471-4159.1988.tb04851.x; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; VANNUCCI RC, 1994, BRAIN RES, V653, P141, DOI 10.1016/0006-8993(94)90382-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	38	358	376	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1289	1293		10.1126/science.1169956	http://dx.doi.org/10.1126/science.1169956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498162				2022-12-28	WOS:000266635100035
J	King, TE; Albera, C; Bradford, WZ; Costabel, U; Hormel, P; Lancaster, L; Noble, PW; Sahn, SA; Szwarcberg, J; Thomeer, M; Valeyre, D; du Bois, RM				King, Talmadge E., Jr.; Albera, Carlo; Bradford, Williamson Z.; Costabel, Ulrich; Hormel, Phil; Lancaster, Lisa; Noble, Paul W.; Sahn, Steven A.; Szwarcberg, Javier; Thomeer, Michiel; Valeyre, Dominique; du Bois, Roland M.		INSPIRE Study Grp	Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial	LANCET			English	Article								Background Idiopathic pulmonary fibrosis is a fatal disease for which no effective treatment exists. We assessed whether treatment with interferon gamma-1b improved survival compared with placebo in patients with idiopathic pulmonary fibrosis and mild-to-moderate impairment of pulmonary function. Methods 826 patients with idiopathic pulmonary fibrosis were enrolled from 81 centres in seven European countries, the USA, and Canada. Patients were randomly assigned (double-blind) in a 2:1 ratio to receive 200 mu g interferon gamma-1b (n=551) or equivalent placebo (n=275) subcutaneously, three times per week. Eligible patients were aged 40-79 years, had been diagnosed in the past 48 months, had a forced vital capacity of 55-90% of the predicted value, and a haemoglobin-corrected carbon monoxide diffusing capacity of 35-90% of the predicted value. The primary endpoint was overall survival time from randomisation measured at the second interim analysis, when the proportion of deaths had reached 75% of those expected by the study conclusion. This study is registered with ClinicalTrials.gov, number NCT00075998. Findings At the second interim analysis, the hazard ratio for mortality in patients on interferon gamma-1b showed absence of minimum benefit compared with placebo (1.15, 95% CI 0.77-1.71, p=0.497), and indicated that the study should be stopped. After a median duration of 64 weeks (IQR 41-84) on treatment, 80 (15%) patients on interferon gamma-1b and 35 (13%) on placebo had died. Almost all patients reported at least one adverse event, and more patients on interferon gamma-1b group had constitutional signs and symptoms (influenza-like illness, fatigue, fever, and chills) than did those on placebo. Occurrence of serious adverse events (eg, pneumonia, respiratory failure) was similar for both treatment groups. Treatment adherence was good and few patients discontinued treatment prematurely in either group. Interpretation We cannot recommend treatment with interferon gamma-1b since the drug did not improve survival for patients with idiopathic pulmonary fibrosis, which refutes previous findings from subgroup analyses of survival in studies of patients with mild-to-moderate physiological impairment of pulmonary function.	[King, Talmadge E., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Albera, Carlo] Univ Turin, San Luigi Gonzaga Med Sch, Turin, Italy; [Bradford, Williamson Z.; Hormel, Phil; Szwarcberg, Javier] InterMune, Brisbane, CA USA; [Costabel, Ulrich] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany; [Costabel, Ulrich] Univ Duisburg Essen, Fac Med, Essen, Germany; [Lancaster, Lisa] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Noble, Paul W.] Duke Univ, Sch Med, Durham, NC USA; [Sahn, Steven A.] Med Univ S Carolina, Charleston, SC 29425 USA; [Thomeer, Michiel] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Valeyre, Dominique] Hosp Avicenne, AP HP, Bobigny, France; [du Bois, Roland M.] Natl Jewish Med & Res Ctr, Denver, CO USA	University of California System; University of California San Francisco; University of Turin; University of Duisburg Essen; University of Duisburg Essen; Vanderbilt University; Duke University; Medical University of South Carolina; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; National Jewish Health	King, TE (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.	tking@medicine.ucsf.edu	Agostini, Carlo/J-3103-2012; Poletti, Venerino/K-8821-2016; Thomeer, Michiel/C-9544-2014	Agostini, Carlo/0000-0001-7786-3574; Poletti, Venerino/0000-0002-8634-2284; Crimi, Nunzio/0000-0002-8591-4535; Thomeer, Michiel/0000-0001-5627-0323; Hollingsworth, Helen/0000-0001-9007-9012; chanez, pascal/0000-0003-4059-0917; Valeyre, dominique/0000-0003-4470-1776	InterMune (Brisbane, CA, USA)	InterMune (Brisbane, CA, USA)	This study was funded by InterMune (Brisbane, CA, USA). We thank Kenneth Glasscock for editorial support in the writing ofthis report, and staff members and patients at all study centres.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Antoniou KM, 2006, EUR RESPIR J, V28, P496, DOI 10.1183/09031936.06.00032605; Bajwa EK, 2005, CHEST, V128, P203, DOI 10.1378/chest.128.1.203; BILLIAU A, 2001, CYTOKINE REFERENCE C, P641; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Chang JA, 1999, CHEST, V116, P1175, DOI 10.1378/chest.116.5.1175; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Eakin EG, 1998, CHEST, V113, P619, DOI 10.1378/chest.113.3.619; EMERSON SS, 1989, BIOMETRICS, V45, P905, DOI 10.2307/2531692; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; KEY LL, 1995, NEW ENGL J MED, V332, P1594, DOI 10.1056/NEJM199506153322402; King TE, 2005, CHEST, V127, P171, DOI 10.1378/chest.127.1.171; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; SCHWARTZ DA, 1994, AM J RESP CRIT CARE, V149, P450, DOI 10.1164/ajrccm.149.2.8306044; Selman M, 2003, AM J RESP CRIT CARE, V167, P945, DOI 10.1164/rccm.2301004; Strieter RM, 2004, AM J RESP CRIT CARE, V170, P133, DOI 10.1164/rccm.200312-1670OC; Ziesche R, 1999, NEW ENGL J MED, V341, P1264, DOI 10.1056/NEJM199910213411703; ZIESCHE R, 2002, CHEST, V122, pS207	22	384	403	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					222	228		10.1016/S0140-6736(09)60551-1	http://dx.doi.org/10.1016/S0140-6736(09)60551-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19570573	Green Submitted			2022-12-28	WOS:000268263000030
J	Peelen, MV; Fei-Fei, L; Kastner, S				Peelen, Marius V.; Fei-Fei, Li; Kastner, Sabine			Neural mechanisms of rapid natural scene categorization in human visual cortex	NATURE			English	Article							FEATURE-BASED ATTENTION; CHANGE-BLINDNESS; TEMPORAL CORTEX; SEARCH; FMRI	The visual system has an extraordinary capability to extract categorical information from complex natural scenes. For example, subjects are able to rapidly detect the presence of object categories such as animals or vehicles in new scenes that are presented very briefly(1,2). This is even true when subjects do not pay attention to the scenes and simultaneously perform an unrelated attentionally demanding task(3), a stark contrast to the capacity limitations predicted by most theories of visual attention(4,5). Here we show a neural basis for rapid natural scene categorization in the visual cortex, using functional magnetic resonance imaging and an object categorization task in which subjects detected the presence of people or cars in briefly presented natural scenes. The multi-voxel pattern of neural activity in the object-selective cortex evoked by the natural scenes contained information about the presence of the target category, even when the scenes were task-irrelevant and presented outside the focus of spatial attention. These findings indicate that the rapid detection of categorical information in natural scenes is mediated by a category-specific biasing mechanism in object-selective cortex that operates in parallel across the visual field, and biases information processing in favour of objects belonging to the target object category.	[Peelen, Marius V.; Fei-Fei, Li; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Peelen, Marius V.; Kastner, Sabine] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA; [Peelen, Marius V.; Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA; [Fei-Fei, Li] Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA	Princeton University; Princeton University; Princeton University; Princeton University	Peelen, MV (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA.	mpeelen@princeton.edu	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303; Kastner, Sabine/0000-0002-9742-965X	National Institutes of Health [2RO1 MH64043, 1RO1 EY017699, 2P50 MH-62196]; Microsoft Research New Faculty Fellowship; NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH064043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft Research New Faculty Fellowship(Microsoft); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Downing, U. Hasson, S. McMains, K. Norman, T. Stein and A. Treisman for suggestions on earlier versions of the manuscript, members of the Kastner laboratory for help with retinotopic mapping, and N. Oosterhof for help with data analysis. This work was supported by grants from the National Institutes of Health (2RO1 MH64043, 1RO1 EY017699, 2P50 MH-62196) to S. K., and a Microsoft Research New Faculty Fellowship and the F. Moss gift to L. F.- F.	Broadbent D.E., 1958, PERCEPTION COMMUNICA; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; FEIFEI L, 2005, VIS COGN, V12, P893, DOI DOI 10.1080/13506280444000571; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MOTTER BC, 1994, J NEUROSCI, V14, P2178; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WALTHER DB, J NEUROSCI IN PRESS; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	25	204	210	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	2009	460	7251					94	U105		10.1038/nature08103	http://dx.doi.org/10.1038/nature08103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19506558	Green Accepted			2022-12-28	WOS:000267545200036
J	Mravec, J; Skupa, P; Bailly, A; Hoyerova, K; Krecek, P; Bielach, A; Petrasek, J; Zhang, J; Gaykova, V; Stierhof, YD; Dobrev, PI; Schwarzerova, K; Rolcik, J; Seifertova, D; Luschnig, C; Benkova, E; Zazimalova, E; Geisler, M; Friml, J				Mravec, Jozef; Skupa, Petr; Bailly, Aurelien; Hoyerova, Klara; Krecek, Pavel; Bielach, Agnieszka; Petrasek, Jan; Zhang, Jing; Gaykova, Vassilena; Stierhof, York-Dieter; Dobrev, Petre I.; Schwarzerova, Katerina; Rolcik, Jakub; Seifertova, Daniela; Luschnig, Christian; Benkova, Eva; Zazimalova, Eva; Geisler, Markus; Friml, Jiri			Subcellular homeostasis of phytohormone auxin is mediated by the ER-localized PIN5 transporter	NATURE			English	Article							BOX PROTEIN TIR1; PLASMA-MEMBRANE; TWISTED DWARF1; ARABIDOPSIS; GRADIENTS; LAND; FLOW	The plant signalling molecule auxin provides positional information in a variety of developmental processes by means of its differential distribution (gradients) within plant tissues(1). Thus, cellular auxin levels often determine the developmental output of auxin signalling. Conceptually, transmembrane transport and metabolic processes regulate the steady-state levels of auxin in any given cell(2,3). In particular, PIN auxin-efflux-carrier-mediated, directional transport between cells is crucial for generating auxin gradients(2,4,5). Here we show that Arabidopsis thaliana PIN5, an atypical member of the PIN gene family, encodes a functional auxin transporter that is required for auxin-mediated development. PIN5 does not have a direct role in cell-to-cell transport but regulates intracellular auxin homeostasis and metabolism. PIN5 localizes, unlike other characterized plasma membrane PIN proteins, to endoplasmic reticulum ( ER), presumably mediating auxin flow from the cytosol to the lumen of the ER. The ER localization of other PIN5-like transporters ( including the moss PIN) indicates that the diversification of PIN protein functions in mediating auxin homeostasis at the ER, and cell-to-cell auxin transport at the plasma membrane, represent an ancient event during the evolution of land plants.	[Mravec, Jozef; Bielach, Agnieszka; Zhang, Jing; Benkova, Eva; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Mravec, Jozef; Bielach, Agnieszka; Zhang, Jing; Benkova, Eva; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Mravec, Jozef; Zhang, Jing; Gaykova, Vassilena; Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Skupa, Petr; Hoyerova, Klara; Krecek, Pavel; Petrasek, Jan; Dobrev, Petre I.; Seifertova, Daniela; Zazimalova, Eva] ASCR, Inst Expt Bot, Prague 16502 6, Czech Republic; [Bailly, Aurelien; Geisler, Markus] Univ Zurich, Inst Plant Biol, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Petrasek, Jan; Schwarzerova, Katerina] Charles Univ Prague, Fac Sci, Dept Plant Physiol, CR-12844 Prague 2, Czech Republic; [Rolcik, Jakub] ASCR, Inst Expt Bot, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Rolcik, Jakub] Palacky Univ, Fac Sci, Olomouc 78371, Czech Republic; [Luschnig, Christian] Univ Nat Resources & Appl Life Sci BOKU, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Friml, Jiri] Masaryk Univ, Fac Sci, Dept Funct Genom & Prote, Brno 62500, Czech Republic	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Eberhard Karls University of Tubingen; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Zurich; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; University of Natural Resources & Life Sciences, Vienna; Masaryk University Brno	Friml, J (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jiri.friml@psb.vib-ugent.be	Petrasek, Jan/C-8240-2009; Hoyerová, Klára/F-6800-2014; Benkova, Eva/E-2910-2012; Petrasek, Jan/AAW-1081-2021; Eva, Zazimalova/G-7432-2014; Schwarzerova, Katerina/D-3989-2009; Hoyerova, Klara/AAF-5519-2020; Geisler, Markus M/B-3921-2012; Dobrev, Petre I./H-2391-2014; Friml, Jiri/D-9511-2012; Skupa, Petr/H-2176-2014; Mravec, Jozef/J-7370-2016	Petrasek, Jan/0000-0002-6719-2735; Hoyerová, Klára/0000-0002-6335-6683; Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Schwarzerova, Katerina/0000-0001-5269-9499; Hoyerova, Klara/0000-0002-6335-6683; Geisler, Markus M/0000-0002-6641-5810; Friml, Jiri/0000-0002-8302-7596; Mravec, Jozef/0000-0003-0331-3304; Luschnig, Christian/0000-0003-2099-9280; Skupa, Petr/0000-0001-9878-0639	Volkswagenstiftung; Odysseus programme of the FWO [IAA601630703, KJB600380604]; Ministry of Education, Youth and Sports of the Czech Republic [LC06034, MSM6198959216]; European Research Council starting independent research grant; Novartis Foundation; Swiss National Funds; Forschungskredit of the University of Zurich; Austrian Science Fund	Volkswagenstiftung(Volkswagen); Odysseus programme of the FWO(FWO); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Research Council starting independent research grant(European Research Council (ERC)); Novartis Foundation(Novartis); Swiss National Funds(Swiss National Science Foundation (SNSF)); Forschungskredit of the University of Zurich; Austrian Science Fund(Austrian Science Fund (FWF))	We thank D. G. Robinson, J. Clarke and NASC for providing material; B. Scheres and H. Hofte for sharing unpublished data, E. Bellinvia, M. Parezova,B. Pesek and V. Vincenzetti for technical help and M. De Cock for critical reading and help with preparing the manuscript. This work was supported by the Volkswagenstiftung ( J. F., J. M., V. G.), the Odysseus programme of the FWO ( J. M., J. Z.), GA ASCR IAA601630703 ( J. F.) and KJB600380604 ( J. P., K. S.), the Ministry of Education, Youth and Sports of the Czech Republic, project number LC06034 ( E. Z., P. S., P. K., K. H., J. P., D. S.) and MSM6198959216 ( J. R.), a European Research Council starting independent research grant to E. B. ( A. Bi.), the Novartis Foundation ( M. G.), the Swiss National Funds ( M. G.), the Forschungskredit of the University of Zurich ( A. Ba.) and the Austrian Science Fund ( C. L).	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brewer PB, 2006, NAT PROTOC, V1, P1462, DOI 10.1038/nprot.2006.226; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fujita T, 2008, EVOL DEV, V10, P176, DOI 10.1111/j.1525-142X.2008.00225.x; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Maeshima M, 2008, PFLUG ARCH EUR J PHY, V456, P709, DOI 10.1007/s00424-007-0363-7; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	46	375	408	6	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1136	U127		10.1038/nature08066	http://dx.doi.org/10.1038/nature08066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19506555				2022-12-28	WOS:000267636700045
J	Clatworthy, MR; Watson, CJE; Plotnek, G; Bardsley, V; Chaudhry, AN; Bradley, JA; Smith, KGC				Clatworthy, Menna R.; Watson, Christopher J. E.; Plotnek, Gemma; Bardsley, Vicky; Chaudhry, Afzal N.; Bradley, J. Andrew; Smith, Kenneth G. C.			B-Cell-Depleting Induction Therapy and Acute Cellular Rejection	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							RITUXIMAB		[Clatworthy, Menna R.; Watson, Christopher J. E.; Plotnek, Gemma; Bardsley, Vicky; Chaudhry, Afzal N.; Bradley, J. Andrew; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Cambridge CB2 2QQ, England	University of Cambridge	Clatworthy, MR (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge CB2 2QQ, England.	kgcs2@cam.ac.uk	Banham, Gemma/AAG-7424-2021	Banham, Gemma/0000-0002-2134-4596; Smith, Kenneth/0000-0003-3829-4326	Wellcome Trust [081020] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agarwal A, 2004, AM J TRANSPLANT, V4, P1357, DOI 10.1111/j.1600-6143.2004.00502.x; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Zarkhin V, 2008, TRANSPLANTATION, V85, P1705, DOI 10.1097/TP.0b013e318177793e	5	185	188	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2683	2685		10.1056/NEJMc0808481	http://dx.doi.org/10.1056/NEJMc0808481			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535812	Green Accepted			2022-12-28	WOS:000267060000038
J	Lainey, V; Arlot, JE; Karatekin, O; Van Hoolst, T				Lainey, Valery; Arlot, Jean-Eudes; Karatekin, Oezguer; Van Hoolst, Tim			Strong tidal dissipation in Io and Jupiter from astrometric observations	NATURE			English	Article							HEAT-FLOW; SECULAR ACCELERATION; VISCOELASTIC MODELS; THERMAL EMISSION; SATELLITES; EVOLUTION	Io is the volcanically most active body in the Solar System and has a large surface heat flux(1-3). The geological activity is thought to be the result of tides raised by Jupiter(4), but it is not known whether the current tidal heat production is sufficiently high to generate the observed surface heat flow(5,6). Io's tidal heat comes from the orbital energy of the Io-Jupiter system (resulting in orbital acceleration), whereas dissipation of energy in Jupiter causes Io's orbital motion to decelerate. Here we report a determination of the tidal dissipation in Io and Jupiter through its effect on the orbital motions of the Galilean moons. Our results show that the rate of internal energy dissipation in Io (k(2)/Q = 0.015 +/- 0.003, where k(2) is the Love number and Q is the quality factor) is in good agreement with the observed surface heat flow5,6, and suggest that Io is close to thermal equilibrium. Dissipation in Jupiter (k(2)/Q = (1.102 +/- 0.203) x 10(-5)) is close to the upper bound of its average value expected from the long-term evolution of the system(7), and dissipation in extrasolar planets may be higher than presently assumed(8). The measured secular accelerations indicate that Io is evolving inwards, towards Jupiter, and that the three innermost Galilean moons (Io, Europa and Ganymede) are evolving out of the exact Laplace resonance.	[Lainey, Valery; Arlot, Jean-Eudes] IMCCE Observ Paris, CNRS, UMR 8028, F-75014 Paris, France; [Karatekin, Oezguer; Van Hoolst, Tim] Observ Royal Belgique, B-1180 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite	Lainey, V (corresponding author), IMCCE Observ Paris, CNRS, UMR 8028, 77 Ave Denfert Rochereau, F-75014 Paris, France.	lainey@imcce.fr	Nikolay, Emelianov/S-6793-2016	Van Hoolst, Tim/0000-0002-9820-8584				Aksnes K, 2001, ASTRON J, V122, P2734, DOI 10.1086/323708; Anderson JD, 2001, J GEOPHYS RES-PLANET, V106, P32963, DOI 10.1029/2000JE001367; De Sitter W., 1928, LEIDEN ANN, V16, P1; FISCHER HJ, 1990, ICARUS, V83, P39, DOI 10.1016/0019-1035(90)90005-T; GAVRILOV SV, 1977, ICARUS, V32, P443, DOI 10.1016/0019-1035(77)90015-X; Goldstein SJ, 1995, ASTRON J, V110, P3054, DOI 10.1086/117746; GREENBERG R, 1987, ICARUS, V70, P334, DOI 10.1016/0019-1035(87)90139-4; Hussmann H, 2004, ICARUS, V171, P391, DOI 10.1016/j.icarus.2004.05.020; JOHNSON TV, 1984, SCIENCE, V226, P134, DOI 10.1126/science.226.4671.134; Keszthelyi L, 2007, ICARUS, V192, P491, DOI 10.1016/j.icarus.2007.07.008; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Levrard B, 2007, ASTRON ASTROPHYS, V462, pL5, DOI 10.1051/0004-6361:20066487; LIESKE JH, 1987, ASTRON ASTROPHYS, V176, P146; MATSON DL, 1981, J GEOPHYS RES, V86, P1664, DOI 10.1029/JB086iB03p01664; McEwen AS, 2004, CAMB PLANET, P307; MOORE B, 2007, GALILEO NEW VIEW JUP, P89; Moore WB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001943; Moore WB, 2001, ICARUS, V154, P548, DOI 10.1006/icar.2001.6739; MORRISON D, 1980, ICARUS, V44, P226, DOI 10.1016/0019-1035(80)90018-4; Ogilvie GI, 2004, ASTROPHYS J, V610, P477, DOI 10.1086/421454; OJAKANGAS GW, 1986, ICARUS, V66, P341, DOI 10.1016/0019-1035(86)90163-6; PEALE SJ, 1979, SCIENCE, V203, P892, DOI 10.1126/science.203.4383.892; Rathbun JA, 2004, ICARUS, V169, P127, DOI 10.1016/j.icarus.2003.10.021; SEGATZ M, 1988, ICARUS, V75, P187, DOI 10.1016/0019-1035(88)90001-2; SINTON WM, 1981, J GEOPHYS RES, V86, P3122, DOI 10.1029/JB086iB04p03122; Spencer JR, 2000, SCIENCE, V288, P1198, DOI 10.1126/science.288.5469.1198; Stone RC, 2001, ASTRON J, V122, P2723, DOI 10.1086/323549; Vasundhara R, 1996, IAU SYMP, P145; VEEDER GJ, 1994, J GEOPHYS RES-PLANET, V99, P17095, DOI 10.1029/94JE00637; Veeder GJ, 2004, ICARUS, V169, P264, DOI 10.1016/j.icarus.2003.11.016; Wu YQ, 2005, ASTROPHYS J, V635, P688, DOI 10.1086/497355; YODER CF, 1979, NATURE, V279, P767, DOI 10.1038/279767a0; YODER CF, 1981, ICARUS, V47, P1, DOI 10.1016/0019-1035(81)90088-9	33	217	218	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					957	959		10.1038/nature08108	http://dx.doi.org/10.1038/nature08108			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536258				2022-12-28	WOS:000267063500036
J	Xu, X; Clark, JM; Mo, JY; Choiniere, J; Forster, CA; Erickson, GM; Hone, DWE; Sullivan, C; Eberth, DA; Nesbitt, S; Zhao, Q; Hernandez, R; Jia, CK; Han, FL; Guo, Y				Xu, Xing; Clark, James M.; Mo, Jinyou; Choiniere, Jonah; Forster, Catherine A.; Erickson, Gregory M.; Hone, David W. E.; Sullivan, Corwin; Eberth, David A.; Nesbitt, Sterling; Zhao, Qi; Hernandez, Rene; Jia, Cheng-kai; Han, Feng-lu; Guo, Yu			A Jurassic ceratosaur from China helps clarify avian digital homologies	NATURE			English	Article							ABELISAUROID DINOSAURIA; THEROPODA; EVOLUTION; EXPRESSION; REDUCTION; PATTERNS; BIRDS	Theropods have traditionally been assumed to have lost manual digits from the lateral side inward, which differs from the bilateral reduction pattern seen in other tetrapod groups. This unusual reduction pattern is clearly present in basal theropods, and has also been inferred in non-avian tetanurans based on identification of their three digits as the medial ones of the hand (I-II-III). This contradicts the many developmental studies indicating II-III-IV identities for the three manual digits of the only extant tetanurans, the birds. Here we report a new basal ceratosaur from the Oxfordian stage of the Jurassic period of China (156-161 million years ago), representing the first known Asian ceratosaur and the only known beaked, herbivorous Jurassic theropod. Most significantly, this taxon possesses a strongly reduced manual digit I, documenting a complex pattern of digital reduction within the Theropoda. Comparisons among theropod hands show that the three manual digits of basal tetanurans are similar in many metacarpal features to digits II-III-IV, but in phalangeal features to digits I-II-III, of more basal theropods. Given II-III-IV identities in avians, the simplest interpretation is that these identities were shared by all tetanurans. The transition to tetanurans involved complex changes in the hand including a shift in digit identities, with ceratosaurs displaying an intermediate condition.	[Xu, Xing; Hone, David W. E.; Sullivan, Corwin; Zhao, Qi; Han, Feng-lu; Guo, Yu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Clark, James M.; Choiniere, Jonah; Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Mo, Jinyou] Nat Hist Museum Guangxi, Nanning 530012, Guangxi, Peoples R China; [Mo, Jinyou] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Hubei, Peoples R China; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Eberth, David A.] Royal Tyrrell Museum, Drumheller, AB T0J 0Y0, Canada; [Nesbitt, Sterling] Amer Museum Nat Hist, New York, NY 10024 USA; [Hernandez, Rene] Univ Nacl Autonoma Mexico, Inst Geol, Mexico City 04510, DF, Mexico; [Jia, Cheng-kai] Xinjiang Oilfield Co, Res Inst Explorat & Dev, Karamay 834000, Xinjiang, Peoples R China; [Han, Feng-lu; Guo, Yu] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; George Washington University; China University of Geosciences; State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Universidad Nacional Autonoma de Mexico; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	xingxu@vip.sina.com	Benton, Michael J/A-5639-2008; Sullivan, Corwin/D-4563-2009	Benton, Michael J/0000-0002-4323-1824; Choiniere, Jonah/0000-0002-1008-0687; Mo, Jinyou/0000-0002-0126-2577; Sullivan, Corwin/0000-0002-5488-6797	Chinese Academy of Sciences; National Science Foundation Division of Earth Sciences of the USA; National Natural Science Foundation of China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation Division of Earth Sciences of the USA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank H.-J. Wang for organizing the fieldwork, R. S. Li for illustrations, L.-S. Xiang and X.-Q. Ding for preparing the specimens, X.-Q. Ding for editing the illustrations, M. Kundrat and J. Gauthier for critical comments, O. Rauhut, P. Makovicky and D. Chure for some theropod images, R.-S. Tykoski for references, and members of the Sino-American expedition team for collecting the fossil. The field work was supported by the National Natural Science Foundation of China, the National Science Foundation Division of Earth Sciences of the USA, the Chinese Academy of Sciences, the National Geographic Society, the Jurassic Foundation, the Hilmar Sallee bequest and George Washington University. Study of the specimens was supported by the Chinese Academy of Sciences, the National Science Foundation Division of Earth Sciences of the USA and the National Natural Science Foundation of China.	Allain R, 2007, J VERTEBR PALEONTOL, V27, P610, DOI 10.1671/0272-4634(2007)27[610:AADTFT]2.0.CO;2; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Bonaparte J.F., 1991, Historical Biology, V5, P1; Burch S, 2008, J VERTEBR PALEONTOL, V28, p58A; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Chatterjee S, 1998, SCIENCE, V280, DOI 10.1126/science.280.5362.355a; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Christiansen P, 2002, J ORNITHOL, V143, P356; Chure DJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P283; CORTIA RA, 2002, J VERTEBR PALEONTOL, V22, P460; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Eberth DA, 2001, CAN J EARTH SCI, V38, P1627, DOI 10.1139/e01-067; Feduccia A, 2002, NATURWISSENSCHAFTEN, V89, P391, DOI 10.1007/s00114-002-0350-y; GALTON P M, 1971, Arnoldia (Rhodesia), V5, P1; GALTON P M, 1982, Palaeontologische Zeitschrift, V56, P265; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Kundrat M, 2002, J EXP ZOOL, V294, P152, DOI 10.1002/jez.10140; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Riedl R., 1975, ORDNUNG LEBENDIGEN S; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Shapiro MD, 2002, J MORPHOL, V254, P211, DOI 10.1002/jmor.10027; Shubin Neil H., 1994, P249; THULBORN RA, 1982, AUST J ZOOL, V30, P611, DOI 10.1071/ZO9820611; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P86, DOI 10.1002/jez.b.21023; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; You Hailu, 2004, P478	44	160	175	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					940	944		10.1038/nature08124	http://dx.doi.org/10.1038/nature08124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536256	Green Published			2022-12-28	WOS:000267063500033
J	Carey, TS				Carey, Timothy S.			Review: Immediate routine lumbar-spine imaging does not improve clinical outcomes in low-back pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Carey, TS (corresponding author), Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA.								0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-7	10.7326/0003-4819-150-12-200906160-02007	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528552				2022-12-28	WOS:000267164800019
J	Hillegass, WB; Brott, BC				Hillegass, William B.; Brott, Brigitta C.			Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY INTERVENTION; DOSE CLOPIDOGREL; TRIAL		[Hillegass, William B.; Brott, Brigitta C.] Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Hillegass, WB (corresponding author), Univ Alabama Birmingham, Birmingham, AL USA.			Brott, Brigitta/0000-0002-9707-7500				Jakubowski JA, 2008, THROMB HAEMOSTASIS, V99, P215, DOI 10.1160/TH07-09-0555; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-10	10.7326/0003-4819-150-12-200906160-02010	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528555				2022-12-28	WOS:000267164800022
J	Hillner, BE				Hillner, Bruce E.			Risk for breast cancer declined after postmenopausal hormone therapy was stopped	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Virginia Commonwealth Univ, Richmond, VA 23284 USA	Virginia Commonwealth University	Hillner, BE (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.							Horner MJ, 2008, SEER CANC STAT REV 1; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-11	10.7326/0003-4819-150-12-200906160-02011	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528556				2022-12-28	WOS:000267164800023
J	Yanovski, JA; Parikh, SJ; Yanoff, LB; Denkinger, BI; Calis, KA; Reynolds, JC; Sebring, NG; McHugh, T				Yanovski, Jack A.; Parikh, Shamik J.; Yanoff, Lisa B.; Denkinger, Blakeley I.; Calis, Karim A.; Reynolds, James C.; Sebring, Nancy G.; McHugh, Teresa			Effects of Calcium Supplementation on Body Weight and Adiposity in Overweight and Obese Adults A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							FOOD FREQUENCY QUESTIONNAIRES; VITAMIN-D SUPPLEMENTATION; DIETARY CALCIUM; UNITED-STATES; DAIRY CALCIUM; FAT LOSS; MILK CONSUMPTION; BLOOD-PRESSURE; MASS INDEX; BONE LOSS	Background: Some data suggest that increasing calcium intake may help prevent weight gain. Objective: To test the hypothesis that calcium supplementation can prevent weight gain in persons who are overweight or obese. Design: Randomized, placebo-controlled trial. Randomization was computer-generated, and allocation was assigned by pharmacy personnel who prepared intervention and placebo capsules. Participants, providers, and those who assessed outcomes were blinded to study group assignment. Setting: Single research center. Participants: 340 overweight (body mass index [BMI], 25 to <30 kg/m(2)) and obese (BMI >= 30 kg/m(2)) adults (mean age, 38.8 years [SD, 10.5]). Intervention: Calcium carbonate (elemental calcium, 1500 mg/d) (n = 170) or placebo (n = 170) with meals for 2 years. Measurements: Changes in body weight and fat mass (primary outcomes). Results: Seventy-five percent of participants completed the trial (78% received calcium; 73% received placebo). There were no statistically or clinically significant differences between the calcium and placebo groups in change in body weight (difference, 0.02 kg [95% CI, -1.64 to 1.69 kg]; P = 0.98), BMI (difference, 0.32 kg/m(2) [CI, -0.41 to 1.02 kg/m(2)]; P = 0.39), or body fat mass (difference, 0.39 kg [CI, -1.04 to 1.92 kg]; P = 0.55). Parathyroid hormone concentrations decreased in the calcium group compared with the placebo group (difference, -0.71 pmol/L [CI, -1.28 to -0.13 pmol/L]). Limitation: The study took place at a research center, and its sample was mostly women. Conclusion: Dietary supplementation with elemental calcium, 1500 mg/d, for 2 years had no statistically or clinically significant effects on weight in overweight and obese adults. Calcium supplementation is unlikely to have clinically significant efficacy as a preventive measure against weight gain in such patients.	[Yanovski, Jack A.] NIH, Hatfield Clin Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Yanovski, JA (corresponding author), NIH, Hatfield Clin Res Ctr, 9000 Rockville Pike,Room 1-3330, Bethesda, MD 20892 USA.	jy15i@nih.gov		Yanovski, Jack/0000-0001-8542-1637	National Institutes of Health [Z01-HD-000641, OD-2067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	By the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health ( grant Z01-HD-000641) ( Dr. Yanovski), and the Office of Dietary Supplements, National Institutes of Health ( grant OD-2067) ( Dr. Yanovski).	BALLARDBARBASH R, 1990, CANCER RES, V50, P2152; Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300; Barba G, 2006, NUTR METAB CARDIOVAS, V16, P445, DOI 10.1016/j.numecd.2006.04.004; BARNETT V, 1984, WILEY SERIES PROBABI, P66; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Boon N, 2005, AM J EPIDEMIOL, V162, P27, DOI 10.1093/aje/kwi161; Bowen J, 2005, INT J OBESITY, V29, P957, DOI 10.1038/sj.ijo.0802895; BRODY JE, 2005, NY TIMES        0614; Caan B, 2007, ARCH INTERN MED, V167, P893, DOI 10.1001/archinte.167.9.893; Carruth BR, 2001, INT J OBESITY, V25, P559, DOI 10.1038/sj.ijo.0801562; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Cummings NK, 2006, BRIT J NUTR, V96, P138, DOI 10.1079/BJN20061803; D DeJongh E, 2006, AM J CLIN NUTR, V84, P1123; Daly RM, 2006, J BONE MINER RES, V21, P397, DOI 10.1359/JBMR.051206; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; Davis MJ, 1999, ANN BEHAV MED, V21, P339, DOI 10.1007/BF02895967; DENKE MA, 1993, J NUTR, V123, P1047; Drapeau V, 2004, AM J CLIN NUTR, V80, P29; Elwood PC, 2005, J EPIDEMIOL COMMUN H, V59, P502, DOI 10.1136/jech.2004.027904; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gonzalez AJ, 2006, J AM DIET ASSOC, V106, P1066, DOI 10.1016/j.jada.2006.04.024; Griffith LE, 1999, AM J HYPERTENS, V12, P84, DOI 10.1016/S0895-7061(98)00224-6; Harris RBS, 2005, INT J OBESITY, V29, P388, DOI 10.1038/sj.ijo.0802878; Harvey-Berino J, 2005, OBES RES, V13, P1720, DOI 10.1038/oby.2005.210; Heaney RP, 2003, J NUTR, V133, p268S, DOI 10.1093/jn/133.1.268S; Hollingshead A. B., 1991, HDB RES DESIGN SOCIA, P351; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1997, DIET REF INT CALC PH; Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448; KALRA S, 2006, TRIBUNE         1129; Lanou AJ, 2008, NUTR REV, V66, P272, DOI 10.1111/j.1753-4887.2008.00032.x; Lappe JM, 2004, J AM DIET ASSOC, V104, P1361, DOI 10.1016/j.jada.2004.06.025; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loos RJF, 2004, J NUTR, V134, P1772, DOI 10.1093/jn/134.7.1772; Lorenzen JK, 2007, AM J CLIN NUTR, V85, P678, DOI 10.1093/ajcn/85.3.678; Lorenzen JK, 2006, AM J CLIN NUTR, V83, P18; Lovejoy JC, 2001, AM J CLIN NUTR, V74, P90; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; MCCARRON DA, 1983, ANN INTERN MED, V98, P800, DOI 10.7326/0003-4819-98-5-800; Melanson EL, 2003, INT J OBESITY, V27, P196, DOI 10.1038/sj.ijo.802202; Melanson EL, 2005, OBES RES, V13, P2102, DOI 10.1038/oby.2005.261; Moore LL, 2006, OBESITY, V14, P1010, DOI 10.1038/oby.2006.116; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Parikh SJ, 2003, AM J CLIN NUTR, V77, P281, DOI 10.1093/ajcn/77.2.281; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Recker RR, 1996, J BONE MINER RES, V11, P1961; Reid IR, 2005, J CLIN ENDOCR METAB, V90, P3824, DOI 10.1210/jc.2004-2205; Roth H J, 2001, Clin Lab, V47, P357; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sahyoun NR, 1999, AM J PUBLIC HEALTH, V89, P391, DOI 10.2105/AJPH.89.3.391; SCHAKEL SF, 1988, J AM DIET ASSOC, V88, P1268; Sebring NG, 2007, J AM DIET ASSOC, V107, P752, DOI 10.1016/j.jada.2007.02.007; SHAFER JL, SOFTWARE MULTIPLE IM; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Shahar DR, 2007, DIABETES CARE, V30, P485, DOI 10.2337/dc06-1564; Shahkhalili Y, 2001, AM J CLIN NUTR, V73, P246; Shapses SA, 2004, J CLIN ENDOCR METAB, V89, P632, DOI 10.1210/jc.2002-021136; Shi H, 2001, FASEB J, V15, P2751, DOI 10.1096/fj.01-0584fje; Shi H, 2001, FASEB J, V15, P291; Shi H, 2000, PHYSIOL GENOMICS, V3, P75, DOI 10.1152/physiolgenomics.2000.3.2.75; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Thompson WG, 2005, OBES RES, V13, P1344, DOI 10.1038/oby.2005.163; Trowman R, 2006, BRIT J NUTR, V95, P1033, DOI 10.1079/BJN20051727; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WILLIAMSON DF, 1991, AM J CLIN NUTR, V53, pS1515, DOI 10.1093/ajcn/53.6.1515S; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; Winzenberg T, 2007, OBESITY, V15, P1789, DOI 10.1038/oby.2007.213; Yanoff LB, 2006, CLIN ENDOCRINOL, V64, P523, DOI 10.1111/j.1365-2265.2006.02502.x; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2005, INT J OBESITY, V29, P391, DOI 10.1038/sj.ijo.0802880; Zemel MB, 2004, NUTR REV, V62, P125, DOI [10.1301/nr.2004.apr.125&ndash;131, 10.1301/nr.2004.apr.125-131, 10.1111/j.1753-4887.2004.tb00034.x]; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; 2006, STUDY CALCIUM COULD	82	59	63	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					821	U17		10.7326/0003-4819-150-12-200906160-00005	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528561	Green Accepted			2022-12-28	WOS:000267164800001
J	Gilman, EB				Gilman, Ernest B.			The art of medicine Plague, arsenic, and a dried toad	LANCET			English	Editorial Material									NYU, Dept English, New York, NY 10003 USA	New York University	Gilman, EB (corresponding author), NYU, Dept English, New York, NY 10003 USA.	ernest.gilman@nyu.edu						Gilman Ernest B., 2009, PLAGUE WRITING EARLY; Healy M., 2001, FICTIONS DIS EARLY M; Karlen A., 1995, MAN MICROBES DIS PLA; Slack, 1985, IMPACT PLAGUE TUDOR, P201; Totaro Rebecca, 2005, SUFFERING PARADISE B	5	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2018	2019		10.1016/S0140-6736(09)61100-4	http://dx.doi.org/10.1016/S0140-6736(09)61100-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19533834				2022-12-28	WOS:000267080100014
J	Hsieh, TF; Ibarra, CA; Silva, P; Zemach, A; Eshed-Williams, L; Fischer, RL; Zilberman, D				Hsieh, Tzung-Fu; Ibarra, Christian A.; Silva, Pedro; Zemach, Assaf; Eshed-Williams, Leor; Fischer, Robert L.; Zilberman, Daniel			Genome-Wide Demethylation of Arabidopsis Endosperm	SCIENCE			English	Article							DNA METHYLATION; GENE; DEMETER; DOMAIN; PLANTS; CELLS; MAPS	Parent-of-origin-specific (imprinted) gene expression is regulated in Arabidopsis thaliana endosperm by cytosine demethylation of the maternal genome mediated by the DNA glycosylase DEMETER, but the extent of the methylation changes is not known. Here, we show that virtually the entire endosperm genome is demethylated, coupled with extensive local non-CG hypermethylation of small interfering RNA-targeted sequences. Mutation of DEMETER partially restores endosperm CG methylation to levels found in other tissues, indicating that CG demethylation is specific to maternal sequences. Endosperm demethylation is accompanied by CHH hypermethylation of embryo transposable elements. Our findings demonstrate extensive reconfiguration of the endosperm methylation landscape that likely reinforces transposon silencing in the embryo.	[Hsieh, Tzung-Fu; Ibarra, Christian A.; Silva, Pedro; Zemach, Assaf; Eshed-Williams, Leor; Fischer, Robert L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu; daniel.zilberman@nature.berkeley.edu	Silva, Pedro/H-9497-2012	Silva, Pedro/0000-0002-9889-3075; Eshed Williams, Leor/0000-0002-2766-2608; Zilberman, Daniel/0000-0002-0123-8649; Zemach, Assaf/0000-0003-3282-4445; Hsieh, Tzung-Fu/0000-0001-7584-3721	NIH [GM69415]; fellow of the Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); fellow of the Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Tonkin for performing Illumina sequencing, J. Shin for gene annotation, and S. Henikoff for sharing unpublished data. This work was partially funded by an NIH grant (GM69415) to R.L.F. A.Z. is a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. Sequencing data are deposited in GEO with accession number GSE15922 [NCBI GEO] .	Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Han YZ, 2000, PLANTA, V211, P158, DOI 10.1007/s004250000289; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huh JH, 2008, CELL, V132, P735, DOI 10.1016/j.cell.2008.02.018; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Munshi Anjana, 2007, Journal of Genetics and Genomics, V34, P93, DOI 10.1016/S1673-8527(07)60010-1; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929	17	474	499	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1451	1454		10.1126/science.1172417	http://dx.doi.org/10.1126/science.1172417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520962	Green Accepted			2022-12-28	WOS:000266878700048
J	Maksymovych, P; Jesse, S; Yu, P; Ramesh, R; Baddorf, AP; Kalinin, SV				Maksymovych, Peter; Jesse, Stephen; Yu, Pu; Ramesh, Ramamoorthy; Baddorf, Arthur P.; Kalinin, Sergei V.			Polarization Control of Electron Tunneling into Ferroelectric Surfaces	SCIENCE			English	Article							LOCAL POLARIZATION; RESISTANCE; CONDUCTION; NANOSCALE; JUNCTIONS; EMISSION	We demonstrate a highly reproducible control of local electron transport through a ferroelectric oxide via its spontaneous polarization. Electrons are injected from the tip of an atomic force microscope into a thin film of lead-zirconate titanate, Pb(Zr0.2Ti0.8)O-3, in the regime of electron tunneling assisted by a high electric field (Fowler-Nordheim tunneling). The tunneling current exhibits a pronounced hysteresis with abrupt switching events that coincide, within experimental resolution, with the local switching of ferroelectric polarization. The large spontaneous polarization of the PZT film results in up to 500-fold amplification of the tunneling current upon ferroelectric switching. The magnitude of the effect is subject to electrostatic control via ferroelectric switching, suggesting possible applications in ultrahigh-density data storage and spintronics.	[Maksymovych, Peter; Jesse, Stephen; Baddorf, Arthur P.; Kalinin, Sergei V.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Yu, Pu; Ramesh, Ramamoorthy] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Yu, Pu; Ramesh, Ramamoorthy] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Maksymovych, P (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.	maksymovychp@ornl.gov	Maksymovych, Petro/C-3922-2016; Yu, Pu/F-1594-2014; Ramesh, Ramamoorthy/ABI-4883-2020; Baddorf, Arthur P/I-1308-2016; Kalinin, Sergei V/I-9096-2012; Kalinin, Sergei V/GQP-1812-2022; Jesse, Stephen/D-3975-2016; Kim, Yu Jin/A-2433-2012	Maksymovych, Petro/0000-0003-0822-8459; Yu, Pu/0000-0002-5513-7632; Baddorf, Arthur P/0000-0001-7023-2382; Kalinin, Sergei V/0000-0001-5354-6152; Kalinin, Sergei V/0000-0001-5354-6152; Jesse, Stephen/0000-0002-1168-8483; 	Semiconductor Research Corporation Nanoelectronics Research Initiative Western Institute of Nanoelectrics program; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the US Department of Energy [DE-AC02-05CH1123]	Semiconductor Research Corporation Nanoelectronics Research Initiative Western Institute of Nanoelectrics program; Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the US Department of Energy(United States Department of Energy (DOE))	Experiments were done at the Center for Nanophase Materials Sciences, Office of Basic Energy Sciences, U.S. Department of Energy. P.M.s research performed as a Eugene P. Wigner Fellow and staff member at the Oak Ridge National Laboratory. The work at Berkeley is partially supported by the Semiconductor Research Corporation Nanoelectronics Research Initiative Western Institute of Nanoelectrics program as well as by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the US Department of Energy under contract no. DE-AC02-05CH1123.	Aguado-Puente P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177601; Ahn CH, 2004, SCIENCE, V303, P488, DOI 10.1126/science.1092508; Bez R, 2003, P IEEE, V91, P489, DOI 10.1109/JPROC.2003.811702; BINNIG G, 1986, IBM J RES DEV, V30, P355; BLOM PWM, 1994, PHYS REV LETT, V73, P2107, DOI 10.1103/PhysRevLett.73.2107; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Esaki L., 1971, IBM TECH DISCL B, V13, P2161; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Gajek M, 2007, NAT MATER, V6, P296, DOI 10.1038/nmat1860; Jesse S, 2006, NANOTECHNOLOGY, V17, P1615, DOI 10.1088/0957-4484/17/6/014; Jesse S, 2008, NAT MATER, V7, P209, DOI 10.1038/nmat2114; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kohlstedt H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125341; Kohlstedt H, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841917; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Morozovska AN, 2006, PHYSICA B, V373, P54, DOI 10.1016/j.physb.2005.11.049; Morozovska AN, 2007, FERROELECTRICS, V354, P198, DOI 10.1080/00150190701454966; Nagarajan V, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337363; Pintilie L, 2005, J APPL PHYS, V98, DOI 10.1063/1.2148622; Pintilie L, 2005, J APPL PHYS, V98, DOI 10.1063/1.2148623; Scott J.F., 2000, FERROELECTRIC MEMORI; Stolichnov I, 1998, APPL PHYS LETT, V73, P1361, DOI 10.1063/1.122374; Stolichnov I, 1999, APPL PHYS LETT, V75, P1790, DOI 10.1063/1.124821; Sze S.M., 2002, SEMICONDUCTOR DEVICE, V2nd; Szot K, 2006, NAT MATER, V5, P312, DOI 10.1038/nmat1614; Tagantsev AK, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337009; Tsymbal EY, 2006, SCIENCE, V313, P181, DOI 10.1126/science.1126230; Tung RT, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.205310; Velev JP, 2009, NANO LETT, V9, P427, DOI 10.1021/nl803318d; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Watanabe Y, 2007, FERROELECTRICS, V349, P190, DOI 10.1080/00150190701261031; Wicks S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465502; Yoshida C, 1999, APPL PHYS LETT, V75, P1449, DOI 10.1063/1.124721	35	397	404	10	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1421	1425		10.1126/science.1171200	http://dx.doi.org/10.1126/science.1171200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520954				2022-12-28	WOS:000266878700039
J	Grove, CS; Follows, GA; Erber, WN				Grove, Carolyn S.; Follows, George A.; Erber, Wendy N.			Rational Testing Incidental finding of lymphocytosis in an asymptomatic patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEUKEMIA		[Grove, Carolyn S.; Follows, George A.; Erber, Wendy N.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Erber, WN (corresponding author), Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England.	wendy.erber@addenbrookes.nhs.uk	Erber, Wendy/A-1955-2012	Erber, Wendy/0000-0002-1028-9376	Cambridge University Hospitals NHS Foundation Trust	Cambridge University Hospitals NHS Foundation Trust	The contributors are employees of Cambridge University Hospitals NHS Foundation Trust.	Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Gudgin EJ, 2005, PATHOLOGY, V37, P457, DOI 10.1080/00313020500368287; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; MONTSERRAT E, 1986, BRIT J HAEMATOL, V62, P567, DOI 10.1111/j.1365-2141.1986.tb02969.x; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Simon MW, 2003, INT PEDIAT, V18, P20; Swerdlow SH, 2008, WHO CLASSIFICATION T	8	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2009	338								b2119	10.1136/bmj.b2119	http://dx.doi.org/10.1136/bmj.b2119			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LI	19515711				2022-12-28	WOS:000267022000006
J	Bindi, L; Steinhardt, PJ; Yao, N; Lu, PJ				Bindi, Luca; Steinhardt, Paul J.; Yao, Nan; Lu, Peter J.			Natural Quasicrystals	SCIENCE			English	Article							QUASICRYSTALS; SYSTEM	Quasicrystals are solids whose atomic arrangements have symmetries that are forbidden for periodic crystals, including configurations with fivefold symmetry. All examples identified to date have been synthesized in the laboratory under controlled conditions. Here we present evidence of a naturally occurring icosahedral quasicrystal that includes six distinct fivefold symmetry axes. The mineral, an alloy of aluminum, copper, and iron, occurs as micrometer-sized grains associated with crystalline khatyrkite and cupalite in samples reported to have come from the Koryak Mountains in Russia. The results suggest that quasicrystals can form and remain stable under geologic conditions, although there remain open questions as to how this mineral formed naturally.	[Steinhardt, Paul J.] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08544 USA; [Bindi, Luca] Univ Florence, Museo Storia Nat, Sez Mineral, I-50121 Florence, Italy; [Steinhardt, Paul J.] Princeton Univ, Joseph Henry Labs, Dept Phys, Princeton, NJ 08544 USA; [Yao, Nan] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA; [Lu, Peter J.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Lu, Peter J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Princeton University; University of Florence; Princeton University; Princeton University; Harvard University; Harvard University	Steinhardt, PJ (corresponding author), Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08544 USA.	steinh@princeton.edu	Lu, Peter J/G-1971-2011; Yao, Nan/H-2423-2011	Lu, Peter J/0000-0003-1489-5725; Steinhardt, Paul/0000-0003-3488-1603; Yao, Nan/0000-0002-4081-1495	U.S. Department of Energy [DE-FG02-91ER40671]; NSF MRSEC program through New York University [DMR-0820341]; Princeton Center for Complex Materials [DMR-0819860]; New Jersey Commission of Science and Technology	U.S. Department of Energy(United States Department of Energy (DOE)); NSF MRSEC program through New York University(National Science Foundation (NSF)); Princeton Center for Complex Materials; New Jersey Commission of Science and Technology	We are indebted to L. Hollister and G. MacPherson for their critical examination of the results, especially regarding the issue of natural origin. We also thank P. Bonazzi, K. Deffeyes, S. Menchetti, and P. Spry for useful discussions and S. Bambi at the Museo di Storia Naturale for the photograph of the original sample in Fig. 1A. L.B. thanks the Ministerio dell Istruzione dell Universita e della Ricerca Programma di Ricerca Nazionale 2007 project "Complexity in minerals: modulation, phase transition, structural disorder," issued to S. Menchetti. This work was supported in part by U.S. Department of Energy grant DE-FG02-91ER40671 (P.J.S.), the NSF MRSEC program through New York University (grant DMR-0820341, P.J.S.), the Princeton Center for Complex Materials (grant DMR-0819860, N.Y.), and the New Jersey Commission of Science and Technology (N.Y.).	Bancel PA, 1991, QUASICRYSTALS STATE, P17; DAM B, 1985, PHYS REV LETT, V55, P2301, DOI 10.1103/PhysRevLett.55.2301; Filatova NI, 1997, TECTONOPHYSICS, V269, P131, DOI 10.1016/S0040-1951(96)00156-4; HAWTHORNE FC, 1986, AM MINERAL, V71, P1277; Janot C., 1994, QUASICRYSTALS PRIMER; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; LEVINE D, 1985, PHYS REV LETT, V54, P1520, DOI 10.1103/PhysRevLett.54.1520; Lu PJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.275507; LUBENSKY TC, 1986, PHYS REV LETT, V57, P1440, DOI 10.1103/PhysRevLett.57.1440; MAKOVICKY E, 1981, STRUCT BOND, V46, P101; Penrose R., 1974, B I MATH APPL, V10, P266; Razin L. V., 1985, ZAPISKI VSES MINERAL, V114, p90 ~ 100; SHECHTMAN D, 1951, PHYS REV LETT, V53, P1984; TSAI AP, 1987, JPN J APPL PHYS 2, V26, pL1505, DOI 10.1143/JJAP.26.L1505; Zhang LM, 2003, Z METALLKD, V94, P774, DOI 10.3139/146.030774	15	184	191	10	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1306	1309		10.1126/science.1170827	http://dx.doi.org/10.1126/science.1170827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498165				2022-12-28	WOS:000266635100039
J	Sundrud, MS; Koralov, SB; Feuerer, M; Calado, DP; Kozhaya, AE; Rhule-Smith, A; Lefebvre, RE; Unutmaz, D; Mazitschek, R; Waldner, H; Whitman, M; Keller, T; Rao, A				Sundrud, Mark S.; Koralov, Sergei B.; Feuerer, Markus; Calado, Dinis Pedro; Kozhaya, Aimee ElHed; Rhule-Smith, Ava; Lefebvre, Rachel E.; Unutmaz, Derya; Mazitschek, Ralph; Waldner, Hanspeter; Whitman, Malcolm; Keller, Tracy; Rao, Anjana			Halofuginone Inhibits T(H)17 Cell Differentiation by Activating the Amino Acid Starvation Response	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; REGULATORY T-CELLS; NF-KAPPA-B; GENE-EXPRESSION; ROR-GAMMA; STRESS; INFLAMMATION; GENERATION; INITIATION; INDUCTION	A central challenge for improving autoimmune therapy is preventing inflammatory pathology without inducing generalized immunosuppression. T helper 17 (T(H)17) cells, characterized by their production of interleukin-17, have emerged as important and broad mediators of autoimmunity. Here we show that the small molecule halofuginone (HF) selectively inhibits mouse and human T(H)17 differentiation by activating a cytoprotective signaling pathway, the amino acid starvation response (AAR). Inhibition of T(H)17 differentiation by HF is rescued by the addition of excess amino acids and is mimicked by AAR activation after selective amino acid depletion. HF also induces the AAR in vivo and protects mice from T(H)17-associated experimental autoimmune encephalomyelitis. These results indicate that the AAR pathway is a potent and selective regulator of inflammatory T cell differentiation in vivo.	[Whitman, Malcolm; Keller, Tracy] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Sundrud, Mark S.; Koralov, Sergei B.; Calado, Dinis Pedro; Lefebvre, Rachel E.; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sundrud, Mark S.; Koralov, Sergei B.; Calado, Dinis Pedro; Lefebvre, Rachel E.; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Feuerer, Markus] Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; [Kozhaya, Aimee ElHed; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Kozhaya, Aimee ElHed; Unutmaz, Derya] NYU, Sch Med, Microbial Pathogenesis Program, New York, NY 10016 USA; [Rhule-Smith, Ava; Waldner, Hanspeter] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA; [Mazitschek, Ralph] Broad Inst, Chem Biol Program, Cambridge, MA 02142 USA; [Mazitschek, Ralph] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02142 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Joslin Diabetes Center, Inc.; New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Whitman, M (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA.	whitman@hms.harvard.edu; tkeller@hms.harvard.edu; arao@idi.harvard.edu	Mazitschek, Ralph/E-3741-2013; Calado, Dinis/U-8379-2019	Mazitschek, Ralph/0000-0002-1105-689X; Calado, Dinis/0000-0001-8239-7184; Koralov, Sergei/0000-0002-4843-3791	NIH [T32, P01]; Juvenile Diabetes Research Foundation; Irvington Institute fellowship program of the Cancer Research Institute; Portuguese Foundation for Science and Technology fellowship; NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, R01AI048213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Irvington Institute fellowship program of the Cancer Research Institute; Portuguese Foundation for Science and Technology fellowship(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D. Littman and A. Rudensky provided reagents for this work, and K. Otipoby prepared recombinant TAT-Cre. We thank J. Hill and K. Leatherbee for technical assistance with microarray data analysis and members of the Rao lab for critical discussion. This work was supported by grants from NIH (to A.R., D.U., and M.W.) and the Juvenile Diabetes Research Foundation (to A.R.). M.S.S. was supported by the Irvington Institute fellowship program of the Cancer Research Institute. D.P.C. was supported by a fellowship from the Portuguese Foundation for Science and Technology. S.K. was supported by an NIH training grant (T32). Further support was provided by a P01 grant to K Rajewsky. M.S.S., A.R., T.K., and M.W. have filed patent applications concerning the use of HF and its derivatives to inhibit TH17 cell differentiation. Array data can be found at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15624 with the accession number of GSE15624 [NCBI GEO] .	Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gnainsky Y, 2007, CELL TISSUE RES, V328, P153, DOI 10.1007/s00441-006-0330-1; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KAMBEROV Y, 2008, THESIS HARVARD U; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Leiba M, 2006, J LEUKOCYTE BIOL, V80, P399, DOI 10.1189/jlb.0705409; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	29	282	307	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1334	1338		10.1126/science.1172638	http://dx.doi.org/10.1126/science.1172638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498172	Green Accepted			2022-12-28	WOS:000266635100048
J	Tabak, AG; Jokela, M; Akbaraly, TN; Brunner, EJ; Kivimaki, M; Witte, DR				Tabak, Adam G.; Jokela, Markus; Akbaraly, Tasnime N.; Brunner, Eric J.; Kivimaki, Mika; Witte, Daniel R.			Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study	LANCET			English	Article							BETA-CELL FUNCTION; IMPAIRED GLUCOSE-TOLERANCE; NATURAL-HISTORY; PLASMA-GLUCOSE; LIFE-STYLE; HIGH-RISK; RESISTANCE; DYSFUNCTION; PROGRESSION; PREVENTION	Background Little is known about the timing of changes in glucose metabolism before occurrence of type 2 diabetes. We aimed to characterise trajectories of fasting and posdoad glucose, insulin sensitivity, and insulin secretion in individuals who develop type 2 diabetes. Methods We analysed data from our prospective occupational cohort study (Whitehall II study) of 6538 (71% male and 91% white) British civil servants without diabetes mellitus at baseline. During a median follow-up period of 9.7 years, 505 diabetes cases were diagnosed (49.1% on the basis of oral glucose tolerance test). We assessed retrospective trajectories of fasting and 2-h postload glucose, homoeostasis model assessment (HOMA) insulin sensitivity, and HOMA beta-cell function from up to 13 years before diabetes diagnosis (diabetic group) or at the end of follow-up (non-diabetics). Findings Multilevel models adjusted for age, sex, and ethnic origin confirmed that all metabolic measures followed linear trends in the group of non-diabetics (10989 measurements), except for insulin secretion that did not change during follow-up. In the diabetic group (801 measurements), a linear increase in fasting glucose was followed by a steep quadratic increase (from 5.79 mmol/L to 7.40 mmol/L) starting 3 years before diagnosis of diabetes. 2-h postload glucose showed a rapid increase starting 3 years before diagnosis (from 7.60 mmol/L to 11.90 mmol/L), and HOMA insulin sensitivity decreased steeply during the 5 years before diagnosis (to 86.7%). HOMA beta-cell function increased between years 4 and 3 before diagnosis (from 85.0% to 92.6%) and then decreased until diagnosis (to 62.4%). Interpretation In this study, we show changes in glucose concentrations, insulin sensitivity, and insulin secretion as much as 3-6 years before diagnosis of diabetes. The description of biomarker trajectories leading to diabetes diagnosis could contribute to more-accurate risk prediction models that use repeated measures available for patients through regular check-ups. Funding Medical Research Council (UK); Economic and Social Research Council (UK); British Heart Foundation (UK); Health and Safety Executive (UK); Department of Health (UK); National Institute of Health (USA); Agency for Health Care Policy Research (USA); the John D and Catherine T MacArthur Foundation (USA); and Academy of Finland (Finland).	[Tabak, Adam G.; Jokela, Markus; Akbaraly, Tasnime N.; Brunner, Eric J.; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary; [Jokela, Markus] Univ Helsinki, Dept Psychol, SF-00100 Helsinki, Finland; [Akbaraly, Tasnime N.] INSERM, U888, Montpellier, France; [Akbaraly, Tasnime N.] Univ Montpellier I, Montpellier, France; [Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark	University of London; University College London; Semmelweis University; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Finnish Institute of Occupational Health; Steno Diabetes Center	Tabak, AG (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	a.tabak@ucl.ac.uk	Jokela, Markus/A-4669-2009; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008; Kivimaki, Mika/B-3607-2012; AKBARALY, Tasnime/H-1389-2018; Tabak, Adam/A-5007-2012; Brunner, Eric/H-2114-2011	Jokela, Markus/0000-0003-0117-0012; Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Kivimaki, Mika/0000-0002-4699-5627; AKBARALY, Tasnime/0000-0002-2150-4190; Brunner, Eric/0000-0002-0595-4474; Tabak, Adam/0000-0002-6234-3936	Medical Research Council New Investigator Award [G0501184]; Medical Research Council, Economic and Social Research Council; British Heart Foundation; Health and Safety Executive, and Department of Health (UK); National Heart Lung and Blood institute [HL36310]; National Institute on Aging [AG13196]; Agency for Health Care Policy Research [HS06516]; The John D and Catherine T MacArthur Foundation (USA); Academy of Finland; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0501184, G0100222, G19/35, G8802774] Funding Source: researchfish; MRC [G0501184] Funding Source: UKRI; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER	Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, Economic and Social Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive, and Department of Health (UK); National Heart Lung and Blood institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); The John D and Catherine T MacArthur Foundation (USA); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank JE Ferrie for her comments on an early version ofthis manuscript. This work is funded by the Medical Research Council New Investigator Award (G0501184). The Whitehall II study is supported by the following bodies: Medical Research Council, Economic and Social Research Council, British Heart Foundation, Health and Safety Executive, and Department of Health (UK); and National Heart Lung and Blood institute (HL36310), National Institute on Aging (AG13196), Agency for Health Care Policy Research (HS06516), The John D and Catherine T MacArthur Foundation (USA). MK is supported by the Academy of Finland.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Ahren B, 2004, EUR J ENDOCRINOL, V150, P97, DOI 10.1530/eje.0.1500097; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALPERT L, 1976, LAB WORLD, V27, P8; ANDERSEN L, 1993, CLIN CHEM, V39, P578; Astles JR, 1996, CLIN BIOCHEM, V29, P27, DOI 10.1016/0009-9120(95)02010-1; Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Cooper G R, 1973, CRC Crit Rev Clin Lab Sci, V4, P101, DOI 10.3109/10408367309151554; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Ferrannini E, 2004, DIABETOLOGIA, V47, P943, DOI 10.1007/s00125-004-1381-z; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Guerrero-Romero F, 2006, EUR J CLIN INVEST, V36, P796, DOI 10.1111/j.1365-2362.2006.01728.x; HANNING I, 1985, DIABETOLOGIA, V28, P831, DOI 10.1007/BF00291073; Hong J, 2007, ENDOCRINE, V31, P93, DOI 10.1007/s12020-007-0002-2; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Laspa E, 2007, DIABETIC MED, V24, P1269, DOI 10.1111/j.1464-5491.2007.02225.x; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Mari A, 2005, CURR OPIN CLIN NUTR, V8, P529, DOI 10.1097/01.mco.0000171130.23441.59; Mari A, 2005, DIABETOLOGIA, V48, P748, DOI 10.1007/s00125-005-1683-9; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; Qiao Q, 2003, DIABETES CARE, V26, P688; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Singer J.D., 2003, APPL LONGITUDINAL DA; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tripathy D, 2000, DIABETES, V49, P975, DOI 10.2337/diabetes.49.6.975; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Xiang AH, 2006, DIABETES, V55, P1074, DOI 10.2337/diabetes.55.04.06.db05-1109	44	545	561	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2215	2221		10.1016/S0140-6736(09)60619-X	http://dx.doi.org/10.1016/S0140-6736(09)60619-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463PQ	19515410	Green Accepted			2022-12-28	WOS:000267444500033
J	Helder, EA; Vink, J; Bassa, CG; Bamba, A; Bleeker, JAM; Funk, S; Ghavamian, P; van der Heyden, KJ; Verbunt, F; Yamazaki, R				Helder, E. A.; Vink, J.; Bassa, C. G.; Bamba, A.; Bleeker, J. A. M.; Funk, S.; Ghavamian, P.; van der Heyden, K. J.; Verbunt, F.; Yamazaki, R.			Measuring the Cosmic-Ray Acceleration Efficiency of a Supernova Remnant	SCIENCE			English	Article							DIFFUSIVE SHOCK ACCELERATION; BALMER-DOMINATED SHOCKS; RCW 86; EMISSION; SPECTROSCOPY; TEMPERATURE; FILAMENTS; SPECTRA; MODEL; SHELL	Cosmic rays are the most energetic particles arriving at Earth. Although most of them are thought to be accelerated by supernova remnants, the details of the acceleration process and its efficiency are not well determined. Here we show that the pressure induced by cosmic rays exceeds the thermal pressure behind the northeast shock of the supernova remnant RCW 86, where the x-ray emission is dominated by synchrotron radiation from ultrarelativistic electrons. We determined the cosmic-ray content from the thermal Doppler broadening measured with optical spectroscopy, combined with a proper-motion study in x-rays. The measured postshock proton temperature, in combination with the shock velocity, does not agree with standard shock heating, implying that >50% of the postshock pressure is produced by cosmic rays.	[Helder, E. A.; Vink, J.; Bleeker, J. A. M.; Verbunt, F.] Univ Utrecht, Astron Inst, NL-3508 TA Utrecht, Netherlands; [Bassa, C. G.; Bleeker, J. A. M.] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Bassa, C. G.] Radboud Univ Nijmegen, Dept Astrophys, NL-6525 ED Nijmegen, Netherlands; [Bamba, A.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept High Energy Astrophys, Sagamihara, Kanagawa 2298510, Japan; [Funk, S.] Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94025 USA; [Ghavamian, P.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [van der Heyden, K. J.] Univ Cape Town, Dept Astron, ZA-7701 Rondebosch, South Africa; [Yamazaki, R.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan	Utrecht University; Radboud University Nijmegen; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Space Telescope Science Institute; University of Cape Town; Hiroshima University	Helder, EA (corresponding author), Univ Utrecht, Astron Inst, POB 80000, NL-3508 TA Utrecht, Netherlands.	e.a.helder@uu.nl	Funk, Stefan/B-7629-2015; Funk, Stefan/AAI-1568-2021	Funk, Stefan/0000-0002-2012-0080; Funk, Stefan/0000-0002-2012-0080; Vink, Jacco/0000-0002-4708-4219; Bassa, Cees/0000-0002-1429-9010	Japanese Ministry of Education, Culture, Sports, Science and Technology [194014, 19047004, 21740184]; Smithsonian Astrophysical Observatory [G07-8073X]; Space Telescope Science Institute [GO-11184.07]; Paranal Observatories [079.D-0735]; Grants-in-Aid for Scientific Research [21740184] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smithsonian Astrophysical Observatory; Space Telescope Science Institute(Space Telescope Science Institute); Paranal Observatories; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, no. 194014 (A.B.) and no. 19047004 and 21740184 (R.Y.). S.F. is supported by Smithsonian Astrophysical Observatory grant G07-8073X. P.G. is supported by the Space Telescope Science Institute grant GO-11184.07. This paper is based in part on observations made with European Southern Observatory Telescopes at the Paranal Observatories under program ID 079.D-0735.	Aharonian F, 2009, ASTROPHYS J, V692, P1500, DOI 10.1088/0004-637X/692/2/1500; Aharonian FA, 2004, NATURE, V432, P75, DOI 10.1038/nature02960; Aharonian FA, 1999, ASTRON ASTROPHYS, V351, P330; Albert J, 2007, ASTRON ASTROPHYS, V474, P937, DOI 10.1051/0004-6361:20078168; Appenzeller I., 1998, MSNGR, V94, P1; Bamba A, 2005, ASTROPHYS J, V621, P793, DOI 10.1086/427620; Berezhko EG, 1999, ASTROPHYS J, V526, P385, DOI 10.1086/307993; BRAND J, 1993, ASTRON ASTROPHYS, V275, P67; Bykov AM, 2008, SPACE SCI REV, V134, P119, DOI 10.1007/s11214-008-9312-9; Cassam-Chenai G, 2008, ASTROPHYS J, V680, P1180, DOI 10.1086/588015; CHEVALIER RA, 1983, ASTROPHYS J, V272, P765, DOI 10.1086/161338; CHEVALIER RA, 1980, ASTROPHYS J, V235, P186, DOI 10.1086/157623; Decourchelle A, 2000, ASTROPHYS J, V543, pL57, DOI 10.1086/318167; Drury LO, 2009, ASTRON ASTROPHYS, V496, P1, DOI 10.1051/0004-6361/200811394; Drury LO, 1996, ASTRON ASTROPHYS, V309, P1002; Dwarkadas VV, 2005, ASTROPHYS J, V630, P892, DOI 10.1086/432109; Ghavamian P, 2000, ASTROPHYS J, V535, P266, DOI 10.1086/308811; Ghavamian P, 2001, ASTROPHYS J, V547, P995, DOI 10.1086/318408; Ghavamian P, 2007, ASTROPHYS J, V654, pL69, DOI 10.1086/510740; Helder EA, 2008, ASTROPHYS J, V686, P1094, DOI 10.1086/591242; Heng K, 2007, ASTROPHYS J, V654, P923, DOI 10.1086/509601; Hughes JP, 2000, ASTROPHYS J, V543, pL61, DOI 10.1086/317102; Katsuda S, 2008, ASTROPHYS J LETT, V678, pL35, DOI 10.1086/588499; KOYAMA K, 1995, NATURE, V378, P255, DOI 10.1038/378255a0; Lee JJ, 2007, ASTROPHYS J, V659, pL133, DOI 10.1086/517520; LONG KS, 1990, ASTROPHYS J, V358, pL13, DOI 10.1086/185768; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Malkov MA, 1999, ASTROPHYS J, V511, pL53, DOI 10.1086/311825; Matsunaga K, 2001, PUBL ASTRON SOC JPN, V53, P1003, DOI 10.1093/pasj/53.6.1003; Patnaude DJ, 2009, ASTROPHYS J, V696, P1956, DOI 10.1088/0004-637X/696/2/1956; Raymond JC, 2008, ASTROPHYS J, V682, P408, DOI 10.1086/589645; Rho JH, 2002, ASTROPHYS J, V581, P1116, DOI 10.1086/344248; Rosado M, 1996, ASTRON ASTROPHYS, V315, P243; SMITH RC, 1991, ASTROPHYS J, V375, P652, DOI 10.1086/170228; Sollerman J, 2003, ASTRON ASTROPHYS, V407, P249, DOI 10.1051/0004-6361:20030839; Starck J.-L., 1998, IMAGE PROCESSING DAT; Stephenson F. R., 2002, INT SERIES ASTRONOMY, V5; van Adelsberg M, 2008, ASTROPHYS J, V689, P1089, DOI 10.1086/592680; Vink J, 1997, ASTRON ASTROPHYS, V328, P628; Vink J, 2006, ASTROPHYS J, V648, pL33, DOI 10.1086/507628; Vink J, 2009, AIP CONF PROC, V1085, P169; Wagner AY, 2009, ASTROPHYS J, V690, P1412, DOI 10.1088/0004-637X/690/2/1412; Warren JS, 2005, ASTROPHYS J, V634, P376, DOI 10.1086/496941; WESTERLU.BE, 1969, ASTRON J, V74, P879, DOI 10.1086/110876; Winkler PF, 2003, ASTROPHYS J, V585, P324, DOI 10.1086/345985	45	124	124	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 7	2009	325	5941					719	722		10.1126/science.1173383	http://dx.doi.org/10.1126/science.1173383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480HF	19556465	Green Published, Green Submitted			2022-12-28	WOS:000268723700041
J	Kornmann, B; Currie, E; Collins, SR; Schuldiner, M; Nunnari, J; Weissman, JS; Walter, P				Kornmann, Benoit; Currie, Erin; Collins, Sean R.; Schuldiner, Maya; Nunnari, Jodi; Weissman, Jonathan S.; Walter, Peter			An ER-Mitochondria Tethering Complex Revealed by a Synthetic Biology Screen	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; BIOSYNTHETIC PATHWAYS; YEAST; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; PROTEINS; PHOSPHATIDYLSERINE; INHERITANCE; MORPHOLOGY	Communication between organelles is an important feature of all eukaryotic cells. To uncover components involved in mitochondria/endoplasmic reticulum (ER) junctions, we screened for mutants that could be complemented by a synthetic protein designed to artificially tether the two organelles. We identified the Mmm1/Mdm10/Mdm12/Mdm34 complex as a molecular tether between ER and mitochondria. The tethering complex was composed of proteins resident of both ER and mitochondria. With the use of genome-wide mapping of genetic interactions, we showed that the components of the tethering complex were functionally connected to phospholipid biosynthesis and calcium-signaling genes. In mutant cells, phospholipid biosynthesis was impaired. The tethering complex localized to discrete foci, suggesting that discrete sites of close apposition between ER and mitochondria facilitate interorganelle calcium and phospholipid exchange.	[Kornmann, Benoit; Currie, Erin; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Collins, Sean R.; Weissman, Jonathan S.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Nunnari, Jodi] Univ Calif Davis, Davis, CA 95616 USA; [Schuldiner, Maya] Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Davis; Weizmann Institute of Science	Kornmann, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	benoit.kornmann@ucsf.edu	Schuldiner, Maya/C-9488-2009; Kornmann, Benoît/B-6388-2018; Weisbart, Erin/AAE-5505-2022	Kornmann, Benoît/0000-0002-6030-8555; Weisbart, Erin/0000-0002-6437-2458; Schuldiner, Maya/0000-0001-9947-115X; Weissman, Jonathan/0000-0003-2445-670X; Collins, Sean/0000-0002-4276-5840	NIH; Swiss National Science Foundation; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942, R01GM032384] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH. B.K. is a fellow of the Swiss National Science Foundation; M.S. is supported by a Human Frontiers Science Program Career Development Award; and P.W. and J.S.W. are investigators at the Howard Hughes Medical Institute.	Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; MCCONNELL SJ, 1990, J CELL BIOL, V111, P967, DOI 10.1083/jcb.111.3.967; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; VANCE JE, 1991, J BIOL CHEM, V266, P89; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; [No title captured]	32	864	882	4	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					477	481		10.1126/science.1175088	http://dx.doi.org/10.1126/science.1175088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19556461	Green Accepted			2022-12-28	WOS:000268255100057
J	Yazici, Y				Yazici, Yusuf			Treatment of rheumatoid arthritis: we are getting there	LANCET			English	Editorial Material							FACTOR-ALPHA INHIBITORS; DISEASE-ACTIVITY SCORE; ROUTINE ASSESSMENT; RANDOMIZED-TRIAL; METHOTREXATE; DRUG; SAFETY; INDEX; TIME; CARE		NYU, Sch Med, NYU Hosp Joint Dis, New York, NY 10003 USA	New York University	Yazici, Y (corresponding author), NYU, Sch Med, NYU Hosp Joint Dis, New York, NY 10003 USA.	yusuf.yazici@nyumc.org						Duclos M, 2006, J RHEUMATOL, V33, P2433; Goekoop-Ruiterman YPM, 2007, ANN INTERN MED, V146, P406, DOI 10.7326/0003-4819-146-6-200703200-00005; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Hjardem E, 2007, ANN RHEUM DIS, V66, P1184, DOI 10.1136/ard.2006.054742; Hyrich KL, 2008, RHEUMATOLOGY, V47, P1000, DOI 10.1093/rheumatology/ken127; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Yazici Y, 2008, RHEUMATOLOGY, V47, P1054, DOI 10.1093/rheumatology/ken190; Yazici Y, 2008, CLIN EXP RHEUMATOL, V26, P449; Yazici Y, 2007, ANN RHEUM DIS, V66, P124, DOI 10.1136/ard.2006.055848; Yazici Y, 2005, ANN RHEUM DIS, V64, P207, DOI 10.1136/ard.2004.023408; Yazici Y, 2008, J RHEUMATOL, V35, P603	15	27	28	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 18	2009	374	9685					178	180		10.1016/S0140-6736(09)60792-3	http://dx.doi.org/10.1016/S0140-6736(09)60792-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19560809				2022-12-28	WOS:000268263000005
J	Iglehart, JK				Iglehart, John K.			Finding Money for Health Care Reform - Rooting Out Waste, Fraud, and Abuse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		IGLEHART JK, HLTH AFF MI IN PRESS; WEEMS K, 2009, WALL STREET J   0414	2	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					229	231		10.1056/NEJMp0904854	http://dx.doi.org/10.1056/NEJMp0904854			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470LL	19516025				2022-12-28	WOS:000267976100002
J	Araki, K; Turner, AP; Shaffer, VO; Gangappa, S; Keller, SA; Bachmann, MF; Larsen, CP; Ahmed, R				Araki, Koichi; Turner, Alexandra P.; Shaffer, Virginia Oliva; Gangappa, Shivaprakash; Keller, Susanne A.; Bachmann, Martin F.; Larsen, Christian P.; Ahmed, Rafi			mTOR regulates memory CD8 T-cell differentiation	NATURE			English	Article							SELECTIVE EXPRESSION; DENDRITIC CELLS; VIRAL-INFECTION; EFFECTOR; RECEPTOR; RAPAMYCIN; SUBSETS; HOMEOSTASIS; PATHWAY; TARGET	Memory CD8 T cells are a critical component of protective immunity, and inducing effective memory T-cell responses is a major goal of vaccines against chronic infections and tumours(1-3). Considerable effort has gone into designing vaccine regimens that will increase the magnitude of the memory response, but there has been minimal emphasis on developing strategies to improve the functional qualities of memory T cells(4). Here we show that mTOR (mammalian target of rapamycin(5), also known as FRAP1) is a major regulator of memory CD8 T-cell differentiation, and in contrast to what we expected, the immunosuppressive drug rapamycin has immunostimulatory effects on the generation of memory CD8 T cells. Treatment of mice with rapamycin following acute lymphocytic choriomeningitis virus infection enhanced not only the quantity but also the quality of virus-specific CD8 T cells. Similar effects were seen after immunization of mice with a vaccine based on non-replicating virus-like particles. In addition, rapamycin treatment also enhanced memory T-cell responses in non-human primates following vaccination with modified vaccinia virus Ankara. Rapamycin was effective during both the expansion and contraction phases of the T-cell response; during the expansion phase it increased the number of memory precursors, and during the contraction phase (effector to memory transition) it accelerated the memory T-cell differentiation program. Experiments using RNA interference to inhibit expression of mTOR, raptor (also known as 4932417H02Rik) or FKBP12 (also known as FKBP1A) in antigen-specific CD8 T cells showed that mTOR acts intrinsically through the mTORC1 (mTOR complex 1) pathway to regulate memory T-cell differentiation. Thus these studies identify a molecular pathway regulating memory formation and provide an effective strategy for improving the functional qualities of vaccine-or infection-induced memory T cells.	[Araki, Koichi; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Araki, Koichi; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Turner, Alexandra P.; Shaffer, Virginia Oliva; Gangappa, Shivaprakash; Larsen, Christian P.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Turner, Alexandra P.; Shaffer, Virginia Oliva; Gangappa, Shivaprakash; Larsen, Christian P.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Keller, Susanne A.; Bachmann, Martin F.] Cytos Biotechnol AG, CH-8952 Zurich, Switzerland	Emory University; Emory University; Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	rahmed@emory.edu	Larsen, Christian P./B-6906-2012; Shaffer, Virginia/G-7945-2012	Larsen, Christian P./0000-0001-6573-2649; Araki, Koichi/0000-0003-3478-6315	NIH [AI030048, N01-AI-50025, AI040519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040519, R01AI030048, R01AI073707, R37AI030048, R01AI040519, N01AI050025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. T. Konieczny for technical assistance; D. Garber for providing us with the MVA; R. Amara for help developing rhesus macaque assays; W. Hahn for providing pMKO. 1 GFP vector; and E. Strobert and P. L. Turner for technical assistance. This work was supported by NIH grants AI030048 (to R. A.) and N01-AI-50025 and AI040519 (to C. P. L).	Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	24	1109	1138	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2009	460	7251					108	U124		10.1038/nature08155	http://dx.doi.org/10.1038/nature08155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	464XW	19543266	Bronze, Green Accepted			2022-12-28	WOS:000267545200039
J	Fischer, B; Lassen, U; Mortensen, J; Larsen, S; Loft, A; Bertelsen, A; Ravn, J; Clementsen, P; Hogholm, A; Larsen, K; Rasmussen, T; Keiding, S; Dirksen, A; Gerke, O; Skov, B; Steffensen, I; Hansen, H; Vilmann, P; Jacobsen, G; Backer, V; Maltbaek, N; Pedersen, J; Madsen, H; Nielsen, H; Hojgaard, L				Fischer, Barbara; Lassen, Ulrik; Mortensen, Jann; Larsen, Soren; Loft, Annika; Bertelsen, Anne; Ravn, Jesper; Clementsen, Paul; Hogholm, Asbjorn; Larsen, Klaus; Rasmussen, Torben; Keiding, Susanne; Dirksen, Asger; Gerke, Oke; Skov, Birgit; Steffensen, Ida; Hansen, Hanne; Vilmann, Peter; Jacobsen, Grete; Backer, Vibeke; Maltbaek, Niels; Pedersen, Jesper; Madsen, Henrik; Nielsen, Henrik; Hojgaard, Liselotte			Preoperative Staging of Lung Cancer with Combined PET-CT.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SYSTEM; TRIAL	Background: Fast and accurate staging is essential for choosing treatment for non-small-cell lung cancer (NSCLC). The purpose of this randomized study was to evaluate the clinical effect of combined positron-emission tomography and computed tomography (PET-CT) on preoperative staging of NSCLC. Methods: We randomly assigned patients who were referred for preoperative staging of NSCLC to either conventional staging plus PET-CT or conventional staging alone. Patients were followed until death or for at least 12 months. The primary end point was the number of futile thoracotomies, defined as any one of the following: a thoracotomy with the finding of pathologically confirmed mediastinal lymph-node involvement (stage IIIA [N2]), stage IIIB or stage IV disease, or a benign lung lesion; an exploratory thoracotomy; or a thoracotomy in a patient who had recurrent disease or death from any cause within 1 year after randomization. Results: From January 2002 through February 2007, we randomly assigned 98 patients to the PET-CT group and 91 to the conventional-staging group. Mediastinoscopy was performed in 94% of the patients. After PET-CT, 38 patients were classified as having inoperable NSCLC, and after conventional staging, 18 patients were classified thus. Sixty patients in the PET-CT group and 73 in the conventional-staging group underwent thoracotomy (P=0.004). Among these thoracotomies, 21 in the PET-CT group and 38 in the conventional-staging group were futile (P=0.05). The number of justified thoracotomies and survival were similar in the two groups. Conclusions: The use of PET-CT for preoperative staging of NSCLC reduced both the total number of thoracotomies and the number of futile thoracotomies but did not affect overall mortality. (ClinicalTrials.gov number, NCT00867412.) N Engl J Med 2009;361:32-9.	[Fischer, Barbara] Odense Univ Hosp, Dept Oncol, DK-5000 Odense C, Denmark; [Fischer, Barbara; Lassen, Ulrik; Mortensen, Jann; Loft, Annika; Bertelsen, Anne; Ravn, Jesper; Steffensen, Ida; Jacobsen, Grete; Pedersen, Jesper; Hojgaard, Liselotte] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Larsen, Soren; Larsen, Klaus; Hansen, Hanne; Backer, Vibeke; Nielsen, Henrik] Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; [Clementsen, Paul; Dirksen, Asger; Vilmann, Peter; Maltbaek, Niels] Gentofte Univ Hosp, Hellerup, Denmark; [Hogholm, Asbjorn] Naestved Hosp, Naestved, Denmark; [Rasmussen, Torben; Keiding, Susanne; Madsen, Henrik] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Gerke, Oke] Univ So Denmark, Odense, Denmark; [Skov, Birgit] Herlev Hosp, Hellerup, Denmark	University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; University of Southern Denmark; University of Copenhagen; Herlev & Gentofte Hospital	Fischer, B (corresponding author), Odense Univ Hosp, Dept Oncol, DK-5000 Odense C, Denmark.	bjerregaard.fischer@gmail.com	Backer, Vibeke/I-9573-2014; Gerke, Oke/X-2197-2019; Backer, Vibeke/AAQ-9379-2021; Højgaard, Liselotte/AAK-8329-2020; Lassen, Ulrik/AAH-2799-2021; Vilmann, Peter/AAJ-8401-2020; Vilmann, Peter/AAP-2730-2021	Backer, Vibeke/0000-0002-7806-7219; Gerke, Oke/0000-0001-6335-3303; Mortensen, Jann/0000-0002-1399-8995; Fischer, Barbara Malene/0000-0002-6065-3375; Clementsen, Paul Frost/0000-0001-6624-4620; Lassen, Ulrik/0000-0002-3865-4574; Rasmussen, Torben Riis/0000-0002-7030-9260	Danish Cancer Society; Danish Center for Health Technology Assessment; John and Birthe Meyer Foundation	Danish Cancer Society(Danish Cancer Society); Danish Center for Health Technology Assessment; John and Birthe Meyer Foundation	Supported by grants from the Danish Cancer Society and the Danish Center for Health Technology Assessment. The John and Birthe Meyer Foundation donated the PET-CT scanner.	Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Beyer T, 2000, J NUCL MED, V41, P1369; Cerfolio RJ, 2004, ANN THORAC SURG, V78, P1017, DOI 10.1016/j.athoracsur.2004.02.067; *DAN LUNG CANC GRO, 2001, LUNG CANC DIAGN THER; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; McCann J, 1997, J NATL CANCER I, V89, P1838; McCann J, 1998, J NATL CANCER I, V90, P94, DOI 10.1093/jnci/90.2.94; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Robinson LA, 2007, CHEST, V132, p243S, DOI 10.1378/chest.07-1379; Swensen SJ, 1996, RADIOLOGY, V201, P447, DOI 10.1148/radiology.201.2.8888239; Tanoue LT, 2008, SEMIN RESP CRIT CARE, V29, P248, DOI 10.1055/s-2008-1076745; van Tinteren H, 2005, J CLIN ONCOL, V23, P1591, DOI 10.1200/JCO.2005.05.201; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Viney RC, 2004, J CLIN ONCOL, V22, P2357, DOI 10.1200/JCO.2004.04.126; von Schulthess GK, 2000, EUR RADIOL, V10, pS377, DOI 10.1007/PL00014098	16	393	410	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					32	39		10.1056/NEJMoa0900043	http://dx.doi.org/10.1056/NEJMoa0900043			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571281				2022-12-28	WOS:000267533100007
J	Rodwin, MA				Rodwin, Marc A.			The Case for Public Ownership of Patient Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROPERTY		Suffolk Univ, Sch Law, Boston, MA 02140 USA	Suffolk University	Rodwin, MA (corresponding author), Suffolk Univ, Sch Law, 120 Tremont St, Boston, MA 02140 USA.	mrodwin@suffolk.edu						Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; ANNAS GJ, 2004, RIGHTS PATIENTS AUTH, P224; BAILEY S, 2006, BOSTON GLOBE    0324, pC1; Burrington-Brown Jill, 2007, J AHIMA, V78, P63; HAISLMAIER EF, 1131 HLTH CAR INF TE; Heller MA, 1998, HARVARD LAW REV, V111, P621, DOI 10.2307/1342203; HELMS WD, 2007, FED REG         0726; *IMS HLTH, IMS HLTH 2007 ANN RE; *NAT COMM QUAL ASS, 2007, 072733 FR AHRQ DEP H; Steinbrook R, 2006, NEW ENGL J MED, V354, P2745, DOI 10.1056/NEJMp068125; Waller A A, 1998, J AHIMA, V69, P28	11	31	31	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					86	88		10.1001/jama.2009.965	http://dx.doi.org/10.1001/jama.2009.965			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567445				2022-12-28	WOS:000267492800028
J	Lameris, W; van Randen, A; van Es, HW; van Heesewijk, JPM; van Ramshorst, B; Bouma, WH; ten Hove, W; van Leeuwen, MS; van Keulen, EM; Dijkgraaf, MGW; Bossuyt, PMM; Boermeester, MA; Stoker, J				Lameris, Wytze; van Randen, Adrienne; van Es, H. Wouter; van Heesewijk, Johannes P. M.; van Ramshorst, Bert; Bouma, Wim H.; ten Hove, Wim; van Leeuwen, Maarten S.; van Keulen, Esteban M.; Dijkgraaf, Marcel G. W.; Bossuyt, Patrick M. M.; Boermeester, Marja A.; Stoker, Jaap		OPTIMA Study Grp	Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; ACUTE ABDOMEN; EMERGENCY-DEPARTMENT; CONTROLLED-TRIAL; DECISION-MAKING; CT; ULTRASOUND; APPENDICITIS; ROUTINE; ULTRASONOGRAPHY	Objective To identify an optimal imaging strategy for the accurate detection of urgent conditions in patients with acute abdominal pain. Design Fully paired multicentre diagnostic accuracy study with prospective data collection. Setting Emergency departments of two university hospitals and four large teaching hospitals in the Netherlands. Participants 1021 patients with non-traumatic abdominal pain of >2 hours' and <5 days' duration. Exclusion criteria were discharge from the emergency department with no imaging considered warranted by the treating physician, pregnancy, and haemorrhagic shock. Intervention All patients had plain radiographs (upright chest and supine abdominal), ultrasonography, and computed tomography (CT) after clinical and laboratory examination. A panel of experienced physicians assigned a final diagnosis after six months and classified the condition as urgent or non-urgent. Main outcome measures Sensitivity and specificity for urgent conditions, percentage of missed cases and false positives, and exposure to radiation for single imaging strategies, conditional imaging strategies (CT after initial ultrasonography), and strategies driven by body mass index and age or by location of pain. Results 661 (65%) patients had a final diagnosis classified as urgent. The initial clinical diagnosis resulted in many false positive urgent diagnoses, which were significantly reduced after ultrasonography or CT. CT detected more urgent diagnoses than did ultrasonography: sensitivity was 89% (95% confidence interval 87% to 92%) for CT and 70% (67% to 74%) for ultrasonography (P<0.001). A conditional strategy with CT only after negative or inconclusive ultrasonography yielded the highest sensitivity, missing only 6% of urgent cases. With this strategy, only 49% (46% to 52%) of patients would have CT. Alternative strategies guided by body mass index, age, or location of the pain would all result in a loss of sensitivity. Conclusion Although CT is the most sensitive imaging investigation for detecting urgent conditions in patients with abdominal pain, using ultrasonography first and CT only in those with negative or inconclusive ultrasonography results in the best sensitivity and lowers exposure to radiation.	[Stoker, Jaap] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Boermeester, Marja A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [van Es, H. Wouter; van Heesewijk, Johannes P. M.] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [van Ramshorst, Bert] St Antonius Hosp, Dept Surg, Nieuwegein, Netherlands; [Bouma, Wim H.] Gelre Hosp, Dept Surg, Apeldoorn, Netherlands; [ten Hove, Wim] Gelre Hosp, Dept Radiol, Apeldoorn, Netherlands; [van Leeuwen, Maarten S.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [van Keulen, Esteban M.] Tergooi Hosp, Dept Radiol, Hilversum, Netherlands; [Dijkgraaf, Marcel G. W.; Bossuyt, Patrick M. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Gelre Hospitals; Gelre Hospitals; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Stoker, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.stoker@amc.uva.nl	Stoker, Jaap/AAH-7597-2019; Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016; Dijkgraaf, Marcel GW/G-6663-2011	Stoker, Jaap/0000-0002-9822-3784; Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; 	Dutch Organization for Health Research and Development; Health Care Efficiency Research programme [945-04-308]	Dutch Organization for Health Research and Development; Health Care Efficiency Research programme	The Dutch Organization for Health Research and Development (ZonMw), Health Care Efficiency Research programme, funded the study (ZonMw grant number: 945-04-308). ZonMw approved the study protocol after consulting national and international independent reviewers. The collection, analysis, and interpretation of data; writing of the article; and decision to submit were left to the authors' discretion and were not influenced by ZonMw.	Allemann F, 1999, EUR J SURG, V165, P966; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Balfe D M, 2000, Radiology, V215 Suppl, P167; Bassler D, 2003, J EMERG MED, V24, P375, DOI 10.1016/S0736-4679(03)00032-5; Bree R L, 2000, Radiology, V215 Suppl, P153; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; *BRER, 2006, HLTH RISKS EXP LOW L; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Dhillon S, 2002, CLIN RADIOL, V57, P268, DOI 10.1053/crad.2001.0862; Esses D, 2004, AM J EMERG MED, V22, P270, DOI 10.1016/j.ajem.2004.04.004; Golash V, 2005, SURG ENDOSC, V19, P882, DOI 10.1007/s00464-004-8866-1; Hertzberg BS, 2000, AM J ROENTGENOL, V174, P1221, DOI 10.2214/ajr.174.5.1741221; Lameris W, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-9; Lee CC, 2007, ACAD EMERG MED, V14, P117, DOI 10.1197/j.aem.2006.08.007; Lewis LM, 2007, EUR J RADIOL, V61, P290, DOI 10.1016/j.ejrad.2006.09.014; Macaskill P, 2002, STAT MED, V21, P2527, DOI 10.1002/sim.1227; Majewski W, 2000, SURG ENDOSC-ULTRAS, V14, P930, DOI 10.1007/s004640000197; MCGRATH FP, 1991, CLIN RADIOL, V44, P172, DOI 10.1016/S0009-9260(05)80862-1; Mitka M, 2005, JAMA-J AM MED ASSOC, V293, P665, DOI 10.1001/jama.293.6.665; Ng CS, 2002, BRIT MED J, V325, P1387, DOI 10.1136/bmj.325.7377.1387; Pradel JA, 1997, RADIOLOGY, V205, P503, DOI 10.1148/radiology.205.2.9356636; PUYLAERT JBCM, 1987, NEW ENGL J MED, V317, P666, DOI 10.1056/NEJM198709103171103; Ralls P W, 2000, Radiology, V215 Suppl, P159; Raman SS, 2008, NEW ENGL J MED, V358, P972, DOI 10.1056/NEJMc0707000; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Rosen MP, 2003, EUR RADIOL, V13, P418, DOI 10.1007/s00330-002-1715-5; Saini S, 2000, Radiology, V215 Suppl, P173; Sala E, 2007, CLIN RADIOL, V62, P961, DOI 10.1016/j.crad.2007.01.030; Stoker J, 2008, BRIT J SURG, V95, P1193, DOI 10.1002/bjs.6378; Tack D, 2005, RADIOLOGY, V237, P189, DOI 10.1148/radiol.2371041432; Walker S, 2000, AM J SURG, V180, P450, DOI 10.1016/S0002-9610(00)00540-7; WALSH PF, 1990, CLIN RADIOL, V42, P47, DOI 10.1016/S0009-9260(05)81622-8; WILLIAMS RJL, 1994, ANN ROY COLL SURG, V76, P228	33	200	204	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2009	338								b2431	10.1136/bmj.b2431	http://dx.doi.org/10.1136/bmj.b2431			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MQ	19561056	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267436700002
J	El-Awady, N				El-Awady, Nadia			Science journalism: The Arab boom	NATURE			English	Editorial Material												nadiaelawady@gmail.com							0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1057	1057		10.1038/4591057a	http://dx.doi.org/10.1038/4591057a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	466BX	19553978	Bronze			2022-12-28	WOS:000267636700022
J	Garbin, CP; Deacon, JP; Rowan, MK; Hartmann, PE; Geddes, DT				Garbin, Catherine P.; Deacon, Jane P.; Rowan, Marnie K.; Hartmann, Peter E.; Geddes, Donna T.			Association of Nipple Piercing With Abnormal Milk Production and Breastfeeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Garbin, Catherine P.; Deacon, Jane P.; Rowan, Marnie K.; Hartmann, Peter E.; Geddes, Donna T.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia	University of Western Australia	Garbin, CP (corresponding author), Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia.	cgarbin@cyllene.uwa.edu.au	Geddes, Donna/H-9254-2014	Geddes, Donna/0000-0002-0431-7078; Hartmann, Peter/0000-0002-7709-0740				Armstrong Myrna L, 2006, AWHONN Lifelines, V10, P212; Kaatz M, 2008, CLIN DERMATOL, V26, P35, DOI 10.1016/j.clindermatol.2007.10.004; Kent JC, 2006, PEDIATRICS, V117, pE387, DOI 10.1542/peds.2005-1417; Meltzer DI, 2005, AM FAM PHYSICIAN, V72, P2029; Peaker M, 1996, J MAMMARY GLAND BIOL, V1, P307, DOI 10.1007/BF02018083; Prosser CG, 1996, J DAIRY SCI, V79, P1184, DOI 10.3168/jds.S0022-0302(96)76472-X	6	8	8	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2550	2551						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549971				2022-12-28	WOS:000267266500019
J	Anderson, T				Anderson, Tatum			Confusion over counterfeit drugs in Uganda	LANCET			English	Editorial Material																			0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2097	2098		10.1016/S0140-6736(09)61134-X	http://dx.doi.org/10.1016/S0140-6736(09)61134-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19551913				2022-12-28	WOS:000267229700011
J	Home, PD; Pocock, SJ; Beck-Nielsen, H; Curtis, PS; Gomis, R; Hanefeld, M; Jones, NP; Komajda, M; McMurray, JJV				Home, Philip D.; Pocock, Stuart J.; Beck-Nielsen, Henning; Curtis, Paula S.; Gomis, Ramon; Hanefeld, Markolf; Jones, Nigel P.; Komajda, Michel; McMurray, John J. V.		RECORD Study Team	Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial	LANCET			English	Article							BLOOD-GLUCOSE CONTROL; MYOCARDIAL-INFARCTION; HEART-ASSOCIATION; CARDIAC OUTCOMES; METFORMIN; RISK; SULFONYLUREAS; COMPLICATIONS; MONOTHERAPY; FAILURE	Background Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people with type 2 diabetes. We assessed cardiovascular outcomes after addition of rosiglitazone to either metformin or sulfonylurea compared with the combination of the two over 5-7 years of follow-up. We also assessed comparative safety. Methods In a multicentre, open-label trial, 4447 patients with type 2 diabetes on metformin or sulfonylurea monotherapy with mean haemoglobin A(1c) (HbA(1c)) of 7.9% were randomly assigned to addition of rosiglitazone (n=2220) or to a combination of metformin and sulfonylurea (active control group, n=2227). The primary endpoint was cardiovascular hospitalisation or cardiovascular death, with a hazard ratio (HR) non-inferiority margin of 1.20. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00379769. Findings 321 people in the rosiglitazone group and 323 in the active control group experienced the primary outcome during a mean 5.5-year follow-up, meeting the criterion of non-inferiority (HR 0.99, 95% CI 0.85-1.16). HR was 0.84 (0.59-1.18) for cardiovascular death, 1.14 (0.80-1.63) for myocardial infarction, and 0.72 (0.49-1.06) for stroke. Heart failure causing admission to hospital or death occurred in 61 people in the rosiglitazone group and 29 in the active control group (HR 2.10, 1.35-3.27, risk difference per 1000 person-years 2.6, 1.1-4.1). Upper and distal lower limb fracture rates were increased mainly in women randomly assigned to rosiglitazone. Mean HbA(1c) was lower in the rosiglitazone group than in the control group at 5 years. Interpretation Addition of rosiglitazone to glucose-lowering therapy in people with type 2 diabetes is confirmed to increase the risk of heart failure and of some fractures, mainly in women. Although the data are inconclusive about any possible effect on myocardial infarction, rosiglitazone does not increase the risk of overall cardiovascular morbidity or mortality compared with standard glucose-lowering drugs. Funding GlaxoSmithKline plc, UK.	[Home, Philip D.] Newcastle Diabet Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Home, Philip D.] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; [Pocock, Stuart J.] London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England; [Beck-Nielsen, Henning] Dept Endocrinol & Metab, Odense, Denmark; [Curtis, Paula S.] GlaxoSmithKline Res & Dev Ltd, Greenford, Middx, England; [Gomis, Ramon] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Hanefeld, Markolf] Forsch Bereich Endokrinol & Stoffwechsel, Zentrum Klin Studien, Dresden, Germany; [Jones, Nigel P.] GlaxoSmithKline Res & Dev Ltd, Harlow, Essex, England; [Komajda, Michel] Univ Paris 06, Paris, France; [Komajda, Michel] Hop La Pitie Salpetriere, Dept Cardiol, Paris, France; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of Barcelona; Hospital Clinic de Barcelona; Technische Universitat Dresden; GlaxoSmithKline; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Glasgow	Home, PD (corresponding author), ICM Diabet, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	philip.home@newcastle.ac.uk	Torres, Manuel Muñoz/O-2330-2016; Böhm, Michael/C-3638-2011; Saudek, František/E-1975-2018; mcmurray, John/B-2467-2013; YAMAMOTO, MASAHIRO/F-9094-2011; Ponikowski, Piotr/O-6454-2015; Jurišić-Eržen, Dubravka/S-1769-2018	Torres, Manuel Muñoz/0000-0002-9645-3260; Saudek, František/0000-0002-0448-4351; mcmurray, John/0000-0002-6317-3975; YAMAMOTO, MASAHIRO/0000-0003-3859-0125; Ponikowski, Piotr/0000-0002-3391-7064; Jurišić-Eržen, Dubravka/0000-0002-6614-9778; Hancu, Nicolae/0000-0002-4688-5110; GAZTAMBIDE, SONIA/0000-0003-3569-2265; Keymeulen, Bart/0000-0002-8671-4527; Landin-Olsson, Mona/0000-0003-0510-9112; Ametov, A.S./0000-0002-7936-7619	GlaxoSmithKline plc, UK.	GlaxoSmithKline plc, UK.(GlaxoSmithKline)	Funding GlaxoSmithKline plc, UK.	Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Bell DSH, 2004, CLIN THER, V26, P1714, DOI 10.1016/j.clinthera.2004.10.014; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; *EUR MED AG, EUR PUBL ASS REP ACT; European Medicines Agency, EUR PUBL ASS REP AV; Freed MI, 2002, AM J CARDIOL, V90, P947, DOI 10.1016/S0002-9149(02)02659-0; *GLAXOSMITHKLINE, FDA ADV COMM BRIEF D; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home PD, 2007, DIABETIC MED, V24, P626, DOI 10.1111/j.1464-5491.2007.02160.x; Home PD, 2005, DIABETOLOGIA, V48, P1726, DOI 10.1007/s00125-005-1869-1; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Komajda M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-10; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; *NIH CLIN EXC, 2009, 87 NICE; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oleksiewicz MB, 2008, PPAR RES, V2008, DOI 10.1155/2008/103167; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	27	1032	1089	2	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2125	2135		10.1016/S0140-6736(09)60953-3	http://dx.doi.org/10.1016/S0140-6736(09)60953-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460YQ	19501900				2022-12-28	WOS:000267229700029
J	Gutberlet, A; Schwaab, G; Birer, O; Masia, M; Kaczmarek, A; Forbert, H; Havenith, M; Marx, D				Gutberlet, Anna; Schwaab, Gerhard; Birer, Oezguer; Masia, Marco; Kaczmarek, Anna; Forbert, Harald; Havenith, Martina; Marx, Dominik			Aggregation-Induced Dissociation of HCl(H2O)(4) Below 1 K: The Smallest Droplet of Acid	SCIENCE			English	Article							PROTONATED WATER CLUSTERS; HELIUM NANODROPLETS; MOLECULAR-DYNAMICS; HYDROCHLORIC-ACID; ICE; HCL; CHEMISTRY; SPECTROSCOPY; IONIZATION; DISSOLUTION	Acid dissociation and the subsequent solvation of the charged fragments at ultracold temperatures in nanoenvironments, as distinct from ambient bulk water, are relevant to atmospheric and interstellar chemistry but remain poorly understood. Here we report the experimental observation of a nanoscopic aqueous droplet of acid formed within a superfluid helium cluster at 0.37 kelvin. High-resolution mass-selective infrared laser spectroscopy reveals that successive aggregation of the acid HCl with water molecules, HCl(H2O)(n), readily results in the formation of hydronium at n = 4. Accompanying ab initio simulations show that undissociated clusters assemble by stepwise water molecule addition in electrostatic steering arrangements up to n = 3. Adding a fourth water molecule to the ringlike undissociated HCl(H2O)(3) then spontaneously yields the compact dissociated H3O+(H2O)(3)Cl- ion pair. This aggregation mechanism bypasses deep local energy minima on the n = 4 potential energy surface and offers a general paradigm for reactivity at ultracold temperatures.	[Gutberlet, Anna; Schwaab, Gerhard; Birer, Oezguer; Havenith, Martina] Ruhr Univ Bochum, Lehrstuhl Phys Chem 2, D-44780 Bochum, Germany; [Masia, Marco; Kaczmarek, Anna; Forbert, Harald; Marx, Dominik] Ruhr Univ Bochum, Lehrstuhl Theoret Chem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Havenith, M (corresponding author), Ruhr Univ Bochum, Lehrstuhl Phys Chem 2, D-44780 Bochum, Germany.	martina.havenith@rub.de	Masia, Marco/A-5571-2010; Kaczmarek-Kedziera, Anna/F-2172-2014; Schwaab, Gerhard/AGZ-2272-2022	Masia, Marco/0000-0003-2257-3101; Kaczmarek-Kedziera, Anna/0000-0002-4931-8701; Schwaab, Gerhard/0000-0003-2136-907X	Deutsche Forschungsgemeinschaft [HA 2394/13, MA 1547/8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are grateful to W. Sander for helpful discussions and K. Merz for support in the synthesis of isotopically pure HCl. We thank D. Habig, S. Henkel, M. Ortlieb, and T. Poerschke for help with the experiment and data evaluation. Support by the Deutsche Forschungsgemeinschaft (grants HA 2394/13 and MA 1547/8 within FOR 618 "Molecular Aggregation") and Fonds der Chemischen Industrie is gratefully acknowledged, as well as computer resources from Bovilab@RUB and Rechnerverbund-Nordrhein-Westfalen (LiDO).	Ando K, 1999, ADV CHEM PHYS, V110, P381, DOI 10.1002/9780470141694.ch6; Bacelo DE, 1999, J PHYS CHEM A, V103, P4631, DOI 10.1021/jp9843003; Bianco R, 2006, ACCOUNTS CHEM RES, V39, P159, DOI 10.1021/ar040197q; Clary DC, 1996, SCIENCE, V271, P1509, DOI 10.1126/science.271.5255.1509; Devlin JP, 2002, NATURE, V417, P269, DOI 10.1038/417269a; Domcke W, 2003, SCIENCE, V302, P1693, DOI 10.1126/science.1093081; Farnik M, 2003, J CHEM PHYS, V118, P10120, DOI 10.1063/1.1571525; Gertner BJ, 1996, SCIENCE, V271, P1563, DOI 10.1126/science.271.5255.1563; GOYAL S, 1992, PHYS REV LETT, V69, P933, DOI 10.1103/PhysRevLett.69.933; Headrick JM, 2005, SCIENCE, V309, P1326; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Hurley SM, 2002, SCIENCE, V298, P202, DOI 10.1126/science.1075307; Huthwelker T, 2006, CHEM REV, V106, P1375, DOI 10.1021/cr020506v; LAASONEN K, 1994, J AM CHEM SOC, V116, P11620, DOI 10.1021/ja00104a073; Lee CW, 2006, ANGEW CHEM INT EDIT, V45, P5529, DOI 10.1002/anie.200601317; Lee CT, 1996, J CHEM PHYS, V104, P7081, DOI 10.1063/1.471426; Lewis WK, 2005, J AM CHEM SOC, V127, P7235, DOI 10.1021/ja042489s; Madeja F, 2004, J CHEM PHYS, V120, P10554, DOI 10.1063/1.1709942; Marx D, 2007, CHEMPHYSCHEM, V8, P209, DOI 10.1002/cphc.200790002; Marx D., 2009, AB INITIO MOL DYNAMI; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Masia M, 2007, J PHYS CHEM A, V111, P12181, DOI 10.1021/jp0740494; McNeill VF, 2006, P NATL ACAD SCI USA, V103, P9422, DOI 10.1073/pnas.0603494103; Milet A, 2001, J CHEM PHYS, V115, P349, DOI 10.1063/1.1377875; Miyazaki M, 2004, SCIENCE, V304, P1134, DOI 10.1126/science.1096037; Mundy CJ, 2006, CHEM REV, V106, P1282, DOI 10.1021/cr040375t; Nauta K, 2000, SCIENCE, V287, P293, DOI 10.1126/science.287.5451.293; Odde S, 2004, J CHEM PHYS, V120, P9524, DOI 10.1063/1.1711596; Ordlieb M, 2007, J PHYS CHEM A, V111, P12192, DOI 10.1021/jp0759980; Pegram LM, 2006, P NATL ACAD SCI USA, V103, P14278, DOI 10.1073/pnas.0606256103; Robertson WH, 2002, SCIENCE, V298, P69, DOI 10.1126/science.1076959; Robertson WH, 2003, SCIENCE, V299, P1367, DOI 10.1126/science.1080695; Scoles G, 2000, SCIENCE, V287, P2429, DOI 10.1126/science.287.5462.2429; Shin JW, 2004, SCIENCE, V304, P1137, DOI 10.1126/science.1096466; Smith IWM, 2000, ACCOUNTS CHEM RES, V33, P261, DOI 10.1021/ar990099i; Stace A, 2001, SCIENCE, V294, P1292, DOI 10.1126/science.1066731; Toennies JP, 2004, ANGEW CHEM INT EDIT, V43, P2622, DOI 10.1002/anie.200300611; Voegele AF, 2003, ANGEW CHEM INT EDIT, V42, P2114, DOI 10.1002/anie.20021613; Weimann M, 2002, PHYS CHEM CHEM PHYS, V4, P3933, DOI 10.1039/b204840j; Zwier TS, 2004, SCIENCE, V304, P1119, DOI 10.1126/science.1098129	40	170	170	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1545	1548		10.1126/science.1171753	http://dx.doi.org/10.1126/science.1171753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541993				2022-12-28	WOS:000267130600039
J	Jones, R; Rubin, G				Jones, Roger; Rubin, Greg			Diagnosis in General Practice Acute diarrhoea in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; GASTROENTERITIS; DISEASE; NETHERLANDS; COMMUNITY; ETIOLOGY		[Jones, Roger] Kings Coll London, Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; [Rubin, Greg] Univ Durham, Sch Med & Hlth, Wolfson Res Inst, Durham DH1 3HP, England	University of London; King's College London; Durham University	Jones, R (corresponding author), Kings Coll London, Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.	roger.jones@kcl.ac.uk	Schneider, Stephane/G-9511-2011	Schneider, Stephane/0000-0001-6256-8169				Almond SC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1878; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; De Wit MAS, 2001, EPIDEMIOL INFECT, V127, P389, DOI 10.1017/S0950268801006082; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; de Wit MAS, 2001, CLIN INFECT DIS, V33, P280, DOI 10.1086/321875; DEBRUYN G, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002242; DUNCAN A, 1992, J ROY SOC MED, V85, P203; FELDMAN RA, 1994, EPIDEMIOL INFECT, V113, P41, DOI 10.1017/S095026880005144X; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; *HLTH PROT AG, 2008, GEN INF GASTR INF; Jones R, 2007, BRIT MED J, V334, P704, DOI 10.1136/bmj.39170.410347.80; Mangiarotti P, 1999, ACTA PAEDIATR, V88, P592, DOI 10.1080/08035259950169206; MASSEY B, 1999, DIAGNOSTIC STRATEGIE, P149; Shelton JH, 2007, CLIN CHEM, V53, P85, DOI 10.1373/clinchem.2006.077883; Spiller RC, 2003, GASTROENTEROLOGY, V124, P1662, DOI 10.1016/S0016-5085(03)00324-X; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Thomas P. D., 2003, Gut, V52, pv1, DOI 10.1136/gut.52.suppl_5.v1; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	21	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2009	338								b1877	10.1136/bmj.b1877	http://dx.doi.org/10.1136/bmj.b1877			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UP	19528114				2022-12-28	WOS:000267216500002
J	House, J				House, John			Calling time on doctors' working hours	LANCET			English	Editorial Material																			0	18	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2011	2012		10.1016/S0140-6736(09)61094-1	http://dx.doi.org/10.1016/S0140-6736(09)61094-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19533832	Bronze			2022-12-28	WOS:000267080100011
J	Scherrer, G; Imamachi, N; Cao, YQ; Contet, C; Mennicken, F; O'Donnell, D; Kieffer, BL; Basbaum, AI				Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Contet, Candice; Mennicken, Francoise; O'Donnell, Dajan; Kieffer, Brigitte L.; Basbaum, Allan I.			Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain	CELL			English	Article							DORSAL-ROOT GANGLIA; MICE LACKING; MORPHINE-TOLERANCE; NEUROPATHIC PAIN; DELTA-AGONISTS; SPINAL-CORD; MU-OPIATE; ANALGESIA; RAT; TRAFFICKING	Delta and mu opioid receptors (DORs and MORs) are inhibitory G protein-coupled receptors that reportedly cooperatively regulate the transmission of pain messages by substance P and TRPV1-expressing pain fibers. Using a DOReGFP reporter mouse we now show that the DOR and MOR are, in fact, expressed by different subsets of primary afferents. The MOR is expressed in peptidergic pain fibers, the DOR in myelinated and nonpeptidergic afferents. Contrary to the prevailing view, we demonstrate that the DOR is trafficked to the cell surface under resting conditions, independently of substance P, and internalized following activation by DOR agonists. Finally, we show that the segregated DOR and MOR distribution is paralleled by a remarkably selective functional contribution of the two receptors to the control of mechanical and heat pain, respectively. These results demonstrate that behaviorally relevant pain modalities can be selectively regulated through the targeting of distinct subsets of primary afferent pain fibers.	[Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Basbaum, Allan I.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Basbaum, Allan I.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Scherrer, Gregory; Imamachi, Noritaka; Cao, Yu-Qing; Basbaum, Allan I.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94158 USA; [Contet, Candice; Kieffer, Brigitte L.] Univ Strasbourg 1, Dept Neurobiol, Inst Genet & Biol Mol & Cellulaire, INSERM,U596,CNRS UMR7104, Illkirch Graffenstaden, France; [Mennicken, Francoise; O'Donnell, Dajan] AstraZeneca R&D, Quebec City, PQ H4S 1Z9, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AstraZeneca	Basbaum, AI (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	allan.basbaum@ucsf.edu	Contet, Candice/H-2774-2019	Scherrer, Gregory/0000-0002-1983-5126; Contet, Candice/0000-0002-4459-9540; Imamachi, Noritaka/0000-0002-8972-7665	Fondation pour la Recherche Medicale;  [NS48499];  [NS14627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014627, P01NS048499, R37NS014627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. D. Shields, D. Julius, D. Cavanaugh and J. Braz for helpful discussions, J. E. Maggio, C. J. Evans and D. Julius for providing the SP, MOR and TRP antibodies, J. Pintar for providing tissue from dor null mice and J. Butterworth and D. Hubatsch for providing excellent technical support. This work was supported by NS48499, NS14627 and Fondation pour la Recherche Medicale. DOD and FM are employees of AstraZeneca and declare that they have competing financial interests.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Aicher SA, 2000, J NEUROSCI, V20, P4345; Aicher SA, 2000, J COMP NEUROL, V422, P181, DOI 10.1002/(SICI)1096-9861(20000626)422:2<181::AID-CNE3>3.0.CO;2-G; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; ARVIDSSON U, 1995, J NEUROSCI, V15, P1215; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Gallantine EL, 2005, BASIC CLIN PHARMACOL, V97, P39, DOI 10.1111/j.1742-7843.2005.pto_97107.x; Gendron L, 2007, NEUROSCIENCE, V150, P807, DOI 10.1016/j.neuroscience.2007.09.060; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219; Goody RJ, 2002, BRAIN RES, V945, P9, DOI 10.1016/S0006-8993(02)02452-6; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3081, DOI 10.1073/pnas.74.7.3081; Hurley RW, 2000, J NEUROSCI, V20, P1249, DOI 10.1523/JNEUROSCI.20-03-01249.2000; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; Ji RR, 1995, J NEUROSCI, V15, P8156; Jutkiewicz EM, 2004, J PHARMACOL EXP THER, V309, P173, DOI 10.1124/jpet.103.061242; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; LACOSTE A, 2003, DELTA RECEPTOR, P15; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mennicken F, 2003, J COMP NEUROL, V465, P349, DOI 10.1002/cne.10839; MINAMI M, 1995, MOL BRAIN RES, V30, P203, DOI 10.1016/0169-328X(94)00290-U; Morinville A, 2003, J NEUROSCI, V23, P4888; MOSBERG HI, 1983, P NATL ACAD SCI-BIOL, V80, P5871, DOI 10.1073/pnas.80.19.5871; NARITA M, 2003, DELTA RECEPTOR, P331; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; ONOFRIO BM, 1983, LANCET, V1, P1386; OSSIPOV MH, 1995, PAIN, V62, P287, DOI 10.1016/0304-3959(94)00231-3; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; PORRECA F, 1987, J PHARMACOL EXP THER, V241, P393; PORTOGHESE PS, 1990, J MED CHEM, V33, P1547, DOI 10.1021/jm00168a004; Powell KJ, 2003, EUR J NEUROSCI, V18, P1572, DOI 10.1046/j.1460-9568.2003.02887.x; Rozenfeld Raphael, 2007, ScientificWorldJournal, V7, P64; Scherrer G, 2004, EUR J NEUROSCI, V19, P2239, DOI 10.1111/j.0953-816X.2004.03339.x; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sora I, 1997, EUR J PHARMACOL, V324, pR1, DOI 10.1016/S0014-2999(97)10016-4; Sun H, 2001, PAIN, V90, P105, DOI 10.1016/S0304-3959(00)00392-4; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Trafton JA, 2000, J NEUROSCI, V20, P8578; Walwyn W, 2005, MOL PHARMACOL, V68, P1688, DOI 10.1124/mol.105.014829; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005; Zhang X, 1998, NEUROSCIENCE, V82, P1225; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	58	357	364	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1148	1159		10.1016/j.cell.2009.04.019	http://dx.doi.org/10.1016/j.cell.2009.04.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524516	Green Accepted, Bronze			2022-12-28	WOS:000266916400025
J	Bombard, Y; Veenstra, G; Friedman, JM; Creighton, S; Currie, L; Paulsen, JS; Bottorff, JL; Hayden, MR				Bombard, Yvonne; Veenstra, Gerry; Friedman, Jan M.; Creighton, Susan; Currie, Lauren; Paulsen, Jane S.; Bottorff, Joan L.; Hayden, Michael R.		Canadian Respond-HD Collaborative	Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RACIAL-DISCRIMINATION; COLORECTAL-CANCER; HEALTH; POPULATION; INSURANCE; EXPERIENCES; CHOREA; SCALE	Objective To assess the nature and prevalence of genetic discrimination experienced by people at risk for Huntington's disease who had undergone genetic testing or remained untested. Design Cross sectional, self reported survey. Setting Seven genetics and movement disorders clinics servicing rural and urban communities in Canada. Participants 233 genetically tested and untested asymptomatic people at risk for Huntington's disease (response rate 80%): 167 underwent testing (83 had the Huntington's disease mutation, 84 did not) and 66 chose not to be tested. Main outcome measures Self reported experiences of genetic discrimination and related psychological distress based on family history or genetic test results. Results Discrimination was reported by 93 respondents (39.9%). Reported experiences occurred most often in insurance (29.2%), family (15.5%), and social (12.4%) settings. There were few reports of discrimination in employment (6.9%), health care (8.6%), or public sector settings (3.9%). Although respondents who were aware that they carried the Huntington's disease mutation reported the highest levels of discrimination, participation in genetic testing was not associated with increased levels of genetic discrimination. Family history of Huntington's disease, rather than the result of genetic testing, was the main reason given for experiences of genetic discrimination. Psychological distress was associated with genetic discrimination (P<0.001). Conclusions Genetic discrimination was commonly reported by people at risk for Huntington's disease and was a source of psychological distress. Family history, and not genetic testing, was the major reason for genetic discrimination.	[Friedman, Jan M.; Creighton, Susan; Currie, Lauren; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [Veenstra, Gerry] Univ British Columbia, Dept Sociol, Vancouver, BC V6T 1Z1, Canada; [Paulsen, Jane S.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Paulsen, Jane S.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Paulsen, Jane S.] Univ Iowa, Dept Psychol & Neurosci, Iowa City, IA 52242 USA; [Bottorff, Joan L.] Univ British Columbia Okanagan, Fac Hlth & Social Dev, Inst Healthy Living & Chron Dis Prevent, Kelowna, BC V1V 1V7, Canada	University of British Columbia; University of British Columbia; University of Iowa; University of Iowa; University of Iowa; University of British Columbia; University of British Columbia Okanagan	Hayden, MR (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Paulsen, Jane/AAQ-2932-2020; Raymond, Lynn A./R-6707-2016; Bottorff, Joan L./AAV-9905-2020; Hayden, Michael R/D-8581-2011; Bottorff, Joan L./A-6420-2018; Raymond, Lynn A/A-6664-2010	Raymond, Lynn A./0000-0002-8610-1042; Bottorff, Joan L./0000-0001-9724-5351; Hayden, Michael R/0000-0001-5159-1419; Bottorff, Joan L./0000-0001-9724-5351; Raymond, Lynn A/0000-0002-8610-1042; Paulsen, Jane/0000-0002-0983-228X; Martin, WR Wayne/0000-0002-3416-691X; Friedman, Jan/0000-0002-7482-9570; Ludman, Mark/0000-0002-9658-6784; Veenstra, Gerry/0000-0001-6917-3784	Canadian Institutes of Health Research (CIHR); National Institutes of Health; National Institute of Neurological Disorders and Stroke [3 R01 NS040068]; Michael Smith Foundation for Health Research, and the Child and Family Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040068] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Smith Foundation for Health Research, and the Child and Family Research Institute(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this project from the Canadian Institutes of Health Research (CIHR) was received by MRH and JLB. Supplemental funding from the National Institutes of Health and the National Institute of Neurological Disorders and Stroke was awarded to JSP (No 3 R01 NS040068). YB was supported by the CIHR, the Michael Smith Foundation for Health Research, and the Child and Family Research Institute. None of these funding agencies played any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Apse KA, 2004, GENET MED, V6, P510, DOI 10.1097/01.GIM.0000144013.96456.6C; BABUL R, 1993, JAMA-J AM MED ASSOC, V270, P2321, DOI 10.1001/jama.270.19.2321; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Bombard Y, 2007, CLIN GENET, V71, P220, DOI 10.1111/j.1399-0004.2007.00770.x; Bombard Y, 2008, EUR J HUM GENET, V16, P279, DOI 10.1038/sj.ejhg.5201937; Borrell LN, 2007, AM J EPIDEMIOL, V166, P1068, DOI 10.1093/aje/kwm180; CODORI AM, 1994, AM J MED GENET, V54, P174, DOI 10.1002/ajmg.1320540304; CRAUFURD DIO, 1986, BRIT MED J, V293, P249, DOI 10.1136/bmj.293.6541.249; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; Evers-Kiebooms G, 2000, SOC SCI MED, V51, P831, DOI 10.1016/S0277-9536(00)00064-2; Friedrich MJ, 2002, JAMA-J AM MED ASSOC, V288, P815, DOI 10.1001/jama.288.7.815; Goizet C, 2002, NEUROLOGY, V59, P1330, DOI 10.1212/01.WNL.0000032255.75650.C2; Greely HT, 2005, NEW ENGL J MED, V353, P865, DOI 10.1056/NEJMp058116; Hadley DW, 2003, ARCH INTERN MED, V163, P573, DOI 10.1001/archinte.163.5.573; Hall MA, 2005, GENET MED, V7, P311, DOI 10.1097/01.GIM.0000162874.58370.C0; Harper PS, 2004, LANCET NEUROL, V3, P249, DOI 10.1016/S1474-4422(04)00711-2; Hayden MR, 2003, LANCET NEUROL, V2, P141, DOI 10.1016/S1474-4422(03)00317-X; HAYDEN MR, 1987, LANCET, V1, P1284; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; KESSLER S, 1994, AM J MED GENET, V54, P161, DOI 10.1002/ajmg.1320540302; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krieger N, 1998, AM J PUBLIC HEALTH, V88, P1308, DOI 10.2105/AJPH.88.9.1308; KRIEGER N, 1999, INT J HLTH SERV, V29, P58; Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621; Low L, 1998, BRIT MED J, V317, P1632, DOI 10.1136/bmj.317.7173.1632; Mayor Susan, 2003, BMJ, V327, P702, DOI 10.1136/bmj.327.7417.702-c; Morrison PJ, 2005, LANCET, V366, P877, DOI 10.1016/S0140-6736(05)67298-4; PERRY TL, 1981, CAN MED ASSOC J, V125, P1098; Peterson EA, 2002, CANCER EPIDEM BIOMAR, V11, P79; QUAID KA, 1993, AM J MED GENET, V45, P41, DOI 10.1002/ajmg.1320450112; QUARRELL OWJ, 1987, LANCET, V1, P1281; Siesling S, 1998, MOVEMENT DISORD, V13, P915, DOI 10.1002/mds.870130609; Sobel SK, 2000, AM J MED GENET, V90, P49, DOI 10.1002/(SICI)1096-8628(20000103)90:1<49::AID-AJMG10>3.0.CO;2-3; Tanne JH, 2008, BRIT MED J, V336, P1038, DOI 10.1136/bmj.39569.467998.DB; Taylor S, 2008, CLIN GENET, V74, P20, DOI 10.1111/j.1399-0004.2008.01016.x; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001	39	61	62	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2009	338								b2175	10.1136/bmj.b2175	http://dx.doi.org/10.1136/bmj.b2175			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458LG	19509425	hybrid, Green Published			2022-12-28	WOS:000267021800004
J	Solberg, KE				Solberg, Kristin Elisabeth			Killed in the name of honour	LANCET			English	Editorial Material																			0	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1933	1934		10.1016/S0140-6736(09)61049-7	http://dx.doi.org/10.1016/S0140-6736(09)61049-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19514112				2022-12-28	WOS:000266832500011
J	Zhang, XH; Halvorsen, K; Zhang, CZ; Wong, WP; Springer, TA				Zhang, Xiaohui; Halvorsen, Kenneth; Zhang, Cheng-Zhong; Wong, Wesley P.; Springer, Timothy A.			Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor	SCIENCE			English	Article							FACTOR A2 DOMAIN; VONWILLEBRAND-FACTOR; FACTOR MULTIMERS; SHEAR-STRESS; PLASMA; ADAMTS13; SUBSTRATE; ADHESION; DISEASE; CONFORMATION	Von Willebrand factor (VWF) is secreted as ultralarge multimers that are cleaved in the A2 domain by the metalloprotease ADAMTS13 to give smaller multimers. Cleaved VWF is activated by hydrodynamic forces found in arteriolar bleeding to promote hemostasis, whereas uncleaved VWF is activated at lower, physiologic shear stresses and causes thrombosis. Single-molecule experiments demonstrate that elongational forces in the range experienced by VWF in the vasculature unfold the A2 domain, and only the unfolded A2 domain is cleaved by ADAMTS13. In shear flow, tensile force on a VWF multimer increases with the square of multimer length and is highest at the middle, providing an efficient mechanism for homeostatic regulation of VWF size distribution by force-induced A2 unfolding and cleavage by ADAMTS13, as well as providing a counterbalance for VWF-mediated platelet aggregation.	[Zhang, Xiaohui; Zhang, Cheng-Zhong; Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Halvorsen, Kenneth; Wong, Wesley P.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA; [Zhang, Xiaohui] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Springer, TA (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	wong@rowland.harvard.edu; springer@idi.harvard.edu		Wong, Wesley/0000-0001-7398-546X; Zhang, Xiaohui (Frank)/0000-0002-8778-595X	NIH [HL-48675]; Rowland Junior Fellows; American Heart Association [525918T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rowland Junior Fellows; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH HL-48675 (T.A.S.), the Rowland Junior Fellows (W.P.W.), and American Heart Association 525918T (X.Z.). The authors thank C. Bustamante, S. Marqusee, and C. Cecconi for protocols for DNA-protein coupling; J. E. Sadler, D. Schaak, J. Kim, J. Seog, C. Lu, and A. Alexander-Katz for reagents and insightful discussions; and G. Dempsey for work on the early stages of this project.	Alexander-Katz A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.138101; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; BATLLE J, 1987, BLOOD, V70, P173; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; EVANS E, HDB SINGLE IN PRESS; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; ODELL JA, 1988, J CHEM PHYS, V88, P4022, DOI 10.1063/1.453855; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shankaran H, 2004, BIOPHYS J, V86, P576, DOI 10.1016/S0006-3495(04)74136-3; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; SLAYTER H, 1985, J BIOL CHEM, V260, P8559; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Tsai HM, 2003, SEMIN THROMB HEMOST, V29, P479; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Valiaev A, 2007, J AM CHEM SOC, V129, P6491, DOI 10.1021/ja070147r; vanGenderen PJJ, 1996, BRIT J HAEMATOL, V93, P962, DOI 10.1046/j.1365-2141.1996.d01-1729.x; Whitelock JL, 2004, J THROMB HAEMOST, V2, P485, DOI 10.1111/j.1538-7836.2004.00601.x; Zanardelli S, 2006, J BIOL CHEM, V281, P1555, DOI 10.1074/jbc.M508316200; ZHANG Q, 2009, P NATL ACAD SCI US	32	377	387	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1330	1334		10.1126/science.1170905	http://dx.doi.org/10.1126/science.1170905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498171	Green Accepted			2022-12-28	WOS:000266635100047
J	Zheng, HM; Smith, RK; Jun, YW; Kisielowski, C; Dahmen, U; Alivisatos, AP				Zheng, Haimei; Smith, Rachel K.; Jun, Young-wook; Kisielowski, Christian; Dahmen, Ulrich; Alivisatos, A. Paul			Observation of Single Colloidal Platinum Nanocrystal Growth Trajectories	SCIENCE			English	Article							ORIENTED ATTACHMENT; CDSE NANOCRYSTALS; IN-SITU; SIZE; NANOSCALE; SHAPE; MONODISPERSE; INTERFACE; INJECTION; MECHANISM	Understanding of colloidal nanocrystal growth mechanisms is essential for the syntheses of nanocrystals with desired physical properties. The classical model for the growth of monodisperse nanocrystals assumes a discrete nucleation stage followed by growth via monomer attachment, but has overlooked particle-particle interactions. Recent studies have suggested that interactions between particles play an important role. Using in situ transmission electron microscopy, we show that platinum nanocrystals can grow either by monomer attachment from solution or by particle coalescence. Through the combination of these two processes, an initially broad size distribution can spontaneously narrow into a nearly monodisperse distribution. We suggest that colloidal nanocrystals take different pathways of growth based on their size- and morphology-dependent internal energies.	[Zheng, Haimei; Kisielowski, Christian; Dahmen, Ulrich] Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA; [Zheng, Haimei; Jun, Young-wook; Kisielowski, Christian; Dahmen, Ulrich; Alivisatos, A. Paul] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Zheng, Haimei; Smith, Rachel K.; Jun, Young-wook; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dahmen, U (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA.	udahmen@lbl.gov; alivis@berkeley.edu	Alivisatos, Paul/N-8863-2015; Jun, Young-wook/A-4141-2008	Alivisatos, Paul/0000-0001-6895-9048; Zheng, Haimei/0000-0003-3813-4170; Jun, Young-wook/0000-0003-3182-5366	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy(United States Department of Energy (DOE))	The authors would like to thank A. Minor and J. Turner for their help with the initial tests on the liquid cells. This project is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy under contract DE-AC02-05CH11231.	Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; BURKE JE, 1952, PROG MET PHYS, V3, P220, DOI 10.1016/0502-8205(52)90009-9; Chen YF, 2007, J AM CHEM SOC, V129, P10937, DOI 10.1021/ja073023n; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Gai PL, 2002, MICROSC MICROANAL, V8, P21, DOI 10.1017/S1431927601010054; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; LEFF DV, 1995, J PHYS CHEM-US, V99, P7036, DOI 10.1021/j100018a041; Liu KL, 2008, LAB CHIP, V8, P1915, DOI 10.1039/b804986f; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; MINOR A, DEAC0205CH11231 US D; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Norris DJ, 2008, SCIENCE, V319, P1776, DOI 10.1126/science.1143802; Pacholski C, 2002, ANGEW CHEM INT EDIT, V41, P1188, DOI 10.1002/1521-3773(20020402)41:7<1188::AID-ANIE1188>3.0.CO;2-5; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Puntes VF, 2001, SCIENCE, V291, P2115, DOI 10.1126/science.1057553; Puntes VF, 2002, J AM CHEM SOC, V124, P12874, DOI 10.1021/ja027262g; REISS H, 1951, J CHEM PHYS, V19, P482, DOI 10.1063/1.1748251; Ross FM, 1998, PHYS REV LETT, V80, P984, DOI 10.1103/PhysRevLett.80.984; SUGIMOTO T, 1987, ADV COLLOID INTERFAC, V28, P65, DOI 10.1016/0001-8686(87)80009-X; Watzky MA, 2008, J AM CHEM SOC, V130, P11959, DOI 10.1021/ja8017412; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Yang YA, 2005, ANGEW CHEM INT EDIT, V44, P6712, DOI 10.1002/anie.200502279; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Yu JH, 2005, J AM CHEM SOC, V127, P5662, DOI 10.1021/ja044593f	29	968	982	19	725	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1309	1312		10.1126/science.1172104	http://dx.doi.org/10.1126/science.1172104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498166	Green Submitted			2022-12-28	WOS:000266635100040
J	MacDonald, R				MacDonald, Rhona			Save Somalia!	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], MED SANS FRONTIERES; MALETTA R, 2008, HUMANITARIAN EX 1001; RUGMAN J, 2009, CHANNEL 4 NEWS  0615	3	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2009	373	9682					2184	2184		10.1016/S0140-6736(09)61164-8	http://dx.doi.org/10.1016/S0140-6736(09)61164-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560588				2022-12-28	WOS:000267444500011
J	Rehm, J; Room, R				Rehm, Juergen; Room, Robin			A case study in how harmful alcohol consumption can be	LANCET			English	Editorial Material							RISK-FACTOR; MORTALITY; DISEASE; RUSSIA		[Room, Robin] Turning Point Alcohol & Drug Ctr, AER Ctr Alcohol Policy Res, Fitzroy, Vic 3065, Australia; [Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, Dresden, Germany; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Room, Robin] Stockholm Univ, Ctr Social Res Alcohol & Drugs, S-10691 Stockholm, Sweden	Turning Point Alcohol & Drug Centre - Australia; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Technische Universitat Dresden; University of Melbourne; Stockholm University	Room, R (corresponding author), Turning Point Alcohol & Drug Ctr, AER Ctr Alcohol Policy Res, Fitzroy, Vic 3065, Australia.	robinr@turningpoint.org.au	Rem, Jürgen/H-1309-2011; Rehm, Jürgen/K-2147-2012; Room, Robin/ABF-7460-2021; Room, Robin/ABH-8505-2020	Rehm, Jürgen/0000-0001-5665-0385; Room, Robin/0000-0002-5618-385X; 				Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Parry C, 2009, ADDICTION, V104, P331, DOI 10.1111/j.1360-0443.2008.02500.x; Pearl R., 1926, ALCOHOL LONGEVITY; Rehm J, 2009, INT J EPIDEMIOL, V38, P154, DOI 10.1093/ije/dyn209; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; ROOM R, 2001, ALCOHOL EUROPEAN REG, P35; Room R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2364; *WHO, 2009, FOLL PROC IMPL WHA 6; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	13	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2176	2177		10.1016/S0140-6736(09)61170-3	http://dx.doi.org/10.1016/S0140-6736(09)61170-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560585				2022-12-28	WOS:000267444500006
J	Rupprecht, R; Rammes, G; Eser, D; Baghai, TC; Schule, C; Nothdurfter, C; Troxler, T; Gentsch, C; Kalkman, HO; Chaperon, F; Uzunov, V; McAllister, KH; Bertaina-Anglade, V; La Rochelle, CD; Tuerck, D; Floesser, A; Kiese, B; Schumacher, M; Landgraf, R; Holsboer, F; Kucher, K				Rupprecht, Rainer; Rammes, Gerhard; Eser, Daniela; Baghai, Thomas C.; Schuele, Cornelius; Nothdurfter, Caroline; Troxler, Thomas; Gentsch, Conrad; Kalkman, Hans O.; Chaperon, Frederique; Uzunov, Veska; McAllister, Kevin H.; Bertaina-Anglade, Valerie; La Rochelle, Christophe Drieu; Tuerck, Dietrich; Floesser, Annette; Kiese, Beate; Schumacher, Michael; Landgraf, Rainer; Holsboer, Florian; Kucher, Klaus			Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects	SCIENCE			English	Article							PANIC DISORDER; PHARMACOLOGICAL-TREATMENT; NEUROACTIVE STEROIDS; GABA(A) RECEPTOR; A RECEPTOR; ANXIETY; NEUROSTEROIDS; PROGESTERONE; STIMULATION; COMORBIDITY	Most antianxiety drugs (anxiolytics) work by modulating neurotransmitters in the brain. Benzodiazepines are fast and effective anxiolytic drugs; however, their long-term use is limited by the development of tolerance and withdrawal symptoms. Ligands of the translocator protein [18 kilodaltons (kD)] may promote the synthesis of endogenous neurosteroids, which also exert anxiolytic effects in animal models. Here, we found that the translocator protein (18 kD) ligand XBD173 enhanced gamma-aminobutyric acid-mediated neurotransmission and counteracted induced panic attacks in rodents in the absence of sedation and tolerance development. XBD173 also exerted antipanic activity in humans and, in contrast to benzodiazepines, did not cause sedation or withdrawal symptoms. Thus, translocator protein (18 kD) ligands are promising candidates for fast-acting anxiolytic drugs with less severe side effects than benzodiazepines.	[Rupprecht, Rainer; Eser, Daniela; Baghai, Thomas C.; Schuele, Cornelius; Nothdurfter, Caroline] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany; [Rupprecht, Rainer; Rammes, Gerhard; Nothdurfter, Caroline; Landgraf, Rainer; Holsboer, Florian] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Rammes, Gerhard] Tech Univ Munich, Dept Anaesthesiol, D-81675 Munich, Germany; [Gentsch, Conrad; Kalkman, Hans O.; Chaperon, Frederique; Uzunov, Veska; McAllister, Kevin H.; Floesser, Annette; Kucher, Klaus] NIBR, CH-4056 Basel, Switzerland; [Bertaina-Anglade, Valerie; La Rochelle, Christophe Drieu] Biotrial, F-3500 Rennes, France; [Tuerck, Dietrich] F Hoffmann La Roche & Cie AG, Drug Metab & Pharmacokinet, CH-4070 Basel, Switzerland; [Kiese, Beate] Novartis Pharma AG, Biostat, CH-4056 Basel, Switzerland; [Schumacher, Michael] INSERM, UMR 788, F-94274 Paris, France; [Schumacher, Michael] Univ Paris 11, F-94274 Paris, France	University of Munich; Max Planck Society; Technical University of Munich; Novartis; Roche Holding; Novartis; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Rupprecht, R (corresponding author), Univ Munich, Dept Psychiat & Psychotherapy, Nussbaumstr 7, D-80336 Munich, Germany.	rainer.rupprecht@med.uni-muenchen.de	Schumacher, Michael/G-3581-2013	Schumacher, Michael/0000-0001-6117-5371; Baghai, Thomas C/0000-0002-7873-4130	Novartis Pharma AG, Basel, Switzerland; Max Planck	Novartis Pharma AG, Basel, Switzerland; Max Planck	The clinical study has been sponsored by Novartis Pharma AG, Basel, Switzerland. Molecular and electrophysiological experiments were supported by a Max Planck Fellow grant to R.R. R.R. has been a paid consultant for Novartis and been on Novartis advisory boards.	Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253; Bandelow B, 2008, WORLD J BIOL PSYCHIA, V9, P248, DOI 10.1080/15622970802465807; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Carboni E, 1996, PSYCHOPHARMACOLOGY, V126, P173, DOI 10.1007/BF02246353; Eser D, 2007, PSYCHOPHARMACOLOGY, V192, P479, DOI 10.1007/s00213-007-0738-7; HARRO J, 1993, TRENDS PHARMACOL SCI, V14, P244, DOI 10.1016/0165-6147(93)90020-K; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kita A, 2004, BRIT J PHARMACOL, V142, P1059, DOI 10.1038/sj.bjp.0705681; Kita A, 2008, PHARMACOL BIOCHEM BE, V89, P171, DOI 10.1016/j.pbb.2007.12.006; Nakamura K, 2006, AM J MED GENET B, V141B, P222, DOI 10.1002/ajmg.b.30211; Nutt DJ, 2002, INT J NEUROPSYCHOPH, V5, P315, DOI 10.1017/S1461145702003048; Okuyama S, 1999, LIFE SCI, V64, P1455, DOI 10.1016/S0024-3205(99)00079-X; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PATCHEV VK, 1994, NEUROSCIENCE, V62, P265, DOI 10.1016/0306-4522(94)90330-1; Pini S, 2005, PSYCHOPHARMACOLOGY, V181, P407, DOI 10.1007/s00213-005-2247-x; ROMEO E, 1993, J PHARMACOL EXP THER, V267, P462; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Serra M, 1999, BRIT J PHARMACOL, V127, P177, DOI 10.1038/sj.bjp.0702530; Shekhar A, 1996, PHARMACOL BIOCHEM BE, V55, P249, DOI 10.1016/S0091-3057(96)00077-9; Strohle A, 2003, ARCH GEN PSYCHIAT, V60, P161, DOI 10.1001/archpsyc.60.2.161; Verleye M, 2005, PHARMACOL BIOCHEM BE, V82, P712, DOI 10.1016/j.pbb.2005.11.013; Zwanzger P, 2005, J PSYCHIATR NEUROSCI, V30, P167; Zwanzger P, 2003, NEUROPSYCHOPHARMACOL, V28, P979, DOI 10.1038/sj.npp.1300131	28	261	274	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 24	2009	325	5939					490	493		10.1126/science.1175055	http://dx.doi.org/10.1126/science.1175055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19541954				2022-12-28	WOS:000268255100061
J	Ganem, NJ; Godinho, SA; Pellman, D				Ganem, Neil J.; Godinho, Susana A.; Pellman, David			A mechanism linking extra centrosomes to chromosomal instability	NATURE			English	Article							MEROTELIC KINETOCHORE ORIENTATION; CLONAL EVOLUTION; CANCER-CELLS; ANEUPLOIDY; AMPLIFICATION; MITOSIS; NUMBERS	Chromosomal instability (CIN) is a hallmark of many tumours and correlates with the presence of extra centrosomes(1-4). However, a direct mechanistic link between extra centrosomes and CIN has not been established. It has been proposed that extra centrosomes generate CIN by promoting multipolar anaphase, a highly abnormal division that produces three or more aneuploid daughter cells. Here we use long-term live-cell imaging to demonstrate that cells with multiple centrosomes rarely undergo multipolar cell divisions, and the progeny of these divisions are typically inviable. Thus, multipolar divisions cannot explain observed rates of CIN. In contrast, we observe that CIN cells with extra centrosomes routinely undergo bipolar cell divisions, but display a significantly increased frequency of lagging chromosomes during anaphase. To define the mechanism underlying this mitotic defect, we generated cells that differ only in their centrosome number. We demonstrate that extra centrosomes alone are sufficient to promote chromosome missegregation during bipolar cell division. These segregation errors are a consequence of cells passing through a transient 'multipolar spindle intermediate' in which merotelic kinetochore-microtubule attachment errors accumulate before centrosome clustering and anaphase. These findings provide a direct mechanistic link between extra centrosomes and CIN, two common characteristics of solid tumours. We propose that this mechanism may be a common underlying cause of CIN in human cancer.	[Ganem, Neil J.; Godinho, Susana A.; Pellman, David] Harvard Univ, Sch Med,Dept Pediat Oncol, Dana Farber Canc Inst,Dept Cell Biol, Howard Hughes Med Inst,Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Pellman, D (corresponding author), Harvard Univ, Sch Med,Dept Pediat Oncol, Dana Farber Canc Inst,Dept Cell Biol, Howard Hughes Med Inst,Childrens Hosp, 44 Binney St, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Ganem, Neil/0000-0003-0269-6585; Godinho, Susana/0000-0003-0638-065X	Leukemia and Lymphoma Society; NIH [GM083299]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Compton, R. King, D. Livingston, A. Manning, T. Rapoport, J. Shah, T. Stukenberg and members of the Pellman laboratory for comments and discussion of the manuscript; L. Cameron for setting up the confocal microscope; P. Schow for help with FACS; D. Neuberg for help with statistical analysis; C. King for help with the model figure; J. Iwasa for creating the animations; and L. Moreau and S. Thompson for technical advice on chromosome spreads and FISH analysis. Reagents were provided by D. Compton, S. Gollin, R. King, A. Khodjakov, E. Nigg and G. Wahl. N.J.G. is a fellow of the Leukemia and Lymphoma Society and D. P. is an HHMI Investigator. This work was supported by NIH grant GM083299.	Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Chandhok NS, 2009, CURR OPIN GENET DEV, V19, P74, DOI 10.1016/j.gde.2008.12.004; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; HENEEN WK, 1975, EXP CELL RES, V91, P57, DOI 10.1016/0014-4827(75)90140-8; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Sato N, 2001, CANCER GENET CYTOGEN, V126, P13, DOI 10.1016/S0165-4608(00)00384-8; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Sluder G, 1997, J CELL SCI, V110, P421; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738	30	958	987	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					278	U146		10.1038/nature08136	http://dx.doi.org/10.1038/nature08136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19506557	Green Accepted			2022-12-28	WOS:000267761000045
J	De Block, CEM; Van Gaal, LF				De Block, Christophe E. M.; Van Gaal, Luc F.			GLP-1 receptor agonists for type 2 diabetes	LANCET			English	Editorial Material							MELLITUS		[De Block, Christophe E. M.] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; Univ Antwerp, Dept Diabetol & Endocrinol, B-2650 Antwerp, Belgium	University of Antwerp; University of Antwerp	De Block, CEM (corresponding author), Univ Antwerp Hosp, Wilrijkstr 10, B-2650 Antwerp, Belgium.	christophe.deblock@ua.ac.be	De+Block, Christophe/ABE-1600-2020					Ahmad SR, 2008, NEW ENGL J MED, V358, P1970; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Costante G, 2009, NAT CLIN PRACT ENDOC, V5, P35, DOI 10.1038/ncpendmet1023; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Van Gaal LF, 2008, EUR J ENDOCRINOL, V158, P773, DOI 10.1530/EJE-07-0804; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487	8	25	27	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2009	374	9683					4	6		10.1016/S0140-6736(09)60942-9	http://dx.doi.org/10.1016/S0140-6736(09)60942-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19515414				2022-12-28	WOS:000267768800005
J	Elliott, P; Chambers, JC; Zhang, WH; Clarke, R; Hopewell, JC; Peden, JF; Erdmann, J; Braund, P; Engert, JC; Bennett, D; Coin, L; Ashby, D; Tzoulaki, I; Brown, IJ; Mt-Isa, S; McCarthy, MI; Peltonen, L; Freimer, NB; Farrall, M; Ruokonen, A; Hamsten, A; Lim, N; Froguel, P; Waterworth, DM; Vollenweider, P; Waeber, G; Jarvelin, MR; Mooser, V; Scott, J; Hall, AS; Schunkert, H; Anand, SS; Collins, R; Samani, NJ; Watkins, H; Kooner, JS				Elliott, Paul; Chambers, John C.; Zhang, Weihua; Clarke, Robert; Hopewell, Jemma C.; Peden, John F.; Erdmann, Jeanette; Braund, Peter; Engert, James C.; Bennett, Derrick; Coin, Lachlan; Ashby, Deborah; Tzoulaki, Ioanna; Brown, Ian J.; Mt-Isa, Shahrul; McCarthy, Mark I.; Peltonen, Leena; Freimer, Nelson B.; Farrall, Martin; Ruokonen, Aimo; Hamsten, Anders; Lim, Noha; Froguel, Philippe; Waterworth, Dawn M.; Vollenweider, Peter; Waeber, Gerard; Jarvelin, Marjo-Riitta; Mooser, Vincent; Scott, James; Hall, Alistair S.; Schunkert, Heribert; Anand, Sonia S.; Collins, Rory; Samani, Nilesh J.; Watkins, Hugh; Kooner, Jaspal S.			Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; LOW-GRADE INFLAMMATION; ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; CRP GENE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; VASCULAR EVENTS; PREDICTION; MEN	Context Plasma levels of C-reactive protein (CRP) are independently associated with risk of coronary heart disease, but whether CRP is causally associated with coronary heart disease or merely a marker of underlying atherosclerosis is uncertain. Objective To investigate association of genetic loci with CRP levels and risk of coronary heart disease. Design, Setting, and Participants We first carried out a genome-wide association (n = 17 967) and replication study (n = 13 615) to identify genetic loci associated with plasma CRP concentrations. Data collection took place between 1989 and 2008 and genotyping between 2003 and 2008. We carried out a mendelian randomization study of the most closely associated single-nucleotide polymorphism (SNP) in the CRP locus and published data on other CRP variants involving a total of 28 112 cases and 100 823 controls, to investigate the association of CRP variants with coronary heart disease. We compared our finding with that predicted from meta-analysis of observational studies of CRP levels and risk of coronary heart disease. For the other loci associated with CRP levels, we selected the most closely associated SNP for testing against coronary heart disease among 14 365 cases and 32 069 controls. Main Outcome Measure Risk of coronary heart disease. Results Polymorphisms in 5 genetic loci were strongly associated with CRP levels (% difference per minor allele): SNP rs6700896 in LEPR (-14.8%; 95% confidence interval [CI], -17.6% to -12.0%; P = 6.2 x 10(-22)), rs4537545 in IL6R (-11.5%; 95% CI, -14.4% to -8.5%; P = 1.3 x 10(-12)), rs7553007 in the CRP locus (-20.7%; 95% CI, -23.4% to -17.9%; P = 1.3 x 10(-38)), rs1183910 in HNF1A (-13.8%; 95% CI, -16.6% to -10.9%; P = 1.9 x 10(-18)), and rs4420638 in APOE-CI-CII (-21.8%; 95% CI, -25.3% to -18.1%; P = 8.1 x 10(-26)). Association of SNP rs7553007 in the CRP locus with coronary heart disease gave an odds ratio (OR) of 0.98 (95% CI, 0.94 to 1.01) per 20% lower CRP level. Our mendelian randomization study of variants in the CRP locus showed no association with coronary heart disease: OR, 1.00; 95% CI, 0.97 to 1.02; per 20% lower CRP level, compared with OR, 0.94; 95% CI, 0.94 to 0.95; predicted from meta-analysis of the observational studies of CRP levels and coronary heart disease (z score, -3.45; P < .001). SNPs rs6700896 in LEPR (OR, 1.06; 95% CI, 1.02 to 1.09; per minor allele), rs4537545 in IL6R (OR, 0.94; 95% CI, 0.91 to 0.97), and rs4420638 in the APOE-CI-CII cluster (OR, 1.16; 95% CI, 1.12 to 1.21) were all associated with risk of coronary heart disease. Conclusion The lack of concordance between the effect on coronary heart disease risk of CRP genotypes and CRP levels argues against a causal association of CRP with coronary heart disease. JAMA. 2009;302(1):37-48	[Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRCHPA Ctr Environm & Hlth, Dept Epidemiol & Publ Hlth, Fac Med, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welfare, Oulu, Finland; [Clarke, Robert; Hopewell, Jemma C.; Bennett, Derrick; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert; Hopewell, Jemma C.; Bennett, Derrick; Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Peden, John F.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Peden, John F.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Inst Hlth Res Biomed Res, Oxford Natl Inst, Oxford, England; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Braund, Peter; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet & Therapeut, Leeds, W Yorkshire, England; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, D-23538 Lubeck, Germany; [Anand, Sonia S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Anand, Sonia S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Vollenweider, Peter; Waeber, Gerard] CHUV Univ Hosp, Dept Med, Lausanne, Switzerland; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Hamsten, Anders] Karolinska Inst, Dept Med, Stockholm, Sweden; [Lim, Noha; Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA	Imperial College London; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Wellcome Trust Sanger Institute; University of Leicester; McGill University; McGill University; University of Leeds; University of Lubeck; McMaster University; Population Health Research Institute; McMaster University; McMaster University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California Los Angeles; Karolinska Institutet; GlaxoSmithKline	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRCHPA Ctr Environm & Hlth, Dept Epidemiol & Publ Hlth, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.elliott@imperial.ac.uk	Bennett, Derrick/AAH-1220-2022; Colaus, PsyColaus/K-6607-2013; Erdmann, Jeanette/A-4417-2009; Mt-Isa, Shahrul/F-1275-2010; Collins, Rory/ABA-8487-2020; Lim, Noha/ABA-2509-2020; , Bennett/O-7998-2019; zhang, weihua/GXV-1334-2022; Erdmann, Jeanette/P-7513-2014; Bennett, Derrick/AFL-9254-2022; Coin, Lachlan JM/A-9001-2014; Tzoulaki, Ioanna/ABE-6269-2020; Coin, Lachlan/O-4976-2019; Hall, Alistair/K-1953-2019; FROGUEL, Philippe/O-6799-2017; Tzoulaki, Ioanna/C-1381-2008; McCarthy, Mark/M-3763-2015	Bennett, Derrick/0000-0002-9170-8447; Mt-Isa, Shahrul/0000-0002-7163-8402; Erdmann, Jeanette/0000-0002-4486-6231; Bennett, Derrick/0000-0002-9170-8447; Coin, Lachlan JM/0000-0002-4300-455X; Tzoulaki, Ioanna/0000-0002-4275-9328; Coin, Lachlan/0000-0002-4300-455X; FROGUEL, Philippe/0000-0003-2972-0784; Elliott, Paul/0000-0002-7511-5684; Waeber, Gerard/0000-0003-4193-788X; Hopewell, Jemma/0000-0002-3870-8018; Engert, James/0000-0001-8411-4790; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Watkins, Hugh/0000-0002-5287-9016; McCarthy, Mark/0000-0002-4393-0510; Hall, Alistair/0000-0003-0306-7887	INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofi-Aventis; Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; European Union [EURODIA LSHM-CT-2006-518153]; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; Deutsche Herzstiftung; National Genome Research Network 2 of the German Federal Ministry of Education and Research; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; International Clinical Epidemiology Network (INCLEN); Chile, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur; Colombia, Colciencias, Ministerio de Salud; Croatia, CroatianMinistry of Science and Technology; Guatemala, Liga Guatemalteca del Corazon; Hungary, Astra Hassle, National Health Science Council, George Gabor Foundation; Iran, Iran Ministry of Health; Italy, Boehringer-Ingelheim; Japan, Sankyo Pharmaceutical Co; Banyu Pharmaceutical Co, Astra Japan; Kuwait, Endowment Fund for Health Development in Kuwait; Pakistan, ATCO Laboratories; Philippines, Philippine Council for Health Research and Development; Pfizer Philippines Foundation, Inc; Astra Pharmaceuticals Inc; Astra Fund for Clinical Research and Continuing Medical Education; Pharmacia and Upjohn Inc; Poland, Foundation PROCLINICA; Singapore, Singapore National Heart Association; South Africa, Medical Research Council of South Africa; Warner-Parke-Davis Pharmaceuticals; Aventis; Swedish State under the LUA agreement; Swedish Heart and Lung Foundation; Thailand, Heart Association of Thailand; Thailand Research Fund; British Heart Foundation; Medical Research Council; Cancer Research UK; Tobacco Products Research Trust; Giorgi-Cavaglieri Foundation; Swiss National Science Foundation [3100AO-116323/1]; Universite de Lausanne, Lausanne, Switzerland.; British Heart Foundation [SP/04/002]; National Heart, Lung, and Blood Institute [5R01HL087679-02]; Medical Research Council of the United Kingdom; European Birth Life-Course Study; European Commission [QLG1-CT2000-01643]; Biocenter Oulu of University of Oulu; Academy of Finland; National Institute of Mental Health [1RL1MH083268-01]; EC Sixth Framework Programme [LSHM33 CT-2007-037273]; Wellcome Trust; MRC [G0600331, MC_U137686857, G0801056, G0700931, G0601966] Funding Source: UKRI; Medical Research Council [G0600331, G0801056B, G0700931, MC_U137686857, G0801056, G0601966] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; European Union(European Commission); GlaxoSmithKline(GlaxoSmithKline); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; National Genome Research Network 2 of the German Federal Ministry of Education and Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); International Clinical Epidemiology Network (INCLEN); Chile, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur; Colombia, Colciencias, Ministerio de Salud(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Croatia, CroatianMinistry of Science and Technology; Guatemala, Liga Guatemalteca del Corazon; Hungary, Astra Hassle, National Health Science Council, George Gabor Foundation; Iran, Iran Ministry of Health; Italy, Boehringer-Ingelheim(Boehringer Ingelheim); Japan, Sankyo Pharmaceutical Co; Banyu Pharmaceutical Co, Astra Japan; Kuwait, Endowment Fund for Health Development in Kuwait; Pakistan, ATCO Laboratories; Philippines, Philippine Council for Health Research and Development; Pfizer Philippines Foundation, Inc; Astra Pharmaceuticals Inc; Astra Fund for Clinical Research and Continuing Medical Education; Pharmacia and Upjohn Inc; Poland, Foundation PROCLINICA; Singapore, Singapore National Heart Association; South Africa, Medical Research Council of South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Warner-Parke-Davis Pharmaceuticals; Aventis(Sanofi-Aventis); Swedish State under the LUA agreement; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Thailand, Heart Association of Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Tobacco Products Research Trust; Giorgi-Cavaglieri Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Universite de Lausanne, Lausanne, Switzerland.; British Heart Foundation(British Heart Foundation); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Birth Life-Course Study; European Commission(European CommissionEuropean Commission Joint Research Centre); Biocenter Oulu of University of Oulu; Academy of Finland(Academy of Finland); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EC Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Data from an Epidemiological Study on the Insulin Resistance syndrome (DESIR) received support from INSERM, CNAMTS, Lilly, Novartis Pharma, Sanofi-Aventis, the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon, and the European Union (P. F.) (Integrated Project EURODIA LSHM-CT-2006-518153 in the Framework Programme 6 [FP06] of the European Community). The Genetic Epidemiology of Metabolic Syndrome (GEMS) study was sponsored in part by GlaxoSmithKline. The German MI Family Study was supported by grants from the Deutsche Forschungsgemeinschaft and the Deutsche Herzstiftung, the National Genome Research Network 2 of the German Federal Ministry of Education and Research, and the Cardiogenics project of the European Union. From the INTERHEART study, Dr Anand holds the Michael G. DeGroot and Heart and Stroke Foundation of Ontario Chair in Population Health and the May Cohen Eli Lilly Endowed Chair in Women's Health Research, McMaster University. The INTERHEART study was funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and the International Clinical Epidemiology Network (INCLEN); through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca, Novartis, Sanofi-Aventis, Knoll Pharmaceuticals [now Abbott], Bristol Myers Squibb, and King Pharma); and by various national bodies in different countries as follows: Chile, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur; Colombia, Colciencias, Ministerio de Salud; Croatia, CroatianMinistry of Science and Technology; Guatemala, Liga Guatemalteca del Corazon; Hungary, Astra Hassle, National Health Science Council, George Gabor Foundation; Iran, Iran Ministry of Health; Italy, Boehringer-Ingelheim; Japan, Sankyo Pharmaceutical Co, Banyu Pharmaceutical Co, Astra Japan; Kuwait, Endowment Fund for Health Development in Kuwait; Pakistan, ATCO Laboratories; Philippines, Philippine Council for Health Research and Development, Pfizer Philippines Foundation, Inc, Astra Pharmaceuticals Inc and the Astra Fund for Clinical Research and Continuing Medical Education, Pharmacia and Upjohn Inc; Poland, Foundation PROCLINICA; Singapore, Singapore National Heart Association; South Africa, Medical Research Council of South Africa, Warner-Parke-Davis Pharmaceuticals, Aventis; Sweden, grant from the Swedish State under the LUA agreement, Swedish Heart and Lung Foundation; Thailand, Heart Association of Thailand, Thailand Research Fund. The International Studies of Infarct Survival (ISIS) trials and epidemiological studies were supported by the manufacturers of the study drugs and by the British Heart Foundation, Medical Research Council, Cancer Research UK, Tobacco Products Research Trust of the UK Department of Health Independent Scientific Committee on Smoking and Health, and Oxford NHS Genetic Knowledge Park. The Lausanne Cohort (CoLaus) study received support from the Giorgi-Cavaglieri Foundation (Toby Johnson, Sven Bergmann), the Universite de Lausanne (Jacques S. Beckmann), and grant 3100AO-116323/1 (Sven Bergmann) from the Swiss National Science Foundation (Murielle Bochud). GlaxoSmithKline provided support to build the CoLaus study (Drs Vollenweider and Waeber). Thiswork was supported by GlaxoSmithKline and the Faculty of Biology and Medicine, Universite de Lausanne, Lausanne, Switzerland.; The London Life Siences Population (LOLIPOP) received support from grant SP/04/002 from the British Heart Foundation. The 1966 North Finland Birth Cohort received support from grant 5R01HL087679-02 from the National Heart, Lung, and Blood Institute through the STAMPEED program; the Medical Research Council of the United Kingdom; the European Birth Life-Course Study; contract QLG1-CT2000-01643 from the European Commission "Quality of Life and Management of Living Resources"; the Biocenter Oulu of University of Oulu; the Academy of Finland; and grant 1RL1MH083268-01 from the National Institute of Mental Health. The Precocious Coronary Artery Disease study (PROCARDIS) was funded by the British Heart Foundation, EC Sixth Framework Programme (LSHM33 CT-2007-037273), AstraZeneca AB, and the Knut and Alice Wallenberg Foundation. The Wellcome Trust Case Control Consortium (WTCCC) study received support for recruitment from grants from the British Heart Foundation and the UK Medical Research Council. It also received support from the Wellcome Trust Functional Genomics Initiative in Cardiovascular Genetics. Dr Samani holds a chair funded by the British Heart Foundation.	Agewall S, 1998, J HYPERTENS, V16, P537, DOI 10.1097/00004872-199816040-00016; Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen JH, 2005, J MOL MED, V83, P72, DOI 10.1007/s00109-004-0585-5; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Backer J, 2002, ATHEROSCLEROSIS, V160, P457, DOI 10.1016/S0021-9150(01)00602-5; Erbel R, 2008, ATHEROSCLEROSIS, V197, P662, DOI 10.1016/j.atherosclerosis.2007.02.031; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Gauderman W, QUANTO 1 1 COMPUTER; Hansma AHG, 2005, ANN ONCOL, V16, P1695, DOI 10.1093/annonc/mdi318; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hlatky MA, 2008, NEW ENGL J MED, V359, P2280, DOI 10.1056/NEJMe0808320; Hung J, 2008, HEART LUNG CIRC, V17, P90, DOI 10.1016/j.hlc.2007.07.002; HUNT D, 1992, LANCET, V339, P753; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P3071, DOI 10.1161/01.ATV.19.12.3071; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pepys MB, 2008, NAT CLIN PRACT NEPHR, V4, P234, DOI 10.1038/ncpneph0778; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sakkinen P, 2002, J CLIN EPIDEMIOL, V55, P445, DOI 10.1016/S0895-4356(01)00502-9; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Verma S, 2005, NAT CLIN PRACT CARD, V2, P29, DOI 10.1038/ncpcardio0074; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wang CH, 2006, INT J HYG ENVIR HEAL, V209, P265, DOI 10.1016/j.ijheh.2005.12.005; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; Wyszynski DF, 2005, AM J CARDIOL, V95, P194, DOI 10.1016/j.amjcard.2004.08.091; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	72	469	488	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					37	48		10.1001/jama.2009.954	http://dx.doi.org/10.1001/jama.2009.954			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567438	Green Accepted, Bronze			2022-12-28	WOS:000267492800020
J	Jaiswal, JK; Rivera, VM; Simon, SM				Jaiswal, Jyoti K.; Rivera, Victor M.; Simon, Sanford M.			Exocytosis of Post-Golgi Vesicles Is Regulated by Components of the Endocytic Machinery	CELL			English	Article							KISS-AND-RUN; FUSION PORE; CONSTITUTIVE EXOCYTOSIS; CALCIUM; DYNAMIN; CELLS; TRANSPORT; PROTEIN; SECRETION; KINETICS	Post-Golgi vesicles target and deliver most biosynthetic cargoes to the cell surface. However, the molecules and mechanisms involved in fusion of these vesicles are not well understood. We have employed a system to simultaneously monitor release of luminal and membrane biosynthetic cargoes from individual post-Golgi vesicles. Exocytosis of these vesicles is not calcium triggered. Release of luminal cargo can be accompanied by complete, partial, or no release of membrane cargo. Partial and no release of membrane cargo of a fusing vesicle are fates associated with kiss-and-run exocytosis, and we find that these are the predominant mode of post-Golgi vesicle exocytosis. Partial cargo release by post-Golgi vesicles occurs because of premature closure of the fusion pore and is modulated by the activity of clathrin, actin, and dynamin. Our results demonstrate that these components of the endocytic machinery modulate the nature and extent of biosynthetic cargo delivery by post-Golgi vesicles at the cell membrane.	[Rivera, Victor M.] ARIAD Gene Therapeut Inc, Cambridge, MA 02139 USA; [Jaiswal, Jyoti K.; Simon, Sanford M.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Jaiswal, JK (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	jaiswaj@rockefeller.edu; simon@rockefeller.edu	Jaiswal, Jyoti/ABI-1666-2020; Jaiswal, JK/M-5891-2013; Jaiswal, Jyoti/AAD-5386-2020	Jaiswal, Jyoti/0000-0002-5992-5185; Jaiswal, JK/0000-0002-5992-5185; Simon, Sanford/0000-0002-8615-4224; Rivera, Victor/0000-0002-7258-3001	National Science Foundation [BES-0620813]; National Institutes of Health [P20 GM072015, R01AR055686]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072015, R01GM087977] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Thomas Kirschhausen for providing us with dynasore and DsRed-CLC, Jennifer Lippincott-Schwartz for VSVG<INF>ts</INF>, and Claire Atkinson for Dynamin2(aa)-mCherry. We thank lab members and others who offered helpful suggestions during the course of this work and Patrick Bhola for comments on the manuscript. Knut Wittkowski helped us with some of the statistical analysis, and the work was funded by grants from the National Science Foundation (BES-0620813) and the National Institutes of Health (P20 GM072015 to S. M. S. and R01AR055686 to J.K.J.). J.K.J. designed the research, performed the experiments, analyzed data, and wrote the paper, all with help from S. M. S. V.M.R. contributed new reagents.	Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Antonny B, 2004, CELL, V119, P581, DOI 10.1016/j.cell.2004.11.026; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Cao H, 2000, J CELL SCI, V113, P1993; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; EDWARDSON JM, 1992, BIOCHEM J, V285, P383, DOI 10.1042/bj2850383; Elhamdani A, 2006, J NEUROSCI, V26, P3030, DOI 10.1523/JNEUROSCI.5275-05.2006; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jaiswal JK, 2007, P NATL ACAD SCI USA, V104, P14151, DOI 10.1073/pnas.0704935104; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; LEW DJ, 1991, J MEMBRANE BIOL, V123, P261, DOI 10.1007/BF01870409; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Puertollano R, 2003, MOL BIOL CELL, V14, P1545, DOI 10.1091/mbc.02-07-0109; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schmoranzer J, 2003, MOL BIOL CELL, V14, P1558, DOI 10.1091/mbc.E02-08-0500; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Zhang Z, 2008, J GEN PHYSIOL, V131, P117, DOI 10.1085/jgp.200709891	52	90	91	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1308	1319		10.1016/j.cell.2009.04.064	http://dx.doi.org/10.1016/j.cell.2009.04.064			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563761	Green Accepted, Bronze			2022-12-28	WOS:000267373400023
J	Purnell, BA; Hines, PJ				Purnell, Beverly A.; Hines, Pamela J.			Steps to the Clinic INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1661	1661		10.1126/science.324_1661	http://dx.doi.org/10.1126/science.324_1661			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556495				2022-12-28	WOS:000267338200024
J	Lenzer, J				Lenzer, Jeanne			Patient Safety Watching over the medical device industry	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com						Curfman GD, 2009, NEW ENGL J MED, V360, P1550, DOI 10.1056/NEJMe0902377; Deyo RA, 1997, NEW ENGL J MED, V336, P1176, DOI 10.1056/NEJM199704173361611; *FDA, 2007, AM2 PAT INC PREF HEP; *FDA, 2005, MEDTR ISS NOT REG CE; *FDA, 2005, GUID IN WORLDW PHYS; *GOV ACC OFF, 2009, MED DEV FDA SHOULD T; HANDA V, 2007, MEDSCAPE; HARDER B, 2005, WASHINGTON POST 0628; HARRIS G, 2009, NY TIMES        0112; Institute of Medicine, 2009, CONFL INT MED RES ED; McGarity T.O., 2008, BENDING SCI SPECIAL; *PROJ GOV OV, 2009, FDAS DEADL GAMBL SAF; RABIN RC, 2009, NY TIMES        0505; RUBENSTEIN S, WALL STREET J; SCHULTZ D, 2008, FDA PUBLIC HLTH INFO	15	16	16	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2009	338								b2321	10.1136/bmj.b2321	http://dx.doi.org/10.1136/bmj.b2321			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MM	19549649				2022-12-28	WOS:000267436300031
J	Sukhovatkin, V; Hinds, S; Brzozowski, L; Sargent, EH				Sukhovatkin, Vlad; Hinds, Sean; Brzozowski, Lukasz; Sargent, Edward H.			Colloidal Quantum-Dot Photodetectors Exploiting Multiexciton Generation	SCIENCE			English	Article							MULTIPLE EXCITON GENERATION; SOLAR-CELLS; IMPACT IONIZATION; SEMICONDUCTOR NANOCRYSTALS; CARRIER MULTIPLICATION; INFRARED PHOTOVOLTAICS; ELECTRICAL-PROPERTIES; EFFICIENCY; PBSE; LEAD	Multiexciton generation (MEG) has been indirectly observed in colloidal quantum dots, both in solution and the solid state, but has not yet been shown to enhance photocurrent in an optoelectronic device. Here, we report a class of solution-processed photoconductive detectors, sensitive in the ultraviolet, visible, and the infrared, in which the internal gain is dramatically enhanced for photon energies E-photon greater than 2.7 times the quantum-confined bandgap E-bandgap. Three thin-film devices with different quantum-confined bandgaps (set by the size of their constituent lead sulfide nanoparticles) show enhancement determined by the bandgap-normalized photon energy, E-photon/E-bandgap, which is a clear signature of MEG. The findings point to a valuable role for MEG in enhancing the photocurrent in a solid-state optoelectronic device. We compare the conditions on carrier excitation, recombination, and transport for photoconductive versus photovoltaic devices to benefit from MEG.	[Sukhovatkin, Vlad; Hinds, Sean; Brzozowski, Lukasz; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	University of Toronto	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.	ted.sargent@utoronto.ca	Sargent, Edward H./O-9520-2014	Sargent, Edward H./0000-0003-0396-6495	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Canada Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	This publication was based on work supported in part by an award from the King Abdullah University of Science and Technology, by the Natural Sciences and Engineering Research Council of Canada, by the Canada Research Chairs, and by the Canada Foundation for Innovation and the Ontario Innovation Trust.	BARYSHEV NS, 1974, SOV PHYS SEMICOND+, V8, P192; Beard MC, 2007, NANO LETT, V7, P2506, DOI 10.1021/nl071486l; Beard MC, 2009, NANO LETT, V9, P836, DOI 10.1021/nl803600v; Ellingson RJ, 2005, NANO LETT, V5, P865, DOI 10.1021/nl0502672; Hinds S, 2008, ADV MATER, V20, P4398, DOI 10.1002/adma.200800452; Istrate E, 2008, J PHYS CHEM B, V112, P2757, DOI 10.1021/jp076809g; Jin YZ, 2008, NANO LETT, V8, P1649, DOI 10.1021/nl0803702; Johnston KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2896295; Johnston KW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912340; Klem EJD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2735674; KLIMOV V, 2000, C QUANT EL LAS SCI Q; Koleilat GI, 2008, ACS NANO, V2, P833, DOI 10.1021/nn800093v; KOLODINSKI S, 1993, APPL PHYS LETT, V63, P2405, DOI 10.1063/1.110489; Konstantatos G, 2008, NANO LETT, V8, P1446, DOI 10.1021/nl080373e; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; Law M, 2008, NANO LETT, V8, P3904, DOI 10.1021/nl802353x; Law M, 2008, J AM CHEM SOC, V130, P5974, DOI 10.1021/ja800040c; Luque A, 2007, MRS BULL, V32, P236, DOI 10.1557/mrs2007.28; Luther JM, 2008, ACS NANO, V2, P271, DOI 10.1021/nn7003348; Mcguire JA, 2008, ACCOUNTS CHEM RES, V41, P1810, DOI 10.1021/ar800112v; Murphy JE, 2006, J AM CHEM SOC, V128, P3241, DOI 10.1021/ja0574973; Mutlugun E, 2008, OPT EXPRESS, V16, P3537, DOI 10.1364/OE.16.003537; Nozik AJ, 2008, CHEM PHYS LETT, V457, P3, DOI 10.1016/j.cplett.2008.03.094; Sargent EH, 2009, NAT PHOTONICS, V3, P325, DOI 10.1038/NPHOTON.2009.89; Schaller RD, 2006, J PHYS CHEM B, V110, P25332, DOI 10.1021/jp065282p; SMITH A, 1958, J OPT SOC AM, V48, P1007, DOI 10.1364/JOSA.48.001007; TAUC J, 1959, J PHYS CHEM SOLIDS, V8, P219, DOI 10.1016/0022-3697(59)90321-X	27	501	512	7	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1542	1544		10.1126/science.1173812	http://dx.doi.org/10.1126/science.1173812			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541992				2022-12-28	WOS:000267130600038
J	Diskin, SJ; Hou, CP; Glessner, JT; Attiyeh, EF; Laudenslager, M; Bosse, K; Cole, K; Mosse, YP; Wood, A; Lynch, JE; Pecor, K; Diamond, M; Winter, C; Wang, K; Kim, C; Geiger, EA; McGrady, PW; Blakemore, AIF; London, WB; Shaikh, TH; Bradfield, J; Grant, SFA; Li, HZ; Devoto, M; Rappaport, ER; Hakonarson, H; Maris, JM				Diskin, Sharon J.; Hou, Cuiping; Glessner, Joseph T.; Attiyeh, Edward F.; Laudenslager, Marci; Bosse, Kristopher; Cole, Kristina; Mosse, Yael P.; Wood, Andrew; Lynch, Jill E.; Pecor, Katlyn; Diamond, Maura; Winter, Cynthia; Wang, Kai; Kim, Cecilia; Geiger, Elizabeth A.; McGrady, Patrick W.; Blakemore, Alexandra I. F.; London, Wendy B.; Shaikh, Tamim H.; Bradfield, Jonathan; Grant, Struan F. A.; Li, Hongzhe; Devoto, Marcella; Rappaport, Eric R.; Hakonarson, Hakon; Maris, John M.			Copy number variation at 1q21.1 associated with neuroblastoma	NATURE			English	Article							PEDIATRIC-ONCOLOGY-GROUP; GENE AMPLIFICATION; GENOME; SCHIZOPHRENIA; EXPRESSION; HYBRIDIZATION; DUPLICATIONS; POLYMORPHISM; PHENOTYPES; CANCER	Common copy number variations (CNVs) represent a significant source of genetic diversity, yet their influence on phenotypic variability, including disease susceptibility, remains poorly understood. To address this problem in human cancer, we performed a genome-wide association study of CNVs in the childhood cancer neuroblastoma, a disease in which single nucleotide polymorphism variations are known to influence susceptibility(1,2). We first genotyped 846 Caucasian neuroblastoma patients and 803 healthy Caucasian controls at similar to 550,000 single nucleotide polymorphisms, and performed a CNV-based test for association. We then replicated significant observations in two independent sample sets comprised of a total of 595 cases and 3,357 controls. Here we describe the identification of a common CNV at chromosome 1q21.1 associated with neuroblastoma in the discovery set, which was confirmed in both replication sets. This CNV was validated by quantitative polymerase chain reaction, fluorescent in situ hybridization and analysis of matched tumour specimens, and was shown to be heritable in an independent set of 713 cancer-free parent offspring trios. We identified a previously unknown transcript within the CNV that showed high sequence similarity to several neuroblastoma breakpoint family (NBPF) genes(3,4) and represents a new member of this gene family (NBPF23). This transcript was preferentially expressed in fetal brain and fetal sympathetic nervous tissues, and the expression level was strictly correlated with CNV state in neuroblastoma cells. These data demonstrate that inherited copy number variation at 1q21.1 is associated with neuroblastoma and implicate a previously unknown neuroblastoma breakpoint family gene in early tumorigenesis of this childhood cancer.	[Diskin, Sharon J.; Hou, Cuiping; Attiyeh, Edward F.; Laudenslager, Marci; Bosse, Kristopher; Cole, Kristina; Mosse, Yael P.; Wood, Andrew; Lynch, Jill E.; Pecor, Katlyn; Diamond, Maura; Winter, Cynthia; Rappaport, Eric R.; Maris, John M.] Univ Penn, Sch Med, Div Oncol, Philadelphia, PA 19104 USA; [Diskin, Sharon J.; Hou, Cuiping; Attiyeh, Edward F.; Laudenslager, Marci; Bosse, Kristopher; Cole, Kristina; Mosse, Yael P.; Wood, Andrew; Lynch, Jill E.; Pecor, Katlyn; Diamond, Maura; Winter, Cynthia; Rappaport, Eric R.; Maris, John M.] Univ Penn, Sch Med, Ctr Childhood Canc Res, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hou, Cuiping; Glessner, Joseph T.; Wang, Kai; Kim, Cecilia; Bradfield, Jonathan; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Ctr Appl Genom, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Attiyeh, Edward F.; Mosse, Yael P.; Shaikh, Tamim H.; Grant, Struan F. A.; Devoto, Marcella; Rappaport, Eric R.; Hakonarson, Hakon; Maris, John M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Maris, John M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Geiger, Elizabeth A.; Shaikh, Tamim H.; Grant, Struan F. A.; Devoto, Marcella; Hakonarson, Hakon] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Li, Hongzhe; Devoto, Marcella] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [McGrady, Patrick W.; London, Wendy B.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [McGrady, Patrick W.; London, Wendy B.] Childrens Oncol Grp, Gainesville, FL 32611 USA; [Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; State University System of Florida; University of Florida; Children's Oncology Group (COG); Imperial College London; Sapienza University Rome	Maris, JM (corresponding author), Univ Penn, Sch Med, Div Oncol, Philadelphia, PA 19104 USA.	maris@chop.edu	Rappaport, Eric/GRO-4051-2022; London, Wendy/ABD-4624-2021; Devoto, Marcella/AAP-7595-2021; Blakemore, Alexandra I F/D-2253-2009; London, Wendy Beth/ABA-8948-2021	Blakemore, Alexandra I F/0000-0003-0661-564X; London, Wendy Beth/0000-0003-3571-6538; DEVOTO, MARCELLA/0000-0002-4431-5114; Grant, Struan/0000-0003-2025-5302; Glessner, Joseph/0000-0001-5131-2811	Children's Oncology Group [U10-CA98543]; NIH [T32-HG000046, R01-CA87847, R01-CA124709, GM081519]; Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute Medical Research Training Fellowship; Center for Applied Genomics; Joseph Stokes Research Institute of the Children's Hospital of Philadelphia; NATIONAL CANCER INSTITUTE [R01CA124709, R00CA151869, R01CA087847, U10CA098543] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081519] Funding Source: NIH RePORTER	Children's Oncology Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giulio D'Angio Endowed Chair; Alex's Lemonade Stand Foundation; Evan Dunbar Foundation; Rally Foundation; Andrew's Army Foundation; Abramson Family Cancer Research Institute; Howard Hughes Medical Institute Medical Research Training Fellowship(Howard Hughes Medical Institute); Center for Applied Genomics; Joseph Stokes Research Institute of the Children's Hospital of Philadelphia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the Children's Oncology Group (U10-CA98543) for providing neuroblastoma specimens and thank the many children who participated in this study. This work was supported in part by NIH grants T32-HG000046 (S. J. D.), R01-CA87847 (J. M. M.) and R01-CA124709, GM081519 (T. H. S.), the Giulio D'Angio Endowed Chair (J. M. M.), the Alex's Lemonade Stand Foundation (J. M. M.), the Evan Dunbar Foundation (J. M. M.), the Rally Foundation (J. M. M.), Andrew's Army Foundation (J. M. M.), the Abramson Family Cancer Research Institute (J. M. M.), Howard Hughes Medical Institute Medical Research Training Fellowship (K. B.) and the Center for Applied Genomics (H. H.) at the Joseph Stokes Research Institute of the Children's Hospital of Philadelphia.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Meza-Zepeda LA, 2002, ONCOGENE, V21, P2261, DOI 10.1038/sj.onc.1205339; Petroziello J, 2004, ONCOGENE, V23, P7734, DOI 10.1038/sj.onc.1207921; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; van den Bogert AJ, 2008, COMPUT METHOD BIOMEC, V11, P3, DOI 10.1080/10255840701550865; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	31	275	292	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					987	U112		10.1038/nature08035	http://dx.doi.org/10.1038/nature08035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536264	Green Accepted			2022-12-28	WOS:000267063500043
J	McCowan, C; Kidd, B; Fahey, T				McCowan, C.; Kidd, B.; Fahey, T.			Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MAINTENANCE TREATMENT; OPIOID DEPENDENCE; COMORBIDITY INDEX; DRUG-USERS; HEROIN; DEATHS; OVERDOSE; ENGLAND; GUIDELINES; IMPACT	Objective To assess predictors of mortality in a population of people prescribed methadone. Design Retrospective cohort study. Setting Geographically defined population in Tayside, Scotland. Participants 2378 people prescribed and dispensed liquid methadone between January 1993 and February 2004. Main outcome measures All cause mortality (primary outcome) and drug dependent cause specific mortality (secondary outcome) by means of Cox proportional hazards models during 12 years of follow-up. Results Overall, 181 (8%) people died. Overuse of methadone (adjusted hazard ratio 1.67, 95% confidence interval 1.05 to 2.67), history of psychiatric admission (2.47, 1.67 to 3.66), and increasing comorbidity measured as Charlson index >= 3 (1.20, 1.15 to 1.26) were all associated with an increase in all cause mortality. Longer duration of use (adjusted hazard ratio 0.95, 0.94 to 0.96), history of having urine tested (0.33, 0.22 to 0.49), and increasing time since last filled prescription were protective in relation to all cause mortality. Drug dependence was identified as the principal cause of death in 60 (33%) people. History of psychiatric admission was significantly associated with drug dependent death (adjusted hazard ratio 2.41, 1.25 to 4.64), as was history of prescription of benzodiazepines (4.35, 1.32 to 14.30). Conclusions Important elements of care in provision of methadone maintenance treatment are likely to influence, or be a marker for, a person's risk of death.	[McCowan, C.; Fahey, T.] Univ Dundee, Div Community Hlth Sci, Dundee DD2 4BF, Scotland; [Kidd, B.] Univ Dundee, Ninewells Hosp & Med Sch, Sect Psychiat & Behav Sci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; [Fahey, T.] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dept Gen Practice & Family Med, Dublin 2, Ireland	University of Dundee; University of Dundee; Royal College of Surgeons - Ireland	Fahey, T (corresponding author), Univ Dundee, Div Community Hlth Sci, Dundee DD2 4BF, Scotland.	tomfahey@rcsi.ie	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; McCowan, Colin/0000-0002-9466-833X	Chief Scientist's Office, NHS Scotland; EastRen project [116-05]; MRC; Medical Research Council [G106/1164] Funding Source: researchfish; MRC [G106/1164] Funding Source: UKRI	Chief Scientist's Office, NHS Scotland; EastRen project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Programme support grant of the Chief Scientist's Office, NHS Scotland and EastRen project grant 116-05. CMcC was supported as an MRC research training fellow in health services research. The funders had no input into the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication. The investigators are fully independent of the funders and have not used a third party to write or prepare the manuscript.	Advisory Council on the Misuse of Drugs, 2000, RED DRUG REL DEATHS; Bloor M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a478; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; *DEP HLTH, 2001, STAT REG DRUG MIS DA; Department of Health Scottish Home and Health Department Welsh Office Northern Ireland Department of Health and Social Services, 1999, DRUG MIS DEP GUID CL; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Faggiano FV-TF, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; Gossop M, 2002, ADDICTION, V97, P39, DOI 10.1046/j.1360-0443.2002.00079.x; Gossop M, 2008, ADDICTION, V103, P1493, DOI 10.1111/j.1360-0443.2008.02311.x; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hall W, 2000, LANCET, V356, P7, DOI 10.1016/S0140-6736(00)02423-5; Hickman M, 2003, ADDICTION, V98, P419, DOI 10.1046/j.1360-0443.2003.00294.x; *ISD SCOTL, 2003, DRUG MIS STAT SCOTL; Keen J, 2003, BRIT J GEN PRACT, V53, P461; Keen J, 1999, BMJ-BRIT MED J, V318, P1503, DOI 10.1136/bmj.318.7197.1503; Krantz MJ, 2004, ARCH INTERN MED, V164, P277, DOI 10.1001/archinte.164.3.277; Law FD, 2003, LANCET, V361, P634, DOI 10.1016/S0140-6736(03)12612-8; Lawrinson P, 2008, ADDICTION, V103, P1484, DOI 10.1111/j.1360-0443.2008.02249.x; Man LH, 2004, EUR ADDICT RES, V10, P35, DOI 10.1159/000073724; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; Morgan O, 2006, INT J EPIDEMIOL, V35, P1579, DOI 10.1093/ije/dyl207; *NAT PRESCR CTR, 2002, MEREC B, V12, P13; *NIH CLIN EXC, 2007, METH BUPR MAN OP DEP; Oliver P, 2002, FAM PRACT, V19, P93, DOI 10.1093/fampra/19.1.93; *ROY COLL GEN PRAC, RCGP SUBST MIS UN; Sporer KA, 2003, BMJ-BRIT MED J, V326, P442, DOI 10.1136/bmj.326.7386.442; SQUIRES T, 2000, NATL CONFIDENTIAL EN; Stille CJ, 2005, ANN INTERN MED, V142, P700, DOI 10.7326/0003-4819-142-8-200504190-00038; Strang J, 2003, BRIT MED J, V327, P321, DOI 10.1136/bmj.327.7410.321; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Teesson M, 2008, ADDICTION, V103, P80, DOI 10.1111/j.1360-0443.2007.02029.x; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2; Weinrich M, 2000, JAMA-J AM MED ASSOC, V283, P1343, DOI 10.1001/jama.283.10.1343; Zador Deborah, 2005, NATL INVESTIGATION D	37	68	69	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2009	338								b2225	10.1136/bmj.b2225	http://dx.doi.org/10.1136/bmj.b2225			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460UR	19535400	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000267216700002
J	Laskar, J; Gastineau, M				Laskar, J.; Gastineau, M.			Existence of collisional trajectories of Mercury, Mars and Venus with the Earth	NATURE			English	Article							LONG-TERM INTEGRATIONS; INSOLATION QUANTITIES; EVOLUTION; STABILITY	It has been established that, owing to the proximity of a resonance with Jupiter, Mercury's eccentricity can be pumped to values large enough to allow collision with Venus within 5 Gyr (refs 1-3). This conclusion, however, was established either with averaged equations(1,2) that are not appropriate near the collisions or with non-relativistic models in which the resonance effect is greatly enhanced by a decrease of the perihelion velocity of Mercury(2,3). In these previous studies, the Earth's orbit was essentially unaffected. Here we report numerical simulations of the evolution of the Solar System over 5 Gyr, including contributions from the Moon and general relativity. In a set of 2,501 orbits with initial conditions that are in agreement with our present knowledge of the parameters of the Solar System, we found, as in previous studies(2), that one per cent of the solutions lead to a large increase in Mercury's eccentricity-an increase large enough to allow collisions with Venus or the Sun. More surprisingly, in one of these high-eccentricity solutions, a subsequent decrease in Mercury's eccentricity induces a transfer of angular momentum from the giant planets that destabilizes all the terrestrial planets similar to 3.34 Gyr from now, with possible collisions of Mercury, Mars or Venus with the Earth.	[Laskar, J.; Gastineau, M.] UPMC, Observ Paris, IMCCE CNRS, UMR8028, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite	Laskar, J (corresponding author), UPMC, Observ Paris, IMCCE CNRS, UMR8028, 77 Ave Denfert Rochereau, F-75014 Paris, France.	laskar@imcce.fr	Laskar, Jacques/E-1098-2011	Laskar, Jacques/0000-0003-2634-789X	French National Research Centre; Paris Observatory; National Research Agency	French National Research Centre(Centre National de la Recherche Scientifique (CNRS)); Paris Observatory; National Research Agency(French National Research Agency (ANR))	This work benefited from support from the Planetology Programme of the French National Research Centre, from Paris Observatory and from National Research Agency grant ASTS-CM. The authors thank the computing centres of Paris Observatory, the Institut de Physique du Globe Paris, the Institute of Development and Resources in Scientific Computing, the Linear Accelerator Laboratory Grid and especially the French National Computing Centre CINES, for providing the necessary computational resources for this work.	Asphaug E, 2006, NATURE, V439, P155, DOI 10.1038/nature04311; Boue G, 2006, ICARUS, V185, P312, DOI 10.1016/j.icarus.2006.07.019; BOUE G, 2008, ICARUS, V196, P1; Fienga A, 2008, ASTRON ASTROPHYS, V477, P315, DOI 10.1051/0004-6361:20066607; Holsapple KA, 2006, ICARUS, V183, P331, DOI 10.1016/j.icarus.2006.03.013; Ito T, 2002, MON NOT R ASTRON SOC, V336, P483, DOI 10.1046/j.1365-8711.2002.05765.x; LASKAR J, 1989, NATURE, V338, P237, DOI 10.1038/338237a0; LASKAR J, 1994, ASTRON ASTROPHYS, V287, pL9; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Laskar J, 2001, CELEST MECH DYN ASTR, V80, P39, DOI 10.1023/A:1012098603882; Laskar J, 1999, PHILOS T R SOC A, V357, P1735, DOI 10.1098/rsta.1999.0399; Laskar J, 1997, ASTRON ASTROPHYS, V317, pL75; LASKAR J, 1992, ICARUS, V95, P148, DOI 10.1016/0019-1035(92)90196-E; SAHA P, 1994, ASTRON J, V108, P1962, DOI 10.1086/117210; Standish EA, 2004, ASTRON ASTROPHYS, V417, P1165, DOI 10.1051/0004-6361:20035663; SUSSMAN GJ, 1992, SCIENCE, V257, P56, DOI 10.1126/science.257.5066.56; Varadi F, 2003, ASTROPHYS J, V592, P620, DOI 10.1086/375560	20	144	147	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					817	819		10.1038/nature08096	http://dx.doi.org/10.1038/nature08096			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516336				2022-12-28	WOS:000267084500033
J	Blander, JM; Amsen, D				Blander, J. Magarian; Amsen, Derk			Amino Acid Addiction	SCIENCE			English	Editorial Material							CELLS; STRESS; DIFFERENTIATION; EXPRESSION		[Blander, J. Magarian] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA; [Amsen, Derk] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol, NL-1105 AZ Amsterdam, Netherlands	Icahn School of Medicine at Mount Sinai; University of Amsterdam; Academic Medical Center Amsterdam	Blander, JM (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA.	julie.blander@mssm.edu; d.amsen@amc.nl		Blander, Julie Magarian/0000-0001-9207-1700				Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007	12	6	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1282	1283		10.1126/science.1175678	http://dx.doi.org/10.1126/science.1175678			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498159				2022-12-28	WOS:000266635100032
J	Perez-Padilla, R; de la Rosa-Zamboni, D; de Leon, SP; Hernandez, M; Quinones-Falconi, F; Bautista, E; Ramirez-Venegas, A; Rojas-Serrano, J; Ormsby, CE; Corrales, A; Higuera, A; Mondragon, E; Cordova-Villalobos, JA				Perez-Padilla, Rogelio; de la Rosa-Zamboni, Daniela; de Leon, Samuel Ponce; Hernandez, Mauricio; Quinones-Falconi, Francisco; Bautista, Edgar; Ramirez-Venegas, Alejandra; Rojas-Serrano, Jorge; Ormsby, Christopher E.; Corrales, Ariel; Higuera, Anjarath; Mondragon, Edgar; Cordova-Villalobos, Jose Angel		INER Working Grp Influenza	Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AVIAN INFLUENZA; VIRUS-INFECTIONS; H5N1; HUMANS; DISEASE	Background In late March 2009, an outbreak of a respiratory illness later proved to be caused by novel swine-origin influenza A (H1N1) virus (S-OIV) was identified in Mexico. We describe the clinical and epidemiologic characteristics of persons hospitalized for pneumonia at the national tertiary hospital for respiratory illnesses in Mexico City who had laboratory-confirmed S-OIV infection, also known as swine flu. Methods We used retrospective medical chart reviews to collect data on the hospitalized patients. S-OIV infection was confirmed in specimens with the use of a real-time reverse-transcriptase-polymerase-chain-reaction assay. Results From March 24 through April 24, 2009, a total of 18 cases of pneumonia and confirmed S-OIV infection were identified among 98 patients hospitalized for acute respiratory illness at the National Institute of Respiratory Diseases in Mexico City. More than half of the 18 case patients were between 13 and 47 years of age, and only 8 had preexisting medical conditions. For 16 of the 18 patients, this was the first hospitalization for their illness; the other 2 patients were referred from other hospitals. All patients had fever, cough, dyspnea or respiratory distress, increased serum lactate dehydrogenase levels, and bilateral patchy pneumonia. Other common findings were an increased creatine kinase level ( in 62% of patients) and lymphopenia ( in 61%). Twelve patients required mechanical ventilation, and seven died. Within 7 days after contact with the initial case patients, a mild or moderate influenza-like illness developed in 22 health care workers; they were treated with oseltamivir, and none were hospitalized. Conclusions S-OIV infection can cause severe illness, the acute respiratory distress syndrome, and death in previously healthy persons who are young to middle-aged. None of the secondary infections among health care workers were severe.	[Perez-Padilla, Rogelio; de la Rosa-Zamboni, Daniela; Quinones-Falconi, Francisco; Bautista, Edgar; Ramirez-Venegas, Alejandra; Rojas-Serrano, Jorge; Ormsby, Christopher E.; Corrales, Ariel; Higuera, Anjarath; Mondragon, Edgar] Inst Nacl Enfermedades Resp, Mexico City 14080, DF, Mexico; [de Leon, Samuel Ponce] Biol & React Mexico BIRMEX, Mexico City, DF, Mexico; [Hernandez, Mauricio; Cordova-Villalobos, Jose Angel] Secretariat Hlth, Mexico City, DF, Mexico		Perez-Padilla, R (corresponding author), Inst Nacl Enfermedades Resp, Tlalpan 4502, Mexico City 14080, DF, Mexico.	perezpad@gmail.com	Carrillo Montiel, Isabel/GXH-4018-2022; Hernandez, Alher Mauricio/AAX-2227-2021; Rojas-Serrano, Jorge/Q-4206-2018	Hernandez, Alher Mauricio/0000-0003-1132-5794; Zuniga, Joaquin/0000-0002-7143-0281				Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; [Anonymous], 2005, STAT STAT SOFTW REL; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; *DIR GEN ADJ EP, 2009, BROT INFL HUM H1N1 M; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hui DSC, 2008, RESPIROLOGY, V13, pS10, DOI 10.1111/j.1440-1843.2008.01247.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; MURRAY JF, 1989, AM REV RESPIR DIS, V139, P1065; Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; *WHO, 2009, CDC PROT REALT RTPCR; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; World Health Organization, 2009, INFL H1N1 UPD 14; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; 2009, MMWR MORB MORTAL WKL, V58, P435; 2009, MMWR MORB MORTAL WKL, V58, P431	20	1005	1134	1	210	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					680	689		10.1056/NEJMoa0904252	http://dx.doi.org/10.1056/NEJMoa0904252			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19564631				2022-12-28	WOS:000268884100008
J	Discher, DE; Mooney, DJ; Zandstra, PW				Discher, Dennis E.; Mooney, David J.; Zandstra, Peter W.			Growth Factors, Matrices, and Forces Combine and Control Stem Cells	SCIENCE			English	Review							INFARCTED RAT HEARTS; BONE-MARROW; FACTOR DELIVERY; SELF-RENEWAL; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SKELETAL-MUSCLE; DIFFERENTIATION; TISSUE; SUBSTRATE	Stem cell fate is influenced by a number of factors and interactions that require robust control for safe and effective regeneration of functional tissue. Coordinated interactions with soluble factors, other cells, and extracellular matrices define a local biochemical and mechanical niche with complex and dynamic regulation that stem cells sense. Decellularized tissue matrices and synthetic polymer niches are being used in the clinic, and they are also beginning to clarify fundamental aspects of how stem cells contribute to homeostasis and repair, for example, at sites of fibrosis. Multifaceted technologies are increasingly required to produce and interrogate cells ex vivo, to build predictive models, and, ultimately, to enhance stem cell integration in vivo for therapeutic benefit.	[Discher, Dennis E.] Univ Penn, Sch Engn & Appl Sci, Biophys Engn & Nanobiopolymers Lab, Philadelphia, PA 19104 USA; [Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Lab Cell & Tissue Engn, Cambridge, MA 02138 USA; [Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Stem Cell Bioengn Lab, Ctr Biomed & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Pennsylvania; Harvard University; University of Toronto	Discher, DE (corresponding author), Univ Penn, Sch Engn & Appl Sci, Biophys Engn & Nanobiopolymers Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu; mooneyd@seas.harvard.edu; peter.zandstra@utoronto.ca		Mooney, David/0000-0001-6299-1194; discher, dennis/0000-0001-6163-2229	NIH; NSF; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Grants from the NIH and NSF are very gratefully acknowledged.	Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Bennett KP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-380; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dhawan V, 2007, TISSUE ENG, V13, P2813, DOI 10.1089/ten.2007.0003; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Guilak F, 2005, ANN BIOMED ENG, V33, P1312, DOI 10.1007/s10439-005-4479-7; Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168; Kirouac DC, 2006, CURR OPIN BIOTECH, V17, P538, DOI 10.1016/j.copbio.2006.07.003; Kluger Y, 2004, P NATL ACAD SCI USA, V101, P6508, DOI 10.1073/pnas.0401136101; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McDevitt TC, 2008, CURR OPIN BIOTECH, V19, P527, DOI 10.1016/j.copbio.2008.08.005; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Patel PN, 2005, J BIOMED MATER RES A, V73A, P313, DOI 10.1002/jbm.a.30291; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027; Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Williams DA, 2008, METHOD ENZYMOL, V439, P365, DOI 10.1016/S0076-6879(07)00427-2; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	71	1965	2016	21	852	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1673	1677		10.1126/science.1171643	http://dx.doi.org/10.1126/science.1171643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556500	Green Accepted			2022-12-28	WOS:000267338200029
J	Hua, SJ; Kittler, R; White, KP				Hua, Sujun; Kittler, Ralf; White, Kevin P.			Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer	CELL			English	Article							NUCLEAR RECEPTORS; IN-VITRO; RESPONSE ELEMENTS; BINDING-SITES; CELL-GROWTH; EXPRESSION; REVEALS; GENES; FOXA1; RAR	Retinoic acid (RA) triggers antiproliferative effects in tumor cells, and therefore RA and its synthetic analogs have great potential as anticarcinogenic agents. Retinoic acid receptors (RARs) mediate RA effects by directly regulating gene expression. To define the genetic network regulated by RARs in breast cancer, we identified RAR genomic targets using chromatin immunoprecipitation and expression analysis. We found that RAR binding throughout the genome is highly coincident with estrogen receptor alpha (ER alpha) binding, resulting in a widespread crosstalk of RA and estrogen signaling to antagonistically regulate breast cancer-associated genes. ER alpha- and RAR-binding sites appear to be coevolved on a large scale throughout the human genome, often resulting in competitive binding activity at nearby or overlapping cis-regulatory elements. The highly coordinated intersection between these two critical nuclear hormone receptor signaling pathways provides a global mechanism for balancing gene expression output via local regulatory	[Hua, Sujun; Kittler, Ralf; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Hua, Sujun; Kittler, Ralf; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Hua, Sujun] Yale Univ, Interdepartmental Program Computat Biol & Bioinfo, New Haven, CT 06520 USA	University of Chicago; University of Chicago; Yale University	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, 920 E 58th St, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	Kittler, Ralf/AAD-4258-2020; Kittler, Ralf/I-4662-2013	Kittler, Ralf/0000-0002-0098-6792; Kittler, Ralf/0000-0002-0098-6792	National Institutes of Health [1R01HG004428, 1P50GM081892]; The Searle Funds at the Chicago Community Trust; International Human Frontier Science Program Organization; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004428, RC2HG005679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Searle Funds at the Chicago Community Trust; International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Pendleton and all members of the Functional Genomics Facility of The University of Chicago for technical assistance, T. Hyman and F. Buchholz for providing the LAP-IRES-neo/kan cassette, and D. Drechsel for the production of the goat eGFP antibody. This work was supported by grants 1R01HG004428 and 1P50GM081892 to K. P. W. from the National Institutes of Health and by a grant to K. P. W. from the Chicago Biomedical Consortium (CBC) with support from The Searle Funds at the Chicago Community Trust. R. K. is supported by a long-term fellowship of the International Human Frontier Science Program Organization.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Glass CK, 2000, GENE DEV, V14, P121; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Joyeux A, 1996, J STEROID BIOCHEM, V58, P507, DOI 10.1016/0960-0760(96)00082-9; Klinge CM, 1997, NUCLEIC ACIDS RES, V25, P1903, DOI 10.1093/nar/25.10.1903; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Levenson AS, 1997, CANCER RES, V57, P3071; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mangelsdorf David J., 1994, P319; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r; Zhou Q, 1997, ONCOGENE, V15, P107, DOI 10.1038/sj.onc.1201142	43	226	230	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1259	1271		10.1016/j.cell.2009.04.043	http://dx.doi.org/10.1016/j.cell.2009.04.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563758	Green Accepted, Bronze			2022-12-28	WOS:000267373400019
J	Bouligand, J; Ghervan, C; Tello, JA; Brailly-Tabard, S; Salenave, S; Chanson, P; Lombes, M; Millar, RP; Guiochon-Mantel, A; Young, J				Bouligand, Jerome; Ghervan, Cristina; Tello, Javier A.; Brailly-Tabard, Sylvie; Salenave, Sylvie; Chanson, Philippe; Lombes, Marc; Millar, Robert P.; Guiochon-Mantel, Anne; Young, Jacques			Isolated Familial Hypogonadotropic Hypogonadism and a GNRH1 Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; CENTRAL PRECOCIOUS PUBERTY; LUTEINIZING-HORMONE; KALLMANN-SYNDROME; GENE STRUCTURE; RECEPTOR GENE; PRECURSOR	We investigated whether mutations in the gene encoding gonadotropin-releasing hormone 1 (GNRH1) might be responsible for idiopathic hypogonadotropic hypogonadism (IHH) in humans. We identified a homozygous GNRH1 frameshift mutation, an insertion of an adenine at nucleotide position 18 (c.18-19insA), in the sequence encoding the N-terminal region of the signal peptide-containing protein precursor of gonadotropin-releasing hormone (prepro-GnRH) in a teenage brother and sister, who had normosmic IHH. Their unaffected parents and a sibling who was tested were heterozygous. This mutation results in an aberrant peptide lacking the conserved GnRH decapeptide sequence, as shown by the absence of immunoreactive GnRH when expressed in vitro. This isolated autosomal recessive GnRH deficiency, reversed by pulsatile GnRH administration, shows the pivotal role of GnRH in human reproduction.	[Young, Jacques] Hop Bicetre, AP HP, INSERM, Serv Endocrinol & Malad Reprod,UMR S693, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Brailly-Tabard, Sylvie; Chanson, Philippe; Lombes, Marc; Guiochon-Mantel, Anne; Young, Jacques] Univ Paris Sud, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France; [Bouligand, Jerome; Brailly-Tabard, Sylvie; Guiochon-Mantel, Anne] Lab Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Salenave, Sylvie; Chanson, Philippe; Lombes, Marc; Young, Jacques] Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Salenave, Sylvie; Chanson, Philippe; Lombes, Marc; Young, Jacques] Ctr Reference Malad Endocriniennes Rares Croissan, Le Kremlin Bicetre, France; [Ghervan, Cristina] Univ Med & Pharm Iuliu Hatieganu, Dept Endocrinol, Cluj Napoca, Romania; [Tello, Javier A.; Millar, Robert P.] Queens Med Res Inst, MRC, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Millar, Robert P.] Univ Cape Town, Div Med Biochem, Res Grp Receptor Biol, ZA-7925 Cape Town, South Africa	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Iuliu Hatieganu University of Medicine & Pharmacy; University of Edinburgh; University of Cape Town	Young, J (corresponding author), Hop Bicetre, AP HP, INSERM, Serv Endocrinol & Malad Reprod,UMR S693, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	jacques.young@bct.aphp.fr	Young, Jacques/T-2976-2018; Lombes, Marc/L-5933-2018; Millar, Robert P/A-4853-2012; BOULIGAND, Jérôme/S-5716-2018; Chanson, Philippe/F-8511-2013; Tello, Javier Ananda A/B-3203-2012; Guiochon-Mantel, Anne S/S-8408-2018; Young, Jacques/N-5251-2019	Young, Jacques/0000-0001-9286-5631; Lombes, Marc/0000-0003-3189-023X; Chanson, Philippe/0000-0001-5096-5722; Tello, Javier Ananda A/0000-0001-6637-2155; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Young, Jacques/0000-0001-9286-5631; Millar, Robert P/0000-0003-3606-2708	University Paris Sud 11; Ferring and Merck Serono France; MRC [MC_U127681325] Funding Source: UKRI; Medical Research Council [MC_U127681325] Funding Source: researchfish	University Paris Sud 11; Ferring and Merck Serono France(Ferring Pharmaceuticals); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported in part by a grant from the University Paris Sud 11 (Bonus Qualite Recherche).; Dr. Young reports receiving grant support from Ferring and Merck Serono France. No other potential conflict of interest relevant to this article was reported.; This article is dedicated to Roger Guillemin and to the memory of Ernst Knobil.; We thank S. Amselem, B. Feve, Y. Lebouc, E. Milgrom, C. Dode, and M. Jeanpierre for their helpful discussions and C. Cogliatti and I. Boucly for their technical assistance.	Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965; Bo-Abbas Y, 2003, J CLIN ENDOCR METAB, V88, P2730, DOI 10.1210/jc.2002-021948; Bry-Gauillard H, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.11.064; Chen AL, 2001, ENDOCRINOLOGY, V142, P830, DOI 10.1210/en.142.2.830; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; De Roux N, 1999, J CLIN ENDOCR METAB, V84, P567, DOI 10.1210/jc.84.2.567; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2004, J MOL MED, V82, P725, DOI 10.1007/s00109-004-0571-y; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Hanein S, 2008, EUR J HUM GENET, V16, P115, DOI 10.1038/sj.ejhg.5201905; Jameson JL, 2007, P NATL ACAD SCI USA, V104, P17247, DOI 10.1073/pnas.0708636104; Kim HG, 2008, NEUROSIGNALS, V16, P165, DOI 10.1159/000111561; KING JA, 1979, SCIENCE, V206, P67, DOI 10.1126/science.384514; LAYMAN LC, 1992, FERTIL STERIL, V57, P42; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; Luan XH, 2007, EUR J ENDOCRINOL, V157, P113, DOI 10.1530/EJE-07-0061; MASON AJ, 1986, SCIENCE, V234, P1372, DOI 10.1126/science.3097822; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; NAKAYAMA Y, 1990, J CLIN ENDOCR METAB, V70, P1233, DOI 10.1210/jcem-70-5-1233; NIKOLICS K, 1985, NATURE, V316, P511, DOI 10.1038/316511a0; Salenave S, 2008, J CLIN ENDOCR METAB, V93, P758, DOI 10.1210/jc.2007-1168; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; THOMAS GB, 1988, NEUROENDOCRINOLOGY, V48, P342, DOI 10.1159/000125033; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Vagenakis GA, 2005, FERTIL STERIL, V84, P1762, DOI 10.1016/j.fertnstert.2005.06.031; WEISS J, 1991, BIOL REPROD, V45, P743, DOI 10.1095/biolreprod45.5.743; WEISS J, 1989, J CLIN ENDOCR METAB, V69, P299, DOI 10.1210/jcem-69-2-299	32	178	184	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2742	2748		10.1056/NEJMoa0900136	http://dx.doi.org/10.1056/NEJMoa0900136			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19535795				2022-12-28	WOS:000267286600008
J	Rensberger, B				Rensberger, Boyce			Science journalism: Too close for comfort	NATURE			English	Editorial Material									MIT, Knight Sci Journalism Fellowship Programme, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Rensberger, B (corresponding author), MIT, Knight Sci Journalism Fellowship Programme, Cambridge, MA 02139 USA.	boycerensberger@gmail.com							0	14	15	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1055	1056		10.1038/4591055a	http://dx.doi.org/10.1038/4591055a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	466BX	19553977	Bronze			2022-12-28	WOS:000267636700021
J	Thompson, SG; Ashton, HA; Gao, L; Scott, RAP				Thompson, S. G.; Ashton, H. A.; Gao, L.; Scott, R. A. P.		Multictr Aneurysm Screening Study	Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study	BRITISH MEDICAL JOURNAL			English	Article							EVAR TRIAL 1; OPEN REPAIR; FOLLOW-UP; EXPANSION; INTERVALS; OUTCOMES; HEALTH; RISK; MASS	Objectives To assess whether the mortality benefit from screening men aged 65-74 for abdominal aortic aneurysm decreases over time, and to estimate the long term cost effectiveness of screening. Design Randomised trial with 10 years of follow-up. Setting Four centres in the UK. Screening and surveillance was delivered mainly in primary care settings, with follow-up and surgery offered in hospitals. Participants Population based sample of 67 770 men aged 65-74. Interventions Participants were individually allocated to invitation to ultrasound screening (invited group) or to a control group not offered screening. Patients with an abdominal aortic aneurysm detected at screening underwent surveillance and were offered surgery if they met predefined criteria. Main outcome measures Mortality and costs related to abdominal aortic aneurysm, and cost per life year gained. Results Over 10 years 155 deaths related to abdominal aortic aneurysm (absolute risk 0.46%) occurred in the invited group and 296 (0.87%) in the control group (relative risk reduction 48%, 95% confidence interval 37% to 57%). The degree of benefit seen in earlier years of follow-up was maintained in later years. Based on the 10 year trial data, the incremental cost per man invited to screening was 100 pound (95% confidence interval 82 pound to 118) pound, leading to an incremental cost effectiveness ratio of 7600 pound (5100 pound to 13 pound 000) per life year gained. However, the incidence of ruptured abdominal aortic aneurysms in those originally screened as normal increased noticeably after eight years. Conclusions The mortality benefit of screening men aged 65-74 for abdominal aortic aneurysm is maintained up to 10 years and cost effectiveness becomes more favourable over time. To maximise the benefit from a screening programme, emphasis should be placed on achieving a high initial rate of attendance and good adherence to clinical follow-up, preventing delays in undertaking surgery, and maintaining a low operative mortality after elective surgery. On the basis of current evidence, rescreening of those originally screened as normal is not justified.	[Thompson, S. G.; Gao, L.] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Ashton, H. A.; Scott, R. A. P.] St Richards Hosp, Scott Res Unit, Chichester, England	MRC Biostatistics Unit; University of Cambridge	Thompson, SG (corresponding author), MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 0SR, England.	simon.thompson@mrc-bsu.cam.ac.uk			Medical Research Council [G0601031, U.1052.00.001]; MRC [MC_EX_G0601031] Funding Source: UKRI; Medical Research Council [MC_EX_G0601031] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (grant numbers G0601031 and U.1052.00.001). The funder had no role in the design, implementation, analysis, or interpretation of the study.	Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Campbell Helen, 2007, J Health Serv Res Policy, V12, P11, DOI 10.1258/135581907779497594; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Epstein DM, 2008, BRIT J SURG, V95, P183, DOI 10.1002/bjs.5911; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Guessous I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001895; Hackam DG, 2006, LANCET, V368, P659, DOI 10.1016/S0140-6736(06)69250-7; Hafez H, 2008, EUR J VASC ENDOVASC, V36, P553, DOI 10.1016/j.ejvs.2008.06.032; Henriksson M, 2005, BRIT J SURG, V92, P976, DOI 10.1002/bjs.5122; Kim LG, 2007, J MED SCREEN, V14, P46, DOI 10.1258/096914107780154477; KIM LG, 2009, HLTH EC         0210; Kim LG, 2007, ANN INTERN MED, V146, P699, DOI 10.7326/0003-4819-146-10-200705150-00003; Kind P., 1999, 172 U YORK CTR HLTH; Lederle FA, 2007, ANN INTERN MED, V146, P735, DOI 10.7326/0003-4819-146-10-200705150-00007; Lin CC, 2006, STAT MED, V25, P1922, DOI 10.1002/sim.2381; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Loeys T, 2003, BIOMETRICS, V59, P100, DOI 10.1111/1541-0420.00012; Mani K, 2008, J ENDOVASC THER, V15, P1, DOI 10.1583/07-2258.1; Marteau TM, 2004, J EPIDEMIOL COMMUN H, V58, P1042, DOI 10.1136/jech.2003.019307; *NHS NAT SERV SCOT, 2008, ABD AORT AN AAA SCRE; *NIH CLIN EXC, 2009, ABD AORT AN END STEN; *OFF NAT STAT, 2007, REV NAT STAT DEATHS; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; *UK DEP HLTH, 2008, IMP ASS NAT SCREEN P; *UK NAT SCREEN COM, 2008, ABD AORT AN SCREEN; Wanhainen A, 2005, J VASC SURG, V41, P741, DOI 10.1016/j.jvs.2005.01.055; Willan AR, 2005, STAT MED, V24, P131, DOI 10.1002/sim.1794; Willan AR, 1996, HEALTH ECON, V5, P297, DOI 10.1002/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T	37	183	189	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 24	2009	338								b2307	10.1136/bmj.b2307	http://dx.doi.org/10.1136/bmj.b2307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MO	19553269	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000267436500005
J	Zeiler, SR; Kaplan, PW				Zeiler, Steven R.; Kaplan, Perter W.			Our digital world: camera phones and the diagnosis of a seizure	LANCET			English	Editorial Material									[Zeiler, Steven R.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Kaplan, Perter W.] Johns Hopkins Bayview Med Ctr, Dept Neurol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zeiler, SR (corresponding author), Johns Hopkins Univ Hosp, Dept Neurol, Pathol 627C,600 N Wolfe St, Baltimore, MD 21287 USA.	steven.zeiler@jhmi.edu							0	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2136	2136		10.1016/S0140-6736(09)60304-4	http://dx.doi.org/10.1016/S0140-6736(09)60304-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541039				2022-12-28	WOS:000267229700030
J	Johnson, LDS; Jameson, SC				Johnson, Lisa D. S.; Jameson, Stephen C.			A Chronic Need for IL-21	SCIENCE			English	Editorial Material							T-CELLS; DIFFERENTIATION; INTERLEUKIN-21; EFFECTOR		[Johnson, Lisa D. S.; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Johnson, LDS (corresponding author), Univ Minnesota, Ctr Immunol, Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu	Johnson, Lisa DS/E-4218-2013; Jameson, Stephen C/D-9892-2013	Johnson, Lisa DS/0000-0002-2019-6560; Jameson, Stephen C/0000-0001-9137-1146				Casey KA, 2007, J IMMUNOL, V178, P7640, DOI 10.4049/jimmunol.178.12.7640; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Silver JS, 2008, IMMUNITY, V29, P7, DOI 10.1016/j.immuni.2008.06.005; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	11	31	33	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1525	1526		10.1126/science.1176487	http://dx.doi.org/10.1126/science.1176487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541985				2022-12-28	WOS:000267130600030
J	Barends, TRM; Hartmann, E; Griese, JJ; Beitlich, T; Kirienko, NV; Ryjenkov, DA; Reinstein, J; Shoeman, RL; Gomelsky, M; Schlichting, I				Barends, Thomas R. M.; Hartmann, Elisabeth; Griese, Julia J.; Beitlich, Thorsten; Kirienko, Natalia V.; Ryjenkov, Dmitri A.; Reinstein, Jochen; Shoeman, Robert L.; Gomelsky, Mark; Schlichting, Ilme			Structure and mechanism of a bacterial light-regulated cyclic nucleotide phosphodiesterase	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; MEDIATED SIGNAL-TRANSDUCTION; FAD-BINDING DOMAIN; BLUF DOMAIN; DENSITY MODIFICATION; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURES; NMR SYSTEM; PHOTORECEPTOR; PROTEIN	The ability to respond to light is crucial for most organisms. BLUF is a recently identified photoreceptor protein domain that senses blue light using a FAD chromophore(1). BLUF domains are present in various proteins from the Bacteria, Euglenozoa and Fungi. Although structures of single-domain BLUF proteins have been determined(2-4), none are available for a BLUF protein containing a functional output domain; the mechanism of light activation in this new class of photoreceptors has thus remained poorly understood. Here we report the biochemical, structural and mechanistic characterization of a full-length, active photoreceptor, BlrP1 (also known as KPN_01598), from Klebsiella pneumoniae(5). BlrP1 consists of a BLUF sensor domain and a phosphodiesterase EAL output domain which hydrolyses cyclic dimeric GMP (c-di-GMP). This ubiquitous second messenger controls motility, biofilm formation, virulence and antibiotic resistance in the Bacteria(6-9). Crystal structures of BlrP1 complexed with its substrate and metal ions involved in catalysis or in enzyme inhibition provide a detailed understanding of the mechanism of the EAL-domain c-di-GMP phosphodiesterases. These structures also sketch out a path of light activation of the phosphodiesterase output activity. Photon absorption by the BLUF domain of one subunit of the antiparallel BlrP1 homodimer activates the EAL domain of the second subunit through allosteric communication transmitted through conserved domain-domain interfaces.	[Kirienko, Natalia V.; Ryjenkov, Dmitri A.; Gomelsky, Mark] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Barends, Thomas R. M.; Hartmann, Elisabeth; Griese, Julia J.; Beitlich, Thorsten; Reinstein, Jochen; Shoeman, Robert L.; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	University of Wyoming; Max Planck Society	Gomelsky, M (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	gomelsky@uwyo.edu; ilme.schlichting@mpimf-heidelberg.mpg.de	gomelsky, mark/F-6209-2010; Schlichting, Ilme/I-1339-2013; Griese, Julia Johanna/GQB-0023-2022	Griese, Julia Johanna/0000-0003-3686-3062; Kirienko, Natalia/0000-0002-1537-4967	Deutsche Forschungsgemeinschaft [FOR 526]; US National Science Foundation [MCB 0645876]; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Science Foundation(National Science Foundation (NSF)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank A. Jung and A. Schmidt for help during the initial stages of the project, C. Fang for c-di-GMP purification and Q. Wu and K. H. Gardner for discussions and for sharing unpublished data. We are grateful to I. Vetter for advice and support for the crystallographic software. Diffraction data were collected at the Swiss Light Source, beamline X10SA, Paul Scherrer Institute, Villigen, Switzerland. We thank the Dortmund-Heidelberg team for data collection and E. Pohl, A. Pauluhn and C. Schulze-Briese for their support in setting up the beamline. The K. pneumoniae genome was sequenced at the School of Medicine of the Washington University in St Louis. We acknowledge financial support from the Deutsche Forschungsgemeinschaft (Research Group FOR 526 'Sensory Blue Light Receptors') to I. S., the US National Science Foundation (MCB 0645876) to M. G. and the Boehringer Ingelheim Fonds to J. J. G. I. S. and J. R. are members of the Cluster of Excellence Cell Networks, Heidelberg.	Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHANG C, 2007, RCSB PDB STRUCTURE E; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; DeLano W.L., 2002, PYMOL MOL VIEWER; Domratcheva T, 2008, BIOPHYS J, V94, P3872, DOI 10.1529/biophysj.107.124172; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P5172, DOI 10.1021/bi00473a025; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hur S, 2003, J AM CHEM SOC, V125, P1472, DOI 10.1021/ja0293047; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MINASOV B, J BIOL CHEM IN PRESS, DOI DOI 10.1074/JBC.M808221200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; ROSS P, 1990, J BIOL CHEM, V265, P18933; Sadeghian K, 2008, J AM CHEM SOC, V130, P12501, DOI 10.1021/ja803726a; Salter EA, 2007, J PHYS CHEM B, V111, P4547, DOI 10.1021/jp066582+; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Tyagi A, 2008, CHEM PHYS, V354, P130, DOI 10.1016/j.chemphys.2008.10.003; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wu Q, 2008, BIOCHEMISTRY-US, V47, P10271, DOI 10.1021/bi8011687; Wu Q, 2009, BIOCHEMISTRY-US, V48, P2620, DOI 10.1021/bi802237r; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Zhan CG, 2001, J AM CHEM SOC, V123, P2835, DOI 10.1021/ja005529a	40	223	238	8	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1015	U150		10.1038/nature07966	http://dx.doi.org/10.1038/nature07966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536266				2022-12-28	WOS:000267063500049
J	Buonamici, S; Trimarchi, T; Ruocco, MG; Reavie, L; Cathelin, S; Mar, BG; Klinakis, A; Lukyanov, Y; Tseng, JC; Sen, F; Gehrie, E; Li, ML; Newcomb, E; Zavadil, J; Meruelo, D; Lipp, M; Ibrahim, S; Efstratiadis, A; Zagzag, D; Bromberg, JS; Dustin, ML; Aifantis, I				Buonamici, Silvia; Trimarchi, Thomas; Ruocco, Maria Grazia; Reavie, Linsey; Cathelin, Severine; Mar, Brenton G.; Klinakis, Apostolos; Lukyanov, Yevgeniy; Tseng, Jen-Chieh; Sen, Filiz; Gehrie, Eric; Li, Mengling; Newcomb, Elizabeth; Zavadil, Jiri; Meruelo, Daniel; Lipp, Martin; Ibrahim, Sherif; Efstratiadis, Argiris; Zagzag, David; Bromberg, Jonathan S.; Dustin, Michael L.; Aifantis, Iannis			CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SECONDARY LYMPHOID ORGANS; IN-VIVO; MOLECULAR PATHOGENESIS; CHEMOKINE RECEPTORS; MULTIPLE-SCLEROSIS; BREAST-CANCER; ACTIVATION; IMMUNITY; INFLAMMATION	T-cell acute lymphoblastic leukaemia (T-ALL) is a blood malignancy afflicting mainly children and adolescents(1). T-ALL patients present at diagnosis with increased white cell counts and hepatosplenomegaly, and are at an increased risk of central nervous system (CNS) relapse(2,3). For that reason, T-ALL patients usually receive cranial irradiation in addition to intensified intrathecal chemotherapy. The marked increase in survival is thought to be worth the considerable side-effects associated with this therapy. Such complications include secondary tumours, neurocognitive deficits, endocrine disorders and growth impairment(3). Little is known about the mechanism of leukaemic cell infiltration of the CNS, despite its clinical importance(4). Here we show, using T-ALL animal modelling and gene-expression profiling, that the chemokine receptor CCR7 (ref. 5) is the essential adhesion signal required for the targeting of leukaemic T-cells into the CNS. Ccr7 gene expression is controlled by the activity of the T-ALL oncogene Notch1 and is expressed in human tumours carrying Notch1-activating mutations. Silencing of either CCR7 or its chemokine ligand CCL19 (ref. 6) in an animal model of T-ALL specifically inhibits CNS infiltration. Furthermore, murine CNS-targeting by human T-ALL cells depends on their ability to express CCR7. These studies identify a single chemokine-receptor interaction as a CNS 'entry' signal, and open the way for future pharmacological targeting. Targeted inhibition of CNS involvement in T-ALL could potentially decrease the intensity of CNS-targeted therapy, thus reducing its associated short- and long-term complications.	[Buonamici, Silvia; Trimarchi, Thomas; Ruocco, Maria Grazia; Reavie, Linsey; Cathelin, Severine; Lukyanov, Yevgeniy; Tseng, Jen-Chieh; Sen, Filiz; Newcomb, Elizabeth; Zavadil, Jiri; Meruelo, Daniel; Ibrahim, Sherif; Zagzag, David; Dustin, Michael L.; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Buonamici, Silvia; Trimarchi, Thomas; Ruocco, Maria Grazia; Reavie, Linsey; Cathelin, Severine; Lukyanov, Yevgeniy; Tseng, Jen-Chieh; Sen, Filiz; Newcomb, Elizabeth; Zavadil, Jiri; Meruelo, Daniel; Ibrahim, Sherif; Zagzag, David; Dustin, Michael L.; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Buonamici, Silvia; Trimarchi, Thomas; Reavie, Linsey; Cathelin, Severine; Sen, Filiz; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Stem Cell Ctr, New York, NY 10016 USA; [Ruocco, Maria Grazia; Dustin, Michael L.] NYU, Sch Med, Program Mol Pathogenesis,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Mar, Brenton G.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Klinakis, Apostolos; Efstratiadis, Argiris] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Gehrie, Eric; Bromberg, Jonathan S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Gehrie, Eric; Bromberg, Jonathan S.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Li, Mengling] NYU, Inst Canc, Div Biostat, New York, NY 10016 USA; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Tumor Genet & Immunogenet, D-13092 Berlin, Germany	New York University; New York University; New York University; New York University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	Zavadil, Jiri/ABG-1780-2020; Lipp, Martin/G-2235-2010; Dustin, Michael/AAM-4611-2020; Gehrie, Eric Abraham/H-9196-2019	Zavadil, Jiri/0000-0003-0640-5562; Gehrie, Eric Abraham/0000-0002-5354-3899; Liu, Mengling/0000-0001-9758-8522; Dustin, Michael/0000-0003-4983-6389; Lipp, Martin/0000-0002-0087-2672; Mar, Brenton/0000-0002-3857-9324	National Institutes of Health [RO1CA105129, RO1CA133379, R56AI070310, P30CA016087, RO1AI41428, RO1AI072039]; American Cancer Society [RSG0806801]; Dana Foundation; Chemotherapy Foundation; Alex's Lemonade Stand Foundation; Lauri Strauss Leukemia Foundation; GP Foundation; NYU Molecular Oncology and Immunology; American Society of Hematology; Juvenile Diabetes Research Foundation [JDRFI1-2008-90, 5-2008-236]; National Cancer Institute [1 P01 CA97403]; Berrie Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA141399, R01CA133379, R01CA105129, R01CA149655, P01CA097403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070310, R01AI062765, R01AI041428, R01AI072039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dana Foundation; Chemotherapy Foundation; Alex's Lemonade Stand Foundation; Lauri Strauss Leukemia Foundation; GP Foundation; NYU Molecular Oncology and Immunology; American Society of Hematology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Berrie Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to G. Randolph, E. Kuan and T. Vilimas for technical help and discussions. We would like to thank P. Lopez and G. De La Cruz for cell sorting; D. Littman, W. Carroll, E. Raetz, S. Lira and S. Schwab for advice and illuminating discussions; C. Loomis and the Histology Facility for advice and troubleshooting tips. This work was supported by the National Institutes of Health (RO1CA105129, RO1CA133379, R56AI070310, P30CA016087 to I. A., RO1AI41428, RO1AI072039 to J.S. B.), the American Cancer Society (RSG0806801 to I. A.), the Dana Foundation, The Chemotherapy Foundation, the Alex's Lemonade Stand Foundation (to I. A.), the Lauri Strauss Leukemia Foundation (to F. S.), the G&P Foundation, NYU Molecular Oncology and Immunology training grant (to S. B.), American Society of Hematology (to S. B.), Juvenile Diabetes Research Foundation (JDRFI1-2008-90 and 5-2008-236 to J. S. B.), the National Cancer Institute (1 P01 CA97403, Project 2 to A. E.) and a gift from the Berrie Foundation (to A. E.). A. K. was supported by a Fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Cardona AE, 2008, J LEUKOCYTE BIOL, V84, P587, DOI 10.1189/jlb.1107763; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tseng JC, 2006, J NUCL MED, V47, P1136; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	29	192	199	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1000	U129		10.1038/nature08020	http://dx.doi.org/10.1038/nature08020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536265	Green Accepted			2022-12-28	WOS:000267063500046
J	LaHaye, MD; Suh, J; Echternach, PM; Schwab, KC; Roukes, ML				LaHaye, M. D.; Suh, J.; Echternach, P. M.; Schwab, K. C.; Roukes, M. L.			Nanomechanical measurements of a superconducting qubit	NATURE			English	Article							RESONATOR; STATES; PHASE	The observation of the quantum states of motion of a macroscopic mechanical structure remains an open challenge in quantum-state preparation and measurement. One approach that has received extensive theoretical attention(1-13) is the integration of superconducting qubits as control and detection elements in nanoelectromechanical systems (NEMS). Here we report measurements of a NEMS resonator coupled to a superconducting qubit, a Cooper-pair box. We demonstrate that the coupling results in a dispersive shift of the nanomechanical frequency that is the mechanical analogue of the 'single-atom index effect'(14) experienced by electromagnetic resonators in cavity quantum electrodynamics. The large magnitude of the dispersive interaction allows us to perform NEMS-based spectroscopy of the superconducting qubit, and enables observation of Landau-Zener interference effects-a demonstration of nanomechanical read-out of quantum interference.	[LaHaye, M. D.; Suh, J.; Roukes, M. L.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Echternach, P. M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Roukes, ML (corresponding author), CALTECH, Kavli Nanosci Inst, MS 114-36, Pasadena, CA 91125 USA.	roukes@caltech.edu	Roukes, Michael L/E-9787-2010	LaHaye, Matthew/0000-0003-1911-0704; Suh, Junho/0000-0002-0112-0499	US National Science Foundation [DMR-0804567]; Foundational Questions Institute [RFP2-08-27]; Center for the Physics of Information, California Institute of Technology; US National Aeronautics and Space Administration	US National Science Foundation(National Science Foundation (NSF)); Foundational Questions Institute; Center for the Physics of Information, California Institute of Technology; US National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	The authors would like to thank T. Duty, C. Wilson, G. Milburn, A. Doherty, E. Babourina-Brooks, A. Armour, A. Clerk and I. Bargatin for discussions; S. Stryker and A. Sears for assistance in constructing the measurement apparatus; and R. E. Muller for electron beam lithography. K. C. S. acknowledges support from the US National Science Foundation (DMR-0804567) and the Foundational Questions Institute (RFP2-08-27). M. D. L. acknowledges support from the Center for the Physics of Information, California Institute of Technology. Part of the research described in this publication was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the US National Aeronautics and Space Administration.	Armour AD, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095004; Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Buks E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174504; Cleland AN, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070501; Clerk AA, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042302; Duty T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.206807; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haroche S., 2006, EXPLORING QUANTUM; Hauss J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.037003; HEINZEN DJ, 1987, PHYS REV LETT, V59, P2623, DOI 10.1103/PhysRevLett.59.2623; Irish EK, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155311; Jacobs K, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/18003; Jacobs K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.147201; Leek PJ, 2007, SCIENCE, V318, P1889, DOI 10.1126/science.1149858; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Martin I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125339; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Palmer BS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054501; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Sillanpaa MA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.206806; Sillanpaa M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.187002; Tian L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195411; Truitt PA, 2007, NANO LETT, V7, P120, DOI 10.1021/nl062278g; Utami D, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042323; Wei LF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237201; Wilson CM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.257003	30	304	314	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					960	964		10.1038/nature08093	http://dx.doi.org/10.1038/nature08093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536259				2022-12-28	WOS:000267063500037
J	Norman, JE; Mackenzie, F; Owen, P; Mactier, H; Hanretty, K; Cooper, S; Calder, A; Mires, G; Danielian, P; Sturgiss, S; MacLennan, G; Tydeman, G; Thornton, S; Martin, B; Thornton, JG; Neilson, JP; Norrie, J				Norman, Jane E.; Mackenzie, Fiona; Owen, Philip; Mactier, Helen; Hanretty, Kevin; Cooper, Sarah; Calder, Andrew; Mires, Gary; Danielian, Peter; Sturgiss, Stephen; MacLennan, Graeme; Tydeman, Graham; Thornton, Steven; Martin, Bill; Thornton, James G.; Neilson, James P.; Norrie, John			Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis	LANCET			English	Article							17-ALPHA-HYDROXYPROGESTERONE CAPROATE; PREMATURITY; TRIAL; WOMEN; RISK	Background Women with twin pregnancy are at high risk for spontaneous preterm delivery. Progesterone seems to be effective in reducing preterm birth in selected high-risk singleton pregnancies, albeit with no significant reduction in perinatal mortality and little evidence of neonatal benefit. We investigated the use of progesterone for prevention of preterm birth in twin pregnancy. Methods In this double-blind, placebo-controlled trial, 500 women with twin pregnancy were recruited from nine UK National Health Service clinics specialising in the management of twin pregnancy. Women were randomised, by permuted blocks of randomly mixed sizes, either to daily vaginal progesterone gel 90 mg (n=250) or to placebo gel (n=250) for 10 weeks from 24 weeks' gestation. All study personnel and participants were masked to treatment assignment for the duration of the study. The primary outcome was delivery or intrauterine death before 34 weeks' gestation. Analysis was by intention to treat. Additionally we undertook a meta-analysis of published and unpublished data to establish the efficacy of progesterone in prevention of early (<34 weeks' gestation) preterm birth or intrauterine death in women with twin pregnancy. This study is registered, number ISRCTN35782581. Findings Three participants in each group were lost to follow-up, leaving 247 analysed per group. The combined proportion of intrauterine death or delivery before 34 weeks of pregnancy was 24.7% (61/247) in the progesterone group and 19.4% (48/247) in the placebo group (odds ratio [OR] 1.36, 95% CI 0.89-2.09; p=0.16). The rate of adverse events did not differ between the two groups. The meta-analysis confirmed that progesterone does not prevent early preterm birth in women with twin pregnancy (pooled OR 1.16, 95% Cl 0.89-1.51). Interpretation Progesterone, administered vaginally, does not prevent preterm birth in women with twin pregnancy.	[Norman, Jane E.] Univ Edinburgh, Ctr Reprod Biol, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Mackenzie, Fiona; Owen, Philip; Mactier, Helen] Princess Royal Matern, Glasgow, Lanark, Scotland; [Hanretty, Kevin] Univ Glasgow, Glasgow, Lanark, Scotland; [Cooper, Sarah] Royal Infirm, Simpson Ctr Reprod, Edinburgh, Midlothian, Scotland; [Mires, Gary] Univ Dundee, Div Clin & Populat Sci & Educ, Dundee, Scotland; [Danielian, Peter] Aberdeen Matern Hosp, Aberdeen, Scotland; [Sturgiss, Stephen] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [MacLennan, Graeme] Univ Aberdeen, Ctr Healthcare Randomised Trials, Aberdeen, Scotland; [Tydeman, Graham] Forth Pk Matern Hosp, Kirkcaldy, Scotland; [Thornton, Steven] Univ Warwick, Warwick Med Sch, Warwick, England; [Thornton, James G.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Martin, Bill] Birmingham Womens Hosp, Birmingham, W Midlands, England; [Neilson, James P.] Liverpool Womens Hosp, Liverpool, Merseyside, England; [Norrie, John] Univ Glasgow, Roberston Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow; Royal Infirmary of Edinburgh; University of Dundee; University of Aberdeen; Newcastle University - UK; University of Aberdeen; University of Warwick; Nottingham University Hospital NHS Trust; Birmingham Women's Hospital; University of Liverpool; University of Glasgow	Norman, JE (corresponding author), Univ Edinburgh, Ctr Reprod Biol, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	jane.norman@ed.ac.uk	Norman, Jane/B-2347-2010; Thornton, Steven/A-7898-2013; Thornton, Jim/B-8336-2008	Thornton, Jim/0000-0001-9764-6876; MacLennan, Graeme/0000-0002-1039-5646; Norman, Jane/0000-0001-6031-6953	Chief Scientist Office of the Scottish Government Health Directorate [CZH/4/200]; Chief Scientist Office [HSRU1] Funding Source: researchfish	Chief Scientist Office of the Scottish Government Health Directorate; Chief Scientist Office	This study was funded by research grant CZH/4/200 from the Chief Scientist Office of the Scottish Government Health Directorate. Active and placebo drugs were manufactured and donated by Serono, London, UK. We are grateful to both organisations for their support. The joint study sponsor in terms of the EU Clinical Directive was the University Glasgow and Greater Glasgow Health Board, UK. The Health Services Research Unit and CHaRT are funded by the Chief Scientists Office of the Scottish Government Health Directorates. The views and opinions expressed in this paper are those of the authors and do not necessarily reflect those of the Scottish Government Health Directorates. We thank our institutions and colleagues for their help and support in enabling us to undertake this study, particularly Gladys McPherson and Alison McDonald at the Centre for Healthcare Randomised Trials (CHaRT), the study data centre at the University of Aberdeen; the research midwives and other recruiting staff who did such an excellent job: Frith Robb and Beth Turner at the Royal Infirmary of Edinburgh (132 recruits), Marion McKean at Princess Royal Maternity Glasgow (99 recruits), Sandra Bosman at the Royal Victoria Infirmary Newcastle (68 recruits), Joan Murphy and Joanne Higgins at the Queen Mother's Hospital, Glasgow (62 recruits), Ann Cameron at Ninewells Hospital Dundee (61 recruits), Myra Kinnaird at Aberdeen Maternity Hospital (54 recruits), Paul Allcoat at Forth Park Hospital, Kirckaldy (15 recruits), Lucy Coyne and Rebecca Robinson at Nottingham University Hospital NHS Trust (four recruits), Spyros Bakalis at Birmingham Women's Hospital (three recruits), and Elizabeth Bailey and Angela Bradley at University Hospitals of Coventry and Warwickshire NHS Trust (two recruits); the Chair of the Trial Steering committee, Deirdre Murphy, Dublin; the independent Data and Safety Monitoring Committee for ensuring safe and appropriate trial conduct (Chair: James P Neilson, Liverpool; members: Peter Brocklehurst, National Perinatal Epidemiology Unit, Oxford and Michael Weindling, Liverpool); the senior authors of the other studies included in our meta-analysis, Dwight Rouse and Kypros Nicolaides, for their assistance in obtaining the relevant data; and all the women who participated in this study.	Caritis SN, 2009, OBSTET GYNECOL, V113, P285, DOI 10.1097/AOG.0b013e318193c677; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dodd JM, 2005, ACTA OBSTET GYN SCAN, V84, P526, DOI 10.1111/j.0001-6349.2005.00835.x; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Hack M, 2006, SEMIN FETAL NEONAT M, V11, P127, DOI 10.1016/j.siny.2005.11.007; HARTIKAINENSORRI AL, 1980, OBSTET GYNECOL, V56, P692; Henderson J, 2004, ARCH DIS CHILD-FETAL, V89, pF542, DOI 10.1136/adc.2003.043851; *INF SERV DIV NHS, 2007, SCOTT PROGR CLIN EFF; *INF SERV DIV NHS, 2008, BIRTHS BAB; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; *OFF NAT STAT, 2008, BIRTH STAT REV NAT S; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Ruddock NK, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.085	15	183	198	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2034	2040		10.1016/S0140-6736(09)60947-8	http://dx.doi.org/10.1016/S0140-6736(09)60947-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19523680	Green Submitted			2022-12-28	WOS:000267080100030
J	Eddy, CR; Gaskill, DK				Eddy, C. R., Jr.; Gaskill, D. K.			Silicon Carbide as a Platform for Power Electronics	SCIENCE			English	Editorial Material							CHEMICAL-VAPOR-DEPOSITION; GROWTH		[Eddy, C. R., Jr.; Gaskill, D. K.] USN, Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Eddy, CR (corresponding author), USN, Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA.	charles.eddy@nrl.navy.mil; david.gaskill@nrl.navy.mil						CUMMINGS D, 2005, 3 VS REV, V18, P18; Dhanaraj G, 2007, J ELECTRON MATER, V36, P332, DOI 10.1007/s11664-006-0084-2; Jepps N. W., 1983, Progress in Crystal Growth and Characterization, V7, P259, DOI 10.1016/0146-3535(83)90034-5; Lely JA, 1955, BER DEUT KERAM GES, V32, P229; Myers-Ward RL, 2009, MATER SCI FORUM, V615-617, P105, DOI 10.4028/www.scientific.net/MSF.615-617.105; TAIROV YM, 1978, J CRYST GROWTH, V43, P209, DOI 10.1016/0022-0248(78)90169-0; VanMil BL, 2009, MATER SCI FORUM, V615-617, P61, DOI 10.4028/www.scientific.net/MSF.615-617.61	7	199	202	11	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1398	1400		10.1126/science.1168704	http://dx.doi.org/10.1126/science.1168704			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520947				2022-12-28	WOS:000266878700030
J	Lentink, D; Dickson, WB; van Leeuwen, JL; Dickinson, MH				Lentink, D.; Dickson, W. B.; van Leeuwen, J. L.; Dickinson, M. H.			Leading-Edge Vortices Elevate Lift of Autorotating Plant Seeds	SCIENCE			English	Article							LONG-DISTANCE DISPERSAL; LOW REYNOLDS-NUMBERS; REVOLVING WINGS; INSECT FLIGHT; VORTEX; AERODYNAMICS; PERFORMANCE; MECHANISMS; SAMARAS; SWIFTS	As they descend, the autorotating seeds of maples and some other trees generate unexpectedly high lift, but how they attain this elevated performance is unknown. To elucidate the mechanisms responsible, we measured the three-dimensional flow around dynamically scaled models of maple and hornbeam seeds. Our results indicate that these seeds attain high lift by generating a stable leading-edge vortex (LEV) as they descend. The compact LEV, which we verified on real specimens, allows maple seeds to remain in the air more effectively than do a variety of nonautorotating seeds. LEVs also explain the high lift generated by hovering insects, bats, and possibly birds, suggesting that the use of LEVs represents a convergent aerodynamic solution in the evolution of flight performance in both animals and plants.	[Lentink, D.; van Leeuwen, J. L.] Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; [Dickson, W. B.; Dickinson, M. H.] CALTECH, Pasadena, CA 91125 USA	Wageningen University & Research; California Institute of Technology	Lentink, D (corresponding author), Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	david.lentink@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019	van Leeuwen, Johan/0000-0002-4433-880X; Lentink, David/0000-0003-4717-6815	Netherlands Organisation for Scientific Research Earth and Life Sciences Council (NWO ALW) [817.02.012]; NSF [IBN-0217229]	Netherlands Organisation for Scientific Research Earth and Life Sciences Council (NWO ALW)(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF))	We thank M. Lino, E. W. Karruppannan, E. Janssen, J. G. M. van den Boogaart, K. M. Leon, and H. Schipper for help with the free flight experiments. We thank G. E. Elsinga, J. R. Usherwood, and G. J. F. van Heijst for valuable comments. Research was funded by Netherlands Organisation for Scientific Research Earth and Life Sciences Council (NWO-ALW, grant 817.02.012) (to D.L. and J.L.v.L.) and NSF grant IBN-0217229 (to M.H.D.).	AZUMA A, 1987, J THEOR BIOL, V129, P263, DOI 10.1016/S0022-5193(87)80001-2; AZUMA A, 1989, J THEOR BIOL, V138, P23, DOI 10.1016/S0022-5193(89)80176-6; Azuma A., 2006, BIOKINETICS FLYING S; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Burrows FM., 1986, SEED DISPERSAL, P1; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dickson WB, 2004, J EXP BIOL, V207, P4269, DOI 10.1242/jeb.01266; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Hubel T., 2006, THESIS TU DARMSTADT; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; LINO M, 81702012 NWOALW NETH; Lorenz R.D., 2006, SPINNING FLIGHT; LUGT HJ, 1983, ANNU REV FLUID MECH, V15, P123, DOI 10.1146/annurev.fl.15.010183.001011; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; Minami S, 2003, J THEOR BIOL, V225, P1, DOI 10.1016/S0022-5193(03)00216-9; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Niklas KJ, 1992, PLANT BIOMECHANICS; NORBERG RA, 1973, BIOL REV, V48, P561, DOI 10.1111/j.1469-185X.1973.tb01569.x; Poelma C, 2006, EXP FLUIDS, V41, P213, DOI 10.1007/s00348-006-0172-3; SETER D, 1992, T ASME, V59, P1000; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Usherwood JR, 2002, J EXP BIOL, V205, P1547; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; Yasuda K, 1997, J THEOR BIOL, V185, P313, DOI 10.1006/jtbi.1996.0299	30	143	149	14	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1438	1440		10.1126/science.1174196	http://dx.doi.org/10.1126/science.1174196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520959				2022-12-28	WOS:000266878700044
J	Masur, H; Kaplan, JE				Masur, Henry; Kaplan, Jonathan E.			New Guidelines for the Management of HIV-Related Opportunistic Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RECOMMENDATIONS		[Masur, Henry] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Kaplan, Jonathan E.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Centers for Disease Control & Prevention - USA	Masur, H (corresponding author), NIH, Ctr Clin, 10 Ctr Dr,Bldg 10,Room 2C145, Bethesda, MD 20892 USA.	hmasur@nih.gov						*AIDSINFO, 2008, GUID PREV TREATM OPP; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Benson Constance A., 2004, Morbidity and Mortality Weekly Report, V53, P1; Centers for Disease Control and Prevention, 2003, MMWR MORB MORTAL WKL, V52, P581; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; *DISTR COL DEP HLT, 2007, DISTR COL HIV AIDS E; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; *HJ KAIS FAM FDN, 2007, HIV AIDS POL FACT SH; Kaplan Jonathan E, 2002, MMWR Recomm Rep, V51, P1; MASUR H, 1993, NEW ENGL J MED, V329, P898, DOI 10.1056/NEJM199309163291228; Mofenson Lynne M., 2004, Morbidity and Mortality Weekly Report, V53, P1; USPHS/IDSA Prevention of Opportunistic Infections Working Group, 1999, MMWR RECOMM REP, V48, P61	15	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2378	2380		10.1001/jama.2008.865	http://dx.doi.org/10.1001/jama.2008.865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509385				2022-12-28	WOS:000266773400031
J	Bowles, S				Bowles, Samuel			Did Warfare Among Ancestral Hunter-Gatherers Affect the Evolution of Human Social Behaviors?	SCIENCE			English	Article							GROUP SELECTION; WAR; CHIMPANZEES; COEVOLUTION; ALTRUISM; DIFFERENTIATION; POPULATION; DIVERSITY	Since Darwin, intergroup hostilities have figured prominently in explanations of the evolution of human social behavior. Yet whether ancestral humans were largely "peaceful" or "warlike" remains controversial. I ask a more precise question: If more cooperative groups were more likely to prevail in conflicts with other groups, was the level of intergroup violence sufficient to influence the evolution of human social behavior? Using a model of the evolutionary impact of between-group competition and a new data set that combines archaeological evidence on causes of death during the Late Pleistocene and early Holocene with ethnographic and historical reports on hunter-gatherer populations, I find that the estimated level of mortality in intergroup conflicts would have had substantial effects, allowing the proliferation of group-beneficial behaviors that were quite costly to the individual altruist.	[Bowles, Samuel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bowles, Samuel] Univ Siena, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	samuel.bowles@gmail.com			Behavioral Sciences Program of the Santa Fe Institute; U.S. National Science Foundation; European Science Foundation; University of Siena	Behavioral Sciences Program of the Santa Fe Institute; U.S. National Science Foundation(National Science Foundation (NSF)); European Science Foundation(European Science Foundation (ESF)European Commission); University of Siena	Thanks to I. Levina and A. Vereshchagina for translating the Russian and Ukrainian archaeological materials; P. Lambert and K. Kennedy for assistance with the Californian and Indian archaeological evidence; M. Alexander, K. Ames, B. Bertram, L. Luigi Cavalli-Sforza, T. Clutton-Brock, W. Cote, E. Einhorn, D. Wood Gordon, H. Kaplan, K. Hill, K. Howard, S.-H. Hwang, K. Langergraber, S. Le Blanc, J. Mitani, C. Resnicke, R. Rowthorn, P. Seabright, E. Alden Smith, T. Taylor, D. Ulibarri, L. Vigilant, E. Wood, and R. Wrangham for valuable contributions; and the Behavioral Sciences Program of the Santa Fe Institute, the U.S. National Science Foundation, the European Science Foundation, and the University of Siena for support of this work. The author declares no competing interests.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; AOKI K, 1982, EVOLUTION, V36, P832, DOI [10.2307/2407896, 10.1111/j.1558-5646.1982.tb05449.x]; BILL JH, 1862, AM J MED SCI, V40, P365; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; BOORMAN SA, 1973, THEOR POPUL BIOL, V4, P85, DOI 10.1016/0040-5809(73)90007-5; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Burch, 2005, ALLIANCE CONFLICT WO, DOI 10.2307/j.ctv6gqqgg; CAMPBELL C, 1986, WORLD ARCHAEOL, V18, P255, DOI 10.1080/00438243.1986.9980002; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; COHEN MN, 1980, BIOSOCIAL MECHANISMS, P275; Darwin C., 1873, DESCENT MAN; EMBER CR, 1992, J CONFLICT RESOLUT, V36, P242, DOI 10.1177/0022002792036002002; FERGUSON B, 1997, TROUBLED TIMES VIOLE, P321; Formicola V, 2007, CURR ANTHROPOL, V48, P446, DOI 10.1086/517592; Gat Azar, 2006, WAR HUMAN CIVILIZATI; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hassan F., 1980, BIOSOCIAL MECHANISMS, P305; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; JOHANSSON SR, 1986, AM J PHYS ANTHROPOL, V71, P233, DOI 10.1002/ajpa.1330710211; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keeley LH., 1996, WAR CIVILIZATION; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; Lambert PM., 2014, TROUBLED TIMES VIOLE, V3, P77; LANCHESTER FW, 1916, AIRCRAFT WARFARE DAW, P222; LeBlanc SA, 2003, CONSTANT BATTLES; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Lourandos H., 1997, CONTINENT HUNTER GAT; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; MELBYE J, 1994, ARCTIC ANTHROPOL, V31, P57; Milner GR, 2005, AM ANTIQUITY, V70, P144, DOI 10.2307/40035273; Morgan J, 1979, LIFE ADVENTURES W BU; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schapera I., 1930, KHOISAN PEOPLES S AF; Smirnov O, 2007, J POLIT, V69, P927, DOI 10.1111/j.1468-2508.2007.00599.x; Ta?on P., 1994, CAMB ARCHAEOL J, V4, P211, DOI DOI 10.1017/S0959774300001086; Tenny J. M., 1990, HUMAN EVOLUTION, V5, P397; Walsh SJ, 2007, J HUM GENET, V52, P712, DOI 10.1007/s10038-007-0172-z; Wendorf F, 1968, PREHISTORY NUBIA; Williams JM, 2004, ANIM BEHAV, V68, P523, DOI 10.1016/j.anbehav.2003.09.015; Woodburn J., 1982, DEATH REGENERATION L, P187; Wrangham RW, 2006, PRIMATES, V47, P14, DOI 10.1007/s10329-005-0140-1	44	409	416	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 5	2009	324	5932					1293	1298		10.1126/science.1168112	http://dx.doi.org/10.1126/science.1168112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453TF	19498163				2022-12-28	WOS:000266635100036
J	Hamilton, F; Car, J; Layton, A				Hamilton, Fiona; Car, Josip; Layton, Alison			10-Minute Consultation Acne vulgaris	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hamilton, Fiona; Car, Josip] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London W6 8RP, England; [Layton, Alison] Harrogate & Dist NHS Fdn Trust, Harrogate, N Yorkshire, England; [Layton, Alison] N Yorkshire & York Primary Care Trust, Harrogate, England	Imperial College London	Car, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Charing Cross Campus, London W6 8RP, England.	josip.car@imperial.ac.uk	Car, Josip/H-6755-2015	Car, Josip/0000-0001-8969-371X; Layton, Alison/0000-0003-0473-3319	National Institute for Health Research [ACF-2006-21-033] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 5	2009	338								a2738	10.1136/bmj.a2738	http://dx.doi.org/10.1136/bmj.a2738			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AJ	19502277				2022-12-28	WOS:000266726600001
J	Moons, KGM; Altman, DG; Vergouwe, Y; Royston, P				Moons, Karel G. M.; Altman, Douglas G.; Vergouwe, Yvonne; Royston, Patrick			Prognosis and prognostic research: application and impact of prognostic models in clinical practice	BRITISH MEDICAL JOURNAL			English	Article							OTTAWA ANKLE RULES; DIFFERENTIAL-DIAGNOSIS; PREDICTION RULES; ACUTE MENINGITIS; NEUROLOGICAL SEQUELAE; POSTOPERATIVE NAUSEA; BACTERIAL-MENINGITIS; PRACTICE GUIDELINES; PEDIATRIC-PATIENTS; CONTROLLED-TRIAL		[Moons, Karel G. M.; Vergouwe, Yvonne] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Royston, Patrick] MRC Clin Trials Unit, London NW1 2DA, England	Utrecht University; Utrecht University Medical Center; University of Oxford; Medical Research Council Clinical Trials Unit	Moons, KGM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	k.g.m.moons@umcutrecht.nl			MRC [MC_EX_G0800814] Funding Source: UKRI; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish; Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman, 2007, BREAST CANC TRANSLAT, P11; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; ALTMAN DG, 2008, BRIT MED J, pB605; Biesheuvel CJ, 2006, SCAND J INFECT DIS, V38, P19, DOI 10.1080/00365540500372671; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cameron C, 1999, CAN MED ASSOC J, V160, P1165; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Deeks JJ., 2007, EVIDENCE BASED LAB M, P95; Eberhart LHJ, 2004, ANESTH ANALG, V99, P1630, DOI 10.1213/01.ANE.0000135639.57715.6C; Eberhart LHJ, 2004, BRIT J ANAESTH, V93, P386, DOI 10.1093/bja/aeh221; Foy R, 2004, BJOG-INT J OBSTET GY, V111, P726, DOI 10.1111/j.1471-0528.2004.00168.x; Gordon-Lubitz RJ, 2003, JAMA-J AM MED ASSOC, V289, P95, DOI 10.1001/jama.289.1.95; Graham ID, 2001, ANN EMERG MED, V37, P259, DOI 10.1067/mem.2001.113506; Harrison DA, 2008, CURR OPIN CRIT CARE, V14, P506, DOI 10.1097/MCC.0b013e328310165a; HOEN B, 1995, EUR J CLIN MICROBIOL, V14, P267, DOI 10.1007/BF02116518; Holbert JM, 1999, ANN EMERG MED, V33, P520, DOI 10.1016/S0196-0644(99)70339-2; Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365; James BC, 2001, NEW ENGL J MED, V345, P991, DOI 10.1056/NEJM200109273451311; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Knottnerus JA, 2002, J CLIN EPIDEMIOL, V55, P1201, DOI 10.1016/S0895-4356(02)00528-0; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liao YL, 1999, AM HEART J, V137, P837, DOI 10.1016/S0002-8703(99)70407-2; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; MCKINNEY WP, 1994, J GEN INTERN MED, V9, P8, DOI 10.1007/BF02599135; Meyer Gabriele, 2005, BMC Geriatr, V5, P14, DOI 10.1186/1471-2318-5-14; Michie S, 2004, BRIT MED J, V328, P343, DOI 10.1136/bmj.328.7435.343; MOONS K, 2008, BRIT MED J, pB375; Oostenbrink R, 2002, ACTA PAEDIATR, V91, P391, DOI 10.1080/080352502317371616; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rinkel GJE, 2005, LANCET NEUROL, V4, P122, DOI 10.1016/S1474-4422(05)00993-2; ROYSTON P, 2008, BRIT MED J, pB604; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 1999, INT J CANCER, V83, P856, DOI 10.1002/(SICI)1097-0215(19991210)83:6<856::AID-IJC31>3.0.CO;2-L; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Van den Bosch JE, 2005, ANESTH ANALG, V100, P1525, DOI 10.1213/01.ANE.0000149325.20542.D4; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	48	584	590	1	52	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 4	2009	338								b606	10.1136/bmj.b606	http://dx.doi.org/10.1136/bmj.b606			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AH	19502216				2022-12-28	WOS:000266726400008
J	Casswell, S; Thamarangsi, T				Casswell, Sally; Thamarangsi, Thaksaphon			Alcohol and Global Health 3 Reducing harm from alcohol: call to action	LANCET			English	Article							PUBLIC-HEALTH; CHRONIC DISEASES; ECONOMIC COST; RISK-FACTOR; BURDEN; INDUSTRY; TOBACCO; POLICY; TRADE; HOSPITALIZATION	Despite clear evidence of the major contribution alcohol makes to the global burden of disease and to substantial economic costs, focus on alcohol control is inadequate internationally and in most countries. Expansion of industrial production and marketing of alcohol is driving alcohol use to rise, both in emerging markets and in young people in mature alcohol markets. Cost-effective and affordable interventions to restrict harm exist, and are in urgent need of scaling up. Most countries do not have adequate policies in place. Factors impeding progress include a failure of political will, unhelpful participation of the alcohol industry in the policy process, and increasing difficulty in free-trade environments to respond adequately at a national level. An effective national and international response will need not only governments, but also non-governmental organisations to support and hold government agencies to account. International health policy, in the form of a Framework Convention on Alcohol Control, is needed to counterbalance the global conditions promoting alcohol-related harm and to support and encourage national action.	[Casswell, Sally] Massey Univ, Ctr Social & Hlth Outcomes Res & Evaluat, Auckland, New Zealand; [Thamarangsi, Thaksaphon] Minist Publ Hlth, Int Hlth Policy Program, Bangkok, Thailand	Massey University; Ministry of Public Health - Thailand	Casswell, S (corresponding author), Massey Univ, Ctr Social & Hlth Outcomes Res & Evaluat, POB 6137,Wellesley St, Auckland, New Zealand.	s.casswell@massey.ac.nz		Casswell, Sally/0000-0002-2211-7096				*ADM COMM SUBST AB, 2008, STAT ALC CONS REP NA; *AM PUBL HLTH ASS, 2006, CALL FRAM CONV ALC C; Anderson P, 2004, ADDICTION, V99, P1376, DOI 10.1111/j.1360-0443.2004.00866.x; Anderson P, 2008, DRUG ALCOHOL REV, V27, P463, DOI 10.1080/09595230802263413; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2007, LANCET, V370, P1102; [Anonymous], 2007, WHO TECHN REP SER; [Anonymous], 2001, MAPPING SOCIAL CONSE; Asma S., 2009, TOBACCO OXFORD TXB P, DOI [10.1093/med/9780199218707.003.0075, DOI 10.1093/MED/9780199218707.003.0075]; Babor Thomas F., 2003, ALCOHOL ORDINARY COM; Baumberg B, 2008, ADDICTION, V103, P1952, DOI 10.1111/j.1360-0443.2008.02322.x; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Bendell J., 2005, BUS STRATEG ENVIRON, V14, P372, DOI [DOI 10.1002/BSE.439, 10.1002/bse.439]; Benegal V., 2005, Alcohol, gender and drinking problems: perspectives from low and middle income countries, P89; BETTCHER D, 2009, OXFORD TXB PUBLIC HL; Bonu S, 2005, HEALTH POLICY PLANN, V20, P41, DOI 10.1093/heapol/czi005; BUNDHAMCHAROEN K, 2007, THAI BURDEN DIS INJU; Caetano R, 2006, ADDICTION, V101, P149, DOI [10.1111/j.1360-0443.2006.01334.x, 10.1111/j.1360-0443.2005.01334.x]; Caetano R, 2008, ADDICTION, V103, P175, DOI 10.1111/j.1360-0443.2007.02104.x; Casswell S, 2005, J PUBLIC HEALTH POL, V26, P343, DOI 10.1057/palgrave.jphp.3200040; CAVANAGH J, 1985, B ALCOHOL POLICY, V4, P7; Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; COOK PJ, 1993, J HEALTH ECON, V12, P411, DOI 10.1016/0167-6296(93)90003-W; CSDH, 2008, CLOS GAP GEN HLTH EQ; *DIAG, 2005, PROM RESP DRINK; *DIAG, ANN REP 2007 DIAG; *DIAG, 2005, G8 SPONS BACKGR BRIE; Droomers M, 2003, J EPIDEMIOL COMMUN H, V57, P704, DOI 10.1136/jech.57.9.704; ENDAL D, 2008, DRINKS IND SUPPLANTI; *FORUT, 2003, ALC DRUGS DEV STRAT; *FRAM CONV ALL, AB US WHAT IS FRAM C; George S, 1997, DISSENT, V44, P47; Giesbrecht N, 2000, ADDICTION, V95, pS581, DOI 10.1046/j.1360-0443.95.12s4.10.x; Gould E, 2005, J PUBLIC HEALTH POL, V26, P359, DOI 10.1057/palgrave.jphp.3200036; Gray D, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P381, DOI 10.1002/9780470713624.ch31; Gulbinat W, 2008, ADDICT RES THEORY, V16, P541, DOI 10.1080/16066350802008694; HEINEKEN NV, ANN REP 2007; Hill L., 2004, ESSENTIAL HDB TREATM, P339; Hill L, 2008, INT ENCY PUBLIC HLTH, P124; Hill L, 2007, DRUG ALCOHOL REV, V26, P683; Hill Linda, 2004, Pac Health Dialog, V11, P116; HOMEL R, 1993, ADDICTION, V88, pS27, DOI 10.1111/j.1360-0443.1993.tb02159.x; *INBEV, ANN REP 2007; *INT CTR ALC POL, 2001, SELF REG BEV ALC ADV; *INT CTR ALC POL, 2006, ICAP REP, V17; *INT CTR ALC POL, 2004, SHAR BEST PRACT SELF; *INT CTR ALC POL, 1998, SUGG FRAM RESP; Jahiel RI, 2007, ADDICTION, V102, P1335, DOI 10.1111/j.1360-0443.2007.01900.x; Jernigan D., 2004, REDUCING UNDERAGE DR, P625; Jernigan DH, 2000, B WORLD HEALTH ORGAN, V78, P491; KONGSAGON R, 2005, 1 NAT C ALC CONS REL; Laranjeira R, 2007, ADDICTION, V102, P1502, DOI 10.1111/j.1360-0443.2007.01964.x; LEVY A, 2007, CARNEGIE SCI, V63, P2; Mackay J, 2003, B WORLD HEALTH ORGAN, V81, P551; *MAR I, 2008, YOU GET WHAT YOU PAY; McCreanor T, 2000, ADDICTION, V95, P179, DOI 10.1046/j.1360-0443.2000.9521794.x; McCreanor Timothy, 2005, CRITICAL PUBLIC HLTH, V15, P251, DOI [10.1080/09581590500372345, DOI 10.1080/09581590500372345]; McKinlay JB, 2000, INT J HEALTH SERV, V30, P49, DOI 10.2190/2V5H-RHBR-FTM1-KGCF; *MED MON PROJ, 2007, ALC ADV FREE TEL PRO; Mehl G., 2005, HARVARD INT REV, V27, P54; MOSHER JF, 1989, ANNU REV PUBL HEALTH, V10, P245; PINSKY L, 2004, ADDICTION, V99, P524; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Rehm J, 2009, ADDICT RES THEORY, V17, P99, DOI 10.1080/16066350802559472; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Renna F, 2007, HEALTH ECON, V16, P407, DOI 10.1002/hec.1178; RICARD P, ANN REPORT 2006 2007; Romelsjo A, 2004, EUR J PUBLIC HEALTH, V14, P53, DOI 10.1093/eurpub/14.1.53; Room R, 2004, ADDICTION, V99, P1083, DOI 10.1111/j.1360-0443.2004.00803.x; Room R, 2005, ADDICTION, V100, P1396, DOI 10.1111/j.1360-0443.2005.01183.x; Room R, 2005, ADDICTION, V100, P579, DOI 10.1111/rp10.1017-S1367943003213238; Room R, 2006, DRUG ALCOHOL REV, V25, P581, DOI 10.1080/09595230600944503; *SABMILLER, 2008, OUR IN; *SHORE, 2006, EC TREAT ALC W PAC R; Smith SW, 2006, HEALTH COMMUN, V20, P1, DOI 10.1207/s15327027hc2001_1; SORNPHAISARN P, 2005, DEV ALCOHOL RELATED; *SPINW, 2008, ALC GROUP PAYS S 240; TAYLOR A, 2003, GLOBAL PUBLIC GOODS, P212; TAYLOR AL, 1996, WHOPSA966; Tesler LE, 2008, AM J PUBLIC HEALTH, V98, P2123, DOI 10.2105/AJPH.2007.128231; *THAIHEALTH, 2007, THAI HLTH; Thamarangsi T, 2006, ADDICTION, V101, P783, DOI 10.1111/j.1360-0443.2006.01477.x; THAMARANGSI T, 2008, THESIS MASSEY U, P269; *WHO, 1992, EUPRC428 WHO; *WHO EX BOARD, 2008, EB122R2 WHO EX BOARD; *WHO REG COMM W PA, 2006, WPRRC57R5 WHO REG CO; *WHO REG OFF S E A, 2006, ALC CONS CONTR POL O; WIBULPOLPRASERT S, 2005, THAILAND HLTH PROFIL; *WORLD BANK GROUP, 2000, NOT ALC BEV; *WORLD BANK GROUP, 2007, WORLD DEV REP 2007; *WORLD BANK GROUP, 2003, ALC; *WORLD HLTH ORG, 2004, GLOB STAT REP ALC PO; *WORLD MED ASS, 2005, WORLD MED ASS STAT R; *WORLD TRAD ORG, WORLD TRAD ORG APP B; *WORLD TRAD ORG WH, 2002, WTO AGR PUBL HLTH JO; Zeigler DW, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02431.x; 2008, GLOBE, P2	98	217	220	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2247	2257		10.1016/S0140-6736(09)60745-5	http://dx.doi.org/10.1016/S0140-6736(09)60745-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560606				2022-12-28	WOS:000267444500037
J	Wain, LV; Armour, JAL; Tobin, MD				Wain, Louise V.; Armour, John A. L.; Tobin, Martin D.			Genomic copy number variation, human health, and disease	LANCET			English	Review							CONTAINING SEGMENTAL DUPLICATIONS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECEPTOR-GENE CLUSTERS; STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; LARGE-SCALE; POLYMORPHISMS; DELETION; SUSCEPTIBILITY	Despite the long recognised effects of chromosomal structural abnormalities and completion of the Human Genome Project, much of the structural variation in the genome has gone unrecognised until recently. Deletions and duplications of DNA strands of between a few hundred bp and several million bp-collectively referred to as copy number variants-are now known to be widespread. Since 2007, rigorous and adequately powered genome-wide association studies based on single nucleotide polymorphisms have yielded replicated associations to several common diseases. Some copy number variants explain rare, previously uncharacterised disorders, and they are now expected to explain some of the genetic contribution to common diseases. We review efforts to map copy number variants and discuss present and future prospects for assessment of their relation to human health and disease.	[Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Armour, John A. L.] Univ Nottingham, Inst Genet, Nottingham NG7 2RD, England; [Armour, John A. L.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Leicester; University of Leicester; University of Nottingham; University of Nottingham	Tobin, MD (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England.	mt47@le.ac.uk	Pillay, Nischalan/F-9536-2012	Armour, John/0000-0002-8558-8506; Wain, Louise/0000-0003-4951-1867; Tobin, Martin/0000-0002-3596-7874	Medical Research Council Clinician Scientist Fellowship [G0501942]; Medical Research Council [G0501942] Funding Source: researchfish; MRC [G0501942] Funding Source: UKRI	Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Ammar Al-Chalabi, Cother Haiat, Ed Hollox, and James R Lupski for providing comments on the report; and anonymous reviewers for their helpful comments and suggestions, MDT holds a Medical Research Council Clinician Scientist Fellowship (G0501942).	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Avent ND, 1997, BLOOD, V89, P2568, DOI 10.1182/blood.V89.7.2568; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Broman KW, 2003, INST MATH S, V40, P237; BRUDER CE, 2008, AM J HUM GENET, V14, P14; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; CHEN HS, 1997, J DESERT RES, V17, P63; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2008, 58 ANN M AM SOC HUM; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; Deeb SS, 2005, CLIN GENET, V67, P369, DOI 10.1111/j.1399-0004.2004.00343.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Holloway K, 2006, HUM MOL GENET, V15, P1099, DOI 10.1093/hmg/ddl025; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Koren G, 2006, LANCET, V368, P704, DOI 10.1016/S0140-6736(06)69255-6; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Lam KWG, 2007, P NATL ACAD SCI USA, V104, P10950, DOI 10.1073/pnas.0703856104; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mamtani M, 2008, ANN RHEUM DIS, V67, P1076, DOI 10.1136/ard.2007.078048; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; MCCARROLL SA, 2008, NAT GENET, V24, P24; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; NGUYEN DQ, 2008, GENOME RES, V7, P7; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; PERRY GH, 2008, AM J HUM GENET, V24, P24; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; WANG K, 2007, GENOME RES, V5, P5; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2006, INT REV NEUROBIOL, V73, P1, DOI 10.1016/S0074-7742(06)73001-X; WISE CA, 1993, AM J HUM GENET, V53, P853; XU B, 2008, NAT GENET, V30, P30; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zondervan KT, 2007, NAT PROTOC, V2, P2492, DOI 10.1038/nprot.2007.366	102	138	147	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2009	374	9686					340	350		10.1016/S0140-6736(09)60249-X	http://dx.doi.org/10.1016/S0140-6736(09)60249-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	477GW	19535135	Green Submitted			2022-12-28	WOS:000268508200031
J	Chen, YL; Analytis, JG; Chu, JH; Liu, ZK; Mo, SK; Qi, XL; Zhang, HJ; Lu, DH; Dai, X; Fang, Z; Zhang, SC; Fisher, IR; Hussain, Z; Shen, ZX				Chen, Y. L.; Analytis, J. G.; Chu, J. -H.; Liu, Z. K.; Mo, S. -K.; Qi, X. L.; Zhang, H. J.; Lu, D. H.; Dai, X.; Fang, Z.; Zhang, S. C.; Fisher, I. R.; Hussain, Z.; Shen, Z. -X.			Experimental Realization of a Three-Dimensional Topological Insulator, Bi2Te3	SCIENCE			English	Article							HGTE QUANTUM-WELLS; SINGLE DIRAC CONE; SURFACE; PHASE; TRANSITION; STATE	Three-dimensional topological insulators are a new state of quantum matter with a bulk gap and odd number of relativistic Dirac fermions on the surface. By investigating the surface state of Bi2Te3 with angle-resolved photoemission spectroscopy, we demonstrate that the surface state consists of a single nondegenerate Dirac cone. Furthermore, with appropriate hole doping, the Fermi level can be tuned to intersect only the surface states, indicating a full energy gap for the bulk states. Our results establish that Bi2Te3 is a simple model system for the three-dimensional topological insulator with a single Dirac cone on the surface. The large bulk gap of Bi2Te3 also points to promising potential for high-temperature spintronics applications.	[Chen, Y. L.; Analytis, J. G.; Chu, J. -H.; Liu, Z. K.; Mo, S. -K.; Qi, X. L.; Lu, D. H.; Zhang, S. C.; Fisher, I. R.; Shen, Z. -X.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Chen, Y. L.; Analytis, J. G.; Chu, J. -H.; Liu, Z. K.; Mo, S. -K.; Qi, X. L.; Zhang, S. C.; Fisher, I. R.; Shen, Z. -X.] Stanford Univ, Dept Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Chen, Y. L.; Analytis, J. G.; Chu, J. -H.; Liu, Z. K.; Mo, S. -K.; Qi, X. L.; Zhang, S. C.; Fisher, I. R.; Shen, Z. -X.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Y. L.; Mo, S. -K.; Hussain, Z.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Zhang, H. J.; Dai, X.; Fang, Z.] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Zhang, H. J.; Dai, X.; Fang, Z.] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS	Shen, ZX (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	zxshen@stanford.edu	Dai, Xi/C-4236-2008; analytis, james/ABE-6100-2020; Hussain, Zahid/HGU-8912-2022; Fang, Zhong/D-4132-2009; Qi, Xiaoliang/F-9245-2010; Zhang, Shou-Cheng/B-2794-2010; Mo, Sung-Kwan/F-3489-2013; Krausnick, Jennifer/D-6291-2013; Zhang, Haijun/E-5098-2013; Chen, Yulin/C-1918-2012; Dai, Xi/HCG-9886-2022; Chu, Jiun-Haw/B-1613-2012; Zhang, Shengbai/D-4885-2013	Dai, Xi/0000-0002-2396-0966; analytis, james/0000-0002-7657-7688; Hussain, Zahid/0000-0003-4989-6496; Qi, Xiaoliang/0000-0003-0388-5003; Mo, Sung-Kwan/0000-0003-0711-8514; Fisher, Ian/0000-0002-1278-7862; Chu, Jiun-Haw/0000-0001-6222-1210; Zhang, Shengbai/0000-0003-0833-5860; Zhang, Haijun/0000-0002-9958-1102	Department of Energy, Office of Basic Energy Sciences [DE-AC02-76SF00515]; NSF of China; National Basic Research Program of China; International Science and Technology Cooperation Program of China	Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Science and Technology Cooperation Program of China	This work was supported by the Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-76SF00515; H.J.Z., Z.F., and X.D. acknowledge the support by the NSF of China, the National Basic Research Program of China, and the International Science and Technology Cooperation Program of China.	AKHNMEROV AR, 2009, PHYS REV LETT, V102, P6404; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Dai X, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125319; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; LaShell S, 1996, PHYS REV LETT, V77, P3419, DOI 10.1103/PhysRevLett.77.3419; Liu Q, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156603; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Qi XL, 2009, SCIENCE, V323, P1184, DOI 10.1126/science.1167747; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; ROY R, PREPRINT; SATTERTHWAITE CB, 1957, PHYS REV, V108, P1164, DOI 10.1103/PhysRev.108.1164; Teo JCY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045426; Vijayakumar M, 1996, J MOL STRUC-THEOCHEM, V361, P15, DOI 10.1016/0166-1280(95)04297-0; Wyckoff R.W.G., 1964, CRYSTAL STRUCTURES, V2; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	25	2755	2795	33	1290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 10	2009	325	5937					178	181		10.1126/science.1173034	http://dx.doi.org/10.1126/science.1173034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19520912				2022-12-28	WOS:000267802000040
J	Wandzioch, E; Zaret, KS				Wandzioch, Ewa; Zaret, Kenneth S.			Dynamic Signaling Network for the Specification of Embryonic Pancreas and Liver Progenitors	SCIENCE			English	Article							EARLY MOUSE EMBRYO; HEPATIC SPECIFICATION; ENDODERM CELLS; INDUCTION; DISTINCT; MESENCHYME; INITIATION; PROX1; SMAD4; PDX-1	Studies of the formation of pancreas and liver progenitors have focused on individual inductive signals and cellular responses. Here, we investigated how bone morphogenetic protein, transforming growth factor-beta (TGF beta), and fibroblast growth factor signaling pathways converge on the earliest genes that elicit pancreas and liver induction in mouse embryos. The inductive network was found to be dynamic; it changed within hours. Different signals functioned in parallel to induce different early genes, and two permutations of signals induced liver progenitor domains, which revealed flexibility in cell programming. Also, the specification of pancreas and liver progenitors was restricted by the TGFb pathway. These findings may enhance progenitor cell specification from stem cells for biomedical purposes and can help explain incomplete programming in stem cell differentiation protocols.	[Wandzioch, Ewa; Zaret, Kenneth S.] Fox Chase Canc Ctr, Cell & Dev Biol Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu			NIH [R37GM36477, U01DK072503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Robertson for SmadCA mice; K. Kaestner for FoxA3cre mice; A. Hines for help with breeding; the Fox Chase Cancer Center (FCCC) Laboratory Animal Facility; F. Roegiers, E. Robertson, H. Fan, R. Lake, and D. Freedman-Cass for comments on the manuscript; and E. Pytko for help in its preparation. E.W. was a Postdoctoral Fellow of the Swedish Research Council. The work was funded by NIH grants R37GM36477 and U01DK072503 to K.S.Z. K.S.Z. is on a Scientific Advisory Board for Johnson & Johnson in the area of embryonic stem cells.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Chung WS, 2008, DEV CELL, V15, P738, DOI 10.1016/j.devcel.2008.08.019; Deutsch G, 2001, DEVELOPMENT, V128, P871; DICKSON MC, 1993, DEVELOPMENT, V117, P625; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; LEDOUARIN N, 1964, J EMBRYOL EXP MORPH, V12, P651; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lokmane L, 2008, DEVELOPMENT, V135, P2777, DOI 10.1242/dev.023010; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Offield MF, 1996, DEVELOPMENT, V122, P983; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	31	180	189	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1707	1710		10.1126/science.1174497	http://dx.doi.org/10.1126/science.1174497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556507	Green Accepted			2022-12-28	WOS:000267338200039
J	Spivey, M; Kellermann, AL				Spivey, Michael; Kellermann, Arthur L.			Rescuing the Safety Net	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spivey, Michael] Spivey Harris Hlth Policy Grp, Washington, DC USA; [Kellermann, Arthur L.] Emory Univ, Sch Med, Atlanta, GA USA	Emory University	Spivey, M (corresponding author), Spivey Harris Hlth Policy Grp, Washington, DC USA.							*AM HOSP ASS, 2006, UNC HOSP CAR COST FA; Andrews RM SD, 2007, PUBLICATION AGENCY H; FAGNANI L, 1999, DEPENDENCE SAFETY NE, P1; FELD S, 2008, REPAIRING HEALTHCARE; HEARNE J, MEDICAID DISPROPORTI	5	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2598	2601		10.1056/NEJMp0900728	http://dx.doi.org/10.1056/NEJMp0900728			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458WR	19535800				2022-12-28	WOS:000267060000003
J	Booth, TC; Hargunani, R				Booth, Thomas C.; Hargunani, Rikin			Picture Quiz A renal riddle	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN; TRACT		[Booth, Thomas C.; Hargunani, Rikin] Royal Free Hosp NHS Trust, Dept Radiol, London NW3 2QG, England	University of London; University College London	Booth, TC (corresponding author), Royal Free Hosp NHS Trust, Dept Radiol, London NW3 2QG, England.	tombooth@doctors.org.uk						Blews DE, 1999, RADIOL CLIN N AM, V37, P1199, DOI 10.1016/S0033-8389(05)70257-8; Conway PH, 2007, JAMA-J AM MED ASSOC, V298, P179, DOI 10.1001/jama.298.2.179; de Bruyn R, 2008, SEMIN FETAL NEONAT M, V13, P133, DOI 10.1016/j.siny.2007.10.008; Fernbach SK, 1997, RADIOGRAPHICS, V17, P109, DOI 10.1148/radiographics.17.1.9017803; MASCATELLO VJ, 1977, AM J ROENTGENOL, V129, P113, DOI 10.2214/ajr.129.1.113; Sidhu G, 2006, PEDIATR NEPHROL, V21, P218, DOI 10.1007/s00467-005-2100-9; WINTERS WD, 1999, AM J ROENTGENOL, V155, P125; Wong DC, 1999, J NUCL MED, V40, P1805	8	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 17	2009	338								b1424	10.1136/bmj.b1424	http://dx.doi.org/10.1136/bmj.b1424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UR	19535401				2022-12-28	WOS:000267216700001
J	Ammar, H; Looney, SC; Malani, A				Ammar, Hussam; Looney, Steven Chris; Malani, Ashok			Epiploic appendagitis	LANCET			English	Editorial Material									[Ammar, Hussam; Malani, Ashok] Heartland & Reg Med Ctr, Dept Internal Med, St Joseph, MO 64506 USA; [Looney, Steven Chris] Heartland & Reg Med Ctr, Dept Radiol, St Joseph, MO 64506 USA		Ammar, H (corresponding author), Heartland & Reg Med Ctr, Dept Internal Med, 802 N Riverside,Suite 330, St Joseph, MO 64506 USA.	h_ammar68@yahoo.com							0	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2054	2054		10.1016/S0140-6736(09)61031-X	http://dx.doi.org/10.1016/S0140-6736(09)61031-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19524781				2022-12-28	WOS:000267080100032
J	Benedito, R; Roca, C; Sorensen, I; Adams, S; Gossler, A; Fruttiger, M; Adams, RH				Benedito, Rui; Roca, Cristina; Soerensen, Inga; Adams, Susanne; Gossler, Achim; Fruttiger, Marcus; Adams, Ralf H.			The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis	CELL			English	Article							INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; CRE-RECOMBINASE; EXPRESSION; DEFECTS; PATHWAY; DELTA1; PROTEOLYSIS; ACTIVATION; REGULATOR	The Notch pathway is a highly conserved signaling system that controls a diversity of growth, differentiation, and patterning processes. In growing blood vessels, sprouting of endothelial tip cells is inhibited by Notch signaling, which is activated by binding of the Notch receptor to its ligand Delta-like 4 (Dll4). Here, we show that the Notch ligand Jagged1 is a potent proangiogenic regulator in mice that antagonizes Dll4-Notch signaling in cells expressing Fringe family glycosyltransferases. Upon glycosylation of Notch, Dll4-Notch signaling is enhanced, whereas Jagged1 has weak signaling capacity and competes with Dll4. Our findings establish that the equilibrium between two Notch ligands with distinct spatial expression patterns and opposing functional roles regulates angiogenesis, a mechanism that might also apply to other Notch-controlled biological processes.	[Benedito, Rui; Roca, Cristina; Adams, Susanne; Adams, Ralf H.] Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; [Benedito, Rui; Adams, Susanne; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Benedito, Rui; Adams, Susanne; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Soerensen, Inga; Gossler, Achim] Hannover Med Sch, Inst Mol Biol OE5250, D-30625 Hannover, Germany; [Fruttiger, Marcus] UCL, Inst Ophthalmol, London EC1V 9EL, England	Cancer Research UK; Max Planck Society; University of Munster; Hannover Medical School; University of London; University College London	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@mpi-muenster.mpg.de	Benedito, Rui/G-8295-2012; Adams, Ralf H/AAE-9274-2019; Benedito, Rui/AAQ-8096-2020	Benedito, Rui/0000-0003-2458-3055; Benedito, Rui/0000-0003-2458-3055; Fruttiger, Marcus/0000-0002-6962-5485	Cancer Research UK; Max Planck Society; University of Muenster; Deutsche Forschungsgemeinschaft; MRC [G0501711] Funding Source: UKRI; Medical Research Council [G0501711] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank L. Benjamin, T. Gridley, and J. Lewis for providing VE-Cadherin-tTA, Lfng, and floxed Jag1 mice; K. Serth and K. Schuster-Gossler for isolating Lfng eyes; and M. Stehling for the FACS isolation of ECs. This study was funded by Cancer Research UK, the Max Planck Society, the University of Muenster, and the Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Glittenberg M, 2006, EMBO J, V25, P4697, DOI 10.1038/sj.emboj.7601337; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gustafsson E, 2001, J CELL SCI, V114, P671; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hofmann JJ, 2007, GENE EXPR PATTERNS, V7, P461, DOI 10.1016/j.modgep.2006.11.002; Kageyama R, 2007, DEV DYNAM, V236, P1403, DOI 10.1002/dvdy.21114; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; 2007, DEVELOPMENT, V134, P839	49	730	763	1	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1124	1135		10.1016/j.cell.2009.03.025	http://dx.doi.org/10.1016/j.cell.2009.03.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524514	Bronze			2022-12-28	WOS:000266916400023
J	Chen, PH; Chuang, CH				Chen, Ping-Hsien; Chuang, Chiao-Hsiung			Biliary Stones	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Ping-Hsien; Chuang, Chiao-Hsiung] Natl Cheng Kung Univ, Med Ctr, Tainan 70428, Taiwan	National Cheng Kung University	Chen, PH (corresponding author), Natl Cheng Kung Univ, Med Ctr, Tainan 70428, Taiwan.	jasonc@mail.ncku.edu.tw		Chuang, Chiao-Hsiung/0000-0003-3283-9145					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2563	2563		10.1056/NEJMicm0801777	http://dx.doi.org/10.1056/NEJMicm0801777			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516036				2022-12-28	WOS:000266813800011
J	Stewart, AM				Stewart, Alexandra M.			When Vaccine Injury Claims Go to Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA	George Washington University	Stewart, AM (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.								0	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2498	2500		10.1056/NEJMp0902316	http://dx.doi.org/10.1056/NEJMp0902316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456BS	19516030				2022-12-28	WOS:000266813800003
J	Watson, EA; Monteiro, MJ				Watson, Elizabeth A.; Monteiro, Michael J.			Change Page Advise use of rear facing child car seats for children under 4 years old	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SAFETY SEATS; CRASHES; DEATH; RISK		[Watson, Elizabeth A.] Sunny Meed Surg, Woking GU22 7EY, Surrey, England; [Monteiro, Michael J.] Royal Surrey Cty Hosp, Dept Oral & Maxillofacial Surg, Guildford GU2 7XX, Surrey, England	Royal Surrey County Hospital	Watson, EA (corresponding author), Sunny Meed Surg, Woking GU22 7EY, Surrey, England.	eliwat1@yahoo.co.uk	Monteiro, Michael/C-5658-2009	Monteiro, Michael/0000-0001-5624-7115				Anund A., 2003, CHILD SAFETY CARS LI; Arbogast Kristy B, 2002, Annu Proc Assoc Adv Automot Med, V46, P213; Bull MJ, 2002, PEDIATRICS, V109, P550; Elliott MR, 2006, ARCH PEDIAT ADOL MED, V160, P617, DOI 10.1001/archpedi.160.6.617; Emam A, 2005, INT J CRASHWORTHINES, V10, P211, DOI 10.1533/ijcr.2005.0339; FUCHS S, 1989, PEDIATRICS, V84, P348; GLOYNS P, 2008, ACCIDENT STUDY PERFO; Henary B, 2007, INJURY PREV, V13, P398, DOI 10.1136/ip.2006.015115; ISAKSSONHELLMAN I, 1997, P 2 CHILD OCC PROT S, P43; Sherwood C P, 2007, Annu Proc Assoc Adv Automot Med, V51, P169; Smith KM, 2006, INJURY PREV, V12, P83, DOI 10.1136/ip.2005.010306; Stalnaker R, 1993, P CHILD OCC PROT 2 S, P173	12	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2009	338								b1994	10.1136/bmj.b1994	http://dx.doi.org/10.1136/bmj.b1994			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LJ	19520728				2022-12-28	WOS:000267022100002
J	Davies, NB; Welbergen, JA				Davies, Nicholas B.; Welbergen, Justin A.			Social Transmission of a Host Defense Against Cuckoo Parasitism	SCIENCE			English	Article							REED WARBLERS; BROOD PARASITISM; NEW-ZEALAND; RECOGNITION; EVOLUTION; NESTS	Coevolutionary arms races between brood parasites and hosts involve genetic adaptations and counter-adaptations. However, hosts sometimes acquire defenses too rapidly to reflect genetic change. Our field experiments show that observation of cuckoo (Cuculus canorus) mobbing by neighbors on adjacent territories induced reed warblers (Acrocephalus scirpaceus) to increase the mobbing of cuckoos but not of parrots (a harmless control) on their own territory. In contrast, observation of neighbors mobbing parrots had no effect on reed warblers' responses to either cuckoos or parrots. These results indicate that social learning provides a mechanism by which hosts rapidly increase their nest defense against brood parasites. Such enemy-specific social transmission enables hosts to track fine-scale spatiotemporal variation in parasitism and may influence the coevolutionary trajectories and population dynamics of brood parasites and hosts.	[Davies, Nicholas B.; Welbergen, Justin A.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Davies, NB (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	n.b.davies@zoo.cam.ac.uk	Welbergen, Justin/AGN-0091-2022	Welbergen, Justin/0000-0002-8085-5759	Natural Environment Research Council; National Trust; Wicken Fen Group; English Nature; Behavioural Ecology Group at Cambridge; Natural Environment Research Council [NE/D001439/1] Funding Source: researchfish; NERC [NE/D001439/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Trust; Wicken Fen Group; English Nature; Behavioural Ecology Group at Cambridge; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Natural Environment Research Council, the National Trust, C. Thorne, and the Wicken Fen Group, English Nature, and M. Brooke, J. Davies, R. Kilner, O. Kruger, and the Behavioural Ecology Group at Cambridge.	Boyd R., 1989, Lectures on Mathematics in the Life Sciences, V20, P1; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; CURIO E, 1978, SCIENCE, V202, P899, DOI 10.1126/science.202.4370.899; Darwin C., 1877, ORIGIN SPECIES; Davies NB, 2008, P ROY SOC B-BIOL SCI, V275, P1817, DOI 10.1098/rspb.2008.0331; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Davies NB, 2003, ANIM BEHAV, V65, P285, DOI 10.1006/anbe.2003.2049; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hale K, 2007, J AVIAN BIOL, V38, P198, DOI 10.1111/j.0908-8857.2007.03734.x; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Lindholm AK, 1999, J ANIM ECOL, V68, P293, DOI 10.1046/j.1365-2656.1999.00286.x; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; MALONEY RF, 1995, ANIM BEHAV, V50, P1193, DOI 10.1016/0003-3472(95)80036-0; Moksnes A, 2000, IBIS, V142, P247, DOI 10.1111/j.1474-919X.2000.tb04864.x; Nakamura H, 1998, OX ORN SER, V9, P94; Oien IJ, 1996, J ANIM ECOL, V65, P147, DOI 10.2307/5717; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rothstein SI, 1998, PARASITIC BIRDS THEI; TAKASU F, 1993, AM NAT, V142, P819, DOI 10.1086/285574; Welbergen JA, 2008, ANIM BEHAV, V76, P811, DOI 10.1016/j.anbehav.2008.03.020; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041	24	124	129	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1318	1320		10.1126/science.1172227	http://dx.doi.org/10.1126/science.1172227			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498167				2022-12-28	WOS:000266635100043
J	Chowell, G; Bertozzi, SM; Colchero, MA; Lopez-Gatell, H; Alpuche-Aranda, C; Hernandez, M; Miller, MA				Chowell, Gerardo; Bertozzi, Stefano M.; Colchero, M. Arantxa; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia; Hernandez, Mauricio; Miller, Mark A.			Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIOLOGIC EVIDENCE; UNITED-STATES; MORTALITY; ENGLAND; WALES; WAVE	Background In the spring of 2009, an outbreak of severe pneumonia was reported in conjunction with the concurrent isolation of a novel swine-origin influenza A (H1N1) virus (S-OIV), widely known as swine flu, in Mexico. Influenza A (H1N1) subtype viruses have rarely predominated since the 1957 pandemic. The analysis of epidemic pneumonia in the absence of routine diagnostic tests can provide information about risk factors for severe disease from this virus and prospects for its control. Methods From March 24 to April 29, 2009, a total of 2155 cases of severe pneumonia, involving 821 hospitalizations and 100 deaths, were reported to the Mexican Ministry of Health. During this period, of the 8817 nasopharyngeal specimens that were submitted to the National Epidemiological Reference Laboratory, 2582 were positive for S-OIV. We compared the age distribution of patients who were reported to have severe pneumonia with that during recent influenza epidemics to document an age shift in rates of death and illness. Results During the study period, 87% of deaths and 71% of cases of severe pneumonia involved patients between the ages of 5 and 59 years, as compared with average rates of 17% and 32%, respectively, in that age group during the referent periods. Features of this epidemic were similar to those of past influenza pandemics in that circulation of the new influenza virus was associated with an off-season wave of disease affecting a younger population. Conclusions During the early phase of this influenza pandemic, there was a sudden increase in the rate of severe pneumonia and a shift in the age distribution of patients with such illness, which was reminiscent of past pandemics and suggested relative protection for persons who were exposed to H1N1 strains during childhood before the 1957 pandemic. If resources or vaccine supplies are limited, these findings suggest a rationale for focusing prevention efforts on younger populations.	[Chowell, Gerardo; Miller, Mark A.] NIH, Fogarty Int Ctr, Div Epidemiol & Populat Studies, Bethesda, MD 20892 USA; [Chowell, Gerardo] Arizona State Univ, Sch Human Evolut & Social Change, Math Computat & Modeling Sci Ctr, Tempe, AZ USA; [Bertozzi, Stefano M.; Colchero, M. Arantxa] Inst Nacl Salud Publ, Ctr Evaluat Res & Surveys, Cuernavaca 62100, Morelos, Mexico; [Bertozzi, Stefano M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Lopez-Gatell, Hugo; Alpuche-Aranda, Celia; Hernandez, Mauricio] Mexican Minist Hlth, Mexico City, DF, Mexico	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Arizona State University; Arizona State University-Tempe; Instituto Nacional de Salud Publica; University of California System; University of California Berkeley	Bertozzi, SM (corresponding author), Inst Nacl Salud Publ, Ctr Evaluat Res & Surveys, Av Univ 655, Cuernavaca 62100, Morelos, Mexico.	sbertozzi@correo.insp.mx	Chowell, Gerardo/F-5038-2012; Chowell, Gerardo/A-4397-2008	Chowell, Gerardo/0000-0003-2194-2251; Bertozzi, Stefano M/0000-0002-1723-7085	Ministry of Health of Mexico; Mexican National Institute of Public Health; Fogarty International Center of the National Institutes of Health	Ministry of Health of Mexico; Mexican National Institute of Public Health; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported by the Ministry of Health of Mexico, the Mexican National Institute of Public Health, and the Fogarty International Center of the National Institutes of Health.	Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Chowell G, 2006, VACCINE, V24, P6747, DOI 10.1016/j.vaccine.2006.05.055; CHOWELL G, 2008, EVALUATING VACCINATI; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; *GEN DIR HLTH CAR, SIST NAC INF SAL NAT; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; *MEX MIN HLTH, SIST NAC VIG EP SINA; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; *NAT CTR BIOT INF, 2009, A TEX 04 2009 H1N1 G; Neustadt Richard E., 1983, EPIDEMIC NEVER WAS P; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 2004, INT CONGR SER, V1263, P791, DOI 10.1016/j.ics.2004.01.029; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; Viboud C, 2006, EMERG INFECT DIS, V12, P661, DOI 10.3201/eid1204.050695; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO, 2009, EP PAND AL RESP EPR	22	503	550	1	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					674	679		10.1056/NEJMoa0904023	http://dx.doi.org/10.1056/NEJMoa0904023			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19564633	Green Published			2022-12-28	WOS:000268884100007
J	Sardiello, M; Palmieri, M; di Ronza, A; Medina, DL; Valenza, M; Gennarino, VA; Di Malta, C; Donaudy, F; Embrione, V; Polishchuk, RS; Banfi, S; Parenti, G; Cattaneo, E; Ballabio, A				Sardiello, Marco; Palmieri, Michela; di Ronza, Alberto; Medina, Diego Luis; Valenza, Marta; Gennarino, Vincenzo Alessandro; Di Malta, Chiara; Donaudy, Francesca; Embrione, Valerio; Polishchuk, Roman S.; Banfi, Sandro; Parenti, Giancarlo; Cattaneo, Elena; Ballabio, Andrea			A Gene Network Regulating Lysosomal Biogenesis and Function	SCIENCE			English	Article							CATHEPSIN-D; TRANSCRIPTION; EXPRESSION; BRAIN; MODEL; AMINO; BETA	Lysosomes are organelles central to degradation and recycling processes in animal cells. Whether lysosomal activity is coordinated to respond to cellular needs remains unclear. We found that most lysosomal genes exhibit coordinated transcriptional behavior and are regulated by the transcription factor EB (TFEB). Under aberrant lysosomal storage conditions, TFEB translocated from the cytoplasm to the nucleus, resulting in the activation of its target genes. TFEB overexpression in cultured cells induced lysosomal biogenesis and increased the degradation of complex molecules, such as glycosaminoglycans and the pathogenic protein that causes Huntington's disease. Thus, a genetic program controls lysosomal biogenesis and function, providing a potential therapeutic target to enhance cellular clearing in lysosomal storage disorders and neurodegenerative diseases.	[Sardiello, Marco; Palmieri, Michela; di Ronza, Alberto; Medina, Diego Luis; Gennarino, Vincenzo Alessandro; Di Malta, Chiara; Donaudy, Francesca; Embrione, Valerio; Banfi, Sandro; Parenti, Giancarlo; Ballabio, Andrea] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Valenza, Marta; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Valenza, Marta; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, I-20133 Milan, Italy; [Polishchuk, Roman S.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Telethon Electron Microscopy Core Facil, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Parenti, Giancarlo; Ballabio, Andrea] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Milan; University of Milan; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Naples Federico II	Ballabio, A (corresponding author), Telethon Inst Genet & Med, Via P Castellino 111, I-80131 Naples, Italy.	ballabio@tigem.it	PALMIERI, MICHELA/G-4292-2016; Gennarino, Vincenzo A./H-3306-2019; BALLABIO, Andrea/AAL-2672-2020; Banfi, Sandro/K-3963-2018; Di Malta, Chiara/AAX-6395-2020; Embrione, Valerio/AAB-3897-2019; Medina, Diego/AAC-9622-2020; VALENZA, MARTA/B-7763-2017	PALMIERI, MICHELA/0000-0001-9373-1133; Gennarino, Vincenzo A./0000-0002-3312-6991; BALLABIO, Andrea/0000-0003-1381-4604; Banfi, Sandro/0000-0002-6541-8833; Embrione, Valerio/0000-0003-0184-3862; Medina, Diego/0000-0002-7347-2645; Polishchuk, Roman/0000-0002-7698-1955; parenti, giancarlo/0000-0002-6287-5748; VALENZA, MARTA/0000-0002-7048-9257; CATTANEO, ELENA/0000-0002-0755-4917	European Union [201678]; Italian Ministry of Research [PRIN 2006064337]; Italian Telethon Foundation; National MPS Society USA	European Union(European Commission); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Italian Telethon Foundation(Fondazione Telethon); National MPS Society USA	This work was supported by the European Union, 7th Framework Program "Euclyd-a European Consortium for Lysosomal Storage Diseases" (health F2/2008 grant agreement 201678) and by the Italian Ministry of Research (PRIN 2006064337). The contributions of the Italian Telethon Foundation and of the National MPS Society USA are gratefully acknowledged. The authors have no conflicts of interest. Expression microarray data are available at the Gene Expression Omnibus repository under accession number GSE16267. A patent application on the discovery of a gene network regulating lysosomal biogenesis and function has been filed to the European Patent Office (patent application EP 091527788). A.B. and M.S. are inventors on this patent.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Helip-Wooley A, 2004, EXP CELL RES, V292, P89, DOI 10.1016/j.yexcr.2003.09.003; Hemsley KM, 2005, BEHAV BRAIN RES, V158, P191, DOI 10.1016/j.bbr.2004.08.019; Karageorgos LE, 1997, EXP CELL RES, V234, P85, DOI 10.1006/excr.1997.3581; KORNFELD S, 2001, METABOLIC MOL BASES, V2, P3469; LADROR US, 1994, J BIOL CHEM, V269, P18422; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; LUBKE T, 2008, BIOCHIM BIOPHYS ACTA, V1793, P625; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Muenzer J, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502762458012; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; SAFTIG P, 2003, MED INTELLIGENCE UNI; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHIEWECK, 2009, BIOCHEM J, DOI DOI 10.1042/BJ20090567; Settembre C, 2007, P NATL ACAD SCI USA, V104, P4506, DOI 10.1073/pnas.0700382104; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717	28	1500	1536	13	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					473	477		10.1126/science.1174447	http://dx.doi.org/10.1126/science.1174447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19556463				2022-12-28	WOS:000268255100056
J	Bouros, D				Bouros, Demosthenes			Interferon gamma for idiopathic pulmonary fibrosis	LANCET			English	Editorial Material									Democritus Univ Thrace, Sch Med, Dept Pneumol, Alexandroupolis 68100, Greece	Democritus University of Thrace	Bouros, D (corresponding author), Democritus Univ Thrace, Sch Med, Dept Pneumol, Alexandroupolis 68100, Greece.	bouros@med.duth.gr	Bouros, Demosthenes/AAP-9138-2020	Bouros, Demosthenes/0000-0002-0685-0765; Bouros, Demosthenes/0000-0003-4245-2227				*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Antoniou KM, 2006, EUR RESPIR J, V28, P496, DOI 10.1183/09031936.06.00032605; Antoniou KM, 2003, CHEST, V123, P209, DOI 10.1378/chest.123.1.209; Bouros D, 2005, EUR RESPIR J, V26, P693, DOI 10.1183/09031936.05.00145004; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Vassilakis DA, 2000, AM J RESP CRIT CARE, V162, P1115, DOI 10.1164/ajrccm.162.3.9911119; Vlachoyiannopoulos PG, 1996, ANN RHEUM DIS, V55, P761, DOI 10.1136/ard.55.10.761; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Ziesche R, 1999, NEW ENGL J MED, V341, P1264, DOI 10.1056/NEJM199910213411703	14	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2009	374	9685					180	182		10.1016/S0140-6736(09)60689-9	http://dx.doi.org/10.1016/S0140-6736(09)60689-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19570574				2022-12-28	WOS:000268263000006
J	Cook, J; Metcalf, J				Cook, Joel; Metcalf, John			Tattoo Allergy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cook, Joel; Metcalf, John] Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Cook, J (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.	cookjw@musc.edu							0	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					E1	E1		10.1056/NEJMicm0706441	http://dx.doi.org/10.1056/NEJMicm0706441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571278				2022-12-28	WOS:000267533100012
J	Vergara, SV; Thiele, DJ				Vergara, Sandra Viviana; Thiele, Dennis J.			Ironing Out a Midlife crisis	CELL			English	Editorial Material							MITOCHONDRIAL-DNA; CANCER; DISEASES; PROTEINS; CELLS; AGE		[Vergara, Sandra Viviana; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Vergara, Sandra Viviana; Thiele, Dennis J.] Duke Univ, Med Ctr, Program Genet & Genom, Durham, NC 27710 USA	Duke University; Duke University	Vergara, SV (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	sandra.vergara@duke.edu						DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; NAGLEY P, 1970, BIOCHEM BIOPH RES CO, V39, P989, DOI 10.1016/0006-291X(70)90422-5; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	9	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 26	2009	137	7					1179	1181		10.1016/j.cell.2009.06.005	http://dx.doi.org/10.1016/j.cell.2009.06.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563748	Bronze			2022-12-28	WOS:000267373400009
J	Yeaney, NK; Murdoch, EM; Lees, CC				Yeaney, Natalie K.; Murdoch, Edile M.; Lees, Christoph C.			The extremely premature neonate: anticipating and managing care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXTREMELY PRETERM; AGE; GESTATION; INFANTS; BORN; MANAGEMENT; DELIVERY; GROWTH		[Lees, Christoph C.] Addenbrookes Hosp, Dept Fetal Maternal Med, Cambridge, England; [Yeaney, Natalie K.; Murdoch, Edile M.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Neonatol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lees, CC (corresponding author), Addenbrookes Hosp, Dept Fetal Maternal Med, Cambridge, England.	christoph.lees@addenbrookes.nhs.uk						Ahluwalia J, 2008, ARCH DIS CHILD-FETAL, V93, pF332, DOI 10.1136/adc.2006.113373; Bracewell MA, 2008, ARCH DIS CHILD-FETAL, V93, pF108, DOI 10.1136/adc.2007.118596; Brandon DH, 2007, NEONATAL NETW, V26, P213, DOI 10.1891/0730-0832.26.4.213; *EPIPAGE STUD GROU, 2008, BJOG, V115, P275; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Fenton AC, 2004, ARCH DIS CHILD-FETAL, V89, pF215, DOI 10.1136/adc.2002.019711; Gabriel R, 2004, EUR J OBSTET GYN R B, V117, pS25, DOI 10.1016/j.ejogrb.2004.07.014; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Grant A, 1996, BRIT J OBSTET GYNAEC, V103, P1197, DOI 10.1111/j.1471-0528.1996.tb09628.x; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Kamoji VM, 2006, PEDIATRICS, V118, P758, DOI 10.1542/peds.2005-2399; King JF, 2004, CURR OPIN OBSTET GYN, V16, P459, DOI 10.1097/00001703-200412000-00004; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Mikkola K, 2005, PEDIATRICS, V116, P1391, DOI 10.1542/peds.2005-0171; Miles M S, 1996, Neonatal Netw, V15, P45; *NHS, 2007, NHS MAT STAT UK 2005; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Ouzounian J, 2001, AM J OBSTET GYNECOL, V185, pS108, DOI 10.1016/S0002-9378(01)80131-9; Riskin A, 2004, BJOG-INT J OBSTET GY, V111, P1365, DOI 10.1111/j.1471-0528.2004.00268.x; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Serenius F, 2004, ACTA PAEDIATR, V93, P1081, DOI [10.1080/08035250410027751, 10.1111/j.1651-2227.2004.tb02721.x]; Streiner DL, 2001, PEDIATRICS, V108, P152, DOI 10.1542/peds.108.1.152; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wilkinson AR, 2009, ARCH DIS CHILD-FETAL, V94, pF2, DOI 10.1136/adc.2008.143321	30	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2009	338								b2325	10.1136/bmj.b2325	http://dx.doi.org/10.1136/bmj.b2325			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MK	19546135				2022-12-28	WOS:000267436100007
J	Kwak, EL; Hong, TS; Berger, DL; Forcione, DG; Uppot, RN; Lauwers, GY				Kwak, Eunice L.; Hong, Theodore S.; Berger, David L.; Forcione, David G.; Uppot, Raul N.; Lauwers, Gregory Y.			A Woman with Carcinoma of the Gastroesophageal Junction Adenocarcinoma of the gastroesophageal junction, pathological stage ypT2N1MX after preoperative chemotherapy, arising in Barrett's esophagus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; ESOPHAGOGASTRIC JUNCTION; PREDICTS SURVIVAL; LYMPH-NODES; CANCER; CHEMORADIATION; RESECTION; SURGERY; CHEMORADIOTHERAPY; LAPAROSCOPY		[Kwak, Eunice L.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Forcione, David G.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Hong, Theodore S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hong, Theodore S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Berger, David L.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Uppot, Raul N.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lauwers, Gregory Y.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kwak, Eunice L.; Forcione, David G.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Hong, Theodore S.] Harvard Univ, Sch Med, Dept Radiat Oncol, Cambridge, MA 02138 USA; [Berger, David L.] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Uppot, Raul N.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Lauwers, Gregory Y.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Kwak, EL (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.		Uppot, Raul/AAF-1859-2019					Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Chirieac LR, 2005, CANCER-AM CANCER SOC, V103, P1347, DOI 10.1002/cncr.20916; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; de Graaf GW, 2007, EJSO-EUR J SURG ONC, V33, P988, DOI 10.1016/j.ejso.2007.01.007; Gu Y, 2006, CANCER-AM CANCER SOC, V106, P1017, DOI 10.1002/cncr.21693; Gunderson LL, 2002, SEMIN RADIAT ONCOL, V12, P150, DOI 10.1053/srao.2002.30817; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Ito H, 2004, J AM COLL SURGEONS, V199, P880, DOI 10.1016/j.jamcollsurg.2004.08.015; Johansson J, 2008, WORLD J SURG, V32, P1013, DOI 10.1007/s00268-008-9470-7; Kaiser GM, 2007, INT SURG, V92, P128; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; LANDRY J, 1990, INT J RADIAT ONCOL, V19, P1357, DOI 10.1016/0360-3016(90)90344-J; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mariette C, 2008, ANN SURG, V247, P365, DOI 10.1097/SLA.0b013e31815aaadf; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Siewert JR, 2006, SCAND J SURG, V95, P260, DOI 10.1177/145749690609500409; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Wang KL, 2006, CANCER-AM CANCER SOC, V107, P1467, DOI 10.1002/cncr.22179	20	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2656	2664		10.1056/NEJMcpc0900638	http://dx.doi.org/10.1056/NEJMcpc0900638			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535805				2022-12-28	WOS:000267060000012
J	Rhyee, JS; Lee, KH; Lee, SM; Cho, E; Kim, SI; Lee, E; Kwon, YS; Shim, JH; Kotliar, G				Rhyee, Jong-Soo; Lee, Kyu Hyoung; Lee, Sang Mock; Cho, Eunseog; Kim, Sang Il; Lee, Eunsung; Kwon, Yong Seung; Shim, Ji Hoon; Kotliar, Gabriel			Peierls distortion as a route to high thermoelectric performance in In4Se3-delta crystals	NATURE			English	Article							MERIT	Thermoelectric energy harvesting-the transformation of waste heat into useful electricity-is of great interest for energy sustainability. The main obstacle is the low thermoelectric efficiency of materials for converting heat to electricity, quantified by the thermoelectric figure of merit, ZT. The best available n-type materials for use in mid-temperature (500-900K) thermoelectric generators have a relatively low ZT of 1 or less, and so there is much interest in finding avenues for increasing this figure of merit(1). Here we report a binary crystalline n-type material, In4Se3-delta, which achieves the ZT value of 1.48 at 705K-very high for a bulk material. Using high-resolution transmission electron microscopy, electron diffraction, and first-principles calculations, we demonstrate that this material supports a charge density wave instability which is responsible for the large anisotropy observed in the electric and thermal transport. The high ZT value is the result of the high Seebeck coefficient and the low thermal conductivity in the plane of the charge density wave. Our results suggest a new direction in the search for high-performance thermoelectric materials, exploiting intrinsic nanostructural bulk properties induced by charge density waves.	[Rhyee, Jong-Soo; Lee, Kyu Hyoung; Lee, Sang Mock; Cho, Eunseog; Kim, Sang Il; Lee, Eunsung] Samsung Adv Inst Technol, Mat Res Lab, Yongin 446712, South Korea; [Kwon, Yong Seung] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Shim, Ji Hoon] Pohang Univ Sci & Technol, Dept Chem, Pohang 790784, South Korea; [Kotliar, Gabriel] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	Samsung; Sungkyunkwan University (SKKU); Pohang University of Science & Technology (POSTECH); Rutgers State University New Brunswick	Lee, SM (corresponding author), Samsung Adv Inst Technol, Mat Res Lab, Yongin 446712, South Korea.	sangmocklee@samsung.com	Shim, Ji Hoon/F-5375-2013; Rhyee, Jong-Soo/AAK-7173-2020	Rhyee, Jong-Soo/0000-0002-3656-2430	WCU [KOSEF: R32-2008-000-10180-0]	WCU	We thank D. Johnson, K. Koumoto and B. I. Min for discussions. We also thank H. R. Choi for TEM measurements. J. H. S. was supported by the WCU programme (KOSEF: R32-2008-000-10180-0).	Balitskii OA, 2004, PHYSICA E, V22, P921, DOI 10.1016/j.physe.2003.11.198; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; Chen N, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2056590; Chiritescu C, 2007, SCIENCE, V315, P351, DOI 10.1126/science.1136494; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; GUNER G, 1994, DENSITY WAVES SOLIDS; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; Lin YM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075304; Losovyj YB, 2008, J APPL PHYS, V104, DOI 10.1063/1.3000453; Losovyj YB, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2894577; Madsen GKH, 2006, COMPUT PHYS COMMUN, V175, P67, DOI 10.1016/j.cpc.2006.03.007; Mahan G, 1997, PHYS TODAY, V50, P42, DOI 10.1063/1.881752; Rhyee JS, 2009, J APPL PHYS, V105, DOI 10.1063/1.3080143; Sales BC, 1998, MRS BULL, V23, P15, DOI 10.1557/S0883769400031419; Shim JH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156406; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Snyder GJ, 2004, NAT MATER, V3, P458, DOI 10.1038/nmat1154; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Wolfing B, 2001, PHYS REV LETT, V86, P4350, DOI 10.1103/PhysRevLett.86.4350	19	436	451	14	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					965	968		10.1038/nature08088	http://dx.doi.org/10.1038/nature08088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536260				2022-12-28	WOS:000267063500038
J	Joy, TR; Hegele, RA				Joy, Tisha R.; Hegele, Robert A.			Narrative Review: Statin-Related Myopathy	ANNALS OF INTERNAL MEDICINE			English	Review							COA REDUCTASE INHIBITORS; CHOLESTEROL ABSORPTION INHIBITOR; SERUM UBIQUINONE CONCENTRATIONS; COENZYME Q(10) LEVEL; SKELETAL-MUSCLE; PRIMARY HYPERCHOLESTEROLEMIA; SIMVASTATIN TREATMENT; INDUCE MYOTOXICITY; DRUG-INTERACTIONS; ADVERSE EVENTS	Statin-related myopathy is a clinically important cause of statin intolerance and discontinuation. The spectrum of statin-related myopathy ranges from common but clinically benign myalgia to rare but life-threatening rhabdomyolysis. Observational studies suggest that myalgia can occur in up to 10% of persons prescribed statins, whereas rhabdomyolysis continues to be rare. The mechanisms of statin-related myopathy are unclear. Options for managing statin myopathy include statin switching, particularly to fluvastatin or low-dose rosuvastatin; nondaily dosing regimens; nonstatin alternatives, such as ezetimibe and bile acid-binding resins; and coenzyme Q10 supplementation. Few of these strategies have high-quality evidence supporting them. Because statin-related myopathy will probably become more common with greater numbers of persons starting high-dose statin therapy and the increasing stringency of low-density lipoprotein cholesterol level targets, research to better identify patients at risk for statin myopathy and to evaluate management strategies for statin-related myopathy is warranted.	[Joy, Tisha R.] Univ Western Ontario, St Josephs Hlth Care, Schulich Sch Med & Dent, Div Endocrinol, London, ON N6A 4V2, Canada; Univ Western Ontario, Robarts Res Inst, London, ON N6A 4V2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Joy, TR (corresponding author), Univ Western Ontario, St Josephs Hlth Care, Schulich Sch Med & Dent, Div Endocrinol, A2-117,268 Grosvenor St, London, ON N6A 4V2, Canada.	tisjoy@hotmail.com	Joy, Tisha/G-3311-2011; Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011; Joy, Tisha/X-3564-2019	Hegele, Robert/0000-0003-2861-5325; 	Heart and Stroke Foundation of Ontario [CI-5710, PRG-5967, NA-Review 6059, T-6018]; Canadian Institutes for Health Research [MOP-13430, MOP-39533, MOP-39833]; Ontario Research Fund; Ontario Genomics Institute	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Ontario Genomics Institute	By the Jacob J. Wolfe Distinguished Medical Research Chair; the Edith Schulich Vinet Canada Research Chair ( Tier I) in Human Genetics; a Career Investigator award from the Heart and Stroke Foundation of Ontario (CI-5710); and operating grants from the Canadian Institutes for Health Research (MOP-13430, MOP-39533, MOP-39833), Heart and Stroke Foundation of Ontario (PRG-5967, NA-Review 6059, T-6018), Ontario Research Fund, and Genome Canada through the Ontario Genomics Institute.	Backes JM, 2008, ANN PHARMACOTHER, V42, P341, DOI 10.1345/aph.1K604; Backes JM, 2007, AM J CARDIOL, V100, P554, DOI 10.1016/j.amjcard.2007.03.059; Baker SK, 2008, CAN J NEUROL SCI, V35, P8, DOI 10.1017/S0317167100007514; Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8; Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006; Becquemont L, 2007, CLIN PHARMACOL THER, V81, P679, DOI 10.1038/sj.clpt.6100098; Bleske B E, 2001, Am Heart J, V142, pE2, DOI 10.1067/mhj.2001.116762; BROWN RH, 2008, HARRISONS PRINCIPLES; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Caso G, 2007, AM J CARDIOL, V99, P1409, DOI 10.1016/j.amjcard.2006.12.063; Davidson MH, 2006, AM J CARDIOL, V97, p32C, DOI 10.1016/j.amjcard.2005.12.008; Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018; Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4; Ferrer-Garcia JC, 2006, ACTA DIABETOL, V43, P75, DOI 10.1007/s00592-006-0216-4; Fichtenbaum CJ, 2002, AIDS, V16, P569, DOI 10.1097/00002030-200203080-00008; Fiegenbaum M, 2005, CLIN PHARMACOL THER, V78, P551, DOI 10.1016/j.clpt.2005.08.003; Flint OP, 1997, TOXICOL APPL PHARM, V145, P91, DOI 10.1006/taap.1997.8131; FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Frudakis TN, 2007, PHARMACOGENET GENOM, V17, P695, DOI 10.1097/FPC.0b013e328012d0a9; FUKAMI M, 1993, RES EXP MED, V193, P263, DOI 10.1007/BF02576234; Gazi IF, 2007, CURR MED RES OPIN, V23, P2183, DOI 10.1185/030079907X226267; GHIRLANDA G, 1993, J CLIN PHARMACOL, V33, P226, DOI 10.1002/j.1552-4604.1993.tb03948.x; Glueck CJ, 2006, CLIN THER, V28, P933, DOI 10.1016/j.clinthera.2006.06.004; Hansen KE, 2005, ARCH INTERN MED, V165, P2671, DOI 10.1001/archinte.165.22.2671; Hermann M, 2006, CLIN PHARMACOL THER, V79, P532, DOI 10.1016/j.clpt.2006.02.014; Huff MW, 2006, ARTERIOSCL THROM VAS, V26, P2433, DOI 10.1161/01.ATV.0000245791.53245.ee; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Jacobson TA, 2006, AM J CARDIOL, V97, p44C, DOI 10.1016/j.amjcard.2005.12.009; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Johnson TE, 2005, TOXICOL APPL PHARM, V208, P210, DOI 10.1016/j.taap.2005.03.004; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Juszczyk Monika A, 2005, Prev Cardiol, V8, P197, DOI 10.1111/j.0197-3118.2005.04404.x; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Klein JP, 2006, PHARMACOPSYCHIATRY, V39, P39, DOI 10.1055/s-2006-931478; Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2; Kyrklund C, 2003, CLIN PHARMACOL THER, V73, P538, DOI 10.1016/S0009-9236(03)00052-3; Kyrklund C, 2001, CLIN PHARMACOL THER, V69, P340, DOI 10.1067/mcp.2001.115542; LAAKSONEN R, 1995, CLIN PHARMACOL THER, V57, P62, DOI 10.1016/0009-9236(95)90266-X; Laaksonen R, 1996, AM J CARDIOL, V77, P851, DOI 10.1016/S0002-9149(97)89180-1; LAAKSONEN R, 1994, EUR J CLIN PHARMACOL, V46, P313; Lamperti C, 2005, ARCH NEUROL-CHICAGO, V62, P1709, DOI 10.1001/archneur.62.11.1709; Landstad BJ, 2001, J REHABIL MED, V33, P216; LANGER T, 1968, NEW ENGL J MED, V279, P856, DOI 10.1056/NEJM196810172791604; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mackie BD, 2007, AM J CARDIOL, V99, P291, DOI 10.1016/j.amjcard.2006.07.093; Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049; Matalka MS, 2002, AM HEART J, V144, P674, DOI 10.1067/mhj.2002.124399; Matzno S, 2005, J PHARM PHARMACOL, V57, P1475, DOI 10.1211/jpp.57.11.0014; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Mitka M, 2003, JAMA-J AM MED ASSOC, V290, P2243, DOI 10.1001/jama.290.17.2243; Mulder AB, 2001, CLIN PHARMACOL THER, V70, P546, DOI 10.1067/mcp.2001.120251; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Nichols GA, 2007, CLIN THER, V29, P1761, DOI 10.1016/j.clinthera.2007.08.022; Oh J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-7; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Prabhala A, 2000, ARCH INTERN MED, V160, P1199, DOI 10.1001/archinte.160.8.1199; Ray GM, 2009, CARDIOL REV, V17, P44, DOI 10.1097/CRD.0b013e3181903b7f; Rivers Shannon M, 2007, Endocr Pract, V13, P11; Ruano G, 2007, MUSCLE NERVE, V36, P329, DOI 10.1002/mus.20871; Rundek T, 2004, ARCH NEUROL-CHICAGO, V61, P889, DOI 10.1001/archneur.61.6.889; Sakamoto K, 2007, FASEB J, V21, P4087, DOI 10.1096/fj.07-8713com; Schneck DW, 2004, CLIN PHARMACOL THER, V75, P455, DOI 10.1016/j.clpt.2003.12.014; Sewright Kimberly A, 2007, Curr Atheroscler Rep, V9, P389, DOI 10.1007/s11883-007-0050-3; Silva MA, 2006, CLIN THER, V28, P26, DOI 10.1016/j.clinthera.2006.01.005; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Silver MA, 2004, AM J CARDIOL, V94, P1306, DOI 10.1016/j.amjcard.2004.07.121; Sinzinger H, 2004, BRIT J CLIN PHARMACO, V57, P525, DOI 10.1111/j.1365-2125.2003.02044.x; SMALS AGH, 1977, NEW ENGL J MED, V296, P942; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tomasetti M, 1999, BIOFACTORS, V9, P231, DOI 10.1002/biof.5520090218; *US FDA, ZOC SIMV PRESCR INF; *US FDA, CREST; *US FDA, INF SIMV AM; *US FDA, NEW DRUG APPL LOV; US Food and Drug Administration, LIP; Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567; WATTS GF, 1993, J CLIN PATHOL, V46, P1055, DOI 10.1136/jcp.46.11.1055; Young JA, 2007, AM J CARDIOL, V100, P1400, DOI 10.1016/j.amjcard.2007.06.030; Zuccaro P, 2007, PHARMACOL RES, V55, P310, DOI 10.1016/j.phrs.2006.12.009	87	305	324	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					858	U63		10.7326/0003-4819-150-12-200906160-00009	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528564				2022-12-28	WOS:000267164800005
J	Moser, K; Patnick, J; Beral, V				Moser, Kath; Patnick, Julietta; Beral, Valerie			Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data	BRITISH MEDICAL JOURNAL			English	Article							PAP-SMEAR; CANCER; POPULATION; MORTALITY; ACCURACY; PROGRAM; HEALTH; WOMEN	Objective To investigate the relation between women's reported use of breast and cervical screening and sociodemographic characteristics. Design Cross sectional multipurpose survey. Setting Private households, Great Britain. Population 3185 women aged 40-74 interviewed in the National Statistics Omnibus Survey 2005-7. Main outcome measures Ever had a mammogram, ever had a cervical smear, and, for each, timing of most recent screen. Results 91% (95% confidence interval 90% to 92%) of women aged 40-74 years reported ever having had a cervical smear, and 93% (92% to 94%) of those aged 53-74 years reported ever having had a mammogram; 3% (2% to 4%) of women aged 53-74 years had never had either breast or cervical screening. Women were significantly more likely to have had a mammogram if they lived in households with cars (compared with no car: one car, odds ratio 1.67, 95% confidence interval 1.06 to 2.62; two or more cars, odds ratio 2.65, 1.34 to 5.26), and in owner occupied housing (compared with rented housing: own with mortgage, odds ratio 2.12, 1.12 to 4.00; own outright, odds ratio 2.19, 1.39 to 3.43), but no significant differences by ethnicity, education, occupation, or region were found. For cervical screening, ethnicity was the most important predictor; white British women were significantly more likely to have had a cervical smear than were women of other ethnicity (odds ratio 2.20, 1.41 to 3.42). Uptake of cervical screening was greater among more educated women but was not significantly associated with cars, housing tenure, or region. Conclusions Most (84%) eligible women report having had both breast and cervical screening, but 3% report never having had either. Some inequalities exist in the reported use of screening, which differ by screening type; indicators of wealth were important for breast screening and ethnicity for cervical screening. The routine collection within general practice of additional sociodemographic information would aid monitoring of inequalities in screening coverage and inform policies to correct them.	[Moser, Kath; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Patnick, Julietta] NHS Canc Screening Programmes, Sheffield S10 3TH, S Yorkshire, England	University of Oxford	Moser, K (corresponding author), Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England.	kath.moser@ceu.ox.ac.uk			NHS Breast Screening Programme; Cancer Research UK	NHS Breast Screening Programme; Cancer Research UK(Cancer Research UK)	This research was supported by the NHS Breast Screening Programme and Cancer Research UK. The funders had no involvement in this research.	Advisory Committee on Breast Cancer Screening, 2006, NHS BREAST SCREEN PR, V61; Ashworth M, 2005, FAM PRACT, V22, P529, DOI 10.1093/fampra/cmi057; Banks E, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr418; Bowman JA, 1997, SOC SCI MED, V44, P969, DOI 10.1016/S0277-9536(96)00222-5; Canfell K, 2006, J MED SCREEN, V13, P72, DOI 10.1258/096914106777589687; Chiu LF, 2003, CANC SCREENING SERIE, V1; Department of Health, 2007, CANC REF STRAT; DURRENT GB, 2007, MULTILEVEL MODELLING; FELL G, 2007, EQUALITY REV NATL SC; HAKAMA M, 1988, CANCER SURV, V7, P403; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V7; Maheswaran R, 2006, J EPIDEMIOL COMMUN H, V60, P208, DOI 10.1136/jech.200X.038398; McGovern PG, 1998, AM J PREV MED, V14, P201, DOI 10.1016/S0749-3797(97)00076-7; Millett C, 2002, PUBLIC HEALTH, V116, P353, DOI 10.1038/sj.ph.1900880; MOSER K, 1994, BRIT MED J, V309, P476, DOI 10.1136/bmj.309.6952.476b; MOSER KA, 1988, BRIT MED J, V296, P1221, DOI 10.1136/bmj.296.6631.1221; *NHS HLTH SOC CAR, 2007, CERV SCREEN PROGR EN; *NHS HLTH SOC CAR, 2008, BREAST SCREEN PROGR; *OFF NAT STAT, OMN SURV; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Raleigh V., 2008, BMJ-BRIT MED J, V337, P645; Sabates R, 2006, SOC SCI MED, V62, P2998, DOI 10.1016/j.socscimed.2005.11.032; Sutton S, 2005, SOC SCI MED, V61, P2460, DOI 10.1016/j.socscimed.2005.07.017	23	194	197	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2009	338								b2025	10.1136/bmj.b2025	http://dx.doi.org/10.1136/bmj.b2025			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460UQ	19531549	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000267216600001
J	Gross, L; Mohn, F; Liljeroth, P; Repp, J; Giessibl, FJ; Meyer, G				Gross, Leo; Mohn, Fabian; Liljeroth, Peter; Repp, Jascha; Giessibl, Franz J.; Meyer, Gerhard			Measuring the Charge State of an Adatom with Noncontact Atomic Force Microscopy	SCIENCE			English	Article							ELECTROSTATIC FORCE; SURFACE; RESOLUTION; GOLD	Charge states of atoms can be investigated with scanning tunneling microscopy, but this method requires a conducting substrate. We investigated the charge-switching of individual adsorbed gold and silver atoms (adatoms) on ultrathin NaCl films on Cu(111) using a qPlus tuning fork atomic force microscope (AFM) operated at 5 kelvin with oscillation amplitudes in the subangstrom regime. Charging of a gold atom by one electron charge increases the force on the AFM tip by a few piconewtons. Moreover, the local contact potential difference is shifted depending on the sign of the charge and allows the discrimination of positively charged, neutral, and negatively charged atoms. The combination of single-electron charge sensitivity and atomic lateral resolution should foster investigations of molecular electronics, photonics, catalysis, and solar photoconversion.	[Gross, Leo; Mohn, Fabian; Liljeroth, Peter; Repp, Jascha; Meyer, Gerhard] IBM Res Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; [Liljeroth, Peter] Univ Utrecht, Debye Inst Nanomat Sci, NL-3508 TA Utrecht, Netherlands; [Repp, Jascha; Giessibl, Franz J.] Univ Regensburg, Inst Expt & Appl Phys, D-93040 Regensburg, Germany	International Business Machines (IBM); Utrecht University; University of Regensburg	Gross, L (corresponding author), IBM Res Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.	lgr@zurich.ibm.com	Gross, Leo/E-1789-2011; Gross, Leo/M-8564-2019; Giessibl, Franz J/K-8022-2013; Repp, Jascha/B-1843-2014; Liljeroth, Peter/A-5594-2009	Gross, Leo/0000-0002-5337-4159; Gross, Leo/0000-0002-5337-4159; Giessibl, Franz J/0000-0002-5585-1326; Repp, Jascha/0000-0003-2883-7083; Liljeroth, Peter/0000-0003-1253-8097	Swiss National Center of Competence in Research (NCCR); European Union project; Nederlandse Organisatie voor Wetenschappelijk Onderzoek [700.56.423]; Volkswagen Foundation through its Lichtenberg program	Swiss National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); European Union project(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Volkswagen Foundation through its Lichtenberg program	We thank R. Allenspach for valuable comments. This work was supported by the Swiss National Center of Competence in Research (NCCR) "Nanoscale Science" and by the European Union project "NanoMan." P.L. and J.R. gratefully acknowledge funding by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Chemical Sciences, Vidi-grant 700.56.423) and Volkswagen Foundation through its Lichtenberg program, respectively.	ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Azuma Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016108; Bocquet F, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035410; Bussmann E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209886; Bussmann E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1897429; Enevoldsen GH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236104; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Ikeda M, 2008, J PHYS CHEM C, V112, P6961, DOI 10.1021/jp077065; Kitamura S, 2000, APPL SURF SCI, V157, P222, DOI 10.1016/S0169-4332(99)00530-9; Klein LJ, 2001, APPL PHYS LETT, V79, P1828, DOI 10.1063/1.1403256; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Okamoto K, 2002, APPL SURF SCI, V188, P381, DOI 10.1016/S0169-4332(01)00953-9; Olsson FE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.176803; Repp J, 2004, SCIENCE, V305, P493, DOI 10.1126/science.1099557; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; SCHONENBERGER C, 1990, PHYS REV LETT, V65, P3162, DOI 10.1103/PhysRevLett.65.3162; Sterrer M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.096107; Stomp R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056802; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Sugimoto Y, 2008, SCIENCE, V322, P413, DOI 10.1126/science.1160601; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; UCHIDA K, 2003, NANOELECTRONICS INFO, pCH16; Zhu J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2139623	27	271	274	8	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1428	1431		10.1126/science.1172273	http://dx.doi.org/10.1126/science.1172273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520956				2022-12-28	WOS:000266878700041
J	Lui, ATY				Lui, A. T. Y.			Comment on "Tail Reconnection Triggering Substorm Onset"	SCIENCE			English	Editorial Material							CURRENT DISRUPTION; EXPANSIVE PHASE; PLASMA SHEET; INSTABILITY; MODELS	Angelopoulos et al. (Research Articles, 15 August 2008, p. 931) reported that magnetic reconnection in Earth's magnetotail triggered the onset of a magnetospheric substorm. We provide evidence that (i) near-Earth current disruption, occurring before the conventional tail reconnection signatures, triggered the onset; (ii) the observed auroral intensification and tail reconnection are not causally linked; and (iii) the onset they identified is a continuation of earlier substorm activities.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Lui, ATY (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	Tony.Lui@jhuapl.edu	Lui, Anthony T Y/G-5051-2019					Akasofu S.I, 1977, PHYS MAGNETOSPHERIC; Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Dobias P, 2004, PHYS PLASMAS, V11, P2046, DOI 10.1063/1.1695357; Donovan E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033794; El-Alaoui M, 2001, J GEOPHYS RES-SPACE, V106, P6229, DOI 10.1029/1999JA000260; Henderson MG, 2009, ANN GEOPHYS-GERMANY, V27, P2129, DOI 10.5194/angeo-27-2129-2009; Lee LC, 1998, J GEOPHYS RES-SPACE, V103, P29419, DOI 10.1029/97JA02141; LIU WW, 2008, GEOPHYS RES LETT, V14; Lui ATY, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013424; LUI ATY, 1991, J GEOPHYS RES-SPACE, V96, P1849, DOI 10.1029/90JA02430; LUI ATY, 1977, J GEOPHYS RES-SPACE, V82, P1547, DOI 10.1029/JA082i010p01547; Mende SB, 2008, SPACE SCI REV, V141, P357, DOI 10.1007/s11214-008-9380-x; Pu ZY, 1999, J GEOPHYS RES-SPACE, V104, P10235, DOI 10.1029/1998JA900104; ROUX A, 1991, J GEOPHYS RES-SPACE, V96, P17697, DOI 10.1029/91JA01106; WIENS RG, 1975, J GEOPHYS RES-SPACE, V80, P2109, DOI 10.1029/JA080i016p02109	15	60	64	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933								10.1126/science.1167726	http://dx.doi.org/10.1126/science.1167726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520943				2022-12-28	WOS:000266878700023
J	Watanabe, H; Nebel, CE; Shikata, S				Watanabe, H.; Nebel, C. E.; Shikata, S.			Isotopic Homojunction Band Engineering from Diamond	SCIENCE			English	Article							DIFFUSION LENGTH; ROOM-TEMPERATURE; SINGLE SPINS; SEMICONDUCTORS; SUPERLATTICES; ELECTRON; GROWTH; SOLIDS; FILMS; C-13	Confinement of charge carriers in semiconductors by quantum wells is usually accomplished with layers that vary in elemental composition, such as aluminum gallium arsenide and gallium arsenide. We fabricated diamond superlattices by creating multilayer structures of isotopically pure carbon isotopes carbon-12 ((12)C) and carbon-13 ((13)C), which confine electrons by a difference in band-gap energy of 17 millielectron volts. Cathodoluminescence experiments performed at 80 kelvin showed that excitonic recombination in the higher-energy band of (13)C vanishes in favor of increased recombination in the lower-energy (12)C material. Carrier confinement was achieved in diamond superlattices made up of both thinner (30 nanometers) and thicker (up to 350 nanometers) layers.	[Watanabe, H.; Nebel, C. E.; Shikata, S.] Natl Inst Adv Ind Sci & Technol, Diamond Res Ctr, Tsukuba, Ibaraki 3058568, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Watanabe, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Diamond Res Ctr, Tsukuba Cent 2-13,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	hideyuki-watanabe@aist.go.jp	Watanabe, Hideyuki/L-7052-2018	Watanabe, Hideyuki/0000-0003-3994-5610	Diamond Research Center, AIST; Technical Research Institute; Japan Society for the Promotion of Machine Industry; Grants-in-Aid for Scientific Research [21360155] Funding Source: KAKEN	Diamond Research Center, AIST; Technical Research Institute; Japan Society for the Promotion of Machine Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank N. Fujimori (Diamond Research Center, AIST) and K. Kajimura (Technical Research Institute, Japan Society for the Promotion of Machine Industry) for their support and encouragement during the early days of the study.	Ager JW, 2006, PHYS STATUS SOLIDI A, V203, P3550, DOI 10.1002/pssa.200622390; Cardona M, 2005, REV MOD PHYS, V77, P1173, DOI 10.1103/RevModPhys.77.1173; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; COLLINS AT, 1990, PHYS REV LETT, V65, P891, DOI 10.1103/PhysRevLett.65.891; EHRENREICH H, 1991, SOLID STAT PHYS ADV, V44; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Haller EE, 2005, SOLID STATE COMMUN, V133, P693, DOI 10.1016/j.ssc.2004.12.021; Itoh KM, 2001, PHYSICA E, V10, P463, DOI 10.1016/S1386-9477(01)00138-2; KANAYA K, 1972, J PHYS D APPL PHYS, V5, P43, DOI 10.1088/0022-3727/5/1/308; Kojima T, 2003, APPL PHYS LETT, V83, P2318, DOI 10.1063/1.1613365; Malinauskas T, 2008, DIAM RELAT MATER, V17, P1212, DOI 10.1016/j.diamond.2008.01.005; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Morita K, 2000, THIN SOLID FILMS, V369, P405, DOI 10.1016/S0040-6090(00)00901-9; Morton JJL, 2006, NAT PHYS, V2, P365, DOI 10.1038/nphys330; Nakajima M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.161304; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Plekhanov VG, 2006, PROG MATER SCI, V51, P287, DOI 10.1016/j.pmatsci.2005.08.002; Prawer S, 2008, SCIENCE, V320, P1601, DOI 10.1126/science.1158340; Ristein J, 1997, PHYS REV LETT, V78, P1803, DOI 10.1103/PhysRevLett.78.1803; Ruf T, 1998, SOLID STATE COMMUN, V105, P311, DOI 10.1016/S0038-1098(97)10196-X; Sauer R, 2004, DIAM RELAT MATER, V13, P691, DOI 10.1016/j.diamond.2003.10.005; SPITZER J, 1994, PHYS REV LETT, V72, P1565, DOI 10.1103/PhysRevLett.72.1565; TAN TY, 1992, J APPL PHYS, V72, P5206, DOI 10.1063/1.352002; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Teraji T, 2004, J APPL PHYS, V96, P7300, DOI 10.1063/1.1805723; Watanabe H, 2008, DIAM RELAT MATER, V17, P511, DOI 10.1016/j.diamond.2007.12.053; Watanabe H, 1998, APPL PHYS LETT, V73, P981, DOI 10.1063/1.122059; Watanabe H., 2008, P NEW DIAMOND NANO C, V2, P202; Widulle F, 2001, SOLID STATE COMMUN, V118, P1, DOI 10.1016/S0038-1098(01)00014-X; Yuan ZL, 2002, SCIENCE, V295, P102, DOI 10.1126/science.1066790	30	56	56	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1425	1428		10.1126/science.1172419	http://dx.doi.org/10.1126/science.1172419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520955				2022-12-28	WOS:000266878700040
J	Palle, E; Osorio, MRZ; Barrena, R; Montanes-Rodriguez, P; Martin, EL				Palle, Enric; Zapatero Osorio, Maria Rosa; Barrena, Rafael; Montanes-Rodriguez, Pilar; Martin, Eduardo L.			Earth's transmission spectrum from lunar eclipse observations	NATURE			English	Article							EXTRASOLAR PLANET; SUPER-EARTHS; WATER-VAPOR; ATMOSPHERE; SEARCH; IONOSPHERE; MISSION	Of the 342 planets so far discovered(1) orbiting other stars, 58 'transit' the stellar disk, meaning that they can be detected through a periodic decrease in the flux of starlight(2). The light from the star passes through the atmosphere of the planet, and in a few cases the basic atmospheric composition of the planet can be estimated(3-5). As we get closer to finding analogues of Earth(6-8), an important consideration for the characterization of extrasolar planetary atmospheres is what the transmission spectrum of our planet looks like. Here we report the optical and near-infrared transmission spectrum of the Earth, obtained during a lunar eclipse. Some biologically relevant atmospheric features that are weak in the reflection spectrum(9) (such as ozone, molecular oxygen, water, carbon dioxide and methane) are much stronger in the transmission spectrum, and indeed stronger than predicted by modelling(10,11). We also find the 'fingerprints' of the Earth's ionosphere and of the major atmospheric constituent, molecular nitrogen (N(2)), which are missing in the reflection spectrum.	[Palle, Enric; Zapatero Osorio, Maria Rosa; Barrena, Rafael; Montanes-Rodriguez, Pilar; Martin, Eduardo L.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Martin, Eduardo L.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	Instituto de Astrofisica de Canarias; State University System of Florida; University of Central Florida	Palle, E (corresponding author), Inst Astrofis Canarias, Via Lactea S-N, E-38205 Tenerife, Spain.	epalle@iac.es	Palle, Enric/AAE-4492-2019; Zapatero Osorio, Maria Rosa/C-2744-2017	Zapatero Osorio, Maria Rosa/0000-0001-5664-2852; Palle, Enric/0000-0003-0987-1593	Spanish Ministry of Science via the Ramon y Cajal [AYA2007-67458]	Spanish Ministry of Science via the Ramon y Cajal(Spanish Government)	We thank F. Grundahl and J. Fynbo for allowing us access to their awarded time at the Nordic Optical Telescope, thus making this work possible. We are also grateful to V. J. S. Bejar, E. Guinan, S. Seager, B. Portmann, A. Garcia-Munoz and Y. Pavlenko for discussions. Support for this project was provided by the Spanish Ministry of Science via the Ramon y Cajal fellowship (E. P.) and project AYA2007-67458. This work was based on observations made with the WHT (operated by the Isaac Newton Group) and the NOT (operated by Denmark, Finland, Iceland, Norway and Sweden), both on the island of La Palma in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias.	Basri G, 2005, NEW ASTRON REV, V49, P478, DOI 10.1016/j.newar.2005.08.026; Borde P, 2003, ASTRON ASTROPHYS, V405, P1137, DOI 10.1051/0004-6361:20030675; CALO JM, 1980, GEOPHYS RES LETT, V7, P289, DOI 10.1029/GL007i005p00289; Cash W, 2006, NATURE, V442, P51, DOI 10.1038/nature04930; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; CHARBONNEAU D, 2007, DYNAMICS BASED APPRO; Ehrenreich D, 2006, ASTRON ASTROPHYS, V448, P379, DOI 10.1051/0004-6361:20053861; Gardner JP, 2006, SPACE SCI REV, V123, P485, DOI 10.1007/s11214-006-8315-7; KALTENEGGER L, 2009, ASTROPHYS J IN PRESS; Klemperer W, 2006, P NATL ACAD SCI USA, V103, P10584, DOI 10.1073/pnas.0508231103; Kopp E, 1997, J GEOPHYS RES-SPACE, V102, P9667, DOI 10.1029/97JA00384; Lindensmith CA, 2004, P SOC PHOTO-OPT INS, V5487, P1226, DOI 10.1117/12.552284; Mayor M, 2009, ASTRON ASTROPHYS, V493, P639, DOI 10.1051/0004-6361:200810451; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; Montanes-Rodriguez P, 2005, ASTROPHYS J, V629, P1175, DOI 10.1086/431420; Montanes-Rodriguez P, 2006, ASTROPHYS J, V651, P544, DOI 10.1086/507694; Moore JH, 1927, PUBL ASTRON SOC PAC, V39, P223; Palle E, 2008, ASTROPHYS J, V676, P1319, DOI 10.1086/528677; Palle E, 2004, SCIENCE, V304, P1299, DOI 10.1126/science.1094070; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; SHANE CD, 1927, PUBL ASTRON SOC PAC, V39, P226; Slipher VM, 1914, ASTRONOMISCHE NACHRI, V199, P103; Solomon S, 1998, J GEOPHYS RES-ATMOS, V103, P3847, DOI 10.1029/97JD03285; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Tinetti G, 2007, NATURE, V448, P169, DOI 10.1038/nature06002; Turnbull MC, 2006, ASTROPHYS J, V644, P551, DOI 10.1086/503322; Woolf NJ, 2002, ASTROPHYS J, V574, P430, DOI 10.1086/340929; ZBINDEN PA, 1975, PLANET SPACE SCI, V23, P1621, DOI 10.1016/0032-0633(75)90090-2	29	99	99	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 11	2009	459	7248					814	816		10.1038/nature08050	http://dx.doi.org/10.1038/nature08050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516335	Green Submitted			2022-12-28	WOS:000267084500032
J	Reeve, G; Mackay-Thomas, S				Reeve, Gill; Mackay-Thomas, Stuart			A Patient's Journey The invisible worm: ovarian cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material												gereeve2002@yahoo.co.uk							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 4	2009	338								b2072	10.1136/bmj.b2072	http://dx.doi.org/10.1136/bmj.b2072			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AH	19502214				2022-12-28	WOS:000266726400003
J	Finlay, I				Finlay, Ilora			The art of medicine Dying and choosing	LANCET			English	Editorial Material									House Lords, London SW1A 0PW, England		Finlay, I (corresponding author), House Lords, London SW1A 0PW, England.	FINLAYI@parliament.uk							0	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1840	1841		10.1016/S0140-6736(09)61012-6	http://dx.doi.org/10.1016/S0140-6736(09)61012-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19504667	Green Submitted, Bronze			2022-12-28	WOS:000266616400015
J	Mello, MM; Brennan, TA				Mello, Michelle M.; Brennan, Troyen A.			Health Care 2009: The Role of Medical Liability Reform in Federal Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Brennan, Troyen A.] CVS Caremark, Woonsocket, RI USA	Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				BAUCUS M, 2009, CALL ACTION HLTH REF; Iglehart JK, 2009, NEW ENGL J MED, V360, P1693, DOI 10.1056/NEJMp0902651	2	58	59	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					1	3		10.1056/NEJMp0903765	http://dx.doi.org/10.1056/NEJMp0903765			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464UK	19528190				2022-12-28	WOS:000267533100001
J	Lurie, N; Fremont, A				Lurie, Nicole; Fremont, Allen			Building Bridges Between Medical Care and Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lurie, Nicole] RAND Corp, Arlington, VA 22202 USA; [Fremont, Allen] RAND Corp, Santa Monica, CA USA	RAND Corporation; RAND Corporation	Lurie, N (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	lurie@rand.org			NIEHS NIH HHS [P50 ES012383] Funding Source: Medline; PHS HHS [1 P50 ESO12383-01] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012383] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*CA DEP MAN HLTH C, CAL RIGHT CAR IN STR; Christensen CM, 2000, HARVARD BUS REV, V78, P102; GRESENZ CR, 2009, TR671ALS RAND; Gresenz CR, 2008, WR534 RAND; Lavizzo-Mourey R, 2007, JAMA-J AM MED ASSOC, V298, P920, DOI 10.1001/jama.298.8.920; Lurie N, 2008, JT COMM J QUAL PATIE, V34, P256, DOI 10.1016/S1553-7250(08)34032-X; Miller RH, 1997, HEALTH AFFAIR, V16, P7, DOI 10.1377/hlthaff.16.5.7; *RAND CORP, Q DART MEAS HEALTHC; SHALALA DE, 1996, NAT C MED PUBL HLTH	9	29	29	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					84	86		10.1001/jama.2009.959	http://dx.doi.org/10.1001/jama.2009.959			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567444	Green Accepted			2022-12-28	WOS:000267492800027
J	Belkacem, K; Samadi, R; Goupil, MJ; Lefevre, L; Baudin, F; Deheuvels, S; Dupret, MA; Appourchaux, T; Scuflaire, R; Auvergne, M; Catala, C; Michel, E; Miglio, A; Montalban, J; Thoul, A; Talon, S; Baglin, A; Noels, A				Belkacem, Kevin; Samadi, Reza; Goupil, Marie-Jo; Lefevre, Laure; Baudin, Frederic; Deheuvels, Sebastin; Dupret, Marc-Antoine; Appourchaux, Thierry; Scuflaire, Richard; Auvergne, Michel; Catala, Claude; Michel, Eric; Miglio, Andrea; Montalban, Josefina; Thoul, Anne; Talon, Suzanne; Baglin, Annie; Noels, Arlette			Solar-Like Oscillations in a Massive Star	SCIENCE			English	Article							MODES	Seismology of stars provides insight into the physical mechanisms taking place in their interior, with modes of oscillation probing different layers. Low-amplitude acoustic oscillations excited by turbulent convection were detected four decades ago in the Sun and more recently in low-mass main-sequence stars. Using data gathered by the Convection Rotation and Planetary Transits mission, we report here on the detection of solar-like oscillations in a massive star, V1449 Aql, which is a known large-amplitude (beta Cephei) pulsator.	[Belkacem, Kevin; Samadi, Reza; Goupil, Marie-Jo; Lefevre, Laure; Deheuvels, Sebastin; Dupret, Marc-Antoine; Auvergne, Michel; Catala, Claude; Michel, Eric; Baglin, Annie] Observ Paris, CNRS, UMR 8109, Lab Etud Spatiales & Instrumentat Astrophys, F-92195 Meudon, France; [Belkacem, Kevin; Samadi, Reza; Goupil, Marie-Jo; Lefevre, Laure; Deheuvels, Sebastin; Dupret, Marc-Antoine; Auvergne, Michel; Catala, Claude; Michel, Eric; Baglin, Annie] Univ Paris 06, F-75252 Paris 05, France; [Belkacem, Kevin; Samadi, Reza; Goupil, Marie-Jo; Lefevre, Laure; Deheuvels, Sebastin; Dupret, Marc-Antoine; Auvergne, Michel; Catala, Claude; Michel, Eric; Baglin, Annie] Univ Paris 07, Paris, France; [Belkacem, Kevin; Dupret, Marc-Antoine; Scuflaire, Richard; Miglio, Andrea; Montalban, Josefina; Thoul, Anne; Noels, Arlette] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Baudin, Frederic; Appourchaux, Thierry] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Baudin, Frederic; Appourchaux, Thierry] Univ Paris 11, CNRS, UMR 8617, F-91405 Orsay, France; [Talon, Suzanne] Univ Montreal, Reseau Quebecois Calcul Haute Performance, Montreal, PQ H3C 3J8, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; University of Liege; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal	Belkacem, K (corresponding author), Observ Paris, CNRS, UMR 8109, Lab Etud Spatiales & Instrumentat Astrophys, Pl J Janssen, F-92195 Meudon, France.	kevin.belkacem@ulg.ac.be	miglio, andrea/O-9594-2019; Miglio, Andrea/M-5789-2018	miglio, andrea/0000-0001-5998-8533; Miglio, Andrea/0000-0001-5998-8533; Deheuvels, Sebastien/0000-0003-4317-5460; Appourchaux, Thierry/0000-0002-1790-1951; Thoul, Anne/0000-0002-8107-118X; Baudin, Frederic/0000-0001-6213-6382	Liege University; Subside Federal pour la Recherche; Belgian Prodex-ESA; CNES	Liege University(University of Liege); Subside Federal pour la Recherche; Belgian Prodex-ESA; CNES(Centre National D'etudes Spatiales)	K.B. acknowledges financial support from Liege University through the Subside Federal pour la Recherche. Part of this research was funded by the Belgian Prodex-ESA. L.L. has been partly supported by CNES. A.T. is Chercheur Qualifie at the Fonds National de la Recherche Scientifique (FNRS) and A.M. is Charge de recherches FNRS.	BAUDIN F, 1994, ASTRON ASTROPHYS, V285, P29; Belkacem K, 2008, ASTRON ASTROPHYS, V478, P163, DOI 10.1051/0004-6361:20077775; Cantiello M, 2009, ASTRON ASTROPHYS, V499, P279, DOI 10.1051/0004-6361/200911643; Dupret MA, 2001, ASTRON ASTROPHYS, V366, P166, DOI 10.1051/0004-6361:20000219; DZIEMBOWSKI WA, 1993, MON NOT R ASTRON SOC, V262, P204, DOI 10.1093/mnras/262.1.204; Michel E, 2008, SCIENCE, V322, P558, DOI 10.1126/science.1163004; MOREL T, 2007, COAST, V150, P201; Uytterhoeven K, 2008, J PHYS CONF SER, V118, DOI 10.1088/1742-6596/118/1/012077; Waelkens C, 1998, ASTRON ASTROPHYS, V330, P215	9	54	54	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1540	1542		10.1126/science.1171913	http://dx.doi.org/10.1126/science.1171913			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541991	Green Submitted, Green Published			2022-12-28	WOS:000267130600037
J	Calonge, N; Petitti, DB; DeWitt, TG; Dietrich, AJ; Gregory, KD; Grossman, D; Isham, G; LeFevre, ML; Leipzig, RM; Marion, LN; Melnyk, B; Moyer, VA; Ockene, JK; Sawaya, GF; Schwartz, JS; Wilt, T				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Marion, Lucy N.; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Screening for Hepatitis B Virus Infection in Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Reaffirmation of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis B virus hepatitis B virus infection in pregnancy. Methods: The USPSTF performed a brief literature update, including a search for new and substantial evidence on the benefits and harms of screening pregnant women for hepatitis B virus infection. Finding: The net benefit of screening continues to be well established. Recommendation: Screen for hepatitis B virus infection in pregnant women at their first prenatal visit. (Grade A recommendation.)	[Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Healthcare Innovat, Phoenix, AZ USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Dietrich, Allen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Isham, George] Hlth Partners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA; [Marion, Lucy N.] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA; [Moyer, Virginia A.] Baylor Coll Med, Houston, TX 77030 USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilt, Timothy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wilt, Timothy] Minneapolis Veteran Affairs Med Ctr, Minneapolis, MN USA	Colorado Department of Public Health & Environment; Agency for Healthcare Research & Quality; Arizona State University; Arizona State University-Downtown Phoenix; Cincinnati Children's Hospital Medical Center; Dartmouth College; Cedars Sinai Medical Center; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University System of Georgia; Augusta University; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities	Calonge, N (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO USA.		Melnyk, Bernadette J/E-9868-2013		USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	*ACIP, 2005, MMWR RECOMM REP, V65, P1; *AM AC FAM PHYS, 2007, SUMM REC CLIN PREV S; *AM AC PED COMM IN, 2006, RED BOOK; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P941; KRISHNARAJ R, 2004, SCREENING HEPATITIS; Lin K, 2009, ANN INTERN MED, V150, P874, DOI 10.7326/0003-4819-150-12-200906160-00012; *US PREV TASK FORC, 2004, SCREEN HEP B VIR INF	7	37	39	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					869	U70						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528565				2022-12-28	WOS:000267164800006
J	Doshi, B; Sarkar, S				Doshi, B.; Sarkar, S.			Drug Point Topical administration of chloramphenicol can induce acute hepatitis	BRITISH MEDICAL JOURNAL			English	Article									[Sarkar, S.] Aintree Univ Hosp NHS Fdn Trust, Aintree Ctr Gastroenterol, Liverpool L9 7AL, Merseyside, England	Aintree University Hospitals NHS Foundation Trust	Doshi, B (corresponding author), Natl Univ Singapore Hosp, Singapore 117548, Singapore.	bdoshi8@yahoo.co.uk						DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; *MED HEALTHC PROD, ADV DRUG REACT ONL I; Naisbitt DJ, 2005, J PHARMACOL EXP THER, V313, P1058, DOI 10.1124/jpet.105.083758; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; BRIT NATL FORMULARY, V51	5	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 12	2009	338								b1699	10.1136/bmj.b1699	http://dx.doi.org/10.1136/bmj.b1699			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LK	19525305				2022-12-28	WOS:000267022200005
J	Silverman, RD				Silverman, Ross D.			Litigation, Regulation, and Education - Protecting the Public's Health through Childhood Immunization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Silverman, Ross D.] So Illinois Univ, Sch Med, Dept Med Humanities, Springfield, IL USA; [Silverman, Ross D.] So Illinois Univ, Sch Law, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Silverman, RD (corresponding author), So Illinois Univ, Sch Med, Dept Med Humanities, Springfield, IL USA.			Silverman, Ross D./0000-0003-4492-3096				BLUMENTHAL R, 2007, NY TIMES        0426, pA16; Casiday RE, 2007, SOC SCI MED, V65, P1059, DOI 10.1016/j.socscimed.2007.04.023; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Opel DJ, 2008, PEDIATRICS, V122, pE504, DOI 10.1542/peds.2007-3218	4	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2500	2501		10.1056/NEJMp0901598	http://dx.doi.org/10.1056/NEJMp0901598			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456BS	19516031	Green Published			2022-12-28	WOS:000266813800004
J	Headdon, WG; Wilson, PM; Dalton, HR				Headdon, W. G.; Wilson, P. M.; Dalton, Harry R.			Case report The management of accidental hypothermia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESUSCITATION; ARREST		[Headdon, W. G.; Wilson, P. M.; Dalton, Harry R.] Peninsula Coll Med & Dent, Plymouth, Devon, England; [Headdon, W. G.; Wilson, P. M.; Dalton, Harry R.] Royal Cornwall Hosp, Truro, Cornwall, England	University of Plymouth; Royal Cornwall Hospital	Dalton, HR (corresponding author), Peninsula Coll Med & Dent, Plymouth, Devon, England.	harry.dalton@rcht.cornwall.nhs.uk		Dalton, Harry/0000-0001-7786-5457				American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, 2005, CIRCULATION, V112, P136; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; Davis PR, 2006, J ROY ARMY MED CORPS, V152, P223; Epstein E, 2006, BMJ-BRIT MED J, V332, P706, DOI 10.1136/bmj.332.7543.706; Farstad M, 2001, EUR J CARDIO-THORAC, V20, P58, DOI 10.1016/S1010-7940(01)00713-8; Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Graham CA, 2001, WILD ENVIRON MED, V12, P232, DOI 10.1580/1080-6032(2001)012[0232:TEIH]2.0.CO;2; HEARSE DJ, 1977, J MOL CELL CARDIOL, V9, P605, DOI 10.1016/S0022-2828(77)80357-X; HISLOP LJ, 1995, BMJ-BRIT MED J, V311, P725, DOI 10.1136/bmj.311.7007.725; Hughes A, 2007, EMERG MED J, V24, P511, DOI 10.1136/emj.2006.040261; Ireland AJ, 1997, J ACCID EMERG MED, V14, P255; Kibayashi K, 2003, MED SCI LAW, V43, P127, DOI 10.1258/rsmmsl.43.2.127; Kornberger E, 1999, RESUSCITATION, V41, P105, DOI 10.1016/S0300-9572(99)00069-6; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Mattu A, 2002, AM J EMERG MED, V20, P314, DOI 10.1053/ajem.2002.32633; McInerney JJ, 2002, EMERG MED J, V19, P219, DOI 10.1136/emj.19.3.219; MOSS J, 1986, SURG GYNECOL OBSTET, V162, P501; Roggla M, 2002, WIEN KLIN WOCHENSCHR, V114, P315; SAFAR P, 1993, ANN EMERG MED, V22, P324, DOI 10.1016/S0196-0644(05)80463-9; SCHNEIDER SM, 1992, EMERG MED REP, V13, P1; SHIELDS CP, 1990, ANN EMERG MED, V19, P1093, DOI 10.1016/S0196-0644(05)81510-0; Silfvast T, 2003, RESUSCITATION, V59, P285, DOI 10.1016/S0300-9572(03)00237-5; Soar J, 2005, RESUSCITATION, V67, pS135, DOI 10.1016/j.resuscitation.2005.10.004; Steedman DJ, 1997, J ACCID EMERG MED, V14, P170; Steele MT, 1996, ANN EMERG MED, V27, P479, DOI 10.1016/S0196-0644(96)70237-8; Torossian A, 2008, BEST PRACT RES-CLIN, V22, P659, DOI 10.1016/j.bpa.2008.07.006; Walpoth BH, 1997, NEW ENGL J MED, V337, P1500, DOI 10.1056/NEJM199711203372103; Wilson E, 2007, EMERG MED J, V24, DOI 10.1136/emj.2006.041590; Wyatt JP, 2006, OXFORD HDB EMERGENCY	30	6	7	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2009	338								b2085	10.1136/bmj.b2085	http://dx.doi.org/10.1136/bmj.b2085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LI	19515708				2022-12-28	WOS:000267022000012
J	Riemer, J; Bulleid, N; Herrmann, JM				Riemer, Jan; Bulleid, Neil; Herrmann, Johannes M.			Disulfide Formation in the ER and Mitochondria: Two Solutions to a Common Process	SCIENCE			English	Review							INTERMEMBRANE SPACE PROTEINS; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; BOND FORMATION; QUALITY-CONTROL; SULFHYDRYL OXIDASE; REDOX ENVIRONMENT; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; IMPORT PATHWAY	The endoplasmic reticulum (ER) was long considered to be the only compartment of the eukaryotic cell in which protein folding is accompanied by enzyme-catalyzed disulfide bond formation. However, it has recently become evident that cells harbor a second oxidizing compartment, the mitochondrial intermembrane space, where disulfide formation facilitates protein translocation from the cytosol. Moreover, protein oxidation has been implicated in many mitochondria-associated processes central for human health such as apoptosis, aging, and regulation of the respiratory chain. Whereas the machineries of ER and mitochondria both form disulfides between cysteine residues, they do not share evolutionary origins and exhibit distinct mechanistic properties. Here, we summarize the current knowledge of these oxidation systems and discuss their functional similarities and differences.	[Riemer, Jan; Herrmann, Johannes M.] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Bulleid, Neil] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Kaiserslautern; University of Manchester	Herrmann, JM (corresponding author), Univ Kaiserslautern, Erwin Schrodinger Str 13, D-67663 Kaiserslautern, Germany.	hannes.herrmann@biologie.uni-kl.de	Riemer, Jan/AAC-1072-2021; Riemer, Jan/B-3340-2012	Bulleid, Neil/0000-0002-9839-5279; Riemer, Jan/0000-0002-7574-8457	fellowship of the Deutsche Forschungsgemeinschaft; fellowship of Stiftung fur Innovation in Rheinland Pfalz; BBSRC [BB/D00764X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00764X/1] Funding Source: researchfish	fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); fellowship of Stiftung fur Innovation in Rheinland Pfalz; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank B. Anstett for help with Fig. 4 and M. Bien and L. Ellgaard for critical reading of the manuscript. Research in the authors laboratories is supported by fellowships of the Deutsche Forschungsgemeinschaft and the Stiftung fur Innovation in Rheinland Pfalz.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Bihlmaier K, 2008, ANN NY ACAD SCI, V1147, P293, DOI 10.1196/annals.1427.005; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Khalimonchulk E, 2008, BBA-MOL CELL RES, V1783, P618, DOI 10.1016/j.bbamcr.2007.10.016; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Reddehase S, 2009, J MOL BIOL, V385, P331, DOI 10.1016/j.jmb.2008.10.088; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103	49	198	200	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1284	1287		10.1126/science.1170653	http://dx.doi.org/10.1126/science.1170653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498160				2022-12-28	WOS:000266635100033
J	Shah, SS; Davis, MM				Shah, Samir S.; Davis, Matthew M.			Old Disease, Innovative Response Accelerating Infant Vaccination During a Community Pertussis Outbreak ABSTRACT AND COMMENTARY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; DIPHTHERIA; TETANUS; IMMUNIZATION; POLIOMYELITIS; ADOLESCENTS; MORBIDITY; SHORTAGE		[Shah, Samir S.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Shah, Samir S.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Epidemiol, Philadelphia, PA 19104 USA; [Davis, Matthew M.] Univ Michigan, Child Hlth Evaluat & Res Unit, Div Gen Pediat, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Child Hlth Evaluat & Res Unit, Div Gen Pediat, 300 NIB,6C23, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu	Shah, Samir/B-2661-2015	Shah, Samir/0000-0001-7902-7000				[Anonymous], 2018, PLOTKINS VACCINES; BARRETT CD, 1962, PEDIATRICS, V30, P720; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Bocchini JA, 2009, PEDIATRICS, V123, P189, DOI 10.1542/peds.2008-3306; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bronson-Lowe D, 2009, ARCH PEDIAT ADOL MED, V163, P417, DOI 10.1001/archpediatrics.2009.53; BRONSONLOWE D, 2009, JAMA-J AM MED ASSOC, V163, P417; BUTLER NR, 1962, LANCET, V2, P112; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Dylag AM, 2008, PEDIATRICS, V122, pE550, DOI 10.1542/peds.2008-0813; Freed GL, 2003, JAMA-J AM MED ASSOC, V289, P575, DOI 10.1001/jama.289.5.575; Gaglia MA, 2006, HUM VACCINES, V2, P34; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012	15	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 3	2009	301	21					2260	2261		10.1001/jama.2009.802	http://dx.doi.org/10.1001/jama.2009.802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452PQ	19504652				2022-12-28	WOS:000266554100024
J	Biehl, J; Petryna, A; Gertner, A; Amon, JJ; Picon, PD				Biehl, Joao; Petryna, Adriana; Gertner, Alex; Amon, Joseph J.; Picon, Paulo D.			Judicialisation of the right to health in Brazil	LANCET			English	Editorial Material									[Biehl, Joao; Gertner, Alex] Princeton Univ, Dept Anthropol, Princeton, NJ 08544 USA; [Petryna, Adriana] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Amon, Joseph J.] Human RightsWatch, New York, NY USA; [Picon, Paulo D.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Picon, Paulo D.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil	Princeton University; University of Pennsylvania; Universidade Federal do Rio Grande do Sul	Biehl, J (corresponding author), Princeton Univ, Dept Anthropol, Princeton, NJ 08544 USA.	jbiehl@princeton.edu	Picon, Paulo/J-2448-2015; Gertner, Alex/S-8417-2019	Gertner, Alex/0000-0001-7781-3681; Amon, Joseph/0000-0002-2455-6703	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AZEVEDO S, 2007, EPACA           1212; Biehl Joao, 2007, WILL LIVE AIDS THERA; DASILVA VA, 2008, CLAIMING RIGHT HLTH; FARIAS I, 2008, PRESA QUADRILHA ACUS; Hunt Paul, 2006, 61 SESS GEN ASS DAT; Messeder Ana Márcia, 2005, Cad. Saúde Pública, V21, P525, DOI 10.1590/S0102-311X2005000200019; Petryna A., 2009, EXPT TRAVEL CLIN TRI; PICON PD, 2007, EXEMPLOS PADROES PRE; SARLET I. W., 2008, DIREITOS FUNDAMENTAI, P11; *UN HIGH COMM HUM, 2008, 31 WHO UN HIGH COMM; 2008, ZERO HORA       0822	11	52	56	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2182	2184		10.1016/S0140-6736(09)61172-7	http://dx.doi.org/10.1016/S0140-6736(09)61172-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560587	Green Submitted			2022-12-28	WOS:000267444500010
J	Lepper, C; Conway, SJ; Fan, CM				Lepper, Christoph; Conway, Simon J.; Fan, Chen-Ming			Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements	NATURE			English	Article							MOLECULAR REGULATION; SELF-RENEWAL; STEM-CELLS; PAX7; POPULATION; FATE; CRE; EFFICIENT	Myogenic potential, survival and expansion of mammalian muscle progenitors depend on the myogenic determinants Pax3 and Pax7 embryonically(1), and Pax7 alone perinatally(2-5). Several in vitro studies support the critical role of Pax7 in these functions of adult muscle stem cells(5-8) (satellite cells), but a formal demonstration has been lacking in vivo. Here we show, through the application of inducible Cre/loxP lineage tracing(9) and conditional gene inactivation to the tibialis anterior muscle regeneration paradigm, that, unexpectedly, when Pax7 is inactivated in adult mice, mutant satellite cells are not compromised in muscle regeneration, they can proliferate and reoccupy the sublaminal satellite niche, and they are able to support further regenerative processes. Dual adult inactivation of Pax3 and Pax7 also results in normal muscle regeneration. Multiple time points of gene inactivation reveal that Pax7 is only required up to the juvenile period when progenitor cells make the transition into quiescence. Furthermore, we demonstrate a cell-intrinsic difference between neonatal progenitor and adult satellite cells in their Pax7-dependency. Our finding of an age-dependent change in the genetic requirement for muscle stem cells cautions against inferring adult stem-cell biology from embryonic studies, and has direct implications for the use of stem cells from hosts of different ages in transplantation-based therapy.	[Lepper, Christoph; Fan, Chen-Ming] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Lepper, Christoph] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Carnegie Institution for Science; Johns Hopkins University; Indiana University System; Indiana University Bloomington	Lepper, C (corresponding author), Carnegie Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	lepper@ciwemb.edu; fan@ciwemb.edu			Carnegie Institution; NIH; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	Carnegie Institution; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank E. Dikovskaia and E. Siple for technical assistance and Y. Zheng, A. Spradling, S.-J. Lee and J. J. Weyers for comments on the manuscript. D. Barry and K. R. Wagner taught us muscle injury techniques and sample preparation. The Carnegie Institution, NIH and Riley Children's Foundation provided funding for this work.	Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Bigard AX, 1999, ACTA PHYSIOL SCAND, V165, P185; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Harlow E., 1988, ANTIBODIES LAB MANUA; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hogan B, 1994, MANIPULATING MOUSE E; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Koushik SV, 2002, GENESIS, V32, P114, DOI 10.1002/gene.10051; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; PASTORET C, 1995, MUSCLE NERVE, V18, P1147, DOI 10.1002/mus.880181011; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Springer Matthew L, 2002, Curr Protoc Hum Genet, VChapter 13, DOI 10.1002/0471142905.hg1304s31; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	30	380	388	2	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					627	U94		10.1038/nature08209	http://dx.doi.org/10.1038/nature08209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19554048	Green Accepted			2022-12-28	WOS:000268454300050
J	Iglehart, JK				Iglehart, John K.			Prioritizing Comparative-Effectiveness Research - IOM Recommendations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Avorn J, 2009, NEW ENGL J MED, V360, P1927, DOI 10.1056/NEJMp0902427; Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355; *I MED, 2009, IN NAT PRIOR COMP EF; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572	5	160	166	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 23	2009	361	4					325	328		10.1056/NEJMp0904133	http://dx.doi.org/10.1056/NEJMp0904133			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473DC	19567828				2022-12-28	WOS:000268184500001
J	Tung, J; Primus, A; Bouley, AJ; Severson, TF; Alberts, SC; Wray, GA				Tung, Jenny; Primus, Alexander; Bouley, Andrew J.; Severson, Tonya F.; Alberts, Susan C.; Wray, Gregory A.			Evolution of a malaria resistance gene in wild primates	NATURE			English	Article							DUFFY-BLOOD-GROUP; PLASMODIUM-VIVAX; NATURAL-SELECTION; GROUP LOCUS; EXPRESSION; POLYMORPHISM; POPULATION; HUMANS; REGION; CIS	The ecology, behaviour and genetics of our closest living relatives, the nonhuman primates, should help us to understand the evolution of our own lineage. Although a large amount of data has been amassed on primate ecology and behaviour, much less is known about the functional and evolutionary genetic aspects of primate biology, especially in wild primates. As a result, even in well-studied populations in which nongenetic factors that influence adaptively important characteristics have been identified, we have almost no understanding of the underlying genetic basis for such traits. Here, we report on the functional consequences of genetic variation at the malaria-related FY (DARC) gene in a well-studied population of yellow baboons (Papio cynocephalus) living in Amboseli National Park in Kenya. FY codes for a chemokine receptor normally expressed on the erythrocyte surface that is the known entry point for the malarial parasite Plasmodium vivax(1-3). We identified variation in the cis-regulatory region of the baboon FY gene that was associated with phenotypic variation in susceptibility to Hepatocystis, a malaria-like pathogen that is common in baboons(4,5). Genetic variation in this region also influenced gene expression in vivo in wild individuals, a result we confirmed using in vitro reporter gene assays. The patterns of genetic variation in and around this locus were also suggestive of non-neutral evolution, raising the possibility that the evolution of the FY cis-regulatory region in baboons has exhibited both mechanistic and selective parallels with the homologous region in humans(6-8). Together, our results represent the first reported association and functional characterization linking genetic variation and a complex trait in a natural population of nonhuman primates.	[Tung, Jenny; Primus, Alexander; Bouley, Andrew J.; Alberts, Susan C.; Wray, Gregory A.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Tung, Jenny; Primus, Alexander; Severson, Tonya F.; Alberts, Susan C.; Wray, Gregory A.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Alberts, Susan C.; Wray, Gregory A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Alberts, Susan C.] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya	Duke University; Duke University; Duke University	Tung, J (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jt5@duke.edu			National Science Foundation; American Society of Primatologists; Duke University and the Duke chapter of Sigma Xi; Duke Institute for Genome Sciences and Policy	National Science Foundation(National Science Foundation (NSF)); American Society of Primatologists; Duke University and the Duke chapter of Sigma Xi; Duke Institute for Genome Sciences and Policy	We thank the Office of the President of the Republic of Kenya and the Kenya Wildlife Service for permission to work in Amboseli National Park, and the Institute of Primate Research for local sponsorship. We thank the wardens and staff of Amboseli National Park, and the pastoral communities of Amboseli and Longido for cooperation. We thank J. Altmann for providing access to long-term data and contributing samples, and J. Altmann and Y. Gilad for providing comments on the manuscript. R. S. Mututua, S. Sayialel, and J. K. Warutere assisted with sample collection. The Integrated Primate Biomaterials and Information Resource, the Coriell Institute, J. Rogers and R. Sapolsky provided access to DNA samples from Mikumi and Masai Mara respectively. G. Gibson, T. F. C. Mackay, L. Goering and D. Tan provided access to a pyrosequencer at NC State University. M. Akinyi assisted with sample collection and analysis. A. D. Pfefferle assisted with sequencing. S. Mukherjee advised and assisted with statistical tests. Financial support came from the National Science Foundation (to S. C. A. and J. T.); the American Society of Primatologists (to J. T.); Duke University and the Duke chapter of Sigma Xi (to J. T.); and the Duke Institute for Genome Sciences and Policy (to G. A. W.).	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; GARNHAM PC, 1961, NATURE, V190, P739, DOI 10.1038/190739b0; Garnham PCC., 1966, MALARIA PARASITES OT; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; LOISEL D, 2007, THESIS DUKE U; Loisel DA, 2006, P NATL ACAD SCI USA, V103, P16331, DOI 10.1073/pnas.0607662103; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MOORE JA, 1975, J MED PRIMATOL, V4, P1; Myers B. J., 1965, Primates, V6, P137, DOI 10.1007/BF01730965; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Seixas S, 2002, MOL BIOL EVOL, V19, P1802, DOI 10.1093/oxfordjournals.molbev.a004003; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tung J, 2008, MOL ECOL, V17, P1998, DOI 10.1111/j.1365-294X.2008.03723.x; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	30	55	56	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					388	U103		10.1038/nature08149	http://dx.doi.org/10.1038/nature08149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19553936				2022-12-28	WOS:000267979000037
J	Ehlenbach, WJ; Barnato, AE; Curtis, JR; Kreuter, W; Koepsell, TD; Deyo, RA; Stapleton, RD				Ehlenbach, William J.; Barnato, Amber E.; Curtis, J. Randall; Kreuter, William; Koepsell, Thomas D.; Deyo, Richard A.; Stapleton, Renee D.			Epidemiologic Study of In-Hospital Cardiopulmonary Resuscitation in the Elderly.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DO-NOT-RESUSCITATE; CARDIAC-ARREST; MYOCARDIAL-INFARCTION; IMPROVED SURVIVAL; RACIAL VARIATION; UNITED-STATES; ORDERS; RACE; CARE; DEFIBRILLATION	Background: It is unknown whether the rate of survival after in-hospital cardiopulmonary resuscitation (CPR) is improving and which characteristics of patients and hospitals predict survival. Methods: We examined fee-for-service Medicare data from 1992 through 2005 to identify beneficiaries 65 years of age or older who underwent CPR in U.S. hospitals. We examined temporal trends in the incidence of CPR and the rate of survival after CPR, as well as patient- and hospital-level predictors of survival to discharge. Results: We identified 433,985 patients who underwent in-hospital CPR; 18.3% of these patients (95% confidence interval [CI], 18.2 to 18.5) survived to discharge. The rate of survival did not change substantially during the period from 1992 through 2005. The overall incidence of CPR was 2.73 events per 1000 admissions; the incidence was higher among black and other nonwhite patients. The proportion of patients undergoing in-hospital CPR before death increased over time and was higher for nonwhite patients. The survival rate was lower among patients who were men, were older, had more coexisting illnesses, or were admitted from a skilled-nursing facility. The adjusted odds of survival for black patients were 23.6% lower than those for similar white patients (95% CI, 21.2 to 25.9). The association between race and survival was partially explained by hospital effects: black patients were more likely to undergo CPR in hospitals that have lower rates of post-CPR survival. Among patients surviving in-hospital CPR, the proportion of patients discharged home rather than to a health care facility decreased over time. Conclusions: Survival after in-hospital CPR did not improve from 1992 through 2005. The proportion of in-hospital deaths preceded by CPR increased, whereas the proportion of survivors discharged home after undergoing CPR decreased. Black race was associated with higher rates of CPR but lower rates of survival after CPR. N Engl J Med 2009;361:22-31.	[Ehlenbach, William J.; Curtis, J. Randall] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care, Seattle, WA 98104 USA; [Ehlenbach, William J.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Kreuter, William] Univ Washington, Compart Effectiveness Cost & Outcomes Res Ctr, Seattle, WA 98104 USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Stapleton, Renee D.] Univ Vermont, Div Pulm & Crit Care, Burlington, VT 05405 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Oregon Health & Science University; University of Vermont	Ehlenbach, WJ (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care, Box 359762,325 9th Ave, Seattle, WA 98104 USA.	wje1@u.washington.edu	Ehlenbach, William J./R-5784-2019	Ehlenbach, William J./0000-0002-2864-5543	Atlantic Philanthropies; CHEST Foundation; John A. Hartford Foundation; Association of Specialty Professors; National Center for Research Resources Roadmap [8K12RR023265, 5P20RR015557]; National Institutes of Health [T32 HL 007287, K08AG021921]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023265, P20RR015557] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG021921] Funding Source: NIH RePORTER	Atlantic Philanthropies; CHEST Foundation; John A. Hartford Foundation; Association of Specialty Professors; National Center for Research Resources Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by an Association of Specialty Professors-CHEST Foundation of the American College of Chest Physicians Geriatric Development Research Award funded by Atlantic Philanthropies, the CHEST Foundation, the John A. Hartford Foundation, and the Association of Specialty Professors; a National Center for Research Resources Roadmap K12 award (8K12RR023265, to Dr. Stapleton); a Centers of Biomedical Research Excellence (COBRE) award (5P20RR015557, to Dr. Stapleton); and a training grant (T32 HL 007287, to Dr. Ehlenbach) and a career award (K08AG021921, to Dr. Barnato) from the National Institutes of Health.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Becker L, 2008, RESUSCITATION, V79, P22, DOI 10.1016/j.resuscitation.2008.06.019; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ebell MH, 1998, J GEN INTERN MED, V13, P805, DOI 10.1046/j.1525-1497.1998.00244.x; EBELL MH, 1995, J FAM PRACTICE, V40, P571; EISENBERG MS, 1980, LANCET, V1, P812; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Hodgetts TJ, 2002, RESUSCITATION, V54, P115, DOI 10.1016/S0300-9572(02)00098-9; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Jackson EA, 2004, ARCH INTERN MED, V164, P776, DOI 10.1001/archinte.164.7.776; Jones-Crawford JL, 2007, AM J MED, V120, P158, DOI 10.1016/j.amjmed.2006.06.032; Kaplan SJ, 2007, ARCH PHYS MED REHAB, V88, P1494, DOI 10.1016/j.apmr.2007.08.112; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Levy CR, 2005, J AM GERIATR SOC, V53, P2060, DOI 10.1111/j.1532-5415.2005.00523.x; LINKO E, 1967, ACTA MED SCAND, V182, P611; Morrill R, 1999, URBAN GEOGR, V20, P727, DOI 10.2747/0272-3638.20.8.727; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; NACHLAS MM, 1965, AM HEART J, V69, P448, DOI 10.1016/0002-8703(65)90414-X; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; SAKLAYEN M, 1995, MEDICINE, V74, P163, DOI 10.1097/00005792-199507000-00001; Sandroni C, 2004, RESUSCITATION, V62, P291, DOI 10.1016/j.resuscitation.2004.03.020; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Skogvoll E, 1999, ACTA ANAESTH SCAND, V43, P177, DOI 10.1034/j.1399-6576.1999.430210.x; TAFFET GE, 1988, JAMA-J AM MED ASSOC, V260, P2069, DOI 10.1001/jama.260.14.2069; TRESCH D, 1994, J AM GERIATR SOC, V42, P137, DOI 10.1111/j.1532-5415.1994.tb04940.x; Virnig BA, 2002, HEALTH AFFAIR, V21, P224, DOI 10.1377/hlthaff.21.6.224; WARNER SC, 1994, RESUSCITATION, V27, P13, DOI 10.1016/0300-9572(94)90016-7; Watkins LO, 2004, CLIN CARDIOL, V27, P2, DOI 10.1002/clc.4960271503; Wellenius GA, 2008, AM HEART J, V156, P483, DOI 10.1016/j.ahj.2008.04.009; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; Wenger NS, 1997, MED CARE, V35, P311, DOI 10.1097/00005650-199704000-00003	40	252	264	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					22	31		10.1056/NEJMoa0810245	http://dx.doi.org/10.1056/NEJMoa0810245			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571280	Green Accepted			2022-12-28	WOS:000267533100006
J	Murakami, H; Tamasawa, N				Murakami, Hiroshi; Tamasawa, Naoki			Lipomatosis of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murakami, Hiroshi; Tamasawa, Naoki] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Hirosaki University	Murakami, H (corresponding author), Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori 0368562, Japan.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					E33	E33		10.1056/NEJMicm0801797	http://dx.doi.org/10.1056/NEJMicm0801797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553642				2022-12-28	WOS:000267286600012
J	Ehlers, L; Overvad, K; Sorensen, J; Christensen, S; Bech, M; Kjolby, M				Ehlers, Lars; Overvad, Kim; Sorensen, Jan; Christensen, Soren; Bech, Merete; Kjolby, Mette			Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; METAANALYSIS	Objective To assess the cost effectiveness of screening men aged 65 for abdominal aortic aneurysm. Design Cost effectiveness analysis based on a probabilistic, enhanced economic decision analytical model from screening to death. Population and setting Hypothetical population of men aged 65 invited (or not invited) for ultrasound screening in the Danish healthcare system. Data sources Published results from randomised trials and observational epidemiological studies retrieved from electronic bibliographic databases, and supplementary data obtained from the Danish Vascular Registry. Data synthesis A hybrid decision tree and Markov model was developed to simulate the short term and long term effects of screening for abdominal aortic aneurysm compared with no systematic screening on clinical and cost effectiveness outcomes. Probabilistic sensitivity analyses using Monte Carlo simulation were carried out. Results were presented in a cost effectiveness acceptability curve, an expected value of perfect information curve, and a curve showing the expected (net) number of avoided deaths from abdominal aortic aneurysm over time after the introduction of screening. The model was validated by calibrating base case health outcomes and expected activity levels against evidence from the recent Cochrane review of screening for abdominal aortic aneurysm. Results The estimated costs per quality adjusted life year (QALY) gained discounted at 3% per year over a lifetime for costs and QALYs was 43 pound 485 ((sic)54 852; $71 160). At a willingness to pay threshold of 30 pound 000 the probability of screening for abdominal aortic aneurysm being cost effective was less than 30%. One way sensitivity analyses showed the incremental cost effectiveness ratio varying from 32 pound 640 to 66 pound 001 per QALY. Conclusion Screening for abdominal aortic aneurysm does not seem to be cost effective. Further research is needed on long term quality of life outcomes and costs.	[Ehlers, Lars; Kjolby, Mette] Aarhus Univ, Inst Publ Hlth, DK-8000 Aarhus C, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Sorensen, Jan] Univ So Denmark, Ctr Appl Hlth Serv Res & Technol Assessment, Odense, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; University of Southern Denmark	Ehlers, L (corresponding author), Aarhus Univ, Inst Publ Hlth, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.	le@folkesundhed.au.dk	Ehlers, Lars/P-7531-2019; Sorensen, Jan/AAN-3738-2020	Sorensen, Jan/0000-0003-0857-9267; Overvad, Kim/0000-0001-6429-7921; Ehlers, Lars Holger/0000-0001-6512-5566	Centre for Public Health, Central Denmark Region	Centre for Public Health, Central Denmark Region	Centre for Public Health, Central Denmark Region.	Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Bergqvist D, 2008, EUR J VASC ENDOVASC, V35, P13, DOI 10.1016/j.ejvs.2007.06.012; Boll APM, 2003, EUR J VASC ENDOVASC, V26, P74, DOI 10.1053/ejvs.2002.1773; Briggs A, 2006, DECISION MODELLING H; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Campbell Helen, 2007, J Health Serv Res Policy, V12, P11, DOI 10.1258/135581907779497594; Connelly JB, 2002, CLIN INVEST MED, V25, P127; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; COSFORD RA, 2007, COCHRANE DB SYST REV; Cronenwett JL, 2007, J VASC SURG, V46, P1093, DOI 10.1016/j.jvs.2007.08.012; *DAN VASC REG, ANN REP 2006; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond MF, 2005, METHODS EVALUATION H; Ehlers L, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-32; Henriksson M, 2005, BRIT J SURG, V92, P976, DOI 10.1002/bjs.5122; Kaper J, 2006, PHARMACOECONOMICS, V24, P453, DOI 10.2165/00019053-200624050-00004; Kim LG, 2007, J MED SCREEN, V14, P46, DOI 10.1258/096914107780154477; Laustsen J, 2004, EUR J VASC ENDOVASC, V27, P216, DOI 10.1016/j.ejvs.2003.11.011; Lee TY, 2002, SURGERY, V132, P399, DOI 10.1067/msy.2002.126510; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lovegrove RE, 2008, BRIT J SURG, V95, P677, DOI 10.1002/bjs.6240; *MED ADV SECR MIN, 2005, ULTR SCREEN ABD AORT; Michaels JA, 2005, BRIT J SURG, V92, P960, DOI 10.1002/bjs.5119; Pentikainen TJ, 2000, INT J TECHNOL ASSESS, V16, P22, DOI 10.1017/S0266462300016135; Rasmussen SR, 2004, EUR J PUBLIC HEALTH, V14, P95, DOI 10.1093/eurpub/14.1.95; Silverstein Marc D, 2005, Proc (Bayl Univ Med Cent), V18, P345; Soisalon-Soininen S, 2001, VASA-J VASCULAR DIS, V30, P262, DOI 10.1024/0301-1526.30.4.262; *STATBANK DENM, SUMM VIT STAT 2005; Wanhainen A, 2005, J VASC SURG, V41, P741, DOI 10.1016/j.jvs.2005.01.055; 2007, DANISH DRG CASEMIX S	30	42	42	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2009	338								b2243	10.1136/bmj.b2243	http://dx.doi.org/10.1136/bmj.b2243			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MO	19553267	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267436500004
J	Francavilla, R; Favia, V; Bucci, N; Indrio, F; Berardi, M; Cavallo, L				Francavilla, Ruggiero; Favia, Veronica; Bucci, Nunzia; Indrio, Flavia; Berardi, Mariangela; Cavallo, Luciano			Bulimia and cough: psychogenic or organic?	LANCET			English	Editorial Material							ESOPHAGUS; ACHALASIA		[Francavilla, Ruggiero; Bucci, Nunzia; Indrio, Flavia; Berardi, Mariangela; Cavallo, Luciano] Univ Bari, Dept Biomed Eta Evolut, I-70124 Bari, Italy; [Favia, Veronica] Univ Bari, Dept Radiol, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Francavilla, R (corresponding author), Univ Bari, Dept Biomed Eta Evolut, Policlin Piazza Giulio Cesare, I-70124 Bari, Italy.	rfrancavilla@libero.it	Indrio, Flavia/E-6539-2012; FRANCAVILLA, RUGGIERO/S-1391-2019	FRANCAVILLA, RUGGIERO/0000-0002-4603-974X; cavallo, luciano/0000-0003-4787-8681				BERQUIST WE, 1983, PEDIATRICS, V71, P798; COHEN S, 1979, NEW ENGL J MED, V301, P184, DOI 10.1056/NEJM197907263010404; Park W, 2005, AM J GASTROENTEROL, V100, P1404, DOI 10.1111/j.1572-0241.2005.41775.x; Sood MR, 2006, PEDIAT GASTROINTESTI, P327; WICKRAMASINGHE LSP, 1988, POSTGRAD MED J, V64, P958, DOI 10.1136/pgmj.64.758.958	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2170	2170		10.1016/S0140-6736(09)60793-5	http://dx.doi.org/10.1016/S0140-6736(09)60793-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541041				2022-12-28	WOS:000267229700032
J	Bernath, PF				Bernath, Peter F.			Extracting Potentials from Spectra	SCIENCE			English	Editorial Material							GROUND-STATE; ENERGY CURVE; BE-2		Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of York - UK	Bernath, PF (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	pfb500@york.ac.uk	Bernath, Peter F/B-6567-2012	Bernath, Peter F/0000-0002-1255-396X	EPSRC [EP/F032455/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032455/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bernath P.F., 2005, SPECTRA ATOMS MOL, Vsecond; DABROWSKI I, 1984, CAN J PHYS, V62, P1639, DOI 10.1139/p84-210; Dunham JL, 1932, PHYS REV, V41, P721, DOI 10.1103/PhysRev.41.721; Gdanitz RJ, 1999, CHEM PHYS LETT, V312, P578, DOI 10.1016/S0009-2614(99)00985-9; HAMILTON CE, 1986, ANNU REV PHYS CHEM, V37, P493; Hutson JM, 2006, INT REV PHYS CHEM, V25, P497, DOI 10.1080/01442350600921772; Le Roy R.J., 2006, CP662R U WAT CHEM PH; Le Roy RJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2064947; Martin JML, 1999, CHEM PHYS LETT, V303, P399, DOI 10.1016/S0009-2614(99)00214-6; Merritt JM, 2009, SCIENCE, V324, P1548, DOI 10.1126/science.1174326; Schwenke DW, 2003, J CHEM PHYS, V118, P6898, DOI 10.1063/1.1561053; Shayesteh A, 2007, J PHYS CHEM A, V111, P12495, DOI 10.1021/jp075704a; Spirko V, 2006, J MOL SPECTROSC, V235, P268, DOI 10.1016/j.jms.2005.11.012	13	16	17	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1526	1527		10.1126/science.1175751	http://dx.doi.org/10.1126/science.1175751			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541986				2022-12-28	WOS:000267130600031
J	Liu, K; Raghavan, S; Nelesen, S; Linder, CR; Warnow, T				Liu, Kevin; Raghavan, Sindhu; Nelesen, Serita; Linder, C. Randal; Warnow, Tandy			Rapid and Accurate Large-Scale Coestimation of Sequence Alignments and Phylogenetic Trees	SCIENCE			English	Article							MULTIPLE ALIGNMENT; MAXIMUM-LIKELIHOOD; IMPROVEMENT; INFERENCE; ALGORITHM	Inferring an accurate evolutionary tree of life requires high-quality alignments of molecular sequence data sets from large numbers of species. However, this task is often difficult, slow, and idiosyncratic, especially when the sequences are highly diverged or include high rates of insertions and deletions (collectively known as indels). We present SATe (simultaneous alignment and tree estimation), an automated method to quickly and accurately estimate both DNA alignments and trees with the maximum likelihood criterion. In our study, it improved tree and alignment accuracy compared to the best two-phase methods currently available for data sets of up to 1000 sequences, showing that coestimation can be both rapid and accurate in phylogenetic studies.	[Liu, Kevin; Raghavan, Sindhu; Nelesen, Serita; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Linder, C. Randal] Univ Texas Austin, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Warnow, T (corresponding author), Univ Texas Austin, Dept Comp Sci, 1 Univ Stn C0500, Austin, TX 78712 USA.	tandy@cs.utexas.edu			U.S. NSF [DEB 0733029, ITR 0331453, ITR 0121680, EIA 0303609, IGERT 0114387]	U.S. NSF(National Science Foundation (NSF))	This research was supported by the U.S. NSF under grants DEB 0733029, ITR 0331453, ITR 0121680, EIA 0303609, and IGERT 0114387. The simulated and biological data sets, true and curated alignments, PIMTs, and all software are available at www.cs.utexas.edu/users/tandy/science-paper.html.	Desper R, 2004, MOL BIOL EVOL, V21, P587, DOI 10.1093/molbev.msh049; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Fleissner R, 2005, SYST BIOL, V54, P548, DOI 10.1080/10635150590950371; Goertzen LR, 2003, MOL PHYLOGENET EVOL, V29, P216, DOI 10.1016/S1055-7903(03)00094-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Liu K, 2009, IEEE ACM T COMPUT BI, V6, P7, DOI 10.1109/TCBB.2008.63; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lunter G, 2005, STAT BIOL HEALTH, P375, DOI 10.1007/0-387-27733-1_14; Lunter G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-83; Nelesen S.M., 2008, PAC S BIOCOMPUT, V13, P25; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1999, BIOINFORMATICS, V15, P87, DOI 10.1093/bioinformatics/15.1.87; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	20	33	33	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1561	1564		10.1126/science.1171243	http://dx.doi.org/10.1126/science.1171243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541996				2022-12-28	WOS:000267130600044
J	Van Dyke, MK; Phares, CR; Lynfield, R; Thomas, AR; Arnold, KE; Craig, AS; Mohle-Boetani, J; Gershman, K; Schaffner, W; Petit, S; Zansky, SM; Morin, CA; Spina, NL; Wymore, K; Harrison, LH; Shutt, KA; Bareta, J; Bulens, SN; Zell, ER; Stat, M; Schuchat, A; Schrag, SJ				Van Dyke, Melissa K.; Phares, Christina R.; Lynfield, Ruth; Thomas, Ann R.; Arnold, Kathryn E.; Craig, Allen S.; Mohle-Boetani, Janet; Gershman, Ken; Schaffner, William; Petit, Susan; Zansky, Shelley M.; Morin, Craig A.; Spina, Nancy L.; Wymore, Kathryn; Harrison, Lee H.; Shutt, Kathleen A.; Bareta, Joseph; Bulens, Sandra N.; Zell, Elizabeth R.; Stat, M.; Schuchat, Anne; Schrag, Stephanie J.			Evaluation of Universal Antenatal Screening for Group B Streptococcus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LABOR SECONDARY; UNITED-STATES; DISEASE; COLONIZATION; PREVENTION; PROPHYLAXIS; ERA; EPIDEMIOLOGY; SURVEILLANCE; ANAPHYLAXIS	Background Group B streptococcal disease is one of the most common infections in the first week after birth. In 2002, national guidelines recommended universal late antenatal screening of pregnant women for colonization with group B streptococcus to identify candidates for intrapartum chemoprophylaxis. Methods We evaluated the implementation of the guidelines in a multistate, retrospective cohort selected from the Active Bacterial Core surveillance, a 10-state, population-based system that monitors invasive group B streptococcal disease. We abstracted data from the labor and delivery records of a stratified random sample of live births and of all cases in which the newborn had early-onset group B streptococcal disease (i.e., disease in infants <7 days of age) in 2003 and 2004. We compared our results with those from a study with a similar design that evaluated screening practices in 1998 and 1999. Results We abstracted records of 254 births in which the infant had group B streptococcal disease and 7437 births in which the infant did not. The rate of screening for group B streptococcus before delivery increased from 48.1% in 1998-1999 to 85.0% in 2003-2004; the percentage of infants exposed to intrapartum antibiotics increased from 26.8% to 31.7%. Chemoprophylaxis was administered in 87.0% of the women who were positive for group B streptococcus and who delivered at term, but in only 63.4% of women with unknown colonization status who delivered preterm. The overall incidence of early-onset group B streptococcal disease was 0.32 cases per 1000 live births. Preterm infants had a higher incidence of early-onset group B streptococcal disease than did term infants (0.73 vs. 0.26 cases per 1000 live births); however, 74.4% of the cases of group B streptococcal disease (189 of 254) occurred in term infants. Missed screening among mothers who delivered at term accounted for 34 of the 254 cases of group B streptococcal disease (13.4%). A total of 61.4% of the term infants with group B streptococcal disease were born to women who had tested negative for group B streptococcus before delivery. Conclusions Recommendations for universal screening were rapidly adopted. Improved management of preterm deliveries and improved collection, processing, and reporting of culture results may prevent additional cases of early-onset group B streptococcal disease.	[Van Dyke, Melissa K.; Phares, Christina R.; Zell, Elizabeth R.; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Van Dyke, Melissa K.; Phares, Christina R.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Lynfield, Ruth; Morin, Craig A.] Minnesota Dept Hlth, St Paul, MN USA; [Thomas, Ann R.] Oregon Publ Hlth Div, Portland, OR USA; [Arnold, Kathryn E.; Bulens, Sandra N.] Georgia Dept Human Resources, Div Publ Hlth, Atlanta, GA USA; [Craig, Allen S.] Tennessee Dept Hlth, Nashville, TN USA; [Mohle-Boetani, Janet; Wymore, Kathryn] Calif Emerging Infect Program, Oakland, CA USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Petit, Susan] Connecticut Dept Publ Hlth & Addict Serv, Hartford, CT 06106 USA; [Zansky, Shelley M.; Spina, Nancy L.] New York State Dept Hlth, Emerging Infect Program, Albany, NY 12237 USA; [Harrison, Lee H.; Shutt, Kathleen A.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Bareta, Joseph] New Mexico Dept Hlth, Santa Fe, NM USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Tennessee Department Health; California Emerging Infections Program; Colorado Department of Public Health & Environment; Vanderbilt University; State University of New York (SUNY) System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New Mexico Department of Health	Schrag, SJ (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,MS C-23, Atlanta, GA 30333 USA.	zha6@cdc.gov	Mohle-Boetani, Janet/AAH-4221-2019	Shutt, Kathleen/0000-0003-3376-6152				ALTAIE SS, 1994, DIAGN MICR INFEC DIS, V18, P141, DOI 10.1016/0732-8893(94)90082-5; *AM COLL OBST GYN, 1996, PREV EARL ONS GROUP; *AM COLL OBST GYN, 2002, OBSTET GYNECOL, V100, P1405; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; BADRI MS, 1977, J INFECT DIS, V135, P308, DOI 10.1093/infdis/135.2.308; Baker CJ, 2003, ARCH DIS CHILD, V88, P375, DOI 10.1136/adc.88.5.375; Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303; BOYER KM, 1986, NEW ENGL J MED, V314, P1665, DOI 10.1056/NEJM198606263142603; BOYER KM, 1985, NEONATAL GROUP B STR, P267; Centers for Disease Control and Prevention, ACT BACT COR SURV ME; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P679; Davies HD, 2004, CLIN INFECT DIS, V39, P1129, DOI 10.1086/424518; Dunn AB, 1999, J REPROD MED, V44, P381; Hager WD, 2000, OBSTET GYNECOL, V96, P141, DOI 10.1016/S0029-7844(00)00848-6; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Honest H, 2006, PEDIATRICS, V117, P1055, DOI 10.1542/peds.2005-1114; Jao MS, 2006, J REPROD MED, V51, P655; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Matteson KA, 2008, OBSTET GYNECOL, V111, P356, DOI 10.1097/AOG.0b013e318160ff9d; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Morin CA, 2005, EMERG INFECT DIS, V11, P1467, DOI 10.3201/eid1109.041109; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Puopolo KM, 2005, PEDIATRICS, V115, P1240, DOI 10.1542/peds.2004-2275; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reingold A., 2007, Morbidity and Mortality Weekly Report, V56, P701; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Whitney CG, 1997, OBSTET GYNECOL, V89, P28, DOI 10.1016/S0029-7844(96)00372-9; Yancey MK, 1996, OBSTET GYNECOL, V88, P811, DOI 10.1016/0029-7844(96)00320-1; YOW MD, 1980, AM J OBSTET GYNECOL, V137, P34, DOI 10.1016/0002-9378(80)90382-8; 2004, MMWR MORB MORTAL WKL, V53, P502; 2005, MMWR MORB MORTAL WKL, V54, P700	37	257	264	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2626	2636		10.1056/NEJMoa0806820	http://dx.doi.org/10.1056/NEJMoa0806820			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535801				2022-12-28	WOS:000267060000007
J	Siegel, D				Siegel, David			Use of nonsteroidal antiinflammatory drugs was associated with increased risks for death and hospitalization for MI and HF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									VA No Calif Hlth Care Syst, Sacramento, CA USA		Siegel, D (corresponding author), VA No Calif Hlth Care Syst, Sacramento, CA USA.							Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-12	10.7326/0003-4819-150-12-200906160-02012	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528557				2022-12-28	WOS:000267164800024
J	Aguzzi, A; Steele, AD				Aguzzi, Adriano; Steele, Andrew D.			Prion Topology and Toxicity	CELL			English	Editorial Material							PROTEIN; NEUROTOXICITY; NEURODEGENERATION	Inactivation of mahogunin, an E3 ubiquitin ligase, causes a spongiform encephalopathy resembling prion disease. Chakrabarti and Hegde (2009) now report that prion proteins with aberrant topologies inactivate mahogunin, providing a plausible explanation for certain aspects of prion pathology.	[Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Steele, Andrew D.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Zurich; University Zurich Hospital; California Institute of Technology	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch; steelea@caltech.edu	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Stewart RS, 2005, J BIOL CHEM, V280, P15855, DOI 10.1074/jbc.M412298200; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014	9	11	11	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6					994	996		10.1016/j.cell.2009.05.041	http://dx.doi.org/10.1016/j.cell.2009.05.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524502	Bronze			2022-12-28	WOS:000266916400011
J	Mathew, R; Karp, CM; Beaudoin, B; Vuong, N; Chen, GH; Chen, HY; Bray, K; Reddy, A; Bhanot, G; Gelinas, C; DiPaola, RS; Karantza-Wadsworth, V; White, E				Mathew, Robin; Karp, Cristina M.; Beaudoin, Brian; Vuong, Nhan; Chen, Guanghua; Chen, Hsin-Yi; Bray, Kevin; Reddy, Anupama; Bhanot, Gyan; Gelinas, Celine; DiPaola, Robert S.; Karantza-Wadsworth, Vassiliki; White, Eileen			Autophagy Suppresses Tumorigenesis through Elimination of p62	CELL			English	Article							GENE-EXPRESSION; CELL-SURVIVAL; DEFICIENT; STEATOHEPATITIS; PATHOGENESIS; DEGRADATION; MANAGEMENT; APOPTOSIS; BECLIN-1; STRESS	Allelic loss of the essential autophagy gene beclin1 occurs in human cancers and renders mice tumor-prone suggesting that autophagy is a tumor-suppression mechanism. While tumor cells utilize autophagy to survive metabolic stress, autophagy also mitigates the resulting cellular damage that may limit tumorigenesis. In response to stress, autophagy-defective tumor cells preferentially accumulated p62/SQSTM1 (p62), endoplasmic reticulum (ER) chaperones, damaged mitochondria, reactive oxygen species (ROS), and genome damage. Moreover, suppressing ROS or p62 accumulation prevented damage resulting from autophagy defects indicating that failure to regulate p62 caused oxidative stress. Importantly, sustained p62 expression resulting from autophagy defects was sufficient to alter NF-kappa B regulation and gene expression and to promote tumorigenesis. Thus, defective autophagy is a mechanism for p62 upregulation commonly observed in human tumors that contributes directly to tumorigenesis likely by perturbing the signal transduction adaptor function of p62-controlling pathways critical for oncogenesis.	[Mathew, Robin; Gelinas, Celine; DiPaola, Robert S.; Karantza-Wadsworth, Vassiliki; White, Eileen] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Med Oncol, Piscataway, NJ 08854 USA; [Beaudoin, Brian; Chen, Guanghua; Gelinas, Celine; White, Eileen] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Karp, Cristina M.; Beaudoin, Brian; Vuong, Nhan; Chen, Hsin-Yi; Bray, Kevin; Bhanot, Gyan; White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Mathew, Robin; Karp, Cristina M.; Bhanot, Gyan; DiPaola, Robert S.; Karantza-Wadsworth, Vassiliki; White, Eileen] Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Reddy, Anupama] Rutgers State Univ, RUTCOR, Piscataway, NJ 08854 USA; [Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick	White, E (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Med Oncol, Piscataway, NJ 08854 USA.	whiteei@umdnj.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	National Institutes of Health [R37 CA53370, RO1 CA130893, W81XWH06-1-0514, W81XWH05]; NATIONAL CANCER INSTITUTE [R00CA133181, R37CA053370, K99CA133181, R01CA130893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Heintz, Yue, and Jin for providing beclin1<SUP>+/+</SUP> and beclin1<SUP>+/-</SUP> mice, Dr. Mizushima for providing atg5<SUP>+/+</SUP> and atg5<SUP>-/-</SUP> mice, Dr. Zimmermann for GRp170 antibody and Dr. Moscat for myc-p62 and p62-EGFP plasmids. This work was supported by grants from the National Institutes of Health (R37 CA53370 and RO1 CA130893) to E. W., (K99CA133181) to V. K. W., and Department of Defense (W81XWH06-1-0514 and W81XWH05) to E. W. and R. S.	Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	42	1314	1383	0	225	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1062	1075		10.1016/j.cell.2009.03.048	http://dx.doi.org/10.1016/j.cell.2009.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524509	Green Accepted, Bronze			2022-12-28	WOS:000266916400018
J	Savigny, P; Watson, P; Underwood, M				Savigny, Pauline; Watson, Paul; Underwood, Martin		Guideline Dev Grp	Guidelines Early management of persistent non-specific low back pain: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Underwood, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Savigny, Pauline] Royal Coll Gen Practitioners, Natl Collaborating Ctr Primary Care, London SW7 1PU, England; [Watson, Paul] Univ Leicester, Acad Unit, Dept Hlth Sci, Leicester LE5 4PW, Leics, England	University of Warwick; University of Leicester	Underwood, M (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	Underwood, Martin/D-6364-2015	Underwood, Martin/0000-0002-0309-1708				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; *ARTHR RES CAMP, 2002, ARTHR BIG PICT; Macfarlane GJ, 2006, PAIN, V122, P219, DOI 10.1016/j.pain.2006.03.013; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V59; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HLTH, V88; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003	6	171	177	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2009	338								b1805	10.1136/bmj.b1805	http://dx.doi.org/10.1136/bmj.b1805			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AH	19502217				2022-12-28	WOS:000266726400001
J	Cubrovic, M; Zaanen, J; Schalm, K				Cubrovic, Mihailo; Zaanen, Jan; Schalm, Koenraad			String Theory, Quantum Phase Transitions, and the Emergent Fermi Liquid	SCIENCE			English	Article								A central problem in quantum condensed matter physics is the critical theory governing the zero-temperature quantum phase transition between strongly renormalized Fermi liquids as found in heavy fermion intermetallics and possibly in high-critical temperature superconductors. We found that the mathematics of string theory is capable of describing such fermionic quantum critical states. Using the anti-de Sitter/conformal field theory correspondence to relate fermionic quantum critical fields to a gravitational problem, we computed the spectral functions of fermions in the field theory. By increasing the fermion density away from the relativistic quantum critical point, a state emerges with all the features of the Fermi liquid.	[Cubrovic, Mihailo; Zaanen, Jan; Schalm, Koenraad] Leiden Univ, Inst Lorentz Theoret Phys, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Schalm, K (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, POB 9506, Leiden, Netherlands.	kschalm@lorentz.leidenuniv.nl		Schalm, Koenraad/0000-0001-7524-0824	VIDI Innovative Research (K.S.) from the Netherlands Organization for Scientific Research (NWO); NWO; Dutch Foundation for Fundamental Research on Matter (FOM)	VIDI Innovative Research (K.S.) from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands))	Supported by a VIDI Innovative Research Incentive Grant (K.S.) from the Netherlands Organization for Scientific Research (NWO) and by a Spinoza Award (J.Z.) from NWO and the Dutch Foundation for Fundamental Research on Matter (FOM).	Adams A, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/11/059; Balasubramanian K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.061601; Cho HT, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.016004; Hartnoll S, 2008, SCIENCE, V322, P1639, DOI 10.1126/science.1166668; Hartnoll SA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.031601; Hartnoll SA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.144502; Hartnoll SA, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/12/015; Herzog CP, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.085020; Karch A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051602; Kovtun PK, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.086009; Kruger F, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035104; Kulaxizi M, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.086004; Lawler MJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085101; Lee SS, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.086006; Lifshitz E.M., 1980, STAT PHYS 2; Randeria M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144509; ROZALI M, 2008, JHEP, V801; Sachdev S., 1999, QUANTUM PHASE TRANSI; SCHULZ HJ, 2000, FIELD THEORIES LOW D, pCH2; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035103; Shieh HH, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/03/019; Son DT, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.046003; Son DT, 2007, ANNU REV NUCL PART S, V57, P95, DOI 10.1146/annurev.nucl.57.090506.123120; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; van der Marel D, 2003, NATURE, V425, P271, DOI 10.1038/nature01978; Zaanen J, 2008, SCIENCE, V319, P1205, DOI 10.1126/science.1152443; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a	29	347	348	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 24	2009	325	5939					439	444		10.1126/science.1174962	http://dx.doi.org/10.1126/science.1174962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474AR	19556462	Green Submitted			2022-12-28	WOS:000268255100047
J	Bajoghli, B; Aghaallaei, N; Hess, I; Rode, I; Netuschil, N; Tay, BH; Venkatesh, B; Yu, JK; Kaltenbach, SL; Holland, ND; Diekhoff, D; Happe, C; Schorpp, M; Boehm, T				Bajoghli, Baubak; Aghaallaei, Narges; Hess, Isabell; Rode, Immanuel; Netuschil, Nikolai; Tay, Boon-Hui; Venkatesh, Byrappa; Yu, Jr-Kai; Kaltenbach, Stacy L.; Holland, Nicholas D.; Diekhoff, Dagmar; Happe, Christiane; Schorpp, Michael; Boehm, Thomas			Evolution of Genetic Networks Underlying the Emergence of Thymopoiesis in Vertebrates	CELL			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; T-CELL DEVELOPMENT; DELTA-LIKE 4; THYMUS COLONIZATION; CHEMOKINE RECEPTOR; LAMPREY; BCL11B; DIFFERENTIATION; EXPRESSION; EPITHELIUM	About 500 million years ago, a new type of adaptive immune defense emerged in basal jawed vertebrates, accompanied by morphological innovations, including the thymus. Did these evolutionary novelties arise de novo or from elaboration of ancient genetic networks? We reconstructed the genetic changes underlying thymopoiesis by comparative genome and expression analyses in chordates and basal vertebrates. The derived models of genetic networks were experimentally verified in bony fishes. Ancestral networks defining circumscribed regions of the pharyngeal epithelium of jawless vertebrates expanded in cartilaginous fishes to incorporate novel genes, notably those encoding chemokines. Correspondingly, novel networks evolved in lymphocytes of jawed vertebrates to control the expression of additional chemokine receptors. These complementary changes enabled unprecedented Delta/Notch signaling between pharyngeal epithelium and lymphoid cells that was exploited for specification to the T cell lineage. Our results provide a framework elucidating the evolution of key features of the adaptive immune system in jawed vertebrates.	[Bajoghli, Baubak; Aghaallaei, Narges; Hess, Isabell; Rode, Immanuel; Netuschil, Nikolai; Diekhoff, Dagmar; Happe, Christiane; Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol, Dept Dev Immunol, D-79108 Freiburg, Germany; [Tay, Boon-Hui; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Biopolis 138673, Singapore; [Yu, Jr-Kai; Kaltenbach, Stacy L.; Holland, Nicholas D.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California San Diego; Scripps Institution of Oceanography	Boehm, T (corresponding author), Max Planck Inst Immunobiol, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de	Yu, Jr-Kai/H-4822-2019; Bajoghli, Baubak/AAF-8388-2020	Yu, Jr-Kai/0000-0001-8591-0529; Bajoghli, Baubak/0000-0002-7368-7523; Aghaallaei, Narges/0000-0002-9890-3229; Venkatesh, Byrappa/0000-0003-3620-0277; Bajoghli, Baubak/0000-0003-1395-6362	Max-Planck Society; Deutsche Forschungsgemeinschaft; Biomedical Research Council of the A*STAR, Singapore	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Biomedical Research Council of the A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	We thank C. Burgtorf, M. Cooper, S. Kuratani, B. Appel, and J. Shin for reagents and J. Wittbrodt, T. Nolting, N. Schmidt, E. Nold, M. Leicht, M. Held, C. Strohmeier, A. Haas- Assenbaum, C. Thomas, P. Kindle, and A. Wu " rch for their help during various phases of the project. The lamprey (P. marinus) genome assembly was provided by the Genome Sequencing Center at Washington University St. Louis School of Medicine. T. B.'s laboratory is supported by the Max-Planck Society and the Deutsche Forschungsgemeinschaft; B.V.'s laboratory is supported by the Biomedical Research Council of the A*STAR, Singapore.	Aghaallaei N, 2007, DEV BIOL, V307, P408, DOI 10.1016/j.ydbio.2007.04.022; Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; BESMER P, 1993, DEVELOPMENT, P125; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2006, NAT REV IMMUNOL, V6, P79, DOI 10.1038/nri1749; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Carl M, 2002, DEVELOPMENT, V129, P4057; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Di Santo JP, 1998, CURR OPIN IMMUNOL, V10, P196, DOI 10.1016/S0952-7915(98)80249-5; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Holland Linda Z., 1996, P267; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kang JS, 2004, CURR OPIN IMMUNOL, V16, P180, DOI 10.1016/j.coi.2004.02.002; Kawamoto H, 2006, TRENDS IMMUNOL, V27, P169, DOI 10.1016/j.it.2006.02.004; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuroda N, 2003, IMMUNOGENETICS, V54, P884, DOI 10.1007/s00251-002-0531-z; Li SG, 2005, P NATL ACAD SCI USA, V102, P10688, DOI 10.1073/pnas.0504799102; Litman GW, 2007, NAT IMMUNOL, V8, P547, DOI 10.1038/ni0607-547; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pastoret P.-P., 1998, HDB VERTEBRATE IMMUN; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rasmussen SLK, 2007, GENESIS, V45, P113, DOI 10.1002/dvg.20278; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; ROUSSET D, 1995, J MOL EVOL, V41, P421, DOI 10.1007/BF00160313; Ruppert EE, 1997, MICROSCOPIC ANATOMY, V15, P349; Savvides SN, 2000, NAT STRUCT BIOL, V7, P486; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wallin IE, 1917, AM J ANAT, V22, P127, DOI 10.1002/aja.1000220106; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; YAMAMOTO T, 1975, MEDAKA KILLIFISH BIO	59	142	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 10	2009	138	1					186	197		10.1016/j.cell.2009.04.017	http://dx.doi.org/10.1016/j.cell.2009.04.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	468UN	19559469	Bronze			2022-12-28	WOS:000267848600024
J	Primorac, D				Primorac, Dragan			Innovating Education in Croatia	SCIENCE			English	Editorial Material									Minist Sci Educ & Sports Republ Croatia, Zagreb 10000, Croatia		Primorac, D (corresponding author), Minist Sci Educ & Sports Republ Croatia, Zagreb 10000, Croatia.	dragan.primorac@st.t-com.hr	Primorac, Dragan/I-6941-2017; Primorac, Dragan/ABF-6238-2020; Primorac, Dragan/GYJ-1505-2022					*CROAT HER FDN, 2007, HRVATSK IS ZBORN 200; MARSHALL E, CROATIA AIMING HIGH; *MSES, 2005, ED SECT DEV PLAN 200; *MSES, 2006, SCI TECHN POL 2006 2; Petrovecki M, 2006, CROAT MED J, V47, P809; PRIMORAC D, 2007, PUBLIC SERVICE REV E, V14, P153; Primorac D, 2008, EMBO REP, V9, P596, DOI 10.1038/embor.2008.117	7	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1650	1650		10.1126/science.1167183	http://dx.doi.org/10.1126/science.1167183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462GE	19556489				2022-12-28	WOS:000267338200018
J	Beral, D; Adair, R; Peckham-Cooper, A; Tolan, D; Botterill, I				Beral, Daniel; Adair, Robert; Peckham-Cooper, Adam; Tolan, Damian; Botterill, Ian			Lesson of the Week Chronic wound sepsis due to retained vacuum assisted closure foam	BRITISH MEDICAL JOURNAL			English	Article									[Beral, Daniel; Peckham-Cooper, Adam; Botterill, Ian] Leeds Gen Infirm, John Goligher Colorectal Unit, Leeds, W Yorkshire, England; [Tolan, Damian] Leeds Gen Infirm, Dept Clin Radiol, Leeds, W Yorkshire, England	Leeds General Infirmary; University of Leeds; Leeds General Infirmary; University of Leeds	Botterill, I (corresponding author), Leeds Gen Infirm, John Goligher Colorectal Unit, Leeds, W Yorkshire, England.	ian.botterill@leedsth.nhs.uk	Peckham-Cooper, Adam/AAE-8454-2021; Tolan, Damian/HHN-4673-2022					Caniano DA, 2005, J PEDIATR SURG, V40, P128, DOI 10.1016/j.jpedsurg.2004.09.016; Fox A, 2004, J Wound Care, V13, P344; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; Saeed Musab U, 2007, Int J Low Extrem Wounds, V6, P153, DOI 10.1177/1534734607305597	4	13	13	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 24	2009	338								b2269	10.1136/bmj.b2269	http://dx.doi.org/10.1136/bmj.b2269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MO	19553260				2022-12-28	WOS:000267436500008
J	Hulley, S; Grady, D				Hulley, Stephen; Grady, Deborah			Postmenopausal Hormone Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; MILD COGNITIVE IMPAIRMENT; HEALTH INITIATIVE MEMORY; CARDIOVASCULAR-DISEASE; WOMEN; THERAPY; REPLACEMENT; DEMENTIA		[Hulley, Stephen] Univ Calif San Francisco, Dept Epidemiol & Biostat, Sch Med, San Francisco, CA 94107 USA; [Grady, Deborah] Univ Calif San Francisco, Dept Med, Sch Med, San Francisco, CA 94107 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hulley, S (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Sch Med, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	shulley@epi.ucsf.edu						Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Ettinger B, 2004, OBSTET GYNECOL, V104, P443, DOI 10.1097/01.AOG.0000137833.43248.79; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1038; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hulley SB, 2004, JAMA-J AM MED ASSOC, V291, P1769, DOI 10.1001/jama.291.14.1769; JEMAL A, RECENT TRENDS BREAST; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Utian WH, 2001, FERTIL STERIL, V75, P1065, DOI 10.1016/S0015-0282(01)01791-5; Wilson RA, 1966, FEMININE FOREVER	15	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2493	2495		10.1001/jama.2009.847	http://dx.doi.org/10.1001/jama.2009.847			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531791				2022-12-28	WOS:000267028100029
J	Valastyan, S; Reinhardt, F; Benaich, N; Calogrias, D; Szasz, AM; Wang, ZGC; Brock, JE; Richardson, AL; Weinberg, RA				Valastyan, Scott; Reinhardt, Ferenc; Benaich, Nathan; Calogrias, Diana; Szasz, Attila M.; Wang, Zhigang C.; Brock, Jane E.; Richardson, Andrea L.; Weinberg, Robert A.			RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (Retracted article. See vol. 161, pg. 417, 2015)	CELL			English	Article; Retracted Publication							EXPRESSION SIGNATURE; TUMOR INVASION; MAMMARY-TUMOR; CELLS; RNAS; SURVIVAL; TARGETS; GENES	MicroRNAs are well suited to regulate tumor metastasis because of their capacity to coordinately repress numerous target genes, thereby potentially enabling their intervention at multiple steps of the invasion-metastasis cascade. We identify a microRNA exemplifying these attributes, miR-31, whose expression correlates inversely with metastasis in human breast cancer patients. Overexpression of miR-31 in otherwise-aggressive breast tumor cells suppresses metastasis. We deploy a stable microRNA sponge strategy to inhibit miR-31 in vivo; this allows otherwise-nonaggressive breast cancer cells to metastasize. These phenotypes do not involve confounding influences on primary tumor development and are specifically attributable to miR-31-mediated inhibition of several steps of metastasis, including local invasion, extravasation or initial survival at a distant site, and metastatic colonization. Such pleiotropy is achieved via coordinate repression of a cohort of metastasis-promoting genes, including RhoA. Indeed, RhoA re-expression partially reverses miR-31-imposed metastasis suppression. These findings indicate that miR-31 uses multiple mechanisms to oppose metastasis.	[Valastyan, Scott; Reinhardt, Ferenc; Benaich, Nathan; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Valastyan, Scott; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Benaich, Nathan] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Calogrias, Diana; Szasz, Attila M.; Brock, Jane E.; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wang, Zhigang C.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Wang, Zhigang C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Weinberg, Robert A.] MIT Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Williams College; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu		Szasz, Attila Marcell/0000-0003-2739-4196	NIH [RO1 CA078461, PO1 CA080111]; MIT Ludwig Center for Molecular Oncology; U. S. Department of Defense; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; DoD BCRP Idea Award; NATIONAL CANCER INSTITUTE [P01CA080111, R01CA078461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Ludwig Center for Molecular Oncology; U. S. Department of Defense(United States Department of Defense); Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; DoD BCRP Idea Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Matthew Saelzler, Julie Valastyan, Lynne Waldman, and Sandra McAllister for critical reading of this manuscript and insightful discussions; W. Guo, T. Shibue, A. Spiegel, and other members of the Weinberg lab for dialogue and materials; D. Bartel, G. Bokoch, S. Crouch, P. Klein, S. Kuwada, P. Sharp, H. Surks, and S. Weiss for reagents; and M. Brown, the MIT Koch Institute Histology Facility, and the MIT Histology Lab for tissue sectioning. This research was supported by the NIH (R. A. W.: RO1 CA078461, PO1 CA080111), MIT Ludwig Center for Molecular Oncology (R. A. W.), U. S. Department of Defense (S. V.), Breast Cancer Research Foundation (Z. C. W., A. L. R., R. A. W.), Harvard Breast Cancer SPORE (A. L. R., R. A. W.), and a DoD BCRP Idea Award (R. A. W.). S. V. and R. A. W. are inventors on a patent application in part based on findings detailed in this manuscript. S. V. is a U. S. Department of Defense Breast Cancer Research Program Predoctoral Fellow. R. A. W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Foundation Cancer Research Professor.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MATTIE MD, 2006, MOL CANCER, V19, P5; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; MORRIS VL, 1993, CLIN EXP METASTAS, V11, P103, DOI 10.1007/BF00880071; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	40	690	740	0	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1032	1046		10.1016/j.cell.2009.03.047	http://dx.doi.org/10.1016/j.cell.2009.03.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524507	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000266916400016
J	Wang, TT; Palese, P				Wang, Taia T.; Palese, Peter			Unraveling the Mystery of Swine Influenza Virus	CELL			English	Editorial Material								Influenza virus outbreaks occur with regularity, but the severity of outbreaks is not consistent. The recent flu epidemic caused by an H1N1 swine influenza virus presents an opportunity to examine what is known about virulence factors and the spread of infection to better prepare for major influenza outbreaks in the future.	[Wang, Taia T.; Palese, Peter] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Palese, P (corresponding author), Mt Sinai Hosp, Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	peter.palese@mssm.edu		Palese, Peter/0000-0002-0337-5823	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, U01AI070469, U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI057158, T32 AI007647, U01 AI70469, U01 AI1074539] Funding Source: Medline; NIGMS NIH HHS [T32 GM007280] Funding Source: Medline; PHS HHS [HHSN266200700010C] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Butler D, 2009, NATURE, V459, P14, DOI 10.1038/459014a; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; PALESE P, 1976, NATURE, V263, P528, DOI 10.1038/263528a0; Palese P., 2007, FIELDS VIROLOGY, P1647; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	10	78	89	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					983	985		10.1016/j.cell.2009.05.032	http://dx.doi.org/10.1016/j.cell.2009.05.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524497	Bronze			2022-12-28	WOS:000266916400006
J	Zanoni, I; Ostuni, R; Capuano, G; Collini, M; Caccia, M; Ronchi, AE; Rocchetti, M; Mingozzi, F; Foti, M; Chirico, G; Costa, B; Zaza, A; Ricciardi-Castagnoli, P; Granucci, F				Zanoni, Ivan; Ostuni, Renato; Capuano, Giusy; Collini, Maddalena; Caccia, Michele; Ronchi, Antonella Ellena; Rocchetti, Marcella; Mingozzi, Francesca; Foti, Maria; Chirico, Giuseppe; Costa, Barbara; Zaza, Antonio; Ricciardi-Castagnoli, Paola; Granucci, Francesca			CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; T-CELLS; IL-2 PRODUCTION; RECEPTORS; INDUCTION; MACROPHAGES; RESISTANCE; PROTEINS; BACTERIA; IMMUNITY	Toll-like receptors (TLRs) are the best characterized pattern recognition receptors(1). Individual TLRs recruit diverse combinations of adaptor proteins, triggering signal transduction pathways and leading to the activation of various transcription factors, including nuclear factor kappa B, activation protein 1 and interferon regulatory factors(2). Interleukin-2 is one of the molecules produced by mouse dendritic cells after stimulation by different pattern recognition receptor agonists(3-6). By analogy with the events after T-cell receptor engagement leading to interleukin-2 production, it is therefore plausible that the stimulation of TLRs on dendritic cells may lead to activation of the Ca2+/calcineurin and NFAT (nuclear factor of activated T cells) pathway. Here we show that mouse dendritic cell stimulation with lipopolysaccharide (LPS) induces Src-family kinase and phospholipase C gamma 2 activation, influx of extracellular Ca2+ and calcineurin-dependent nuclear NFAT translocation. The initiation of this pathway is independent of TLR4 engagement, and dependent exclusively on CD14. We also show that LPS-induced NFAT activation via CD14 is necessary to cause the apoptotic death of terminally differentiated dendritic cells, an event that is essential for maintaining self-tolerance and preventing autoimmunity(7,8). Consequently, blocking this pathway in vivo causes prolonged dendritic cell survival and an increase in T-cell priming capability. Our findings reveal novel aspects of molecular signalling triggered by LPS in dendritic cells, and identify a new role for CD14: the regulation of the dendritic cell life cycle through NFAT activation. Given the involvement of CD14 in disease, including sepsis and chronic heart failure(9,10), the discovery of signal transduction pathways activated exclusively via CD14 is an important step towards the development of potential treatments involving interference with CD14 functions.	[Zanoni, Ivan; Ostuni, Renato; Capuano, Giusy; Ronchi, Antonella Ellena; Rocchetti, Marcella; Mingozzi, Francesca; Foti, Maria; Costa, Barbara; Zaza, Antonio; Ricciardi-Castagnoli, Paola; Granucci, Francesca] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Collini, Maddalena; Caccia, Michele; Chirico, Giuseppe] Univ Milano Bicocca, Dept Phys, I-20126 Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca	Granucci, F (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, I-20126 Milan, Italy.	francesca.granucci@unimib.it	Caccia, Michele/AAW-2808-2021; Castagnoli, Paola/E-8288-2010; Caccia, Michele/Q-5623-2018; Foti, Maria/AAB-9961-2022; Zaza, Antonio/N-2646-2019; GRANUCCI, Francesca/K-6150-2019; Ostuni, Renato/AAB-8832-2022; Costa, Barbara/AAB-4181-2021	Caccia, Michele/0000-0002-2968-5635; Zaza, Antonio/0000-0001-9355-4958; Ostuni, Renato/0000-0003-0460-3426; FOTI, MARIA/0000-0002-4481-1900; granucci, francesca/0000-0002-7046-4914; COSTA, BARBARA SIMONA/0000-0002-2910-6736; Zanoni, Ivan/0000-0002-3423-7474; RONCHI, ANTONELLA ELLENA/0000-0002-3905-1038; CHIRICO, Giuseppe/0000-0001-6578-6460	CARIPLO Foundation; European Commission; Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Education and Research (COFIN)	CARIPLO Foundation(Fondazione Cariplo); European Commission(European CommissionEuropean Commission Joint Research Centre); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education and Research (COFIN)(Ministry of Education, Universities and Research (MIUR))	We thank S. Akira, C. Kirschning and K. Miyake for mutant mice; M. Colonna for mutant mice and advice on PLC-gamma 2 activation; E. Serfling for mutant mice and advice on NFAT activation; A. Rao for the VIVIT peptide. We also thank Genopolis-Consorzio di Genomica Funzionale for microarray hybridization and data analysis and K. Mahnke for the anti-DEC205-OVA conjugate. This work was supported by grants from the CARIPLO Foundation, the European Commission 6th Framework Program (MUGEN and DC-THERA contracts), the European Commission 7th Framework Program (TOLERAGE and ENCITE contracts), the Associazione Italiana per la Ricerca sul Cancro (AIRC) and the and the Italian Ministry of Education and Research (COFIN).	Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Dendorfer U, 1996, ARTIF ORGANS, V20, P437, DOI 10.1111/j.1525-1594.1996.tb04529.x; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Genth-Zotz S, 2006, EUR J HEART FAIL, V8, P366, DOI 10.1016/j.ejheart.2005.10.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422	33	229	241	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					264	U130		10.1038/nature08118	http://dx.doi.org/10.1038/nature08118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19525933				2022-12-28	WOS:000267761000042
J	Heysell, SK				Heysell, Scott K.			The Quiet Storm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT					scott.heysell@gmail.com						Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; BRUST JCM, 2008, INT AIDS SOC AUG 3 8; MOLL AP, 2009, S AFR AIDS C MARCH 3; MOODLEY P, 2007, 38 WORLD C LUNG HLTH; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					13	14		10.1001/jama.2009.952	http://dx.doi.org/10.1001/jama.2009.952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567425				2022-12-28	WOS:000267492800001
J	Menke, FLH; Scheres, B				Menke, Frank L. H.; Scheres, Ben			Plant Asymmetric Cell Division, Vive la Difference!	CELL			English	Review							DEPENDENT AUXIN GRADIENTS; APICAL-BASAL AXIS; FATE; EXPRESSION; ESTABLISH; SYSTEM		[Menke, Frank L. H.; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	Menke, FLH (corresponding author), Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands.	f.l.h.menke@uu.nl; b.scheres@uu.nl	Menke, Frank L.H./F-2739-2014; Menke, Frank LH/B-8903-2011	Menke, Frank L.H./0000-0003-2490-4824; Scheres, Ben/0000-0001-5400-9578				Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; Cartwright HN, 2009, SCIENCE, V323, P649, DOI 10.1126/science.1161686; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; ten Hove CA, 2008, CURR OPIN PLANT BIOL, V11, P34, DOI 10.1016/j.pbi.2007.11.001	19	17	18	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1189	1192		10.1016/j.cell.2009.06.007	http://dx.doi.org/10.1016/j.cell.2009.06.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563752	Bronze			2022-12-28	WOS:000267373400013
J	Phillips, JE; Corces, VG				Phillips, Jennifer E.; Corces, Victor G.			CTCF: Master Weaver of the Genome	CELL			English	Review							IMPRINTING CONTROL REGION; BETA-GLOBIN LOCUS; CHROMOSOME CONFORMATION CAPTURE; INSULATOR PROTEIN CTCF; ENHANCER-BLOCKING ACTIVITY; ORDER CHROMATIN-STRUCTURE; THYROID-HORMONE RECEPTOR; CCCTC-BINDING FACTOR; RNA-POLYMERASE-II; C-MYC GENE		[Phillips, Jennifer E.; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Phillips, JE (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	jephill@emory.edu; vcorces@emory.edu		Phillips-Cremins, Jennifer/0000-0002-4702-0450; Corces, Victor/0000-0001-5140-4337	NIGMS NIH HHS [R01 GM035463-25, R01 GM035463, GM35463] Funding Source: Medline; NINDS NIH HHS [1F32NS065603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS065603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Bender MA, 1998, BLOOD, V92, P4394, DOI 10.1182/blood.V92.11.4394.423k48_4394_4403; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boumil RM, 2006, MOL CELL BIOL, V26, P2109, DOI 10.1128/MCB.26.6.2109-2117.2006; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Defossez PA, 2005, J BIOL CHEM, V280, P43017, DOI 10.1074/jbc.M510802200; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Klenova EM, 2001, MOL CELL BIOL, V21, P2221, DOI 10.1128/MCB.21.6.2221-2234.2001; KOHNE AC, 1993, J MOL BIOL, V232, P747, DOI 10.1006/jmbi.1993.1428; Komura JI, 2007, P NATL ACAD SCI USA, V104, P15741, DOI 10.1073/pnas.0702363104; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Rand E, 2004, CURR BIOL, V14, P1007, DOI 10.1016/j.cub.2004.05.041; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yoon YS, 2007, MOL CELL BIOL, V27, P3499, DOI 10.1128/MCB.02170-06; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	100	1094	1129	1	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1194	1211		10.1016/j.cell.2009.06.001	http://dx.doi.org/10.1016/j.cell.2009.06.001			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563753	Green Accepted, Bronze			2022-12-28	WOS:000267373400014
J	Lucey, MR; Mathurin, P; Morgan, TR				Lucey, Michael R.; Mathurin, Philippe; Morgan, Timothy R.			MEDICAL PROGRESS Alcoholic Hepatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TUMOR-NECROSIS-FACTOR; INDUCED LIVER-INJURY; PLACEBO-CONTROLLED TRIAL; PROTEIN-CALORIE MALNUTRITION; TYPE-1 HEPATORENAL-SYNDROME; INDUCED FATTY LIVER; SHORT-TERM SURVIVAL; HEP G2 CELLS; DOUBLE-BLIND; FACTOR-ALPHA		[Lucey, Michael R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Sect Gastroenterol & Hepatol, Madison, WI USA; [Mathurin, Philippe] Univ Lille 2, INSERM, Unite 795, Serv Malad Appareil Digestif,Hop Claude Huriez, Lille, France; [Morgan, Timothy R.] Vet Affairs Long Beach Healthcare Syst, Gastroenterol Sect, Long Beach, CA USA; [Morgan, Timothy R.] Univ Calif Irvine, Div Gastroenterol, Irvine, CA 92717 USA	University of Wisconsin System; University of Wisconsin Madison; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	Lucey, MR (corresponding author), Univ Wisconsin Hosp & Clin, Sect Gastroenterol & Hepatol, CSC H6 516, 600 Highland Ave, Madison, WI 53792 USA.	mrl@medicine.wisc.edu	Lucey, Michael/AAR-4571-2020; Mathurin, Philippe/A-9121-2018	Mathurin, Philippe/0000-0003-3447-2025	Bristol-Myers Squibb; Human Genome Sciences; Integrated Therapeutics; Salix; Vertex; Roche; Schering-Plough; Idenix	Bristol-Myers Squibb(Bristol-Myers Squibb); Human Genome Sciences(GlaxoSmithKline); Integrated Therapeutics; Salix; Vertex(Vertex Pharmaceuticals); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Idenix	Dr. Lucey reports receiving consulting fees from Astellas Pharma and grant support from Bristol-Myers Squibb, Human Genome Sciences, Integrated Therapeutics, Salix, Vertex, Roche, Schering-Plough, and Idenix; Dr. Mathurin, consulting fees from Vertex, Sanofi-Aventis, Gilead, Roche, Schering-Plough, Bristol-Myers Squibb, and Bayer HealthCare and lecture fees from Roche, Gilead, Schering-Plough, Bristol-Myers Squibb, and Bayer HealthCare; and Dr. Morgan, consulting fees from Gilead, Roche, and Vertex, lecture fees from Roche and Schering Plough, and grant support from Roche, Schering-Plough, and Vertex. No other potential conflict of interest relevant to this article was reported.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Addolorato G, 2007, LANCET, V370, P1915, DOI 10.1016/S0140-6736(07)61814-5; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; ALEXANDER JF, 1971, AM J GASTROENTEROL, V56, P515; Angeli P, 1999, HEPATOLOGY, V29, P1690, DOI 10.1002/hep.510290629; [Anonymous], 1995, NATURAL HIST ALCOHOL, DOI DOI 10.4159/9780674044562; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barr SI, 2006, APPL PHYSIOL NUTR ME, V31, P66, DOI [10.1139/h05-020, 10.1139/H05-020]; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; BIRD GLA, 1990, ANN INTERN MED, V112, P917, DOI 10.7326/0003-4819-112-12-917; BJARNASON I, 1984, LANCET, V1, P179; Boetticher NC, 2008, GASTROENTEROLOGY, V135, P1953, DOI 10.1053/j.gastro.2008.08.057; Cabre E, 2000, HEPATOLOGY, V32, P36, DOI 10.1053/jhep.2000.8627; Christensen E, 1999, AM J GASTROENTEROL, V94, P3065, DOI 10.1111/j.1572-0241.1999.03065.x; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Enomoto N, 2002, GASTROENTEROLOGY, V123, P291, DOI 10.1053/gast.2002.34161; Everhart J E, 1997, Liver Transpl Surg, V3, P220, DOI 10.1053/jlts.1997.v3.ajlts0030220; Fischer M, 2003, J BIOL CHEM, V278, P27997, DOI 10.1074/jbc.M302140200; Forrest EH, 2007, GUT, V56, P1743, DOI 10.1136/gut.2006.099226; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Han SHB, 2002, J CLIN GASTROENTEROL, V34, P573, DOI 10.1097/00004836-200205000-00019; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; IMPERIALE TF, 1990, ANN INTERN MED, V113, P299, DOI 10.7326/0003-4819-113-4-299; Imperiale TF, 1999, AM J GASTROENTEROL, V94, P3066, DOI 10.1111/j.1572-0241.1999.03066.x; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; KAMIMURA S, 1992, HEPATOLOGY, V16, P448, DOI 10.1002/hep.1840160225; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Lim JK, 2008, GASTROENTEROLOGY, V134, P1608, DOI 10.1053/j.gastro.2008.03.034; Louvet A, 2008, J HEPATOL, V48, P465, DOI 10.1016/j.jhep.2007.10.010; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lucey M R, 1997, Liver Transpl Surg, V3, P628; Lucey MR, 2008, AM J GASTROENTEROL, V103, P1698, DOI 10.1111/j.1572-0241.2008.01837.x; Lucey MR, 2007, LIVER TRANSPLANT, V13, P190, DOI 10.1002/lt.21014; LUDWIG S, 1980, GASTROENTEROLOGY, V79, P545; MACSWEEN RNM, 1986, SEMIN LIVER DIS, V6, P221, DOI 10.1055/s-2008-1040605; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4; Mathurin P, 2003, HEPATOLOGY, V38, P1363, DOI 10.1016/j.hep.2003.09.038; Mathurin P, 2002, J HEPATOL, V36, P480, DOI 10.1016/S0168-8278(01)00289-6; MATLOFF DS, 1980, GASTROENTEROLOGY, V78, P1389; McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; MENDENHALL CL, 1986, AM J CLIN NUTR, V43, P213, DOI 10.1093/ajcn/43.2.213; MENDENHALL CL, 1984, NEW ENGL J MED, V311, P1464, DOI 10.1056/NEJM198412063112302; MENDENHALL CL, 1984, AM J MED, V76, P211, DOI 10.1016/0002-9343(84)90776-9; Menon KVN, 2004, AM J GASTROENTEROL, V99, P255, DOI 10.1111/j.1572-0241.2004.04034.x; Mezey E, 2004, J HEPATOL, V40, P40, DOI 10.1016/S0168-8278(03)00476-8; Minagawa M, 2004, GASTROENTEROLOGY, V126, P1387, DOI 10.1053/j.gastro.2004.01.022; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mookerjee RP, 2003, GUT, V52, P1182, DOI 10.1136/gut.52.8.1182; MUTIMER DJ, 1993, Q J MED, V86, P649, DOI 10.1093/qjmed/86.10.649; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; Neuman MG, 1998, GASTROENTEROLOGY, V115, P157, DOI 10.1016/S0016-5085(98)70377-4; NISHIGUCHI S, 1991, HEPATOLOGY, V14, P985, DOI 10.1002/hep.1840140606; O'Shea R, 2006, J HEPATOL, V44, P633, DOI 10.1016/j.jhep.2006.01.011; ORREGO H, 1979, LANCET, V2, P1354; Pares A, 1998, J HEPATOL, V28, P615, DOI 10.1016/S0168-8278(98)80285-7; Rambaldi A, 2008, ALIMENT PHARM THER, V27, P1167, DOI 10.1111/j.1365-2036.2008.03685.x; Roman J, 1999, HEPATOLOGY, V30, P1473, DOI 10.1002/hep.510300623; Saitz R, 2007, ANN INTERN MED, V146, P167, DOI 10.7326/0003-4819-146-3-200702060-00005; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1360, DOI 10.1053/j.gastro.2008.02.014; Song ZY, 2004, HEPATOLOGY, V40, P989, DOI 10.1002/hep.20412; Spahr L, 2002, J HEPATOL, V37, P448, DOI 10.1016/S0168-8278(02)00230-1; Spahr L, 2001, J HEPATOL, V35, P582, DOI 10.1016/S0168-8278(01)00190-8; Srikureja W, 2005, J HEPATOL, V42, P700, DOI 10.1016/j.jhep.2004.12.022; Stickel F, 2003, ALIMENT PHARM THER, V18, P357, DOI 10.1046/j.1365-2036.2003.01660.x; Taieb J, 2000, J HEPATOL, V32, P579, DOI 10.1016/S0168-8278(00)80219-6; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; TSUKAMOTO H, 1984, AM J PHYSIOL, V247, pR595, DOI 10.1152/ajpregu.1984.247.3.R595; Uesugi T, 2002, J IMMUNOL, V168, P2963, DOI 10.4049/jimmunol.168.6.2963; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Urbaschek R, 2001, ALCOHOL CLIN EXP RES, V25, P261; VEITCH RL, 1975, J CLIN INVEST, V55, P1026, DOI 10.1172/JCI108003; Veldt BJ, 2002, J HEPATOL, V36, P93, DOI 10.1016/S0168-8278(01)00228-8; Wells JT, 2007, LIVER TRANSPLANT, V13, P1728, DOI 10.1002/lt.21298; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Yin M, 2001, J IMMUNOL, V166, P4737, DOI 10.4049/jimmunol.166.7.4737; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Yin M, 2001, HEPATOLOGY, V34, P935, DOI 10.1053/jhep.2001.28888; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049; Zhou ZX, 2001, AM J PATHOL, V159, P329, DOI 10.1016/S0002-9440(10)61699-9; 2004, MMWR MORB MORTAL WKL, V53, P866	99	608	646	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2758	2769		10.1056/NEJMra0805786	http://dx.doi.org/10.1056/NEJMra0805786			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553649				2022-12-28	WOS:000267286600010
J	Zwier, TS				Zwier, Timothy S.			Squeezing the Water Out of HCl(aq)	SCIENCE			English	Editorial Material							HELIUM NANODROPLETS; SPECTROSCOPY; COMPLEXES; CLUSTERS		Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zwier, TS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	zwier@purdue.edu						Burnham CJ, 2002, J CHEM PHYS, V117, P1109, DOI 10.1063/1.1483259; Choi MY, 2006, INT REV PHYS CHEM, V25, P15, DOI 10.1080/01442350600625092; Devlin JP, 2005, J PHYS CHEM A, V109, P955, DOI 10.1021/jp044212k; Devlin JP, 2002, NATURE, V417, P269, DOI 10.1038/417269a; Douberly GE, 2007, J PHYS CHEM A, V111, P7282, DOI 10.1021/jp070015k; Gutberlet A, 2009, SCIENCE, V324, P1545, DOI 10.1126/science.1171753; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Metzger RM, 2008, J MATER CHEM, V18, P4364, DOI 10.1039/b802804b; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Moore AM, 2008, ANNU REV ANAL CHEM, V1, P857, DOI 10.1146/annurev.anchem.1.031207.112932; Toennies JP, 2004, ANGEW CHEM INT EDIT, V43, P2622, DOI 10.1002/anie.200300611; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+	12	19	19	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1522	1523		10.1126/science.1175387	http://dx.doi.org/10.1126/science.1175387			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541983				2022-12-28	WOS:000267130600028
J	Graham, BB; Kaul, DR; Saint, S; Janssen, WJ				Graham, Brian B.; Kaul, Daniel R.; Saint, Sanjay; Janssen, William J.			Kiss of Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; FULMINANT HEPATIC-FAILURE; ACUTE LIVER-FAILURE; UNITED-STATES; INFECTION; TYPE-1; ADULT		[Graham, Brian B.; Janssen, William J.] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA; [Kaul, Daniel R.] Univ Michigan, Div Infect Dis, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Vet Affairs Hlth Serv Res, Ann Arbor, MI 48109 USA; Univ Michigan, Dev Ctr Excellence, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Janssen, William J.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Jewish Health	Graham, BB (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, 4200 E 9th Ave,Box C-272, Denver, CO 80262 USA.	brian.graham@uchsc.edu	Saint, Sanjay/AAF-5126-2019	Graham, Brian/0000-0001-7541-2585				Abbo L, 2007, TRANSPL INFECT DIS, V9, P323, DOI 10.1111/j.1399-3062.2007.00207.x; Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014; Chan TYK, 2001, J TOXICOL-CLIN TOXIC, V39, P175, DOI 10.1081/CLT-100103837; DIX RD, 1983, INFECT IMMUN, V40, P103, DOI 10.1128/IAI.40.1.103-112.1983; Farr RW, 1997, CLIN INFECT DIS, V24, P1191, DOI 10.1086/513646; Kaufman B, 1997, CLIN INFECT DIS, V24, P334, DOI 10.1093/clinids/24.3.334; MIYAZAKI Y, 1991, APMIS, V99, P1001, DOI 10.1111/j.1699-0463.1991.tb01292.x; Montalbano M, 2005, TRANSPLANT P, V37, P4393, DOI 10.1016/j.transproceed.2005.10.031; Norvell JP, 2007, LIVER TRANSPLANT, V13, P1428, DOI 10.1002/lt.21250; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Schiodt FV, 2003, AM J GASTROENTEROL, V98, P448, DOI 10.1016/S0002-9270(02)05891-4; Stocher M, 2003, J CLIN VIROL, V26, P85, DOI 10.1016/S1386-6532(02)00042-2; TREY C, 1968, NEW ENGL J MED, V279, P798, DOI 10.1056/NEJM196810102791504; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	14	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2564	2568		10.1056/NEJMcps0806935	http://dx.doi.org/10.1056/NEJMcps0806935			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516037				2022-12-28	WOS:000266813800013
J	Pasachoff, JM				Pasachoff, Jay M.			Solar eclipses as an astrophysical laboratory	NATURE			English	Review							WHITE-LIGHT CORONA; ELECTRON-TEMPERATURE; SPECTRUM; WAVES; SHAPE	Observations of the Sun during total eclipses have led to major discoveries, such as the existence of helium (from its spectrum), the high temperature of the corona (though the reason for the high temperature remains controversial), and the role of magnetic fields in injecting energy into-and trapping ionized gases within-stellar atmospheres. Anew generation of ground-based eclipse observations reaches spatial, temporal and spectral-resolution domains that are inaccessible from space and therefore complement satellite studies.	[Pasachoff, Jay M.] Williams Coll, Hopkins Observ, Williamstown, MA 01267 USA; [Pasachoff, Jay M.] CALTECH, Dept Planetary Sci, Pasadena, CA 91125 USA	Johns Hopkins University; Williams College; California Institute of Technology	Pasachoff, JM (corresponding author), Williams Coll, Hopkins Observ, 33 Lab Campus Dr, Williamstown, MA 01267 USA.	jmp@williams.edu			Committee for Research and Exploration of the National Geographic Society; Astronomy and Atmospheric Sciences Divisions of the National Science Foundation; Heliophysics Division of NASA	Committee for Research and Exploration of the National Geographic Society(National Geographic Society); Astronomy and Atmospheric Sciences Divisions of the National Science Foundation; Heliophysics Division of NASA	The author is glad to acknowledge his mentors and eclipse colleagues over the 50-year period that he has been observing his 48 solar eclipses, including D. H. Menzel, J. P. Schierer, B. A. Babcock, S. P. Souza, V. Rus. in, M. Druckmuller, M. Saniga and others; L. Golub, R. W. Noyes, E. H. Avrett and H. Zirin for other aspects of solar physics; F. Espenak for eclipse- path calculations; and generations of undergraduate students from Williams College who have participated in expeditions and/or studied eclipse data. At various times, his eclipse research has been supported by the Committee for Research and Exploration of the National Geographic Society, the Astronomy and Atmospheric Sciences Divisions of the National Science Foundation, and the Heliophysics Division of NASA, as well as by Williams College. He thanks M. Brown and the Division of Geological and Planetary Sciences of the California Institute of Technology for hospitality during the writing of this Review. The preparation of the article benefited from NASA's Astrophysical Data System.	Aschwanden M., 2009, PHYS SOLAR CORONA; BECKMAN J, 1973, NATURE, V246, P72, DOI 10.1038/246072a0; Bertotti B, 2003, NATURE, V425, P374, DOI 10.1038/nature01997; Chang ML, 2006, LIVER INT, V26, P3; Cook A, 1996, Q J ROY ASTRON SOC, V37, P349; Cowsik R, 1999, SOL PHYS, V188, P89, DOI 10.1023/A:1005149303094; Crelinsten Jeffrey, 2013, E JURY RACE TEST REL; Davidson C., 1920, PHILOS T R SOC A, V220, P291, DOI DOI 10.1098/RSTA.1920.0009; DEMIRCAN O, 2007, ASP C SER, V370; DRUCKMULLER M, 2006, CONTRIB ASTRON OBS S, V36, P131; Edlen B, 1942, Z ASTROPHYS, V22, P30; Espenak F., 2006, TECHNICAL PUBLICATIO; ESPENAK F, 2008, NASA; ESPENAK F, 2008, TECHNICAL PUBLICATIO; ESPENAK F, 2006, NASA; Evans David S., 2005, HARLANS GLOBETROTTER; Foukal P.V., 2004, SOLAR ASTROPHYSICS; Froeschle M, 1997, ESA SP PUBL, V402, P49; GABRIEL AH, 1971, ASTROPHYS J, V169, P595, DOI 10.1086/151178; Golub L., 1997, SOLAR CORONA; GUILLERMIER P, 1998, ECLIPSES TOTALES HIS; HELD W, 2005, ASTRONOMISCHE STERNS; Ichimoto K, 1996, PUBL ASTRON SOC JPN, V48, P545, DOI 10.1093/pasj/48.3.545; Isaacson W., 2007, EINSTEIN HIS LIFE UN; Kim IS, 2000, ASTR SOC P, V205, P69; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; KOHL JL, 1994, SPACE SCI REV, V70, P253, DOI 10.1007/BF00777876; KOUTCHMY S, 1994, ASTRON ASTROPHYS, V281, P249; Koutchmy S., 2005, ESA; KOUTCHMY S, 2004, P IAU S, V233, P509; LAFFINEUR M, 1969, NATURE, V222, P461, DOI 10.1038/222461a0; Lang Kenneth R., 2009, SUN SPACE; LENA P, 1974, ASTRON ASTROPHYS, V37, P81; LINDSEY C, 1992, NATURE, V458, P308; Littmann Mark, 2008, TOTALITY ECLIPSES SU; Meadows A. J., 1970, EARLY SOLAR PHYS; MENZEL DH, 1968, PUBL ASTRON SOC PAC, V80, P458, DOI 10.1086/128659; MENZEL DH, 1931, PUBL LICK OBS 11, V17; Mobberley M, 2007, TOTAL SOLAR ECLIPSES; MUHLEMAN DO, 1970, PHYS REV LETT, V24, P1377, DOI 10.1103/PhysRevLett.24.1377; Noble MW, 2008, APPL OPTICS, V47, P5744, DOI 10.1364/AO.47.005744; OTTEWELL G, 1991, UNDERSTANDING ECLIPS; OZKAN MT, 2007, MODERN SOLAR FACILIT, P201; Pang Alex Soojung-Kim, 2002, EMPIRE SUN VICTORIAN; Pasachoff JM, 2008, ASTROPHYS J, V682, P638, DOI 10.1086/588020; Pasachoff JM, 2007, ASTROPHYS J, V665, P824, DOI 10.1086/519680; Pasachoff J.M., 1996, J HIST ASTRON, V27, P129; Pasachoff JM, 2006, SOL PHYS, V238, P261, DOI 10.1007/s11207-006-0176-4; Pasachoff JM, 2002, SOL PHYS, V207, P241, DOI 10.1023/A:1016297800478; PASACHOFF JM, 2007, ASTRONOMY DEV WORLD, P265; PASACHOFF JM, 1998, IAU C, V162, P202; Pasachoff JM, 1993, CAMBRIDGE ECLIPSE PH; PASACHOFF JM, 1999, ASTRON GEOPHYS, V40; PASACHOFF JM, 2009, B AM ASTRON SOC, V41; Quemerais E, 2002, ASTRON ASTROPHYS, V393, P295, DOI 10.1051/0004-6361:20021019; Rayet G. A. P., 1868, CR HEBD ACAD SCI, V67, P757; Reginald NL, 2004, SOL PHYS, V225, P249, DOI 10.1007/s11207-004-3516-2; Reginald NL, 2003, ASTROPHYS J, V599, P596, DOI 10.1086/379148; Rusin V, 2000, ASTR SOC P, V205, P17; RUSIN V, 2008, T AM GEOPHYS UN; SAITO K, 1973, SOL PHYS, V31, P105, DOI 10.1007/BF00156076; Shapiro SS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.121101; *SOHO, 2008, PICK WEEK SOL ECL; Stephenson F.R., 1997, HIST ECLIPSES EARTHS; Van Doorsselaere T, 2008, ASTROPHYS J LETT, V676, pL73, DOI 10.1086/587029; Vazquez M., 2009, SUN RECORDED HIST SC; WILLIAMS DR, 2004, ESA, P513; Williams S., 1996, UK SOLAR ECLIPSES YE; Zirin H, 1988, ASTROPHYSICS SUN; Zirker J B., 1995, TOTAL ECLIPSES SUN; 1976, ASTRON J, V81, P452; [No title captured]	72	34	36	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					789	795		10.1038/nature07987	http://dx.doi.org/10.1038/nature07987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516332				2022-12-28	WOS:000267084500028
J	Honigsbaum, M				Honigsbaum, Mark			Historical keyword Pandemic	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London, England	University of London; University College London	Honigsbaum, M (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London, England.			honigsbaum, mark/0000-0002-1891-8763					0	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1939	1939		10.1016/S0140-6736(09)61053-9	http://dx.doi.org/10.1016/S0140-6736(09)61053-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19501732	Green Submitted			2022-12-28	WOS:000266832500013
J	Macnaughton, J				Macnaughton, Jane			The art of medicine The dangerous practice of empathy	LANCET			English	Editorial Material									Univ Durham, Ctr Med Humanities, Durham DH1 1SZ, England	Durham University	Macnaughton, J (corresponding author), Univ Durham, Ctr Med Humanities, Durham DH1 1SZ, England.	jane.macnaughton@durham.ac.uk			Wellcome Trust [086049] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buber Martin., 2020, I THOU; Keen Suzanna., 2007, EMPATHY NOVEL; KIRSCHENBAUM H, 1990, C ROGERS DIALOGUES C; Midgley M., 2001, SCI POETRY; Plath Sylvia, 1963, BELL JAR; Stein E., 1989, PROBLEM EMPATHY	6	46	46	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1940	1941		10.1016/S0140-6736(09)61055-2	http://dx.doi.org/10.1016/S0140-6736(09)61055-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19514114	Green Accepted, Green Submitted			2022-12-28	WOS:000266832500015
J	Hastings, MG; Jarvis, JC; Steig, EJ				Hastings, M. G.; Jarvis, J. C.; Steig, E. J.			Anthropogenic Impacts on Nitrogen Isotopes of Ice-Core Nitrate	SCIENCE			English	Article									[Hastings, M. G.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hastings, M. G.] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Jarvis, J. C.; Steig, E. J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Brown University; Brown University; University of Washington; University of Washington Seattle	Hastings, MG (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	meredith_hastings@brown.edu	Steig, Eric J/G-9088-2015; Hastings, Meredith/C-6199-2008	Steig, Eric J/0000-0002-8191-5549; Hastings, Meredith/0000-0001-6716-6783	NSF [OPP 0454803]; Joint Institute for the Study of the Atmosphere and Ocean (JISAO) [1747]; National Oceanic and Atmospheric Administration (NOAA) [NA17RJ1232]	NSF(National Science Foundation (NSF)); Joint Institute for the Study of the Atmosphere and Ocean (JISAO); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	We acknowledge financial support from NSF (OPP 0454803) and the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under National Oceanic and Atmospheric Administration (NOAA) cooperative agreement no. NA17RJ1232 (JISAO Contribution no. 1747); logistical support from VECO Polar Resources and Ice Coring and Drilling Services (ICDS); and analytical and technical support from D. Gleason, S. Kunasek, P. Neff, J. Wettstein, and A. Schauer.	Burkhart JF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006771; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GLEASON D, JISAO CONTRIBUTION, V1747; Hastings MG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002502; Jarvis JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035551; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Marland G., 2008, TRENDS COMPENDIUM DA; Morin S, 2008, SCIENCE, V322, P730, DOI 10.1126/science.1161910; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; Wolfe AP, 2006, ARCT ANTARCT ALP RES, V38, P465, DOI 10.1657/1523-0430(2006)38[465:ACROAN]2.0.CO;2	10	161	172	10	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1288	1288		10.1126/science.1170510	http://dx.doi.org/10.1126/science.1170510			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498161				2022-12-28	WOS:000266635100034
J	Matthews, DR; Levy, JC				Matthews, David R.; Levy, Jonathan C.			Impending type 2 diabetes	LANCET			English	Editorial Material							MELLITUS; GLUCOSE; FAILURE		[Matthews, David R.; Levy, Jonathan C.] Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Levy, Jonathan C.] Oxford Biomed Res Ctr, NIHR, Oxford, England	University of Oxford; University of Oxford	Matthews, DR (corresponding author), Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	david.matthews@ocdem.ox.ac.uk		Levy, Jonathan/0000-0002-9486-1885				Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Lindstrom J, 2003, J AM SOC NEPHROL, V14, pS108, DOI 10.1097/01.ASN.0000070157.96264.13; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; ROSE G, 1977, LANCET, V1, P105; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	9	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2009	373	9682					2178	2179		10.1016/S0140-6736(09)60865-5	http://dx.doi.org/10.1016/S0140-6736(09)60865-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19515411				2022-12-28	WOS:000267444500007
J	Qiu, J				Qiu, Jane			China clamps down on controversial therapies	LANCET			English	Editorial Material																			0	11	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1834	1835		10.1016/S0140-6736(09)61007-2	http://dx.doi.org/10.1016/S0140-6736(09)61007-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19504665				2022-12-28	WOS:000266616400012
J	Chi, SW; Zang, JB; Mele, A; Darnell, RB				Chi, Sung Wook; Zang, Julie B.; Mele, Aldo; Darnell, Robert B.			Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps	NATURE			English	Article							SYSTEMATIC IDENTIFICATION; NEURONAL DIFFERENTIATION; TARGET PREDICTIONS; BINDING PROTEINS; CROSS-LINKING; BRAIN; ELEGANS; CELLS; IMMUNOPRECIPITATION; TRANSLATION	MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 628 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.	[Chi, Sung Wook; Zang, Julie B.; Mele, Aldo; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; [Chi, Sung Wook; Zang, Julie B.; Mele, Aldo; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	NIH; Cornell/Rockefeller/Sloan-Kettering Tri-Institutional Program in Computational Biology and Medicine; MD-PhD Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell/Rockefeller/Sloan-Kettering Tri-Institutional Program in Computational Biology and Medicine; MD-PhD Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Darnell laboratory for discussion, J. Fak for help with exon arrays, C. Zhang for bioinformatic discussions, and G. Dunn, D. Licatalosi, C. Marney, M. Frias, T. Eom, J. Darnell, M. Yano and C. Zhang for critical review of the manuscript. Wealso thank Z. Mourelatos for supplying the 2A8 antibody and communicating unpublished results; G. Hannon for discussions; and S. Dewell for help with high-throughput sequencing. This work was supported in part by grants from the NIH (R. B. D.), the Cornell/Rockefeller/Sloan-Kettering Tri-Institutional Program in Computational Biology and Medicine (S. W. C.) and MD-PhD Program (J. B. Z.). R. B. D. is an Investigator of the Howard Hughes Medical Institute.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; HE L, 2004, NAT REV GENET, V5, P522; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	50	1308	1352	5	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 23	2009	460	7254					479	486		10.1038/nature08170	http://dx.doi.org/10.1038/nature08170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	474BK	19536157	Green Accepted			2022-12-28	WOS:000268257000031
J	Coureuil, M; Mikaty, G; Miller, F; Lecuyer, H; Bernard, C; Bourdoulous, S; Dumenil, G; Mege, RM; Weksler, BB; Romero, IA; Couraud, PO; Nassif, X				Coureuil, Mathieu; Mikaty, Guillain; Miller, Florence; Lecuyer, Herve; Bernard, Christine; Bourdoulous, Sandrine; Dumenil, Guillaume; Mege, Rene-Marc; Weksler, Babette B.; Romero, Ignacio A.; Couraud, Pierre-Olivier; Nassif, Xavier			Meningococcal Type IV Pili Recruit the Polarity Complex to Cross the Brain Endothelium	SCIENCE			English	Article							HUMAN EPITHELIAL-CELLS; NEISSERIA-MENINGITIDIS; PATHOGENIC NEISSERIA; TWITCHING MOTILITY; BARRIER; ADHESION; ADHERENS; RECEPTOR; CDC42; PAR3	Type IV pili mediate the initial interaction of many bacterial pathogens with their host cells. In Neisseria meningitidis, the causative agent of cerebrospinal meningitis, type IV pili-mediated adhesion to brain endothelial cells is required for bacteria to cross the blood-brain barrier. Here, type IV pili-mediated adhesion of N. meningitidis to human brain endothelial cells was found to recruit the Par3/Par6/PKC zeta polarity complex that plays a pivotal role in the establishment of eukaryotic cell polarity and the formation of intercellular junctions. This recruitment leads to the formation of ectopic intercellular junctional domains at the site of bacteria-host cell interaction and a subsequent depletion of junctional proteins at the cell-cell interface with opening of the intercellular junctions of the brain-endothelial interface.	[Coureuil, Mathieu; Mikaty, Guillain; Lecuyer, Herve; Bernard, Christine; Dumenil, Guillaume; Nassif, Xavier] Univ Paris 05, Fac Med, INSERM, U570, F-75015 Paris, France; [Miller, Florence; Bourdoulous, Sandrine; Couraud, Pierre-Olivier] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75015 Paris, France; [Miller, Florence; Bourdoulous, Sandrine; Couraud, Pierre-Olivier] INSERM, U567, F-75014 Paris, France; [Lecuyer, Herve; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Mege, Rene-Marc] Univ Paris 06, Inst Fer Moulin, INSERM, UMR S 839, F-75005 Paris, France; [Weksler, Babette B.] Weill Cornell Med Coll, New York, NY 10021 USA; [Romero, Ignacio A.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Cornell University; Open University - UK	Coureuil, M (corresponding author), Univ Paris 05, Fac Med, INSERM, U570, F-75015 Paris, France.	mathieu.coureuil@inserm.fr	Coureuil, Mathieu/D-4793-2017; Dumenil, Guillaume/F-7567-2015; Dumenil, Guillaume/N-3377-2019; Mege, Rene Marc/M-9569-2013	Coureuil, Mathieu/0000-0001-7655-9685; Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Romero, Ignacio/0000-0002-0322-9180; Mege, Rene-Marc/0000-0001-8128-5543	la Fondation pour la Recherche Medicale (FRM)	la Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	M.C. was funded by la Fondation pour la Recherche Medicale (FRM).	Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Eugene E, 2002, J CELL SCI, V115, P1231; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Madgula VLM, 2007, PLANTA MED, V73, P330, DOI 10.1055/s-2007-967137; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x	26	155	164	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 3	2009	325	5936					83	87		10.1126/science.1173196	http://dx.doi.org/10.1126/science.1173196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19520910	Green Submitted, Green Accepted			2022-12-28	WOS:000267594000040
J	Schaefer, GO; Emanuel, EJ; Wertheimer, A				Schaefer, G. Owen; Emanuel, Ezekiel J.; Wertheimer, Alan			The Obligation to Participate in Biomedical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETHINKING RESEARCH ETHICS; 20-YEAR FOLLOW-UP; CLINICAL-RESEARCH; BREAST-CANCER; DUTY; TRIALS; MASTECTOMY	The current prevailing view is that participation in biomedical research is above and beyond the call of duty. While some commentators have offered reasons against this, we propose a novel public goods argument for an obligation to participate in biomedical research. Biomedical knowledge is a public good, available to any individual even if that individual does not contribute to it. Participation in research is a critical way to support an important public good. Consequently, all have a duty to participate. The current social norm is that individuals participate only if they have a good reason to do so. The public goods argument implies that individuals should participate unless they have a good reason not to. Such a shift would be of great aid to the progress of biomedical research, eventually making society significantly healthier and longer lived. JAMA. 2009;302(1):67-72	[Schaefer, G. Owen; Emanuel, Ezekiel J.; Wertheimer, Alan] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Wertheimer, A (corresponding author), NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA.	wertheimera@cc.nih.gov	Schaefer, G. Owen/I-3138-2019	Schaefer, G. Owen/0000-0002-6915-6148	Intramural NIH HHS [NIH0013833506] Funding Source: Medline; PHS HHS [NIH0013833506] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allhoff F, 2005, AM J BIOETHICS, V5, P50, DOI 10.1080/15265160590927688; ALLHOFF F, 2005, AM J BIOETHICS, V5, pW15; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Barnbaum DR, 2008, MED HEALTH CARE PHIL, V11, P343, DOI 10.1007/s11019-008-9124-4; Barnes K., 2010, PHARM GIANTS RISK RE; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; BENSON AB, 1991, J CLIN ONCOL, V9, P2067, DOI 10.1200/JCO.1991.9.11.2067; Brassington I, 2007, BIOETHICS, V21, P160, DOI 10.1111/j.1467-8519.2007.00539.x; Caplan Arthur L, 1984, IRB, V6, P1, DOI 10.2307/3563928; Chan S, 2009, BIOETHICS, V23, P161, DOI 10.1111/j.1467-8519.2008.00648.x; Cohen, 2002, REGULATING INTIMACY; Cornes R., 1996, THEORY EXTERNALITIES; *COUNC EUR EUR CON, 1950, 5 ETS COUNC EUR EUR; *CTR INF STUD RES, 101 FACTS CLIN RES; de Melo-Martin I, 2008, AM J BIOETHICS, V8, P28, DOI 10.1080/15265160802393017; Evans HM, 2004, J MED ETHICS, V30, P198, DOI 10.1136/jme.2003.002444; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Frankena W.K., 1980, THINKING MORALITY; GHOSH J, 2003, GLOBAL PUBLIC GOODS, P119; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Harris J, 2005, J MED ETHICS, V31, P242, DOI 10.1136/jme.2005.011973; HEAD JG, 1969, ECON J, V79, P567, DOI 10.2307/2230383; Herrera CD, 2003, THEOR MED BIOETH, V24, P215, DOI 10.1023/A:1024888622358; HEYD D, 2003, ETHICAL REGULATORY A, P161; Jenkins VA, 1999, EUR J CANCER, V35, P1187, DOI 10.1016/S0959-8049(99)00116-1; Jonas H., 2003, ETHICAL REGUL ASP CL, P155; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kenny C, 2005, WORLD DEV, V33, P1, DOI 10.1016/j.worlddev.2004.06.016; LEMMON EJ, 1962, PHILOS REV, V71, P139, DOI 10.2307/2182983; LEVINE ROBERT J., 1988, ETHICS REGULATION CL, V2nd; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Madsen SM, 2000, J INTERN MED, V248, P463, DOI 10.1046/j.1365-2796.2000.00755.x; Murphy L., 2000, MORAL DEMANDS NONIDE; Orentlicher D, 2005, HASTINGS CENT REP, V35, P20, DOI 10.2307/3528330; *PEW RES CTR PEOPL, 2008, PEW RES CTR PEOPL PR; Rhodes R, 2005, AM J BIOETHICS, V5, P7, DOI 10.1080/15265160590900678; Rhodes R, 2008, AM J BIOETHICS, V8, P37, DOI 10.1080/15265160802478594; Ross W., 2002, RIGHT GOOD; Samuelson PA, 1955, REV ECON STAT, V37, P350, DOI 10.2307/1925849; Sharp RR, 2005, AM J BIOETHICS, V5, P40, DOI 10.1080/15265160590927804; SHARP RR, 2005, AM J BIOETHICS, V5, pW15; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; Tait AR, 1998, ANESTH ANALG, V86, P50, DOI 10.1097/00000539-199801000-00010; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Wachbroit R, 2005, AM J BIOETHICS, V5, P48, DOI 10.1080/15265160590927831; WACHBROIT R, 2005, AM J BIOETHICS, V5, pW15; Wertheimer A., 1975, PARTICIPATION POLITI; Woodward, 2003, GLOBAL PUBLIC GOODS, P3	50	103	104	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					67	72		10.1001/jama.2009.931	http://dx.doi.org/10.1001/jama.2009.931			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567441	Green Submitted, Green Accepted			2022-12-28	WOS:000267492800023
J	Fink, DW				Fink, Donald W., Jr.			FDA Regulation of Stem Cell-Based Products	SCIENCE			English	Editorial Material								Cell self-renewal and the capacity to differentiate into multiple cell types (pluripotency) are biological attributes casting stem cells as attractive candidates for development of therapies targeting indications that involve functional restoration of damaged tissues. In the United States, clinical trials designed to demonstrate the safety and effectiveness of stem cell-based products are regulated by the U. S. Food and Drug Administration (FDA). To ensure that subjects enrolled in a clinical study involving stem cell-based products are not exposed to significant and unreasonable risk, the FDA reviews medical and scientific information that encompasses delineation of product-specific characteristics and preclinical testing to determine whether there is sufficient safety assurance to permit initiation of human clinical studies.	US FDA, Cell Therapy Branch,Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Fink, DW (corresponding author), US FDA, Cell Therapy Branch,Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies, Ctr Biol Evaluat & Res, 1401 Rockville Pike,Suite 200N,Mail Code HFM 720, Rockville, MD 20852 USA.	donald.fink@fda.hhs.gov						Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; FINK DW, 2005, ESSENTIALS STEM CELL, P503; Long CM, 2009, EXPERT OPIN BIOL TH, V9, P293, DOI 10.1517/14712590802715723 ; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Moos Malcolm Jr, 2008, Trends Pharmacol Sci, V29, P591, DOI 10.1016/j.tips.2008.09.003; Preynat-Seauve O, 2009, J CELL MOL MED, V13, P3556, DOI 10.1111/j.1582-4934.2009.00746.x; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	10	106	108	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1662	1663		10.1126/science.1173712	http://dx.doi.org/10.1126/science.1173712			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462GE	19556496				2022-12-28	WOS:000267338200025
J	Majumder, MA; Cohen, CB				Majumder, Mary A.; Cohen, Cynthia B.			The NIH Draft Guidelines on Human Stem Cell Research	SCIENCE			English	Editorial Material							EMBRYOS; DONATE; LINES		[Majumder, Mary A.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Cohen, Cynthia B.] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA	Baylor College of Medicine; Georgetown University	Majumder, MA (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	majumder@bcm.edu						Cohen CB, 2009, STEM CELL REV REP, V5, P116, DOI 10.1007/s12015-009-9060-6; Holden C, 2009, SCIENCE, V323, P1412, DOI 10.1126/science.323.5920.1412; Hug K, 2008, FERTIL STERIL, V89, P263, DOI 10.1016/j.fertnstert.2007.09.017; Hynes RO, 2008, NAT REV MOL CELL BIO, V9, P993, DOI 10.1038/nrm2528; *I MED, 2002, RESP RES SYST APPR P; *INT SOC STEM CELL, 2009, ISCCR COMM NIH UNPUB; Lyerly AD, 2007, SCIENCE, V317, P46, DOI 10.1126/science.1145067; National Institute of Health (NIH), 2000, FED REGISTER, V65, P51976; *NBAC, 1999, ETH ISS HUM STEM CEL; *NRC, 2007, 2007 AM NAT AC GUID; *NRC, 2005, GUID HUM EMBR STEM C; NRC and IOM, 2008, 2008 AM NAT AC GUID; OBAMA BH, 2009, REMARKS DELIVERY STE; STEIN R, 2009, WASHINGTON POST 0525, pA9; Sugarman J, 2008, SCIENCE, V322, P379, DOI 10.1126/science.1164441; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; Taylor PL, 2009, CELL STEM CELL, V4, P479, DOI 10.1016/j.stem.2009.05.002; 2009, FED REG, V74, P18578	18	4	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1648	1649		10.1126/science.1176253	http://dx.doi.org/10.1126/science.1176253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462GE	19556488				2022-12-28	WOS:000267338200017
J	Nakatani, J; Tamada, K; Hatanaka, F; Ise, S; Ohta, H; Inoue, K; Tomonaga, S; Watanabe, Y; Chung, YJ; Banerjee, R; Iwamoto, K; Kato, T; Okazawa, M; Yamauchi, K; Tanda, K; Takao, K; Miyakawa, T; Bradley, A; Takumi, T				Nakatani, Jin; Tamada, Kota; Hatanaka, Fumiyuki; Ise, Satoko; Ohta, Hisashi; Inoue, Kiyoshi; Tomonaga, Shozo; Watanabe, Yasuhito; Chung, Yeun Jun; Banerjee, Ruby; Iwamoto, Kazuya; Kato, Tadafumi; Okazawa, Makoto; Yamauchi, Kenta; Tanda, Koichi; Takao, Keizo; Miyakawa, Tsuyoshi; Bradley, Allan; Takumi, Toru			Abnormal Behavior in a Chromosome-Engineered Mouse Model for Human 15q11-13 Duplication Seen in Autism	CELL			English	Article							SOCIAL-INTERACTION; DEVELOPMENTAL NEUROBIOLOGY; SPECTRUM DISORDERS; PROXIMAL 15Q; GENETICS; COMPLEX; BRAIN; MICE; REARRANGEMENTS; DEFICITS	Substantial evidence suggests that chromosomal abnormalities contribute to the risk of autism. The duplication of human chromosome 15q11-13 is known to be the most frequent cytogenetic abnormality in autism. We have modeled this genetic change in mice by using chromosome engineering to generate a 6.3 Mb duplication of the conserved linkage group on mouse chromosome 7. Mice with a paternal duplication display poor social interaction, behavioral inflexibility, abnormal ultrasonic vocalizations, and correlates of anxiety. An increased MBII52 snoRNA within the duplicated region, affecting the serotonin 2c receptor (5-HT2cR), correlates with altered intracellular Ca2+ responses elicited by a 5-HT2cR agonist in neurons of mice with a paternal duplication. This chromosome-engineered mouse model for autism seems to replicate various aspects of human autistic phenotypes and validates the relevance of the human chromosome abnormality. This model will facilitate forward genetics of developmental brain disorders and serve as an invaluable tool for therapeutic development.	[Nakatani, Jin; Tamada, Kota; Hatanaka, Fumiyuki; Inoue, Kiyoshi; Tomonaga, Shozo; Watanabe, Yasuhito; Okazawa, Makoto; Takumi, Toru] Osaka Biosci Inst, Osaka 5650874, Japan; [Tamada, Kota; Watanabe, Yasuhito] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Hatanaka, Fumiyuki; Takumi, Toru] Kyoto Univ, Dept Mol Neurosci, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Ise, Satoko; Ohta, Hisashi] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan; [Chung, Yeun Jun; Banerjee, Ruby; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Iwamoto, Kazuya; Kato, Tadafumi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Kato, Tadafumi; Takumi, Toru] Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348553, Japan; [Yamauchi, Kenta; Tanda, Koichi; Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Frontier Technol Inst, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med, Inst Comprehens Med Sci, Aichi 4701192, Japan	Kyoto University; Kyoto University; Merck & Company; Novartis; Wellcome Trust Sanger Institute; RIKEN; Hiroshima University; Kyoto University; Fujita Health University	Takumi, T (corresponding author), Osaka Biosci Inst, Osaka 5650874, Japan.	takumi@hiroshima-u.ac.jp	Takao, Keizo/B-9527-2008; Kato, Tadafumi/J-3583-2014; Miyakawa, Tsuyoshi/A-7741-2008; Tomonaga, Shozo/S-3307-2018	Takao, Keizo/0000-0002-4734-3583; Kato, Tadafumi/0000-0001-7856-3952; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Tomonaga, Shozo/0000-0003-0888-1407; Yamauchi, Kenta/0000-0002-7090-3067; Bradley, Allan/0000-0002-2349-8839	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Neuroinformatics Japan Center; Institute for Bioinformatics Research and Development; Core Research for Evolutional Science and Technology; Mitsubishi Foundation; Mother and Child Health Foundation; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Sony Corporation; Nippon Boehringer Ingelheim Co., Ltd; Wellcome Trust	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Neuroinformatics Japan Center; Institute for Bioinformatics Research and Development; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Mitsubishi Foundation; Mother and Child Health Foundation(Mother and Child Health Foundation); Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Sony Corporation; Nippon Boehringer Ingelheim Co., Ltd(Boehringer Ingelheim); Wellcome Trust(Wellcome TrustEuropean Commission)	T. T. acknowledges M. Young for discussions that led to start this project and K. Tanaka, O. Hayaishi, H. Hanafusa, and S. Nakanishi for general support. The authors thank K. Sakimura and M. Abe for their help in the initial stage of this study; N. Nakai, A. Yamamoto, T. Sudo, F. Law, A. Beasley, E. Grau, T. Hamilton, L. Davis, H. Kitson, H. Ogino, and R. Takayama for technical assistance; W. Wang, D. Adams, N. Conte, T. Kishino, T. Manabe, and P. Levitt for valuable comments; and all members of the Takumi laboratory. We also thank K. Nakao and members of Animal Resource Unit, RIKEN Center for Developmental Biology, for breeding of mice. J. N. and S. T. were supported by a Japan Society for the Promotion of Science fellowship. This work was supported in part by a grant from the Grants-in-Aid for Scientific Research on Priority AreasResearch on Pathomechanisms of Brain Disorders from the Ministry of Education, Culture, Sports, Science and Technology, the Neuroinformatics Japan Center, the Institute for Bioinformatics Research and Development, and Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, and by research grants from the Mitsubishi Foundation, the Mother and Child Health Foundation, the Mitsubishi Pharma Research Foundation, the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, Sony Corporation, Nippon Boehringer Ingelheim Co., Ltd, and the Wellcome Trust.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bolton PF, 2004, PSYCHIAT GENET, V14, P131, DOI 10.1097/00041444-200409000-00002; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Caston J, 1998, EUR J NEUROSCI, V10, P2677, DOI 10.1046/j.1460-9568.1998.t01-1-00272.x; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cook EH, 1997, AM J HUM GENET, V60, P928; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Dykens EM, 2004, MENT RETARD DEV D R, V10, P284, DOI 10.1002/mrdd.20042; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geurts HM, 2009, TRENDS COGN SCI, V13, P74, DOI 10.1016/j.tics.2008.11.006; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Maestrini E, 2000, NEURON, V28, P19, DOI 10.1016/S0896-6273(00)00081-7; Mao R, 2000, GENET MED, V2, P131, DOI 10.1097/00125817-200003000-00003; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Mohandas TK, 1999, AM J MED GENET, V82, P294, DOI 10.1002/(SICI)1096-8628(19990212)82:4<294::AID-AJMG4>3.3.CO;2-L; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Murcia CL, 2005, INT J DEV NEUROSCI, V23, P265, DOI 10.1016/j.ijdevneu.2004.07.001; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; NOIROT E, 1966, ANIM BEHAV, V14, P459, DOI 10.1016/S0003-3472(66)80045-3; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Roberts SE, 2002, HUM GENET, V110, P227, DOI 10.1007/s00439-002-0678-6; Rosenzweig-Lipson S, 2006, BRAIN RES, V1073, P240, DOI 10.1016/j.brainres.2005.12.052; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; van der Weyden L, 2006, ANNU REV GENOM HUM G, V7, P247, DOI 10.1146/annurev.genom.7.080505.115741; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Veltman MWM, 2005, J AUTISM DEV DISORD, V35, P117, DOI 10.1007/s10803-004-1039-1; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Whitaker-Azmitia PM, 2005, INT J DEV NEUROSCI, V23, P75, DOI 10.1016/j.ijdevneu.2004.07.022; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Young LJ, 2007, NEURON, V54, P353, DOI 10.1016/j.neuron.2007.04.011; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	60	323	340	4	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1235	1246		10.1016/j.cell.2009.04.024	http://dx.doi.org/10.1016/j.cell.2009.04.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563756	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000267373400017
J	Skaar, JR; D'Angiolella, V; Pagan, JK; Pagano, M				Skaar, Jeffrey R.; D'Angiolella, Vincenzo; Pagan, Julia K.; Pagano, Michele			SnapShot: F Box Proteins II	CELL			English	Editorial Material							CELL-CYCLE; PROTEOLYSIS; LIGASE; FAMILY		[Skaar, Jeffrey R.; D'Angiolella, Vincenzo; Pagan, Julia K.; Pagano, Michele] NYU, Sch Med, New York, NY 10016 USA; [Pagano, Michele] Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute	Skaar, JR (corresponding author), NYU, Sch Med, New York, NY 10016 USA.		Pagan, Julia/O-1929-2016	Pagan, Julia/0000-0002-7079-6388; pagano, michele/0000-0003-3210-2442	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA076584] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	10	95	99	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 26	2009	137	7					1358	U100	1358.e1	10.1016/j.cell.2009.05.040	http://dx.doi.org/10.1016/j.cell.2009.05.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563764	Bronze			2022-12-28	WOS:000267373400028
J	Upadhyay, D; Scherer, EE; Mezger, K				Upadhyay, Dewashish; Scherer, Erik E.; Mezger, Klaus			Nd-142 evidence for an enriched Hadean reservoir in cratonic roots	NATURE			English	Article							EARLY DIFFERENTIATION; MAGMA OCEAN; MANTLE; CRUST; HETEROGENEITY; NEODYMIUM; MARS; GA; SYSTEMATICS; ISOTOPES	The isotope Sm-146 undergoes alpha-decay to Nd-142, with a half-life of 103 million years. Measurable variations in the Nd-142/Nd-144 values of rocks resulting from Sm-Nd fractionation could therefore only have been produced within about 400 million years of the Solar System's formation ( that is, when Sm-146 was extant). The Nd-142/(144) Nd compositions of terrestrial rocks(1-7) are accordingly a sensitive monitor of the main silicate differentiation events that took place in the early Earth. High Nd-142/(144) Nd values measured in some Archaean rocks from Greenland(1-5) hint at the existence of an early incompatible-element-depleted mantle. Here we present measurements of low Nd-142/(144) Nd values in 1.48-gigayear-(Gyr)old lithospheric mantle-derived alkaline rocks from the Khariar nepheline syenite complex in southeastern India(8). These data suggest that a reservoir that was relatively enriched in incompatible elements formed at least 4.2 Gyr ago and traces of its isotopic signature persisted within the lithospheric root of the Bastar craton until at least 1.48 Gyr ago. These low Nd-142/(144) Nd compositions may represent a diluted signature of a Hadean (4 to 4.57 Gyr ago) enriched reservoir that is characterized by even lower values. That no evidence of the early depleted mantle has been observed in rocks younger than 3.6 Gyr (refs 3, 4, 7) implies that such domains had effectively mixed back into the convecting mantle by then. In contrast, some early enriched components apparently escaped this fate. Thus, the mantle sampled by magmatism since 3.6 Gyr ago may be biased towards a depleted composition that would be balanced by relatively more enriched reservoirs that are 'hidden' in Hadean crust(6), the D '' layer(9-11) of the lowermost mantle or, as we propose here, also within the roots of old cratons.	[Upadhyay, Dewashish; Scherer, Erik E.; Mezger, Klaus] Univ Munster, Inst Mineral, Zent Lab Geochronol, D-48149 Munster, Germany	University of Munster	Upadhyay, D (corresponding author), Univ Munster, Inst Mineral, Zent Lab Geochronol, Corrensstr 24, D-48149 Munster, Germany.	upadhyay@uni-muenster.de	Mezger, Klaus/D-9502-2011; Scherer, Erik E/P-3388-2017	Mezger, Klaus/0000-0002-2443-8539; Scherer, Erik E/0000-0001-6049-6202; UPADHYAY, DEWASHISH/0000-0001-5654-0872	Deutsche Forschungsgemeinschaft [ME1717]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	D. U. thanks A. Bhattacharya and M. Raith for help during field work and sample collection. This project was funded by grants from the Deutsche Forschungsgemeinschaft (ME1717).	Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; Andreasen R, 2008, EARTH PLANET SC LETT, V266, P14, DOI 10.1016/j.epsl.2007.10.009; Andreasen R, 2006, SCIENCE, V314, P806, DOI 10.1126/science.1131708; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2007, EARTH PLANET SC LETT, V262, P505, DOI 10.1016/j.epsl.2007.08.009; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Carlson RW, 2007, SCIENCE, V316, P1175, DOI 10.1126/science.1140189; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; Caro G, 2008, NATURE, V452, P336, DOI 10.1038/nature06760; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; Foley CN, 2005, GEOCHIM COSMOCHIM AC, V69, P4557, DOI 10.1016/j.gca.2005.05.009; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; HARPER CL, 1995, SCIENCE, V267, P213, DOI 10.1126/science.7809625; Harrison TM, 2008, EARTH PLANET SC LETT, V268, P476, DOI 10.1016/j.epsl.2008.02.011; Harrison TM, 2005, SCIENCE, V310, P1947, DOI 10.1126/science.1117926; Helffrich G, 2006, TECTONOPHYSICS, V416, P23, DOI 10.1016/j.tecto.2005.11.012; JORDAN TH, 1975, REV GEOPHYS, V13, P1, DOI 10.1029/RG013i003p00001; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; MARESCHAL M, 1995, NATURE, V375, P134, DOI 10.1038/375134a0; NYQUIST LE, 1995, GEOCHIM COSMOCHIM AC, V59, P2817, DOI 10.1016/0016-7037(95)00175-Y; O'Neil J, 2008, SCIENCE, V321, P1828, DOI 10.1126/science.1161925; Rankenburg K, 2006, SCIENCE, V312, P1369, DOI 10.1126/science.1126114; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; Upadhyay D, 2008, J ANAL ATOM SPECTROM, V23, P561, DOI 10.1039/b715585a; Upadhyay D, 2006, CONTRIB MINERAL PETR, V151, P434, DOI 10.1007/s00410-006-0069-4	27	43	45	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1118	1121		10.1038/nature08089	http://dx.doi.org/10.1038/nature08089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553997				2022-12-28	WOS:000267636700041
J	Retnakaran, R; Zinman, B				Retnakaran, Ravi; Zinman, Bernard			Thiazolidinediones and clinical outcomes in type 2 diabetes	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR EVENTS; EUROPEAN-ASSOCIATION; CONSENSUS ALGORITHM; ROSIGLITAZONE; PIOGLITAZONE; THERAPY; RISK; MELLITUS; HYPERGLYCEMIA		[Retnakaran, Ravi; Zinman, Bernard] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON M5T 3L9, Canada; [Retnakaran, Ravi; Zinman, Bernard] Univ Toronto, Div Endocrinol, Toronto, ON, Canada; [Zinman, Bernard] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Zinman, B (corresponding author), Mt Sinai Hosp, Leadership Sinai Ctr Diabet, 60 Murray St, Toronto, ON M5T 3L9, Canada.	zinman@lunenfeld.ca	Retnakaran, Ravi/P-2002-2015; Zinman, Bernard/E-7266-2013	Retnakaran, Ravi/0000-0003-1989-027X; 				Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-9016, 10.2337/dc08-0545]; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zinman B, 2006, DIABETES OBES METAB, V8, P531, DOI 10.1111/j.1463-1326.2005.00540.x	16	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2009	373	9681					2088	2090		10.1016/S0140-6736(09)61029-1	http://dx.doi.org/10.1016/S0140-6736(09)61029-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460YQ	19501899				2022-12-28	WOS:000267229700006
J	Eldrett, JS; Greenwood, DR; Harding, IC; Huber, M				Eldrett, James S.; Greenwood, David R.; Harding, Ian C.; Huber, Matthew			Increased seasonality through the Eocene to Oligocene transition in northern high latitudes	NATURE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; MODEL VERSION-3 CCSM3; EOCENE/OLIGOCENE BOUNDARY; CALCITE COMPENSATION; PALEOCLIMATIC CHANGE; CLIMATE SENSITIVITY; BIPOLAR GLACIATION; GREENLAND; ICE; SIMULATION	A profound global climate shift took place at the Eocene-Oligocene transition (similar to 33.5 million years ago) when Cretaceous/early Palaeogene greenhouse conditions gave way to icehouse conditions(1-3). During this interval, changes in the Earth's orbit and a long-term drop in atmospheric carbon dioxide concentrations(4-6) resulted in both the growth of Antarctic ice sheets to approximately their modern size(2,3) and the appearance of Northern Hemisphere glacial ice(7,8). However, palaeoclimatic studies of this interval are contradictory: although some analyses indicate no major climatic changes(9,10), others imply cooler temperatures(11), increased seasonality(12,13) and/or aridity(12-15). Climatic conditions in high northern latitudes over this interval are particularly poorly known. Here we present northern high-latitude terrestrial climate estimates for the Eocene to Oligocene interval, based on bioclimatic analysis of terrestrially derived spore and pollen assemblages preserved in marine sediments from the Norwegian-Greenland Sea. Our data indicate a cooling of similar to 5 degrees C in cold-month (winter) mean temperatures to 0-2 degrees C, and a concomitant increased seasonality before the Oi-1 glaciation event. These data indicate that a cooling component is indeed incorporated in the delta 18O isotope shift across the Eocene Oligocene transition. However, the relatively warm summer temperatures at that time mean that continental ice on East Greenland was probably restricted to alpine outlet glaciers.	[Eldrett, James S.] Shell Explorat & Prod UK Ltd, Aberdeen AB12 3FY, Scotland; [Greenwood, David R.] Brandon Univ, Dept Biol, Brandon, MB R7A 6A9, Canada; [Harding, Ian C.] Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Huber, Matthew] Purdue Univ, Dept Earth & Atmospher Sci, Purdue Climate Change Res Ctr, W Lafayette, IN 47906 USA	Brandon University; NERC National Oceanography Centre; University of Southampton; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Eldrett, JS (corresponding author), Shell Explorat & Prod UK Ltd, 1 Altens Farm Rd, Aberdeen AB12 3FY, Scotland.	james.eldrett@shell.com	Greenwood, David R./C-2758-2008; Huber, Matthew/A-7677-2008; Harding, Ian C/K-3320-2012	Greenwood, David R./0000-0002-8569-9695; Huber, Matthew/0000-0002-2771-9977; Harding, Ian/0000-0003-4281-0581; eldrett, james/0000-0001-5196-3112	US National Science Foundation (NSF); NSERC (Canada)	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research used samples provided by the Ocean Drilling Program (ODP). ODP was sponsored by the US National Science Foundation (NSF) and participating countries under management of Consortium for Ocean Leadership. D. R. G.'s research is supported by NSERC (Canada). We thank S. Akbari for sample preparation.	Billups K, 2003, EARTH PLANET SC LETT, V209, P181, DOI 10.1016/S0012-821X(03)00067-0; Bonow JM, 2006, GEOMORPHOLOGY, V80, P325, DOI 10.1016/j.geomorph.2006.03.006; Brozena JM, 2003, GEOLOGY, V31, P825, DOI 10.1130/G19528.1; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Edgar KM, 2007, NATURE, V448, P908, DOI 10.1038/nature06053; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; Eldrett JS, 2004, MAR GEOL, V204, P91, DOI 10.1016/S0025-3227(03)00357-8; Greenwood DR, 2005, CAN J EARTH SCI, V42, P167, DOI 10.1139/E04-100; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Grimes ST, 2005, GEOLOGY, V33, P189, DOI 10.1130/G21019.1; Huber M, 2001, J ATMOS SCI, V58, P2377, DOI 10.1175/1520-0469(2001)058<2377:ACOTDI>2.0.CO;2; Huber M, 2001, GEOPHYS RES LETT, V28, P3481, DOI 10.1029/2001GL012943; HUBER M, 2003, GEOL SOC AM SPEC PAP, V369, P25, DOI DOI 10.1130/0-8137-2369-8.25; *IBIS, AUSTR NAT HERB; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Kiehl JT, 2006, J CLIMATE, V19, P2584, DOI 10.1175/JCLI3747.1; Kiehl JT, 2005, GEOLOGY, V33, P757, DOI 10.1130/G21654.1; Kobashi T, 2001, GEOLOGY, V29, P983, DOI 10.1130/0091-7613(2001)029<0983:ROCETT>2.0.CO;2; Kohn MJ, 2004, GEOLOGY, V32, P621, DOI 10.1130/G20442.1; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; NORRIS G, 1982, NATURE, V297, P387, DOI 10.1038/297387a0; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Retallack GJ, 2004, GEOL SOC AM BULL, V116, P817, DOI 10.1130/B25281.1; Schouten S, 2008, GEOLOGY, V36, P147, DOI 10.1130/G24332A.1; Sewall JO, 2000, GLOBAL PLANET CHANGE, V26, P445, DOI 10.1016/S0921-8181(00)00056-4; Sheldon ND, 2002, J GEOL, V110, P687, DOI 10.1086/342865; St John K, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001483; Terry DO, 2001, PALAEOGEOGR PALAEOCL, V168, P1, DOI 10.1016/S0031-0182(00)00248-0; Thompson R.S., 1999, ATLAS RELATIONS CLIM; Thorn VC, 2006, PALAEOGEOGR PALAEOCL, V231, P134, DOI 10.1016/j.palaeo.2005.07.032; Tripati AK, 2008, EARTH PLANET SC LETT, V265, P112, DOI 10.1016/j.epsl.2007.09.045; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; Via RK, 2006, GEOLOGY, V34, P441, DOI 10.1130/G22545.1; YANG H, 1994, J ATMOS SCI, V51, P3437, DOI 10.1175/1520-0469(1994)051<3437:PODABI>2.0.CO;2; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551; PALAEOFLORA DATABASE	48	195	204	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					969	U91		10.1038/nature08069	http://dx.doi.org/10.1038/nature08069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536261				2022-12-28	WOS:000267063500039
J	Aoki, ST; Settembre, EC; Trask, SD; Greenberg, HB; Harrison, SC; Dormitzer, PR				Aoki, Scott T.; Settembre, Ethan C.; Trask, Shane D.; Greenberg, Harry B.; Harrison, Stephen C.; Dormitzer, Philip R.			Structure of Rotavirus Outer-Layer Protein VP7 Bound with a Neutralizing Fab	SCIENCE			English	Article							RHESUS ROTAVIRUS; 3-DIMENSIONAL STRUCTURE; SEQUENCE; CALCIUM; HEMAGGLUTININ; ANTIBODIES; EPITOPES; VACCINE; BINDING	Rotavirus outer-layer protein VP7 is a principal target of protective antibodies. Removal of free calcium ions (Ca2+) dissociates VP7 trimers into monomers, releasing VP7 from the virion, and initiates penetration-inducing conformational changes in the other outer-layer protein, VP4. We report the crystal structure at 3.4 angstrom resolution of VP7 bound with the Fab fragment of a neutralizing monoclonal antibody. The Fab binds across the outer surface of the intersubunit contact, which contains two Ca2+ sites. Mutations that escape neutralization by other antibodies suggest that the same region bears the epitopes of most neutralizing antibodies. The monovalent Fab is sufficient to neutralize infectivity. We propose that neutralizing antibodies against VP7 act by stabilizing the trimer, thereby inhibiting the uncoating trigger for VP4 rearrangement. A disulfide-linked trimer is a potential subunit immunogen.	[Aoki, Scott T.; Settembre, Ethan C.; Trask, Shane D.; Harrison, Stephen C.; Dormitzer, Philip R.] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Harrison, Stephen C.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA.	harrison@crystal.harvard.edu; philip.dormitzer@novartis.com		greenberg, harry/0000-0002-2128-9080	NIH [CA-13202, AI-21362, DK-56339]; NATIONAL CANCER INSTITUTE [R01CA013202, R37CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI021362, R56AI021362, R01AI021362, R37AI021362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Babyonyshev for help with protein preparations, the staff of the Northeastern Collaborative Access Team (Advanced Photon Source, Argonne National Laboratory) for assistance with x-ray data collection, R. Stanfield for the library of Fab structures, and J. Patton for help with sequence variability analysis. Supported by NIH grant CA-13202 (S.C.H.), by a VA Merit Award and NIH grants AI-21362 and DK-56339 (H.B.G.), and by an Ellison Medical Foundation New Investigators in Infectious Diseases Award (P.R.D.). S.C.H. is an Investigator of the Howard Hughes Medical Institute. Atomic coordinates and structure factor amplitudes for the VP7-4F8 Fab complex have been deposited in the Protein Data Bank (www.rcsb.org) with accession code 3FMG.	ANDREW ME, 1990, J VIROL, V64, P4776, DOI 10.1128/JVI.64.10.4776-4783.1990; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; Dormitzer PR, 2000, VIROLOGY, V277, P420, DOI 10.1006/viro.2000.0625; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; DORMITZER PR, 1994, VIROLOGY, V204, P391, DOI 10.1006/viro.1994.1543; Estes MK, 2007, FIELDS VIROLOGY, V2, P1918; FIORE L, 1991, VIROLOGY, V181, P553, DOI 10.1016/0042-6822(91)90888-I; Gajardo R, 1997, J VIROL, V71, P2211, DOI 10.1128/JVI.71.3.2211-2216.1997; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; GREEN KY, 1988, J VIROL, V62, P1819, DOI 10.1128/JVI.62.5.1819-1823.1988; Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008; Li ZL, 2009, J VIROL, V83, P1754, DOI 10.1128/JVI.01855-08; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Ludert JE, 2002, J VIROL, V76, P6643, DOI 10.1128/JVI.76.13.6643-6651.2002; MACKOW ER, 1988, VIROLOGY, V165, P511, DOI 10.1016/0042-6822(88)90595-8; MICHELANGELI F, 1995, J VIROL, V69, P3838, DOI 10.1128/JVI.69.6.3838-3847.1995; NISHIKAWA K, 1989, VIROLOGY, V171, P503, DOI 10.1016/0042-6822(89)90620-X; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; RUGGERI FM, 1991, J VIROL, V65, P2211, DOI 10.1128/JVI.65.5.2211-2219.1991; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Santos N, 2008, J CLIN MICROBIOL, V46, P462, DOI 10.1128/JCM.01361-07; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; SHAW RD, 1986, VIROLOGY, V155, P434, DOI 10.1016/0042-6822(86)90205-9; SVENSSON L, 1994, J VIROL, V68, P5204, DOI 10.1128/JVI.68.8.5204-5215.1994; Trask SD, 2006, J VIROL, V80, P11293, DOI 10.1128/JVI.01346-06; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133	29	173	185	4	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1444	1447		10.1126/science.1170481	http://dx.doi.org/10.1126/science.1170481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520960	Green Accepted			2022-12-28	WOS:000266878700046
J	Kharlip, J; Cooper, DS				Kharlip, Julia; Cooper, David S.			Recent developments in hyperthyroidism	LANCET			English	Editorial Material							GRAVES-DISEASE; ANTITHYROID DRUGS; RADIOIODINE; MORTALITY; SURGERY; TSH		[Kharlip, Julia; Cooper, David S.] Johns Hopkins Univ, Sch Med, Div Endocrinol, Baltimore, MD 21201 USA	Johns Hopkins University	Cooper, DS (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol, Baltimore, MD 21201 USA.	dscooper@jhmi.edu						Abraham P, 2005, COCHRANE DB SYST REV, V2; Abraham-Nordling M, 2005, THYROID, V15, P1279, DOI 10.1089/thy.2005.15.1279; Bousquet-Santos K, 2006, ARCH PHYS MED REHAB, V87, P1123, DOI 10.1016/j.apmr.2006.04.017; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Carani C, 2005, J CLIN ENDOCR METAB, V90, P6472, DOI 10.1210/jc.2005-1135; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Haentjens P, 2008, EUR J ENDOCRINOL, V159, P329, DOI 10.1530/EJE-08-0110; Laurberg P, 2008, EUR J ENDOCRINOL, V158, P69, DOI 10.1530/EJE-07-0450; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Rodien P, 2008, EUR J ENDOCRINOL, V159, P515, DOI 10.1530/EJE-08-0630; Schreckenberger MF, 2006, J CLIN ENDOCR METAB, V91, P4786, DOI 10.1210/jc.2006-0573; Sun L, 2006, ANN NY ACAD SCI, V1068, P309, DOI 10.1196/annals.1346.033; Tauchmanova L, 2004, MATURITAS, V48, P299, DOI 10.1016/j.maturitas.2004.02.017; WALTER MA, 2007, BRIT MED J, V334, pS14	14	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2009	373	9679					1930	1932		10.1016/S0140-6736(09)61047-3	http://dx.doi.org/10.1016/S0140-6736(09)61047-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19501730				2022-12-28	WOS:000266832500009
J	Fuhrmann, J; Schmidt, A; Spiess, S; Lehner, A; Turgay, K; Mechtler, K; Charpentier, E; Clausen, T				Fuhrmann, Jakob; Schmidt, Andreas; Spiess, Silvia; Lehner, Anita; Turgay, Kuersad; Mechtler, Karl; Charpentier, Emmanuelle; Clausen, Tim			McsB Is a Protein Arginine Kinase That Phosphorylates and Inhibits the Heat-Shock Regulator CtsR	SCIENCE			English	Article							GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; NEGATIVE REGULATOR; STRESS-RESPONSE; 1ST GENE; REPRESSOR; ENCODES; OPERON; CLP	All living organisms face a variety of environmental stresses that cause the misfolding and aggregation of proteins. To eliminate damaged proteins, cells developed highly efficient stress response and protein quality control systems. We performed a biochemical and structural analysis of the bacterial CtsR/McsB stress response. The crystal structure of the CtsR repressor, in complex with DNA, pinpointed key residues important for high-affinity binding to the promoter regions of heat-shock genes. Moreover, biochemical characterization of McsB revealed that McsB specifically phosphorylates arginine residues in the DNA binding domain of CtsR, thereby impairing its function as a repressor of stress response genes. Identification of the CtsR/McsB arginine phospho-switch expands the repertoire of possible protein modifications involved in prokaryotic and eukaryotic transcriptional regulation.	[Fuhrmann, Jakob; Lehner, Anita; Mechtler, Karl; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schmidt, Andreas] Univ Vienna, Christian Doppler Lab Proteome Anal, A-1030 Vienna, Austria; [Spiess, Silvia; Charpentier, Emmanuelle] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Turgay, Kuersad] Free Univ Berlin, Inst Biol Microbiol, D-14195 Berlin, Germany; [Mechtler, Karl] Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Charpentier, Emmanuelle] Umea Univ, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Free University of Berlin; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Umea University	Clausen, T (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Turgay, Kürsad/D-4828-2011; Turgay, Kürşad/Q-5285-2019	Mechtler, Karl/0000-0002-3392-9946; Turgay, Kürsad/0000-0002-8959-492X; Turgay, Kürşad/0000-0002-8959-492X; Schmidt, Andreas/0000-0001-9369-3747; Clausen, Tim/0000-0003-1582-6924	Boehringer Ingelheim; Wiener Wissenschafts; Forschungs und Technologiefonds; Christian-Doppler-Society; Deutsche Forschungsgemeinschaft; European Molecular Biology Organization Young Investigator Program; Austrian Proteomics Platform (GEN-AU)	Boehringer Ingelheim(Boehringer Ingelheim); Wiener Wissenschafts; Forschungs und Technologiefonds; Christian-Doppler-Society; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Austrian Proteomics Platform (GEN-AU)	We thank D. Fiegen and D. Reinert (Boehringer Ingelheim) and the staff at Swiss Light Source for assistance with collecting synchrotron data, A. Carrieri for his contribution with the kinase assays, L. Becker for the NMR analysis of phosphopeptides, T. Krojer and D. Hellerschmied for their support in the structural analysis of CtsR, and C. Stingl and M. Mazanek for assisting MS analysis. The Research Institute of Molecular Pathology is funded by Boehringer Ingelheim. J.F., S.S., E.C., and T.C. were supported by Wiener Wissenschafts, Forschungs und Technologiefonds; A.S. by the Christian-Doppler-Society; K.T. by the Deutsche Forschungsgemeinschaft; and T.C. by the European Molecular Biology Organization Young Investigator Program. This work was further supported by the Austrian Proteomics Platform (GEN-AU). The Protein Data Bank accession number for the CtsR2/DNA complex is 3H0D.	Derre I, 1999, MOL MICROBIOL, V32, P581, DOI 10.1046/j.1365-2958.1999.01374.x; Derre I, 2000, MOL MICROBIOL, V38, P335, DOI 10.1046/j.1365-2958.2000.02124.x; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; Hecker M, 1996, MOL MICROBIOL, V19, P417, DOI 10.1046/j.1365-2958.1996.396932.x; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; JAMES TL, 1985, CRC CR REV BIOCH MOL, V18, P1, DOI 10.3109/10409238509082538; Kirstein J, 2005, J MOL MICROB BIOTECH, V9, P182, DOI 10.1159/000089646; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Kruger E, 1998, J BACTERIOL, V180, P6681; Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schulz A, 1996, J BACTERIOL, V178, P1088, DOI 10.1128/jb.178.4.1088-1093.1996; SCHUMANN W, 2002, BACILLUS SUBTILIS IT; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; Tholey A, 1999, J MASS SPECTROM, V34, P117, DOI 10.1002/(SICI)1096-9888(199902)34:2<117::AID-JMS769>3.0.CO;2-V; WAKIM BT, 1994, J BIOL CHEM, V269, P2722; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888	20	129	134	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1323	1327		10.1126/science.1170088	http://dx.doi.org/10.1126/science.1170088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498169				2022-12-28	WOS:000266635100045
J	Kamiyama, D; Chiba, A				Kamiyama, Daichi; Chiba, Akira			Endogenous Activation Patterns of Cdc42 GTPase Within Drosophila Embryos	SCIENCE			English	Article							RHO-FAMILY GTPASES; NEURONAL DEVELOPMENT; IN-VIVO; CELLS; GUIDANCE; GROWTH; RAC	Knowing when and where a given protein is activated within intact animals assists in elucidating its in vivo function. With the use of a genetically encoded A-probe (activation bioprobe), we revealed that Cdc42 guanosine triphosphatase (GTPase) remains inactive within Drosophila embryos during the first two-thirds of embryogenesis. Within the central nervous system where Cdc42 activity first becomes up-regulated, individual neurons display patterns restricted to specific subcellular compartments. At both organismal and cellular levels, Cdc42's endogenous activation patterns in the wild type allow predictions of where loss-of-function phenotypes will emerge in cdc42/cdc42 mutants. Genetic tests support the importance of suppressing endogenous Cdc42 activities until needed. Thus, bioprobe-assisted analysis uncovers how ubiquitously expressed signaling proteins control cellular events through continual regulation of their activities within animals.	[Chiba, Akira] Univ Miami, Dept Biol, Coral Gables, FL 33146 USA; Univ Miami, Miami Inst Mol Imaging & Computat, Coral Gables, FL 33146 USA	University of Miami; University of Miami	Chiba, A (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33146 USA.	akira.chiba@miami.edu	Chiba, Akira/AAF-5073-2020		NIH/National Institute of Neurological Disorders and Stroke; NIH/National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079432, R01MH068650] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Hayden, K. Chittanon-Buranachai, R. Clegg, S. Rogers, S. Siechen, and I. Vasenkova for advice; S. Hsu, O. Alpcan, M. Furrer, S. Deng, and R. Kamiyama for technical assistance; Bloomington Drosophila Stock Center and Developmental Studies Hybridoma Bank for reagents; and E. Giniger, J. Baker, and M. Kim for comments on manuscript. Supported by grants from NIH/National Institute of Neurological Disorders and Stroke and NIH/National Institute of Mental Health (A.C.).	Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Nakamura T, 2005, MOL BRAIN RES, V139, P277, DOI 10.1016/j.molbrainres.2005.05.030; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	21	31	31	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1338	1340		10.1126/science.1170615	http://dx.doi.org/10.1126/science.1170615			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498173	Green Accepted			2022-12-28	WOS:000266635100049
J	Thijs, RD; Wieling, W; van Dijk, JG				Thijs, Roland D.; Wieling, Wouter; van Dijk, J. Gert			Status vasovagalis	LANCET			English	Editorial Material									[Thijs, Roland D.; van Dijk, J. Gert] Leiden Univ, Med Ctr, Dept Neurol & Clin Neurophysiol, NL-2300 RC Leiden, Netherlands; [Wieling, Wouter] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Thijs, RD (corresponding author), Leiden Univ, Med Ctr, Dept Neurol & Clin Neurophysiol, POB 9600, NL-2300 RC Leiden, Netherlands.	r.d.thijs@lumc.nl	Thijs, Roland D/AGE-5180-2022	Thijs, Roland D/0000-0003-1435-8970					0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2009	373	9682					2222	2222		10.1016/S0140-6736(09)60305-6	http://dx.doi.org/10.1016/S0140-6736(09)60305-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463PQ	19560603				2022-12-28	WOS:000267444500034
J	Yoo, AS; Staahl, BT; Chen, L; Crabtree, GR				Yoo, Andrew S.; Staahl, Brett T.; Chen, Lei; Crabtree, Gerald R.			MicroRNA-mediated switching of chromatin-remodelling complexes in neural development	NATURE			English	Article							MAMMALIAN SWI/SNF COMPLEXES; STEM-CELLS; TRANSCRIPTION; GENES; NEURONS; MIR-124; MOUSE; REST; IDENTIFICATION; EMBRYOGENESIS	One of the most distinctive steps in the development of the vertebrate nervous system occurs at mitotic exit when cells lose multi-potency and begin to develop stable connections that will persist for a lifetime(1,2). This transition is accompanied by a switch in ATP-dependent chromatin-remodelling mechanisms that appears to coincide with the final mitotic division of neurons. This switch involves the exchange of the BAF53a (also known as ACTL6a) and BAF45a (PHF10) subunits within Swi/Snf-like neural-progenitor-specific BAF (npBAF) complexes for the homologous BAF53b (ACTL6b) and BAF45b (DPF1) subunits within neuron-specific BAF (nBAF) complexes in post-mitotic neurons. The subunits of the npBAF complex are essential for neural-progenitor proliferation, and mice with reduced dosage for the genes encoding its subunits have defects in neural-tube closure similar to those in human spina bifida(3), one of the most serious congenital birth defects. In contrast, BAF53b and the nBAF complex are essential for an evolutionarily conserved program of post-mitotic neural development and dendritic morphogenesis(4,5). Here we show that this essential transition is mediated by repression of BAF53a by miR-9* and miR-124. We find that BAF53a repression is mediated by sequences in the 3' untranslated region corresponding to the recognition sites for miR-9* and miR-124, which are selectively expressed in post-mitotic neurons. Mutation of these sites led to persistent expression of BAF53a and defective activity-dependent dendritic outgrowth in neurons. In addition, overexpression of miR-9* and miR-124 in neural progenitors caused reduced proliferation. Previous studies have indicated that miR-9* and miR-124 are repressed by the repressor-element-1-silencing transcription factor (REST, also known as NRSF)(6). Indeed, expression of REST in post-mitotic neurons led to derepression of BAF53a, indicating that REST-mediated repression of microRNAs directs the essential switch of chromatin regulatory complexes.	[Yoo, Andrew S.; Staahl, Brett T.; Chen, Lei; Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Yoo, Andrew S.; Staahl, Brett T.; Chen, Lei; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Yoo, Andrew S.; Chen, Lei; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu		Yoo, Andrew/0000-0002-0304-3247	Helen Hay Whitney Foundation; US National Institutes of Health (NIH) [2 T32 HD007249]; Howard Hughes Medical Institute; NIH [HD55391, AI060037, NS046789]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249, R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R01NS046789] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. I. Wu and J. Lessard for suggestions. We thank N. Copeland and N. Jenkins for providing us with the reagents for recombineering techniques. A. S. Y. is a fellow of Helen Hay Whitney Foundation. B. T. S. is supported by the Developmental and Neonatal Biology Training Program 2 T32 HD007249 from the US National Institutes of Health (NIH). This work was supported by grants from the Howard Hughes Medical Institute and the NIH, HD55391, AI060037 and NS046789, to G. R. C.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Didiano D, 2008, RNA, V14, P1297, DOI 10.1261/rna.1082708; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021	32	457	473	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2009	460	7255					642	U112		10.1038/nature08139	http://dx.doi.org/10.1038/nature08139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19561591	Green Accepted			2022-12-28	WOS:000268454300053
J	DiCarlo, L; Chow, JM; Gambetta, JM; Bishop, LS; Johnson, BR; Schuster, DI; Majer, J; Blais, A; Frunzio, L; Girvin, SM; Schoelkopf, RJ				DiCarlo, L.; Chow, J. M.; Gambetta, J. M.; Bishop, Lev S.; Johnson, B. R.; Schuster, D. I.; Majer, J.; Blais, A.; Frunzio, L.; Girvin, S. M.; Schoelkopf, R. J.			Demonstration of two-qubit algorithms with a superconducting quantum processor	NATURE			English	Article							SEARCH ALGORITHM; QUBITS; STATE; IMPLEMENTATION; ENTANGLEMENT; CIRCUIT; PHOTON; CAVITY; BITS	Quantum computers, which harness the superposition and entanglement of physical states, could outperform their classical counterparts in solving problems with technological impact-such as factoring large numbers and searching databases(1,2). A quantum processor executes algorithms by applying a programmable sequence of gates to an initialized register of qubits, which coherently evolves into a final state containing the result of the computation. Building a quantum processor is challenging because of the need to meet simultaneously requirements that are in conflict: state preparation, long coherence times, universal gate operations and qubit readout. Processors based on a few qubits have been demonstrated using nuclear magnetic resonance(3-5), cold ion trap(6,7) and optical(8) systems, but a solid-state realization has remained an outstanding challenge. Here we demonstrate a two-qubit superconducting processor and the implementation of the Grover search and Deutsch-Jozsa quantum algorithms(1,2). We use a two-qubit interaction, tunable in strength by two orders of magnitude on nanosecond timescales, which is mediated by a cavity bus in a circuit quantum electrodynamics architecture(9,10). This interaction allows the generation of highly entangled states with concurrence up to 94 per cent. Although this processor constitutes an important step in quantum computing with integrated circuits, continuing efforts to increase qubit coherence times, gate performance and register size will be required to fulfil the promise of a scalable technology.	[DiCarlo, L.; Chow, J. M.; Bishop, Lev S.; Johnson, B. R.; Schuster, D. I.; Frunzio, L.; Girvin, S. M.; Schoelkopf, R. J.] Yale Univ, Dept Phys, New Haven, CT 06511 USA; [DiCarlo, L.; Chow, J. M.; Bishop, Lev S.; Johnson, B. R.; Schuster, D. I.; Frunzio, L.; Girvin, S. M.; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; [Gambetta, J. M.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Gambetta, J. M.] Yale Univ, Inst Quantum Comp, New Haven, CT 06511 USA; [Majer, J.] TU Wien, Atominst Osterreich Univ, A-1020 Vienna, Austria; [Blais, A.] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	Yale University; Yale University; University of Waterloo; Yale University; Technische Universitat Wien; University of Sherbrooke	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06511 USA.	robert.schoelkopf@yale.edu	DiCarlo, Leonardo/F-8714-2010; Frunzio, Luigi/O-1573-2019; Blais, Alexandre/E-3315-2010; Schoelkopf, Robert J/J-8178-2012; Bishop, Lev/C-5476-2009; Majer, Johannes B/C-1864-2008	Frunzio, Luigi/0000-0002-0272-5481; Blais, Alexandre/0000-0002-0591-2012; Bishop, Lev/0000-0003-1318-1149; Majer, Johannes B/0000-0002-5192-1809; schuster, david/0000-0002-0012-3874	LPS/NSA [W911NF-05-1-0365]; NSF [DMR-0653377, DMR-0603369]; CIFAR; MRI; MITACS; NSERC; Alfred P. Sloan Foundation; CNR-Istituto di Cibernetica, Pozzuoli, Italy	LPS/NSA(National Security Agency); NSF(National Science Foundation (NSF)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); MRI; MITACS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); CNR-Istituto di Cibernetica, Pozzuoli, Italy	We thank V. Manucharyan and E. Boaknin for experimental contributions, and M. H. Devoret, I. L. Chuang and A. Nunnenkamp for discussions. This work was supported by LPS/NSA under ARO contract W911NF-05-1-0365, and by the NSF under grants DMR-0653377 and DMR-0603369. We acknowledge additional support from CIFAR, MRI, MITACS and NSERC (J. M. G.), NSERC, CIFAR and the Alfred P. Sloan Foundation (A. B.), and from CNR-Istituto di Cibernetica, Pozzuoli, Italy (L. F.).	Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Blais A, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032329; Brickman KA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.050306; Chow JM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.090502; Chuang IL, 1998, NATURE, V393, P143, DOI 10.1038/30181; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200402; Gulde S, 2003, NATURE, V421, P48, DOI 10.1038/nature01336; Houck AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080502; Jones JA, 1998, NATURE, V393, P344, DOI 10.1038/30687; Kaye P., 2007, INTRO QUANTUM COMPUT; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kwiat PG, 2000, J MOD OPTIC, V47, P257, DOI 10.1080/095003400148187; Lucero E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247001; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Niskanen AO, 2007, SCIENCE, V316, P723, DOI 10.1126/science.1141324; Plantenberg JH, 2007, NATURE, V447, P836, DOI 10.1038/nature05896; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Siddiqi I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207002; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Strauch FW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167005; TAVIS M, 1968, PHYS REV, V170, P379, DOI 10.1103/PhysRev.170.379; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Yamamoto T, 2003, NATURE, V425, P941, DOI 10.1038/nature02015	30	806	833	4	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					240	244		10.1038/nature08121	http://dx.doi.org/10.1038/nature08121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19561592				2022-12-28	WOS:000267761000037
J	Guterman, L				Guterman, Lila			Seeing Green in Conference Season	CELL			English	Editorial Material																			0	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 26	2009	137	7					1169	1171		10.1016/j.cell.2009.06.003	http://dx.doi.org/10.1016/j.cell.2009.06.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563745	Bronze			2022-12-28	WOS:000267373400006
J	Webster, P				Webster, Paul			Profile Toakase Fakakovikaetau: pioneering paediatrician in Tonga	LANCET			English	Biographical-Item												pcwebster@sympatico.ca							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2103	2103		10.1016/S0140-6736(09)61138-7	http://dx.doi.org/10.1016/S0140-6736(09)61138-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460YQ	19541025				2022-12-28	WOS:000267229700013
J	McElwain, JC; Wagner, PJ; Hesselbo, SP				McElwain, Jennifer C.; Wagner, Peter J.; Hesselbo, Stephen P.			Fossil Plant Relative Abundances Indicate Sudden Loss of Late Triassic Biodiversity in East Greenland	SCIENCE			English	Article							JURASSIC BOUNDARY; EXTINCTION EVENT; NORTHERN; DISTRIBUTIONS; STRATIGRAPHY; TERRESTRIAL; TRANSITION; VEGETATION	The pace of Late Triassic (LT) biodiversity loss is uncertain, yet it could help to decipher causal mechanisms of mass extinction. We investigated relative abundance distributions (RADs) of six LT plant assemblages from the Kap Stewart Group, East Greenland, to determine the pace of collapse of LT primary productivity. RADs displayed not simply decreases in the number of taxa, but decreases in the number of common taxa. Likelihood tests rejected a hypothesis of continuously declining diversity. Instead, the RAD shift occurred over the upper two-to-four fossil plant assemblages and most likely over the last three (final 13 meters), coinciding with increased atmospheric carbon dioxide concentration and global warming. Thus, although the LT event did not induce mass extinction of plant families, it accompanied major and abrupt change in their ecology and diversity.	[McElwain, Jennifer C.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland; [Wagner, Peter J.] Natl Museum Nat Hist, Dept Paleobiol, Smithsonian Inst, Washington, DC 20560 USA; [Hesselbo, Stephen P.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University College Dublin; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford	McElwain, JC (corresponding author), Natl Univ Ireland Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland.	jennifer.mcelwain@ucd.ie	Wagner, Peter/A-5514-2009; McElwain, Jennifer/AAX-1605-2020; McElwain, Jennifer/B-1735-2009	Wagner, Peter/0000-0002-9083-9787; McElwain, Jennifer/0000-0002-1729-6755	Marie Curie [MEXT-CT- 2006-042531, NSF-EAR-0207874]	Marie Curie(European Commission)	J.C.M. collected plant paleoecological data, S.P.H collected isotopic and stratigraphic data, and P.J.W. undertook data analyses. J.C.M and P.J.W cowrote the paper, and all authors contributed equally to interpretation. We gratefully acknowledge funding from a Marie Curie Excellence Grant (MEXT-CT- 2006-042531) to J.C.M. and NSF-EAR-0207874 to P.J.W. This is Paleobiology Database contribution 95.	Beerling DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001637; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; BURNHAM RJ, 1989, REV PALAEOBOT PALYNO, V58, P5, DOI 10.1016/0034-6667(89)90054-7; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Edwards AWF, 1992, LIKELIHOOD EXPANDED; Galli MT, 2007, PALAEOGEOGR PALAEOCL, V244, P52, DOI 10.1016/j.palaeo.2006.06.023; Gomez JJ, 2007, PALAEOGEOGR PALAEOCL, V244, P89, DOI 10.1016/j.palaeo.2006.06.025; Gray J.S., 1987, P53; HAMES WE, 2002, AM GEOPHYS UNION MON, V136, P241; Harris T.M., 1937, MEDD GRON, V112, P82; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hesselbo SP, 2007, PALAEOGEOGR PALAEOCL, V244, P1, DOI 10.1016/j.palaeo.2006.06.020; Hubbell Stephen P., 2001, V32, pi; KEMPTON RA, 1979, BIOMETRICS, V35, P307, DOI 10.2307/2529952; Kosnik MA, 2006, EVOL ECOL RES, V8, P195; Kuerschner WM, 2007, PALAEOGEOGR PALAEOCL, V244, P257, DOI 10.1016/j.palaeo.2006.06.031; MANDER L, 2008, COMMUNICATION; Mander L, 2008, J GEOL SOC LONDON, V165, P319, DOI 10.1144/0016-76492007-029; May Robert M., 2007, P111; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; SIGNOR PW, 1982, 190 GEOL SOC AM, P291; van de Schootbrugge B, 2007, PALAEOGEOGR PALAEOCL, V244, P126, DOI 10.1016/j.palaeo.2006.06.026; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Wang SC, 2007, PALEOBIOLOGY, V33, P324, DOI 10.1666/06056.1; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035	28	91	93	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1554	1556		10.1126/science.1171706	http://dx.doi.org/10.1126/science.1171706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541995				2022-12-28	WOS:000267130600042
J	Ciochon, RL				Ciochon, Russell L.			The mystery ape of Pleistocene Asia	NATURE			English	Editorial Material							TEETH; HOMO		Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Ciochon, RL (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	russell-ciochon@uiowa.edu						Ciochon RL, 2009, NATURE, V458, P153, DOI 10.1038/458153a; Etler D.A., 2001, Human Evolution, V16, P1, DOI 10.1007/BF02438918; HUANG WP, 1995, NATURE, V378, P275; Huang WP, 1996, NATURE, V381, P202; Jin CZ, 2009, CHINESE SCI BULL, V54, P788, DOI 10.1007/s11434-008-0531-y; Schwartz Jeffrey H., 1995, Anthropological Papers of the American Museum of Natural History, V76, P1; Schwartz JH, 1996, NATURE, V381, P201, DOI 10.1038/381201a0; Wu Xinzhi, 2000, Acta Anthropologica Sinica, V19, P1	8	53	56	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					910	911		10.1038/459910a	http://dx.doi.org/10.1038/459910a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458XS	19536242	Bronze			2022-12-28	WOS:000267063500019
J	Hawton, K; Bergen, H; Simkin, S; Brock, A; Griffiths, C; Romeri, E; Smith, KL; Kapur, N; Gunnell, D				Hawton, Keith; Bergen, Helen; Simkin, Sue; Brock, Anita; Griffiths, Clare; Romeri, Ester; Smith, Karen L.; Kapur, Navneet; Gunnell, David			Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis	BRITISH MEDICAL JOURNAL			English	Article							SUICIDE-PREVENTION; UK	Objective To assess the effect of the UK Committee on Safety of Medicines' announcement in January 2005 of withdrawal of co-proxamol on analgesic prescribing and poisoning mortality. Design Interrupted time series analysis for 1998-2007. Setting England and Wales. Data sources Prescribing data from the prescription statistics department of the Information Centre for Health and Social Care (England) and the Prescribing Services Unit, Health Solutions Wales (Wales). Mortality data from the Office for National Statistics. Main outcome measures Prescriptions. Deaths from drug poisoning (suicides, open verdicts, accidental poisonings) involving single analgesics. Results A steep reduction in prescribing of co-proxamol occurred in the post-intervention period 2005-7, such that number of prescriptions fell by an average of 859 (95% confidence interval 653 to 1065) thousand per quarter, equating to an overall decrease of about 59%. Prescribing of some other analgesics (co-codamol, paracetamol, co-dydramol, and codeine) increased significantly during this time. These changes were associated with a major reduction in deaths involving co-proxamol compared with the expected number of deaths (an estimated 295 fewer suicides and 349 fewer deaths including accidental poisonings), but no statistical evidence for an increase in deaths involving either other analgesics or other drugs. Conclusions Major changes in prescribing after the announcement of the withdrawal of co-proxamol have had a marked beneficial effect on poisoning mortality involving this drug, with little evidence of substitution of suicide method related to increased prescribing of other analgesics.	[Hawton, Keith; Bergen, Helen; Simkin, Sue] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; [Brock, Anita; Griffiths, Clare; Romeri, Ester] Off Natl Stat, London EC1R 1UW, England; [Smith, Karen L.] Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England; [Kapur, Navneet] Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Oxford; University of Oxford; University of Manchester; University of Bristol	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Kapur, Nav/0000-0002-3100-3234	National Institute of Health Research (NIHR) [RP-PG-0606-1247]; Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust; Department of Health; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust; Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by a National Institute of Health Research (NIHR) Programme Grant for Applied Research (RP-PG-0606-1247). The views and opinions expressed in this paper do not necessarily reflect those of the Department of Health/NIHR or NHS. The funders played no role in the analysis or write up of this paper. KH is also supported by Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust and HB by the Department of Health.	ADELSTEIN AM, 1975, POPULATION TRENDS, V2, P13; Bateman DN, 2003, BRIT MED J, V327, P287, DOI 10.1136/bmj.327.7409.287; BROCK A, 2006, HLTH STAT Q, V31, P6; Committee on Safety of Medicines, 2006, CURR PROBL PHARMACOV, V31, P11; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; FINKLE BS, 1984, HUMAN TOXICOL, V3, P115; Gottlieb S, 2005, BRIT MED J, V330, P9, DOI 10.1136/bmj.330.7481.9-c; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Hawton K, 2005, BRIT J CLIN PHARMACO, V59, P207, DOI 10.1111/j.1365-2125.2004.02252.x; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2003, BMJ-BRIT MED J, V326, P1006, DOI 10.1136/bmj.326.7397.1006; Hawton K, 2007, CRISIS, V28, P4, DOI 10.1027/0227-5910.28.S1.4; *INF CTR HLTH SOC, 2006, PRESCR COST AN ENGL; *INF CTR HLTH SOC, 2007, PRESCR COST AN ENGL; Jonasson U, 2004, RESTRICTIONS PRESCRI; *MED HEALTHC PROD, CEMCMO20052 MED HEAL; *OFF NAT STAT, 2007, HLTH STAT Q, V33, P82; *OFF NAT STAT, 2008, HLTH STAT Q, V39, P82; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Sandilands EA, 2008, BRIT J CLIN PHARMACO, V66, P290, DOI 10.1111/j.1365-2125.2008.03206.x; Segest E, 1993, Med Law, V12, P141; Simkin S, 2005, QJM-INT J MED, V98, P159, DOI 10.1093/qjmed/hci026; *STAT CORP, 2007, STAT STAT SOFTW REL; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; ZHANG F, 15 ANN NESUG NE SAS; 1983, DTB, V21, P17	26	45	45	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 18	2009	338								b2270	10.1136/bmj.b2270	http://dx.doi.org/10.1136/bmj.b2270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460US	19541707	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267216800005
J	Csete, J; Gathumbi, A; Wolfe, D; Cohen, J				Csete, Joanne; Gathumbi, Anne; Wolfe, Daniel; Cohen, Jonathan			Lives to save: PEPFAR, HIV, and injecting drug use in Africa	LANCET			English	Editorial Material									[Csete, Joanne] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA; [Gathumbi, Anne] Open Soc Initiat E Africa, Nairobi, Kenya; [Wolfe, Daniel; Cohen, Jonathan] Open Soc Inst, New York, NY USA	Columbia University	Csete, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA.	jc1188@columbia.edu						[Anonymous], 2022, COMP DRUG TREATM REH; *INT HARM RED ASS, GLOB STAT HARM RED 2; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McCurdy S, 2007, INT J DRUG POLICY, V18, P155, DOI 10.1016/j.drugpo.2007.05.001; Needle R. H., 2006, AFR J DRUG ALCOHOL S, V5, P83; Parfitt T, 2006, LANCET, V368, P279, DOI 10.1016/S0140-6736(06)69060-0; *UN OFF DRUGS CRIM, WORLD DRUG REP 2005; *US AG INT DEV, 2005, MEM RESP C INQ REG H; *US PEPFAR, 2008, CEL LIF LAT PEPFAR R; *WHO, 2006, BAS PRINC TREATM PSY; World Health Organization, 2004, EFFECTIVENESS STERIL	11	7	7	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2006	2007		10.1016/S0140-6736(09)61092-8	http://dx.doi.org/10.1016/S0140-6736(09)61092-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19524764				2022-12-28	WOS:000267080100008
J	Chakrabarti, O; Hegde, RS				Chakrabarti, Oishee; Hegde, Ramanujan S.			Functional Depletion of Mahogunin by Cytosolically Exposed Prion Protein Contributes to Neurodegeneration	CELL			English	Article							ENDOPLASMIC-RETICULUM; DISEASE; SCRAPIE; PRP; NEUROTOXICITY; TRANSLOCATION; DEGRADATION; PATHWAY; TRANSMISSION; PURIFICATION	The pathways leading from aberrant Prion protein (PrP) metabolism to neurodegeneration are poorly understood. Some familial PrP mutants generate increased (PrP)-Pr-Ctm, a transmembrane isoform associated with disease. In other disease situations, a potentially toxic cytosolic form (termed cyPrP) might be produced. However, the mechanisms by which (PrP)-Pr-Ctm or cyPrP cause selective neuronal dysfunction are unknown. Here, we show that both (PrP)-Pr-Ctm and cyPrP can interact with and disrupt the function of Mahogunin (Mgrn), a cytosolic ubiquitin ligase whose loss causes spongiform neurodegeneration. Cultured cells and transgenic mice expressing either (PrP)-Pr-Ctm-producing mutants or cyPrP partially phenocopy Mgrn depletion, displaying aberrant lysosomal morphology and loss of Mgrn in selected brain regions. These effects were rescued by either Mgrn overexpression, competition for PrP-binding sites, or prevention of cytosolic PrP exposure. Thus, transient or partial exposure of PrP to the cytosol leads to inappropriate Mgrn sequestration that contributes to neuronal dysfunction and disease.	[Chakrabarti, Oishee; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X	NICHD at the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008835] Funding Source: NIH RePORTER	NICHD at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to N. Rane for providing transgenic mouse tissues and constructs, E. Whiteman for making the initial Mgrn constructs, Y. Abebe for expert animal care, L. Greene and H. Lorenz for constructs and sharing unpublished results, G. Patterson for help with microscopy, and L. DaSilva, G. Mardones, and P. Burgos for advice and reagents. This work was supported by the Intramural Research Program of the NICHD at the National Institutes of Health.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; BENDHEIM PE, 1988, J INFECT DIS, V158, P1198, DOI 10.1093/infdis/158.6.1198; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	35	96	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1136	1147		10.1016/j.cell.2009.03.042	http://dx.doi.org/10.1016/j.cell.2009.03.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524515	Green Accepted, Bronze			2022-12-28	WOS:000266916400024
J	Kim, D; Tsai, LH				Kim, Dohoon; Tsai, Li-Huei			Bridging Physiology and Pathology in AD	CELL			English	Review							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CELL-DEATH	The APP-processing pathway is a pathological component of Alzheimer's disease (AD), but there is no consensus regarding the physiological functions of APP and its products. Two studies (Nikolaev et al., 2009; Lauren et al., 2009) link the physiological and pathological aspects of APP processing. They show that the APP products, N-APP and A beta 42, are ligands for death receptor 6 and cellular prion protein, respectively, which are important in nervous system development and synaptic suppression.	[Kim, Dohoon; Tsai, Li-Huei] MIT Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Tsai, Li-Huei] MIT, Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02142 USA; [Tsai, Li-Huei] Harvard Univ, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Tsai, LH (corresponding author), MIT Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	lhtsai@mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011	17	60	63	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					997	1000		10.1016/j.cell.2009.05.042	http://dx.doi.org/10.1016/j.cell.2009.05.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524503	Bronze			2022-12-28	WOS:000266916400012
J	Cicchillo, RM; Zhang, HJ; Blodgett, JAV; Whitteck, JT; Li, GY; Nair, SK; van der Donk, WA; Metcalf, WW				Cicchillo, Robert M.; Zhang, Houjin; Blodgett, Joshua A. V.; Whitteck, John T.; Li, Gongyong; Nair, Satish K.; van der Donk, Wilfred A.; Metcalf, William W.			An unusual carbon-carbon bond cleavage reaction during phosphinothricin biosynthesis	NATURE			English	Article							ISOPENICILLIN N-SYNTHASE; MYOINOSITOL OXYGENASE; MECHANISM; ACTIVATION; FOSFOMYCIN; ENZYME; PRODUCTS; INSIGHT; WATER	Natural products containing phosphorus-carbon bonds have found widespread use in medicine and agriculture(1). One such compound, phosphinothricin tripeptide, contains the unusual amino acid phosphinothricin attached to two alanine residues. Synthetic phosphinothricin (glufosinate) is a component of two top-selling herbicides (Basta and Liberty), and is widely used with resistant transgenic crops including corn, cotton and canola. Recent genetic and biochemical studies showed that during phosphinothricin tripeptide biosynthesis 2-hydroxyethylphosphonate (HEP) is converted to hydroxymethylphosphonate (HMP)(2). Here we report the in vitro reconstitution of this unprecedented C(sp(3))-C(sp(3)) bond cleavage reaction and X-ray crystal structures of the enzyme. The protein is a mononuclear non-haem iron(II)-dependent dioxygenase that converts HEP to HMP and formate. In contrast to most other members of this family, the oxidative consumption of HEP does not require additional cofactors or the input of exogenous electrons. The current study expands the scope of reactions catalysed by the 2-His-1-carboxylate mononuclear non-haem iron family of enzymes.	[Cicchillo, Robert M.; Zhang, Houjin; Whitteck, John T.; Nair, Satish K.; van der Donk, Wilfred A.; Metcalf, William W.] Univ Illinois, Inst Genom Biol, Urbana, IL 61802 USA; [Cicchillo, Robert M.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61802 USA; [Zhang, Houjin; Nair, Satish K.; van der Donk, Wilfred A.] Univ Illinois, Dept Biochem, Urbana, IL 61802 USA; [Blodgett, Joshua A. V.; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61802 USA; [Cicchillo, Robert M.; Whitteck, John T.; Li, Gongyong; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61802 USA.	s-nair@life.uiuc.edu; vddonk@illinois.edu; metcalf@illinois.edu	Blodgett, Joshua/AAW-8242-2020; van der Donk, Wilfred/K-2961-2015; Blodgett, Joshua/G-9355-2011; Nair, Satish/AAY-2510-2021	Blodgett, Joshua/0000-0002-7080-5870; van der Donk, Wilfred/0000-0002-5467-7071; Blodgett, Joshua/0000-0002-7080-5870; 	National Institutes of Health [PO1 GM077596, RO1 GM59334]; University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059334, P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Griffin, J. M. Bollinger, S. E. Denmark and T. Begley for discussions. This work was supported by grants from the National Institutes of Health (PO1 GM077596 to W. W. M., W. A. v. d. D. and S. K. N., and NIH RO1 GM59334 to W. W. M.) and by the University of Illinois.	BALDWIN JE, 1993, TETRAHEDRON, V49, P7499, DOI 10.1016/S0040-4020(01)87226-4; Beinert H, 1978, Methods Enzymol, V54, P435; Blodgett JAV, 2007, NAT CHEM BIOL, V3, P480, DOI 10.1038/nchembio.2007.9; Brown CD, 2007, J AM CHEM SOC, V129, P7427, DOI 10.1021/ja071364v; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Grogan G, 2005, BIOCHEM J, V388, P721, DOI 10.1042/BJ20042038; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; KIKUCHI Y, 1983, BIOCHEM J, V213, P507, DOI 10.1042/bj2130507; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Lieberman S, 2001, J STEROID BIOCHEM, V78, P1, DOI 10.1016/S0960-0760(01)00068-1; LINDBLAD B, 1970, J AM CHEM SOC, V92, P7446, DOI 10.1021/ja00728a032; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Pestovsky O, 2006, INORG CHEM, V45, P814, DOI 10.1021/ic051868z; SABOURIN PJ, 1982, J BIOL CHEM, V257, P7468; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Shyadehi AZ, 1996, J BIOL CHEM, V271, P12445, DOI 10.1074/jbc.271.21.12445; WACKETT LP, 1988, BIOCHEMISTRY-US, V27, P1360, DOI 10.1021/bi00404a041; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; Xing G, 2006, P NATL ACAD SCI USA, V103, P6130, DOI 10.1073/pnas.0508473103; Xing G, 2006, BIOCHEMISTRY-US, V45, P5402, DOI 10.1021/bi0526276	22	102	104	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					871	U10		10.1038/nature07972	http://dx.doi.org/10.1038/nature07972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516340	Green Accepted			2022-12-28	WOS:000267084500045
J	Iraci, GS; Fux-Otta, C				Iraci, Gabriel Santino; Fux-Otta, Carolina			Graves' Hyperthyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Iraci, Gabriel Santino] Hosp Nacl Clin, Cordoba, Argentina; [Fux-Otta, Carolina] Hosp Univ Maternidad, Cordoba, Argentina		Iraci, GS (corresponding author), Hosp Nacl Clin, X5009, Cordoba, Argentina.	gabysi_01@yahoo.com		Fux Otta, Carolina/0000-0003-0815-5755					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					E31	E31		10.1056/NEJMicm0707562	http://dx.doi.org/10.1056/NEJMicm0707562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516029				2022-12-28	WOS:000266813800012
J	Jansen, JO; Thomas, R; Loudon, MA; Brooks, A				Jansen, Jan O.; Thomas, Rhys; Loudon, Malcolm A.; Brooks, Adam			Damage control resuscitation for patients with major trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RED-BLOOD-CELL; EARLY COAGULOPATHY; MORTALITY; INJURY; HYPOPERFUSION; TRANSFUSIONS; REGISTRY; PLASMA; RATIO				Jansen, JO (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.	jan.jansen@nhs.net						BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Boyd JH, 2008, CURR OPIN CRIT CARE, V14, P379, DOI 10.1097/MCC.0b013e3283069d5c; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Gunter OL, 2008, J TRAUMA, V65, P527, DOI 10.1097/TA.0b013e3181826ddf; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hodgetts T J, 2007, J R Army Med Corps, V153, P299; Holcomb JB, 2005, J TRAUMA, V59, P990, DOI 10.1097/01.ta.0000188010.65920.26; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Kirkman E, 2008, J ROY ARMY MED CORPS, V153, P302; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; Nahas GG, 1998, DRUGS, V55, P191, DOI 10.2165/00003495-199855020-00003; Rotondo MF, 1997, SURG CLIN N AM, V77, P761, DOI 10.1016/S0039-6109(05)70582-X; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Turner J., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4310, DOI 10.3310/hta4310]	25	87	96	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2009	338								b1778	10.1136/bmj.b1778	http://dx.doi.org/10.1136/bmj.b1778			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AJ	19502278				2022-12-28	WOS:000266726600002
J	Soshnikova, N; Duboule, D				Soshnikova, Natalia; Duboule, Denis			Epigenetic Temporal Control of Mouse Hox Genes in Vivo	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; POLYCOMB GROUP GENES; COMPLEX; MURINE; ORGANIZATION; EXPRESSION; CLUSTERS; ENHANCER; LOCI	During vertebrate development, the temporal control of Hox gene transcriptional activation follows the genomic order of the genes within the Hox clusters. Although it is recognized that this "Hox clock" serves to coordinate body patterning, the underlying mechanism remains elusive. We have shown that successive Hox gene activation in the mouse embryo is closely associated with a directional transition in chromatin status, as judged by the dynamic progression of transcription-competent modifications: Increases in activation marks correspond to decreases in repressive marks. Furthermore, using a mouse in which a Hox cluster was split into two pieces, we document the necessity to maintain a clustered organization to properly implement this process. These results suggest that chromatin modifications are important parameters in the temporal regulation of this gene family.	[Soshnikova, Natalia; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Duboule, Denis] Fed Inst Technol EPFL, Sch Life Sci, Natl Res Ctr Frontiers Genet, Lausanne, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Sci 3,Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	Denis.Duboule@unige.ch		duboule, denis/0000-0001-9961-2960	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund; National Research Center Frontiers in Genetics; European Union program Crescendo	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Center Frontiers in Genetics; European Union program Crescendo	We thank T. Montavon, A. Puglisi, and D. Schubeler for advice; F. Chabaud for cell culture; and P. Descombes and members of the Genomics Platform for their help with tiling arrays. N.S. was supported by a European Molecular Biology Organization long-term fellowship. This work was funded by the University of Geneva, the Federal Institute of Technology in Lausanne, the Swiss National Research Fund, the National Research Center Frontiers in Genetics, and the European Union program Crescendo. Data and analysis are available for download from ArrayExpress (accession E-TABM-677).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee AP, 2006, P NATL ACAD SCI USA, V103, P6994, DOI 10.1073/pnas.0601492103; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SIMON J, 1992, DEVELOPMENT, V114, P493; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126	28	191	196	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1320	1323		10.1126/science.1171468	http://dx.doi.org/10.1126/science.1171468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498168	Green Published			2022-12-28	WOS:000266635100044
J	Anderson, P; Chisholm, D; Fuhr, DC				Anderson, Peter; Chisholm, Dan; Fuhr, Daniela C.			Alcohol and Global Health 2 Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol	LANCET			English	Article							ATTRIBUTABLE MORTALITY; DRINKING PATTERNS; TAX CUTS; CONSUMPTION; METAANALYSIS; IMPACT; RISK; INTERVENTIONS; DEMAND; INJURY	This paper reviews the evidence for the effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol, in the areas of education and information, the health sector, community action, driving while under the influence of alcohol (drink-driving), availability, marketing, pricing, harm reduction, and illegally and informally produced alcohol. Systematic reviews and meta-analyses show that policies regulating the environment in which alcohol is marketed (particularly its price and availability) are effective in reducing alcohol-related harm. Enforced legislative measures to reduce drink-driving and individually directed interventions to already at-risk drinkers are also effective. However, school-based education does not reduce alcohol-related harm, although public information and education-type programmes have a role in providing information and in increasing attention and acceptance of alcohol on political and public agendas. Making alcohol more expensive and less available, and banning alcohol advertising, are highly cost-effective strategies to reduce harm. In settings with high amounts of unrecorded production and consumption, increasing the proportion of alcohol that is taxed could be a more effective pricing policy than a simple increase in tax.	[Anderson, Peter] Univ Maastricht, Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands; [Chisholm, Dan] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Fuhr, Daniela C.] Free Univ Berlin, D-1000 Berlin, Germany	Maastricht University; World Health Organization; Free University of Berlin	Anderson, P (corresponding author), Univ Maastricht, Sch Publ Hlth & Primary Care, POB 616, NL-6200 MD Maastricht, Netherlands.	peteranderson.mail@gmail.com	Stockwell, Tim/B-6662-2012					Allamani A., 2007, CONTEMP DRUG PROBL, V34, P187, DOI DOI 10.1177/009145090703400203; Anderson P, 2004, J STUD ALCOHOL, V65, P191, DOI 10.15288/jsa.2004.65.191; Anderson P.Anderson, 2008, ALCOHOL EUROPE PUBLI; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Babor T.F., 2003, TREATMENT MATCHING A; Babor Thomas F., 2003, ALCOHOL ORDINARY COM; BAGARDI V, 2008, J EPIDEMIOL COMMUNIT, V62, P615; Baumberg B, 2008, ADDICTION, V103, P1952, DOI 10.1111/j.1360-0443.2008.02322.x; Baumberg B, 2008, EUR J PUBLIC HEALTH, V18, P392, DOI 10.1093/eurpub/ckn026; BECK C, 2005, POWER GLOBAL AGE; BLAKELY T, 2004, COMP QUANTIFICATION, P1941; Blomgren J, 2004, SOC SCI MED, V58, P2523, DOI 10.1016/j.socscimed.2003.09.027; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; Cargiulo T, 2007, AM J HEALTH-SYST PH, V64, pS5, DOI 10.2146/ajhp060647; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; Cherpitel CJ, 2003, ALCOHOL CLIN EXP RES, V27, P1805, DOI 10.1097/01.ALC.0000095863.78842.F0; Chikritzhs T, 2005, ADDICTION, V100, P1625, DOI 10.1111/j.1360-0443.2005.01234.x; CHIKRITZHS T, 2007, SERIES NATL DRUG LAW, V28; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Christie J, 2001, J PUBLIC POLICY MARK, V20, P240, DOI 10.1509/jppm.20.2.240.17372; Cook PJ., 2007, PAYING TAB COSTS BEN; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Crombie IK, 2007, ALCOHOL ALCOHOLISM, V42, P492, DOI 10.1093/alcalc/agm001; Crook Clive, 2005, ECONOMIST, P3; Ditter SM, 2005, AM J PREV MED, V28, P280, DOI 10.1016/j.amepre.2005.02.013; Duailibi S, 2007, AM J PUBLIC HEALTH, V97, P2276, DOI 10.2105/AJPH.2006.092684; Engels RCME, 2009, ALCOHOL ALCOHOLISM, V44, P244, DOI 10.1093/alcalc/agp003; Faden V. B., 2005, ALCOHOL RES HEALTH, V28, P125; Farrell S, 2003, J HEALTH ECON, V22, P117, DOI 10.1016/S0167-6296(02)00099-1; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fogarty J, 2006, BRIT FOOD J, V108, P316, DOI 10.1108/00070700610657155; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; Giesbrecht Norman, 2003, NORDIC STUD ALCOHO S, V20, P25; Gil-Gonzalez D, 2006, EUR J PUBLIC HEALTH, V16, P278, DOI 10.1093/eurpub/ckl016; Graham K, 2004, DRUG ALCOHOL REV, V23, P31, DOI 10.1080/09595230410001645538; Grube Joel W, 2004, Traffic Inj Prev, V5, P199, DOI 10.1080/15389580490465229; Gururaj G., 2006, ALCOHOL CONTROL SERI, V1; Herttua K, 2008, AM J EPIDEMIOL, V168, P1110, DOI 10.1093/aje/kwn216; HOLDER H, 2008, ALCOHOL MONOPOLY PUB; Huckle T, 2008, ADDICTION, V103, P1614, DOI 10.1111/j.1360-0443.2008.02318.x; *INT AG RES CTR, 2007, IARC MON EV CARC RIS; JONES L, 2007, 143A NICE PHIAC; Jones SC, 2008, DRUG ALCOHOL REV, V27, P29, DOI 10.1080/09595230701499175; JOOSSENS L, 2000, TOBACCO CONTROL DEV, P393; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; KER K, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD005244.PUB2; Koski A, 2007, ADDICTION, V102, P362, DOI 10.1111/j.1360-0443.2006.01715.x; Lachenmeier DW, 2007, ALCOHOL CLIN EXP RES, V31, P1613, DOI 10.1111/j.1530-0277.2007.00474.x; Lachenmeier DW, 2009, ALCOHOL ALCOHOLISM, V44, P93, DOI 10.1093/alcalc/agn095; Lachenmeier DW, 2009, ADDICTION, V104, P533, DOI 10.1111/j.1360-0443.2009.02516.x; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Levintova M, 2007, ALCOHOL ALCOHOLISM, V42, P500, DOI 10.1093/alcalc/agm040; Livingston M, 2007, DRUG ALCOHOL REV, V26, P557, DOI 10.1080/09595230701499191; LOCKWOOD B, WARWICK EC RES PAPER, V847; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; LOXLEY W, 1992, J STUD ALCOHOL, V53, P420, DOI 10.15288/jsa.1992.53.420; Makela P, 2009, ADDICTION, V104, P554, DOI 10.1111/j.1360-0443.2009.02517.x; Mangione TW, 1999, J STUD ALCOHOL, V60, P261, DOI 10.15288/jsa.1999.60.261; Mann K, 2004, ALCOHOL CLIN EXP RES, V28, P51, DOI 10.1097/01.ALC.0000108656.81563.05; Mann RE, 2001, ACCIDENT ANAL PREV, V33, P569, DOI 10.1016/S0001-4575(00)00077-4; Meier P, 2008, MODELLING POTENTIAL; *NAT I ALC ALC, 2001, ALCOHOL RES HEALTH, V25, P153; NORSTROM T, 2001, MORTALITY POPULATION; NTAIS C, 2005, COCHRANE DB SYST REV, V3; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Pan SW, 2006, APPL ECON LETT, V13, P975, DOI 10.1080/13504850500425964; Parry CD, 2003, S AFR J ECON, V71, P265; Parry C, 2009, ADDICTION, V104, P331, DOI 10.1111/j.1360-0443.2008.02500.x; Petrie J, 2007, HEALTH EDUC RES, V22, P177, DOI 10.1093/her/cyl061; Rabinovich L., 2009, AFFORDABILITY ALCOHO; Rajaraman I, 2007, J POLICY MODEL, V29, P195, DOI 10.1016/j.jpolmod.2007.01.001; Rehm J, 2006, ADDICTION, V101, P373, DOI 10.1111/j.1360-0443.2005.01338.x; Rehm J, 2002, SOZ PRAVENTIV MED, V47, P48, DOI 10.1007/BF01318406; REHM J, AVOIDABLE COST ALCOH; Rehm J., 2004, COMP QUANTIFICATION; Rehm J, 2008, INT J METH PSYCH RES, V17, P141, DOI 10.1002/mpr.259; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; RICHARDSON A, 2003, 263 HOM OFF RES DEV; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x; ROOM R, 2002, ALCOHOL DEV COUNTRIE; Saffer H, 2006, HEALTH ECON, V15, P617, DOI 10.1002/hec.1091; SAMARASINGHE D, 2006, ALCOHOL CONTROL SERI, V5; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Smith SW, 2006, HEALTH COMMUN, V20, P1, DOI 10.1207/s15327027hc2001_1; SRISURAPANONT M, 2005, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001867.PUB2; Stead M, 2007, HEALTH EDUC, V107, P126, DOI 10.1108/09654280710731548; Taki Y, 2006, ALCOHOL CLIN EXP RES, V30, P1045, DOI 10.1111/j.1530-0277.2006.00118.x; Taylor B, 2008, AM J EPIDEMIOL, V168, P1119, DOI 10.1093/aje/kwn215; *UN DEV PROGR, 2002, HUM DEV REP 2002 DEE; Wagenaar A, 2000, CONTEMP DRUG PROBL, V27, P681, DOI [DOI 10.1177/009145090002700402, 10.1177/009145090002700402]; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Wallin E, 2003, J STUD ALCOHOL, V64, P270, DOI 10.15288/jsa.2003.64.270; Walters GD, 2000, BEHAV THER, V31, P135, DOI 10.1016/S0005-7894(00)80008-8; Waters E, 2007, EUROPE-ASIA STUD, V59, P999, DOI 10.1080/09668130701489188; Webb G, 2009, ADDICTION, V104, P365, DOI 10.1111/j.1360-0443.2008.02472.x; Wells S, 2003, ADDICTION, V98, P33, DOI 10.1046/j.1360-0443.2003.00253.x; WELLSPARKER E, 1995, ADDICTION, V90, P907, DOI 10.1046/j.1360-0443.1995.9079074.x; *WHO, 2008, 61 WORLD HLTH ASS A6; WHO Commission on Social Determinants of Health, 2008, CLOS GAP GEN; *WHO EXP COMM PROB, 2007, WHO TECHN REP SER; WILKINSON C, 2009, DRUG ALCOHOL REV, DOI DOI 10.1111/J.1465.3362.2009.00055.X; Willis C, 2004, COCHRANE DB SYST REV, V4; World Health Organization, 2004, NEUR PSYCH SUBST US; World Health Organization, 2001, MACR HLTH INV HLTH E; Zatonski W., 2008, CLOSING HLTH GAP EUR	110	712	718	3	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2234	2246		10.1016/S0140-6736(09)60744-3	http://dx.doi.org/10.1016/S0140-6736(09)60744-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560605				2022-12-28	WOS:000267444500036
J	Marodi, L; Casanova, JL				Marodi, Laszlo; Casanova, Jean-Laurent			Primary immunodeficiency diseases: the J Project	LANCET			English	Editorial Material							GENE-THERAPY		[Marodi, Laszlo] Univ Debrecen, Dept Infect & Pediat Immunol, H-4032 Debrecen, Hungary; [Casanova, Jean-Laurent] Paris Descartes Univ, INSERM, Necker Med Sch, Lab Human Genet Infect Dis, Paris, France; [Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Univ Hosp, Lab Human Genet Infect Dis, New York, NY 10021 USA	University of Debrecen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University	Marodi, L (corresponding author), Univ Debrecen, Dept Infect & Pediat Immunol, H-4032 Debrecen, Hungary.	lmarodi@dote.hu	Casanova, Jean-Laurent/I-3418-2017; Marodi, Laszlo/AAU-9915-2020	Casanova, Jean-Laurent/0000-0002-7782-4169				Alapi K, 2006, CLIN CHEM, V52, P901, DOI 10.1373/clinchem.2005.064816; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Knerr V, 2007, CURR OPIN ALLERGY CL, V7, P475, DOI 10.1097/ACI.0b013e3282f2162c; Marodi L, 2007, NAT REV IMMUNOL, V7, P851, DOI 10.1038/nri2195; Toth B, 2009, MOL IMMUNOL, V46, P2140, DOI 10.1016/j.molimm.2009.03.012	8	24	27	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2179	2181		10.1016/S0140-6736(09)61171-5	http://dx.doi.org/10.1016/S0140-6736(09)61171-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560586				2022-12-28	WOS:000267444500008
J	Smolen, JS; Kay, J; Doyle, MK; Landewe, R; Matteson, EL; Wollenhaupt, J; Gaylis, N; Murphy, FT; Neal, JS; Zhou, YY; Visvanathan, S; Hsia, EC; Rahman, MU				Smolen, Josef S.; Kay, Jonathan; Doyle, Mittie K.; Landewe, Robert; Matteson, Eric L.; Wollenhaupt, Juergen; Gaylis, Norman; Murphy, Frederick T.; Neal, Jeffrey S.; Zhou, Yiying; Visvanathan, Sudha; Hsia, Elizabeth C.; Rahman, Mahboob U.		GO-AFTER Study Investigators	Golimumab inpatients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial	LANCET			English	Article							DISEASE-ACTIVITY; MONOCLONAL-ANTIBODY; CLINICAL-TRIALS; CONCOMITANT METHOTREXATE; EFFICACY; ETANERCEPT; THERAPY; SAFETY; INFLIXIMAB; ADALIMUMAB	Background Turnout necrosis factor a (TNF alpha) inhibitors are frequently used to treat rheumatoid arthritis, but whether use of a different TNF alpha inhibitor can improve patient response is unknown. We assess the efficacy and safety of the TNF alpha inhibitor golimumab in patients with active rheumatoid arthritis who had previously received one or more TNF alpha inhibitors. Methods 461 patients with active rheumatoid arthritis from 82 sites in 10 countries were randomly allocated by interactive voice response system, stratified by study site and methotrexate use, to receive subcutaneous injections of placebo (n=155), 50 mg golimumab (n=153), or 100 mg golimumab (n=153) every 4 weeks between Feb 21, 2006, and Sept 26, 2007. Allocation was double-blind. Eligible patients had been treated with at least one dose of a TNF alpha inhibitor previously. Patients continued stable doses of methotrexate, sulfasalazine, hydroxychloroquine, oral corticosteroids, and non-steroidal anti-inflammatory drugs. The primary endpoint was achievement at week 14 of 20% or higher improvement in American College of Rheumatology criteria for assessment of rheumatoid arthritis (ACR20). At week 16, patients who had less than 20% improvement in tender and swollen joint counts were given rescue therapy and changed treatment from placebo to 50 mg golimumab, or from 50 mg to 100 mg golimumab. Drug efficacy was assessed by intention to treat and safety was assessed according to the study drug given. This study is registered with ClinicalTrials.gov, number NCT00299546. Findings Patients had discontinued previous TNF alpha inhibitors because of lack of effectiveness (269 [58%] patients) or reasons unrelated to effectiveness (246 [53%] patients), such as intolerance and accessibility issues. Patients had active disease, which was indicated by a median of 14.0 (IQR 9.0-22.0) swollen and 26.0 (16.0-41.0) tender joints for the whole group. 28 (18%) patients on placebo, 54 (35%) patients on 50 mg golimumab (odds ratio 2.5 [95% Cl 1.5-4.2], p=0.0006), and 58 (38%) patients on 100 mg golimumab (2.8 [1.6-4.7], p=0.0001) achieved ACR20 at week 14. Two patients were never treated, and 57 patients did not complete the study because of adverse events, unsatisfactory treatment effect, loss to follow-up, death, or other reasons. 155 patients on placebo, 153 on 50 mg golimumab, and 153 on 100 mg golimumab were assessed for drug efficacy. For weeks 1-16, serious adverse events were recorded in 11 (7%) patients on placebo, 8 (5%) on 50 mg golimumab, and 4 (3%) on 100 mg golimumab. For weeks 1-24, after some patients were given rescue therapy, serious adverse events were recorded in 15 (10%) patients on placebo, 14 (5%) on 50 mg golimumab, and 8 (4%) on 100 mg golimumab. Interpretation Golimumab reduced the signs and symptoms of rheumatoid arthritis in patients with active disease who had previously received one or more TNF alpha inhibitors.	[Smolen, Josef S.] Med Univ Vienna, A-1090 Vienna, Austria; [Smolen, Josef S.] Hietzing Hosp, Vienna, Austria; [Kay, Jonathan] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kay, Jonathan] Havard Med Sch, Boston, MA USA; [Doyle, Mittie K.; Zhou, Yiying; Visvanathan, Sudha; Hsia, Elizabeth C.; Rahman, Mahboob U.] Centocor Researc & Dev, Malvern, PA USA; [Doyle, Mittie K.; Murphy, Frederick T.; Hsia, Elizabeth C.; Rahman, Mahboob U.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Landewe, Robert] Univ Hosp Maastricht, Maastricht, Netherlands; [Matteson, Eric L.] Mayo Clin, Rochester, MN USA; [Wollenhaupt, Juergen] Klin Eibek, Hamburg, Germany; [Gaylis, Norman] Arthrit & Rheumat Dis Specialties, Aventura, FL USA; [Murphy, Frederick T.] Altoona Ctr Clin Res, Duncansville, PA USA; [Neal, Jeffrey S.] Bluegrass Community Res, Lexington, KY USA	Medical University of Vienna; Hietzing Hospital; Harvard University; Massachusetts General Hospital; Johnson & Johnson; Johnson & Johnson USA; University of Pennsylvania; Maastricht University; Maastricht University Medical Centre (MUMC); Mayo Clinic; Altoona Center for Clinical Research	Smolen, JS (corresponding author), Med Univ Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	josef.smolen@wienkav.at	Khraishi, Majed/HDN-4826-2022; Kay, Jonathan/HGE-1248-2022; LANDEWE, ROBERT B.M./ABD-7388-2021	Khraishi, Majed/0000-0003-0293-5128; LANDEWE, ROBERT B.M./0000-0002-0577-6620; Machold, Klaus/0000-0002-9551-1975; Kay, Jonathan/0000-0002-8970-4260	Centocor Research and Development and Schering-Plough Research Institute	Centocor Research and Development and Schering-Plough Research Institute	This study was sponsored by Centocor Research and Development and Schering-Plough Research Institute. We thank the patients, investigators, and study personnel who made the trial possible; and Scott Newcomer, medical writer for Centocor Ortho Biotech Services, a wholly owned subsidiary of Johnson & Johnson, for his assistance in the preparation of this report.	Aletaha D, 2008, ARTHRIT RHEUM-ARTHR, V59, P1371, DOI 10.1002/art.24123; Aletaha D, 2005, ARTHRITIS RHEUM-US, V52, P2625, DOI 10.1002/art.21235; Aletaha D, 2002, RHEUMATOLOGY, V41, P1367, DOI 10.1093/rheumatology/41.12.1367; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Bennett AN, 2005, RHEUMATOLOGY, V44, P1026, DOI 10.1093/rheumatology/keh673; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Cohen G, 2005, CLIN EXP RHEUMATOL, V23, P795; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Furst DE, 2007, ANN RHEUM DIS, V66, P893, DOI 10.1136/ard.2006.068304; Gartlehner G, 2006, J RHEUMATOL, V33, P2398; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gomez-Reino JJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1881; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Nikas SN, 2006, ANN RHEUM DIS, V65, P257, DOI 10.1136/ard.2005.039099; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Schiff M, 1999, ARTHRITIS RHEUM, V42, pS81; Scott DL, 2000, EULAR HDB CLIN ASSES; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Sokka T, 2003, J RHEUMATOL, V30, P1138; Weinblatt ME, 2006, ANN RHEUM DIS, V65, P89, DOI 10.1136/ard.2006.060939; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; WELLS GA, 1993, J RHEUMATOL, V20, P557; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6	39	422	445	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 18	2009	374	9685					210	221		10.1016/S0140-6736(09)60506-7	http://dx.doi.org/10.1016/S0140-6736(09)60506-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474DP	19560810				2022-12-28	WOS:000268263000029
J	Zelcer, N; Hong, C; Boyadjian, R; Tontonoz, P				Zelcer, Noam; Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter			LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor	SCIENCE			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; LEUCINE ZIPPER PROTEIN; LIVER-X RECEPTORS; POSTTRANSCRIPTIONAL REGULATION; FAMILIAL HYPERCHOLESTEROLEMIA; MICE; MUTATIONS; PCSK9; ERM; ATHEROSCLEROSIS	Cellular cholesterol levels reflect a balance between uptake, efflux, and endogenous synthesis. Here we show that the sterol-responsive nuclear liver X receptor (LXR) helps maintain cholesterol homeostasis, not only through promotion of cholesterol efflux but also through suppression of low-density lipoprotein (LDL) uptake. LXR inhibits the LDL receptor ( LDLR) pathway through transcriptional induction of Idol ( inducible degrader of the LDLR), an E3 ubiquitin ligase that triggers ubiquitination of the LDLR on its cytoplasmic domain, thereby targeting it for degradation. LXR ligand reduces, whereas LXR knockout increases, LDLR protein levels in vivo in a tissue-selective manner. Idol knockdown in hepatocytes increases LDLR protein levels and promotes LDL uptake. Conversely, adenovirus-mediated expression of Idol in mouse liver promotes LDLR degradation and elevates plasma LDL levels. The LXR-Idol-LDLR axis defines a complementary pathway to sterol response element-binding proteins for sterol regulation of cholesterol uptake.	[Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Zelcer, Noam/C-6393-2009	Zelcer, Noam/0000-0001-6935-7532	Human Frontier Science Program Organization; Howard Hughes Medical Institute; NIH [HL066088, HL090553, HL030568]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL090553, P01HL030568] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	N.Z. was supported by a long-term postdoctoral fellowship from the Human Frontier Science Program Organization. P.T. is an investigator of the Howard Hughes Medical Institute. This work was also supported by NIH grants HL066088, HL090553, and HL030568. UCLA and two of the authors (N.Z. and P.T.) have filed a patent related to this work.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; ANDERSON RA, 1984, NATURE, V307, P655, DOI 10.1038/307655a0; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2003, CURR OPIN LIPIDOL, V14, P121, DOI 10.1097/00041433-200304000-00002; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SHARKEY MF, 1990, J LIPID RES, V31, P2167; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	31	537	588	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2009	325	5936					100	104		10.1126/science.1168974	http://dx.doi.org/10.1126/science.1168974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465NL	19520913	Green Accepted			2022-12-28	WOS:000267594000045
J	Kwon, HJ; Abi-Mosleh, L; Wang, ML; Deisenhofer, J; Goldstein, JL; Brown, MS; Infante, RE				Kwon, Hyock Joo; Abi-Mosleh, Lina; Wang, Michael L.; Deisenhofer, Johann; Goldstein, Joseph L.; Brown, Michael S.; Infante, Rodney E.			Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; PICK C1 PROTEIN; LYSOSOMAL MEMBRANE; STEROL BINDING; METABOLISM; PROTEOLYSIS; DEFICIENT; MECHANISM; TRANSPORT; PATHWAY	LDL delivers cholesterol to lysosomes by receptor-mediated endocytosis. Exit of cholesterol from lysosomes requires two proteins, membrane-bound Niemann-Pick C1 (NPC1) and soluble NPC2. NPC2 binds cholesterol with its isooctyl side chain buried and its 3 beta-hydroxyl exposed. Here, we describe high-resolution structures of the N-terminal domain (NTD) of NPC1 and complexes with cholesterol and 25-hydroxycholesterol. NPC1(NTD) binds cholesterol in an orientation opposite to NPC2: 3 beta-hydroxyl buried and isooctyl side chain exposed. Cholesterol transfer from NPC2 to NPC1(NTD) requires reorientation of a helical subdomain in NPC1(NTD), enlarging the opening for cholesterol entry. NPC1 with point mutations in this subdomain (distinct from the binding subdomain) cannot accept cholesterol from NPC2 and cannot restore cholesterol exit from lysosomes in NPC1-deficient cells. We propose a working model wherein after lysosomal hydrolysis of LDL-cholesteryl esters, cholesterol binds NPC2, which transfers it to NPC1(NTD), reversing its orientation and allowing insertion of its isooctyl side chain into the outer lysosomal membranes.	[Abi-Mosleh, Lina; Wang, Michael L.; Goldstein, Joseph L.; Brown, Michael S.; Infante, Rodney E.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kwon, Hyock Joo; Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu	Infante, Rodney/ABG-7756-2020	Infante, Rodney/0000-0003-2605-822X	National Institutes of Health [HL20948]; Welch Foundation [IL1185]; Perot Family Foundation; Medical Scientist Training Program [5T32 (GM08014)]; Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Perot Family Foundation; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dorothy Goddard, Lisa Henry, Bethany Cartwright, and Maya Palnitkar for excellent technical assistance; Lisa Beatty and Shomanike Head for invaluable help with tissue culture; Dr. Chad Brautigam for help with analytical ultracentrifugation; and Dr. Laura Liscum for the gift of CHO 4-4-19 cells. This work was supported by grants from the National Institutes of Health (HL20948), Welch Foundation (IL1185), and Perot Family Foundation. R. E. I. and M. L. W. are supported by Medical Scientist Training Program Grant 5T32 (GM08014). R. E. I. is also supported by the Ara Parseghian Medical Research Foundation. J. D. is an Investigator of the Howard Hughes Medical Institute. Crystallographic structures were derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source (operated by UChicago Argonne, LLC, for the U. S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357).	ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Babalola JO, 2007, BIOL CHEM, V388, P617, DOI 10.1515/BC.2007.063; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DAHL NK, 1992, J BIOL CHEM, V267, P4889; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; NEISS WF, 1984, HISTOCHEMISTRY, V80, P603, DOI 10.1007/BF00553724; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Roth MG, 2006, NAT REV MOL CELL BIO, V7, P63, DOI 10.1038/nrm1783; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Subramanian K, 2008, P NATL ACAD SCI USA, V105, P15223, DOI 10.1073/pnas.0808256105; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	43	458	465	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1213	1224		10.1016/j.cell.2009.03.049	http://dx.doi.org/10.1016/j.cell.2009.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563754	Bronze, Green Accepted			2022-12-28	WOS:000267373400015
J	Murcott, T				Murcott, Toby			Science journalism: Toppling the priesthood	NATURE			English	Editorial Material												toby.murcott@ketoe.co.uk							0	10	12	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1054	1055		10.1038/4591054a	http://dx.doi.org/10.1038/4591054a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	466BX	19553976				2022-12-28	WOS:000267636700020
J	Steinbrook, R				Steinbrook, Robert			HEALTH CARE 2009 Easing the Shortage in Adult Primary Care - Is It All about Money?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Freed GL, 2009, JAMA-J AM MED ASSOC, V301, P1920, DOI 10.1001/jama.2009.619; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Phillips RL, 2009, SPECIALTY GEOGRAPHIC	3	44	46	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2696	2699		10.1056/NEJMp0903460	http://dx.doi.org/10.1056/NEJMp0903460			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461RC	19553644				2022-12-28	WOS:000267286600002
J	Roth, J				Roth, Jesse			Evolutionary Speculation About Tuberculosis and the Metabolic and Inflammatory Processes of Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION		[Roth, Jesse] Yeshiva Univ, Albert Einstein Coll Med, Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA	Northwell Health; Yeshiva University	Roth, J (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, 149-37 Powells Cove Blvd, Whitestone, NY 11357 USA.	jesserothmd@hotmail.com						BALDWIN ER, 1907, MODERN MED ITS THEOR, V3, P137; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Osler W, 1892, PRINCIPLES PRACTICE; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Ryan F, 1994, FORGOTTEN PLAGUE BAT; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	15	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2586	2588		10.1001/jama.2009.930	http://dx.doi.org/10.1001/jama.2009.930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549976				2022-12-28	WOS:000267266500024
J	Rechel, B; Sikorskaya, I; Mckee, M				Rechel, Bernd; Sikorskaya, Inga; McKee, Martin			Hope for health in Turkmenistan?	LANCET			English	Editorial Material									[Rechel, Bernd; McKee, Martin] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Sikorskaya, Inga] Inst War & Peace Reporting, London, England	University of London; London School of Hygiene & Tropical Medicine	Rechel, B (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	bernd.rechel@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Rechel, Bernd/0000-0001-8020-3956				*EUR UN, 2007, EUR COMM REG STRAT P; GLAESSNER S, 2005, GRIM REALITY TURKMEN; *IRIN, 2007, TURKM COUNTR JOINS R; *MIN HLTH MED IND, 2006, DCR 217 INTR PROC TA; Open Society Institute, 2008, HARM RED DEV 2008 CO; Rechel B, 2005, HUMAN RIGHTS HLTH TU; Rechel B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-21; *UNICEF, 2008, TRANSMONEE DAT; *USAID, 2007, TURKM CONV WHO LIV B; World Health Organization Regional Office for Europe, 2009, EUR HLTH ALL DAT; 2003, LANCET, V361, P69	11	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2093	2095		10.1016/S0140-6736(09)61133-8	http://dx.doi.org/10.1016/S0140-6736(09)61133-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541024				2022-12-28	WOS:000267229700009
J	Maricich, SM; Wellnitz, SA; Nelson, AM; Lesniak, DR; Gerling, GJ; Lumpkin, EA; Zoghbi, HY				Maricich, Stephen M.; Wellnitz, Scott A.; Nelson, Aislyn M.; Lesniak, Daine R.; Gerling, Gregory J.; Lumpkin, Ellen A.; Zoghbi, Huda Y.			Merkel Cells Are Essential for Light-Touch Responses	SCIENCE			English	Article							CUTANEOUS MECHANORECEPTORS; SKIN; MATH1; MICE; MECHANISMS; RECEPTORS; PATTERNS; REVEALS; P75	The peripheral nervous system detects different somatosensory stimuli, including pain, temperature, and touch. Merkel cell-neurite complexes are touch receptors composed of sensory afferents and Merkel cells. The role that Merkel cells play in light-touch responses has been the center of controversy for over 100 years. We used Cre-loxP technology to conditionally delete the transcription factor Atoh1 from the body skin and foot pads of mice. Merkel cells are absent from these areas in Atoh1(CKO) animals. Ex vivo skin/nerve preparations from Atoh1(CKO) animals demonstrate complete loss of the characteristic neurophysiologic responses normally mediated by Merkel cell-neurite complexes. Merkel cells are, therefore, required for the proper encoding of Merkel receptor responses, suggesting that these cells form an indispensible part of the somatosensory system.	[Wellnitz, Scott A.; Nelson, Aislyn M.; Lumpkin, Ellen A.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Maricich, Stephen M.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lesniak, Daine R.; Gerling, Gregory J.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22904 USA; [Lumpkin, Ellen A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Lumpkin, Ellen A.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lumpkin, Ellen A.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Virginia; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Lumpkin, EA (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	lumpkin@bcm.edu; hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Lumpkin, Ellen/0000-0002-1166-3374	NIH [5K08NS53419, HD024064, AR051219]; McNair Scholars Program; National Library of Medicine [T15LM009462]; Defense Advanced Research Projects Agency [HR0011-08-1-0072]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS053419] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM009462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McNair Scholars Program; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Capecchi for generously providing us with Hoxb1Cre animals; N. Ao, K. Firozi, E. Mathes, K. Morrison, and S. Vaishav for technical assistance; and G. Landreth, L. Landmesser, and R. Miller for critical reading of the manuscript. Funding sources are as follows: NIH grant 5K08NS53419 (to S.M.M.), McNair Scholars Program (to A.M.N.), National Library of Medicine grant T15LM009462 (to D.R.L.), Defense Advanced Research Projects Agency grant HR0011-08-1-0072 (to G.J.G.), NIH grant HD024064, and NIH grant AR051219 (to E.A.L.). H.Y.Z. is an investigator with HHMI.	Arenkiel BR, 2003, DEV DYNAM, V227, P379, DOI 10.1002/dvdy.10323; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; Cronk KM, 2002, DEVELOPMENT, V129, P3739; Diamond J, 1988, Prog Brain Res, V74, P51; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Johnson KO, 2000, J CLIN NEUROPHYSIOL, V17, P539, DOI 10.1097/00004691-200011000-00002; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Merkel F., 1875, ARCH MIKROSK ANAT, V11, P636, DOI [DOI 10.1007/BF02933819, 10.1007/BF02933819]; Meyers JR, 2003, J NEUROSCI, V23, P4054; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; Nunzi MG, 2004, J NEUROCYTOL, V33, P359, DOI 10.1023/B:NEUR.0000044196.45602.92; Pacitti E G, 1988, Prog Brain Res, V74, P37; Senok SS, 1996, EXP BRAIN RES, V110, P325; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; VIELKIND U, 1995, ACTA ANAT, V152, P93; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517	28	191	197	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1580	1582		10.1126/science.1172890	http://dx.doi.org/10.1126/science.1172890			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541997	Green Accepted			2022-12-28	WOS:000267130600049
J	Crowley, T; Goldmeier, D; Hiller, J				Crowley, Tessa; Goldmeier, David; Hiller, Janice			Diagnosing and managing vaginismus	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEXUAL PAIN; VULVAR VESTIBULITIS; WOMEN; DYSFUNCTIONS; DYSPAREUNIA; PREVALENCE		[Crowley, Tessa] Bristol Sexual Hlth Serv, Bristol BS2 0JD, Avon, England; [Goldmeier, David] Imperial NHS Trust, London W2 1NY, England; [Hiller, Janice] Goodmayes Hosp, Dept Psychol, Ilford IG3 8XJ, Essex, England		Crowley, T (corresponding author), Bristol Sexual Hlth Serv, Bristol BS2 0JD, Avon, England.	tessa.crowley@bristol.ac.uk						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Basson R, 2004, J SEX MED, V1, P24, DOI 10.1111/j.1743-6109.2004.10105.x; Binik YM, 2002, ARCH SEX BEHAV, V31, P425, DOI 10.1023/A:1019892125163; Danielsson I, 2003, SCAND J PUBLIC HEALT, V31, P113, DOI 10.1080/14034940210134040; Davis HJ., 2007, SEX RELATSH THER, V22, P245, DOI [10.1080/14681990601026601, DOI 10.1080/14681990601026601]; de Jong PJ, 2009, ARCH SEX BEHAV, V38, P244, DOI 10.1007/s10508-007-9240-x; Eccleston KJ, 2008, INT J STD AIDS, V19, P797, DOI 10.1258/ijsa.2008.008255; Engman M, 2004, J PSYCHOSOM OBST GYN, V25, P281, DOI 10.1080/01674820400017921; Frasson E, 2009, CLIN NEUROPHYSIOL, V120, P117, DOI 10.1016/j.clinph.2008.10.156; Huber JD, 2009, J SEX MED, V6, P791, DOI 10.1111/j.1743-6109.2008.01139.x; Kadri N, 2002, Arch Womens Ment Health, V5, P59, DOI 10.1007/s00737-002-0141-7; McGuire H, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Payne KA, 2005, EUR J PAIN, V9, P427, DOI 10.1016/j.ejpain.2004.10.003; Reissing ED, 2004, ARCH SEX BEHAV, V33, P5, DOI 10.1023/B:ASEB.0000007458.32852.c8; Reissing ED, 1999, J NERV MENT DIS, V187, P261, DOI 10.1097/00005053-199905000-00001; Reissing ED, 2003, J SEX MARITAL THER, V29, P47, DOI 10.1080/713847095; Schultz WW, 2005, J SEX MED, V2, P301, DOI 10.1111/j.1743-6109.2005.20347.x; Simons JS, 2001, ARCH SEX BEHAV, V30, P177, DOI 10.1023/A:1002729318254; Ter Kuile MM, 2005, J PSYCHOSOM OBST GYN, V26, P245, DOI 10.1080/01674820500165935; Tugrul C., 1997, J SEX MARITAL THER, V12, P23, DOI [DOI 10.1080/02674659708408199, 10.1080/02674659708408199]; van der Velde J, 2001, INT UROGYNECOL J PEL, V12, P328, DOI 10.1007/s001920170035; van Lankveld JJDM, 2006, J CONSULT CLIN PSYCH, V74, P168, DOI 10.1037/0022-006X.74.1.168; vanLankveld JJD, 1995, J PSYCHOSOM OBST GYN, V16, P201, DOI 10.3109/01674829509024470; Ward E, 1994, SEX MARITAL THER, V9, P33, DOI [DOI 10.1080/02674659408409565, 10.1080/02674659408409565]; Zargooshi J, 2008, J SEX MED, V5, P2895, DOI 10.1111/j.1743-6109.2008.01004.x	25	35	35	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2009	338								b2284	10.1136/bmj.b2284	http://dx.doi.org/10.1136/bmj.b2284			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460US	19541697				2022-12-28	WOS:000267216800006
J	Regge, D; Laudi, C; Galatola, G; Della Monica, P; Bonelli, L; Angelelli, G; Asnaghi, R; Barbaro, B; Bartolozzi, C; Bielen, D; Boni, L; Borghi, C; Bruzzi, P; Cassinis, MC; Galia, M; Gallo, TM; Grasso, A; Hassan, C; Laghi, A; Martina, MC; Neri, E; Senore, C; Simonetti, G; Venturini, S; Gandini, G				Regge, Daniele; Laudi, Cristiana; Galatola, Giovanni; Della Monica, Patrizia; Bonelli, Luigina; Angelelli, Giuseppe; Asnaghi, Roberto; Barbaro, Brunella; Bartolozzi, Carlo; Bielen, Didier; Boni, Luca; Borghi, Claudia; Bruzzi, Paolo; Cassinis, Maria Carla; Galia, Massimo; Gallo, Teresa Maria; Grasso, Andrea; Hassan, Cesare; Laghi, Andrea; Martina, Maria Cristina; Neri, Emanuele; Senore, Carlo; Simonetti, Giovanni; Venturini, Silvia; Gandini, Giovanni			Diagnostic Accuracy of Computed Tomographic Colonography for the Detection of Advanced Neoplasia in Individuals at Increased Risk of Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTRAST BARIUM ENEMA; FECAL OCCULT BLOOD; CT COLONOGRAPHY; 1ST-DEGREE RELATIVES; VIRTUAL COLONOSCOPY; ASYMPTOMATIC ADULTS; LARGE ADENOMAS; SURVEILLANCE; SIGMOIDOSCOPY; POPULATION	Context Computed tomographic (CT) colonography has been recognized as an alternative for colorectal cancer (CRC) screening in average-risk individuals, but less information is available on its performance in individuals at increased risk of CRC. Objective To assess the accuracy of CT colonography in detecting advanced colorectal neoplasia in asymptomatic individuals at increased risk of CRC using unblinded colonoscopy as the reference standard. Design, Setting, and Participants This was a multicenter, cross-sectional study. Individuals at increased risk of CRC due to either family history of advanced neoplasia in first-degree relatives, personal history of colorectal adenomas, or positive results from fecal occult blood tests (FOBTs) were recruited in 11 Italian centers and 1 Belgian center between December 2004 and May 2007. Each participant underwent CT colonography followed by colonoscopy on the same day. Main Outcome Measures Sensitivity and specificity of CT colonography in detecting individuals with advanced neoplasia (ie, advanced adenoma or CRC) 6 mm or larger. Results Of 1103 participants, 937 were included in the final analysis: 373 cases in the family-history group, 343 in the group with personal history of adenomas, and 221 in the FOBT-positive group. Overall, CT colonography identified 151 of 177 participants with advanced neoplasia 6 mm or larger (sensitivity, 85.3%; 95% confidence interval [CI], 79.0%-90.0%) and correctly classified results as negative for 667 of 760 participants without such lesions (specificity, 87.8%; 95% CI, 85.2%-90.0%). The positive and negative predictive values were 61.9% (95% CI, 55.4%-68.0%) and 96.3% (95% CI, 94.6%-97.5%), respectively; after group stratification, a significantly lower negative predictive value was found for the FOBT-positive group (84.9%; 95% CI, 76.2%-91.3%; P < .001). Conclusions In a group of persons at increased risk for CRC, CT colonography compared with colonoscopy resulted in a negative predictive value of 96.3% overall. When limited to FOBT-positive persons, the negative predictive value was 84.9%. JAMA. 2009; 301(23):2453-2461	[Laudi, Cristiana; Galatola, Giovanni] Inst Canc Res & Treatment, Gastroenterol Unit, I-10060 Turin, Italy; [Regge, Daniele; Della Monica, Patrizia; Gallo, Teresa Maria] Inst Canc Res & Treatment, Radiol Unit, I-10060 Turin, Italy; [Bonelli, Luigina; Boni, Luca; Bruzzi, Paolo] Natl Inst Canc Res, Epidemiol Unit, Genoa, Italy; [Grasso, Andrea] Natl Inst Canc Res, Radiol Unit, Genoa, Italy; [Angelelli, Giuseppe] Univ Bari, Dept Radiol, Policlin Hosp, Bari, Italy; [Asnaghi, Roberto] Salvatore Maugeri IRCCS Fdn, Radiol Unit, Novara, Italy; [Barbaro, Brunella] Univ Cattolica Sacro Cuore, Dept Radiol, Policlin Agostino Gemelli, Rome, Italy; [Bartolozzi, Carlo; Neri, Emanuele] Univ Pisa, Dept Radiol, Pisa, Italy; [Bielen, Didier] Katholieke Univ Leuven, UZ Gasthuisberg, Dept Radiol, Louvain, Belgium; [Borghi, Claudia] Valduce Hosp, Radiol Unit, Como, Italy; [Cassinis, Maria Carla; Martina, Maria Cristina; Gandini, Giovanni] Univ Turin, Dept Radiol, San Giovanni Battista Hosp, Turin, Italy; [Galia, Massimo] Univ Palermo, Dept Radiol, Policlin Paolo Giaccone, Palermo, Italy; [Hassan, Cesare] Nuovo Regina Margherita Hosp, Gastrointestinal Unit, Rome, Italy; [Laghi, Andrea] Univ Roma La Sapienza, Dept Radiol, Polo Didatt Pontino ICOT, Rome, Italy; [Senore, Carlo] ASO San Giovanni Battista, CPO Piemonte, Turin, Italy; [Simonetti, Giovanni] Univ Roma Tor Vergata, Dept Radiol, Rome, Italy; [Venturini, Silvia] Natl Canc Inst, Radiol Unit, Aviano, Pordenone, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; Universita degli Studi di Bari Aldo Moro; Istituti Clinici Scientifici Maugeri IRCCS; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Pisa; KU Leuven; University Hospital Leuven; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Palermo; Policlinico Paolo Giaccone; Poliambulatorio Nuovo Regina Margherita; Sapienza University Rome; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Rome Tor Vergata	Laudi, C (corresponding author), Inst Canc Res & Treatment, Gastroenterol Unit, Str Prov 142,Km 3-95, I-10060 Turin, Italy.	cristiana.laudi@ircc.it	Regge, Daniele/AAC-6816-2022; Bonelli, Luigina Ada/AAB-7726-2019; Bruzzi, Paolo/AAU-3363-2021; Laghi, Andrea/A-2343-2011; hassan, cesare/H-2844-2012; Neri, Emanuele/N-1378-2019; Boni, Luca/ABI-6243-2020; Galia, Massimo/K-5458-2016; Laghi, Andrea/AAQ-9807-2020	Bonelli, Luigina Ada/0000-0002-9034-9630; Laghi, Andrea/0000-0002-3091-7819; hassan, cesare/0000-0001-7167-1459; Neri, Emanuele/0000-0001-7950-4559; Boni, Luca/0000-0003-2217-4047; Galia, Massimo/0000-0003-3913-6290; Senore, Carlo/0000-0003-1023-7477; GALLO, TERESA MARIA/0000-0003-0476-9100; Bielen, Didier/0000-0002-8899-8383; Cassinis, Maria Carla/0000-0002-9147-1347; Bruzzi, Paolo/0000-0002-7874-2077; Regge, Daniele/0000-0001-8267-5279; Asnaghi, Roberto/0000-0001-9746-6955; Gandini, Giovanni/0000-0001-8409-702X	AIRC (Italian Association for Cancer Research); Regione Piemonte; Fondazione Cassa di Risparmio di Torino; Compagnia di San Paolo	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte); Fondazione Cassa di Risparmio di Torino(Fondazione CRT); Compagnia di San Paolo(Compagnia di San Paolo)	Funding/Support: This study was funded by a grant from the AIRC (Italian Association for Cancer Research) for 2005 through 2007, a grant for Progetti di Ricerca Finalizzata from Regione Piemonte, the Fondazione Cassa di Risparmio di Torino, and the Compagnia di San Paolo. The study was also endorsed by the Italian Society of Medical Radiology (SIRM) and the Italian Society of Gastroenterology (SIGE). Role of the Sponsor: The funding organizations had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Bujanda L, 2007, GUT, V56, P1714, DOI 10.1136/gut.2007.120709; CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P; Cottet V, 2007, GASTROENTEROLOGY, V133, P1086, DOI 10.1053/j.gastro.2007.07.023; Cotton PB, 2004, JAMA-J AM MED ASSOC, V291, P1713, DOI 10.1001/jama.291.14.1713; Edwards JT, 2004, RADIOLOGY, V230, P459, DOI 10.1148/radiol.2302021422; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gluecker TM, 2004, AM J ROENTGENOL, V182, P881, DOI 10.2214/ajr.182.4.1820881; Gluecker TM, 2003, RADIOLOGY, V227, P378, DOI 10.1148/radiol.2272020293; Hamilton SR, 2000, WHO CLASSIFICATION T; Iannaccone R, 2003, RADIOLOGY, V229, P775, DOI 10.1148/radiol.2293021399; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; Nadel MR, 2005, ANN INTERN MED, V142, P86, DOI 10.7326/0003-4819-142-2-200501180-00007; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Rapuri S, 2008, INT J COLORECTAL DIS, V23, P453, DOI 10.1007/s00384-007-0430-8; Rockey DC, 2005, LANCET, V365, P305; Segnan N, 2007, GASTROENTEROLOGY, V132, P2304, DOI 10.1053/j.gastro.2007.03.030; Taylor SA, 2003, AM J ROENTGENOL, V181, P913, DOI 10.2214/ajr.181.4.1810913; Taylor SA, 2007, EUR RADIOL, V17, P575, DOI 10.1007/s00330-006-0407-y; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zalis ME, 2006, RADIOLOGY, V239, P149, DOI 10.1148/radiol.2383041308	30	152	161	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2453	2461		10.1001/jama.2009.832	http://dx.doi.org/10.1001/jama.2009.832			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531785	Bronze			2022-12-28	WOS:000267028100023
J	Lin, K; Vickery, J				Lin, Kenneth; Vickery, John			Screening for Hepatitis B Virus Infection in Pregnant Women: Evidence for the US Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; TRANSMISSION; IMMUNIZATION; INFANTS	Background: Screening for hepatitis B virus (HBV) infection in pregnant women to identify newborns who will require prophylaxis against perinatal infection is a well-established, evidence-based standard of current medical practice. In 2004, the U.S. Preventive Services Task Force (USPSTF) recommended universal screening of pregnant women for HBV infection at the first prenatal visit. Purpose: To search for large, high-quality studies related to hepatitis B screening in pregnancy that have been published since the 2004 USPSTF recommendation. Data Sources: English-language studies indexed in PubMed and the Cochrane Database of Systematic Reviews and published between 1 January 2001 and 5 March 2008. Study Selection: For benefits of screening and newborn prophylaxis, we included systematic reviews; meta-analyses; and randomized, controlled trials. For harms of screening, we included systematic reviews; meta-analyses; randomized, controlled trials; cohort studies; case-control studies; and case series of large, multisite databases. Abstracts and full articles were independently reviewed for inclusion by both reviewers. Data Extraction: Data on the benefits of screening, including benefits of hepatitis B immune globulin and hepatitis B vaccine prophylaxis of newborns of hepatitis B surface antigen-positive mothers, were extracted by 1 reviewer. Data Synthesis: No new studies met inclusion criteria. A 2006 systematic review of randomized, controlled trials found that newborn prophylaxis reduced perinatal transmission of HBV infection; all relevant trials were published in 1996 or earlier. Limitation: The focused search strategy, which was restricted to English-language articles, may have missed some smaller studies or new research published in languages other than English. Conclusion: No new evidence was found on the benefits or harms of screening for HBV infection in pregnant women. Previously published randomized trials support the 2004 USPSTF recommendation for screening.	[Lin, Kenneth] Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, Rockville, MD 20850 USA	Agency for Healthcare Research & Quality	Lin, K (corresponding author), Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnerships, 540 Gaither Rd, Rockville, MD 20850 USA.	Kenneth.Lin@ahrq.hhs.gov						*CDC, 1988, MMWR-MORBID MORTAL W, V37, P341; *CDCP IMM SERV DIV, 2007, PER HEP B 2005 ANN R; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P351; KRISHNARAJ R, 2004, SCREENING HEPATITIS; Lazaroff J., 2008, 42 NAT IMM C ATL GEO; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; *US PREV SERV TASK, 1996, US PREV TASK FORC GU, P269; *US PREV TASK FORC, 2004, SCREEN HEP B VIR INF	10	26	28	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12					874	876		10.7326/0003-4819-150-12-200906160-00012	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528566				2022-12-28	WOS:000267164800007
J	Chaubo, C; Hot, A; Chevallier-Queyron, P; Ritter, J; Scoazec, JY; Zoulim, F; Karame, A; Brunet, M; Touraine, JL; Morelon, E				Chaubo, Catherine; Hot, Arnaud; Chevallier-Queyron, Philippe; Ritter, Jacques; Scoazec, Jean-Yves; Zoulim, Fabien; Karame, Alexandre; Brunet, Maria; Touraine, Jean-Louis; Morelon, Emmanuel			Kidney transplant and cryptic hepatitis	LANCET			English	Editorial Material							REACTIVATION		[Chaubo, Catherine; Zoulim, Fabien; Karame, Alexandre; Brunet, Maria; Touraine, Jean-Louis; Morelon, Emmanuel] Hop Edouard Herriot, Dept Nephrol Transplantat & Clin Immunol, F-69003 Lyon, France; [Hot, Arnaud] Hop Edouard Herriot, Dept Internal Med, F-69003 Lyon, France; [Chevallier-Queyron, Philippe; Ritter, Jacques] Hop Edouard Herriot, Dept Virol, F-69003 Lyon, France; [Scoazec, Jean-Yves] Hop Edouard Herriot, Dept Pathol, F-69003 Lyon, France; [Zoulim, Fabien] Hop Edouard Herriot, Hosp Civils Lyon, Dept Hepatogastroenterol, F-69003 Lyon, France; Univ Lyon 1, F-69622 Villeurbanne, France	CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Chaubo, C (corresponding author), Hop Edouard Herriot, Dept Nephrol Transplantat & Clin Immunol, 5 Pl Arsonval, F-69003 Lyon, France.	catherinechaubo1@yahoo.fr	Zoulim, Fabien/ABD-5594-2021	Zoulim, Fabien/0000-0002-2245-0083				Blanpain C, 1998, TRANSPLANTATION, V66, P883, DOI 10.1097/00007890-199810150-00012; LAU JYN, 1991, LANCET, V337, P802, DOI 10.1016/0140-6736(91)91433-U; Manegold C, 2001, CLIN INFECT DIS, V32, P144, DOI 10.1086/317535; Mindikoglu AL, 2006, CLIN GASTROENTEROL H, V4, P1076, DOI 10.1016/j.cgh.2006.05.027; Osiowy C, 2006, J MED VIROL, V78, pS48, DOI 10.1002/jmv.20607	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2082	2082		10.1016/S0140-6736(09)60739-X	http://dx.doi.org/10.1016/S0140-6736(09)60739-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DJ	19524783				2022-12-28	WOS:000267080100036
J	Annane, D; Bellissant, E; Bollaert, PE; Briegel, J; Confalonieri, M; De Gaudio, R; Keh, D; Kupfer, Y; Oppert, M; Meduri, GU				Annane, Djillali; Bellissant, Eric; Bollaert, Pierre-Edouard; Briegel, Josef; Confalonieri, Marco; De Gaudio, Raffaele; Keh, Didier; Kupfer, Yizhak; Oppert, Michael; Meduri, G. Umberto			Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LOW-DOSE HYDROCORTISONE; COMMUNITY-ACQUIRED PNEUMONIA; DOUBLE-BLIND; STEROID-THERAPY; METHYLPREDNISOLONE; DEXAMETHASONE; MANAGEMENT; METAANALYSIS; MORTALITY; CONSENSUS	Context The benefit of corticosteroids in severe sepsis and septic shock remains controversial. Objective We examined the benefits and risks of corticosteroid treatment in severe sepsis and septic shock and the influence of dose and duration. Data Sources We searched the CENTRAL, MEDLINE, EMBASE, and LILACS (through March 2009) databases as well as reference lists of articles and proceedings of major meetings, and we contacted trial authors. Study Selection Randomized and quasi-randomized trials of corticosteroids vs placebo or supportive treatment in adult patients with severe sepsis/septic shock per the American College of Chest Physicians/Society of Critical Care Medicine consensus definition were included. Data Extraction All reviewers agreed on trial eligibility. One reviewer extracted data, which were checked by the other reviewers and by the trials' authors whenever possible. Some unpublished data were obtained from the trials' authors. The primary outcome for this review was 28-day mortality. Results We identified 17 randomized trials (n=2138) and 3 quasi-randomized trials (n=246) that had acceptable methodological quality to pool in a meta-analysis. Twenty-eight-day mortality for treated vs control patients was 388/1099 (35.3%) vs 400/1039 (38.5%) in randomized trials (risk ratio [RR], 0.84; 95% confidence interval [CI], 0.71-1.00; P=.05; I-2=53% by random-effects model) and 28/121 (23.1%) vs 24/125 (19.2%) in quasi-randomized trials (RR, 1.05, 95% CI, 0.69-1.58; P=.83). In 12 trials investigating prolonged low-dose corticosteroid treatment, 28-day mortality for treated vs control patients was 236/629 (37.5%) vs 264/599 (44%) ( RR, 0.84; 95% CI, 0.72-0.97; P=.02). This treatment increased 28-day shock reversal ( 6 trials; 322/481 [66.9%] vs 276/471 [58.6%]; RR, 1.12; 95% CI, 1.02-1.23; P=.02; I-2=4%) and reduced intensive care unit length of stay by 4.49 days (8 trials; 95% CI, -7.04 to -1.94; P<.001; I-2=0%) without increasing the risk of gastroduodenal bleeding (13 trials; 65/800 [8.1%] vs 56/764 [7.3%]; P=.50; I-2=0%), superinfection (14 trials; 184/998 [18.4%] vs 170/950 [17.9%]; P=.92; I-2=8%), or neuromuscular weakness (3 trials; 4/407 [1%] vs 7/404 [1.7%]; P=.58; I-2=30%). Corticosteroids increased the risk of hyperglycemia (9 trials; 363/703 [51.6%] vs 308/670 [46%]; P<.001; I-2=0%) and hypernatremia (3 trials; 127/404 [31.4%] vs 77/401 [ 19.2%]; P<.001; I-2=0%). Conclusions Corticosteroid therapy has been used in varied doses for sepsis and related syndromes for more than 50 years, with no clear benefit on mortality. Since 1998, studies have consistently used prolonged low-dose corticosteroid therapy, and analysis of this subgroup suggests a beneficial drug effect on short-term mortality. JAMA. 2009;301(22):2362-2375 www.jama.com	[Annane, Djillali] Univ Versailles, APHP, Crit Care Dept, Hop Raymond Poincare, F-92380 Garches, France; [Bellissant, Eric] Univ Rennes 1, Hop Pontchaillou, Ctr Hosp Univ, Pharmacol Dept,Clin Invest Ctr,INSERM 0203, Rennes, France; [Bollaert, Pierre-Edouard] Univ Nancy 1, Intens Care Unit, Hop Cent, Ctr Hosp Univ, Nancy, France; [Briegel, Josef] Anasthesiol Klin, Dept Anesthesiol & Intens Care Med, Munich, Germany; [Confalonieri, Marco] Univ Hosp Trieste, Dept Pneumol, Trieste, Italy; [De Gaudio, Raffaele] Univ Florence AOUC Careggi, Dept Crit Care, Sect Anaesthesiol & Intens Care, Florence, Italy; [Keh, Didier] Charite Campus Virchow Clin, Intens Care Unit, Berlin, Germany; [Kupfer, Yizhak] Maimonides Hosp, Div Pulm & Crit Care Med, New York, NY USA; [Oppert, Michael] Charite Campus Virchow Klinikum, Klin Schwerpunkt Nephrol & Internist Intens Med, Berlin, Germany; [Meduri, G. Umberto] Univ Tennessee, Ctr Hlth Sci, Div Pulm Crit Care & Sleep Med, Memphis, TN 38163 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU de Nancy; Universite de Lorraine; University of Munich; University of Trieste; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Maimonides Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Tennessee System; University of Tennessee Health Science Center	Annane, D (corresponding author), Univ Versailles, APHP, Crit Care Dept, Hop Raymond Poincare, 104 Blvd Raymond Poincare, F-92380 Garches, France.	djillali.annane@rpc.ap-hop-paris.fr	Briegel, Josef/AAG-3774-2019; Annane, Djillali/R-7947-2019; Josef, Briegel/ABF-3522-2021; Confalonieri, Marco/AAA-3665-2019	Briegel, Josef/0000-0003-2837-8008; Confalonieri, Marco/0000-0002-4791-768X	UK Department for International Development	UK Department for International Development	This review was initially developed within the Cochrane Collaboration Infectious Diseases Group, supported by a grant from the UK Department for International Development. The review was transferred to the Cochrane Collaboration Anaesthesia Group in May 2005. There was no funding for this review in particular.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2003, SHOCK, V20, P197, DOI 10.1097/01.shk.0000079423.72656.2f; Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; ANNANE D, COCHRANE DA IN PRESS; Annane D, 2009, CRIT CARE MED, V37, pS117, DOI 10.1097/CCM.0b013e318192078b; [Anonymous], 2008, REV MAN REVMAN VERS; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Chawla K, 1999, CRIT CARE MED, V27, pA33, DOI 10.1097/00003246-199901001-00022; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cicarelli Domingos Dias, 2006, Sao Paulo Med. J., V124, P90, DOI 10.1590/S1516-31802006000200008; Cicarelli DD, 2007, SAO PAULO MED J, V125, P237, DOI 10.1590/S1516-31802007000400009; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; de Kruif MD, 2007, J IMMUNOL, V178, P1845, DOI 10.4049/jimmunol.178.3.1845; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; FABIAN TC, 1982, AM SURGEON, V48, P614; Group CS, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI DOI 10.1001/JAMA.1963.63700060029012; Guyatt G., 2008, USERS GUIDES MEDICAL; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HAHN EO, 1951, J CLIN INVEST, V30, P274, DOI 10.1172/JCI102441; Heller AR, 2003, INTENS CARE MED, V29, P1456, DOI 10.1007/s00134-003-1831-y; HUANG ZH, 1987, CIRC SHOCK, V23, P27; HUGHES GS, 1984, LIFE SCI, V35, P2319, DOI 10.1016/0024-3205(84)90523-X; Huh JW, 2006, CRIT CARE MED, V34, P2697, DOI 10.1097/01.CCM.0000243975.53041.4f; JAATTELA M, 1991, ENDOCRINOLOGY, V128, P623; Kaufmann I, 2008, INTENS CARE MED, V34, P344, DOI 10.1007/s00134-007-0868-8; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206; Loisa P, 2007, CRIT CARE, V11, DOI 10.1186/cc5696; LUCAS CE, 1984, ARCH SURG-CHICAGO, V119, P537; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; MCKEE JI, 1983, LANCET, V1, P484; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Minneci PC, 2004, ANN INTERN MED, V141, P47, DOI 10.7326/0003-4819-141-1-200407060-00014; MOLIJN GJ, 1995, CLIN ENDOCRINOL, V43, P197, DOI 10.1111/j.1365-2265.1995.tb01915.x; Oppert M, 2005, CRIT CARE MED, V33, P2457, DOI 10.1097/01.CCM.0000186370.78639.23; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; Rinaldi S, 2006, CRIT CARE MED, V34, P2334, DOI 10.1097/01.CCM.0000233872.04706.BB; ROGERS J, 1970, British Journal of Urology, V42, P742; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Slusher T, 1996, PEDIATR INFECT DIS J, V15, P579, DOI 10.1097/00006454-199607000-00004; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Tandan SM, 2005, P AM THOR SOC M, pA24; THOMPSON WL, 1976, CLIN RES, V24, pA258; Tsao CM, 2004, SHOCK, V21, P484, DOI 10.1097/00024382-200405000-00014; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536; Yildiz O, 2002, CRIT CARE, V6, P251, DOI 10.1186/cc1498	60	374	409	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2362	2375		10.1001/jama.2009.815	http://dx.doi.org/10.1001/jama.2009.815			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509383	Bronze, Green Published			2022-12-28	WOS:000266773400029
J	Siva, N				Siva, Nayanah			Race relations in the UK's National Health Service	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1935	1936		10.1016/S0140-6736(09)61050-3	http://dx.doi.org/10.1016/S0140-6736(09)61050-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456GT	19514113	Bronze			2022-12-28	WOS:000266832500012
J	Guarente, L				Guarente, Leonard			Hypoxic Hookup	SCIENCE			English	Editorial Material							TRANSCRIPTION FACTORS; SIRT1; DEACETYLASE		[Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Paul F Glenn Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Bell EL, 2007, ESSAYS BIOCHEM, V43, P17, DOI 10.1042/bse0430017; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167	11	15	15	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1281	1282		10.1126/science.1175679	http://dx.doi.org/10.1126/science.1175679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498158				2022-12-28	WOS:000266635100031
J	Luce, BR; Kramer, JM; Goodman, SN; Connor, JT; Tunis, S; Whicher, D; Schwartz, JS				Luce, Bryan R.; Kramer, Judith M.; Goodman, Steven N.; Connor, Jason T.; Tunis, Sean; Whicher, Danielle; Schwartz, J. Sanford			Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change	ANNALS OF INTERNAL MEDICINE			English	Article							PHASE-III; LEUKEMIA; CANCER; DESIGN		[Luce, Bryan R.] United BioSource Corp, Bethesda, MD 20814 USA; Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Publ Hlth, Baltimore, MD USA; Ctr Med Technol Policy, Baltimore, MD USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Duke Univ, Duke Translat Med Inst, Durham, NC USA; Berry Consultants, Orlando, FL USA; Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	United Biosource Corporation; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Duke University; State University System of Florida; University of Central Florida	Luce, BR (corresponding author), United BioSource Corp, 7101 Wisconsin Ave,Suite 600, Bethesda, MD 20814 USA.	bryan.luce@unitedbiosource.com		Goodman, Steven/0000-0002-3872-5723				[Anonymous], CLIN TRANSLATIONAL S; [Anonymous], COV EV DEV; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; BERGER JO, 1988, AM SCI, V76, P159; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; *CLIN TRIALS TRANS, MEMB ORG; Congressional Budget Office, RES COMP EFF MED TRE; *CTR MED MED SERV, 2009, BAYES STAT METH MED; Dilts DM, 2006, J CLIN ONCOL, V24, P4553, DOI 10.1200/JCO.2006.06.7819; Eisenstein EL, 2005, AM HEART J, V149, P482, DOI 10.1016/j.ahj.2004.04.049; Getz KA, 2008, AM J THER, V15, P450, DOI 10.1097/MJT.0b013e31816b9027; Giles FJ, 2003, J CLIN ONCOL, V21, P1722, DOI 10.1200/JCO.2003.11.016; *I MED, PUBL WORKSH STREAML; Inoue LYT, 2002, BIOMETRICS, V58, P823, DOI 10.1111/j.0006-341X.2002.00823.x; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; MAYFIELD E, 2009, NCI CANC B, V6; National Cancer Institute and CEO Roundtable on Cancer, 2008, PROP STAND HARM CLAU; Olsen L, LEARNING HEALTHCARE; Schwartz D, 2009, J CLIN EPIDEMIOL, V62, P499, DOI 10.1016/j.jclinepi.2009.01.012; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; U.S. Food Drug Adm. (FDA), 2006, GUID US BAYES STAT M; *US FDA, MEM UND; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	25	251	254	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					206	W45		10.7326/0003-4819-151-3-200908040-00126	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00126			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19567619				2022-12-28	WOS:000268947800008
J	Thomson, M; Gunawardena, J				Thomson, Matthew; Gunawardena, Jeremy			Unlimited multistability in multisite phosphorylation systems	NATURE			English	Article							PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; HISTONE CODE; TRANSCRIPTION; KINASE; ULTRASENSITIVITY; MEMORY; SWITCH	Reversible phosphorylation on serine, threonine and tyrosine is the most widely studied posttranslational modification of proteins(1,2). The number of phosphorylated sites on a protein (n) shows a significant increase from prokaryotes, with n <= 7 sites, to eukaryotes, with examples having n >= 150 sites(3). Multisite phosphorylation has many roles(4,5) and site conservation indicates that increasing numbers of sites cannot be due merely to promiscuous phosphorylation. A substrate with n sites has an exponential number (2(n)) of phospho-forms and individual phospho-forms may have distinct biological effects(6,7). The distribution of these phospho-forms and how this distribution is regulated have remained unknown. Here we show that, when kinase and phosphatase act in opposition on a multisite substrate, the system can exhibit distinct stable phospho-form distributions at steady state and that the maximum number of such distributions increases with n. Whereas some stable distributions are focused on a single phospho-form, others are more diffuse, giving the phosphoproteome the potential to behave as a fluid regulatory network able to encode information and flexibly respond to varying demands. Such plasticity may underlie complex information processing in eukaryotic cells(8) and suggests a functional advantage in having many sites. Our results follow from the unusual geometry of the steady-state phospho-form concentrations, which we show to constitute a rational algebraic curve, irrespective of n. We thereby reduce the complexity of calculating steady states from simulating 3 x 2(n) differential equations to solving two algebraic equations, while treating parameters symbolically. We anticipate that these methods can be extended to systems with multiple substrates and multiple enzymes catalysing different modifications, as found in posttranslational modification 'codes'(9) such as the histone code(10,11). Whereas simulations struggle with exponentially increasing molecular complexity, mathematical methods of the kind developed here can provide a new language in which to articulate the principles of cellular information processing(12).	[Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomson, Matthew] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Gunawardena, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jeremy@hms.harvard.edu			NIH [R01-GM081578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081578] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the NIH under grant R01-GM081578. We thank A. Manrai for scientific discussions, R. Ward for editorial help and HMS RITG for support with cluster computing. We acknowledge the encouragement of the late Stephen Thomson (1946-2006) and Charles Gunawardena (1929-2007).	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cohen JE, 2004, PLOS BIOL, V2, P2017, DOI 10.1371/journal.pbio.0020439; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P23; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Walsh C., 2006, POSTTRANSLATIONAL MO; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019	30	180	180	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					274	277		10.1038/nature08102	http://dx.doi.org/10.1038/nature08102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19536158	Green Accepted, Green Submitted			2022-12-28	WOS:000267761000044
J	Schmid, P; Nagai, Y; Agarwal, R; Hancock, B; Savage, PM; Sebire, NJ; Lindsay, I; Wells, M; Fisher, RA; Short, D; Newlands, ES; Wischnewsky, MB; Seckl, MJ				Schmid, Peter; Nagai, Yutaka; Agarwal, Roshan; Hancock, Barry; Savage, Philip M.; Sebire, Neil J.; Lindsay, Iain; Wells, Michael; Fisher, Rosemary A.; Short, Delia; Newlands, Edward S.; Wischnewsky, Manfred B.; Seckl, Michael J.			Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study	LANCET			English	Article							HYDATIDIFORM MOLE; MANAGEMENT; CHEMOTHERAPY; FERTILITY; NEOPLASIA; HYSTERECTOMY; PSEUDOTUMOR; EXPERIENCE	Background Placental-site trophoblastic tumours are a rare form of gestational trophoblastic disease and consequently information about optimum management or prognostic factors is restricted. We aimed to assess the long-term outcome of stage-adapted management by surgery, chemotherapy, or both for patients with the disorder. Methods 35550 women were registered with gestational trophoblastic disease in the UK (1976-2006), of whom 62 were diagnosed with placental-site trophoblastic tumours and included, retrospectively, in the study. Patients were treated by surgery, chemotherapy, or both. We estimated the probabilities of overall survival and survival without recurrence of disease 5 and 10 years after the date of first treatment, and calculated the association of these endpoints with prognostic factors, including time since antecedent pregnancy, serum concentration of beta-human chorionic gonadotropin, and stage of disease, with both univariate and multivariate analyses. Findings Probabilities of overall and recurrence-free survival 10 years after first treatment were 70% (95% CI 54-82) and 73% (54-85), respectively. Patients with stage I disease had a 10-year probability of overall survival of 90% (77-100) and did not benefit from postoperative chemotherapy. By contrast, patients with stage II, III, and IV disease required combined treatment with surgery and chemotherapy; probability of overall survival at 10 years was 52% (3-100) for patients with stage II disease and 49% (26-72) for stage III or IV disease. Outcome for patients who had recurrent or refractory disease was poor: only four (22%) patients achieved long-term survival beyond 60 months. Multivariate analysis showed that the only significant independent predictor of overall and recurrence-free survival was time since antecedent pregnancy. A cutoff point of 48 months since antecedent pregnancy could differentiate between patients' probability of survival (<48 months) or death (>= 48 months) with 93% specificity and 100% sensitivity, and with a positive predictive value of 100% and a negative predictive value of 98%. Interpretation Stage-adapted management with surgery for stage I disease, and combined surgery and chemotherapy for stage II, III, and IV disease could improve the effectiveness of treatment for placental-site trophoblastic tumours. Use of 48 months since antecedent pregnancy as a prognostic indicator of survival could help select patients for risk-adapted treatment.	[Schmid, Peter] Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Ctr, London W6 8RF, England; [Schmid, Peter; Agarwal, Roshan; Seckl, Michael J.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Nagai, Yutaka] Univ Ryukyus, Okinawa, Japan; [Hancock, Barry; Wells, Michael] Weston Pk Hosp, Gestat Trophoblast Dis Ctr, Sheffield, S Yorkshire, England; [Wells, Michael] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Wischnewsky, Manfred B.] Univ Bremen, Bremen, Germany	Imperial College London; University of the Ryukyus; Weston Park Hospital; University of Sheffield; University of Bremen	Schmid, P (corresponding author), Imperial Coll NHS Healthcare Trust, Dept Med Oncol, Charing Cross Gestat Trophoblast Dis Ctr, Charing Cross Hosp Campus,Fulham Palace Rd, London W6 8RF, England.	p.schmid@imperial.ac.uk; m.seckl@imperial.ac.uk	Schmid, Peter/AAE-2788-2019	Fisher, Rosemary/0000-0002-2721-8726; Savage, Philip/0000-0002-4792-6869; Sebire, Neil/0000-0001-5348-9063	National Commissioning Group; Cancer Research UK; Department of Health Imperial College London Experimental Cancer Medicine Centre; Biomedical Research Centre at Impefial College London	National Commissioning Group; Cancer Research UK(Cancer Research UK); Department of Health Imperial College London Experimental Cancer Medicine Centre; Biomedical Research Centre at Impefial College London	This study was funded by the National Commissioning Group. We thank Cancer Research UK, the Department of Health Imperial College London Experimental Cancer Medicine Centre, and our Biomedical Research Centre at Impefial College London for grant support; and John Tidy, Richard Smith, and Angus McIndoe for their surgical management.	Baergen RN, 2006, GYNECOL ONCOL, V100, P511, DOI 10.1016/j.ygyno.2005.08.058; Berkowitz RS, 2009, GYNECOL ONCOL, V112, P654, DOI 10.1016/j.ygyno.2008.09.005; Bower M, 1997, J CLIN ONCOL, V15, P2636, DOI 10.1200/JCO.1997.15.7.2636; Chang YL, 1999, GYNECOL ONCOL, V73, P216, DOI 10.1006/gyno.1999.5344; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; ECKSTEIN RP, 1982, HISTOPATHOLOGY, V6, P211, DOI 10.1111/j.1365-2559.1982.tb02716.x; Feltmate CM, 2001, GYNECOL ONCOL, V82, P415, DOI 10.1006/gyno.2001.6265; FISHER RA, 1992, BRIT J CANCER, V65, P355, DOI 10.1038/bjc.1992.72; Hassadia A, 2005, GYNECOL ONCOL, V99, P603, DOI 10.1016/j.ygyno.2005.06.054; KURMAN RJ, 1976, CANCER, V38, P1214, DOI 10.1002/1097-0142(197609)38:3<1214::AID-CNCR2820380323>3.0.CO;2-J; Leiserowitz GS, 1996, OBSTET GYNECOL, V88, P696, DOI 10.1016/0029-7844(96)00124-X; Machtinger R, 2005, GYNECOL ONCOL, V96, P56, DOI 10.1016/j.ygyno.2004.08.049; Newlands ES, 1998, J REPROD MED, V43, P53; Newlands ES, 2000, J CLIN ONCOL, V18, P854, DOI 10.1200/JCO.2000.18.4.854; Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285; Palmieri C, 2005, LANCET, V366, P688, DOI 10.1016/S0140-6736(05)67143-7; Papadopoulos AJ, 2002, J REPROD MED, V47, P460; Pfeffer PE, 2007, LANCET ONCOL, V8, P744, DOI 10.1016/S1470-2045(07)70243-7; Powles T, 2006, BRIT J CANCER, V94, P51, DOI 10.1038/sj.bjc.6602899; Savage P, 2008, J REPROD MED, V53, P774; SCULLY RE, 1981, AM J SURG PATHOL, V5, P75, DOI 10.1097/00000478-198101000-00010; Tsuji Y, 2002, GYNECOL ONCOL, V87, P303, DOI 10.1006/gyno.2002.6827; TWIGGS LB, 1981, GYNECOL ONCOL, V12, P238, DOI 10.1016/0090-8258(81)90153-0; Wang J, 2008, ANN ONCOL, V19, P1578, DOI 10.1093/annonc/mdn181	24	148	160	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 4	2009	374	9683					48	55		10.1016/S0140-6736(09)60618-8	http://dx.doi.org/10.1016/S0140-6736(09)60618-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19552948				2022-12-28	WOS:000267768800033
J	Checkley, DM; Dickson, AG; Takahashi, M; Radich, JA; Eisenkolb, N; Asch, R				Checkley, David M., Jr.; Dickson, Andrew G.; Takahashi, Motomitsu; Radich, J. Adam; Eisenkolb, Nadine; Asch, Rebecca			Elevated CO2 Enhances Otolith Growth in Young Fish	SCIENCE			English	Article							OCEAN ACIDIFICATION		[Checkley, David M., Jr.; Dickson, Andrew G.; Takahashi, Motomitsu; Radich, J. Adam; Eisenkolb, Nadine; Asch, Rebecca] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Checkley, DM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA.	dcheckley@ucsd.edu			Academic Senate of the University of California, San Diego; Division Of Ocean Sciences [0752972] Funding Source: National Science Foundation	Academic Senate of the University of California, San Diego; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Hubbs-SeaWorld Research Institute for providing fertilized fish eggs. E. York assisted with electron microscopy. V. Fabry, G. Somero, V. Vaquier, and two anonymous reviewers improved the manuscript. Supported by the Academic Senate of the University of California, San Diego. Data available at http://repositories.cdlib.org/sio/techreport/97/.	Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Gagliano M, 2008, P R SOC B, V275, P527, DOI 10.1098/rspb.2007.1388; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelster B, 1999, COMP BIOCHEM PHYS A, V124, P407, DOI 10.1016/S1095-6433(99)00132-4; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156	6	159	166	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1683	1683		10.1126/science.1169806	http://dx.doi.org/10.1126/science.1169806			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556502				2022-12-28	WOS:000267338200031
J	Hubbard, SR				Hubbard, Stevan R.			The Juxtamembrane Region of EGFR Takes center stage	CELL			English	Editorial Material							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; ACTIVATION; AUTOINHIBITION; FAMILY		NYU, Sturct Biol Program, Kimmel Ctr Biol & Med, Skirball Inst,Sch Med, New York, NY 10016 USA	New York University	Hubbard, SR (corresponding author), NYU, Sturct Biol Program, Kimmel Ctr Biol & Med, Skirball Inst,Sch Med, New York, NY 10016 USA.	stevan.hubbard@med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383				Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARPENTER G, 1978, NATURE, V276, P409, DOI 10.1038/276409a0; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	9	21	21	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1181	1183		10.1016/j.cell.2009.06.008	http://dx.doi.org/10.1016/j.cell.2009.06.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563749	Bronze			2022-12-28	WOS:000267373400010
J	Le Goff, L; Lecuit, T				Le Goff, Loic; Lecuit, Thomas			Phase Transition in a Cell	SCIENCE			English	Editorial Material							TRANSPORT; MECHANISMS; DIVISION		[Le Goff, Loic; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, UMR6216, IBDML, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Le Goff, L (corresponding author), Univ Aix Marseille 2, CNRS, UMR6216, IBDML, Campus Luminy Case 907, F-13288 Marseille 09, France.	lecuit@ibdml.univ-mrs.fr		Le Goff, Loic/0000-0003-4114-971X				Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; [Anonymous], 1992, INTERMOLECULAR SURFA; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2	8	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1654	1655		10.1126/science.1176523	http://dx.doi.org/10.1126/science.1176523			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556492				2022-12-28	WOS:000267338200021
J	Wu, Q; Boyle, MP; Palmiter, RD				Wu, Qi; Boyle, Maureen P.; Palmiter, Richard D.			Loss of GABAergic Signaling by AgRP Neurons to the Parabrachial Nucleus Leads to Starvation	CELL			English	Article							GABA(A) RECEPTOR SUBTYPES; NEUROPEPTIDE-Y; ENERGY-BALANCE; FOOD-INTAKE; BODY-WEIGHT; EXPRESSING NEURONS; NPY/AGRP NEURONS; ARCUATE NUCLEUS; TASTE-AVERSION; AGOUTI	Neurons in the arcuate nucleus that produce AgRP, NPY, and GABA (AgRP neurons) promote feeding. Ablation of AgRP neurons in adult mice results in Fos activation in postsynaptic neurons and starvation. Loss of GABA is implicated in starvation because chronic subcutaneous delivery of bretazenil (a GABA(A) receptor partial agonist) suppresses Fos activation and maintains feeding during ablation of AgRP neurons. Moreover, under these conditions, direct delivery of bretazenil into the parabrachial nucleus (PBN), a direct target of AgRP neurons that also relays gustatory and visceral sensory information, is sufficient to maintain feeding. Conversely, inactivation of GABA biosynthesis in the ARC or blockade of GABAA receptors in the PBN of mice promote anorexia. We suggest that activation of the PBN by AgRP neuron ablation or gastrointestinal malaise inhibits feeding. Chronic delivery of bretazenil during loss of AgRP neurons provides time to establish compensatory mechanisms that eventually allow mice to eat.	[Wu, Qi; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Wu, Qi; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Boyle, Maureen P.] Allen Inst Brain Sci, Seattle, WA 98103 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Allen Institute for Brain Science	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@u.washington.edu			National Institutes of Health [DA024908]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grant DA024908 to R.D.P.	Andre V, 2007, EPILEPSIA, V48, P41, DOI 10.1111/j.1528-1167.2007.01288.x; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Broberger C, 2001, PHYSIOL BEHAV, V74, P669, DOI 10.1016/S0031-9384(01)00611-4; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Chaijale NN, 2008, BRAIN RES, V1240, P111, DOI 10.1016/j.brainres.2008.08.066; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cooper SJ, 2005, APPETITE, V44, P133, DOI 10.1016/j.appet.2005.01.003; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Duke AN, 2006, PSYCHOPHARMACOLOGY, V187, P321, DOI 10.1007/s00213-006-0431-2; Ebenezer IS, 2007, EUR J PHARMACOL, V569, P90, DOI 10.1016/j.ejphar.2007.05.022; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Flier JS, 2006, CELL METAB, V3, P83, DOI 10.1016/j.cmet.2006.01.003; Gerra G, 2002, ADDICT BIOL, V7, P385, DOI 10.1080/1355621021000005973; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Higgs S, 1996, EUR J PHARMACOL, V313, P1, DOI 10.1016/0014-2999(96)00446-3; Horvath TL, 2006, OBESITY, V14, P228; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Lamprecht R, 1995, NEUROREPORT, V7, P289, DOI 10.1097/00001756-199512290-00069; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Paxinos G., 2001, MOUSE BRAIN STEROTAX; PECKNOLD JC, 1993, J PSYCHIAT RES, V27, P155, DOI 10.1016/0022-3956(93)90025-W; Phillips CT, 2008, ENDOCRINOLOGY, V149, P544, DOI 10.1210/en.2007-1153; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Reilly S, 2000, BRAIN RES BULL, V52, P269, DOI 10.1016/S0361-9230(00)00263-X; Rinaman L, 2007, AM J PHYSIOL-REG I, V293, pR1495, DOI 10.1152/ajpregu.00393.2007; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Scopinho AA, 2008, BRIT J PHARMACOL, V155, P752, DOI 10.1038/bjp.2008.295; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SWANK MW, 1994, BRAIN RES, V636, P202, DOI 10.1016/0006-8993(94)91018-9; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Trifunovic R, 2002, BRAIN RES BULL, V58, P107, DOI 10.1016/S0361-9230(02)00766-9; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Wilson JD, 2003, AM J PHYSIOL-REG I, V285, pR1055, DOI 10.1152/ajpregu.00108.2003; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105	50	316	320	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1225	1234		10.1016/j.cell.2009.04.022	http://dx.doi.org/10.1016/j.cell.2009.04.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563755	Bronze, Green Accepted			2022-12-28	WOS:000267373400016
J	Avram, MM; Hoang, M				Avram, Mathew M.; Hoang, Mai			A Woman with a Blistering Cutaneous Eruption Acute generalized exanthematous pustulosis due to hydroxychloroquine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EUROSCAR; AGEP		[Avram, Mathew M.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Hoang, Mai] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Avram, Mathew M.] Harvard Univ, Sch Med, Dept Dermatol, Cambridge, MA 02138 USA; [Hoang, Mai] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Avram, MM (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.							Bachot N, 2003, AM J CLIN DERMATOL, V4, P561, DOI 10.2165/00128071-200304080-00006; Britschgi M, 2001, J CLIN INVEST, V107, P1433, DOI 10.1172/JCI12118; Britschgi M, 2002, CURR OPIN ALLERGY CL, V2, P325, DOI 10.1097/00130832-200208000-00006; Mockenhaupt M, 2005, J INVEST DERMATOL, V124, P700, DOI 10.1111/j.0022-202X.2005.23642.x; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; ROUJEAU JC, 1991, ARCH DERMATOL, V127, P1333, DOI 10.1001/archderm.127.9.1333; Schmid S, 2002, AM J PATHOL, V161, P2079, DOI 10.1016/S0002-9440(10)64486-0; Sidoroff A, 2007, BRIT J DERMATOL, V157, P989, DOI 10.1111/j.1365-2133.2007.08156.x; Sidoroff A, 2001, J CUTAN PATHOL, V28, P113, DOI 10.1034/j.1600-0560.2001.028003113.x; Tas S, 2003, DERMATOLOGY, V206, P353, DOI 10.1159/000069956; Vine John E., 1996, Journal of Dermatology (Tokyo), V23, P357; Yasuda H, 2000, BRIT J DERMATOL, V143, P144, DOI 10.1046/j.1365-2133.2000.03604.x; ZELICKSON BD, 1991, ARCH DERMATOL, V127, P1339, DOI 10.1001/archderm.127.9.1339	13	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2771	2777		10.1056/NEJMcpc0900639	http://dx.doi.org/10.1056/NEJMcpc0900639			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553651				2022-12-28	WOS:000267286600013
J	Scott, KL; Kabbarah, O; Liang, MC; Ivanova, E; Anagnostou, V; Wu, J; Dhakal, S; Wu, M; Chen, SJ; Feinberg, T; Huang, J; Saci, A; Widlund, HR; Fisher, DE; Xiao, YH; Rimm, DL; Protopopov, A; Wong, KK; Chin, L				Scott, Kenneth L.; Kabbarah, Omar; Liang, Mei-Chih; Ivanova, Elena; Anagnostou, Valsamo; Wu, Joyce; Dhakal, Sabin; Wu, Min; Chen, Shujuan; Feinberg, Tamar; Huang, Joseph; Saci, Abdel; Widlund, Hans R.; Fisher, David E.; Xiao, Yonghong; Rimm, David L.; Protopopov, Alexei; Wong, Kwok-Kin; Chin, Lynda			GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer	NATURE			English	Article							P70 S6 KINASE; CELL-SIZE; GOLGI; TARGET; GROWTH; TOR; GLYCOSYLTRANSFERASES; PHOSPHORYLATION; LOCALIZATION; PROGRESSION	Genome-wide copy number analyses of human cancers identified a frequent 5p13 amplification in several solid tumour types, including lung (56%), ovarian (38%), breast (32%), prostate (37%) and melanoma ( 32%). Here, using integrative analysis of a genomic profile of the region, we identify a Golgi protein, GOLPH3, as a candidate targeted for amplification. Gain- and loss-of-function studies in vitro and in vivo validated GOLPH3 as a potent oncogene. Physically, GOLPH3 localizes to the trans- Golgi network and interacts with components of the retromer complex, which in yeast has been linked to target of rapamycin ( TOR) signalling. Mechanistically, GOLPH3 regulates cell size, enhances growth-factor-induced mTOR (also known as FRAP1) signalling in human cancer cells, and alters the response to an mTOR inhibitor in vivo. Thus, genomic and genetic, biological, functional and biochemical data in yeast and humans establishes GOLPH3 as a new oncogene that is commonly targeted for amplification in human cancer, and is capable of modulating the response to rapamycin, a cancer drug in clinical use.	[Scott, Kenneth L.; Kabbarah, Omar; Liang, Mei-Chih; Wu, Joyce; Dhakal, Sabin; Wu, Min; Chen, Shujuan; Feinberg, Tamar; Huang, Joseph; Wong, Kwok-Kin; Chin, Lynda] Harvard Univ, Ctr Canc, Dept Med Oncol, Boston, MA 02115 USA; [Ivanova, Elena; Xiao, Yonghong; Protopopov, Alexei; Chin, Lynda] Harvard Univ, Ctr Canc, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Widlund, Hans R.; Fisher, David E.] Harvard Univ, Ctr Canc, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wong, Kwok-Kin] Harvard Univ, Ctr Canc, Ludwig Ctr Dana Farber, Boston, MA 02115 USA; [Anagnostou, Valsamo; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Saci, Abdel] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Widlund, Hans R.; Chin, Lynda] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA	Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Yale University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Chin, L (corresponding author), Harvard Univ, Ctr Canc, Dept Med Oncol, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu		Widlund, Hans/0000-0002-7506-2447; wong, kwok kin/0000-0001-6323-235X; Rimm, David/0000-0001-5820-4397; Ivanova, Elena/0000-0002-5069-4974; Liang, Mei-Chih/0000-0002-7389-2455	American Cancer Society [PF-07-039-01-CSM]; National Institutes of Health (NIH) [5-T32-AR07098-31, R01 AG2400401, R01 CA122794, RO-1 CA 114277, RO1 CA93947, P50 CA93683]; Program of Research Excellence (SPORE) grant [P50 CA090578]; NATIONAL CANCER INSTITUTE [R01CA093947, P50CA093683, R01CA114277, P50CA090578, R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Research Excellence (SPORE) grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. DePinho for critical reading of the manuscript, and L. Cantley, as well as members of the Chin laboratory, for helpful discussion. We thank H. Ying for assistance with confocal microscopy. The rabbit polyclonal antibody against human GOLPH3 was kindly provided by J. J. Bergeron of McGill University. Mouse monoclonal antibody against human GOLPH3, C19, was generated at the Dana-Farber/Harvard Cancer Center Monoclonal Antibody Core Facility. K. L. S. is at present supported by a Postdoctoral Fellowship from the American Cancer Society (PF-07-039-01-CSM), and K. L. S. and O. K. were previously supported by a National Institutes of Health (NIH) Training Grant appointment in the Department of Dermatology at Brigham and Women's Hospital (5-T32-AR07098-31). K.-K. W. was supported by a Program of Research Excellence (SPORE) grant (P50 CA090578) and NIH grants (R01 AG2400401; R01 CA122794). The AQUA immunofluorescence study was supported by a grant from the NIH to D. L. R. (RO-1 CA 114277). This work is primarily supported by grants from the NIH to L. C. (RO1 CA93947; P50 CA93683).	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	33	268	299	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1085	U68		10.1038/nature08109	http://dx.doi.org/10.1038/nature08109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553991	Green Accepted			2022-12-28	WOS:000267636700034
J	Smith, GJD; Vijaykrishna, D; Bahl, J; Lycett, SJ; Worobey, M; Pybus, OG; Ma, SK; Cheung, CL; Raghwani, J; Bhatt, S; Peiris, JSM; Guan, Y; Rambaut, A				Smith, Gavin J. D.; Vijaykrishna, Dhanasekaran; Bahl, Justin; Lycett, Samantha J.; Worobey, Michael; Pybus, Oliver G.; Ma, Siu Kit; Cheung, Chung Lam; Raghwani, Jayna; Bhatt, Samir; Peiris, J. S. Malik; Guan, Yi; Rambaut, Andrew			Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; VIRUS; TRANSMISSION; INFECTION; PIGS	In March and early April 2009, a new swine-origin influenza A (H1N1) virus (S-OIV) emerged in Mexico and the United States(1). During the first few weeks of surveillance, the virus spread worldwide to 30 countries (as of May 11) by human-to-human transmission, causing the World Health Organization to raise its pandemic alert to level 5 of 6. This virus has the potential to develop into the first influenza pandemic of the twenty-first century. Here we use evolutionary analysis to estimate the time-scale of the origins and the early development of the S-OIV epidemic. We show that it was derived from several viruses circulating in swine, and that the initial transmission to humans occurred several months before recognition of the outbreak. A phylogenetic estimate of the gaps in genetic surveillance indicates a long period of unsampled ancestry before the S-OIV outbreak, suggesting that the reassortment of swine lineages may have occurred years before emergence in humans, and that the multiple genetic ancestry of S-OIV is not indicative of an artificial origin. Furthermore, the unsampled history of the epidemic means that the nature and location of the genetically closest swine viruses reveal little about the immediate origin of the epidemic, despite the fact that we included a panel of closely related and previously unpublished swine influenza isolates. Our results highlight the need for systematic surveillance of influenza in swine, and provide evidence that the mixing of new genetic elements in swine can result in the emergence of viruses with pandemic potential in humans(2).	[Lycett, Samantha J.; Raghwani, Jayna; Rambaut, Andrew] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Smith, Gavin J. D.; Vijaykrishna, Dhanasekaran; Bahl, Justin; Ma, Siu Kit; Cheung, Chung Lam; Peiris, J. S. Malik; Guan, Yi] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Smith, Gavin J. D.; Vijaykrishna, Dhanasekaran; Bahl, Justin; Ma, Siu Kit; Cheung, Chung Lam; Peiris, J. S. Malik; Guan, Yi] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85705 USA; [Pybus, Oliver G.; Bhatt, Samir] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Edinburgh; University of Hong Kong; University of Hong Kong; University of Arizona; University of Oxford	Rambaut, A (corresponding author), Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Kings Bldg, Edinburgh EH9 3JT, Midlothian, Scotland.	yguan@hku.hk; a.rambaut@ed.ac.uk	Bhatt, Samir/ABE-7938-2020; Cheung, Yiu Man/T-2708-2019; Bahl, Justin/A-4728-2011; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Rambaut, Andrew/B-2481-2009; Lycett, Samantha/F-9598-2013; Dhanasekaran, Vijaykrishna/D-1011-2010; Pybus, Oliver G/B-2640-2012	Bahl, Justin/0000-0001-7572-4300; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Rambaut, Andrew/0000-0003-4337-3707; Lycett, Samantha/0000-0003-3159-596X; Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Pybus, Oliver G/0000-0002-8797-2667; Guan, Yi/0000-0001-6057-9243; Raghwani, Jayna/0000-0001-8538-4995; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Bhatt, Samir/0000-0002-0891-4611; Smith, Gavin JD/0000-0001-5031-468X	The Royal Society of London; National Institute of Allergy and Infectious Diseases ( NIAID); Biotechnology and Biological Sciences Research Council ( BBSRC); David and Lucile Packard Foundation; Interdisciplinary Centre for Human and Avian Influenza Research ( ICHAIR); National Institutes of Health [HHSN266200700005C]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR Government [AoE/M-12/06]; BBSRC [BB/E009670/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009670/1] Funding Source: researchfish	The Royal Society of London(Royal Society of London); National Institute of Allergy and Infectious Diseases ( NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council ( BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Interdisciplinary Centre for Human and Avian Influenza Research ( ICHAIR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. C. Holmes for comments and encouragement. We acknowledge support from The Royal Society of London ( A. R. and O. G. P.), the National Institute of Allergy and Infectious Diseases ( NIAID) ( G. J. D. S. and M. W.), the Biotechnology and Biological Sciences Research Council ( BBSRC) ( S. J. L.), and the David and Lucile Packard Foundation ( M. W.). A. R. works as a part of the Interdisciplinary Centre for Human and Avian Influenza Research ( ICHAIR). This study was supported by the National Institutes of Health ( NIAID contract HHSN266200700005C) and the Area of Excellence Scheme of the University Grants Committee ( grant AoE/M-12/06) of the Hong Kong SAR Government.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; *CDCP, 2009, NOV INFL A VIR INF 2; Choi YK, 2004, EMERG INFECT DIS, V10, P2156, DOI 10.3201/eid1012.040581; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; GARTEN RJ, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Jung K, 2007, VET REC, V161, P104, DOI 10.1136/vr.161.3.104; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; SHOPE RICHARD E., 1931, JOUR EXP MED, V54, P349, DOI 10.1084/jem.54.3.349; SHORTRIDGE KF, 1977, SCIENCE, V196, P1454, DOI 10.1126/science.867041; Smith G. J. D., P NATL ACAD IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trifonov V, 2009, EUROSURVEILLANCE, V14, P6; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000	29	1513	1624	9	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1122	U107		10.1038/nature08182	http://dx.doi.org/10.1038/nature08182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19516283	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000267636700042
J	Edelstein, RA				Edelstein, Robert A.			"Minutes From Fishing and the Opera"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rob.edelstein@comcast.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2533	2534		10.1001/jama.2009.805	http://dx.doi.org/10.1001/jama.2009.805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549962				2022-12-28	WOS:000267266500001
J	Korte, M				Korte, Martin			Bridging the Gap and Staying Local	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; MEMORY STORAGE; PLASTICITY; SYNAPSES; LTP		Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Korte, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany.	m.korte@tu-bs.de						Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205	14	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1527	1528		10.1126/Science.1176484	http://dx.doi.org/10.1126/Science.1176484			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541987				2022-12-28	WOS:000267130600032
J	Harousseau, JL; Moreau, P				Harousseau, Jean-Luc; Moreau, Philippe			Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; HIGH-DOSE THERAPY; INTERGROUPE FRANCOPHONE; RANDOMIZED-TRIAL; STANDARD CHEMOTHERAPY; PLUS DEXAMETHASONE; IMPROVES SURVIVAL; ELDERLY-PATIENTS; MELPHALAN; THALIDOMIDE	A previously healthy 59-year-old man presents with persistent pain in his lower back and fatigue. A complete blood count reveals a hemoglobin level of 9.8 g per deciliter. A monoclonal protein (M component) is detected on serum protein electrophoresis and is characterized as an IgG kappa by immunofixation. A radiologic skeletal bone survey shows diffuse lytic bone lesions of the vertebrae and the pelvis. The diagnosis of multiple myeloma is confirmed by bone marrow aspiration, which reveals an infiltrate of 32% plasma cells. The serum calcium and creatinine levels are normal, the albumin level is 3.7 g per deciliter, and the beta(2)-microglobulin level is 2.8 mg per liter. Fluorescence in situ hybridization of bone marrow plasma cells shows deletion of chromosome 13, with no adverse prognostic factors. Considering the patient's relatively young age and the absence of coexisting illnesses, a hematologist recommends induction therapy followed by high-dose therapy with autologous hematopoietic stem-cell transplantation as the initial treatment.	[Harousseau, Jean-Luc] Rene Gauducheau Canc Ctr, F-44805 Nantes, France; [Moreau, Philippe] Univ Hosp Hotel Dieu, Nantes, France	UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes	Harousseau, JL (corresponding author), Rene Gauducheau Canc Ctr, Blvd J Monod, F-44805 Nantes, France.	jl-harousseau@nantes.fnclcc.fr		moreau, philippe/0000-0003-1780-8746				Anderson Kenneth C, 2007, J Natl Compr Canc Netw, V5, P118; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 2004, NEW ENGL J MED, V350, P1467; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Auwerda JJA, 2007, HAEMATOLOGICA, V92, P279, DOI 10.3324/haematol.10454; Avet-Loiseau H, 2002, BLOOD, V99, P2185, DOI 10.1182/blood.V99.6.2185; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Barlogie B, 2006, J CLIN ONCOL, V24, P2687, DOI 10.1200/JCO.2006.04.004; Barlogie B, 2004, BLOOD, V103, P20, DOI 10.1182/blood-2003-04-1045; BARLOGIE B, 1986, BLOOD, V67, P1298; Barlogie B, 1999, BLOOD, V93, P55, DOI 10.1182/blood.V93.1.55.401k04_55_65; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2006, J CLIN ONCOL, V24, P929, DOI 10.1200/JCO.2005.04.5807; Barlogie B, 2008, CANCER-AM CANCER SOC, V113, P355, DOI 10.1002/cncr.23546; Barlogie B, 2008, BLOOD, V111, P94, DOI 10.1182/blood-2007-06-097444; Barosi G, 2004, HAEMATOLOGICA, V89, P717; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Blade J, 2005, BLOOD, V106, P3755, DOI 10.1182/blood-2005-03-1301; Cavo M, 2007, BLOOD, V110, p30A, DOI 10.1182/blood.V110.11.73.73; Cavo M, 2007, J CLIN ONCOL, V25, P2434, DOI 10.1200/JCO.2006.10.2509; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Chng WJ, 2007, BEST PRACT RES CL HA, V20, P571, DOI 10.1016/j.beha.2007.08.004; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Durie BGM, 2006, LEUKEMIA, V20, P2220, DOI 10.1038/sj.leu.2404428; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Esteve FR, 2007, BEST PRACT RES CL HA, V20, P613, DOI 10.1016/j.beha.2007.08.003; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Fermand J, 2005, J CLIN ONCOL, V23, P9227, DOI 10.1200/JCO.2005.03.0551; Fermand JP, 1998, BLOOD, V92, P3131, DOI 10.1182/blood.V92.9.3131.421k30_3131_3136; Harousseau JL, 1999, HAEMATOLOGICA, V84, P548; HAROUSSEAU JL, 2008, J CLIN ONCOL, V26, pS455; He Y., 2003, COCHRANE DATABASE SY, V2003, DOI [DOI 10.1002/14651858.CD004023, 10.1002/14651858.CD004023]; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Jones JA, 2008, CANCER, V112, P1096, DOI 10.1002/cncr.23281; Kucia M, 2004, J MOL HISTOL, V35, P233; Kuehl W Michael, 2005, Hematology Am Soc Hematol Educ Program, P346; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Lacy MQ, 2007, MAYO CLIN PROC, V82, P1179, DOI 10.4065/82.10.1179; MCELWAIN TJ, 1983, LANCET, V2, P822; Moreau P, 2002, BLOOD, V99, P731, DOI 10.1182/blood.V99.3.731; Niesvizky R, 2008, BLOOD, V111, P1101, DOI 10.1182/blood-2007-05-090258; Palumbo A, 2004, BLOOD, V104, P3052, DOI 10.1182/blood-2004-02-0408; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Pineda-Roman M, 2008, BRIT J HAEMATOL, V140, P625, DOI 10.1111/j.1365-2141.2007.06921.x; Podar K, 2007, BEST PRACT RES CL HA, V20, P597, DOI 10.1016/j.beha.2007.08.002; Rajkumar SV, 2007, BLOOD, V110, p31A, DOI 10.1182/blood.V110.11.74.74; Rajkumar S Vincent, 2005, Hematology Am Soc Hematol Educ Program, P340; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; RICHARDSON PG, 2008, J CLIN ONCOL S, V26, pS459; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; San-Miguel J, 2008, J CLIN ONCOL, V26, P2761, DOI 10.1200/JCO.2007.15.2546; Sauer-Heilborn A, 2004, TRANSFUSION, V44, P907, DOI 10.1111/j.1537-2995.2004.03230.x; Silvestris F, 2002, BLOOD, V99, P1305, DOI 10.1182/blood.V99.4.1305; Smith A, 2006, BRIT J HAEMATOL, V132, P410, DOI 10.1111/j.1365-2141.2005.05867.x; Spencer A, 2009, J CLIN ONCOL, V27, P1788, DOI 10.1200/JCO.2008.18.8573	61	146	153	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2645	2654		10.1056/NEJMct0805626	http://dx.doi.org/10.1056/NEJMct0805626			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535803				2022-12-28	WOS:000267060000009
J	Kovalenko, MV; Scheele, M; Talapin, DV				Kovalenko, Maksym V.; Scheele, Marcus; Talapin, Dmitri V.			Colloidal Nanocrystals with Molecular Metal Chalcogenide Surface Ligands	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; CHARGE-TRANSPORT; CLUSTERS; SOLIDS; ASSEMBLIES; FILMS	Similar to the way that atoms bond to form molecules and crystalline structures, colloidal nanocrystals can be combined together to form larger assemblies. The properties of these structures are determined by the properties of individual nanocrystals and by their interactions. The insulating nature of organic ligands typically used in nanocrystal synthesis results in very poor interparticle coupling. We found that various molecular metal chalcogenide complexes can serve as convenient ligands for colloidal nanocrystals and nanowires. These ligands can be converted into semiconducting phases upon gentle heat treatment, generating inorganic nanocrystal solids. The utility of the inorganic ligands is demonstrated for model systems, including highly conductive arrays of gold nanocrystals capped with Sn2S64- ions and field-effect transistors on cadmium selenide nanocrystals.	[Kovalenko, Maksym V.; Talapin, Dmitri V.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Scheele, Marcus] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Talapin, Dmitri V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory	Talapin, DV (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	dvtalapin@uchicago.edu	Scheele, Marcus/F-8522-2010; Kovalenko, Maksym V/B-6844-2008	Kovalenko, Maksym V/0000-0002-6396-8938; Scheele, Marcus/0000-0002-2704-3591	Deutsche Studienstiftung; American Chemical Society Petroleum Research Fund [48636-G10]; Chicago Energy Initiative, and Evident Technologies Inc.; U.S. Department of Energy [DE-AC02-05CH11357]	Deutsche Studienstiftung; American Chemical Society Petroleum Research Fund(American Chemical Society); Chicago Energy Initiative, and Evident Technologies Inc.; U.S. Department of Energy(United States Department of Energy (DOE))	We thank D. B. Mitzi and P. Guyot-Sionnest for stimulating discussions, M. Bodnarchuk and J. Huang for synthesis of Au nanoparticles and CdSe/CdS tetrapods, E. Shevchenko and I. Steele for help with energy-dispersive x-ray and SEM measurements, J.-S. Lee and R. Divan for help with electrical measurements, the Analytical Chemistry Laboratory at Argonne National Laboratory for elemental analysis, and F. Stafford for reading the manuscript. Supported by Deutsche Studienstiftung (M.S.), American Chemical Society Petroleum Research Fund grant 48636-G10, the Chicago Energy Initiative, and Evident Technologies Inc. Work at the Center for Nanoscale Materials, Argonne National Laboratory, was supported by the U.S. Department of Energy under contract DE-AC02-05CH11357.	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bag S, 2007, SCIENCE, V317, P490, DOI 10.1126/science.1142535; Beloborodov IS, 2007, REV MOD PHYS, V79, P469, DOI 10.1103/RevModPhys.79.469; Caruge JM, 2008, NAT PHOTONICS, V2, P247, DOI 10.1038/nphoton.2008.34; Collier CP, 1997, SCIENCE, V277, P1978, DOI 10.1126/science.277.5334.1978; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Hecht DS, 2007, CURR APPL PHYS, V7, P60, DOI 10.1016/j.cap.2005.09.001; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kirchmeyer S, 2005, J MATER CHEM, V15, P2077, DOI 10.1039/b417803n; Kuno M, 1997, J CHEM PHYS, V106, P9869, DOI 10.1063/1.473875; Law M, 2008, J AM CHEM SOC, V130, P5974, DOI 10.1021/ja800040c; MacLachlan MJ, 1999, NATURE, V397, P681, DOI 10.1038/17776; Milliron DJ, 2007, NAT MATER, V6, P352, DOI 10.1038/nmat1887; Mitzi DB, 2007, INORG CHEM, V46, P926, DOI 10.1021/ic0621291; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; Mitzi DB, 2005, INORG CHEM, V44, P7078, DOI 10.1021/ic050833w; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Ni T, 2002, J AM CHEM SOC, V124, P3980, DOI 10.1021/ja017149a; Ridley BA, 1999, SCIENCE, V286, P746, DOI 10.1126/science.286.5440.746; Riley AE, 2006, ANGEW CHEM INT EDIT, V45, P235, DOI 10.1002/anie.200501361; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Vanmaekelbergh D, 2005, CHEM SOC REV, V34, P299, DOI 10.1039/b314945p; Yu D, 2003, SCIENCE, V300, P1277, DOI 10.1126/science.1084424; Yu D, 2006, J APPL PHYS, V99, DOI 10.1063/1.2192288; Yuan M, 2007, INORG CHEM, V46, P7238, DOI 10.1021/ic7007107; Zabet-Khosousi A, 2008, CHEM REV, V108, P4072, DOI 10.1021/cr0680134	27	842	857	14	557	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1417	1420		10.1126/science.1170524	http://dx.doi.org/10.1126/science.1170524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520953				2022-12-28	WOS:000266878700038
J	Matthews, HD; Gillett, NP; Stott, PA; Zickfeld, K				Matthews, H. Damon; Gillett, Nathan P.; Stott, Peter A.; Zickfeld, Kirsten			The proportionality of global warming to cumulative carbon emissions	NATURE			English	Article							DYNAMICS; MODEL	The global temperature response to increasing atmospheric CO2 is often quantified by metrics such as equilibrium climate sensitivity and transient climate response(1). These approaches, however, do not account for carbon cycle feedbacks and therefore do not fully represent the net response of the Earth system to anthropogenic CO2 emissions. Climate-carbon modelling experiments have shown that: (1) the warming per unit CO2 emitted does not depend on the background CO2 concentration(2); (2) the total allowable emissions for climate stabilization do not depend on the timing of those emissions(3-5); and (3) the temperature response to a pulse of CO2 is approximately constant on timescales of decades to centuries(3,6-8). Here we generalize these results and show that the carbon-climate response (CCR), defined as the ratio of temperature change to cumulative carbon emissions, is approximately independent of both the atmospheric CO2 concentration and its rate of change on these timescales. From observational constraints, we estimate CCR to be in the range 1.0-2.1 degrees C per trillion tonnes of carbon (Tt C) emitted (5th to 95th percentiles), consistent with twenty-first-century CCR values simulated by climate-carbon models. Uncertainty in land-use CO2 emissions and aerosol forcing, however, means that higher observationally constrained values cannot be excluded. The CCR, when evaluated from climate-carbon models under idealized conditions, represents a simple yet robust metric for comparing models, which aggregates both climate feedbacks and carbon cycle feedbacks. CCR is also likely to be a useful concept for climate change mitigation and policy; by combining the uncertainties associated with climate sensitivity, carbon sinks and climate-carbon feedbacks into a single quantity, the CCR allows CO2-induced global mean temperature change to be inferred directly from cumulative carbon emissions.	[Matthews, H. Damon] Concordia Univ, Dept Geog Planning & Environm, Montreal, PQ H3G 1M8, Canada; [Gillett, Nathan P.; Zickfeld, Kirsten] Environm Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC V8P 5C2, Canada; [Stott, Peter A.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England	Concordia University - Canada; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Met Office - UK; Hadley Centre	Matthews, HD (corresponding author), Concordia Univ, Dept Geog Planning & Environm, 1455 Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	dmatthew@alcor.concordia.ca	Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016; Matthews, Damon/A-8965-2008; /AAD-2430-2020	Stott, Peter/0000-0003-4853-7686; /0000-0003-3625-390X	National Science and Engineering Research Council of Canada; Canadian Foundation for Climate and Atmospheric Sciences Project; DECC; Defra and MoD Integrated Climate Programme; Leverhulme Trust; Climate Change Detection and Attribution Project; NOAA's Office of Global Programs; US Department of Energy	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Climate and Atmospheric Sciences Project; DECC; Defra and MoD Integrated Climate Programme; Leverhulme Trust(Leverhulme Trust); Climate Change Detection and Attribution Project; NOAA's Office of Global Programs(National Oceanic Atmospheric Admin (NOAA) - USA); US Department of Energy(United States Department of Energy (DOE))	We thank A. Weaver, M. Eby, V. Arora, N. Ramankutty, M. Allen, S. Solomon, K. Keller, K. Caldeira and S. Turner for commentary and discussions on this work. We also thank P. Forster for providing radiative forcing time series, and P. Friedlingstein and the C4MIP modelling community for the availability of their model output. H. D. M. acknowledges support from the National Science and Engineering Research Council of Canada, and the Canadian Foundation for Climate and Atmospheric Sciences Project Grants. P. A. S. was supported by the Joint DECC, Defra and MoD Integrated Climate Programme. N. P. G. received support from the Leverhulme Trust. N. P. G. and P. A. S. acknowledge support from the Climate Change Detection and Attribution Project, jointly funded by NOAA's Office of Global Programs and the US Department of Energy.	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; CALDEIRA K, 1993, NATURE, V366, P251, DOI 10.1038/366251a0; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Eby M, 2009, J CLIMATE, V22, P2501, DOI 10.1175/2008JCLI2554.1; European Commission, 2007, LIM GLOB CLIM CHANG; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gregory JM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010405; Houghton R. A, 2008, TRENDS COMPENDIUM DA; Huntingford C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024831; Marland G., 2008, TRENDS COMPENDIUM DA; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2006, TELLUS B, V58, P591, DOI 10.1111/j.1600-0889.2006.00200.x; Matthews HD, 2005, J CLIMATE, V18, P1609, DOI 10.1175/JCLI3359.1; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meissner KJ, 2003, CLIM DYNAM, V21, P515, DOI 10.1007/s00382-003-0352-2; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Shine KP, 2005, CLIMATIC CHANGE, V68, P281, DOI 10.1007/s10584-005-1146-9; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; ZICKFELD K, P NATL ACAD SC UNPUB	24	540	560	18	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					829	U3		10.1038/nature08047	http://dx.doi.org/10.1038/nature08047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516338				2022-12-28	WOS:000267084500036
J	Koreth, J; Schlenk, R; Kopecky, KJ; Honda, S; Sierra, J; Djulbegovic, BJ; Wadleigh, M; DeAngelo, DJ; Stone, RM; Sakamaki, H; Appelbaum, FR; Dohner, H; Antin, JH; Soiffer, RJ; Cutler, C				Koreth, John; Schlenk, Richard; Kopecky, Kenneth J.; Honda, Sumihisa; Sierra, Jorge; Djulbegovic, Benjamin J.; Wadleigh, Martha; DeAngelo, Daniel J.; Stone, Richard M.; Sakamaki, Hisashi; Appelbaum, Frederick R.; Doehner, Hartmut; Antin, Joseph H.; Soiffer, Robert J.; Cutler, Corey			Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; FRENCH AML INTERGROUP; HIGH-DOSE CYTARABINE; POSTREMISSION THERAPY; CONSOLIDATION THERAPY; COMORBIDITY INDEX; COOPERATIVE-GROUP; ADULT PATIENTS; ONCOLOGY-GROUP	Context The optimal treatment of acute myeloid leukemia (AML) in first complete remission (CR1) is uncertain. Current consensus, based on cytogenetic risk, recommends myeloablative allogeneic stem cell transplantation (SCT) for poor-risk but not for good-risk AML. Allogeneic SCT, autologous transplantation, and consolidation chemotherapy are considered of equivalent benefit for intermediate-risk AML. Objective To quantify relapse-free survival (RFS) and overall survival benefit of allogeneic SCT for AML in CR1 overall and also for good-, intermediate-, and poor-risk AML. Methods Systematic review and meta-analysis of prospective trials evaluating allogeneic SCT vs nonallogeneic SCT therapies for AML in CR1. The search used the combined search terms allogeneic; acut* and leukem*/leukaem*/leucem*/leucaem*/aml; myelo* or nonlympho* in the PubMed, Embase, and Cochrane Registry of Controlled Trials databases in March 2009. The search identified 1712 articles. Study Selection Prospective trials assigning adult patients with AML in CR1 to undergo allogeneic SCT vs nonallogeneic SCT treatment(s) based on donor availability and trials reporting RFS and/or overall survival outcomes on an intention-to-treat, donor vs no-donor basis were identified. Data Extraction Two reviewers independently extracted study characteristics, interventions, and outcomes. Hazard ratios (HRs) with 95% confidence intervals (CIs) were determined. Data Synthesis Overall, 24 trials and 6007 patients were analyzed (5951 patients in RFS analyses and 5606 patients in overall survival analyses); 3638 patients were analyzed by cytogenetic risk (547, 2499, and 592 with good-, intermediate-, and poor-risk AML, respectively). Interstudy heterogeneity was not significant. Fixed-effects meta-analysis was performed. Compared with nonallogeneic SCT, the HR of relapse or death with allogeneic SCT for AML in CR1 was 0.80 (95% CI, 0.74-0.86). Significant RFS benefit of allogeneic SCT was documented for poor- risk (HR, 0.69; 95% CI, 0.57-0.84) and intermediate- risk AML (HR, 0.76; 95% CI, 0.68-0.85) but not for good- risk AML (HR, 1.06; 95% CI, 0.80-1.42). The HR of death with allogeneic SCT for AML in CR1 was 0.90 ( 95% CI, 0.82-0.97). Significant overall survival benefit with allogeneic SCT was documented for poor- risk (HR, 0.73; 95% CI, 0.59-0.90) and intermediate- risk AML (HR, 0.83; 95% CI, 0.74-0.93) but not for good- risk AML (HR, 1.07; 95% CI, 0.83-1.38). Conclusion Compared with nonallogeneic SCT therapies, allogeneic SCT has significant RFS and overall survival benefit for intermediate- and poor- risk AML but not for good- risk AML in first complete remission. JAMA. 2009;301(22):2349-2361 www.jama.com	[Koreth, John; Wadleigh, Martha; DeAngelo, Daniel J.; Stone, Richard M.; Antin, Joseph H.; Soiffer, Robert J.; Cutler, Corey] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Schlenk, Richard; Doehner, Hartmut] Univ Hosp Ulm, Ulm, Germany; [Kopecky, Kenneth J.; Appelbaum, Frederick R.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Honda, Sumihisa] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Sierra, Jorge] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Djulbegovic, Benjamin J.] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes, Tampa, FL USA; [Djulbegovic, Benjamin J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Sakamaki, Hisashi] Tokyo Metropolitan Komagome Hosp, Tokyo, Japan	Harvard University; Dana-Farber Cancer Institute; Ulm University; Fred Hutchinson Cancer Center; Nagasaki University; Hospital of Santa Creu i Sant Pau; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital	Koreth, J (corresponding author), Dana Farber Canc Inst, Div Hematol Malignancies, 44 Binney St, Boston, MA 02115 USA.	john_koreth@dfci.harvard.edu	Honda, Sumihisa/V-7060-2019; Döhner, Hartmut/C-8933-2016; Djulbegovic, Benjamin/I-3661-2012; Schlenk, Richard/AAG-3218-2019	Döhner, Hartmut/0000-0003-2116-5536; Djulbegovic, Benjamin/0000-0003-0671-1447; 	Stem Cell Cyclists of the Pan-Massachusetts Challenge; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER	Stem Cell Cyclists of the Pan-Massachusetts Challenge; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Sakamaki reported serving as a member of the advisory boards of Bristol-Myers Squibb Co and Wyeth Inc. Dr Cutler reported receiving partial funding from the Stem Cell Cyclists of the Pan-Massachusetts Challenge. No other authors reported financial disclosures.	ARCHIMBAUD E, 1994, J CLIN ONCOL, V12, P262, DOI 10.1200/JCO.1994.12.2.262; Basara N, 2009, LEUKEMIA, V23, P635, DOI 10.1038/leu.2008.352; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Breems DA, 2005, BRIT J HAEMATOL, V128, P59, DOI 10.1111/j.1365-2141.2004.05282.x; Brunet S, 2004, HAEMATOLOGICA, V89, P940; Burnett A. K., 2004, Annals of Hematology, V83, pS135; Burnett Alan K, 2006, Clin Adv Hematol Oncol, V4, P445; CASSILETH PA, 1992, LEUKEMIA, V6, P116; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cornelissen JJ, 2007, BLOOD, V109, P3658, DOI 10.1182/blood-2006-06-025627; Delaunay J, 2003, BLOOD, V102, P462, DOI 10.1182/blood-2002-11-3527; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; FERRANT A, 1991, BONE MARROW TRANSPL, V7, P303; GRAY R, 1991, BONE MARROW TRANSPL, V7, P9; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; Hamadani M, 2008, BIOL BLOOD MARROW TR, V14, P556, DOI 10.1016/j.bbmt.2008.02.019; Harousseau JL, 1997, BLOOD, V90, P2978; HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662, DOI 10.1080/10473289.1992.10467018; HEWLETT J, 1995, LEUKEMIA, V9, P562; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jourdan E, 2005, J CLIN ONCOL, V23, P7676, DOI 10.1200/JCO.2005.02.5940; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Keating S, 1998, BRIT J HAEMATOL, V102, P1344, DOI 10.1111/j.1365-2141.1998.896hm3674.x; Levi I, 2004, LEUKEMIA RES, V28, P605, DOI 10.1016/j.leukres.2003.10.029; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nathan PC, 2004, JNCI-J NATL CANCER I, V96, P38, DOI 10.1093/jnci/djh003; Nguyen S, 2002, BLOOD, V99, P3517, DOI 10.1182/blood.V99.10.3517; Oliansky DM, 2008, BIOL BLOOD MARROW TR, V14, P137, DOI 10.1016/j.bbmt.2007.11.002; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Sakamaki H, 2008, BLOOD, V112, P135; SCHILLER GJ, 1992, J CLIN ONCOL, V10, P41, DOI 10.1200/JCO.1992.10.1.41; Schlenk RF, 2003, LEUKEMIA, V17, P1521, DOI 10.1038/sj.leu.2403009; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Sierra J, 1996, J CLIN ONCOL, V14, P1353, DOI 10.1200/JCO.1996.14.4.1353; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suciu S, 2003, BLOOD, V102, P1232, DOI 10.1182/blood-2002-12-3714; Visani G, 2006, LEUKEMIA LYMPHOMA, V47, P1091, DOI 10.1080/10428190500513595; Yanada M, 2005, CANCER-AM CANCER SOC, V103, P1652, DOI 10.1002/cncr.20945	45	598	625	3	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2349	2361		10.1001/jama.2009.813	http://dx.doi.org/10.1001/jama.2009.813			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509382	Green Accepted			2022-12-28	WOS:000266773400028
J	Hawkes, N				Hawkes, Nigel			Patient Safety Standing up for safety	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2009	338								b2286	10.1136/bmj.b2286	http://dx.doi.org/10.1136/bmj.b2286			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LG	19509032				2022-12-28	WOS:000267021800026
J	Vanlerberghe, V; Toledo, ME; Rodriguez, M; Gomez, D; Baly, A; Benitez, JR; Van der Stuyft, P				Vanlerberghe, V.; Toledo, M. E.; Rodriguez, M.; Gomez, D.; Baly, A.; Benitez, J. R.; Van der Stuyft, P.			Community involvement in dengue vector control: cluster randomised trial	BRITISH MEDICAL JOURNAL			English	Article							AEDES-AEGYPTI CONTROL; CONTROL PROGRAMS ACHIEVE; PUBLISHED EVALUATIONS; MESOCYCLOPS COPEPODA; COST-EFFECTIVENESS; CUBA; PARTICIPATION; VIETNAM; MEXICO; SURVEILLANCE	Objective To assess the effectiveness of an integrated community based environmental management strategy to control Aedes aegypti, the vector of dengue, compared with a routine strategy. Design Cluster randomised trial. Setting Guantanamo, Cuba. Participants 32 circumscriptions (around 2000 inhabitants each). Interventions The circumscriptions were randomly allocated to control clusters (n=16) comprising routine Aedes control programme (entomological surveillance, source reduction, selective adulticiding, and health education) and to intervention clusters (n=16) comprising the routine Aedes control programme combined with a community based environmental management approach. Main outcome measures The primary outcome was levels of Aedes infestation: house index (number of houses positive for at least one container with immature stages of Ae aegypti per 100 inspected houses), Breteau index (number of containers positive for immature stages of Ae aegypti per 100 inspected houses), and the pupae per inhabitant statistic (number of Ae aegypti pupae per inhabitant). Results All clusters were subjected to the intended intervention; all completed the study protocol up to February 2006 and all were included in the analysis. At baseline the Aedes infestation levels were comparable between intervention and control clusters: house index 0.25% v 0.20%, pupae per inhabitant 0.44x10(-3)v 0.29x10(-3). At the end of the intervention these indices were significantly lower in the intervention clusters: rate ratio for house indices 0.49 (95% confidence interval 0.27 to 0.88) and rate ratio for pupae per inhabitant 0.27 (0.09 to 0.76). Conclusion A community based environmental management embedded in a routine control programme was effective at reducing levels of Aedes infestation. Trial registration Current Controlled Trials ISRCTN88405796.	[Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Toledo, M. E.; Baly, A.] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Rodriguez, M.; Gomez, D.; Benitez, J. R.] Prov Ctr Surveillance & Vector Control, Guantanamo, Cuba	Institute of Tropical Medicine (ITM)		vvanlerberghe@itg.be		Vanlerberghe, Veerle/0000-0002-6531-0793	Institute of Tropical Medicine and the Belgian Directorate-General for Development Co-operation [95900]	Institute of Tropical Medicine and the Belgian Directorate-General for Development Co-operation	This study received partial funding from the framework agreement between the Institute of Tropical Medicine and the Belgian Directorate-General for Development Co-operation (project No 95900). The funding source was not involved in any stage of the research process.	Baly A, 2007, T ROY SOC TROP MED H, V101, P578, DOI 10.1016/j.trstmh.2007.01.002; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; KINDHAUSER MK, 2003, COMMUNICABLE DIS 200, P140; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Parks W, 2005, DENGUE B S, V28, P1; Perez D, 2007, TROP MED INT HEALTH, V12, P664, DOI 10.1111/j.1365-3156.2007.01833.x; Perez D, 2007, T ROY SOC TROP MED H, V101, P630, DOI 10.1016/j.trstmh.2007.02.010; RIFKIN SB, 1988, SOC SCI MED, V26, P931, DOI 10.1016/0277-9536(88)90413-3; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Simmons R, 2002, STUD FAMILY PLANN, V33, P61, DOI 10.1111/j.1728-4465.2002.00061.x; *TDR, 2006, SCI WORK GROUP M DEN; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; Ukoumunne OC, 1999, BRIT MED J, V319, P376, DOI 10.1136/bmj.319.7206.376; VORDAM V, 1997, DENGUE DENGUE HEMORR, P313; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; Zakus JDL, 1998, HEALTH POLICY PLANN, V13, P1, DOI 10.1093/heapol/13.1.1	34	87	89	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2009	338								b1959	10.1136/bmj.b1959	http://dx.doi.org/10.1136/bmj.b1959			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458LG	19509031	hybrid, Green Published			2022-12-28	WOS:000267021800002
J	Henderson, C; Thornicroft, G				Henderson, Claire; Thornicroft, Graham			Stigma and discrimination in mental illness: Time to Change	LANCET			English	Editorial Material							REDUCING PSYCHIATRIC STIGMA; CONTACT; ENGLAND		[Henderson, Claire; Thornicroft, Graham] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE5 8AF, England	University of London; King's College London	Henderson, C (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE5 8AF, England.	claire.henderson@iop.kcl.ac.uk	Corbin, Melody/B-8937-2009; Thornicroft, Graham/B-4027-2010; Henderson, Claire/E-4664-2010	Thornicroft, Graham/0000-0003-0662-0879; Henderson, Claire/0000-0002-6998-5659				Allport G.W., 1954, NATURE PREJUDICE; [Anonymous], TIME CHANGE; Corrigan PW, 2001, SCHIZOPHRENIA BULL, V27, P187, DOI 10.1093/oxfordjournals.schbul.a006865; Corrigan PW, 2004, STIGMA MENTAL ILLNES; Kolodziej ME, 1996, J CONSULT CLIN PSYCH, V64, P1387, DOI 10.1037/0022-006X.64.6.1387; Mehta N, 2009, BRIT J PSYCHIAT, V194, P278, DOI 10.1192/bjp.bp.108.052654; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Pinfold V, 2003, SOC PSYCH PSYCH EPID, V38, P337, DOI 10.1007/s00127-003-0641-4; Pinfold V, 2003, BRIT J PSYCHIAT, V182, P342, DOI 10.1192/bjp.182.4.342; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; FORESIGHT MENTAL CAP	12	153	153	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1928	1930		10.1016/S0140-6736(09)61046-1	http://dx.doi.org/10.1016/S0140-6736(09)61046-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19501729	Green Submitted			2022-12-28	WOS:000266832500008
J	Subramaniam, S; Sixt, KM; Barrow, R; Snyder, SH				Subramaniam, Srinivasa; Sixt, Katherine M.; Barrow, Roxanne; Snyder, Solomon H.			Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity	SCIENCE			English	Article							KNOCK-IN MICE; BEHAVIORAL ABNORMALITIES; INTRANUCLEAR INCLUSIONS; NEURONAL DEATH; MOUSE MODEL; CELL-DEATH; DISEASE; DEXRAS1; NUCLEAR; RAS	Huntington's disease (HD) is caused by a polyglutamine repeat in the protein huntingtin (Htt) with mutant Htt (mHtt) expressed throughout the body and similarly in all brain regions. Yet, HD neuropathology is largely restricted to the corpus striatum. We report that the small guanine nucleotide-binding protein Rhes, which is localized very selectively to the striatum, binds physiologically to mHtt. Using cultured cells, we found Rhes induces sumoylation of mHtt, which leads to cytotoxicity. Thus, Rhes-mHtt interactions can account for the localized neuropathology of HD.	[Subramaniam, Srinivasa; Sixt, Katherine M.; Barrow, Roxanne; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			USPHS [MH18501]; Research Scientist Award [DA00074]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank I. Rao, A. Hayashi, K. Ishizuka and M. Chakraborty for technical support. We thank N. Shahani and R. Mealer for critically reading the manuscript. We thank E. Fossale and M. Macdonald for generously providing striatal cell lines. We thank M. Matunis for providing SUMO-related constructs, H. Zoghbi for ataxin constructs, S. Li and X. J.Li for purified Htt, J. Nathans for use of his cell culture facility and Alessandro Usiello for providing antibody to Rhes. Supported by USPHS grant MH18501 and Research Scientist Award DA00074 (SHS).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; USUI H, 1994, J NEUROSCI, V14, P4915; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200	29	242	252	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1327	1330		10.1126/science.1172871	http://dx.doi.org/10.1126/science.1172871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19498170	Green Accepted			2022-12-28	WOS:000266635100046
J	Sudlow, C; Warlow, C				Sudlow, Cathie; Warlow, Charles			Getting the priorities right for stroke care	BRITISH MEDICAL JOURNAL			English	Editorial Material							CASE-FATALITY; POPULATION; MORTALITY; UK		[Sudlow, Cathie; Warlow, Charles] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sudlow, C (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk	Sudlow, Cathie LM/F-3420-2010	Sudlow, Cathie/0000-0002-7725-7520	Medical Research Council [G0700704B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BOYLE R, 2009, NATL STROKE STRATEGY; Coombes R, 2005, BRIT MED J, V331, P1161, DOI 10.1136/bmj.331.7526.1161; Department of Health, 2007, NAT STROK STRAT; Department of Health, 2005, RED BRAIN DAM FAST A; Dudley N, 2008, AGE AGEING, V37, P236, DOI 10.1093/ageing/afm199; Govan L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub2; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; Healthcare for London, 2008, STROK STRAT LOND; *KINGS COLL LOND, 2005, EC BURD STROK ENGL; Markus H, 2007, BRIT MED J, V335, P359, DOI 10.1136/bmj.39296.711563.AD; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; *ROYAL COLL PHYS C, 2009, NAT SENT STROK AUD P; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; WARLOW C, 2008, STROKE PRACTICAL MAN, P509; 2009, BMJ, V57; 3 INT STROKE TRIAL; 2009, DRUG THER B, V47, P14	22	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 4	2009	338								b2083	10.1136/bmj.b2083	http://dx.doi.org/10.1136/bmj.b2083			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455AH	19502221				2022-12-28	WOS:000266726400004
J	Wakabi, W				Wakabi, Wairagala			West African meningitis outbreak strains vaccine supplies	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1836	1836		10.1016/S0140-6736(09)61008-4	http://dx.doi.org/10.1016/S0140-6736(09)61008-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19504666				2022-12-28	WOS:000266616400013
J	Myhre, G				Myhre, Gunnar			Consistency Between Satellite-Derived and Modeled Estimates of the Direct Aerosol Effect	SCIENCE			English	Article							ANTHROPOGENIC SULFATE; CLIMATE; RADIATION	In the Intergovernmental Panel on Climate Change Fourth Assessment Report, the direct aerosol effect is reported to have a radiative forcing estimate of -0.5 watt per square meter (W m(-2)), offsetting the warming from CO2 by almost one-third. The uncertainty, however, ranges from -0.9 to -0.1 W m(-2), which is largely due to differences between estimates from global aerosol models and observation-based estimates, with the latter tending to have stronger (more negative) radiative forcing. This study demonstrates consistency between a global aerosol model and adjustment to an observation-based method, producing a global and annual mean radiative forcing that is weaker than -0.5 W m(-2), with a best estimate of -0.3 W m(-2). The physical explanation for the earlier discrepancy is that the relative increase in anthropogenic black carbon (absorbing aerosols) is much larger than the overall increase in the anthropogenic abundance of aerosols.	CICERO, N-0318 Oslo, Norway		Myhre, G (corresponding author), CICERO, POB 1129 Blindern, N-0318 Oslo, Norway.	gunnar.myhre@cicero.uio.no	Myhre, Gunnar/A-3598-2008; Myhre, Gunnar/J-5483-2014	Myhre, Gunnar/0000-0002-4309-476X; Myhre, Gunnar/0000-0002-4309-476X	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research has been funded by the Norwegian Research Council.	Bellouin N, 2005, NATURE, V438, P1138, DOI 10.1038/nature04348; Bellouin N, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009385; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Chung CE, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006356; Dentener F, 2006, ATMOS CHEM PHYS, V6, P4321, DOI 10.5194/acp-6-4321-2006; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Hansen J, 1997, J GEOPHYS RES-ATMOS, V102, P6831, DOI 10.1029/96JD03436; HAYWOOD JM, 1995, GEOPHYS RES LETT, V22, P603, DOI 10.1029/95GL00075; Haywood JM, 1997, J CLIMATE, V10, P1562, DOI 10.1175/1520-0442(1997)010<1562:GCMCOT>2.0.CO;2; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Kaufman YJ, 2002, NATURE, V419, P215, DOI 10.1038/nature01091; Myhre G, 2009, ATMOS CHEM PHYS, V9, P1365, DOI 10.5194/acp-9-1365-2009; Myhre G, 2001, ATMOS ENVIRON, V35, P2361, DOI 10.1016/S1352-2310(00)00531-8; Myhre G, 1998, TELLUS B, V50, P463, DOI 10.1034/j.1600-0889.1998.t01-4-00005.x; Myhre G, 2007, TELLUS B, V59, P115, DOI 10.1111/j.1600-0889.2006.00238.x; Quaas J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008962; Ramanathan V, 2008, P NATL ACAD SCI USA, V105, P14245, DOI 10.1073/pnas.0803838105; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Remer LA, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009661; Schulz M, 2006, ATMOS CHEM PHYS, V6, P5225, DOI 10.5194/acp-6-5225-2006; Schwarz JP, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007076; Textor C, 2006, ATMOS CHEM PHYS, V6, P1777, DOI 10.5194/acp-6-1777-2006; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Yu H, 2006, ATMOS CHEM PHYS, V6, P613, DOI 10.5194/acp-6-613-2006	24	186	208	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					187	190		10.1126/science.1174461	http://dx.doi.org/10.1126/science.1174461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19541952				2022-12-28	WOS:000267802000043
J	Naveiras, O; Nardi, V; Wenzel, PL; Hauschka, PV; Fahey, F; Daley, GQ				Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Hauschka, Peter V.; Fahey, Frederic; Daley, George Q.			Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment	NATURE			English	Article							STEM-CELL NICHE; INSULIN-RESISTANCE; PROGENITOR CELLS; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; GROWTH; IDENTIFICATION; ROSIGLITAZONE; ADIPONECTIN	Osteoblasts and endothelium constitute functional niches that support haematopoietic stem cells in mammalian bone marrow(1-3). Adult bone marrow also contains adipocytes, the number of which correlates inversely with the haematopoietic activity of the marrow. Fatty infiltration of haematopoietic red marrow follows irradiation or chemotherapy and is a diagnostic feature in biopsies from patients with marrow aplasia(4). To explore whether adipocytes influence haematopoiesis or simply fill marrow space, we compared the haematopoietic activity of distinct regions of the mouse skeleton that differ in adiposity. Here we show, by flow cytometry, colony-forming activity and competitive repopulation assay, that haematopoietic stem cells and short-term progenitors are reduced in frequency in the adipocyte-rich vertebrae of the mouse tail relative to the adipocyte-free vertebrae of the thorax. In lipoatrophic A-ZIP/F1 'fatless' mice, which are genetically incapable of forming adipocytes(5), and in mice treated with the peroxisome proliferator-activated receptor-c inhibitor bisphenol A diglycidyl ether, which inhibits adipogenesis(6), marrow engraftment after irradiation is accelerated relative to wild-type or untreated mice. These data implicate adipocytes as predominantly negative regulators of the bone-marrow microenvironment, and indicate that antagonizing marrow adipogenesis may enhance haematopoietic recovery in clinical bone-marrow transplantation.	[Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Nardi, Valentina; Wenzel, Pamela L.; Daley, George Q.] Manton Ctr Orphan Dis, Boston, MA 02115 USA; [Hauschka, Peter V.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02115 USA; [Hauschka, Peter V.] Harvard Univ, Sch Med, Dept Oral & Dev Biol, Boston, MA 02115 USA; [Hauschka, Peter V.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; [Fahey, Frederic] Harvard Univ, Childrens Hosp, Sch Med, Dept Radiol,Div Nucl Med PET, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Wenzel, Pamela/A-2992-2010; Wenzel, Pamela/AAJ-1944-2021	Wenzel, Pamela/0000-0002-4530-015X; Naveiras, Olaia/0000-0003-3434-0022	Barrie de la Maza Foundation; National Institutes of Health (NIH) [T32-HL-7623]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279, R01DK070055] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	Barrie de la Maza Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Lazo-Kallanian, J. Daley, G. Losyev and R. Mathieu for assistance with flow cytometry; R. Bronson for assistance with pathological analysis; P. Dunning, E. Snay and S. Carlton for assistance with small animal imaging; S. Loewer for translation of historical references; and S. McKinney-Freeman, A. Yabuuchi, K. Ng and R. Chapman for mouse and technical assistance. O.N. was partially funded by the Barrie de la Maza Foundation. P. L. W. was supported by a Hematology Training Grant from the National Institutes of Health (NIH T32-HL-7623). G. Q. D. was supported by grants from the NIH and the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research. G. Q. D. is the recipient of the Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and is an Investigator of the Howard Hughes Medical Institute.	Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Berria R, 2007, CLIN PHARMACOL THER, V82, P275, DOI 10.1038/sj.clpt.6100146; BRYON PA, 1979, PATHOL BIOL, V27, P209; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CALVO W, 1976, BLOOD, V47, P593; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; Digman C, 2005, ANN INTERN MED, V143, P465, DOI 10.7326/0003-4819-143-6-200509200-00016; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; LITTEN M, 1877, BERL KLIN WSCHR, V51, P743; Maaravi Y, 2005, DIABETES CARE, V28, P1536, DOI 10.2337/diacare.28.6.1536; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; NEUMANN E, 1882, ZENTBL MED WISS, V18, P321; NISHIKAWA M, 1993, BLOOD, V81, P1184; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pan Z, 2008, STEM CELLS DEV, V17, P795, DOI 10.1089/scd.2008.0254; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Rotolin S, 2006, J CELL PHYSIOL, V209, P967, DOI 10.1002/jcp.20804; TAVASSOLI M, 1974, BLOOD, V43, P33, DOI 10.1182/blood.V43.1.33.33; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZHANG Y, 1995, BLOOD, V86, P2930	33	753	799	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					259	U124		10.1038/nature08099	http://dx.doi.org/10.1038/nature08099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19516257	Green Accepted, Green Submitted			2022-12-28	WOS:000267761000041
J	Cantor, WJ; Fitchett, D; Borgundvaag, B; Ducas, J; Heffernan, M; Cohen, EA; Morrison, LJ; Langer, A; Dzavik, V; Mehta, SR; Lazzam, C; Schwartz, B; Casanova, A; Goodman, SG				Cantor, Warren J.; Fitchett, David; Borgundvaag, Bjug; Ducas, John; Heffernan, Michael; Cohen, Eric A.; Morrison, Laurie J.; Langer, Anatoly; Dzavik, Vladimir; Mehta, Shamir R.; Lazzam, Charles; Schwartz, Brian; Casanova, Amparo; Goodman, Shaun G.		TRANSFER-AMI Trial Investigators	Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT-ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; IMMEDIATE ANGIOPLASTY; PLASMINOGEN-ACTIVATOR; NATIONAL-REGISTRY; INVASIVE STRATEGY; THROMBOLYSIS; THERAPY; REPERFUSION; ABCIXIMAB	Background Patients with a myocardial infarction with ST-segment elevation who present to hospitals that do not have the capability of performing percutaneous coronary intervention (PCI) often cannot undergo timely primary PCI and therefore receive fibrinolysis. The role and optimal timing of routine PCI after fibrinolysis have not been established. Methods We randomly assigned 1059 high-risk patients who had a myocardial infarction with ST-segment elevation and who were receiving fibrinolytic therapy at centers that did not have the capability of performing PCI to either standard treatment (including rescue PCI, if required, or delayed angiography) or a strategy of immediate transfer to another hospital and PCI within 6 hours after fibrinolysis. All patients received aspirin, tenecteplase, and heparin or enoxaparin; concomitant clopidogrel was recommended. The primary end point was the composite of death, reinfarction, recurrent ischemia, new or worsening congestive heart failure, or cardiogenic shock within 30 days. Results Cardiac catheterization was performed in 88.7% of the patients assigned to standard treatment a median of 32.5 hours after randomization and in 98.5% of the patients assigned to routine early PCI a median of 2.8 hours after randomization. At 30 days, the primary end point occurred in 11.0% of the patients who were assigned to routine early PCI and in 17.2% of the patients assigned to standard treatment (relative risk with early PCI, 0.64; 95% confidence interval, 0.47 to 0.87; P = 0.004). There were no significant differences between the groups in the incidence of major bleeding. Conclusions Among high-risk patients who had a myocardial infarction with ST-segment elevation and who were treated with fibrinolysis, transfer for PCI within 6 hours after fibrinolysis was associated with significantly fewer ischemic complications than was standard treatment. (ClinicalTrials.gov number, NCT00164190.)	[Cantor, Warren J.] Southlake Reg Hlth Ctr, Newmarket, ON L3Y 2P9, Canada; [Cantor, Warren J.; Fitchett, David; Borgundvaag, Bjug; Cohen, Eric A.; Morrison, Laurie J.; Langer, Anatoly; Dzavik, Vladimir; Schwartz, Brian; Goodman, Shaun G.] Univ Toronto, Toronto, ON, Canada; [Fitchett, David; Langer, Anatoly; Goodman, Shaun G.] St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada; [Fitchett, David; Langer, Anatoly; Casanova, Amparo; Goodman, Shaun G.] Canadian Heart Res Ctr, Toronto, ON, Canada; [Borgundvaag, Bjug] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Cohen, Eric A.; Morrison, Laurie J.; Schwartz, Brian] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Dzavik, Vladimir] Univ Hlth Network, Toronto, ON, Canada; [Ducas, John] St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; [Heffernan, Michael] Halton Healthcare Serv, Oakville, ON, Canada; [Mehta, Shamir R.] McMaster Univ, Hamilton, ON, Canada; [Mehta, Shamir R.] Hamilton Hlth Sci Corp, Hamilton, ON, Canada; [Lazzam, Charles] Trillium Hlth Ctr, Mississauga, ON, Canada	Southlake Regional Health Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Heart Research Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; McMaster University	Cantor, WJ (corresponding author), Southlake Reg Hlth Ctr, 596 Davis Dr, Newmarket, ON L3Y 2P9, Canada.	cantorw@rogers.com	Borgundvaag, Bjug/AAH-4446-2020; Morrison, Laurie Jean/A-6325-2012; Borgundvaag, Bjug/AAE-8228-2020	Morrison, Laurie Jean/0000-0001-8369-9774; Ducas, John/0000-0001-5953-3352	Canadian Institutes of Health Research; Roche, Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Roche, Canada(Roche Holding)	Supported by a grant from the Canadian Institutes of Health Research and an unrestricted research grant from Roche, Canada. Coronary stents were provided free of charge by Abbott Vascular Canada.	[Anonymous], 1989, NEW ENGL J MED, V320, P618; Antman EM, 2008, J AM COLL CARDIOL, V51, P977, DOI 10.1016/j.jacc.2008.01.007; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Armstrong PW, 2006, EUR HEART J, V27, P1530, DOI 10.1093/eurheartj/ehl088; ARNOLD AER, 1991, J AM COLL CARDIOL, V17, P11, DOI 10.1016/0735-1097(91)90699-A; Bates ER, 2008, CIRCULATION, V118, P567, DOI 10.1161/CIRCULATIONAHA.108.788620; Bednar F, 2003, CAN J CARDIOL, V19, P1133; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; Cantor WJ, 2008, AM HEART J, V155, P19, DOI 10.1016/j.ahj.2007.08.025; Cantor WJ, 2007, CATHETER CARDIO INTE, V69, P73, DOI 10.1002/ccd.20897; Cantor WJ, 2006, CAN J CARDIOL, V22, P1121, DOI 10.1016/S0828-282X(06)70948-5; Cantor WJ, 2005, CAN MED ASSOC J, V173, P1473, DOI 10.1503/cmaj.045278; Collet JP, 2006, J AM COLL CARDIOL, V48, P1326, DOI 10.1016/j.jacc.2006.03.064; Coulter SA, 2000, CIRCULATION, V101, P2690, DOI 10.1161/01.CIR.101.23.2690; De Luca G, 2005, JAMA-J AM MED ASSOC, V293, P1759, DOI 10.1001/jama.293.14.1759; Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8; Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816; Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1; Fernandez-Aviles F, 2007, EUR HEART J, V28, P949, DOI 10.1093/eurheartj/ehl461; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2006, LANCET, V367, P579, DOI 10.1016/S0140-6736(06)68148-8; Keeley EC, 2006, LANCET, V367, P1656; Le May MR, 2005, J AM COLL CARDIOL, V46, P417, DOI 10.1016/j.jacc.2005.04.042; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Scheller B, 2003, J AM COLL CARDIOL, V42, P634, DOI 10.1016/S0735-1097(03)00763-0; SCHOMIG A, 1994, CIRCULATION, V90, P2716, DOI 10.1161/01.CIR.90.6.2716; SIMOONS ML, 1988, LANCET, V1, P199; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Van de Werf F, 2001, EUR HEART J, V22, P2253, DOI 10.1053/euhj.2001.2686; Wijeysundera HC, 2008, AM HEART J, V156, P564, DOI 10.1016/j.ahj.2008.04.024; Yang EH, 2005, J AM COLL CARDIOL, V46, P2004, DOI 10.1016/j.jacc.2005.06.083	34	375	419	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2705	2718		10.1056/NEJMoa0808276	http://dx.doi.org/10.1056/NEJMoa0808276			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553646				2022-12-28	WOS:000267286600005
J	Laprise, P; Lau, KM; Harris, KP; Silva-Gagliardi, NF; Paul, SM; Beronja, S; Beitel, GJ; McGlade, CJ; Tepass, U				Laprise, Patrick; Lau, Kimberly M.; Harris, Kathryn P.; Silva-Gagliardi, Nancy F.; Paul, Sarah M.; Beronja, Slobodan; Beitel, Greg J.; McGlade, C. Jane; Tepass, Ulrich			Yurt, Coracle, Neurexin IV and the Na+,K+-ATPase form a novel group of epithelial polarity proteins	NATURE			English	Article							DROSOPHILA TRACHEAL SYSTEM; TUBE-SIZE CONTROL; SEPTATE JUNCTION FUNCTION; BLOOD-NERVE BARRIER; CELL POLARITY; PLASMA-MEMBRANE; NA+/K+ ATPASE; MESENCHYMAL TRANSITION; APICAL MEMBRANE; CRUMBS COMPLEX	The integrity of polarized epithelia is critical for development and human health. Many questions remain concerning the full complement and the function of the proteins that regulate cell polarity(1). Here we report that the Drosophila FERM proteins Yurt (Yrt)(2) and Coracle (Cora)(3) and the membrane proteins Neurexin IV(Nrx-IV)(4) and Na+,K+-ATPase(5) are a new group of functionally cooperating epithelial polarity proteins. This 'Yrt/Cora group' promotes basolateral membrane stability and shows negative regulatory interactions with the apical determinant Crumbs (Crb). Genetic analyses indicate that Nrx-IV and Na+,K+-ATPase act together with Cora in one pathway, whereas Yrt acts in a second redundant pathway. Moreover, we show that the Yrt/Cora group is essential for epithelial polarity during organogenesis but not when epithelial polarity is first established or during terminal differentiation. This property of Yrt/Cora group proteins explains the recovery of polarity in embryos lacking the function of the Lethal giant larvae (Lgl) group of basolateral polarity proteins(6,7). We also find that the mammalian Yrt orthologue EPB41L5 ( also known as YMO1 and Limulus)(8-10) is required for lateral membrane formation, indicating a conserved function of Yrt proteins in epithelial polarity.	[Laprise, Patrick; Harris, Kathryn P.; Beronja, Slobodan; Tepass, Ulrich] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Lau, Kimberly M.; Silva-Gagliardi, Nancy F.; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Lau, Kimberly M.; Silva-Gagliardi, Nancy F.; McGlade, C. Jane] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Paul, Sarah M.; Beitel, Greg J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Northwestern University	Tepass, U (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada.	u.tepass@utoronto.ca		Beronja, Slobodan/0000-0002-6769-9261; Harris, Kathryn/0000-0003-1769-2587	CIHR; Vision Science Research Program, University of Toronto; NIH Lung Biology Training; Foundation Fighting Blindness Canada; NIH	CIHR(Canadian Institutes of Health Research (CIHR)); Vision Science Research Program, University of Toronto(University of Toronto); NIH Lung Biology Training; Foundation Fighting Blindness Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank V. Auld, J. Casanova, H. Bellen, M. Hortsch, R. Fehon, M. Bhat, R. Schuh, the Developmental Studies Hybridoma Bank and the Bloomington Drosophila Stock Center for reagents. Wethank D. Godt, R. Winklbauer and T. Harris for critical comments on the manuscript, and H. Hong, M. Pellikka and W. Russin for technical assistance. This work was supported by postdoctoral fellowships from the CIHR ( to P. L.), a predoctoral fellowship from the Vision Science Research Program, University of Toronto ( to S. B.) and by NIH Lung Biology Training Grant 5 ( to S. M. P.). Operating support was provided by the CIHR ( to U. T. and P. L.), the Foundation Fighting Blindness Canada ( to C. J. M.) and the NIH ( to G. J. B.).	AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chou TB, 1996, GENETICS, V144, P1673; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FEHON RG, 1994, DEVELOPMENT, V120, P545; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hoover KB, 2002, DEV GENES EVOL, V212, P230, DOI 10.1007/s00427-002-0231-6; HORTSCH M, 1995, J BIOL CHEM, V270, P18809, DOI 10.1074/jbc.270.32.18809; Hortsch M, 2003, TRENDS CELL BIOL, V13, P557, DOI 10.1016/j.tcb.2003.09.004; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; WHITLOCK KE, 1993, DEVELOPMENT, V117, P1251; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	46	117	118	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1141	U134		10.1038/nature08067	http://dx.doi.org/10.1038/nature08067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553998				2022-12-28	WOS:000267636700046
J	Samb, B; Evans, T; Dybul, M; Atun, R; Moatti, JP; Nishtar, S; Wright, A; Celletti, F; Hsu, J; Kim, JY; Brugha, R; Russell, A; Etienne, C; De, S; Mwase, T; Wang, WJ; Wright, J; Dare, L; Delfraissy, JF; Boillot, F; Miege, P; Zhang, XL; Rhatigan, J; Weintraub, R; Pun, S; Abe, C; Caceres, C; Camara, M; Coriat, B; d'Almeida, C; Aleshkina, J; Murzalieva, G; Kadzandira, J; Hammami, N; Mwapasa, V; Chkhatarashvili, K; Buch, E; Miti, K; Kamenga, C; Elouma, MSE; Schwalbe, N; Greenberg, A; Frehywot, S; Markus, A; Goeman, L; Khan, A; Amati, J; Mwaura-Muiru, E; Ivers, LC; Ellner, A; Shakow, A; Kim, JY; Kley, NC; Irwin, A; Sullivan, E; Baker, B; Cohn, J; Davis, P; Headley, J; Russell, A; Siplon, P; Nishtar, S; Dickinson, C; Pearson, M; Waddington, C; Atun, R; Pearson, M; Boyer, S; Eboko, F; Moatti, JP; Orsi, F; Larouze, B; Le Loup, G; Ndubani, P; Simbaya, J; Boelaert, M; Cavalli, A; Ooms, G; Pirard, M; Polman, K; Van Damme, W; Van Dormael, M; Vermeiren, P; Teokul, W; Dlodlo, R; Fujiwara, P; Ruppol, S; Vella, S; Semigina, T; Corbett, E; Godfrey-Faussett, P; Spicer, N; Walt, G; Kanchanachitra, C; Philips, M; Riva, G; Kabuayi, JP; Kiputsu, AK; Ndongosieme, A; Koulla-Shiro, S; Samake, S; Bamba, SI; Coulibaly, Y; Traore, MN; Berthe, IBI; Wibulpolprasert, S; Chunharas, S; Jerome, G; Mukherjee, J; Nguini, MEO; Rao, KD; Reddy, S; Nyirenda, L; Biesma, R; Bruen, C; Brugha, R; Dicker, P; Walsh, A; Cailhol, J; Parsons, A; Mathole, T; Sanders, D; Raghavan, SS; Mwanza, F; Michael, EB; Richard, W; Banati, P; Blakley, M; Ingenkamp, N; Lansang, MA; Low-Beer, D; Shakarishvili, G; Dybul, M; Kayongo, A; Buse, K; Martineau, T; Dehne, K; Pett, I; Salama, P; Chilundo, B; Ndumbe, P; Atashili, J; Sow, PS; Hill, PS; Brenzel, L; Babaley, M; Celletti, F; Dayrit, M; de Zoysa, I; Dyrhauge, J; Etienne, C; Evans, T; Galichet, B; Hsu, J; Kadama, P; Porignon, D; Russell, S; Samb, B; Tata, H; Van Lerberghe, W; Wright, A				Samb, Badara; Evans, Tim; Dybul, Mark; Atun, Rifat; Moatti, Jean-Paul; Nishtar, Sania; Wright, Anna; Celletti, Francesca; Hsu, Justine; Kim, Jim Yong; Brugha, Ruairi; Russell, Asia; Etienne, Carissa; De, Susna; Mwase, Takondwa; Wang, Wenjuan; Wright, Jenna; Dare, Lola; Delfraissy, Jean-Francois; Boillot, Francois; Miege, Pierre; Zhang, Xiulan; Rhatigan, Joseph; Weintraub, Rebecca; Pun, Sok; Abe, C.; Caceres, Carlos; Camara, Mamadou; Coriat, Benjamin; d'Almeida, Cristina; Aleshkina, Julia; Murzalieva, Gulgun; Kadzandira, John; Hammami, N.; Mwapasa, Victor; Chkhatarashvili, Ketevan; Buch, Eric; Miti, Katabaro; Kamenga, Claudes; Elouma, Marthe Sylvie Essengue; Schwalbe, Nina; Greenberg, Alan; Frehywot, Seble; Markus, Anne; Goeman, Lieve; Khan, Alia; Amati, Jael; Mwaura-Muiru, Esther; Ivers, Louise C.; Ellner, Andrew; Shakow, Aaron; Kim, Jim Yong; Kley, Nicole C.; Irwin, Alec; Sullivan, Erin; Baker, Brook; Cohn, Jennifer; Davis, Paul; Headley, Jamila; Russell, Asia; Siplon, Patricia; Nishtar, Sania; Dickinson, Clare; Pearson, Mark; Waddington, Catriona; Atun, Rifat; Pearson, Mark; Boyer, Sylvie; Eboko, Fred; Moatti, Jean-Paul; Orsi, Fabienne; Larouze, Bernard; Le Loup, Guillaume; Ndubani, Phillimon; Simbaya, Joseph; Boelaert, Marleen; Cavalli, Anna; Ooms, Gorik; Pirard, Marjan; Polman, Katja; Van Damme, Wim; Van Dormael, Monique; Vermeiren, Peter; Teokul, Waranya; Dlodlo, Riitta; Fujiwara, Paula; Ruppol, Sandrine; Vella, Stefano; Semigina, Tetyana; Corbett, Elizabeth; Godfrey-Faussett, Peter; Spicer, Neil; Walt, Gill; Kanchanachitra, Churnrurtai; Philips, Mit; Riva, Guglielmo; Kabuayi, Jean-Pierre; Kiputsu, Alain Kambale; Ndongosieme, Andre; Koulla-Shiro, Sinata; Samake, Salif; Bamba, Sory Ibrahima; Coulibaly, Youssouf; Traore, Mamadou Namory; Berthe, Issa Bara Issa; Wibulpolprasert, Suwit; Chunharas, Somsak; Jerome, Gregory; Mukherjee, Joia; Nguini, Mathias Eric Owona; Rao, Krishna Dipankar; Reddy, Srinath; Nyirenda, Lot; Biesma, Regien; Bruen, Carlos; Brugha, Ruairi; Dicker, Patrick; Walsh, Aisling; Cailhol, Johann; Parsons, Ann; Mathole, Thubelihle; Sanders, David; Raghavan, Sai Subhasree; Mwanza, Felix; Michael, Etukoit Bernard; Richard, Wanyama; Banati, P.; Blakley, Matthew; Ingenkamp, N.; Lansang, M. A.; Low-Beer, Daniel; Shakarishvili, George; Dybul, Mark; Kayongo, Alice; Buse, Kent; Martineau, Tim; Dehne, Karl; Pett, Ian; Salama, Peter; Chilundo, Baltazar; Ndumbe, Peter; Atashili, Julius; Sow, Papa Salif; Hill, Peter S.; Brenzel, Logan; Babaley, Magali; Celletti, Francesca; Dayrit, Manuel; de Zoysa, Isabelle; Dyrhauge, Jane; Etienne, Carissa; Evans, Timothy; Galichet, Benedicte; Hsu, Justine; Kadama, Patrick; Porignon, Denis; Russell, Sarah; Samb, Badara; Tata, Helen; Van Lerberghe, Wim; Wright, Anna		World Hlth Org Maximizing Positive	An assessment of interactions between global health initiatives and country health systems	LANCET			English	Review							RAPID SCALE-UP; ANTIRETROVIRAL THERAPY; HUMAN-RESOURCES; HIV/AIDS TREATMENT; ONCHOCERCIASIS CONTROL; IMMUNIZATION DATA; CARE PROGRAM; HIV; WORKERS; FUND	Since 2000, the emergence of several large disease-specific global health initiatives (GHIs) has changed the way in which international donors provide assistance for public health. Some critics have claimed that these initiatives burden health systems that are already fragile in countries with few resources, whereas others have asserted that weak health systems prevent progress in meeting disease-specific targets. So far, most of the evidence for this debate has been provided by speculation and anecdotes. We use a review and analysis of existing data, and 15 new studies that were submitted to WHO for the purpose of writing this Report to describe the complex nature of the interplay between country health systems and GHIs. We suggest that this Report provides the most detailed compilation of published and emerging evidence so far, and provides a basis for identification of the ways in which GHIs and health systems can interact to mutually reinforce their effects. On the basis of the findings, we make some general recommendations and identify a series of action points for international partners, governments, and other stakeholders that will help ensure that investments in GHIs and country health systems can fulfil their potential to produce comprehensive and lasting results in disease-specific work, and advance the general public health agenda. The target date for achievement of the health-related Millennium Development Goals is drawing close, and the economic downturn threatens to undermine the improvements in health outcomes that have been achieved in the past few years. If adjustments to the interactions between GHIs and country health systems will improve efficiency, equity value for money, and outcomes in global public health, then these opportunities should not be missed.	[De, Susna; Mwase, Takondwa; Wang, Wenjuan; Wright, Jenna] ABT Associates Inc, Bethesda, MD USA; [Delfraissy, Jean-Francois] Agence Natl Rech Sida & Hepatites Virales ANRS, Paris, France; [Boillot, Francois] Alter Sante Int & Dev, Montpellier, France; [Miege, Pierre; Zhang, Xiulan] Beijing Normal Univ, Beijing 100875, Peoples R China; [Rhatigan, Joseph; Weintraub, Rebecca] Brigham & Womens Hosp, Boston, MA 02115 USA; [Caceres, Carlos] Univ Peruana Cayetano Heredia, Lima, Peru; [Camara, Mamadou; Coriat, Benjamin; d'Almeida, Cristina] Univ Paris 13, CEPN, F-93430 Villetaneuse, France; [Kadzandira, John] Univ Malawi, Ctr Social Res, Zomba, Malawi; [Mwapasa, Victor] Univ Malawi, Coll Med, Zomba, Malawi; [Buch, Eric; Miti, Katabaro] Univ Pretoria, Dept Polit Sci, ZA-0002 Pretoria, South Africa; [Elouma, Marthe Sylvie Essengue; Schwalbe, Nina] GAVI, Geneva, Switzerland; [Greenberg, Alan; Frehywot, Seble; Markus, Anne] George Washington Univ, Washington, DC USA; [Khan, Alia] Glabal AIDS Alliance, Washington, DC USA; [Ivers, Louise C.; Ellner, Andrew; Shakow, Aaron] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Jim Yong; Kley, Nicole C.; Irwin, Alec; Sullivan, Erin] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Russell, Asia; Baker, Brook; Cohn, Jennifer; Davis, Paul; Headley, Jamila; Siplon, Patricia] Hlth GAP, Philadelphia, PA USA; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Dickinson, Clare; Pearson, Mark; Waddington, Catriona] HLSP Inst, London, England; [Atun, Rifat; Pearson, Mark] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Moatti, Jean-Paul; Boyer, Sylvie; Eboko, Fred; Orsi, Fabienne] Aix Marseille Univ, INSERM, IRD, UMR 912, Marseille, France; [Larouze, Bernard; Le Loup, Guillaume] Univ Paris 06, INSERM, UMR 707, Paris, France; [Ndubani, Phillimon; Simbaya, Joseph] Univ Zambia, Inst Econ & Social Res, Lusaka, Zambia; [Boelaert, Marleen; Cavalli, Anna; Ooms, Gorik; Pirard, Marjan; Polman, Katja; Van Damme, Wim; Van Dormael, Monique; Vermeiren, Peter] Inst Trop Med, B-2000 Antwerp, Belgium; [Dlodlo, Riitta; Fujiwara, Paula; Ruppol, Sandrine] Int Union TB & Lung Dis, Paris, France; [Vella, Stefano] Ist Super Sanita, I-00161 Rome, Italy; [Semigina, Tetyana] Kyiv Mohyla Acad, Kiev, Ukraine; [Corbett, Elizabeth; Godfrey-Faussett, Peter; Spicer, Neil; Walt, Gill] London Sch Hyg & Trop Med, London, England; [Kanchanachitra, Churnrurtai] Mahidol Univ, Bangkok 10700, Thailand; [Riva, Guglielmo] Minist Foreign Affairs, Rome, Italy; [Kabuayi, Jean-Pierre; Kiputsu, Alain Kambale; Ndongosieme, Andre] Natl TB Programme, Minist Hlth, Kinshasa, DEM REP CONGO; [Koulla-Shiro, Sinata] Minist Publ Hlth, Yaounde, Cameroon; [Samake, Salif; Bamba, Sory Ibrahima; Coulibaly, Youssouf; Traore, Mamadou Namory; Berthe, Issa Bara Issa] Minist Publ Hlth, Bamako, Mali; [Wibulpolprasert, Suwit] Minist Publ Hlth, Bangkok, Thailand; [Jerome, Gregory; Mukherjee, Joia] Partners Hlth, Boston, MA USA; [Nguini, Mathias Eric Owona] Paul Ango Ela Fdn FPAE, Yaounde, Cameroon; [Brugha, Ruairi; Biesma, Regien; Bruen, Carlos; Dicker, Patrick; Walsh, Aisling] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Cailhol, Johann; Parsons, Ann; Mathole, Thubelihle; Sanders, David] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa; [Michael, Etukoit Bernard; Richard, Wanyama] AIDS Support Org TASO, Kampala, Uganda; [Banati, P.; Blakley, Matthew; Ingenkamp, N.; Lansang, M. A.; Low-Beer, Daniel; Shakarishvili, George] Global Fund Fights AIDS TB & Malaria, Geneva, Switzerland; [Dybul, Mark] Georgetown Univ, ONeill Inst, Washington, DC USA; [Kayongo, Alice] UCOBAC, Kampala, Uganda; [Buse, Kent; Martineau, Tim; Dehne, Karl] UNAIDS, Geneva, Switzerland; [Pett, Ian; Salama, Peter] UNICEF, New York, NY USA; [Chilundo, Baltazar] Univ Eduardo Mondlane, Maputo, Mozambique; [Ndumbe, Peter; Atashili, Julius] Univ Buea, Buea, Cameroon; [Sow, Papa Salif] Univ Dakar, Dakar, Senegal; [Hill, Peter S.] Univ Queensland, Brisbane, Qld 4072, Australia; [Brenzel, Logan] World Bank, Washington, DC 20433 USA; [Samb, Badara; Wright, Anna; Celletti, Francesca; Hsu, Justine; Etienne, Carissa; Babaley, Magali; Dayrit, Manuel; de Zoysa, Isabelle; Dyrhauge, Jane; Evans, Timothy; Galichet, Benedicte; Kadama, Patrick; Porignon, Denis; Russell, Sarah; Tata, Helen; Van Lerberghe, Wim] WHO, CH-1211 Geneva, Switzerland	ABT Associates; Beijing Normal University; Harvard University; Brigham & Women's Hospital; Universidad Peruana Cayetano Heredia; Universite Paris 13; University of Malawi; University of Malawi; University of Pretoria; George Washington University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Zambia; Institute of Tropical Medicine (ITM); Istituto Superiore di Sanita (ISS); Ministry of Education & Science of Ukraine; National University of Kyiv Mohyla Academy; University of London; London School of Hygiene & Tropical Medicine; Mahidol University; Ministry of Public Health - Thailand; Partners Healthcare System; Royal College of Surgeons - Ireland; University of the Western Cape; Georgetown University; UNAIDS; UNICEF; Eduardo Mondlane University; University of Queensland; The World Bank; World Health Organization	Samb, B (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	sambb@who.int	Atun, Rifat/AAH-5537-2021; Bruen, Carlos/HGC-2745-2022; Dayrit, Manuel M./AAJ-6750-2020; Van Damme, Wim/F-7404-2011; Semigina, Tetyana/O-1616-2016; Boelaert, Marleen/E-2698-2012; Brugha, Ruairi/C-8420-2012; Hill, Peter Stewart/AAL-8053-2020; Ivers, Louise C/Q-4164-2018; Ooms, Gorik/A-2537-2015; Bruen, Carlos/F-1697-2015; VELLA, STEFANO/ABI-3368-2020; Buse, Kent/AAK-6688-2020; Martineau, Tim C/G-2258-2015; Brenzel, Logan/AAH-2824-2020; Hill, Peter/F-2768-2010; Ndubani, Phillimon/AAB-3724-2020; Vella, Stefano/GZM-0519-2022; Dicker, Patrick/ABA-9881-2021; Biesma, Regien/D-8803-2017	Bruen, Carlos/0000-0002-3637-0973; Van Damme, Wim/0000-0002-6344-3007; Semigina, Tetyana/0000-0001-5677-1785; Boelaert, Marleen/0000-0001-8051-6776; Brugha, Ruairi/0000-0003-0729-0197; Hill, Peter Stewart/0000-0001-7091-5108; Ivers, Louise C/0000-0003-2314-9230; Ooms, Gorik/0000-0002-9804-0128; Bruen, Carlos/0000-0002-3637-0973; Buse, Kent/0000-0002-5485-0110; Martineau, Tim C/0000-0003-4833-3149; Brenzel, Logan/0000-0002-7506-7686; Hill, Peter/0000-0001-7091-5108; Caceres, Carlos F./0000-0002-8101-0790; Biesma, Regien/0000-0002-5532-0242; Lansang, Mary Ann/0000-0002-6606-0466; Porignon, Denis/0000-0002-0843-5696; Miege, Pierre/0000-0003-1898-2578; Hsu, Justine/0000-0002-1228-4042; Mwapasa, Victor/0000-0002-2748-8902; Walsh, Aisling/0000-0002-5312-5101; Corbett, Elizabeth/0000-0002-3552-3181	Directorate General for Development Cooperation, Ministry of Foreign Affairs, Rome, Italy	Directorate General for Development Cooperation, Ministry of Foreign Affairs, Rome, Italy	We thank the Directorate General for Development Cooperation, Ministry of Foreign Affairs, Rome, Italy, for their support.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; ABBAT F, 2005, SCALING HLTH ED WORK; Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436; Amazigo U, 2006, LANCET, V368, P1946, DOI 10.1016/S0140-6736(06)69786-9; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Anheier H., 2001, GLOBAL CIVIL SOC 200, P3; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], UN ACC SCAL PRIOR HI; Atun R, 2009, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-7818-2; ATUN R, 2006, HLTH POLICY, V79, P91; Atun RA, 2008, DO VERTICAL STAND AL; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; BANATI P, 2008, B WORLD HEALTH ORGAN, V86, P817; Bangoura O, 2008, ANN TROP MED PARASIT, V102, P31, DOI 10.1179/136485908X337463; BANTEYERGA H, 2006, SYSTEMWIDE EFFECTS G; Barnett T., 2002, AIDS 21 CENTURY DIS; Behague DP, 2008, AM J PUBLIC HEALTH, V98, P644, DOI 10.2105/AJPH.2007.123117; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; *BILL MEL GAT FDN, 2005, GLOB HLTH PARTN ASS; *BILL MEL GAT FDN, 2000 2007 ANN REP; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Brown H, 2007, LANCET, V370, P1115, DOI 10.1016/S0140-6736(07)61493-7; Bruce RD, 2007, INT J DRUG POLICY, V18, P326, DOI 10.1016/j.drugpo.2006.12.011; Brugha R, 2004, LANCET, V364, P95, DOI 10.1016/S0140-6736(04)16595-1; Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9; Brugha R, 2001, BRIT MED J, V323, P152, DOI 10.1136/bmj.323.7305.152; Brugha R., 2005, GLOBAL FUND TRACKING; Center for Global Development, 2007, DOES IMF CONSTR HLTH; CHAUEAU J, 2008, POLITICAL EC HIV AID, P78; Chee G, 2008, EVALUATION GAVI PHAS; Chee G, 2004, EVALUATION GAVI IMMU; Chen L, 2005, B WORLD HEALTH ORGAN, V83, P243; Cisse B, 2007, HEALTH POLICY, V80, P51, DOI 10.1016/j.healthpol.2006.02.011; Clifford GD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-18; Colindres R, 2008, AIDS CARE, V20, P139, DOI 10.1080/09540120701506804; Dabbagh A., 2008, Morbidity and Mortality Weekly Report, V57, P1303; DeRoeck D, 2006, INT J HEALTH PLAN M, V21, P23, DOI 10.1002/hpm.822; Dong K, 2007, J INFECT DIS, V196, pS491, DOI 10.1086/521111; Doyle C, 2008, SOC SCI MED, V66, P1928, DOI 10.1016/j.socscimed.2007.12.029; Drager Sigrid, 2006, Hum Resour Health, V4, P23, DOI 10.1186/1478-4491-4-23; Elzinga G, 2005, B WORLD HEALTH ORGAN, V83, P242; Evans T, 2003, B WORLD HEALTH ORGAN, V81, P856; Farquhar SA, 2005, AM J PUBLIC HEALTH, V95, P596, DOI 10.2105/AJPH.2004.048280; *FED DEM REP ETH, 2008, REP PROGR IMPL UN DE; FINN T, 2007, LESSONS LEARNED USG; FLAVELL S, 2004, MULTICOUNTRY STUDY I, P1; GBANGBADTHORE S, 2006, SYSTEM WIDE EFFECTS; *GFATM, 2007, PARTN IMP RES REP; *GFATM, 2004, COUNTR COORD MECH SY; *GFATM, GLOB FUNDS STRAT ENS; *GFATM, 2009, DISTR FUND 7 ROUNDS; *GFATM, 2008, DISTR FUND 7 ROUNDS; *GFATM INT HIV AID, 2008, CIV SOC SUCC GROUND; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; *GLOB FUND, 2009, 5 YEAR EV GLOB FUND; *GLOB FUND, 2008, COUNTR COORD MECH HA; *GLOB FUND, 2004, PAP NEW GUIN ROUND 3; GOTTRET P, 2006, HLTH FINANCING REV P; GRACE C, 2002, GLOBAL FUND COUNTRY; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P409, DOI 10.1046/j.1365-3156.2002.00879.x; Hagmann M, 2001, B WORLD HEALTH ORGAN, V79, P904; Hanefeld Johanna, 2008, Promot Educ, V15, P19, DOI 10.1177/1025382307088094; Hanefeld J, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-8; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; High Level Forum on the Health MDGs, 2005, BEST PRACT PRINC GLO; HOCHGESANG K, 2007, 366 DEV NATL ELECT D; Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673; HSU LN, 2004, BUILDING DYNAMIC DEM; HUDDART J, 2004, ZAMBIA HIV AIDS WORK; *IHP, 2007, GLOB COMP ACH HLTH M; *IND EV OFF IMF, 2007, EV IMF AID SUBS AFR; *INT HIV AIDS ALL, 2008, POL ADV COMM POST PA; *ITOC, 2008, HIV RESP HLTH SYST B; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Kalichman SC, 2002, AIDS EDUC PREV, V14, P51, DOI 10.1521/aeap.14.1.51.24335; Kalichman SC, 2000, J ACQ IMMUN DEF SYND, V25, P337, DOI 10.1097/00126334-200012010-00007; Kallings LO, 2008, J INTERN MED, V263, P218, DOI 10.1111/j.1365-2796.2007.01910.x; Kamara L, 2008, VACCINE, V26, P6717, DOI 10.1016/j.vaccine.2008.10.014; Kamat S, 2004, REV INT POLIT ECON, V11, P155, DOI 10.1080/0969229042000179794; Katabarwa MN, 2002, ANN TROP MED PARASIT, V96, P61, DOI 10.1179/000349802125000529; KELLY K, COMMUNITY PERSPECTIV; Kober Katharina, 2006, Hum Resour Health, V4, P13, DOI 10.1186/1478-4491-4-13; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Laing RO, 2000, INT J TUBERC LUNG D, V4, pS194; Lane C, 2007, HEALTH AFFAIR, V26, P935, DOI 10.1377/hlthaff.26.4.935; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; Levy NC, 2005, J URBAN HEALTH, V82, P498, DOI 10.1093/jurban/jti090; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Loaiza E, 2008, LANCET, V372, P874, DOI 10.1016/S0140-6736(08)61378-1; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; LOWBEER D, 2009, SCALING IMPACT RESUL; Lowrance D, 2007, TROP MED INT HEALTH, V12, P377, DOI 10.1111/j.1365-3156.2006.01800.x; Lydon P, 2008, VACCINE, V26, P6706, DOI 10.1016/j.vaccine.2008.10.015; Makombe SD, 2007, B WORLD HEALTH ORGAN, V85, P851; MANGHAM L, 2007, ADDRESSING HUMAN RES; MANGHAM L, 2006, ADDRESSING HUMAN RES; MANNING R, 2007, OECD J DEV, V9, P1; MATIRU R, 2007, B WORLD HEALTH ORGAN, V85, P325; Mccoy D, 2008, LANCET, V371, P675, DOI 10.1016/S0140-6736(08)60306-2; McNabb ME, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-29; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills A, 2005, B WORLD HEALTH ORGAN, V83, P315; Milstien JB, 2008, VACCINE, V26, P6699, DOI 10.1016/j.vaccine.2008.07.061; *MIN HLTH, 2009, Q REP ANT TREATM PRO; *MIN HLTH SOC WELF, 2008, IN DEPTH ASS MED SUP; Moerman F, 2003, LANCET INFECT DIS, V3, P99, DOI 10.1016/S1473-3099(03)00518-8; Morreim H, 2009, AM J BIOETHICS, V9, P9, DOI 10.1080/15265160802662049; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; MTONYA B, 2006, SYSTEMWIDE EFFECTS G; MURZALIEVA G, 2008, TRACKING GLOBAL HIV; MUSANGO T, 2008, MONTHL M REP SMART C; Muula AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-208; Naimoli JF, 2009, INT J HEALTH PLAN M, V24, P3, DOI 10.1002/hpm.969; *NAT AIDS COMM, 2006, MAL HIV AIDS MON EV; Nierengarten MB, 2003, LANCET INFECT DIS, V3, P266, DOI 10.1016/S1473-3099(03)00632-7; Ntata P R T, 2007, SAHARA J, V4, P564; *OECD, INT DEV IDS ONL STAT; *OECD, 2005, PAR DECL EFF OWN HAR; OGUNGBEMI K, 2007, SUCCESSFUL IMPLEMENT; Oliveira-Cruz V., 2003, J INT DEV, V15, P67, DOI [DOI 10.1002/JID.966, 10.1002/jid.966]; Onta SR, 1998, HEALTH POLICY PLANN, V13, P131, DOI 10.1093/heapol/13.2.131; OOMMMAN N, 2008, SEIZING OPPORTUNITY; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Palmer D, 2006, REPROD HEALTH MATTER, V14, P27, DOI 10.1016/S0968-8080(06)27244-6; PEPFAR, 2009, CEL LIF US PRES EM P; *PEPFAR, 2008, REP C US GLOB AIDS C; *PEPFAR, 2007, POW PARTN PRES EM PL; *PEPFAR, 2005, ALL COUNTR PARTN SUB; *PEPFAR, 2009, GEND HIV AIDS PRES E; *PEPFAR, 2007, 2007 COUNTR PROF; PIOT P, 2009, LANCET, V373, P1; Plamondon KM, 2008, CAN J PUBLIC HEALTH, V99, P355, DOI 10.1007/BF03403771; Prasad A, 2006, MEASURING EFFICIENCY; Preker Alexander S, 2005, SPENDING WISELY BUYI; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Puthanakit T, 2007, CLIN INFECT DIS, V44, P599, DOI 10.1086/510489; Radelet S, 2007, LANCET, V369, P1807, DOI 10.1016/S0140-6736(07)60818-6; Renggli V, 2008, LANCET, V372, P341, DOI 10.1016/S0140-6736(08)61119-8; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Rosenzweig S., 2007, FOLLOWING FUNDING HI; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Schatz JJ, 2008, LANCET, V371, P638, DOI 10.1016/S0140-6736(08)60287-1; Schleber GJ, 2007, HEALTH AFFAIR, V26, P921, DOI 10.1377/hlthaff.26.4.921; SCHOTT W, 2005, EFFECTS GLOBAL FUND; SECKEINEGLIN H, 2002, TIME STOP THINK HIV; Seckinelgin H, 2005, GLOBAL GOV, V11, P351, DOI 10.1163/19426720-01103006; SEEBREGTS CJ, 2007, OPENMRS IMPLEMENTERS; SEMIGINA T, 2008, TRACKING GLOBAL HIV; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Sharma DC, 2003, LANCET, V362, P1467, DOI 10.1016/S0140-6736(03)14735-6; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Simba D, 2010, INT J HEALTH PLAN M, V25, P17, DOI 10.1002/hpm.950; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; Steen R, 2006, SEX TRANSM INFECT, V82, P381, DOI 10.1136/sti.2006.020438; Stiglitz Joseph E., 2000, WORLD BANK STRUCTURE, P1; Stillman K, 2005, SYSTEMWIDE EFFECTS G; STONEBURNER R, 2006, 16 INT AIDS C TOR; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Szekeres G, 2008, AIDS, V22, pS9, DOI 10.1097/01.aids.0000327432.82795.92; TAFWIK S, 2003, IMPACT HIV AIDS HLTH; *TASKF INN INT FIN, 2009, WORK GROUP 2 RAIS CH; Twahirwa A, 2008, B WORLD HEALTH ORGAN, V86, P823, DOI 10.2471/BLT.08.021108; Ullah AZ, 2006, HEALTH POLICY PLANN, V21, P143, DOI 10.1093/heapol/czj014; *UN, 2008, TRACNET RWAND FIGHT; UNAIDS, 2004, 3 ON KEY PRINC COORD; *UNAIDS WHO, 2005, PROGR GLOB ACC HIV A; *UNGASS, 2001, DECL COMM HIV AIDS; *UNICEF, 2008, EST IMM COV 1980 200; UNICEF, 2009, STATE WORLDS CHILDRE; United Nations General Assembly, 2000, UN MILL DECL; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; *WHO, 2000, B0029 WHO; WHO, 2009, GLOB TUB CONTR 2009; *WHO, 2007, SCAL BETT HLTH CAMB; *WHO, 2007, VACC PREV DIS MON SY; WHO, 2007, EV BUS STRENGTH HLTH; *WHO, 1951, 382 WHO; *WHO, 2007, APPR ASS MAPP UND TR; *WHO PEPFAR UNAIDS, 2008, TASK SHIFT RAT RED T; *WHO UNAIDS, 2004, GUID ETH EQ ACC HIV; Wilkinson D., 2006, ASSESSMENT PROPOSAL; WISNER B, 1988, SOC SCI MED, V26, P963, DOI 10.1016/0277-9536(88)90417-0; Wolfe Benjamin A, 2006, AMIA Annu Symp Proc, P1146; *WORLD BANK, INT REV MULT HIV AID; World Bank, 2004, ADDR CHALL GLOB IND; World Bank, 2005, COMM RES IMPR EFF HI; *WORLD BANK, 2008, GLOB HIV AIDS MON EV; World Bank, 2001, WORLD DEV REP 2002 B; *WORLD BANK, 2008, EFF AID BETT HLTH RE; World Health Organization, 2008, COMM DIR INT MAJ HLT; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2008, HLTH METR NETW FRAM; World Health Organization, 2007, WORLD HLTH REP 2007; World Health Organization, 2007, SURV QUAL ANT MED CI; World Health Organization, 2007, GLOB ATL HLTH WORKF; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yakam JCYT, 2009, INT NURS REV, V56, P50, DOI 10.1111/j.1466-7657.2008.00680.x; YU D, 2008, GLOBAL HLTH, V16, P4; Zhongdan C, 2008, EVAL PROGRAM PLANN, V31, P10, DOI 10.1016/j.evalprogplan.2007.09.001	217	362	367	1	104	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2009	373	9681					2137	2169						33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19541040				2022-12-28	WOS:000267229700031
J	Alexander, GC; Stafford, RS				Alexander, G. Caleb; Stafford, Randall S.			Does Comparative Effectiveness Have a Comparative Edge?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS; USERS		[Alexander, G. Caleb] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Chicago Hosp, Dept Med, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Chicago, Dept Pharm Practice, Sch Pharm, Chicago, IL 60637 USA; [Stafford, Randall S.] Stanford Univ, Program Prevent Outcomes & Practices, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	University of Chicago; University of Chicago; University of Illinois System; University of Chicago; Stanford University	Alexander, GC (corresponding author), Univ Chicago, MacLean Ctr Clin Med Eth, 5841 S Maryland,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu	Stafford, Randall/F-3974-2017	Stafford, Randall/0000-0003-1805-1271	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER; AHRQ HHS [K08 HS015699, K08 HS15699] Funding Source: Medline; NHLBI NIH HHS [K24 HL086703] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Chernew ME, 2004, HEALTH AFFAIR, V23, P122, DOI 10.1377/hlthaff.23.6.122; Coleman J. S., 1966, MED INNOVATION DIFFU; *COMM ASS US DRUG, 2006, FUT DRUG SAF PROM PR; Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; Davies LM, 2007, BRIT J PSYCHIAT, V191, P14, DOI 10.1192/bjp.bp.106.028654; Deyo RA, 2004, J AM BOARD FAM PRACT, V17, P142, DOI 10.3122/jabfm.17.2.142; Domino ME, 2008, PSYCHIAT SERV, V59, P507, DOI 10.1176/ps.2008.59.5.507; GOODWIN JS, 1984, JAMA-J AM MED ASSOC, V251, P2387, DOI 10.1001/jama.251.18.2387; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Redelmeier DA, 2002, CAN MED ASSOC J, V166, P1680; *US DEP HHS, SENT IN NAT STRAT MO	13	46	46	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2488	2490		10.1001/jama.2009.851	http://dx.doi.org/10.1001/jama.2009.851			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531789	Green Accepted			2022-12-28	WOS:000267028100027
J	Brook, RH				Brook, Robert H.			The Science of Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROSPECTIVE PAYMENT SYSTEM; QUALITY; SERVICES; ADULTS		RAND Hlth, Santa Monica, CA 90407 USA	RAND Corporation	Brook, RH (corresponding author), RAND Hlth, 1776 Main St, Santa Monica, CA 90407 USA.	robert_brook@rand.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; CHASSIN MR, 1989, APPROPRIATENESS USE; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; GRAY D, 1990, LANCET, V335, P1317, DOI 10.1016/0140-6736(90)91196-H; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1953, DOI 10.1001/jama.264.15.1953; Kerr EA, 2004, HEALTH AFFAIR, V23, P247, DOI 10.1377/hlthaff.23.3.247; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; Leape LL, 2000, AM HEART J, V139, P106, DOI 10.1016/S0002-8703(00)90316-8; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Newhouse JP, 1993, FREE ALL LESSONS RAN; PARK RE, 1993, HEALTH SERV RES, V28, P401; Skinner J, 2009, HEALTH AFFAIR, V28, pW119, DOI 10.1377/hlthaff.28.1.w119; Wennberg JE, 2008, TRACKING CARE PATIEN	14	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2486	2487		10.1001/jama.2009.866	http://dx.doi.org/10.1001/jama.2009.866			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458MO	19531788				2022-12-28	WOS:000267028100026
J	Girart, JM; Beltran, MT; Zhang, QZ; Rao, R; Estalella, R				Girart, Josep M.; Beltran, Maria T.; Zhang, Qizhou; Rao, Ramprasad; Estalella, Robert			Magnetic Fields in the Formation of Massive Stars	SCIENCE			English	Article							SUBMILLIMETER ARRAY; CLOUD CORES; ACCRETION; COLLAPSE; POLARIZATION; G31.41+0.31; BRAKING; GAS; FRAGMENTATION; OUTFLOW	Massive stars play a crucial role in the production of heavy elements and in the evolution of the interstellar medium, yet how they form is still a matter of debate. We report high-angular-resolution submillimeter observations toward the massive hot molecular core (HMC) in the high-mass star-forming region G31.41+0.31. We find that the evolution of the gravitational collapse of the HMC is controlled by the magnetic field. The HMC is simultaneously contracting and rotating, and the magnetic field lines threading the HMC are deformed along its major axis, acquiring an hourglass shape. The magnetic energy dominates over the centrifugal and turbulence energies, and there is evidence of magnetic braking in the contracting core.	[Girart, Josep M.] Inst Estudis Catalunya IEEC, CSIC, Inst Ciencies Espai, Bellaterra 08193, Catalunya, Spain; [Beltran, Maria T.; Estalella, Robert] Univ Barcelona, Dept Astron & Meteorol IEEC UB, Inst Ciencies Cosmos, E-08028 Barcelona, Catalunya, Spain; [Beltran, Maria T.; Estalella, Robert] Univ Barcelona, Unitat Assoc CSIC, E-08028 Barcelona, Catalunya, Spain; [Zhang, Qizhou] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rao, Ramprasad] Acad Sinica, Inst Astron & Astrophys, Hilo, HI 96720 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; University of Barcelona; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Academia Sinica - Taiwan	Girart, JM (corresponding author), Inst Estudis Catalunya IEEC, CSIC, Inst Ciencies Espai, Campus Univ Autonoma Barcelona,Torre C5 Parell 2A, Bellaterra 08193, Catalunya, Spain.	girart@ieec.cat	Girart, Josep/O-1638-2014; Estalella, Robert/N-7353-2018; Girart, Josep M/P-3931-2019; Rao, Ramprasad/L-2115-2017	Girart, Josep/0000-0002-3829-5591; Estalella, Robert/0000-0001-7341-8641; Zhang, Qizhou/0000-0003-2384-6589; Beltran Sorolla, Maria Teresa/0000-0003-3315-5626; Rao, Ramprasad/0000-0002-1407-7944	Ministerio de Ciencia e Innovacion (Spain) [AYA2005-08523-C03, AYA2008-06189-C03]; Agencia de Gestio d Ajuts Universitaris i de Recerca [2005-SGR00489]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	The Submillimeter Array is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics and is funded by the Smithsonian Institution and the Academia Sinica. We thank D. Galli, R. R. Cesaroni, and J. M. Torrelles for helpful comments. J.M.G., M.T.B., and R.E. acknowledge Ministerio de Ciencia e Innovacion (Spain) for support through grants AYA2005-08523-C03 and AYA2008-06189-C03. J.M.G. also acknowledges support from Agencia de Gestio d Ajuts Universitaris i de Recerca 2005-SGR00489 grant.	Araya E, 2008, ASTROPHYS J, V675, P420, DOI 10.1086/527284; BASU S, 1994, ASTROPHYS J, V432, P720, DOI 10.1086/174611; Beltran MT, 2006, NATURE, V443, P427, DOI 10.1038/nature05074; Beltran MT, 2005, ASTRON ASTROPHYS, V435, P901, DOI 10.1051/0004-6361:20042381; Bonnell IA, 2005, MON NOT R ASTRON SOC, V362, P915, DOI 10.1111/j.1365-2966.2005.09360.x; Boss AP, 2007, ASTROPHYS J, V658, P1136, DOI 10.1086/512061; CESARONI R, 1994, ASTRON ASTROPHYS, V288, P903; Cortes P, 2006, ASTROPHYS J, V639, P965, DOI 10.1086/498971; Di Francesco J, 2001, ASTROPHYS J, V562, P770, DOI 10.1086/323854; Galli D, 2006, ASTROPHYS J, V647, P374, DOI 10.1086/505257; Girart JM, 2006, SCIENCE, V313, P812, DOI 10.1126/science.1129093; Goncalves J, 2008, ASTRON ASTROPHYS, V490, pL39, DOI 10.1051/0004-6361:200810861; Ho PTP, 2004, ASTROPHYS J, V616, pL1, DOI 10.1086/423245; KETO ER, 1987, ASTROPHYS J, V318, P712, DOI 10.1086/165405; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; Krumholz MR, 2005, ASTROPHYS J, V618, pL33, DOI 10.1086/427555; Lai SP, 2001, ASTROPHYS J, V561, P864, DOI 10.1086/323372; Machida MN, 2005, MON NOT R ASTRON SOC, V362, P369, DOI 10.1111/j.1365-2966.2005.09297.x; Marrone DP, 2006, ASTROPHYS J, V640, P308, DOI 10.1086/500106; Mellon RR, 2008, ASTROPHYS J, V681, P1356, DOI 10.1086/587542; MOUSCHOVIAS TC, 1976, ASTROPHYS J, V210, P326, DOI 10.1086/154835; NAKANO T, 1989, ASTROPHYS J, V345, P464, DOI 10.1086/167919; Olmi L, 1996, ASTRON ASTROPHYS, V307, P599; OSSENKOPF V, 1994, ASTRON ASTROPHYS, V291, P943; Schleuning DA, 1998, ASTROPHYS J, V493, P811, DOI 10.1086/305139; Tang YW, 2009, ASTROPHYS J, V695, P1399, DOI 10.1088/0004-637X/695/2/1399; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264; Zapata LA, 2008, ASTRON ASTROPHYS, V479, pL25, DOI 10.1051/0004-6361:20078846	29	173	174	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1408	1411		10.1126/science.1171807	http://dx.doi.org/10.1126/science.1171807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520952				2022-12-28	WOS:000266878700035
J	Inomata, K; Aoto, T; Binh, NT; Okamoto, N; Tanimura, S; Wakayama, T; Iseki, S; Hara, E; Masunaga, T; Shimizu, H; Nishimura, EK				Inomata, Ken; Aoto, Takahiro; Binh, Nguyen Thanh; Okamoto, Natsuko; Tanimura, Shintaro; Wakayama, Tomohiko; Iseki, Shoichi; Hara, Eiji; Masunaga, Takuji; Shimizu, Hiroshi; Nishimura, Emi K.			Genotoxic Stress Abrogates Renewal of Melanocyte Stem Cells by Triggering Their Differentiation	CELL			English	Article							DNA-DAMAGE; IONIZING-RADIATION; CELLULAR SENESCENCE; ATAXIA-TELANGIECTASIA; TUMOR SUPPRESSION; MICE DEFICIENT; CYCLE ARREST; ATM; MOUSE; PHENOTYPES	Somatic stem cell depletion due to the accumulation of DNA damage has been implicated in the appearance of aging-related phenotypes. Hair graying, a typical sign of aging in mammals, is caused by the incomplete maintenance of melanocyte stem cells (MSCs) with age. Here, we report that irreparable DNA damage, as caused by ionizing radiation, abrogates renewal of MSCs in mice. Surprisingly, the DNA-damage response triggers MSC differentiation into mature melanocytes in the niche, rather than inducing their apoptosis or senescence. The resulting MSC depletion leads to irreversible hair graying. Furthermore, deficiency of Ataxia-telangiectasia mutated (ATM), a central transducer kinase of the DNA-damage response, sensitizes MSCs to ectopic differentiation, demonstrating that the kinase protects MSCs from their premature differentiation by functioning as a "stemness checkpoint'' to maintain the stem cell quality and quantity.	[Inomata, Ken; Aoto, Takahiro; Binh, Nguyen Thanh; Okamoto, Natsuko; Tanimura, Shintaro; Nishimura, Emi K.] Kanazawa Univ, Div Stem Cell Med, Ctr Canc & Stem Cell Res, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Inomata, Ken; Masunaga, Takuji] KOSE Corp, Fundamental Res Labs, Itabashi Ku, Tokyo 1740051, Japan; [Inomata, Ken; Tanimura, Shintaro; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Aoto, Takahiro; Nishimura, Emi K.] Tokyo Med & Dent Univ, Dept Stem Cell Biol, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan; [Okamoto, Natsuko] Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Dept Histol & Embryol, Grad Sch Med Sci, Kanazawa, Ishikawa 9200934, Japan; [Hara, Eiji] Japanese Fdn Canc Res, Div Canc Biol, Inst Canc, Koto Ku, Tokyo 1358550, Japan	Kanazawa University; Hokkaido University; Tokyo Medical & Dental University (TMDU); Kyoto University; Kanazawa University; Japanese Foundation for Cancer Research	Nishimura, EK (corresponding author), Kanazawa Univ, Div Stem Cell Med, Ctr Canc & Stem Cell Res, Canc Res Inst, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan.	nishscm@tmd.ac.jp	Shimizu, Hiroshi/A-5193-2012	Inomata, Ken/0000-0002-3556-1380	Japanese Ministry of Education, Culture, Sports, Science and Technology [17689033, 19390293, 20012017]; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation	We thank Dr. Ian Jackson for the Dct-lacZ transgenic mice; Dr. Peter McKinnon and Dr. Atsushi Hirao for the ATM-deficient mice; Dr. Jan Hoeijmaker for the TTD mice; Dr. Vincent Hearing for antibodies; Dr. Naoko Ohtani, Dr. Kimi Yamakoshi, Dr. Keiyo Takubo, and Dr. Toshio Suda for immunostaining information; Ms. Lica Ishida, Ms. Misa Suzuki, Ms. Yuika Osaki, and Ms. Noriko Ikeda for technical assistance; Mr. Hideki Nakamura for mouse importation; and Dr. Richard Wong and Dr. Hiroyuki Nishimura for critical reading of the manuscript. The research was funded by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (17689033, 19390293, 20012017), Uehara Memorial Foundation, and Kato Memorial Bioscience Foundation to E. K. N.	ARGYRIS TS, 1960, ANAT REC, V136, P445, DOI 10.1002/ar.1091360403; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Bennett DC, 2002, PIGM CELL RES, V15, P242, DOI 10.1034/j.1600-0749.2002.02036.x; Boder E, 1970, Psychiatr Neurol Med Psychol Beih, V13-14, P8; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Coolidge WD, 1925, SCIENCE, V62, P441, DOI 10.1126/science.62.1611.441; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Ha LN, 2008, CELL CYCLE, V7, P1944, DOI 10.4161/cc.7.13.6230; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hirobe T, 2007, EUR J CELL BIOL, V86, P315, DOI 10.1016/j.ejcb.2007.03.007; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; MEDRANO EE, 1994, MOL BIOL CELL, V5, P497, DOI 10.1091/mbc.5.4.497; Meng AM, 2003, CANCER RES, V63, P5414; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; POTTEN CS, 1970, J INVEST DERMATOL, V55, P410, DOI 10.1111/1523-1747.ep12260552; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruzankina Y, 2008, MECH AGEING DEV, V129, P460, DOI 10.1016/j.mad.2008.03.009; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Simonatto M, 2007, J CELL PHYSIOL, V213, P642, DOI 10.1002/jcp.21275; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; van Heemst D, 2007, EUR J CANCER, V43, P2144, DOI 10.1016/j.ejca.2007.07.011; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200	59	249	257	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1088	1099		10.1016/j.cell.2009.03.037	http://dx.doi.org/10.1016/j.cell.2009.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524511	Bronze, Green Submitted			2022-12-28	WOS:000266916400020
J	Moscat, J; Diaz-Meco, MT				Moscat, Jorge; Diaz-Meco, Maria T.			p62 at the Crossroads of Autophagy, Apoptosis, and Cancer	CELL			English	Review							INTERACTING PROTEIN P62; SIGNALING ADAPTER P62; PAGET-DISEASE; DEGRADATION; MUTATION; OSTEOCLASTOGENESIS; POLYUBIQUITINATION; AGGREGATION; SQSTM1/P62; DEFICIENT	The signaling adaptor p62 is a multidomain protein implicated in the activation of the transcription factor NF-kappa B. Recent findings link p62 activity to the extrinsic apoptosis pathway, and Mathew et al. (2009) now show that the modulation of p62 by autophagy is a key factor in tumorigenesis. These findings place p62 at critical decision points that control cell death and survival.	[Moscat, Jorge; Diaz-Meco, Maria T.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Moscat, J (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA.	jorge.moscat@uc.edu		Diaz-Meco, Maria/0000-0003-0147-0998	NIH [R01-AI072581, R01-CA134530]; NATIONAL CANCER INSTITUTE [R01CA134530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Daston for editing, D. Plas and S. Khan for critically reading this manuscript, and G. Doerman for preparing the figures. Our research is funded by NIH grants R01-AI072581 (J.M.) and R01-CA134530 (M.T.D.-M.).	Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Hiruma Y, 2008, HUM MOL GENET, V17, P3708, DOI 10.1093/hmg/ddn266; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	19	825	847	4	174	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6					1001	1004		10.1016/j.cell.2009.05.023	http://dx.doi.org/10.1016/j.cell.2009.05.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524504	Bronze, Green Accepted			2022-12-28	WOS:000266916400013
J	Silva, JM; Ezhkova, E; Silva, J; Heart, S; Castillo, M; Campos, Y; Castro, V; Bonilla, F; Cordon-Cardo, C; Muthuswamy, SK; Powers, S; Fuchs, E; Hannon, GJ				Silva, Jose M.; Ezhkova, Elena; Silva, Javier; Heart, Stephen; Castillo, Mireia; Campos, Yolanda; Castro, Veronica; Bonilla, Felix; Cordon-Cardo, Carlos; Muthuswamy, Senthil K.; Powers, Scott; Fuchs, Elaine; Hannon, Gregory J.			Cyfip1 Is a Putative Invasion Suppressor in Epithelial Cancers	CELL			English	Article							MENTAL-RETARDATION PROTEIN; NF-KAPPA-B; CELL MIGRATION; ACTIN; ADHESION; PROLIFERATION; PLASTICITY; MEMBRANE; DYNAMICS; CATENIN	Identification of bona fide tumor suppressors is often challenging because of the large number of genetic alterations present in most human cancers. To evaluate candidate genes present within chromosomal regions recurrently deleted in human cancers, we coupled high-resolution genomic analysis with a two-stage genetic study using RNA interference (RNAi). We found that Cyfip1, a subunit of the WAVE complex, which regulates cytoskeletal dynamics, is commonly deleted in human epithelial cancers. Reduced expression of CYFIP1 is commonly observed during invasion of epithelial tumors and is associated with poor prognosis in this setting. Silencing of Cyfip1 disturbed normal epithelial morphogenesis in vitro and cooperated with oncogenic Ras to produce invasive carcinomas in vivo. Mechanistically, we have linked alterations in WAVE-regulated actin dynamics with impaired cell-cell adhesion and cell-ECM interactions. Thus, we propose Cyfip1 as an invasion suppressor gene.	[Silva, Jose M.; Heart, Stephen; Castro, Veronica; Muthuswamy, Senthil K.; Powers, Scott; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Ezhkova, Elena; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Silva, Javier; Bonilla, Felix] Puerta Hierro Hosp, Genet Oncol Dept, Madrid 28035, Spain; [Castillo, Mireia; Cordon-Cardo, Carlos] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Campos, Yolanda] Virgen Salud Hosp, Dept Pathol, Toledo 45004, Spain	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Rockefeller University; Hospital Puerta de Hierro-Majadahonda; Columbia University	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Castillo-Martin, Mireia/H-6152-2013; Campos-MArtín, Yolanda/R-2630-2017; Muthuswamy, Senthil K/AGY-2834-2022; Fuchs, Elaine/G-1565-2016; Hannon, Gregory/AAB-3568-2019	Campos-MArtín, Yolanda/0000-0001-9686-7036; Muthuswamy, Senthil K/0000-0001-6564-9634; Powers, Scott/0000-0003-2769-1932; Ezhkova, Elena/0000-0003-4154-1615; Castillo-Martin, Mireia/0000-0001-8926-6013	NCI [54010101-5411]; New York Stem Cell Institute; N.I.H [R01-AR27883]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York Stem Cell Institute; N.I.H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are especially thankful to Victoria Aranda (CSHL) for help with the 3D model, to Alberto Munoz (Instituto de Investigaciones Biomedicas "Alberto Sols'') for providing the Snail expression vector, and to Geraldine Guasch (Rockefeller University) for providing tissue sections of HRas/TGF-b R-II-KO mouse tumors. We also thank June Racelis for help with in situ hybridizations and Nicole Stokes for assistance with skin chamber grafting. We thank Ken Chang and Edie Davis for comments on the manuscript and for helpful discussion. This work was partially supported by the NCI with the K99/R00 project # 54010101-5411 (J. M. S.). G. J. H. and E. F. are Investigators of the Howard Hughes Medical Institute and E. E. is a Life Sciences Foundation Postdoctoral Fellow supported by the New York Stem Cell Institute. This work was supported by grants from the N.I.H (G. J. H. and E. F. R01-AR27883) and by a kind gift from Kathryn W. Davis (G. J. H.).	Azzoli CG, 1998, MOL CARCINOGEN, V21, P50, DOI 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hempen PM, 2003, CANCER RES, V63, P994; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raghavan S, 2003, DEV CELL, V5, P415, DOI 10.1016/S1534-5807(03)00261-2; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; WEINBERG WC, 1991, CARCINOGENESIS, V12, P1119, DOI 10.1093/carcin/12.6.1119; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wilkemeyer MF, 2002, J PHARMACOL EXP THER, V303, P110, DOI 10.1124/jpet.102.036277; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	58	64	68	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1047	1061		10.1016/j.cell.2009.04.013	http://dx.doi.org/10.1016/j.cell.2009.04.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524508	Green Accepted, Bronze			2022-12-28	WOS:000266916400017
J	Xu, XLL; Fang, YQ; Lee, TC; Forrest, D; Gregory-Evans, C; Almeida, D; Liu, AH; Jhanwar, SC; Abramson, DH; Cobrinik, D				Xu, Xiaoliang L.; Fang, Yuqiang; Lee, Thomas C.; Forrest, Douglas; Gregory-Evans, Cheryl; Almeida, Dena; Liu, Aihong; Jhanwar, Suresh C.; Abramson, David H.; Cobrinik, David			Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling	CELL			English	Article							THYROID-HORMONE RECEPTOR; GENOMIC INSTABILITY; RETINAL DEVELOPMENT; CELL; EXPRESSION; RB; MOUSE; GENE; P53; PROGRESSION	Retinoblastomas result from the inactivation of the RB1 gene and the loss of Rb protein, yet the cell type in which Rb suppresses retinoblastoma and the circuitry that underlies the need for Rb are undefined. Here, we show that retinoblastoma cells express markers of postmitotic cone precursors but not markers of other retinal cell types. We also demonstrate that human cone precursors prominently express MDM2 and N-Myc, that retinoblastoma cells require both of these proteins for proliferation and survival, and that MDM2 is needed to suppress ARF-induced apoptosis in cultured retinoblastoma cells. Interestingly, retinoblastoma cell MDM2 expression was regulated by the cone-specific RXR gamma transcription factor and a human-specific RXR gamma consensus binding site, and proliferation required RXR gamma, as well as the cone-specific thyroid hormone receptor-beta 2. These findings provide support for a cone precursor origin of retinoblastoma and suggest that human cone-specific signaling circuitry sensitizes to the oncogenic effects of RB1 mutations.	[Xu, Xiaoliang L.; Almeida, Dena; Liu, Aihong; Cobrinik, David] Weill Cornell Med Coll, Dyson Vis Res Inst, New York, NY 10021 USA; [Xu, Xiaoliang L.; Almeida, Dena; Liu, Aihong; Abramson, David H.; Cobrinik, David] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY 10021 USA; [Xu, Xiaoliang L.; Fang, Yuqiang; Jhanwar, Suresh C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Jhanwar, Suresh C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Lee, Thomas C.] Childrens Hosp Los Angeles, Vis Ctr, Los Angeles, CA 90027 USA; [Forrest, Douglas] NIDDK, NIH, Bethesda, MD 20892 USA; [Gregory-Evans, Cheryl] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London SW7 2AZ, England; [Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA	Cornell University; Dyson; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Children's Hospital Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Imperial College London; Memorial Sloan Kettering Cancer Center	Cobrinik, D (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	cobrinid@mskcc.org	Gregory-Evans, Cheryl Y/G-9550-2011		Starr Foundation Tri-Institutional Stem Cell Initiative; Research to Prevent Blindness; Fund for Ophthalmic Knowledge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047036] Funding Source: NIH RePORTER	Starr Foundation Tri-Institutional Stem Cell Initiative; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fund for Ophthalmic Knowledge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Nathans and A. Swaroop for antibodies, H. te Riele for mou tumors, J. Blaydes for plasmids, M. Pappas for compiling Table S1, and A. Koff for facilitating the completion of this study. This work was supported by the Starr Foundation Tri-Institutional Stem Cell Initiative, Research to Prevent Blindness, and the Fund for Ophthalmic Knowledge.	Abramson DH, 1996, RETINA-J RET VIT DIS, V16, P232, DOI 10.1097/00006982-199616030-00009; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; BOGENMANN E, 1988, SCIENCE, V240, P76, DOI 10.1126/science.2451289; Bremner R, 2009, CELL, V137, P992, DOI 10.1016/j.cell.2009.05.034; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-72; Cornish EE, 2004, EXP EYE RES, V78, P1143, DOI 10.1016/j.exer.2004.01.004; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Danko CG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-407; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; DOWHAN DH, 1994, ENDOCRINOLOGY, V135, P2595, DOI 10.1210/en.135.6.2595; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gallie BL, 1999, CANCER RES, V59, p1731S; GONZALEZFERNANDEZ F, 1992, AM J PATHOL, V141, P363; Hendrickson A, 2006, RETINAL DEVELOPMENT, P126, DOI 10.1017/CBO9780511541629.009; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; HURWITZ RL, 1990, J CLIN INVEST, V85, P1872, DOI 10.1172/JCI114648; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kleinerman RA, 2005, J CLIN ONCOL, V23, P2272, DOI 10.1200/JCO.2005.05.054; Kondo Y, 1997, EXP CELL RES, V236, P51, DOI 10.1006/excr.1997.3693; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lee TC, 2006, INVEST OPHTH VIS SCI, V47, P5590, DOI 10.1167/iovs.06-0063; Lomazzi M, 2002, NAT GENET, V31, P190, DOI 10.1038/ng891; MAATKIEVIT JA, 1993, PRENATAL DIAG, V13, P377, DOI 10.1002/pd.1970130510; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; MacPherson D, 2007, EMBO J, V26, P784, DOI 10.1038/sj.emboj.7601515; Mori M, 2001, INVEST OPHTH VIS SCI, V42, P1312; MUNIER FL, 1994, OPHTHALMIC GENET, V15, P101, DOI 10.3109/13816819409057835; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P791, DOI 10.1001/archopht.1995.01100060117046; Pacal M, 2006, CURR MOL MED, V6, P759; Rich KA, 1997, J COMP NEUROL, V388, P47; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; RODRIGUES MM, 1992, CURR EYE RES, V11, P425, DOI 10.3109/02713689209001796; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Spencer C, 2005, GENE EXPR PATTERNS, V5, P687, DOI 10.1016/j.modgep.2005.02.003; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; VIRTANEN I, 1988, LAB INVEST, V59, P649; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELLER CARL V., 1937, AMER JOUR CANCER, V30, P39	56	156	168	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					1018	1031		10.1016/j.cell.2009.03.051	http://dx.doi.org/10.1016/j.cell.2009.03.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524506	Bronze, Green Accepted			2022-12-28	WOS:000266916400015
J	Sokol, DK				Sokol, Daniel K.			Ethics Man The slipperiness of futility	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						Burns JP, 2007, CHEST, V132, P1987, DOI 10.1378/chest.07-1441; Davis JK, 2008, J MED PHILOS, V33, P356, DOI 10.1093/jmp/jhn019; Fins J, 2006, PALLIATIVE ETHIC CAR; Gillon R, 1997, J MED ETHICS, V23, P339, DOI 10.1136/jme.23.6.339; Grossman E, 2009, WORLD J SURG, V33, P1338, DOI 10.1007/s00268-009-9997-2; Jonsen AR, 2006, CLIN ETHICS; Kite S, 2002, LANCET ONCOL, V3, P638, DOI 10.1016/S1470-2045(02)00878-1; Russell IJ, 2000, J MUSCULOSKELET PAIN, V8, P1; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Sokol DK, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a994	10	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 5	2009	338								b2222	10.1136/bmj.b2222	http://dx.doi.org/10.1136/bmj.b2222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	455AJ	19502279				2022-12-28	WOS:000266726600003
J	Houghton, AM; Hartzell, WO; Robbins, CS; Gomis-Ruth, FX; Shapiro, SD				Houghton, A. McGarry; Hartzell, William O.; Robbins, Clinton S.; Xavier Gomis-Rueth, F.; Shapiro, Steven D.			Macrophage elastase kills bacteria within murine macrophages	NATURE			English	Article							NEUTROPHIL ELASTASE; MATRIX METALLOPROTEINASES; HOST-DEFENSE; GELATINASE-A; MICE; CLEAVAGE; ANGIOGENESIS; DEGRADATION; ACTIVATION; MECHANISMS	Macrophages are aptly positioned to function as the primary line of defence against invading pathogens in many organs, including the lung and peritoneum. Their ability to phagocytose and clear microorganisms has been well documented(1,2). Macrophages possess several substances with which they can kill bacteria, including reactive oxygen species, nitric oxide, and antimicrobial proteins(3-9). We proposed that macrophage-derived proteinases may contribute to the antimicrobial properties of macrophages. Macrophage elastase (also known as matrix metalloproteinase 12 or MMP12) is an enzyme predominantly expressed in mature tissue macrophages(10) and is implicated in several disease processes, including emphysema(11). Physiological functions for MMP12 have not been described. Here we show that Mmp12(-/-) mice exhibit impaired bacterial clearance and increased mortality when challenged with both Gram-negative and Gram-positive bacteria at macrophage-rich portals of entry, such as the peritoneum and lung. Intracellular stores of MMP12 are mobilized to macrophage phagolysosomes after the ingestion of bacterial pathogens. Once inside phagolysosomes, MMP12 adheres to bacterial cell walls where it disrupts cellular membranes resulting in bacterial death. The antimicrobial properties of MMP12 do not reside within its catalytic domain, but rather within the carboxyterminal domain. This domain contains a unique four amino acid sequence on an exposed beta loop of the protein that is required for the observed antimicrobial activity. The present study represents, to our knowledge, the first report of direct antimicrobial activity by a matrix metallopeptidase, and describes a new antimicrobial peptide that is sequentially and structurally unique in nature.	[Houghton, A. McGarry; Robbins, Clinton S.; Shapiro, Steven D.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Hartzell, William O.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, E-08028 Barcelona, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Houghton, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.	houghtonm@dom.pitt.edu		Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Robbins, Clinton/0000-0001-9848-1495	National Institutes of Health (NIH); National Heart, Lung and Blood Institute (NHLBI); Spanish and European public agencies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082541] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Spanish and European public agencies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) (S. D. S.) and Spanish and European public agencies (F. X. G.-R.).	Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; BIGGAR WD, 1977, INFECT IMMUN, V16, P974, DOI 10.1128/IAI.16.3.974-982.1977; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Ganz T, 1999, P ASSOC AM PHYSICIAN, V111, P390, DOI 10.1111/paa.1999.111.5.390; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; GREEN GM, 1964, J EXP MED, V119, P167, DOI 10.1084/jem.119.1.167; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; HIEMSTRA PS, 1993, INFECT IMMUN, V61, P3038, DOI 10.1128/IAI.61.7.3038-3046.1993; Hiemstra PS, 1999, J LEUKOCYTE BIOL, V66, P423, DOI 10.1002/jlb.66.3.423; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; LEHRER RI, 1990, BLOOD, V76, P2169; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lijnen HR, 1999, THROMB HAEMOSTASIS, V81, P799; Limb GA, 2005, AM J PATHOL, V166, P1555, DOI 10.1016/S0002-9440(10)62371-1; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Raza SL, 2000, J BIOL CHEM, V275, P41243, DOI 10.1074/jbc.M005788200; SELSTED ME, 1995, TRENDS CELL BIOL, V5, P114, DOI 10.1016/S0962-8924(00)88961-8; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	30	118	122	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 30	2009	460	7255					637	U106		10.1038/nature08181	http://dx.doi.org/10.1038/nature08181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PK	19536155	Green Accepted			2022-12-28	WOS:000268454300052
J	Blumberg, LJ; Holahan, J				Blumberg, Linda J.; Holahan, John			Health Care 2009: The Individual Mandate -- An Affordable and Fair Approach to Achieving Universal Coverage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blumberg, Linda J.; Holahan, John] Urban Inst, Washington, DC 20037 USA	Urban Institute	Blumberg, LJ (corresponding author), Urban Inst, Washington, DC 20037 USA.							Blumberg LJ, 2006, INQUIRY-J HEALTH CAR, V43, P102, DOI 10.5034/inquiryjrnl_43.2.102; HOLAHAN D, 2006, BLUEPRINT UNIVERSAL; *URB I KAIS COMM M, 2008, UN PRIM SUPPL DAT TA; Zuvekas SH, 2007, HEALTH AFFAIR, V26, P249, DOI 10.1377/hlthaff.26.1.249	4	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					6	7		10.1056/NEJMp0904729	http://dx.doi.org/10.1056/NEJMp0904729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464UK	19535794				2022-12-28	WOS:000267533100003
J	Conder, R; Knoblich, JA				Conder, Ryan; Knoblich, Juergen A.			Fly stem cell Research Gets Infectious	CELL			English	Editorial Material							HOST-DEFENSE; ACTIVATION; MIDGUT		[Conder, Ryan; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404				Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763	9	3	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1185	1187		10.1016/j.cell.2009.06.006	http://dx.doi.org/10.1016/j.cell.2009.06.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563751	Bronze			2022-12-28	WOS:000267373400012
J	Gough, DJ; Corlett, A; Schlessinger, K; Wegrzyn, J; Larner, AC; Levy, DE				Gough, Daniel J.; Corlett, Alicia; Schlessinger, Karni; Wegrzyn, Joanna; Larner, Andrew C.; Levy, David E.			Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation	SCIENCE			English	Article							SIGNAL TRANSDUCER; GENE; ACTIVATION; PROTEIN; PHOSPHORYLATION; INTERLEUKIN-6; INTERFERONS; CYTOKINES; TARGET; CANCER	Signal transducer and activator of transcription 3 (STAT3) is a latent cytoplasmic transcription factor responsive to cytokine signaling and tyrosine kinase oncoproteins by nuclear translocation when it is tyrosine-phosphorylated. We report that malignant transformation by activated Ras is impaired without STAT3, in spite of the inability of Ras to drive STAT3 tyrosine phosphorylation or nuclear translocation. Moreover, STAT3 mutants that cannot be tyrosine-phosphorylated, that are retained in the cytoplasm, or that cannot bind DNA nonetheless supported Ras-mediated transformation. Unexpectedly, STAT3 was detected within mitochondria, and exclusive targeting of STAT3 to mitochondria without nuclear accumulation facilitated Ras transformation. Mitochondrial STAT3 sustained altered glycolytic and oxidative phosphorylation activities characteristic of cancer cells. Thus, in addition to its nuclear transcriptional role, STAT3 regulates a metabolic function in mitochondria, supporting Ras-dependent malignant transformation.	[Gough, Daniel J.; Corlett, Alicia; Schlessinger, Karni; Levy, David E.] New York Univ, Sch Med, Dept Pathol, New York, NY 10016 USA; [Gough, Daniel J.; Corlett, Alicia; Schlessinger, Karni; Levy, David E.] New York Univ, Sch Med, Inst Canc, New York, NY 10016 USA; [Wegrzyn, Joanna; Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Larner, Andrew C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	New York University; New York University; Virginia Commonwealth University; Virginia Commonwealth University	Levy, DE (corresponding author), New York Univ, Sch Med, Dept Pathol, 550 1st Ave, New York, NY 10016 USA.	david.levy@med.nyu.edu	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788; Gough, Daniel/0000-0001-6479-1735; Corlett, Alicia/0000-0003-1146-2465; Gough, Daniel/0000-0001-5725-8668	NIH [R01AI28900]; NYSTEM Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Pellicer, L. Feig, C. Der, R. Jove, S. Watowich, and M. Philips for gifts of reagents and helpful discussions. This work was supported by NIH grant R01AI28900 and the NYSTEM Foundation.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GAO SP, 2006, SCI STKE, pPE30; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P6415, DOI 10.1074/jbc.M608952200; RAZ R, 1994, J BIOL CHEM, V269, P24391; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	24	526	542	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1713	1716		10.1126/science.1171721	http://dx.doi.org/10.1126/science.1171721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556508	Green Accepted			2022-12-28	WOS:000267338200041
J	Fusseis, F; Regenauer-Lieb, K; Liu, J; Hough, RM; De Carlo, F				Fusseis, F.; Regenauer-Lieb, K.; Liu, J.; Hough, R. M.; De Carlo, F.			Creep cavitation can establish a dynamic granular fluid pump in ductile shear zones	NATURE			English	Article							DEFORMATION; MYLONITES; ROCKS; LITHOSPHERE; PROPAGATION; TRANSITION; NUCLEATION; TRANSPORT; GROWTH; PHASE	The feedback between fluid migration and rock deformation in mid-crustal shear zones is acknowledged as being critical for earthquake nucleation, the initiation of subduction zones and the formation of mineral deposits(1-3). The importance of this poorly understood feedback is further highlighted by evidence for shear-zone-controlled advective flow of fluids in the ductile lower crust(4) and the recognition that deformation-induced grain-scale porosity is a key to large-scale geodynamics(5,6). Fluid migration in the middle crust cannot be explained in terms of classical concepts. The environment is considered too hot for a dynamic fracture-sustained permeability as in the upper crust(7), and fluid pathways are generally too deformed to be controlled by equilibrium wetting angles that apply to hotter, deeper environments(8-10). Here we present evidence that mechanical and chemical potentials control a syndeformational porosity generation in mid-crustal shear zones. High-resolution synchrotron X-ray tomography and scanning electron microscopy observations allow us to formulate a model for fluid migration in shear zones where a permeable porosity is dynamically created by viscous grain-boundary sliding, creep cavitation, dissolution and precipitation. We propose that syndeformational fluid migration in our 'granular fluid pump' model is a self-sustained process controlled by the explicit role of the rate of entropy production of the underlying irreversible mechanical and chemical microprocesses. The model explains fluid transfer through the middle crust, where strain localization in the creep regime is required for plate tectonics, the formation of giant ore deposits, mantle degassing and earthquake nucleation. Our findings provide a key component for the understanding of creep instabilities in the middle crust.	[Fusseis, F.; Regenauer-Lieb, K.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Regenauer-Lieb, K.; Liu, J.; Hough, R. M.] CSIRO Explorat & Min, Kensington, WA 6151, Australia; [De Carlo, F.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Energy (DOE); Argonne National Laboratory	Fusseis, F (corresponding author), Univ Western Australia, Sch Earth & Environm, 35 Stirling Highway, Crawley, WA 6009, Australia.	fusseis@cyllene.uwa.edu.au	Liu, Jie/G-3551-2011; Regenauer-Lieb, Klaus/H-5706-2014; Regenauer-Lieb, Klaus/F-9560-2011; Fusseis, Florian/M-5321-2016	Regenauer-Lieb, Klaus/0000-0002-2198-5895; Fusseis, Florian/0000-0002-3104-8109	Commonwealth of Australia; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Western Australian Premier's Research Fellowship; University of Western Australia	Commonwealth of Australia(Australian Government); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Western Australian Premier's Research Fellowship; University of Western Australia	This work was supported by the Australian Synchrotron Research Program, which is funded by the Commonwealth of Australia under the Major National Research Facilities Program. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357. The work was supported by iVEC through the use of visualization resources and expertise provided by the WASP and ARRC facilities. We acknowledge the Centre for Microscopy, Characterization and Analysis at the University of Western Australia for the use of its FESEM. Our work was financially supported by the Western Australian Premier's Research Fellowship program and the University of Western Australia through a research grant. The Multiscale Earth System Dynamics group as well as H. Stuenitz, R. Heilbronner and D. Healy participated in discussions. C. Schrank assisted with data processing.	ATKINSON BK, 1982, J STRUCT GEOL, V4, P41, DOI 10.1016/0191-8141(82)90005-0; Bercovici D, 1998, EARTH PLANET SC LETT, V154, P139, DOI 10.1016/S0012-821X(97)00182-9; BLANCHARD CR, 1993, J AM CERAM SOC, V76, P1651, DOI 10.1111/j.1151-2916.1993.tb06631.x; Chokshi AH, 2005, MAT SCI ENG A-STRUCT, V410, P95, DOI 10.1016/j.msea.2005.08.069; COX SF, 1989, J STRUCT GEOL, V11, P147, DOI 10.1016/0191-8141(89)90040-0; ETHERIDGE MA, 1983, J METAMORPH GEOL, V1, P205, DOI 10.1111/j.1525-1314.1983.tb00272.x; Fliervoet TF, 1997, J STRUCT GEOL, V19, P1495, DOI 10.1016/S0191-8141(97)00076-X; Fusseis F, 2008, J STRUCT GEOL, V30, P1242, DOI 10.1016/j.jsg.2008.06.005; Hiraga T, 1999, PHYS CHEM MINER, V26, P617, DOI 10.1007/s002690050226; Holness M, 2006, SCIENCE, V314, P934, DOI 10.1126/science.1135922; Kassner ME, 2003, INT J PLASTICITY, V19, P1715, DOI 10.1016/S0749-6419(02)00111-0; Kennedy BM, 2007, SCIENCE, V318, P1433, DOI 10.1126/science.1146511; KOHLSTEDT DL, 2009, ANN REV EARTH PLANET, V37, P1; Kolb J, 2008, TECTONOPHYSICS, V446, P1, DOI 10.1016/j.tecto.2007.10.001; Kruse R, 1999, TECTONOPHYSICS, V303, P223, DOI 10.1016/S0040-1951(98)00255-8; MITRA G, 1978, AM J SCI, V278, P1057, DOI 10.2475/ajs.278.8.1057; OHARA K, 1989, GEOLOGY, V17, P524, DOI 10.1130/0091-7613(1989)017<0524:VLMFTE>2.3.CO;2; PATERSON MS, 1990, MATER RES SOC SYMP P, V196, P303, DOI 10.1557/PROC-196-303; Regenauer-Lieb K, 2001, SCIENCE, V294, P578, DOI 10.1126/science.1063891; Regenauer-Lieb K, 1999, J GEODYN, V27, P1; REGENAUERLIEB K, PURE APPL G IN PRESS; Rybacki E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032478; Shigematsu N, 2004, EARTH PLANET SC LETT, V222, P1007, DOI 10.1016/j.epsl.2004.04.001; SIBSON RH, 1994, SPECIAL PUBLICATION, V78, P69, DOI DOI 10.1144/GSL.SP.1994.078.01.07; Tullis J, 1996, GEOLOGY, V24, P63, DOI 10.1130/0091-7613(1996)024<0063:DEFDIF>2.3.CO;2; Wang YX, 2001, REV SCI INSTRUM, V72, P2062, DOI 10.1063/1.1355270; Wark DA, 2000, GEOPHYS RES LETT, V27, P2029, DOI 10.1029/2000GL011503; WATSON EB, 1987, EARTH PLANET SC LETT, V85, P497; WHITE SH, 1980, J STRUCT GEOL, V2, P175, DOI 10.1016/0191-8141(80)90048-6; Wintsch RP, 2002, J STRUCT GEOL, V24, P1179, DOI 10.1016/S0191-8141(01)00100-6	30	175	178	10	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					974	977		10.1038/nature08051	http://dx.doi.org/10.1038/nature08051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536262				2022-12-28	WOS:000267063500040
J	Cheng, TL; Jenkins, RR				Cheng, Tina L.; Jenkins, Renee R.			Health Disparities Across the Lifespan Where Are the Children?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cheng, Tina L.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA; [Jenkins, Renee R.] Howard Univ, Dept Pediat & Child Hlth, Washington, DC 20059 USA; [Cheng, Tina L.; Jenkins, Renee R.] DC Baltimore Res Ctr Child Hlth Dispar, Washington, DC USA	Johns Hopkins University; Howard University	Cheng, TL (corresponding author), Johns Hopkins Univ, Dept Pediat, 200 N Wolfe St,Ste 2055, Baltimore, MD 21287 USA.	Tcheng2@jhmi.edu			National Institute on Minority Health and Health Disparities [P20MD000198] Funding Source: NIH RePORTER; NIMHD NIH HHS [P20 MD000198-069007, P20 MD000198] Funding Source: Medline	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		*FED INT FOR CHILD, POP3 RAC ETHN COMP P; Halfon N, 2002, MILBANK Q, V80, P433, DOI 10.1111/1468-0009.00019; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; *I MED, 2003, UN TREATM CONFR RAC; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Kuh D, 1997, LIFE COURSE APPROACH; National Center for Children in Poverty, WHO AR AM POOR CHILD; National Research Council and Institute of Medicine, 2004, CHILDR HLTH NAT WEAL; *PARTN AM EC SUCC, TELL PRINC INV YOUNG; Shone LP, 2005, PEDIATRICS, V115, pE697, DOI 10.1542/peds.2004-1726; Szilagyi PG, 2009, ACAD PEDIATR, V9, P4, DOI 10.1016/j.acap.2008.12.002; UNICEF, 2007, CHILD POV PERSP OV C	12	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2491	2492		10.1001/jama.2009.848	http://dx.doi.org/10.1001/jama.2009.848			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458MO	19531790	Green Accepted			2022-12-28	WOS:000267028100028
J	Cruz, DN; Antonelli, M; Fumagalli, R; Foltran, F; Brienza, N; Donati, A; Malcangi, V; Petrini, F; Volta, G; Pallavicini, FMB; Rottoli, F; Giunta, F; Ronco, C				Cruz, Dinna N.; Antonelli, Massimo; Fumagalli, Roberto; Foltran, Francesca; Brienza, Nicola; Donati, Abele; Malcangi, Vincenzo; Petrini, Flavia; Volta, Giada; Pallavicini, Franco M. Bobbio; Rottoli, Federica; Giunta, Francesco; Ronco, Claudio			Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock The EUPHAS Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	14th International Conference on Continuous Renal Replacement Therapies	FEB 25-28, 2009	San Diego, CA				IMMOBILIZED FIBER COLUMN; FAILURE ASSESSMENT SCORE; SEVERE SEPSIS; ENDOTOXIN REMOVAL; SOFA SCORE; THERAPY; CARTRIDGE; INFANTS	Context Polymyxin B fiber column is a medical device designed to reduce blood endotoxin levels in sepsis. Gram-negative-induced abdominal sepsis is likely associated with high circulating endotoxin. Reducing circulating endotoxin levels with polymyxin B hemoperfusion could potentially improve patient clinical outcomes. Objective To determine whether polymyxin B hemoperfusion added to conventional medical therapy improves clinical outcomes (mean arterial pressure [MAP], vasopressor requirement, oxygenation, organ dysfunction) and mortality compared with conventional therapy alone. Design, Setting, and Patients A prospective, multicenter, randomized controlled trial (Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis [EUPHAS]) conducted at 10 Italian tertiary care intensive care units between December 2004 and December 2007. Sixty-four patients were enrolled with severe sepsis or septic shock who underwent emergency surgery for intra-abdominal infection. Intervention Patients were randomized to either conventional therapy (n=30) or conventional therapy plus 2 sessions of polymyxin B hemoperfusion (n=34). Main Outcome Measures Primary outcome was change in MAP and vasopressor requirement, and secondary outcomes were PaO2/FIO2 (fraction of inspired oxygen) ratio, change in organ dysfunction measured using Sequential Organ Failure Assessment (SOFA) scores, and 28-day mortality. Results MAP increased (76 to 84 mm Hg; P=.001) and vasopressor requirement decreased (inotropic score, 29.9 to 6.8; P<.001) at 72 hours in the polymyxin B group but not in the conventional therapy group (MAP, 74 to 77 mm Hg; P=.37; inotropic score, 28.6 to 22.4; P=.14). The PaO2/FIO2 ratio increased slightly (235 to 264; P=.049) in the polymyxin B group but not in the conventional therapy group (217 to 228; P=.79). SOFA scores improved in the polymyxin B group but not in the conventional therapy group (change in SOFA, -3.4 vs -0.1; P<.001), and 28-day mortality was 32% (11/34 patients) in the polymyxin B group and 53% (16/30 patients) in the conventional therapy group (unadjusted hazard ratio [HR], 0.43; 95% confidence interval [CI], 0.20-0.94; adjusted HR, 0.36; 95% CI, 0.16-0.80). Conclusion In this preliminary study, polymyxin B hemoperfusion added to conventional therapy significantly improved hemodynamics and organ dysfunction and reduced 28-day mortality in a targeted population with severe sepsis and/or septic shock from intra-abdominal gram-negative infections.	[Cruz, Dinna N.; Ronco, Claudio] St Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, I-36100 Vicenza, Italy; [Cruz, Dinna N.; Ronco, Claudio] Int Renal Res Inst Vicenza, Vicenza, Italy; [Antonelli, Massimo] Univ Cattolica Sacro Cuore, Dept Anesthesiol & Intens Care, Policlin Gemelli, I-00168 Rome, Italy; [Fumagalli, Roberto] Milano Bicocca Univ, St Gerardo dei Tintori Hosp, Dept Anesthesiol & Intens Care 1, Monza, Italy; [Foltran, Francesca; Giunta, Francesco] Univ Pisa, Dept Surg, Pisa, Italy; [Brienza, Nicola; Malcangi, Vincenzo] Univ Bari, Anesthesia & Intens Care Unit, Dept Emergency & Organ Transplantat, Bari, Italy; [Donati, Abele] Polytech Univ Marche, Dept Neurosci Anesthesia & Intens Care, Ancona, Italy; [Petrini, Flavia] Univ G dAnnunzio, Dept Anesthesia Intens Care & Emergency, Chieti, Italy; [Volta, Giada] St Orsola Marcello Malpighi Hosp, Policlin S Orsola, Dept Anesthesiol & Intens Care, Bologna, Italy; [Pallavicini, Franco M. Bobbio] S Martino Univ Hosp, Dept Intens Care, Genoa, Italy; [Rottoli, Federica] Riuniti Hosp, Dept Anesthesiol & Intens Care, Bergamo, Italy	ULSS 8 Berica; Ospedale San Bortolo di Vicenza; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milano-Bicocca; University of Pisa; Universita degli Studi di Bari Aldo Moro; Marche Polytechnic University; G d'Annunzio University of Chieti-Pescara; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Genoa; IRCCS AOU San Martino IST; Ospedali Riuniti di Bergamo	Ronco, C (corresponding author), St Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Viale Rodolfi 37, I-36100 Vicenza, Italy.	cronco@goldnet.it	Donati, Abele/E-3649-2012; Fumagalli, Roberto/AAB-9746-2019; Antonelli, Massimo/F-9848-2010; Antonelli, Massimo/K-9915-2016	Fumagalli, Roberto/0000-0003-0398-1329; Antonelli, Massimo/0000-0003-3007-1670; Donati, Abele/0000-0001-6792-8741; Ronco, Claudio/0000-0002-6697-4065				Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Cantaluppi V, 2008, INTENS CARE MED, V34, P1638, DOI 10.1007/s00134-008-1124-6; Cruz DN, 2007, CRIT CARE, V11, DOI 10.1186/cc5780; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Enomoto N, 2008, RESPIROLOGY, V13, P452, DOI 10.1111/j.1440-1843.2008.01290.x; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kellum JA, 2007, CRIT CARE, V11, DOI 10.1186/cc5918; Kushi H, 2005, CRIT CARE, V9, pR653, DOI 10.1186/cc3815; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Nakamura T, 2004, ASAIO J, V50, P563, DOI 10.1097/01.MAT.0000142875.62592.3A; Nakamura T, 2004, INTENS CARE MED, V30, P1838, DOI 10.1007/s00134-004-2357-7; Nakamura T, 2003, NEPHRON CLIN PRACT, V94, pC33, DOI 10.1159/000071279; Nakamura T, 2003, DIALYSIS TRANSPLANT, V32, P602; Nakamura T, 2003, J HOSP INFECT, V53, P58, DOI 10.1053/jhin.2002.1332; Nakamura T, 2002, ASAIO J, V48, P244, DOI 10.1097/00002480-200205000-00008; Nakamura T, 1999, INFLAMM RES, V48, P171, DOI 10.1007/s000110050442; Nemoto H, 2001, BLOOD PURIFICAT, V19, P361, DOI 10.1159/000046966; Noma S, 2007, INTERNAL MED, V46, P1447, DOI 10.2169/internalmedicine.46.0117; Opal SM, 2003, CRIT CARE MED, V31, pS57, DOI 10.1097/00003246-200301001-00009; Perego A F, 2006, G Ital Nefrol, V23 Suppl 36, pS94; Pocock SJ., 2013, CLIN TRIALS PRACTICA; ROSSI C, 2005, PROGETTO MARGHERITA; Ruberto F, 2007, INT J ARTIF ORGANS, V30, P915, DOI 10.1177/039139880703001009; Shoji H, 2003, THER APHER DIAL, V7, P108, DOI 10.1046/j.1526-0968.2003.00005.x; Shore S, 2001, AM J CARDIOL, V88, P591, DOI 10.1016/S0002-9149(01)01751-9; Suzuki H, 2002, THER APHER, V6, P234, DOI 10.1046/j.1526-0968.2002.00416.x; Tsujimoto H, 2004, J ENDOTOXIN RES, V10, P229, DOI 10.1179/096805104225005814; Uriu K, 2002, AM J KIDNEY DIS, V39, P937, DOI 10.1053/ajkd.2002.32767; Vincent JL, 2005, SHOCK, V23, P400, DOI 10.1097/01.shk.0000159930.87737.8a; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; WERNOVSKY G, 1995, CIRCULATION, V92, P2226, DOI 10.1161/01.CIR.92.8.2226; Zuppa AF, 2004, CRIT CARE MED, V32, P2318, DOI 10.1097/01.CCM.0000146133.52982.17	37	510	549	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2445	2452		10.1001/jama.2009.856	http://dx.doi.org/10.1001/jama.2009.856			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	458MO	19531784	Bronze			2022-12-28	WOS:000267028100022
J	Nabel, EG; Stevens, S; Smith, R				Nabel, Elizabeth G.; Stevens, Simon; Smith, Richard			Combating chronic disease in developing countries	LANCET			English	Editorial Material									[Nabel, Elizabeth G.] NHLBI, Bethesda, MD 20892 USA; [Stevens, Simon; Smith, Richard] UnitedHlth Grp, Minneapolis, MN 55440 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Nabel, EG (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.	nhlbiiod@nhlbi.nih.gov		Smith, Richard/0000-0003-3837-6559				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2005, PREV CHRON DIS VIT I; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Quam L, 2006, LANCET, V368, P1221, DOI 10.1016/s0140-6736(06)69422-1; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Suhrcke M., 2006, CHRONIC DIS EC PERSP; World Health Organization, 2008, 2008 2013 ACT PLAN G	12	37	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2009	373	9680					2004	2006		10.1016/S0140-6736(09)61074-6	http://dx.doi.org/10.1016/S0140-6736(09)61074-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19523681				2022-12-28	WOS:000267080100007
J	Rodrigues, ASL; Ewers, RM; Parry, L; Souza, C; Verissimo, A; Balmford, A				Rodrigues, Ana S. L.; Ewers, Robert M.; Parry, Luke; Souza, Carlos, Jr.; Verissimo, Adalberto; Balmford, Andrew			Boom-and-Bust Development Patterns Across the Amazon Deforestation Frontier	SCIENCE			English	Article							LAND-USE; FOREST DEGRADATION; BRAZILIAN AMAZONIA; CONSERVATION; ENVIRONMENT; EMISSIONS; SERVICES; PASTURE; CLIMATE; BASIN	The Brazilian Amazon is globally important for biodiversity, climate, and geochemical cycles, but is also among the least developed regions in Brazil. Economic development is often pursued through forest conversion for cattle ranching and agriculture, mediated by logging. However, on the basis of an assessment of 286 municipalities in different stages of deforestation, we found a boom-and-bust pattern in levels of human development across the deforestation frontier. Relative standards of living, literacy, and life expectancy increase as deforestation begins but then decline as the frontier evolves, so that pre- and postfrontier levels of human development are similarly low. New financial incentives and policies are creating opportunities for a more sustained development trajectory that is not based on the depletion of nature and ecosystem services.	[Rodrigues, Ana S. L.; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Rodrigues, Ana S. L.] CNRS, UMR5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier, France; [Ewers, Robert M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Parry, Luke] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Souza, Carlos, Jr.; Verissimo, Adalberto] IMAZON Amazon Inst People & Environm, Belem, Para, Brazil	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Imperial College London; University of East Anglia	Rodrigues, ASL (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England.	ana.rodrigues@cefe.cnrs.fr	Rodrigues, Ana/GYQ-6273-2022; Parry, Luke/ABD-4194-2021; Parry, Luke/E-8244-2012; Rodrigues, Ana S.L./A-5914-2009; Souza, CARLOS/AAK-8207-2021	Parry, Luke/0000-0003-0330-9516; Rodrigues, Ana S.L./0000-0003-4775-0127; Souza, CARLOS/0000-0002-0205-6134; Balmford, Andrew/0000-0002-0144-3589	Marie Curie Intra European Fellowship under the European Community Sixth Framework Programme; Fundacao para a Ciencia e Tecnologia Postdoctoral Fellowship (Portugal) (A.S.L.R.); Gordon and Betty Moore Foundation; Leverhulme Trust	Marie Curie Intra European Fellowship under the European Community Sixth Framework Programme(European Commission); Fundacao para a Ciencia e Tecnologia Postdoctoral Fellowship (Portugal) (A.S.L.R.); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Leverhulme Trust(Leverhulme Trust)	Supported by a Marie Curie Intra European Fellowship under the European Community Sixth Framework Programme and by a Fundacao para a Ciencia e Tecnologia Postdoctoral Fellowship (Portugal) (A.S.L.R.), the Gordon and Betty Moore Foundation (C.S. and A.V.), and the "Valuing the Arc" program of the Leverhulme Trust (A.B.). We thank J. Barlow, T. Gardner, R. Green, B. Strassburg, and three anonymous reviewers for valuable and constructive comments.	Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Bhattarai M, 2001, WORLD DEV, V29, P995, DOI 10.1016/S0305-750X(01)00019-5; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; Celentano D., 2007, AVANCO FRONTEIRA AMA; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Diamond J, 2004, NATURE, V429, P616, DOI 10.1038/429616a; Fearnside Philip M., 1998, Forest Ecology and Management, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; Fearnside PM, 2008, ECOL SOC, V13; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Hall A., 2008, Journal of International Development, V20, P965, DOI 10.1002/jid.1456; Hall A, 2006, J LAT AM STUD, V38, P689, DOI 10.1017/S0022216X0600157X; INPE, 2008, PROJ PRODES MON FLOR; Jacoby HG, 2000, ECON J, V110, P713, DOI 10.1111/1468-0297.00562; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; *MMA, 2009, AC MMA MUN; Muller MML, 2004, AGR ECOSYST ENVIRON, V103, P279, DOI 10.1016/j.agee.2003.12.003; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; NEPSTAD DC, 2007, COSTS BENEFITS REDUC; Rudel T., 2005, TROPICAL FORESTS REG; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Schneider R., 2000, SUSTAINABLE AMAZON L; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Tollefson J, 2008, NATURE, V452, P134, DOI 10.1038/452134a; UNDP, 2008, HUM DEV IND; *UNDP BRAZ, 2003, ATL DES HUM BRAZ; Verissimo A, 2002, SCIENCE, V297, P1478, DOI 10.1126/science.1072807; White D, 2001, AGRICULTURAL TECHNOLOGIES AND TROPICAL DEFORESTATION, P91, DOI 10.1079/9780851994512.0091	33	167	176	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1435	1437		10.1126/science.1174002	http://dx.doi.org/10.1126/science.1174002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520958				2022-12-28	WOS:000266878700043
J	Driscoll, DA; Gross, S				Driscoll, Deborah A.; Gross, Susan			Prenatal Screening for Aneuploidy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FETAL NUCHAL-TRANSLUCENCY; DOWN-SYNDROME; NASAL BONE; CHROMOSOMAL-ABNORMALITIES; GENETIC AMNIOCENTESIS; TWIN PREGNANCIES; 1ST TRIMESTER; 1ST-TRIMESTER; TRISOMY-21; DEFECTS		[Driscoll, Deborah A.] Univ Penn, Dept Obstet & Gynecol, Sch Med & Hlth Syst, Philadelphia, PA 19104 USA; [Gross, Susan] N Bronx Healthcare Network, Dept Obstet & Gynecol, Bronx, NY USA; [Gross, Susan] Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine	Driscoll, DA (corresponding author), Hosp Univ Penn, Dept Obstet & Gynecol, 3400 Spruce St, Philadelphia, PA 19104 USA.	ddriscoll@obgyn.upenn.edu						ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; ALFIREVIC A, 2003, COCHRANE DB SYST REV, V3; *AM COLL OBST GYN, 2007, OBSTET GYNECOL, V110, P1459, DOI DOI 10.1097/01.AOG.0000291570.63450.44; Bahado-Singh RO, 2005, SEMIN PERINATOL, V29, P209, DOI 10.1053/j.semperi.2005.06.005; Bahado-Singh RO, 2005, AM J OBSTET GYNECOL, V192, P1357, DOI 10.1016/j.ajog.2004.12.086; Benacerraf BR, 2005, SEMIN PERINATOL, V29, P386, DOI 10.1053/j.semperi.2005.12.003; Breathnach FM, 2007, OBSTET GYNECOL, V110, P651, DOI 10.1097/01.AOG.0000278570.76392.a6; Cicero S, 2001, LANCET, V358, P1665, DOI 10.1016/S0140-6736(01)06709-5; Cicero S, 2006, AM J OBSTET GYNECOL, V195, P109, DOI 10.1016/j.ajog.2005.12.057; Cleary-Goldman J, 2005, SEMIN PERINATOL, V29, P395, DOI 10.1053/j.semperi.2006.01.002; Cleary-Goldman J, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.010; Cuckle HS, 2008, PRENATAL DIAG, V28, P89, DOI 10.1002/pd.1913; Driscoll DA, 2008, GENET MED, V10, P156, DOI 10.1097/GIM.0b013e31815efde8; Driscoll DA, 2004, GENET MED, V6, P540, DOI 10.1097/00125817-200411000-00013; Driscoll DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.027; Egan JFX, 2004, AM J OBSTET GYNECOL, V191, P1044, DOI 10.1016/j.ajog.2004.06.050; Hyett J, 1999, BRIT MED J, V318, P81, DOI 10.1136/bmj.318.7176.81; Knight GJ, 2005, PRENATAL DIAG, V25, P1162, DOI 10.1002/pd.1305; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Malone FD, 2003, OBSTET GYNECOL, V102, P1066, DOI 10.1016/j.obstetgynecol.2003.08.004; MERKATZ IR, 1984, AM J OBSTET GYNECOL, V148, P886, DOI 10.1016/0002-9378(84)90530-1; Nassar AH, 2004, GYNECOL OBSTET INVES, V58, P100, DOI 10.1159/000078793; Neveux LM, 1996, PRENATAL DIAG, V16, P29, DOI 10.1002/(SICI)1097-0223(199601)16:1<29::AID-PD801>3.0.CO;2-K; NICOLAIDES KH, 1992, BRIT MED J, V304, P867, DOI 10.1136/bmj.304.6831.867; Nicolaides KH, 2004, AM J OBSTET GYNECOL, V191, P45, DOI 10.1016/j.ajog.2004.03.090; Nicolaides KH, 2000, BEST PRACT RES CL OB, V14, P581, DOI 10.1053/beog.2000.0098; Nussbaum R. L., 2007, THOMPSON THOMPSON GE; Odibo AO, 2008, OBSTET GYNECOL, V111, P589, DOI 10.1097/AOG.0b013e318162eb53; Palomaki GE, 2006, OBSTET GYNECOL, V107, P955; Palomaki GE, 2006, OBSTET GYNECOL, V107, P367, DOI 10.1097/01.AOG.0000195061.48747.f4; Platt LD, 2004, OBSTET GYNECOL, V104, P661, DOI 10.1097/01.AOG.0000139832.79658.b9; Prefumo F, 2006, AM J OBSTET GYNECOL, V194, P828, DOI 10.1016/j.ajog.2005.09.008; Rosen T, 2007, OBSTET GYNECOL, V110, P399, DOI 10.1097/01.AOG.0000275281.19344.66; Smith-Bindman R, 2007, PRENATAL DIAG, V27, P535, DOI 10.1002/pd.1725; Snijders RJM, 2002, ULTRASOUND OBST GYN, V19, P353, DOI 10.1046/j.1469-0705.2002.00637.x; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Sundberg K, 1997, LANCET, V350, P697, DOI 10.1016/S0140-6736(97)02449-5; Wald NJ, 2006, PRENATAL DIAG, V26, P769, DOI 10.1002/pd.1498; WALD NJ, 1988, BRIT MED J, V297, P1029; Wald NJ, 2003, PRENATAL DIAG, V23, P588, DOI 10.1002/pd.627; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Weisz B, 2007, BJOG-INT J OBSTET GY, V114, P493, DOI 10.1111/j.1471-0528.2007.01238.x; WILLIAMSON RA, 1987, OBSTET GYNECOL, V69, P15	45	129	153	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2556	2562		10.1056/NEJMcp0900134	http://dx.doi.org/10.1056/NEJMcp0900134			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516035				2022-12-28	WOS:000266813800010
J	Tebruegge, M; Ritz, N; Connell, T; Curtis, N				Tebruegge, Marc; Ritz, Nicole; Connell, Tom; Curtis, Nigel			Picture quiz A 2 year old girl with fever, cough, and tachypnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MILIARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; CHILDREN; DIAGNOSIS; MANAGEMENT; INFECTION; DISEASE; PATTERN; HIV		[Curtis, Nigel] Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia; [Connell, Tom] Royal Childrens Hosp Melbourne, Infect Dis Unit, Dept Gen Med, Parkville, Vic 3052, Australia; [Connell, Tom] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Curtis, N (corresponding author), Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia.	nigel.curtis@rch.org.au	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019; Curtis, Nigel/B-3491-2012	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Curtis, Nigel/0000-0003-3446-4594				Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Das Manoja, 2004, Indian Journal of Pediatrics, V71, P553, DOI 10.1007/BF02724303; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Gurkan F, 1998, SCAND J INFECT DIS, V30, P359; *HLTH PROT AG, 2008, POS STAT US INT GAMM; HUSSEY G, 1991, PEDIATR INFECT DIS J, V10, P832, DOI 10.1097/00006454-199111000-00008; Irfan M, 2007, TROP DOCT, V37, P182, DOI 10.1258/004947507781524755; JACQUES J, 1970, THORAX, V25, P237, DOI 10.1136/thx.25.2.237; Krishnaswami K V, 1977, J Indian Med Assoc, V69, P227; Kwong JS, 1996, CHEST, V110, P339, DOI 10.1378/chest.110.2.339; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Mert A, 2001, Ann Thorac Cardiovasc Surg, V7, P45; National Institute for Health and Clinical Excellence, 2006, CLIN DIAGN MAN TUB M; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; SCHUIT KE, 1979, AM J DIS CHILD, V133, P583, DOI 10.1001/archpedi.1979.02130060023003; Sharma SK, 2005, LANCET INFECT DIS, V5, P415, DOI 10.1016/S1473-3099(05)70163-8; SHARMA SK, 1995, QJM-MON J ASSOC PHYS, V88, P29; Starke JR, 2000, PEDIATR INFECT DIS J, V19, P1095, DOI 10.1097/00006454-200011000-00015; Wammanda RD, 2003, ANN TROP PAEDIATR, V23, P149, DOI 10.1179/027249303235002233; WILLCOX PA, 1986, THORAX, V41, P681, DOI 10.1136/thx.41.9.681	26	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2009	338								b1210	10.1136/bmj.b1210	http://dx.doi.org/10.1136/bmj.b1210			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458LI	19515707				2022-12-28	WOS:000267022000001
J	Conard, NJ; Malina, M; Munzel, SC				Conard, Nicholas J.; Malina, Maria; Muenzel, Susanne C.			New flutes document the earliest musical tradition in southwestern Germany	NATURE			English	Article							WESTERN EURASIA; LATE MIDDLE; CAVE; AURIGNACIAN	Considerable debate surrounds claims for early evidence of music in the archaeological record(1-5). Researchers universally accept the existence of complex musical instruments as an indication of fully modern behaviour and advanced symbolic communication(1) but, owing to the scarcity of finds, the archaeological record of the evolution and spread of music remains incomplete. Although arguments have been made for Neanderthal musical traditions and the presence of musical instruments in Middle Palaeolithic assemblages, concrete evidence to support these claims is lacking(1-4). Here we report the discovery of bone and ivory flutes from the early Aurignacian period of southwestern Germany. These finds demonstrate the presence of a well-established musical tradition at the time when modern humans colonized Europe, more than 35,000 calendar years ago. Other than the caves of the Swabian Jura, the earliest secure archaeological evidence for music comes from sites in France and Austria and post-date 30,000 years ago(6-8).	[Muenzel, Susanne C.] Univ Tubingen, Zentrum Nat Wissensch Archaol, D-72070 Tubingen, Germany; [Conard, Nicholas J.] Univ Tubingen, Abt Altere Urgeschichte & Quartarokol, Inst Ur & Fruhgeschichte & Archaol Mittelalters, D-72070 Tubingen, Germany; [Malina, Maria] Heidelberger Akad Wissensch, Res Project Role Culture Early Expans Humans, D-72070 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Conard, NJ (corresponding author), Univ Tubingen, Zentrum Nat Wissensch Archaol, Rumelinstr 23, D-72070 Tubingen, Germany.	nicholas.conard@uni-tuebingen.de		Conard, Nicholas/0000-0002-4633-0385				ALBRECHT G, 1998, ARCHAOL KORRESPONDEN, V28, P1; BOLUS M, 2009, EURASIAN PREHIST, V5, P19; Brock F, 2007, RADIOCARBON, V49, P187, DOI 10.1017/S0033822200042107; Buisson D., 1990, BULL SOC PREHIST FR, V87, P420, DOI DOI 10.3406/BSPF.1990.9925; Conard N., 2006, NEANDERTHALS MODERN, P305; Conard N.J., 2004, ARCHAOL KORRESPONDEN, V34, P447; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Conard NJ, 2008, J HUM EVOL, V55, P886, DOI 10.1016/j.jhevol.2008.08.006; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; CONARD NJ, 2006, ARCHAOL AUSGR BADEN, P21; CONARD NJ, 2006, P S TRAB ARQ, V45, P211; D'Errico F, 1998, ANTIQUITY, V72, P65, DOI 10.1017/S0003598X00086282; d'Errico F, 2003, J WORLD PREHIST, V17, P1, DOI 10.1023/A:1023980201043; Einwogerer T., 1998, ARCHAOL KORRESPONDEN, V28, P21; Hahn J., 1995, FUNDBERICHTE BADEN W, V20, P1; HEIN W, 1998, EXPT ARCHAOLOGIE BIL, P65; Huls MC, 2007, RADIOCARBON, V49, P193, DOI 10.1017/S0033822200042119; Joris O, 2008, J HUM EVOL, V55, P782, DOI 10.1016/j.jhevol.2008.04.002; Lawson G., 2002, STUDIEN MUSIKARCHAOL, P119; Mithen S., 2005, SINGING NEANDERTHALS; MUNZEL SC, 2002, ORIENT ARCHAOLOGIE, V10, P107; Richter D, 2000, J ARCHAEOL SCI, V27, P71, DOI 10.1006/jasc.1999.0458; SEEBERGER F, 2004, KLANGWELTEN ALTSTEIN; Tarasov N, 2005, WINDKANAL, V1, P6; TURK I, 1997, BONE FLUTE OTHER FIN; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; ZILHAO J, 2003, P S TRAB ARQ, V33, P313	27	245	258	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					737	740		10.1038/nature08169	http://dx.doi.org/10.1038/nature08169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	479OO	19553935				2022-12-28	WOS:000268670300038
J	Rempel, M; Schussler, M; Cameron, RH; Knolker, M				Rempel, M.; Schuessler, M.; Cameron, R. H.; Knoelker, M.			Penumbral Structure and Outflows in Simulated Sunspots	SCIENCE			English	Article							FINE-STRUCTURE; RESOLUTION; FILAMENTS	Sunspots are concentrations of magnetic field on the visible solar surface that strongly affect the convective energy transport in their interior and surroundings. The filamentary outer regions (penumbrae) of sunspots show systematic radial outward flows along channels of nearly horizontal magnetic field. These flows were discovered 100 years ago and are present in all fully developed sunspots. By using a comprehensive numerical simulation of a sunspot pair, we show that penumbral structures with such outflows form when the average magnetic field inclination to the vertical exceeds about 45 degrees. The systematic outflows are a component of the convective flows that provide the upward energy transport and result from anisotropy introduced by the presence of the inclined magnetic field.	[Rempel, M.; Knoelker, M.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Schuessler, M.; Cameron, R. H.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany	National Center Atmospheric Research (NCAR) - USA; Max Planck Society	Rempel, M (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.	rempel@hao.ucar.edu		Cameron, Robert/0000-0001-9474-8447; Rempel, Matthias/0000-0001-5850-3119				DIALETIS D, 1985, ASTRON ASTROPHYS, V147, P93; Evershed J, 1908, MON NOT R ASTRON SOC, V69, P0454; Heinemann T, 2007, ASTROPHYS J, V669, P1390, DOI 10.1086/520827; Ichimoto K, 2007, SCIENCE, V318, P1597, DOI 10.1126/science.1146046; Keppens R, 1996, ASTRON ASTROPHYS, V316, P229; Kubo M, 2007, ASTROPHYS J, V659, P812, DOI 10.1086/512353; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Rubio LRB, 2006, ASTRON ASTROPHYS, V453, P1117, DOI 10.1051/0004-6361:20054768; Almeida JS, 2007, ASTROPHYS J, V658, P1357, DOI 10.1086/511254; Scharmer GB, 2008, ASTROPHYS J LETT, V677, pL149, DOI 10.1086/587982; Scharmer GRB, 2002, NATURE, V420, P151, DOI 10.1038/nature01173; Schussler M, 2006, ASTROPHYS J, V641, pL73, DOI 10.1086/503772; Solanki SK, 2003, ASTRON ASTROPHYS REV, V11, P153, DOI 10.1007/s00159-003-0018-4; Thomas J. H., 2008, CAM ASTROPH; Thomas JH, 2004, ANNU REV ASTRON ASTR, V42, P517, DOI 10.1146/annurev.astro.42.010803.115226; Zakharov V, 2008, ASTRON ASTROPHYS, V488, pL17, DOI 10.1051/0004-6361:200810266	16	152	153	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					171	174		10.1126/science.1173798	http://dx.doi.org/10.1126/science.1173798			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19541955				2022-12-28	WOS:000267802000038
J	Melander, O; Newton-Cheh, C; Almgren, P; Hedblad, B; Berglund, G; Engstrom, G; Persson, M; Smith, JG; Magnusson, M; Christensson, A; Struck, J; Morgenthaler, NG; Bergmann, A; Pencina, MJ; Wang, TJ				Melander, Olle; Newton-Cheh, Christopher; Almgren, Peter; Hedblad, Bo; Berglund, Goeran; Engstrom, Gunnar; Persson, Margaretha; Smith, J. Gustav; Magnusson, Martin; Christensson, Anders; Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas; Pencina, Michael J.; Wang, Thomas J.			Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; PROATRIAL NATRIURETIC PEPTIDE; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; MULTIPLE BIOMARKERS; PHOSPHOLIPASE A(2); RISK PREDICTION; PRO-ADRENOMEDULLIN; CASE-FATALITY; PREVENTION	Context Prior studies have demonstrated conflicting results regarding how much information novel biomarkers add to cardiovascular risk assessment. Objective To evaluate the utility of contemporary biomarkers for predicting cardiovascular risk when added to conventional risk factors. Design, Setting, and Participants Cohort study of 5067 participants (mean age, 58 years; 60% women) without cardiovascular disease from Malmo, Sweden, who attended a baseline examination between 1991 and 1994. Participants underwent measurement of C-reactive protein (CRP), cystatin C, lipoprotein-associated phospholipase 2, midregional proadrenomedullin (MR-proADM), midregional proatrial natriuretic peptide, and N-terminal pro-B-type natriuretic peptide (N-BNP) and underwent follow-up until 2006 using the Swedish national hospital discharge and cause-of-death registers and the Stroke in Malmo register for first cardiovascular events (myocardial infarction, stroke, coronary death). Main Outcome Measures Incident cardiovascular and coronary events. Results During median follow-up of 12.8 years, there were 418 cardiovascular and 230 coronary events. Models with conventional risk factors had C statistics of 0.758 (95% confidence interval [CI], 0.734 to 0.781) and 0.760 (0.730 to 0.789) for cardiovascular and coronary events, respectively. Biomarkers retained in backward-elimination models were CRP and N-BNP for cardiovascular events and MR-proADM and N-BNP for coronary events, which increased the C statistic by 0.007 (P = .04) and 0.009 (P = .08), respectively. The proportion of participants reclassified was modest (8% for cardiovascular risk, 5% for coronary risk). Net reclassification improvement was nonsignificant for cardiovascular events (0.0%; 95% CI, -4.3% to 4.3%) and coronary events (4.7%; 95% CI, -0.76% to 10.1%). Greater improvements were observed in analyses restricted to intermediate-risk individuals (cardiovascular events: 7.4%; 95% CI, 0.7% to 14.1%; P = .03; coronary events: 14.6%; 95% CI, 5.0% to 24.2%; P = .003). However, correct reclassification was almost entirely confined to down-classification of individuals without events rather than up-classification of those with events. Conclusions Selected biomarkers may be used to predict future cardiovascular events, but the gains over conventional risk factors are minimal. Risk classification improved in intermediate-risk individuals, mainly through the identification of those unlikely to develop events. JAMA. 2009;302(1):49-57	[Melander, Olle; Almgren, Peter; Hedblad, Bo; Berglund, Goeran; Engstrom, Gunnar; Persson, Margaretha; Smith, J. Gustav; Magnusson, Martin; Christensson, Anders] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Newton-Cheh, Christopher; Smith, J. Gustav] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas] BRAHMS AG, Res Dept, Hennigsdorf, Germany; [Pencina, Michael J.] Boston Univ, Dept Biostat, Boston, MA 02215 USA	Lund University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Thermo Fisher Scientific; Brahms AG; Boston University	Melander, O (corresponding author), Lund Univ, Clin Res Ctr, Dept Clin Sci, Malmo Univ Hosp, Entrance 72,Bldg 91,Floor 12, SE-20502 Malmo, Sweden.	olle.melander@med.lu.se; tjwang@partners.org	Magnusson, Martin/AAE-1185-2020	Magnusson, Martin/0000-0003-1710-5936; Pencina, Michael/0000-0001-5798-8855; Engstrom, Gunnar/0000-0002-8618-9152; Melander, Olle/0000-0002-2581-484X; Persson, Margaretha/0000-0001-8188-5792; Christensson, Anders/0000-0002-7328-8418; Wang, Thomas/0000-0003-4063-6508	Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Wallenberg Foundation; National Institutes of Health (NIH) [K23-HL-080025, R01-HL-086875, R01-HL083197, R01-DK-081572]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Burroughs Wellcome Fund Career Award for Medical Scientists; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL080025, R01HL083197, R01HL086875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Wallenberg Foundation(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Melander was supported by grants from the Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Pahlsson Research Foundation, the Crafoord foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation, the King Gustaf V and Queen Victoria Foundation, the Lennart Hanssons Memorial Fund, and the Wallenberg Foundation. Dr Newton-Cheh was supported by National Institutes of Health (NIH) grant K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. Dr Wang was supported by NIH grants R01-HL-086875, R01-HL083197, and R01-DK-081572 and by a grant from the American Heart Association.	Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Corson MA, 2008, AM J CARDIOL, V101, p41F, DOI 10.1016/j.amjcard.2008.04.018; D'Agostino RB, 2004, HDB STAT, P1; de Lemos JA, 2008, NEW ENGL J MED, V358, P2172, DOI 10.1056/NEJMe0801721; Di Serio F, 2005, CLIN CHEM LAB MED, V43, P1263, DOI 10.1515/CCLM.2005.217; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Garza CA, 2007, MAYO CLIN PROC, V82, P159; Gegenhuber A, 2007, J CARD FAIL, V13, P42, DOI 10.1016/j.cardfail.2006.09.004; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Khan SQ, 2008, J AM COLL CARDIOL, V51, P1857, DOI 10.1016/j.jacc.2008.01.041; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; *NAT BOARD HLTH WE, 2000, EV QUAL DIAGN AC MYO; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang TJ, 2007, JAMA-J AM MED ASSOC, V298, P176, DOI 10.1001/jama.298.2.176-a; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	40	435	465	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 1	2009	302	1					49	57		10.1001/jama.2009.943	http://dx.doi.org/10.1001/jama.2009.943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464GH	19567439	Bronze, Green Accepted			2022-12-28	WOS:000267492800021
J	Degos, L; Amalberti, R; Bacou, J; Carlet, J; Bruneau, C				Degos, Laurent; Amalberti, Rene; Bacou, Jean; Carlet, Jean; Bruneau, Charles			Breaking the mould in patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; PRIMARY-CARE; HEALTH; PROPHYLAXIS; ANESTHESIA; MORTALITY; SYSTEMS		[Degos, Laurent; Amalberti, Rene; Bacou, Jean; Carlet, Jean; Bruneau, Charles] HAS, F-93218 La Plaine St Denis, France		Amalberti, R (corresponding author), HAS, 2 Ave Stade France, F-93218 La Plaine St Denis, France.	r.amalberti@has-sante.fr						Auroy Y, 2009, ANESTHESIOLOGY, V110, P209, DOI 10.1097/ALN.0b013e318194caea; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Bellam S, 2008, ARCH INTERN MED, V168, P2404, DOI 10.1001/archinte.168.22.2404; Berry LL, 2003, ANN INTERN MED, V139, P568, DOI 10.7326/0003-4819-139-7-200310070-00009; Botney R, 2008, INT J RADIAT ONCOL, V71, pS182, DOI 10.1016/j.ijrobp.2007.05.095; Bramhall SR, 2001, WORLD J GASTROENTERO, V7, P602; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Cameron JI, 2008, STROKE, V39, P2637, DOI 10.1161/STROKEAHA.107.501064; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Donnan Geoffrey A, 2003, Adv Neurol, V92, P347; Dorner D., 1996, LOGIC FAILURE WHY TH; FABRY J, 2002, HELICS FINAL REPORT; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gusmano MK, 2006, HEALTH AFFAIR, V25, P510, DOI 10.1377/hlthaff.25.2.510; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lester H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2095; Lienhart A, 2006, ANESTHESIOLOGY, V105, P1087, DOI 10.1097/00000542-200612000-00008; Longo DR, 2005, JAMA-J AM MED ASSOC, V294, P2858, DOI 10.1001/jama.294.22.2858; Michel P, 2007, QUAL SAF HEALTH CARE, V16, P369, DOI 10.1136/qshc.2005.016964; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Olsson Lars-Eric, 2006, J Orthop Surg Res, V1, P3, DOI 10.1186/1749-799X-1-3; *ORG EC COOP DEV, 2006, HLTH CAR QUAL IND PR; OVRETVEIT J, 2005, WHICH INTERVENTIONS; Royal S, 2006, QUAL SAF HEALTH CARE, V15, P23, DOI 10.1136/qshc.2004.012153; Schiele F, 2005, EUR HEART J, V26, P873, DOI 10.1093/eurheartj/ehi107; Seiden SC, 2006, ARCH SURG-CHICAGO, V141, P931, DOI 10.1001/archsurg.141.9.931; Seliger SL, 2008, J AM SOC NEPHROL, V19, P2414, DOI 10.1681/ASN.2008010022; Smith PC, 2005, JAMA-J AM MED ASSOC, V293, P565, DOI 10.1001/jama.293.5.565; STUART B, 2008, DIS BURDEN INFLUENCE; VINCENT C, 2001, CLIN RISK MANAGEMENT; Vincent C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2426; Winterstein AG, 2002, ANN PHARMACOTHER, V36, P1238, DOI 10.1345/aph.1A225	35	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2009	339								b2585	10.1136/bmj.b2585	http://dx.doi.org/10.1136/bmj.b2585			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	466QV	19564180				2022-12-28	WOS:000267678300005
J	Lindvall, O; Hyun, I				Lindvall, Olle; Hyun, Insoo			Medical Innovation Versus Stem Cell Tourism	SCIENCE			English	Editorial Material								Stem cell tourism is criticized on grounds of consumer fraud, blatant lack of scientific justification, and patient safety. However, the issues are complex because they invoke questions concerning the limits of acceptable medical innovation and medical travel. Here we discuss these issues and articulate conditions under which "unproven" therapies may be offered to patients outside of regular clinical trials.	[Lindvall, Olle] Univ Lund Hosp, Wallenberg Neurosci Ctr, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden; [Lindvall, Olle] Univ Lund Hosp, Lund Stem Cell Ctr, SE-22184 Lund, Sweden; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Case Western Reserve University	Lindvall, O (corresponding author), Univ Lund Hosp, Wallenberg Neurosci Ctr, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se; insoo.hyun@case.edu						Agich GJ, 2001, J MED ETHICS, V27, P295; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Biffl WL, 2008, J AM COLL SURGEONS, V206, P1204, DOI 10.1016/j.jamcollsurg.2008.02.011; Cosgrove Delos M, 2008, Cleve Clin J Med, V75 Suppl 6, pS6; Cronin DC, 2001, NEW ENGL J MED, V344, P1633, DOI 10.1056/NEJM200105243442112; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; *ISSCR, GUID CLIN TRANSL STE; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Margo CE, 2001, J MED ETHICS, V27, P40, DOI 10.1136/jme.27.1.40; Morreim H, 2005, AM J BIOETHICS, V5, P42, DOI 10.1080/15265160590931205; Reitsma A. M., 2006, ETHICAL GUIDELINES I; BELMONT REPORT	12	98	102	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1664	1665		10.1126/science.1171749	http://dx.doi.org/10.1126/science.1171749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556497				2022-12-28	WOS:000267338200026
J	Parmar, MS				Parmar, Malvinder S.			Lesson of the week Diabetic muscle infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MELLITUS		[Parmar, Malvinder S.] Laurentian Univ, No Ontario Sch Med, Div Clin Sci, Sudbury, ON P3E 2C6, Canada; [Parmar, Malvinder S.] Lakehead Univ, Thunder Bay, ON P7B 5E1, Canada	Laurentian University; Northern Ontario School of Medicine; Lakehead University	Parmar, MS (corresponding author), Timmins & Dist Hosp, Med Off Bldg,Suite E,640 Ross Ave E, Timmins, ON P4N 8P2, Canada.	atbeat@ntl.sympatico.ca	Parmar, Malvinder S/Q-1532-2019	Parmar, Malvinder S/0000-0003-3182-0530				Aboulafia AJ, 1999, J BONE JOINT SURG BR, V81B, P323, DOI 10.1302/0301-620X.81B2.9205; Angervall L., 1965, DIABETOLOGIA, V1, P39; Gee R, 2003, CAN ASSOC RADIOL J, V54, P296; Grigoriadis E, 2000, J RHEUMATOL, V27, P1063; Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki.5002338; Jelinek JS, 1999, RADIOLOGY, V211, P241, DOI 10.1148/radiology.211.1.r99ap44241; Kapur S, 2005, JCR-J CLIN RHEUMATOL, V11, P8, DOI 10.1097/01.rhu.0000152142.33358.f1; LLINAS L, 2006, HOSP PHYS        JUL, P55; MacIsaac RJ, 2002, MED J AUSTRALIA, V177, P323, DOI 10.5694/j.1326-5377.2002.tb04793.x; Trujillo-Santos AJ, 2003, DIABETES CARE, V26, P211, DOI 10.2337/diacare.26.1.211	10	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2009	338								b2271	10.1136/bmj.b2271	http://dx.doi.org/10.1136/bmj.b2271			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UT	19542105				2022-12-28	WOS:000267216900001
J	Roy, M; Jordan, TH; Pederson, J				Roy, Mousumi; Jordan, Thomas H.; Pederson, Joel			Colorado Plateau magmatism and uplift by warming of heterogeneous lithosphere	NATURE			English	Article							UPPER-MANTLE BENEATH; ULTRAMAFIC INCLUSIONS; PERIDOTITE XENOLITHS; TRANSITION ZONE; KILBOURNE-HOLE; VOLCANIC FIELD; FARALLON SLAB; LOWER CRUSTAL; SAN-CARLOS; BEARING	The forces that drove rock uplift of the low-relief, high-elevation, tectonically stable Colorado Plateau are the subject of long-standing debate(1-5). While the adjacent Basin and Range province and Rio Grande rift province underwent Cenozoic shortening followed by extension(6), the plateau experienced similar to 2km of rock uplift(7) without significant internal deformation(2-4). Here we propose that warming of the thicker, more iron-depleted Colorado Plateau lithosphere(8-10) over 35-40 Myr following mid-Cenozoic removal of the Farallon plate from beneath North America(11,12) is the primary mechanism driving rock uplift. In our model, conductive re-equilibration not only explains the rock uplift of the plateau, but also provides a robust geodynamic interpretation of observed contrasts between the Colorado Plateau margins and the plateau interior. In particular, the model matches the encroachment of Cenozoic magmatism from the margins towards the plateau interior at rates of 3-6 km Myr(-1) and is consistent with lower seismic velocities(13) and more negative Bouguer gravity(14) at the margins than in the plateau interior. We suggest that warming of heterogeneous lithosphere is a powerful mechanism for driving epeirogenic rock uplift of the Colorado Plateau and may be of general importance in plate-interior settings.	[Roy, Mousumi] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Jordan, Thomas H.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Pederson, Joel] Utah State Univ, Dept Geol, Logan, UT 84322 USA	University of New Mexico; University of Southern California; Utah System of Higher Education; Utah State University	Roy, M (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	mroy@unm.edu	Jordan, Thomas/W-5579-2019; Roy, Mousumi/I-7141-2012	Jordan, Thomas/0000-0001-6511-148X; Roy, Mousumi/0000-0002-1639-2235	US National Science Foundation (NSF) [EAR0538022, EAR0408513]; Lamont-Doherty Earth Observatory	US National Science Foundation (NSF)(National Science Foundation (NSF)); Lamont-Doherty Earth Observatory	This work was supported by the US National Science Foundation (NSF) grants EAR0538022 and EAR0408513 and an NSF Advance Fellowship from the Lamont-Doherty Earth Observatory to M. R. The authors thank C. Jones for comments that significantly improved the model and manuscript and C. Callahan for compiling a database of xenolith compositions. The ideas in this paper benefited from our discussions with M. Hirschmann, L. Farmer, J. Selverstone and K. Condie.	ALIBERT C, 1994, J GEOPHYS RES-SOL EA, V99, P21605, DOI 10.1029/94JB01555; BALDRIDGE WS, 1979, J VOLCANOL GEOTH RES, V6, P319, DOI 10.1016/0377-0273(79)90009-X; BEARD BL, 1985, J GEOPHYS RES, V100, P4169; BERMAN SC, 1981, EARTH PLANET SC LETT, V56, P343; BIRD P, 1979, J GEOPHYS RES, V84, P7561, DOI 10.1029/JB084iB13p07561; BUSSOD GYA, 1983, LA9616T LOS AL NAT L; Condie KC, 2004, GEOCHIM COSMOCHIM AC, V68, P3919, DOI 10.1016/j.gca.2004.03.025; EHRENBERG SN, 1982, J PETROL, V23, P507, DOI 10.1093/petrology/23.4.507; English JM, 2003, EARTH PLANET SC LETT, V214, P619, DOI 10.1016/S0012-821X(03)00399-6; EVANS SH, 1979, AM MINERAL, V64, P249; FEIGENSON MD, 1986, GEOPHYS RES LETT, V13, P965, DOI 10.1029/GL013i009p00965; Flowers RM, 2008, GEOL SOC AM BULL, V120, P571, DOI 10.1130/B26231.1; FODOR RV, 1978, GEOL SOC AM BULL, V89, P451, DOI 10.1130/0016-7606(1978)89<451:UAMIAM>2.0.CO;2; FREY FA, 1978, EARTH PLANET SC LETT, V38, P129, DOI 10.1016/0012-821X(78)90130-9; GALER SJG, 1989, J PETROL, V30, P1033, DOI 10.1093/petrology/30.4.1033; Goes S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000049; Hervig R.L., 1986, EARTH ENV SCI T R SO, V77, P181, DOI DOI 10.1017/S026359330001083X; Humphreys E, 2003, INT GEOL REV, V45, P575, DOI 10.2747/0020-6814.45.7.575; HUMPHREYS ED, 1995, GEOLOGY, V23, P987, DOI 10.1130/0091-7613(1995)023<0987:PLROTF>2.3.CO;2; Hunt C.B., 1956, 279 US GEOL SURV; JOHNSON KE, 1990, THESIS NW U; Jones CH, 1996, NATURE, V381, P37, DOI 10.1038/381037a0; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Kelly RK, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000399; LAUGHLIN AW, 1971, GEOCHIM COSMOCHIM AC, V35, P107, DOI 10.1016/0016-7037(71)90108-6; Lee CT, 2001, NATURE, V411, P69, DOI 10.1038/35075048; Lenardic A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001859; LIPMAN PW, 1991, J GEOPHYS RES-SOLID, V96, P13193, DOI 10.1029/91JB01397; LOWRY AR, 1994, J GEOPHYS RES-SOL EA, V99, P20123, DOI 10.1029/94JB00960; McGuire AV, 1997, CONTRIB MINERAL PETR, V128, P52, DOI 10.1007/s004100050293; McMillan ME, 2006, GEOL SOC AM BULL, V118, P393, DOI 10.1130/B25712.1; McQuarrie N, 2000, GEOLOGY, V28, P91, DOI 10.1130/0091-7613(2000)028<0091:RTCP>2.3.CO;2; Menzies M, 2007, LITHOS, V96, P1, DOI 10.1016/j.lithos.2006.09.008; MORGAN P, 1985, J GEODYN, V3, P39, DOI 10.1016/0264-3707(85)90021-3; Moucha R, 2008, GEOLOGY, V36, P439, DOI 10.1130/G24577A.1; Pederson J.L., 2002, GSA TODAY, V12, P4, DOI DOI 10.1130/1052-5173(2002)012<0004:CPUAEE>2.0.C0;2; Peterson C. H. L. O. E., 2005, GEOLOGY CHAMA BASIN, V56, P105; Riter J. C. A., 1999, THESIS U TEXAS AUSTI; RODEN MF, 1993, J GEOPHYS RES-SOL EA, V98, P14091, DOI 10.1029/93JB00124; RODEN MF, 1988, GEOCHIM COSMOCHIM AC, V52, P461, DOI 10.1016/0016-7037(88)90101-9; Rosenbaum JM, 1996, GEOCHIM COSMOCHIM AC, V60, P3229, DOI 10.1016/0016-7037(96)00167-6; Roy M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC001008; Schutt DL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2003JB002950; Sine CR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033391; Smith D, 2005, J PETROL, V46, P1901, DOI 10.1093/petrology/egi042; SMITH D, 1976, EARTH PLANET SC LETT, V29, P107, DOI 10.1016/0012-821X(76)90031-5; Smith D, 2000, J GEOPHYS RES-SOL EA, V105, P16769, DOI 10.1029/2000JB900103; Smith D, 1997, CONTRIB MINERAL PETR, V127, P391, DOI 10.1007/s004100050288; Spencer JE, 1996, J GEOPHYS RES-SOL EA, V101, P13595, DOI 10.1029/96JB00818; TYNER GN, 1986, CONTRIB MINERAL PETR, V94, P63, DOI 10.1007/BF00371227; Wang K, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000209; WENRICH KJ, 1995, J GEOPHYS RES-SOL EA, V100, P10417, DOI 10.1029/95JB00373; Wernicke B.P., 1987, SPECIAL PUBLICATIONS, P203, DOI [DOI 10.1144/GSL, DOI 10.1144/GSL.SP.1987.028.01.15]; Wilshire H.G., 1988, 1443 US GEOL SURV; WILSHIRE HG, 1991, J PETROL, V32, P169, DOI 10.1093/petrology/32.1.169	55	115	116	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					978	U102		10.1038/nature08052	http://dx.doi.org/10.1038/nature08052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19536263				2022-12-28	WOS:000267063500041
J	Markel, H				Markel, Howard			Physician, Heal Thyself Arthur Miller, Henrik Ibsen, and the Enemies of the People	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Ctr Hist Med, 100 Simpson Inst,Box 0724,100 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						ATKINSON B, 1950, NY TIMES        1229, P14; BENTLEY E, 1971, 30 YEARS TREASON EXC, P789; KELLY W, 1973, WE HAVE MET ENEMY HE; Matos TC, 2008, MOD DRAMA, V51, P353, DOI 10.3138/md.51.3.353; McFarlane J, 1999, ENEMY PEOPLE WILD DU; MENCKEN HL, 1959, 11 PLAYS H IBSEN INT, pR7; MEYER M, 1971, BIOGRAPHY, P493; MILLER A, 1979, ENEMY PEOPLE ADAPTAT; MILLER A, 1950, NY TIMES        1224, P41; MILLER A, 1987, TIMEBENDS LIFE, P329; ZOLOTOW S, 1950, NY TIMES        0828, P13; ZOLOTOW S, 1951, NY TIMES        0126, P34	12	0	0	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 17	2009	301	23					2506	2507		10.1001/jama.2009.863	http://dx.doi.org/10.1001/jama.2009.863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	458MO	19531794				2022-12-28	WOS:000267028100032
J	Moloney, A				Moloney, Anastasia			Caring for Colombia's landmine survivors	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 13	2009	373	9680					2013	2014		10.1016/S0140-6736(09)61095-3	http://dx.doi.org/10.1016/S0140-6736(09)61095-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DJ	19533833	Bronze			2022-12-28	WOS:000267080100012
J	Raizen, MG				Raizen, Mark G.			Comprehensive Control of Atomic Motion	SCIENCE			English	Review							MAXWELL DEMON; NOBEL LECTURE	Recent work provides a general two-step solution to trapping and cooling of atoms. The first step is magnetic stopping of paramagnetic atoms with the use of a sequence of pulsed fields. The second step is single-photon cooling, which is based on a one-way barrier. This cooling method is related intimately to the historic problem of "Maxwell's Demon" and subsequent work by L. Szilard. Here, I discuss the connections between single-photon cooling and information entropy. I also outline future application of these methods to fundamental tests with hydrogen isotopes.	[Raizen, Mark G.] Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA; [Raizen, Mark G.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Raizen, MG (corresponding author), Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA.	raizen@physics.utexas.edu			NSF; Army Research Office; R. A. Welch Foundation; State of Texas Advanced Research Program; Sid W. Richardson Foundation	NSF(National Science Foundation (NSF)); Army Research Office; R. A. Welch Foundation(The Welch Foundation); State of Texas Advanced Research Program; Sid W. Richardson Foundation	This work is supported by NSF, the Army Research Office, the R. A. Welch Foundation, the State of Texas Advanced Research Program, and the Sid W. Richardson Foundation.	Amoretti M, 2002, NATURE, V419, P456, DOI 10.1038/nature01096; BANNERMAN ST, NEW J PHYS IN PRESS; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; Campbell WC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.213001; Dudarev AM, 2005, EUROPHYS LETT, V70, P761, DOI 10.1209/epl/i2005-10051-1; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213401; Hansch TW, 2006, REV MOD PHYS, V78, P1297, DOI 10.1103/RevModPhys.78.1297; Hall JL, 2006, REV MOD PHYS, V78, P1279, DOI 10.1103/RevModPhys.78.1279; Hancox CI, 2004, NATURE, V431, P281, DOI 10.1038/nature02938; HESS HF, 1987, PHYS REV LETT, V59, P672, DOI 10.1103/PhysRevLett.59.672; Hogan SD, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023412; Hogan SD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.143001; JERKINS M, PREPRINT; Leff H., 1990, MAXWELLS DEMON ENTRO; MAXWELL JC, 1871, THEORY HEAT, P308; Metcalf HJ., 1999, LASER COOLING TRAPPI; Narevicius E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/358; Narevicius E, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/096; Narevicius E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093003; Narevicius E, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.051401; Narevicius E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055046; Price GN, 2007, LASER PHYS, V17, P965, DOI 10.1134/S1054660X07070109; Price GN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093004; Raizen MG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053003; Ruschhaupt A, 2006, J PHYS B-AT MOL OPT, V39, P3833, DOI 10.1088/0953-4075/39/18/012; Ruschhaupt A, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.061604; Sawyer BC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253002; SCOLES G, 2000, ATOMIC MOL BEAM METH, V1; SCOLES G, 2000, ATOMIC MOL BEAM METH, V2; Scully R.J., 2007, DEMON QUANTUM; SKORDOS PA, 1992, AM J PHYS, V60, P876, DOI 10.1119/1.17007; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; Thorn JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240407; van de Meerakker SYT, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.023004; Vanhaecke N, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.031402; VEKSLER V, 1945, J PHYS USSR, V9, P153; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949	40	50	52	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1403	1406		10.1126/science.1171506	http://dx.doi.org/10.1126/science.1171506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520950				2022-12-28	WOS:000266878700033
J	Suchting, S; Eichmann, A				Suchting, Steven; Eichmann, Anne			Jagged Gives Endothelial Tip Cells an Edge	CELL			English	Editorial Material							NOTCH	Sprouting blood vessels have tip cells that lead and stalk cells that follow. Benedito et al. (2009) now show that competition between endothelial cells for the tip position is regulated by glycosylation of Notch receptors and by the opposing actions of the Notch ligands Jagged1 and Delta-like 4.	[Suchting, Steven; Eichmann, Anne] Coll France, INSERM, U833, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Eichmann, A (corresponding author), Coll France, INSERM, U833, F-75005 Paris, France.	anne.eichmann@college-de-france.fr						D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	8	25	28	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 12	2009	137	6					988	990		10.1016/j.cell.2009.05.024	http://dx.doi.org/10.1016/j.cell.2009.05.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524499	Bronze			2022-12-28	WOS:000266916400008
J	Woolf, CJ				Woolf, Clifford J.			Mu and Delta Opioid Receptors Diverge	CELL			English	Editorial Material							ANALGESIA; MORPHINE; TOLERANCE; MICE	Contrary to current models, Scherrer et al. (2009) provide evidence that mu and delta opioid receptors are not expressed by the same pain-sensing neurons. In mice, agonists for these receptors produce analgesia restricted to either noxious heat or mechanical stimuli, implying that the receptors act on distinct fibers to mediate completely different types of pain relief.	[Woolf, Clifford J.] Massachusetts Gen Hosp, Neural Plast Res Grp, Dept Anesthesia & Crit Care, Boston, MA 02129 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Neural Plast Res Grp, Dept Anesthesia & Crit Care, Boston, MA 02129 USA.	cwoolf@partners.org	Woolf, Clifford/A-9784-2010					Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Codd EE, 2009, J PHARMACOL EXP THER, V329, P241, DOI 10.1124/jpet.108.146969; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Wang HB, 2008, NEUROCHEM RES, V33, P2028, DOI 10.1007/s11064-008-9678-9; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	9	15	19	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 12	2009	137	6					987	988		10.1016/j.cell.2009.05.033	http://dx.doi.org/10.1016/j.cell.2009.05.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	457GL	19524498	Bronze			2022-12-28	WOS:000266916400007
J	Bolla, M; de Reijke, TM; Van Tienhoven, G; Van den Bergh, ACM; Oddens, J; Poortmans, PMP; Gez, E; Kil, P; Akdas, A; Soete, G; Kariakine, O; Van der Steen-Banasik, EM; Musat, E; Pierart, M; Mauer, ME; Collette, L				Bolla, Michel; de Reijke, Theodorus M.; Van Tienhoven, Geertjan; Van den Bergh, Alphonsus C. M.; Oddens, Jorg; Poortmans, Philip M. P.; Gez, Eliahu; Kil, Paul; Akdas, Atif; Soete, Guy; Kariakine, Oleg; Van der Steen-Banasik, Elsbietha M.; Musat, Elena; Pierart, Marianne; Mauer, Murielle E.; Collette, Laurence		EORTC Radiation Oncology Grp; Genito-Urinary Tract Canc Grp	Duration of Androgen Suppression in the Treatment of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; PHASE-III; DEPRIVATION THERAPY; RADIATION-THERAPY; RADIOTHERAPY; ADJUVANT; TRIAL; IRRADIATION; MANAGEMENT; OUTCOMES	BACKGROUND The combination of radiotherapy plus long-term medical suppression of androgens (>= 2 years) improves overall survival in patients with locally advanced prostate cancer. We compared the use of radiotherapy plus short-term androgen suppression with the use of radiotherapy plus long-term androgen suppression in the treatment of locally advanced prostate cancer. METHODS We randomly assigned patients with locally advanced prostate cancer who had received external-beam radiotherapy plus 6 months of androgen suppression to two groups, one to receive no further treatment (short-term suppression) and the other to receive 2.5 years of further treatment with a luteinizing hormone-releasing hormone agonist (long-term suppression). An outcome of noninferiority of short-term androgen suppression as compared with long-term suppression required a hazard ratio of more than 1.35 for overall survival, with a one-sided alpha level of 0.05. An interim analysis showed futility, and the results are presented with an adjusted one-sided alpha level of 0.0429. RESULTS A total of 1113 men were registered, of whom 970 were randomly assigned, 483 to short-term suppression and 487 to long-term suppression. After a median follow-up of 6.4 years, 132 patients in the short-term group and 98 in the long-term group had died; the number of deaths due to prostate cancer was 47 in the short-term group and 29 in the long-term group. The 5-year overall mortality for short-term and long-term suppression was 19.0% and 15.2%, respectively; the observed hazard ratio was 1.42 (upper 95.71% confidence limit, 1.79; P=0.65 for noninferiority). Adverse events in both groups included fatigue, diminished sexual function, and hot flushes. CONCLUSIONS The combination of radiotherapy plus 6 months of androgen suppression provides inferior survival as compared with radiotherapy plus 3 years of androgen suppression in the treatment of locally advanced prostate cancer. (ClinicalTrials.gov number, NCT00003026.)	[Bolla, Michel] CHR Univ Grenoble, Grenoble, France; [de Reijke, Theodorus M.; Van Tienhoven, Geertjan] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Van den Bergh, Alphonsus C. M.] Univ Groningen, Med Ctr, Groningen, Netherlands; [Oddens, Jorg] Jeroen Bosch Medictr, Shertogenbosch, Netherlands; [Poortmans, Philip M. P.] Doctor Bernard Verbeeten Inst, Tilburg, Netherlands; [Kil, Paul] Sint Elisabeth Ziekenhuis, Tilburg, Netherlands; [Van der Steen-Banasik, Elsbietha M.] Arnhems RadioTherapeut Inst, Arnhem, Netherlands; [Gez, Eliahu] Rambam Med Ctr, Haifa, Israel; [Akdas, Atif] Marmara Univ Hosp, Istanbul, Turkey	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Jeroen Bosch Ziekenhuis; Instituut Verbeeten; Elisabeth-TweeSteden Ziekenhuis (ETZ); Rambam Health Care Campus; Technion Israel Institute of Technology; Marmara University	Bolla, M (corresponding author), Grenoble Univ Hosp, Dept Radiat Oncol, BP 217, F-38043 Grenoble 9, France.	mbolla@chu-grenoble.fr	Magrini, Stefano Maria/C-7201-2011; Magrini, Stefano Maria/ABE-8820-2020; Poortmans, P.M.P./L-4581-2015	Magrini, Stefano Maria/0000-0002-4126-733X; Maldonado, Xavier/0000-0003-2045-4723; van Tienhoven, Geertjan/0000-0002-2516-2263; Collette, Laurence/0000-0003-2518-7281; Oddens, Jorg/0000-0002-6079-5613	Ipsen Pharma; French Ministry of Health [PHRC 1998]; Association pour la Recherche contre le Cancer (France); Vlaamse Liga tegen Kanker (the Netherlands)	Ipsen Pharma(Ipsen); French Ministry of Health; Association pour la Recherche contre le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); Vlaamse Liga tegen Kanker (the Netherlands)(Netherlands Government)	Supported by grants from Ipsen Pharma, the French Ministry of Health (PHRC 1998), Association pour la Recherche contre le Cancer (France), and Vlaamse Liga tegen Kanker (the Netherlands).	[Anonymous], 1993, 50 INT COMM RAD UN M; Bolla M, 2008, INT J RADIAT ONCOL, V72, pS30, DOI 10.1016/j.ijrobp.2008.06.834; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; BOLLA M, 2007, J CLIN ONCOL S, V25, pS238; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; COMNOUGUE C, 1993, STAT MED, V12, P1353, DOI 10.1002/sim.4780121407; COX DR, 1972, J R STAT SOC B, V34, P187; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; D'Amico AV, 2007, J CLIN ONCOL, V25, P8, DOI 10.1200/JCO.2006.08.8260; Fayers P, 2001, EORTC QLQ C30 SCORIN; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; HANKS GE, 1995, CANCER, V75, P1972, DOI 10.1002/1097-0142(19950401)75:7+<1972::AID-CNCR2820751636>3.0.CO;2-P; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Kouloulias VE, 2004, RADIOTHER ONCOL, V73, P11, DOI 10.1016/j.radonc.2004.08.005; KUMAR RJ, 2005, REV UROL S5, V57, pS37; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lubeck DP, 2001, UROLOGY, V58, P94, DOI 10.1016/S0090-4295(01)01250-X; *NAT CANC I CAN CL, 1994, EXP COMM TOX CRIT, P1; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Potosky AL, 2001, J CLIN ONCOL, V19, P3750, DOI 10.1200/JCO.2001.19.17.3750; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; *UN INT CONTR CANC, 1992, UICC TNM CLASS MAL T; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2	31	690	707	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2516	2527		10.1056/NEJMoa0810095	http://dx.doi.org/10.1056/NEJMoa0810095			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516032				2022-12-28	WOS:000266813800006
J	Duffy, MR; Chen, TH; Hancock, WT; Powers, AM; Kool, JL; Lanciotti, RS; Pretrick, M; Marfel, M; Holzbauer, S; Dubray, C; Guillaumot, L; Griggs, A; Bel, M; Lambert, AJ; Laven, J; Kosoy, O; Panella, A; Biggerstaff, BJ; Fischer, M; Hayes, EB				Duffy, Mark R.; Chen, Tai-Ho; Hancock, W. Thane; Powers, Ann M.; Kool, Jacob L.; Lanciotti, Robert S.; Pretrick, Moses; Marfel, Maria; Holzbauer, Stacey; Dubray, Christine; Guillaumot, Laurent; Griggs, Anne; Bel, Martin; Lambert, Amy J.; Laven, Janeen; Kosoy, Olga; Panella, Amanda; Biggerstaff, Brad J.; Fischer, Marc; Hayes, Edward B.			Zika Virus Outbreak on Yap Island, Federated States of Micronesia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEST-NILE-VIRUS; POLYMERASE-CHAIN-REACTION; ORIGINAL ANTIGENIC SIN; YELLOW-FEVER; INFECTIONS; NIGERIA; EPIDEMIC; ANTIBODIES; DENGUE; ENCEPHALITIS	BACKGROUND In 2007, physicians on Yap Island reported an outbreak of illness characterized by rash, conjunctivitis, and arthralgia. Although serum from some patients had IgM antibody against dengue virus, the illness seemed clinically distinct from previously detected dengue. Subsequent testing with the use of consensus primers detected Zika virus RNA in the serum of the patients but no dengue virus or other arboviral RNA. No previous outbreaks and only 14 cases of Zika virus disease have been previously documented. METHODS We obtained serum samples from patients and interviewed patients for information on clinical signs and symptoms. Zika virus disease was confirmed by a finding of Zika virus RNA or a specific neutralizing antibody response to Zika virus in the serum. Patients with IgM antibody against Zika virus who had a potentially cross-reactive neutralizing-antibody response were classified as having probable Zika virus disease. We conducted a household survey to estimate the proportion of Yap residents with IgM antibody against Zika virus and to identify possible mosquito vectors of Zika virus. RESULTS We identified 49 confirmed and 59 probable cases of Zika virus disease. The patients resided in 9 of the 10 municipalities on Yap. Rash, fever, arthralgia, and conjunctivitis were common symptoms. No hospitalizations, hemorrhagic manifestations, or deaths due to Zika virus were reported. We estimated that 73% (95% confidence interval, 68 to 77) of Yap residents 3 years of age or older had been recently infected with Zika virus. Aedes hensilli was the predominant mosquito species identified. CONCLUSIONS This outbreak of Zika virus illness in Micronesia represents transmission of Zika virus outside Africa and Asia. Although most patients had mild illness, clinicians and public health officials should be aware of the risk of further expansion of Zika virus transmission.	[Fischer, Marc] CDC, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Arboviral Dis Branch, Ft Collins, CO 80521 USA; [Chen, Tai-Ho; Holzbauer, Stacey; Dubray, Christine] CDC, Epidem Intelligence Serv Field Assignments Branch, Atlanta, GA 30333 USA; [Hancock, W. Thane; Bel, Martin] Waab Community Hlth Ctr, Yap, Micronesia; [Marfel, Maria] Yap State Dept Hlth Serv, Yap, Micronesia; [Kool, Jacob L.] WHO, Off S Pacific, Suva, Fiji; [Pretrick, Moses] Dept Hlth Educ & Social Affairs, Ponape, Micronesia; [Guillaumot, Laurent] Inst Pasteur, Noumea, New Caledonia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Fischer, M (corresponding author), CDC, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Arboviral Dis Branch, 3150 Rampart Rd, Ft Collins, CO 80521 USA.	mfischer@cdc.gov		Kool, Jacob/0000-0002-9605-2918				ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Durand Mark A, 2005, Pac Health Dialog, V12, P99; FAGBAMI A, 1977, TROP GEOGR MED, V29, P187; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147; Gubler D., 2001, FIELDS VIROLOGY, P1152; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x; JAN C, 1978, B SOC PATHOL EXOT, V71, P140; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nasci RS, 2002, J AM MOSQUITO CONTR, V18, P294; NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Sarndal CE, 2005, WILEY SER SURV METH, P1; Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630	36	1952	2088	20	3803	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2536	2543		10.1056/NEJMoa0805715	http://dx.doi.org/10.1056/NEJMoa0805715			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19516034				2022-12-28	WOS:000266813800008
J	Raff, GL; Chinnaiyan, KM; Share, DA; Goraya, TY; Kazerooni, EA; Moscucci, M; Gentry, RE; Abidov, A				Raff, Gilbert L.; Chinnaiyan, Kavitha M.; Share, David A.; Goraya, Tauqir Y.; Kazerooni, Ella A.; Moscucci, Mauro; Gentry, Ralph E.; Abidov, Aiden		Adv Cardiovasc Imaging Consortium	Radiation Dose From Cardiac Computed Tomography Before and After Implementation of Radiation Dose-Reduction Techniques	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY CT ANGIOGRAPHY; IMAGE QUALITY; DIAGNOSTIC PERFORMANCE; IMPACT; ASSOCIATION; EXPERIENCE; EXPOSURE; STENOSIS; ARTERIES; PROTOCOL	Context Cardiac computed tomography angiography (CCTA) can accurately diagnose coronary artery disease, but radiation dose from this procedure is of concern. Objectives To determine whether a collaborative radiation dose-reduction program would be associated with reduced radiation dose in patients undergoing CCTA in a statewide registry over a 1-year period and to define its effect on image quality. Design, Setting, and Patients A prospective, controlled, nonrandomized study conducted during a control period (July-August 2007), an intervention period ( September 2007-April 2008), and a follow-up period (May-June 2008) at 15 hospital imaging centers participating in the Advanced Cardiovascular Imaging Consortium in Michigan, which included small community hospitals and large academic medical centers. A total of 4995 sequential patients undergoing CCTA for suspected coronary artery disease were enrolled; 4862 patients (97.3%) had complete radiation data for analysis. Intervention A best-practice CCTA scan model was used, which included minimized scan range, heart rate reduction, electrocardiographic-gated tube current modulation, and reduced tube voltage in suitable patients. Main Outcome Measures Primary outcomes included dose-length product and effective radiation dose from all phases of the CCTA scan. Secondary outcomes were image quality assessed by a 4-point scale (1 indicated excellent; 2, good; 3, adequate; and 4, nondiagnostic) and frequency of diagnostic-quality scans. Results Compared with the control period, patients' estimated median radiation dose in the follow-up period was reduced by 53.3% (dose-length product decreased from 1493 mGy x cm [interquartile range {IQR}, 855-1823 mGy x cm] to 697 mGy x cm [IQR, 4071163 mGy x cm]; P<.001) and effective dose from 21 mSv (IQR, 12-26 mSv) to 10 mSv (IQR, 6-16 mSv) (P<.001). The greatest reduction in dose occurred at low-volume sites. There were no significant changes in median image quality assessment during the control period compared with the follow-up period (median image quality of 2 [ images rated as good] vs median image quality of 2; P=.13) or frequency of diagnostic-quality scans (554/620 patients [89%] vs 769/835 patients [92%]; P=.07). Conclusion Consistent application of currently available dose-reduction techniques was associated with a marked reduction in estimated radiation doses in a statewide CCTA registry, without impairment of image quality. Trial Registration clinicaltrials.gov Identifier: NCT00640068 JAMA.2009;301(22):2340-2348 www.jama.com	[Raff, Gilbert L.; Chinnaiyan, Kavitha M.; Gentry, Ralph E.; Abidov, Aiden] William Beaumont Hosp, Div Cardiol, Royal Oak, MI 48073 USA; [Share, David A.] Univ Michigan, Dept Family Med, Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Kazerooni, Ella A.] Univ Michigan, Dept Radiol, Sch Med, Ann Arbor, MI 48109 USA; [Moscucci, Mauro] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Goraya, Tauqir Y.] Michigan Heart PC, Ann Arbor, MI USA; [Moscucci, Mauro] Univ Miami, Miller Sch Med, Div Cardiovasc, Miami, FL 33136 USA	Beaumont Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Miami	Raff, GL (corresponding author), William Beaumont Hosp, Div Cardiol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	GRaff@beaumont.edu		Moscucci, Mauro/0000-0002-9123-4472; Al-Mallah, Mouaz/0000-0003-2348-0484	Blue Cross/Blue Shield of Michigan, Detroit	Blue Cross/Blue Shield of Michigan, Detroit	The Florine and J. Peter Ministrelli Endowed Chair in Cardiovascular Research supported Dr Raff's research salary. Blue Cross/Blue Shield of Michigan, Detroit, funded the study but no compensation was received for work on this project by author or nonauthor participants other than for research support.	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Achenbach S, 2010, J CARDIOVASC COMPUT, V4, P110, DOI 10.1016/j.jcct.2010.01.013; *AM COLL RAD, PRACT GUID STAND; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Bongartz G., 2004, EUROPEAN GUIDELINES; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Choi SI, 2009, INT J CARDIOVAS IMAG, V25, P23, DOI 10.1007/s10554-009-9443-4; Donnino R, 2009, AM J ROENTGENOL, V192, P1051, DOI 10.2214/AJR.08.1198; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Gerber TC, 2005, INVEST RADIOL, V40, P556, DOI 10.1097/01.rli.0000170628.69792.cb; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Goldstein JA, 2007, J AM COLL CARDIOL, V49, P863, DOI 10.1016/j.jacc.2006.08.064; Gopal A, 2009, INT J CARDIOL, V132, P435, DOI 10.1016/j.ijcard.2007.08.072; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Hein PA, 2009, EUR RADIOL, V19, P1148, DOI 10.1007/s00330-008-1255-8; Herzog BA, 2009, ACAD RADIOL, V16, P15, DOI 10.1016/j.acra.2008.06.010; Hirai N, 2008, RADIOLOGY, V248, P424, DOI 10.1148/radiol.2482071804; Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; *INT COMM RAD PROT, 2007 REC; Kaufmann PA, 2008, J AM COLL CARDIOL, V52, P1456, DOI 10.1016/j.jacc.2008.07.046; Lloyd-Jones, 2009, CIRCULATION, V119, pE182, DOI 10.1161/CIRCULATIONAHA.108.191898; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2008, RADIOLOGY, V249, P62, DOI 10.1148/radiol.2483071453; Morin RL, 2003, CIRCULATION, V107, P917, DOI 10.1161/01.CIR.0000048965.56529.C2; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; SHRIMPTON PC, APPENDIX C; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Takakuwa KM, 2009, AM J ROENTGENOL, V192, P866, DOI 10.2214/AJR.08.1758; Weigold Wm Guy, 2008, J Cardiovasc Comput Tomogr, V2, P220, DOI 10.1016/j.jcct.2008.06.003	37	179	192	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2340	2348		10.1001/jama.2009.814	http://dx.doi.org/10.1001/jama.2009.814			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509381	Bronze			2022-12-28	WOS:000266773400027
J	Zaridze, D; Brennan, P; Boreham, J; Boroda, A; Karpov, R; Lazarev, A; Konobeevskaya, I; Igitov, V; Terechova, T; Boffetta, P; Peto, R				Zaridze, David; Brennan, Paul; Boreham, Jillian; Boroda, Alex; Karpov, Rostislav; Lazarev, Alexander; Konobeevskaya, Irina; Igitov, Vladimir; Terechova, Tatiana; Boffetta, Paolo; Peto, Richard			Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48 557 adult deaths	LANCET			English	Article							BINGE DRINKING; RISK-FACTOR; CONSUMPTION; DISEASE; TRENDS; RATES	Background Alcohol is an important determinant of the high and fluctuating adult mortality rates in Russia, but cause-specific detail is lacking. Our case-control study investigated the effects of alcohol consumption on male and female cause-specific mortality. Methods In three Russian industrial cities with typical 1990s mortality patterns (Tomsk, Bamaul, Biysk), the addresses of 60416 residents who had died at ages 15-74 years in 1990-2001 were visited in 2001-05. Family members were present for 50 066 decedents; for 48 557 (97%), the family gave proxy information on the decedents' past alcohol use and on potentially confounding factors. Cases (n=43082) were those certified as dying from causes we judged beforehand might be substantially affected by alcohol or tobacco; controls were the other 5475 decedents. Case versus control relative risks (RRs; calculated as odds ratios by confounder-adjusted logistic regression) were calculated in ever-drinkers, defining the reference category by two criteria: usual weekly consumption always less than 0.5 half-litre bottles of vodka (or equivalent in total alcohol content) and maximum consumption of spirits in 1 day always less than 0.5 half-litre bottles. Other ever-drinkers were classified by usual weekly consumption into three categories: less than one, one to less than three, and three or more (mean 5.4 [SD 1.4]) bottles of vodka or equivalent. Findings In men, the three causes accounting for the most alcohol-associated deaths were accidents and violence (RR 5.94, 95% CI 5.35-6.59, in the highest consumption category), alcohol poisoning (21.68, 17.94-26.20), and acute ischaemic heart disease other than myocardial infarction (3.04, 2.73-3.39), which includes some misclassified alcohol poisoning. There were significant excesses of upper aerodigestive tract cancer (3.48, 2.84-4.27) and liver cancer (2.11, 1.64-2.70). Another five disease groups had RRs of more than 3.00 in the highest alcohol category: tuberculosis (4.14, 3.44-4.98), pneumonia (3.29, 2.83-3.83), liver disease (6.21, 5.16-7.47), pancreatic disease (6.69, 4.98-9.00), and ill-specified conditions (7.74, 6.48-9.25). Although drinking was less common in women, the RRs associated with it were generally more extreme. After correction for reporting errors, alcohol-associated excesses accounted for 52% of all study deaths at ages 15-54 years (men 8182 [59%] of 13968, women 1565 [33%] of 4751) and 18% of those at 55-74 years (men 3944 [22%] of 17 536, women 1493 [12%] of 12 302). Allowance for under-representation of extreme drinkers would further increase alcohol-associated proportions. Large fluctuations in mortality from these ten strongly alcohol-associated causes were the main determinants of recent fluctuations in overall mortality in the study region and in Russia as a whole. Interpretation Alcohol-attributable mortality varies by year; in several recent years, alcohol was a cause of more than half of all Russian deaths at ages 15-54 years. Alcohol accounts for most of the large fluctuations in Russian mortality, and alcohol and tobacco account for the large difference in adult mortality between Russia and western Europe. Funding UK Medical Research Council, Cancer Research UK, British Heart Foundation, International Agency for Research on Cancer, and European Commission Directorate-General for Research.	[Zaridze, David; Boroda, Alex] Russian Canc Res Ctr, Moscow, Russia; [Brennan, Paul; Boffetta, Paolo] Int Agcy Res Canc, F-69372 Lyon, France; [Boreham, Jillian; Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Boreham, Jillian; Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Karpov, Rostislav; Konobeevskaya, Irina] Tomsk Res Ctr, Inst Cardiol, Tomsk, Russia; [Lazarev, Alexander; Igitov, Vladimir; Terechova, Tatiana] Russian Canc Res Ctr, Altai Branch, Barnaul, Russia	World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; University of Oxford; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk	Zaridze, D (corresponding author), NN Blokhin Russian Canc Res Ctr, Dept Epidemiol & Prevent, Kashirskoye Shosse 24, Moscow 115478, Russia.	dgzaridze@crc.umos.ru; secretary@ctsu.ox.ac.uk	Zaridze, David/K-5605-2013; Boroda, Alexander/K-5129-2013; Konobeevskaya, Irina/J-4519-2017; Karpov, Rostislav S./F-5406-2014; Boffetta, Paolo/AAI-7767-2021	Konobeevskaya, Irina/0000-0002-4843-6642; Karpov, Rostislav S./0000-0002-7011-4316; Boffetta, Paolo/0000-0002-3811-2791; Karpov, Rostislav S./0000-0001-8578-6636; Boroda, Alexander/0000-0002-4196-6042	UK Medical Research Council; Cancer Research UK; British Heart Foundation; IARC collaborative research agreements [GEE/07/05, GEP/08/07]; EC D-G [ICA2-1999-10139, ICA2-CT-200110002]; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); IARC collaborative research agreements; EC D-G; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by CTSU core support from the UK Medical Research Council, Cancer Research UK, and British Heart Foundation, IARC collaborative research agreements (GEE/07/05 & GEP/08/07), and EC D-G for Research (grants ICA2-1999-10139 & ICA2-CT-200110002). We thank the field workers for their help and the interviewees for their cooperation.	ALLEN T, 2009, J NATL CANCER I, V101, P282; FERNANDEZSOLA J, 1995, ARCH INTERN MED, V155, P1649, DOI 10.1001/archinte.155.15.1649; Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x; IARC, 1988, IARC MON EV CARC RIS, V44; Kristiansen L, 2008, AM J EPIDEMIOL, V168, P932, DOI 10.1093/aje/kwn222; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Nemtsov AV, 2000, DRUG ALCOHOL DEPEN, V58, P133, DOI 10.1016/S0376-8716(99)00069-1; NICKOLSON A, 2005, B WORLD HEALTH ORGAN, V83, P812; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETO R, DEATHS SMOKING; Pridemore WA, 2002, AM J PUBLIC HEALTH, V92, P1921, DOI 10.2105/AJPH.92.12.1921; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2004, COMP QUANTIFICATION, P959; Rehm J, 2009, INT J EPIDEMIOL, V38, P154, DOI 10.1093/ije/dyn209; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Sher L, 2006, QJM-INT J MED, V99, P57, DOI 10.1093/qjmed/hci146; SHESTOV DB, 1993, CIRCULATION, V88, P846, DOI 10.1161/01.CIR.88.3.846; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov V, 2004, DEMRES, V2, P71; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; UN Population Division, 2005, WORLD POP PROSP; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; World Health Organization, 2007, WHO STAT INF SYST WH; World Health Organization, 1992, INT CLASS DIS REL HL; ZARIDZE D, 1986, IARC SCI PUBLICATION, V74; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	34	219	240	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2201	2214		10.1016/S0140-6736(09)61034-5	http://dx.doi.org/10.1016/S0140-6736(09)61034-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560602	Green Published, Bronze			2022-12-28	WOS:000267444500032
J	Morens, DM; Taubenberger, JK; Fauci, AS				Morens, David M.; Taubenberger, Jeffery K.; Fauci, Anthony S.			The Persistent Legacy of the 1918 Influenza Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morens, David M.; Taubenberger, Jeffery K.; Fauci, Anthony S.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Taubenberger, Jeffery/AAQ-1407-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000995, ZIAAI000996, ZIAAI001114, ZIAAI000986] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		GARTEN RJ, 2009, SCIENCE         0522; NOBLE GR, 1982, BASIC APPL INFLUENZA, P11; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179	5	230	248	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2009	361	3					225	229		10.1056/NEJMp0904819	http://dx.doi.org/10.1056/NEJMp0904819			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	470LL	19564629	Green Accepted			2022-12-28	WOS:000267976100001
J	Takeda, A; Baffi, JZ; Kleinman, ME; Cho, WG; Nozaki, M; Yamada, K; Kaneko, H; Albuquerque, RJC; Dridi, S; Saito, K; Raisler, BJ; Budd, SJ; Geisen, P; Munitz, A; Ambati, BK; Green, MG; Ishibashi, T; Wright, JD; Humbles, AA; Gerard, CJ; Ogura, Y; Pan, YZ; Smith, JR; Grisanti, S; Hartnett, ME; Rothenberg, ME; Ambati, J				Takeda, Atsunobu; Baffi, Judit Z.; Kleinman, Mark E.; Cho, Won Gil; Nozaki, Miho; Yamada, Kiyoshi; Kaneko, Hiroki; Albuquerque, Romulo J. C.; Dridi, Sami; Saito, Kuniharu; Raisler, Brian J.; Budd, Steven J.; Geisen, Pete; Munitz, Ariel; Ambati, Balamurali K.; Green, Martha G.; Ishibashi, Tatsuro; Wright, John D.; Humbles, Alison A.; Gerard, Craig J.; Ogura, Yuichiro; Pan, Yuzhen; Smith, Justine R.; Grisanti, Salvatore; Hartnett, M. Elizabeth; Rothenberg, Marc E.; Ambati, Jayakrishna			CCR3 is a target for age-related macular degeneration diagnosis and therapy	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; GENE-EXPRESSION PROFILES; MAST-CELLS; EOSINOPHIL RECRUITMENT; VISUAL FUNCTION; EOTAXIN; VEGF; MODEL	Age-related macular degeneration (AMD), a leading cause of blindness worldwide, is as prevalent as cancer in industrialized nations. Most blindness in AMD results from invasion of the retina by choroidal neovascularisation (CNV). Here we show that the eosinophil/mast cell chemokine receptor CCR3 is specifically expressed in choroidal neovascular endothelial cells in humans with AMD, and that despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV. Genetic or pharmacological targeting of CCR3 or eotaxins inhibited injury-induced CNV in mice. CNV suppression by CCR3 blockade was due to direct inhibition of endothelial cell proliferation, and was uncoupled from inflammation because it occurred in mice lacking eosinophils or mast cells, and was independent of macrophage and neutrophil recruitment. CCR3 blockade was more effective at reducing CNV than vascular endothelial growth factor A (VEGF-A) neutralization, which is in clinical use at present, and, unlike VEGF-A blockade, is not toxic to the mouse retina. In vivo imaging with CCR3-targeting quantum dots located spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion. CCR3 targeting might reduce vision loss due to AMD through early detection and therapeutic angioinhibition.	[Takeda, Atsunobu; Baffi, Judit Z.; Kleinman, Mark E.; Cho, Won Gil; Nozaki, Miho; Yamada, Kiyoshi; Kaneko, Hiroki; Albuquerque, Romulo J. C.; Dridi, Sami; Saito, Kuniharu; Raisler, Brian J.; Green, Martha G.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Albuquerque, Romulo J. C.; Raisler, Brian J.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Nozaki, Miho; Ogura, Yuichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678601, Japan; [Budd, Steven J.; Geisen, Pete; Wright, John D.; Hartnett, M. Elizabeth] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27599 USA; [Munitz, Ariel; Rothenberg, Marc E.] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Div Allergy & Immunol,Dept Pediat, Cincinnati, OH 45229 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Humbles, Alison A.; Gerard, Craig J.] Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02215 USA; [Pan, Yuzhen; Smith, Justine R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Grisanti, Salvatore] Med Univ Lubeck, Dept Ophthalmol, D-23538 Lubeck, Germany	University of Kentucky; University of Kentucky; Nagoya City University; University of North Carolina; University of North Carolina Chapel Hill; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Kyushu University; Harvard University; Boston Children's Hospital; Harvard Medical School; Oregon Health & Science University; University of Lubeck	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Smith, Justine/Y-9044-2019; Pan, YZ/GVS-2269-2022; Dridi, Sami/Q-8207-2019; Kaneko, Hiroki/O-7695-2015; Kaneko, Hiroki/AHA-2461-2022	Smith, Justine/0000-0002-4756-5493; Kaneko, Hiroki/0000-0003-0731-6465; Kaneko, Hiroki/0000-0003-0731-6465; Kleinman, Mark/0000-0001-8557-7949	National Eye Institute/National Institutes of Health (NIH) [EY015422, EY018350, EY018836]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Awar; Macula Vision Research Foundation; E. Matilda Ziegler Foundation for the Blind; American Health Assistance Foundation; NIH [EY017182, EY017950, AI45898, DK076893, AI039759, EY017011, EY015130, EY010572]; VA Merit Award and the Department of Defense; RPB Career Development Award; NATIONAL EYE INSTITUTE [R56EY015130, R01EY015422, R01EY017182, R01EY018836, R01EY015130, R01EY017011, R01EY017950, R01EY018350, P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI045898, R01AI039759, R01AI045898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893] Funding Source: NIH RePORTER	National Eye Institute/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Awar(Burroughs Wellcome Fund); Macula Vision Research Foundation; E. Matilda Ziegler Foundation for the Blind; American Health Assistance Foundation(BrightFocus Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award and the Department of Defense; RPB Career Development Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Acknowledgements We thank R. King, L. Xu, M. McConnell, K. Emerson, G. R. Pattison and M. Mingler for technical assistance, J. M. Farber for the gift of a reagent, R. J. Kryscio for statistical guidance, and B. Appukuttan, M. W. Fannon, R. Mohan, A. P. Pearson, A. M. Rao, G. S. Rao and K. Ambati for discussions. J. A. was supported by National Eye Institute/National Institutes of Health (NIH) grants EY015422, EY018350 and EY018836, the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, the Macula Vision Research Foundation, the E. Matilda Ziegler Foundation for the Blind, the Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, the Lew R. Wassermann Merit & Physician Scientist Awards ( Research to Prevent Blindness, RPB), the American Health Assistance Foundation, and a departmental unrestricted grant from the RPB. J. Z. B. was supported by the University of Kentucky Physician Scientist Award. M. E. K. was supported by the International Retinal Research Foundation Dr. Charles Kelman Postdoctoral Scholar Award. R. J. C. A. was supported by Fight for Sight. B. K. A. was supported by NIH grants EY017182 and EY017950, the VA Merit Award and the Department of Defense. M. E. R. was supported by NIH grants AI45898 and DK076893. C. J. G. was supported by NIH grant AI039759. M. E. H. was supported by NIH grants EY017011 and EY015130 and a RPB departmental unrestricted grant. J. R. S. was supported by NIH grant EY010572, and RPB Career Development Award and a departmental unrestricted grant.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Famiglietti EV, 2003, BRAIN RES, V969, P195, DOI 10.1016/S0006-8993(02)03766-6; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fulkerson PC, 2005, BLOOD, V106, P436, DOI 10.1182/blood-2005-02-0489; Fulkerson PC, 2004, P NATL ACAD SCI USA, V101, P1987, DOI 10.1073/pnas.0308544100; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Grossniklaus HE, 2005, ARCH OPHTHALMOL-CHIC, V123, P914; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; KITAMURA Y, 1978, BLOOD, V52, P447; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Puxeddu A, 2005, INT J BIOCHEM CELL B, V37, P628, DOI 10.1016/j.biocel.2004.09.001; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Sayanagi K, 2009, BRIT J OPHTHALMOL, V93, P622, DOI 10.1136/bjo.2008.151977; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; St Croix B, 2000, SCIENCE, V289, P1197; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Yodoi Y, 2009, AM J OPHTHALMOL, V147, P816, DOI 10.1016/j.ajo.2008.11.020; Zamora DO, 2007, MOL VIS, V13, P2058; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhou JH, 2005, MOL VIS, V11, P414	47	189	213	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2009	460	7252					225	U87		10.1038/nature08151	http://dx.doi.org/10.1038/nature08151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467RV	19525930	Green Accepted, Green Submitted			2022-12-28	WOS:000267761000034
J	Kohorn, EI				Kohorn, Ernest I.			Long-term outcome of placental-site trophoblastic tumours	LANCET			English	Editorial Material							DISEASE		Yale Univ, Sch Med, Dept Gynecol, New Haven, CT 06510 USA	Yale University	Kohorn, EI (corresponding author), Yale Univ, Sch Med, Dept Gynecol, New Haven, CT 06510 USA.	ernest.kohorn@yale.edu						BAGSHAWE KD, 1959, LANCET, V1, P653; Cole LA, 2006, GYNECOL ONCOL, V102, P160, DOI 10.1016/j.ygyno.2005.12.046; ECKSTEIN RP, 1982, HISTOPATHOLOGY, V6, P211, DOI 10.1111/j.1365-2559.1982.tb02716.x; HANCOCK EW, 2008, GESTATIONAL TROPHOBL; HERTZ R, 1959, ANN NY ACAD SCI, V80, P262, DOI 10.1111/j.1749-6632.1959.tb49206.x; Kohorn EI, 2001, INT J GYNECOL CANCER, V11, P73, DOI 10.1046/j.1525-1438.2001.011001073.x; Kohorn EI, 2009, GYNECOL ONCOL S1, V112, P85; KURMAN RJ, 1976, CANCER, V38, P1214, DOI 10.1002/1097-0142(197609)38:3<1214::AID-CNCR2820380323>3.0.CO;2-J; Schmid P, 2009, LANCET, V374, P48, DOI 10.1016/S0140-6736(09)60618-8; TWIGGS LB, 1981, GYNECOL ONCOL, V12, P238, DOI 10.1016/0090-8258(81)90153-0	10	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 4	2009	374	9683					6	7		10.1016/S0140-6736(09)60791-1	http://dx.doi.org/10.1016/S0140-6736(09)60791-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467UO	19552947				2022-12-28	WOS:000267768800006
J	Mauer, M; Zinman, B; Gardiner, R; Suissa, S; Sinaiko, A; Strand, T; Drummond, K; Donnelly, S; Goodyer, P; Gubler, MC; Klein, R				Mauer, Michael; Zinman, Bernard; Gardiner, Robert; Suissa, Samy; Sinaiko, Alan; Strand, Trudy; Drummond, Keith; Donnelly, Sandra; Goodyer, Paul; Gubler, Marie Claire; Klein, Ronald			Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; STRUCTURAL-FUNCTIONAL RELATIONSHIPS; ENDOTHELIAL GROWTH-FACTOR; BLOOD-PRESSURE CONTROL; EARLY NATURAL-HISTORY; CORTICAL INTERSTITIUM; RETINOPATHY; NEPHROPATHY; PROGRESSION; RECEPTOR	Background: Nephropathy and retinopathy remain important complications of type 1 diabetes. It is unclear whether their progression is slowed by early administration of drugs that block the renin-angiotensin system. Methods: We conducted a multicenter, controlled trial involving 285 normotensive patients with type 1 diabetes and normoalbuminuria and who were randomly assigned to receive losartan (100 mg daily), enalapril (20 mg daily), or placebo and followed for 5 years. The primary end point was a change in the fraction of glomerular volume occupied by mesangium in kidney-biopsy specimens. The retinopathy end point was a progression on a retinopathy severity scale of two steps or more. Intention-to-treat analysis was performed with the use of linear regression and logistic-regression models. Results: A total of 90% and 82% of patients had complete renal-biopsy and retinopathy data, respectively. Change in mesangial fractional volume per glomerulus over the 5-year period did not differ significantly between the placebo group (0.016 units) and the enalapril group (0.005, P=0.38) or the losartan group (0.026, P=0.26), nor were there significant treatment benefits for other biopsy-assessed renal structural variables. The 5-year cumulative incidence of microalbuminuria was 6% in the placebo group; the incidence was higher with losartan (17%, P=0.01 by the log-rank test) but not with enalapril (4%, P=0.96 by the log-rank test). As compared with placebo, the odds of retinopathy progression by two steps or more was reduced by 65% with enalapril (odds ratio, 0.35; 95% confidence interval [CI], 0.14 to 0.85) and by 70% with losartan (odds ratio, 0.30; 95% CI, 0.12 to 0.73), independently of changes in blood pressure. There were three biopsy-related serious adverse events that completely resolved. Chronic cough occurred in 12 patients receiving enalapril, 6 receiving losartan, and 4 receiving placebo. Conclusions: Early blockade of the renin-angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy. (ClinicalTrials.gov number, NCT00143949.) N Engl J Med 2009;361:40-51.	[Mauer, Michael; Sinaiko, Alan; Strand, Trudy] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Zinman, Bernard; Donnelly, Sandra] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gardiner, Robert] McGill Univ, Dept Med, Montreal, PQ, Canada; [Suissa, Samy] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Drummond, Keith; Goodyer, Paul] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Gubler, Marie Claire] Hop Necker Enfants Malad, Paris, France; [Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University; McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Wisconsin System; University of Wisconsin Madison	Mauer, M (corresponding author), Univ Minnesota, Dept Pediat, 420 Delaware St SE,MMC 491, Minneapolis, MN 55455 USA.	mauer002@umn.edu	Zinman, Bernard/E-7266-2013; Katavetin, Pisut/Q-4199-2019; Mauer, Michael/ABD-5415-2020	Katavetin, Pisut/0000-0001-8779-500X; Klein, Ronald/0000-0002-4428-6237; Gubler, Marie-Claire/0000-0002-3526-5661	National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [DK51975]; Merck; Canadian Institutes of Health Research (CIHR) [DCT 14281]; National Center for Research Resources of the NIH; University of Minnesota General Clinical Research Center (GCRC) [M01-RR00400]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051975] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Merck(Merck & Company); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Minnesota General Clinical Research Center (GCRC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by research grants from the National Institutes of Health (NIH), the National Institute of Diabetes and Digestive and Kidney Diseases (DK51975), Merck (in the United States), Merck Frosst (in Canada), and the Canadian Institutes of Health Research (CIHR) (DCT 14281). RASS was supported in part by a grant from the National Center for Research Resources of the NIH, to the University of Minnesota General Clinical Research Center (GCRC) (M01-RR00400). Dr. Suissa was the recipient of a Distinguished Investigator Award from the CIHR.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Andersen S, 2000, KIDNEY INT, V57, P601, DOI 10.1046/j.1523-1755.2000.t01-1-00880.x; [Anonymous], 1991, Ophthalmology, V98, P823; BILOUS R, 2009, ANN INTERN MED  0518; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Calvo G, 2004, KIDNEY INT, V66, pS126, DOI 10.1111/j.1523-1755.2004.09232.x; Caramori ML, 2003, DIABETES, V52, P1036, DOI 10.2337/diabetes.52.4.1036; Caramori ML, 2002, DIABETES, V51, P1294; Caramori ML, 2002, DIABETES, V51, P506, DOI 10.2337/diabetes.51.2.506; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Cordonnier DJ, 1999, J AM SOC NEPHROL, V10, P1253; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Fioretto P, 1998, DIABETOLOGIA, V41, P233, DOI 10.1007/s001250050895; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Ishizaki E, 2006, AM J OPHTHALMOL, V141, P129, DOI 10.1016/j.ajo.2005.08.066; Jerums G, 2008, AM J NEPHROL, V28, P614, DOI 10.1159/000117461; Katz A, 2002, KIDNEY INT, V61, P2058, DOI 10.1046/j.1523-1755.2002.00370.x; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P547; Klein R, 2006, OPHTHALMOLOGY, V113, P2231, DOI 10.1016/j.ophtha.2006.06.003; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; Mathiesen ER, 1999, BRIT MED J, V319, P24, DOI 10.1136/bmj.319.7201.24; Matthews DR, 2004, ARCH OPHTHALMOL-CHIC, V122, P1631; Mauer M, 2002, J RENIN-ANGIO-ALDO S, V3, P262, DOI 10.3317/jraas.2002.048; Mauer M, 2002, DIABETES, V51, P1572, DOI 10.2337/diabetes.51.5.1572; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; PARVING HH, 2008, DIABETIC NEPHROPATHY; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Perrin NESS, 2008, PEDIATR NEPHROL, V23, P947, DOI 10.1007/s00467-008-0745-x; ROSSING P, 1994, DIABETOLOGIA, V37, P511, DOI 10.1007/s001250050140; Rule, 2005, AM J KIDNEY DIS, V46, P170; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; STEFFES MW, 1992, DIABETES, V41, P679, DOI 10.2337/diabetes.41.6.679; STEFFES MW, 1983, LAB INVEST, V49, P82; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; WISEMAN MJ, 1987, NEPHRON, V46, P37, DOI 10.1159/000184293	43	525	551	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					40	51		10.1056/NEJMoa0808400	http://dx.doi.org/10.1056/NEJMoa0808400			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464UK	19571282	Green Accepted			2022-12-28	WOS:000267533100008
J	Dietrich, MO; Horvath, TL				Dietrich, Marcelo O.; Horvath, Tamas L.			GABA Keeps Up an Appetite for Life	CELL			English	Editorial Material							NEUROPEPTIDE-Y; NEURONS		[Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Program Cell & Neurobiol Energy Metab, Comparat Med Sect, Sch Med, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Programa Pos Grad Bioquim, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil	Yale University; Universidade Federal do Rio Grande do Sul	Horvath, TL (corresponding author), Yale Univ, Program Cell & Neurobiol Energy Metab, Comparat Med Sect, Sch Med, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221				Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pu SY, 1999, ENDOCRINOLOGY, V140, P933, DOI 10.1210/en.140.2.933; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415	9	17	17	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1177	1179		10.1016/j.cell.2009.06.002	http://dx.doi.org/10.1016/j.cell.2009.06.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563747	Bronze			2022-12-28	WOS:000267373400008
J	Friedman, WE				Friedman, William E.			Auxin at the Evo-Devo Intersection	SCIENCE			English	Editorial Material							FEMALE GAMETOPHYTE; FLOWERING PLANTS; ENDOSPERM		Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	ned@colorado.edu		Friedman, William Edward/0000-0003-0374-3427				Coen E, 2001, CR ACAD SCI III-VIE, V324, P523, DOI 10.1016/S0764-4469(01)01321-X; DOMELAS MC, 2005, J PLANT PHYSL, V17, P335; Friedman WE, 2003, EVOLUTION, V57, P216, DOI 10.1111/j.0014-3820.2003.tb00257.x; Friedman WE, 2008, INT J PLANT SCI, V169, P79, DOI 10.1086/523354; Friedman WE, 2009, AM J BOT, V96, P129, DOI 10.3732/ajb.0800311; GOETHE JW, 1790, VERSUCH METAMORPHASE; Kaplan DR, 2001, AM J BOT, V88, P1711, DOI 10.2307/3558347; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Williams JH, 2002, NATURE, V415, P522, DOI 10.1038/415522a	9	6	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1652	1653		10.1126/science.1176526	http://dx.doi.org/10.1126/science.1176526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556491				2022-12-28	WOS:000267338200020
J	Jura, N; Endres, NF; Engel, K; Deindl, S; Das, R; Lamers, MH; Wemmer, DE; Zhang, XW; Kuriyan, J				Jura, Natalia; Endres, Nicholas F.; Engel, Kate; Deindl, Sebastian; Das, Rahul; Lamers, Meindert H.; Wemmer, David E.; Zhang, Xuewu; Kuriyan, John			Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; KINASE DOMAIN; TRANSMEMBRANE DOMAIN; CRYSTAL-STRUCTURE; MUTATIONS; DIMERIZATION; INHIBITION; PHOSPHORYLATION; ASSOCIATION; INSIGHTS	Signaling by the epidermal growth factor receptor requires an allosteric interaction between the kinase domains of two receptors, whereby one activates the other. We show that the intracellular juxtamembrane segment of the receptor, known to potentiate kinase activity, is able to dimerize the kinase domains. The C-terminal half of the juxtamembrane segment latches the activated kinase domain to the activator, and the N-terminal half of this segment further potentiates dimerization, most likely by forming an antiparallel helical dimer that engages the transmembrane helices of the activated receptor. Our data are consistent with a mechanism in which the extracellular domains block the intrinsic ability of the transmembrane and cytoplasmic domains to dimerize and activate, with ligand binding releasing this block. The formation of the activating juxtamembrane latch is prevented by the C-terminal tails in a structure of an inactive kinase domain dimer, suggesting how alternative	[Jura, Natalia; Endres, Nicholas F.; Engel, Kate; Deindl, Sebastian; Das, Rahul; Lamers, Meindert H.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Jura, Natalia; Endres, Nicholas F.; Engel, Kate; Deindl, Sebastian; Das, Rahul; Lamers, Meindert H.; Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Lamers, Meindert/AGG-8911-2022; Das, Rahul/AAU-5123-2020	Lamers, Meindert/0000-0002-4205-1338; Das, Rahul/0000-0001-7841-8229; Deindl, Sebastian/0000-0001-6807-8654	NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1997, ONCOGENE, V14, P687, DOI 10.1038/sj.onc.1200873; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Choowongkomon K, 2005, J BIOL CHEM, V280, P24043, DOI 10.1074/jbc.M502698200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Frederick L, 2000, CANCER RES, V60, P1383; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; SOROKIN A, 1995, ONCOGENE, V11, P1531; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P3495, DOI 10.1016/j.bmcl.2008.05.024; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424	50	417	423	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1293	1307		10.1016/j.cell.2009.04.025	http://dx.doi.org/10.1016/j.cell.2009.04.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563760	Bronze, Green Accepted			2022-12-28	WOS:000267373400022
J	Rosen, JM; Jordan, CT				Rosen, Jeffrey M.; Jordan, Craig T.			The Increasing Complexity of the Cancer Stem Cell Paradigm	SCIENCE			English	Review							ACUTE MYELOID-LEUKEMIA; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; BREAST-CANCER; PROGENITOR CELLS; IDENTIFICATION; PROGRESSION; RESISTANCE; GROWTH; MODEL	The investigation and study of cancer stem cells (CSCs) have received enormous attention over the past 5 to 10 years but remain topics of considerable controversy. Opinions about the validity of the CSC hypothesis, the biological properties of CSCs, and the relevance of CSCs to cancer therapy differ widely. In the following commentary, we discuss the nature of the debate, the parameters by which CSCs can or cannot be defined, and the identification of new potential therapeutic targets elucidated by considering cancer as a problem in stem cell biology.	[Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jordan, Craig T.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	Baylor College of Medicine; University of Rochester	Rosen, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465	NIH [R37-CA16303, R01-CA122206]; NATIONAL CANCER INSTITUTE [R37CA016303, R01CA122206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by NIH grants R37-CA16303 and R01-CA122206.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	36	539	568	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 26	2009	324	5935					1670	1673		10.1126/science.1171837	http://dx.doi.org/10.1126/science.1171837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556499	Green Accepted			2022-12-28	WOS:000267338200028
J	Geim, AK				Geim, A. K.			Graphene: Status and Prospects	SCIENCE			English	Review							FILMS; MEMBRANES	Graphene is a wonder material with many superlatives to its name. It is the thinnest known material in the universe and the strongest ever measured. Its charge carriers exhibit giant intrinsic mobility, have zero effective mass, and can travel for micrometers without scattering at room temperature. Graphene can sustain current densities six orders of magnitude higher than that of copper, shows record thermal conductivity and stiffness, is impermeable to gases, and reconciles such conflicting qualities as brittleness and ductility. Electron transport in graphene is described by a Dirac-like equation, which allows the investigation of relativistic quantum phenomena in a benchtop experiment. This review analyzes recent trends in graphene research and applications, and attempts to identify future directions in which the field is likely to develop.	Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England	University of Manchester	Geim, AK (corresponding author), Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England.		Li, jiayu/H-3827-2014; Geim, Andre K/J-7888-2012	Li, jiayu/0000-0003-2639-213X; Geim, Andre K/0000-0003-2861-8331	Engineering and Physical Science Research Council (UK); U.S. Office of Naval Research; U.S. Air Force Office of Scientific Research; Engineering and Physical Sciences Research Council [EP/E051227/1, EP/D053331/1] Funding Source: researchfish; EPSRC [EP/E051227/1, EP/D053331/1] Funding Source: UKRI	Engineering and Physical Science Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); U.S. Office of Naval Research(Office of Naval Research); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the Engineering and Physical Science Research Council (UK), U.S. Office of Naval Research, and U.S. Air Force Office of Scientific Research. I thank I. Grigorieva, A. Castro Neto, A. MacDonald, P. Kim, and K. Novoselov for many helpful comments, and the staff of the Max Planck Institute for Solid-State Research for their hospitality during my sabbatical when this review was partially written.	Allor D, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.096009; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; BEENAKKER CWJ, 1991, SOLID STATE PHYS, P1; Booth TJ, 2008, NANO LETT, V8, P2442, DOI 10.1021/nl801412y; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Checkelsky JG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115434; Das Sarma S, 2007, SOLID STATE COMMUN, V143, P1, DOI 10.1016/j.ssc.2007.04.030; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gruneis A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.193401; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kim S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.176802; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Li YB, 2008, NAT MATER, V7, P966, DOI 10.1038/nmat2331; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; Meyer JC, 2007, NATURE, V446, P60, DOI 10.1038/nature05545; Min HK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.121401; Molitor F, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075426; Orlita M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267601; Oshima C, 1997, J PHYS-CONDENS MAT, V9, P1, DOI 10.1088/0953-8984/9/1/004; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Robinson JT, 2008, NANO LETT, V8, P3441, DOI 10.1021/nl8023092; Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967; Shytov AV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246802; Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401; Stander N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.026807; Standley B, 2008, NANO LETT, V8, P3345, DOI 10.1021/nl801774a; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198; Zheng Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3119215; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003	39	10635	11035	197	9732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1530	1534		10.1126/science.1158877	http://dx.doi.org/10.1126/science.1158877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19541989	Green Submitted			2022-12-28	WOS:000267130600034
J	Almond, SC; Summerton, N				Almond, Susanna C.; Summerton, Nick			Diagnosis in General Practice Test of time	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; NATURAL-HISTORY; COMMON SYMPTOMS; ACUTE COUGH; CHILDREN; PROGNOSIS; DISEASE		[Summerton, Nick] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford		susanna.almond@doctors.org.uk						Barsky AJ, 2002, ARCH INTERN MED, V162, P981, DOI 10.1001/archinte.162.9.981; Brueren MM, 1997, FAM PRACT, V14, P130, DOI 10.1093/fampra/14.2.130; Bytzer P, 2001, ANN INTERN MED, V134, P815, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00004; Cumberland P, 2003, EPIDEMIOL INFECT, V130, P453, DOI 10.1017/S0950268803008410; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Glasziou P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1312; Gray DP, 1998, BRIT J GEN PRACT, V48, P1816; HARGARTEN SW, 1992, AM J EMERG MED, V10, P290, DOI 10.1016/0735-6757(92)90004-H; Harnden A, 2006, BRIT MED J, V333, P174, DOI 10.1136/bmj.38870.655405.AE; Hay AD, 2003, FAM PRACT, V20, P696, DOI 10.1093/fampra/cmg613; Hay AD, 2002, BRIT J GEN PRACT, V52, P401; Heneghan C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b946; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; Mansson J, 1999, NEOPLASMA, V46, P93; Marjorie K, 2007, J FAM PRACTICE, V56, P147; Mayou R, 2002, BRIT MED J, V325, P265, DOI 10.1136/bmj.325.7358.265; McWhinney I, 1997, TXB FAMILY MED; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Nylenna M, 1987, Scand J Prim Health Care, V5, P117, DOI 10.3109/02813438709013987; Rea T D, 2001, J Am Board Fam Pract, V14, P234; Rose PW, 2005, LANCET, V366, P37, DOI 10.1016/S0140-6736(05)66709-8; SHEIKH A, 2006, COCHRANE DB SYST REV, V19; Sinclair MI, 2005, J GASTROEN HEPATOL, V20, P1685, DOI 10.1111/j.1440-1746.2005.04047.x; Streiner DL., 1995, HLTH MEASUREMENT SCA, V2nd ed.; Summerton N, 2003, FAM PRACT, V20, P340, DOI 10.1093/fampra/cmg317; Summerton N, 2007, PATIENT CTR DIAGNOSI; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Tubach F, 2004, J CLIN EPIDEMIOL, V57, P174, DOI 10.1016/S0895-4356(03)00257-9; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van der Waal JM, 2005, ARTHRIT RHEUM-ARTHR, V53, P920, DOI 10.1002/art.21581	34	18	18	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2009	338								b1878	10.1136/bmj.b1878	http://dx.doi.org/10.1136/bmj.b1878			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UP	19528115				2022-12-28	WOS:000267216500003
J	Peters, A				Peters, Anne			Clinic of Tears	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												momofmax@mac.com		Peters, Anne/0000-0003-0520-0776					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 10	2009	301	22					2309	2309		10.1001/jama.2009.806	http://dx.doi.org/10.1001/jama.2009.806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455OT	19509369				2022-12-28	WOS:000266773400001
J	Hill, DA; Ivanovich, J; Priest, JR; Gurnett, CA; Dehner, LP; Desruisseau, D; Jarzembowski, JA; Wikenheiser-Brokamp, KA; Suarez, BK; Whelan, AJ; Williams, G; Bracamontes, D; Messinger, Y; Goodfellow, PJ				Hill, D. Ashley; Ivanovich, Jennifer; Priest, John R.; Gurnett, Christina A.; Dehner, Louis P.; Desruisseau, David; Jarzembowski, Jason A.; Wikenheiser-Brokamp, Kathryn A.; Suarez, Brian K.; Whelan, Alison J.; Williams, Gretchen; Bracamontes, Dawn; Messinger, Yoav; Goodfellow, Paul J.			DICER1 Mutations in Familial Pleuropulmonary Blastoma	SCIENCE			English	Article									[Hill, D. Ashley; Ivanovich, Jennifer; Gurnett, Christina A.; Dehner, Louis P.; Desruisseau, David; Suarez, Brian K.; Whelan, Alison J.; Bracamontes, Dawn; Goodfellow, Paul J.] Washington Univ, Med Ctr, St Louis, MO 63110 USA; [Hill, D. Ashley; Priest, John R.; Williams, Gretchen; Bracamontes, Dawn; Messinger, Yoav] Childrens Hosp & Clin Minnesota, Int Pleuropulm Blastoma Registry, Minneapolis, MN 55404 USA; [Jarzembowski, Jason A.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Wikenheiser-Brokamp, Kathryn A.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Washington University (WUSTL); Children's Hospitals & Clinics of Minnesota; Children's Hospital of Wisconsin; Cincinnati Children's Hospital Medical Center	Hill, DA (corresponding author), Washington Univ, Med Ctr, St Louis, MO 63110 USA.	dashill@cnmc.org	Jarzembowski, Jason/L-6551-2019	Jarzembowski, Jason/0000-0002-9027-5686; Gurnett, Christina/0000-0001-9129-315X	NATIONAL CANCER INSTITUTE [R01CA143167, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109265] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA091842, P30 CA091842-07, P30 CA091842-08, R01 CA143167] Funding Source: Medline; NCRR NIH HHS [UL1 RR024992] Funding Source: Medline; NHLBI NIH HHS [R01 HL109265] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hill DA, 2008, AM J SURG PATHOL, V32, P282, DOI 10.1097/PAS.0b013e3181484165; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Priest JR, 1996, J PEDIATR-US, V128, P220, DOI 10.1016/S0022-3476(96)70393-1; Priest JR, 1997, CANCER, V80, P147, DOI 10.1002/(SICI)1097-0142(19970701)80:1<147::AID-CNCR20>3.3.CO;2-U	6	429	455	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					965	965		10.1126/science.1174334	http://dx.doi.org/10.1126/science.1174334			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19556464	Green Accepted			2022-12-28	WOS:000269242800037
J	Sox, HC; Greenfield, S				Sox, Harold C.; Greenfield, Sheldon			Comparative Effectiveness Research: A Report From the Institute of Medicine	ANNALS OF INTERNAL MEDICINE			English	Article									[Sox, Harold C.] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Calif Irvine, Irvine, CA USA	American College of Physicians; University of California System; University of California Irvine	Sox, HC (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.			Greenfield, Sheldon/0000-0003-4628-1998				Eden J, 2008, KNOWING WHAT WORKS H; Gawande A., 2009, NEW YORKER; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Ratner REJ, 2009, INITIAL NATL PRIORIT; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	6	381	389	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2009	151	3					203	W44		10.7326/0003-4819-151-3-200908040-00125	http://dx.doi.org/10.7326/0003-4819-151-3-200908040-00125			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483FM	19567618				2022-12-28	WOS:000268947800007
J	Gruber, J				Gruber, Jonathan			Health Care 2009: A Win-Win Approach to Financing Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gruber, J (corresponding author), MIT, Cambridge, MA 02139 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2009	361	1					4	5		10.1056/NEJMp0904855	http://dx.doi.org/10.1056/NEJMp0904855			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	464UK	19516024				2022-12-28	WOS:000267533100002
J	Johnston, LA				Johnston, Laura A.			Competitive Interactions Between Cells: Death, Growth, and Geography	SCIENCE			English	Review							RIBOSOMAL-RNA SYNTHESIS; GERMLINE STEM-CELLS; DROSOPHILA-OVARY; MYC; NICHE; TRANSCRIPTION; COMPARTMENTS; GENES; PROLIFERATION; APOPTOSIS	Competitive interactions between cells are the basis of many homeostatic processes in biology. Some of the best-described cases of competition between cells occur in Drosophila: cell competition, whereby somatic cells within a growing epithelium compete with one another for contribution to the adult, and stem cell competition, in which germline or somatic stem cells vie for residency in the niche. Both types of competition are conserved physiological processes, with much to tell us about how cellular neighborhoods influence cell behavior, and have importance to stem cell biology, regeneration and transplantation, and cancer.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Johnston, LA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	lj180@columbia.edu	Johnston, Laura A/ABC-1945-2021	JOHNSTON, LAURA A/0000-0001-9477-7897	NIH [HD42770, GMO78464]; Rita Allen Foundation; Uehara Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work on cell competition in our laboratory has been supported by NIH (grants HD42770 and GMO78464), the Rita Allen Foundation, and the Uehara Memorial Foundation.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Baker NE, 2008, CANCER RES, V68, P5505, DOI 10.1158/0008-5472.CAN-07-6348; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; Burke R, 1996, DEVELOPMENT, V122, P2261; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Krieser RJ, 2007, DEVELOPMENT, V134, P2407, DOI 10.1242/dev.02860; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MILLER BE, 1988, CANCER RES, V48, P5747; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; NETOSILVA R, 2009, ANNU REV CELL DEV BI, V25, P1139; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rhiner C, 2009, DEVELOPMENT, V136, P995, DOI 10.1242/dev.033340; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; SIMPSON P, 1981, J EMBRYOL EXP MORPH, V65, P77; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	39	156	159	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1679	1682		10.1126/science.1163862	http://dx.doi.org/10.1126/science.1163862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556501	Green Accepted			2022-12-28	WOS:000267338200030
J	Li, DH; Morris, JS; Liu, J; Hassan, MM; Day, RS; Bondy, ML; Abbruzzese, JL				Li, Donghui; Morris, Jeffrey S.; Liu, Jun; Hassan, Manal M.; Day, R. Sue; Bondy, Melissa L.; Abbruzzese, James L.			Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; ANTHROPOMETRIC FACTORS; OBESITY; POPULATION; OVERWEIGHT; ADIPOSITY; ADULTS; METAANALYSIS; ASSOCIATION; PREVALENCE	Context Obesity has been implicated as a risk factor for pancreatic cancer. Objective To demonstrate the association of excess body weight across an age cohort and the risk, age of onset, and overall survival of patients with pancreatic cancer. Design, Setting, and Participants A case-control study of 841 patients with pancreatic adenocarcinoma and 754 healthy individuals frequency matched by age, race, and sex. The study was conducted at a university cancer center in the United States from 2004 to 2008. Height and body weight histories were collected by personal interview starting at ages 14 to 19 years and over 10-year intervals progressing to the year prior to recruitment in the study. Main Outcome Measures The associations between patients' body mass index (BMI) and risk of pancreatic cancer, age at onset, and overall survival were examined by unconditional logistic regression, linear regression, and Cox proportional hazard regression models, respectively. Results Individuals who were overweight (a BMI of 25-29.9) from the ages of 14 to 39 years (highest odds ratio [OR], 1.67; 95% confidence interval [CI], 1.20-2.34) or obese (a BMI >= 30) from the ages of 20 to 49 years (highest OR, 2.58; 95% CI, 1.70-3.90) had an associated increased risk of pancreatic cancer, independent of diabetes status. The association was stronger in men (adjusted OR, 1.80; 95% CI, 1.45-2.23) by mean BMI from the ages of 14 to 59 years than in women (adjusted OR, 1.32; 95% CI, 1.02-1.70) and in ever smokers (adjusted OR, 1.75; 95% CI, 1.37-2.22) than in never smokers (adjusted OR, 1.46; 95% CI, 1.16-1.84). The population-attributable risk percentage of pancreatic cancer based on the mean BMI from the ages of 14 to 59 years was 10.3% for never smokers and 21.3% for ever smokers. Individuals who were overweight or obese from the ages of 20 to 49 years had an earlier onset of pancreatic cancer by 2 to 6 years (median age of onset was 64 years for patients with normal weight, 61 years for overweight patients [P = .02], and 59 years for obese patients [P < .001]). Compared with those with normal body weight and after adjusting for all clinical factors, individuals who were overweight or obese from the ages of 30 to 79 years or in the year prior to recruitment had reduced overall survival of pancreatic cancer regardless of disease stage and tumor resection status (overweight patients: hazard ratio, 1.26 [95% CI, 0.94-1.69], P = .04; obese patients: hazard ratio, 1.86 [95% CI, 1.35-2.56], P < .001). Conclusions Overweight or obesity during early adulthood was associated with a greater risk of pancreatic cancer and a younger age of disease onset. Obesity at an older age was associated with a lower overall survival in patients with pancreatic cancer. JAMA. 2009; 301(24):2553-2562	[Li, Donghui] Univ Texas MD Anderson Canc Ctr, Unit 426, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Bondy, Melissa L.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Morris, Jeffrey S.; Liu, Jun] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Day, R. Sue] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Li, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 426, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dli@mdanderson.org			National Institutes of Health [CA98380, CA101936]; M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA098380, P20CA101936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: This study was supported by National Institutes of Health grants CA98380 and CA101936 (SPORE P20) and a multidisciplinary research program grant from M. D. Anderson Cancer Center.	BEINE J, SOCIAL SECURITY DEAT; Berkey CS, 1998, OBES RES, V6, P187, DOI 10.1002/j.1550-8528.1998.tb00336.x; Berrington de Gonzalez A, 2003, BRIT J CANCER, V89, P519, DOI 10.1038/sj.bjc.6601140; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Dawood S, 2008, CLIN CANCER RES, V14, P1718, DOI 10.1158/1078-0432.CCR-07-1479; de Gonzalez AB, 2006, CANCER EPIDEM BIOMAR, V15, P879, DOI 10.1158/1055-9965.EPI-05-0800; Eberle CA, 2005, CANCER CAUSE CONTROL, V16, P1235, DOI 10.1007/s10552-005-0354-y; Efstathiou JA, 2007, CANCER-AM CANCER SOC, V110, P2691, DOI 10.1002/cncr.23093; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fleming JB, 2009, ARCH SURG-CHICAGO, V144, P216, DOI 10.1001/archsurg.2008.580; Fryzek JP, 2005, AM J EPIDEMIOL, V162, P222, DOI 10.1093/aje/kwi183; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Greene FL, 2002, AJCC CANC STAGING MA, P157, DOI DOI 10.1007/978-1-4757-3656-4_18; Hanley AJG, 2001, INT J CANCER, V94, P140, DOI 10.1002/ijc.1446; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hillier TA, 2001, DIABETES CARE, V24, P1522, DOI 10.2337/diacare.24.9.1522; James TA, 2004, CANCER-AM CANCER SOC, V101, P2722, DOI 10.1002/cncr.20700; Larsson SC, 2005, BRIT J CANCER, V93, P1310, DOI 10.1038/sj.bjc.6602868; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Lin YS, 2007, INT J CANCER, V120, P2665, DOI 10.1002/ijc.22614; McWilliams RR, 2006, CLIN GASTROENTEROL H, V4, P1143, DOI 10.1016/j.cgh.2006.05.029; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P2678, DOI 10.1158/1055-9965.EPI-05-0428; Nothlings U, 2007, CANCER CAUSE CONTROL, V18, P165, DOI 10.1007/s10552-006-0100-0; Noun R, 2008, J PANCREAS, V9, P468; Park SM, 2007, J CLIN ONCOL, V25, P4835, DOI 10.1200/JCO.2006.10.3416; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; SMITH DE, 1994, JAMA-J AM MED ASSOC, V271, P1747, DOI 10.1001/jama.271.22.1747; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stolzenberg-Solomon RZ, 2008, AM J EPIDEMIOL, V167, P586, DOI 10.1093/aje/kwm361; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593	39	299	314	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 24	2009	301	24					2553	2562		10.1001/jama.2009.886	http://dx.doi.org/10.1001/jama.2009.886			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461KU	19549972	Bronze, Green Accepted			2022-12-28	WOS:000267266500020
J	Coombes, R				Coombes, Rebecca			Public Health Vaccine disputes	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEASLES					rcoombes@bmjgroup.com						Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; [Anonymous], 2009, NY TIMES        0113; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; Grigg M. A., 2008, Morbidity and Mortality Weekly Report, V57, P893; Hobson-West P, 2007, SOCIOL HEALTH ILL, V29, P198, DOI 10.1111/j.1467-9566.2007.00544.x; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; 2008, JAMA, V299, P1660	9	7	7	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2009	338								b2435	10.1136/bmj.b2435	http://dx.doi.org/10.1136/bmj.b2435			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MK	19546136				2022-12-28	WOS:000267436100011
J	Leach, J				Leach, Joan			The art of medicine Valuing communication	LANCET			English	Editorial Material									Univ Queensland, Sch English Media Studies & Art Hist, Sci Commun Programme, St Lucia, Qld 4072, Australia	University of Queensland	Leach, J (corresponding author), Univ Queensland, Sch English Media Studies & Art Hist, Sci Commun Programme, St Lucia, Qld 4072, Australia.	j.leach@uq.edu.au	Leach, Joan/I-9667-2018	Leach, Joan/0000-0002-1376-5761				Fleck L., 1981, GENESIS DEV SCI FACT; FULLER S, 2005, INTELLECTUAL POSITIV; Peters John Durham, 1999, SPEAKING AIR HIST ID, P206; Segal JZ., 2005, HLTH RHETORIC MED	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2104	2105		10.1016/S0140-6736(09)61139-9	http://dx.doi.org/10.1016/S0140-6736(09)61139-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19551916				2022-12-28	WOS:000267229700014
J	Carron, PN; Yersin, B				Carron, Pierre-Nicolas; Yersin, Bertrand			Management of the effects of exposure to tear gas	BRITISH MEDICAL JOURNAL			English	Review							O-CHLOROBENZYLIDENE MALONONITRILE; CROWD-CONTROL AGENTS; CS SPRAY; SECONDARY CONTAMINATION; INCAPACITANT SPRAYS; OLEORESIN CAPSICUM; SHORT-TERM; DECONTAMINATION; PERSONNEL		[Carron, Pierre-Nicolas] CHU Vaudois, Univ Hosp Ctr, Serv Emergency Med, CH-1011 Lausanne, Switzerland; Univ Lausanne, CHUV, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Carron, PN (corresponding author), CHU Vaudois, Univ Hosp Ctr, Serv Emergency Med, CH-1011 Lausanne, Switzerland.	Pierre-Nicolas.Carron@chuv.ch						Anderson PJ, 1996, HUM EXP TOXICOL, V15, P461, DOI 10.1177/096032719601500601; Blaho K, 2000, BRIT MED J, V321, P46, DOI 10.1136/bmj.321.7252.46; Euripidou E, 2004, EMERG MED J, V21, P548, DOI 10.1136/emj.2003.012773; Hill AR, 2000, MEDICINE, V79, P234, DOI 10.1097/00005792-200007000-00004; Horton DK, 2005, ANN EMERG MED, V45, P655, DOI 10.1016/j.annemergmed.2005.01.031; Horton DK, 2003, AM J EMERG MED, V21, P199, DOI 10.1016/s0735-6757(02)42245-0; Kales SN, 2004, NEW ENGL J MED, V350, P800, DOI 10.1056/NEJMra030370; Karagama YG, 2003, J ROY SOC MED, V96, P172, DOI 10.1258/jrsm.96.4.172; Kluchinsky TA, 2002, AIHAJ, V63, P493, DOI 10.1080/15428110208984739; Martin C, 2001, J Emerg Nurs, V27, P478, DOI 10.1067/men.2001.118573; McMahon SB, 2006, CELL, V124, P1123, DOI 10.1016/j.cell.2006.03.006; MORRONE A, 2005, CLIN EXP DERMATOL, V230, P435; Olajos EJ, 2001, J APPL TOXICOL, V21, P355, DOI 10.1002/jat.767; *OMEGA FDN, 2000, CROWD CONTR TECHN AP; Recer GM, 2002, REGUL TOXICOL PHARM, V36, P1, DOI 10.1006/rtph.2002.1569; SANFORD JP, 1976, ANNU REV MED, V27, P421, DOI 10.1146/annurev.me.27.020176.002225; Smith J, 2002, J TRAUMA, V52, P595, DOI 10.1097/00005373-200203000-00036; Solomon I, 2003, ARCH TOXICOL, V77, P601, DOI 10.1007/s00204-003-0479-2; THORBURN KM, 1982, ARCH ENVIRON HEALTH, V37, P182, DOI 10.1080/00039896.1982.10667560; Vaca FE, 1996, AM J EMERG MED, V14, P402, DOI 10.1016/S0735-6757(96)90060-1; Viala B, 2005, J EMERG MED, V29, P5, DOI 10.1016/j.jemermed.2005.01.002; Vilke GM, 2007, POLICING, V30, P341, DOI 10.1108/13639510710778787; Watson K, 2005, CONTACT DERMATITIS, V53, P9, DOI 10.1111/j.0105-1873.2005.00585.x; Watson WA, 1996, ANN PHARMACOTHER, V30, P733, DOI 10.1177/106002809603000704; Weir E, 2001, CAN MED ASSOC J, V164, P1889; Wheeler H, 1998, LANCET, V352, P991, DOI 10.1016/S0140-6736(05)61550-4; WILLIAMS SR, 1994, ANN EMERG MED, V25, P713; Winslow JE, 2006, ANN EMERG MED, V48, pS51; ZEKRI AMB, 1995, BURNS, V21, P586, DOI 10.1016/0305-4179(95)00063-H; 1998, LANCET, V352, P159	30	13	13	1	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 19	2009	338								b2283	10.1136/bmj.b2283	http://dx.doi.org/10.1136/bmj.b2283			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460UT	19542106				2022-12-28	WOS:000267216900002
J	Johnson, BE; Johnson, CA				Johnson, Bruce E.; Johnson, Cynda Ann			Postmenopausal hormone therapy was cost-effective when started at age 50 years but not at 65 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Johnson, Bruce E.; Johnson, Cynda Ann] Virginia Tech, Caril Sch Med, Roanoke, VA USA	Virginia Polytechnic Institute & State University	Johnson, BE (corresponding author), Virginia Tech, Caril Sch Med, Roanoke, VA USA.							Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12								10.7326/0003-4819-150-12-200906160-02015	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528560				2022-12-28	WOS:000267164800027
J	Kahr, B; Freudenthal, J; Phillips, S; Kaminsky, W				Kahr, Bart; Freudenthal, John; Phillips, Shane; Kaminsky, Werner			Herapathite	SCIENCE			English	Article							POLYIODIDE; COMPLEXES; SPECTRA		[Kahr, Bart; Freudenthal, John; Phillips, Shane; Kaminsky, Werner] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kahr, B (corresponding author), New York Univ, Dept Chem, 100 Washington Sq E, New York, NY 10003 USA.	bart.kahr@nyu.edu	Kaminsky, Werner/AAF-2578-2020; Arteaga, Oriol/F-7465-2011	Kaminsky, Werner/0000-0002-9100-4909; Freudenthal, John/0000-0001-7521-8627	NSF; American Chemical Society Petroleum Research Fund; Division Of Chemistry [0845526] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); American Chemical Society Petroleum Research Fund(American Chemical Society); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank NSF and the donors to the American Chemical Society Petroleum Research Fund.	BERNAUER F, 1953, FORTSCHR MINERAL KRI, V19, P22; BREWSTER D, 1987, KALEIDOSCOPE; Haidinger W, 1853, PHILOS MAG, V6, P284; HERBSTEIN FH, 1985, ACTA CRYSTALLOGR C, V41, P510, DOI 10.1107/S0108270185004462; HOSHINO Y, 1943, J PHYS MATH SCO JPN, V17, P265; Jorgensen SM, 1877, J PRAKT CHEM, V15, P65; JORGENSEN SM, 1877, J PRAKT CHEM, V14, P215; LAND EH, 1951, J OPT SOC AM, V41, P957, DOI 10.1364/JOSA.41.000957; LAND EH, 1900, COLLOID CHEM, V6, P160; MAYER AM, 1896, AM J SCI, V151, P467; MIZUNO M, 1981, J PHYS CHEM-US, V85, P1789, DOI 10.1021/j150613a006; ROBIN MB, 1964, J CHEM PHYS, V40, P3369, DOI 10.1063/1.1725009; SMIRNOV LV, 1949, TEKHNOL I PISHCH PRO, V1, P112; STOKES GG, 1853, PHILOS MAG, V6, P393; STOKES GG, 1852, REP BRIT ASS, V22, P15; Svensson PH, 2003, CHEM REV, V103, P1649, DOI 10.1021/cr0204101; TOJIMA K, 1994, Patent No. 5368780; West CD, 1937, AM MINERAL, V22, P731; [No title captured]; [No title captured]	20	26	27	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1407	1407		10.1126/science.1173605	http://dx.doi.org/10.1126/science.1173605			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520951				2022-12-28	WOS:000266878700034
J	Severinghaus, JP; Beaudette, R; Headly, MA; Taylor, K; Brook, EJ				Severinghaus, Jeffrey P.; Beaudette, Ross; Headly, Melissa A.; Taylor, Kendrick; Brook, Edward J.			Oxygen-18 of O-2 Records the Impact of Abrupt Climate Change on the Terrestrial Biosphere	SCIENCE			English	Article							MILLENNIAL-SCALE; ASIAN MONSOON; ISOTOPIC COMPOSITION; ATMOSPHERIC OXYGEN; HIGH-RESOLUTION; GREENLAND; ANTARCTICA; FRACTIONATION; HOLOCENE; OCEAN	Photosynthesis and respiration occur widely on Earth's surface, and the O-18/O-16 ratio of the oxygen produced and consumed varies with climatic conditions. As a consequence, the history of climate is reflected in the deviation of the O-18/O-16 of air (delta O-18(atm)) from seawater delta O-18 (known as the Dole effect). We report variations in delta O-18(atm) over the past 60,000 years related to Heinrich and Dansgaard-Oeschger events, two modes of abrupt climate change observed during the last ice age. Correlations with cave records support the hypothesis that the Dole effect is primarily governed by the strength of the Asian and North African monsoons and confirm that widespread changes in low-latitude terrestrial rainfall accompanied abrupt climate change. The rapid delta O-18(atm) changes can also be used to synchronize ice records by providing global time markers.	[Severinghaus, Jeffrey P.; Beaudette, Ross; Headly, Melissa A.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Taylor, Kendrick] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Brook, Edward J.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Oregon State University	Severinghaus, JP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA.	jseveringhaus@ucsd.edu	Taylor, Kendrick/A-3469-2016; Brook, Edward/AAB-7807-2021	Taylor, Kendrick/0000-0001-8535-1261; Severinghaus, Jeffrey/0000-0001-8883-3119	NSF [NSF-OPP 04-40975, NSF-OPP 01-26057, NSF-OPP 95-26421]; Gary Comer Science and Education Foundation	NSF(National Science Foundation (NSF)); Gary Comer Science and Education Foundation	We thank B. Luz, L. Edwards, R. Keeling, M. Bender, A. Landais, K. Kawamura, C. Wunsch, G. Farquhar, and W. Broecker for helpful conversations. B. Cornuelle did the Fourier-series curve fitting. M. Henkart analyzed the tank of air from 1976 to test for anthropogenic change in the Dole effect. We thank J. Rhoades and the staff of the National Ice Core Laboratory for help in sampling the Siple Dome ice core. This work was supported by NSF-OPP 04-40975 (J.P.S), NSF-OPP 01-26057 (E.J.B), and the Gary Comer Science and Education Foundation, and recovery of the Siple Dome ice core was supported by NSF-OPP 95-26421 (K.T.).	Alley RB, 1999, GEOPH MONOG SERIES, V112, P385; Angert A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002056; Barkan E, 2005, RAPID COMMUN MASS SP, V19, P3737, DOI 10.1002/rcm.2250; BARKAN E, 2009, P GOLDSCHM 2009 DAV; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; Bender ML, 1999, GEOPH MONOG SERIES, V112, P149; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Brook EJ, 2005, QUATERNARY SCI REV, V24, P1333, DOI 10.1016/j.quascirev.2005.02.002; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Campen RK, 2003, GEOLOGY, V31, P231, DOI 10.1130/0091-7613(2003)031<0231:EOMCMW>2.0.CO;2; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; CHIANG JCH, 2008, GEOPHYS RES LETT, V35, DOI DOI 10.1029/2008GL033292; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; DENTON GH, 2006, PAGES NEWS, V14, P1416; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Farquhar GD, 2007, PLANT PHYSIOL, V143, P11, DOI 10.1104/pp.106.093278; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Hendricks MB, 2004, DEEP-SEA RES PT I, V51, P1541, DOI 10.1016/j.dsr.2004.06.006; Landais A, 2007, EARTH PLANET SC LETT, V258, P101, DOI 10.1016/j.epsl.2007.03.027; Malaize B, 1999, J GEOPHYS RES-ATMOS, V104, P14199, DOI 10.1029/1999JD900116; Masson V, 2000, GEOPHYS RES LETT, V27, P1747, DOI 10.1029/1999GL006070; Melieres MA, 1997, GEOPHYS RES LETT, V24, P1235, DOI 10.1029/97GL01025; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Petrenko VV, 2006, QUATERNARY SCI REV, V25, P865, DOI 10.1016/j.quascirev.2005.09.005; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; SOWERS T, 1989, J GEOPHYS RES-ATMOS, V94, P5137, DOI 10.1029/JD094iD04p05137; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wunsch C, 2003, QUATERNARY SCI REV, V22, P1631, DOI 10.1016/S0277-3791(03)00152-5	36	112	114	6	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1431	1434		10.1126/science.1169473	http://dx.doi.org/10.1126/science.1169473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520957				2022-12-28	WOS:000266878700042
J	Jiang, SY; Pi, DH; Heubeck, C; Frimmel, H; Liu, YP; Deng, HL; Ling, HF; Yang, JH				Jiang, Shao-Yong; Pi, Dao-Hui; Heubeck, Christoph; Frimmel, Hartwig; Liu, Yu-Ping; Deng, Hai-Lin; Ling, Hong-Fei; Yang, Jing-Hong			Early Cambrian ocean anoxia in South China	NATURE			English	Letter							MO-PGE-AU; BLACK SHALES; YANGTZE PLATFORM; BOUNDARY		[Jiang, Shao-Yong; Pi, Dao-Hui; Ling, Hong-Fei; Yang, Jing-Hong] Nanjing Univ, Dept Earth Sci, State Key Lab Mineral Deposits Res, Nanjing 210093, Peoples R China; [Jiang, Shao-Yong] Chinese Acad Geol Sci, Beijing SHRIMP Ctr, Beijing 100037, Peoples R China; [Pi, Dao-Hui; Liu, Yu-Ping; Deng, Hai-Lin] Chinese Acad Sci, State Key Lab Ore Deposit Geochem, Inst Geochem, Guiyang 550002, Peoples R China; [Heubeck, Christoph] Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; [Frimmel, Hartwig] Univ Wurzburg, Geodynam & Geomat Res Div, D-97074 Wurzburg, Germany	Nanjing University; Chinese Academy of Geological Sciences; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Free University of Berlin; University of Wurzburg	Jiang, SY (corresponding author), Nanjing Univ, Dept Earth Sci, State Key Lab Mineral Deposits Res, Nanjing 210093, Peoples R China.	shyjiang@nju.edu.cn	Deng, Hailin/B-4601-2011; Frimmel, Hartwig/R-3324-2019; Ling, Hong-Fei/K-3362-2016	Frimmel, Hartwig/0000-0003-3041-8208				Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; Jiang SY, 2007, PALAEOGEOGR PALAEOCL, V254, P217, DOI 10.1016/j.palaeo.2007.03.024; Jiang SY, 2006, MINER DEPOSITA, V41, P453, DOI 10.1007/s00126-006-0066-6; Li GX, 2007, PALAEOGEOGR PALAEOCL, V254, P229, DOI 10.1016/j.palaeo.2007.03.017; Steiner M, 2001, PALAEOGEOGR PALAEOCL, V169, P165, DOI 10.1016/S0031-0182(01)00208-5; Wille M, 2008, NATURE, V453, P767, DOI 10.1038/nature07072; Zhu MY, 2003, PROG NAT SCI-MATER, V13, P951, DOI 10.1080/10020070312331344710	7	128	155	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 11	2009	459	7248					E5	E6		10.1038/nature08048	http://dx.doi.org/10.1038/nature08048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19516284				2022-12-28	WOS:000267084500047
J	Harper, DM				Harper, Diane M.			Preliminary HPV vaccine results for women older than 25 years	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; PARTICLE VACCINE; YOUNG-WOMEN; INFECTION; EFFICACY; CANCER; TRIAL		[Harper, Diane M.] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Harper, Diane M.] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA; [Harper, Diane M.] Univ Missouri, Sch Med, Dept Bioinformat & Personalized Med, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA.	Diane.M.Harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8; EINSTEIN MH, 2009, 25 INT PAP C MAY 8 1; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; *US FDA, 2008, CLIN REV BIOL LIC AP; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7	12	12	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 6	2009	373	9679					1921	1922		10.1016/S0140-6736(09)61045-X	http://dx.doi.org/10.1016/S0140-6736(09)61045-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456GT	19501728				2022-12-28	WOS:000266832500004
J	Gilmore, I				Gilmore, Ian			Action needed to tackle a global drink problem	LANCET			English	Editorial Material							ALCOHOL		Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Gilmore, I (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	lan.Gilmore@rcplondon.ac.uk						Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Anderson P.Anderson, 2008, ALCOHOL EUROPE PUBLI; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; *DEP HLTH, 2001, STAT PUBL HLTH ANN R; Donaldson L, 2009, 150 YEARS ANN REPORT; *EUR COMM, CHART EST EUR ALC HL; HENKE D, 2009, GORDON BROWN REJECTS; MEIER P, 2009, INDEPENDENT REV EF B; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; *ROYAL COLL PHYS, PUBL HLTH PRIOR ALC; Royal College of Physicians, 1962, SMOK HLTH	12	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2009	373	9682					2174	2176		10.1016/S0140-6736(09)61169-7	http://dx.doi.org/10.1016/S0140-6736(09)61169-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19560584				2022-12-28	WOS:000267444500005
J	Henry, RR; Lincoff, AM; Mudaliar, S; Rabbia, M; Chognot, C; Herz, M				Henry, Robert R.; Lincoff, A. Michael; Mudaliar, Sunder; Rabbia, Minchael; Chognot, Cathy; Herz, Matthias			Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study	LANCET			English	Article							MYOCARDIAL-INFARCTION; GLUCOSE CONTROL; HEART-FAILURE; PIOGLITAZONE; ROSIGLITAZONE; EVENTS; OUTCOMES; GLIMEPIRIDE; PREVENTION; GUIDELINES	Background Despite previous reports of potential adverse cardiovascular effects of peroxisome proliferator-activated receptor (PPAR) agonists, the promise for PPAR agonists to positively affect risk of cardiovascular disease in patients with type 2 diabetes is of continued interest. The SYNCHRONY study aimed to establish the glucose-lowering and lipid-modifying effects, and safety profile, of the dual PPAR-a and PPAR-gamma agonist aleglitazar. Methods In this double-blind study, patients with type 2 diabetes (either drug-naive or pre-treated with <= two oral agents) were enrolled from 47 sites in seven countries. After a single-blind, 4-5-week placebo run-in period, 332 patients were randomised double-blind (via an interactive voice-response system) to 16 weeks' treatment with aleglitazar at once-daily doses of 50 mu g, 150 mu g, 300 mu g, or 600 mu g, or matching placebo (n=55 in each group), or to open-label pioglitazone 45 mg once daily (n=57) as a reference. The primary efficacy endpoint was the change in glycosylated haemoglobin (HbA(1c)) concentration from baseline to the end of treatment. Patients who received at least one dose of study drug and had at least one evaluable post-baseline HbA(1c) measurement were included in the efficacy analysis. This study is registered with ClinicalTrials.gov, number NCT00388518. Findings The efficacy analysis excluded six patients (n=0 in pioglitazone group; n=1 in each of placebo, 50 mu g, 150 mu g, and 600 mu g aleglitazar groups; and n=2 in 300 mu g aleglitazar group). Aleglitazar significantly reduced baseline HbA(1c) versus placebo in a dose-dependent manner, from -0.36% (95% CI 0.00 to -0.70, p=0.048) with 50 mu g to -1.35% (-0.99 to -1.70, p<0.0001) with 600 mu g. The trend of changes over time suggests that the maximum effect of aleglitazar on HbA(1c) concentration was not yet reached after 16 weeks of treatment. Oedema, haemodilution, and weight gain occurred in a dose-dependent manner. However, at aleglitazar doses less than 300 mu g, no patients had congestive heart failure, frequency of oedema was similar to placebo (one case at 50 mu g, two at 150 mu g, and three with placebo) and less than with pioglitazone (four cases), and bodyweight gain was less than with pioglitazone (0.52 kg at 150 mu g vs 1.06 kg). Interpretation The favourable balance in the safety and efficacy profile of aleglitazar represents encouraging short-term clinical data for this agent and provides good evidence to enter phase III investigation.	[Henry, Robert R.; Mudaliar, Sunder] Univ Calif San Diego, Dept Med, San Diego, CA 92161 USA; [Henry, Robert R.; Mudaliar, Sunder] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Lincoff, A. Michael] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Rabbia, Minchael] Hoffmann La Roche Inc, Nutley, NJ 07110 USA; [Chognot, Cathy; Herz, Matthias] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Cleveland Clinic Foundation; Roche Holding; Roche Holding	Henry, RR (corresponding author), Univ Calif San Diego, Dept Med, 3350 La Jolla Village Dr 111G, San Diego, CA 92161 USA.	rrhenry@ucsd.edu	Mudaliar, Sunder/R-2781-2019; Mudaliar, Sunder/N-5813-2019		F Hoffmann-La Roche AG; Hoffmann-La Roche	F Hoffmann-La Roche AG(Hoffmann-La Roche); Hoffmann-La Roche(Hoffmann-La Roche)	The SYNCHRONY study was funded by F Hoffmann-La Roche AG. Editorial assistance in preparation of the report for submission was provided by Steve Dobson of Evidence Scientific Solutions, Horsham, UK, and was funded by Hoffmann-La Roche.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; *GLAXOSMITHKLINE, 2008, AV ROS MAL TABL US P; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; *TAK PHARM AM, 2007, ACT PIOGL HYDR TABL; *WHO, 2008, 312 WHO	27	163	173	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2009	374	9684					126	135		10.1016/S0140-6736(09)60870-9	http://dx.doi.org/10.1016/S0140-6736(09)60870-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472EG	19515415				2022-12-28	WOS:000268111600030
J	Fong, PC; Boss, DS; Yap, TA; Tutt, A; Wu, PJ; Mergui-Roelvink, M; Mortimer, P; Swaisland, H; Lau, A; O'Connor, MJ; Ashworth, A; Carmichael, J; Kaye, SB; Schellens, JHM; de Bono, JS				Fong, Peter C.; Boss, David S.; Yap, Timothy A.; Tutt, Andrew; Wu, Peijun; Mergui-Roelvink, Marja; Mortimer, Peter; Swaisland, Helen; Lau, Alan; O'Connor, Mark J.; Ashworth, Alan; Carmichael, James; Kaye, Stan B.; Schellens, Jan H. M.; de Bono, Johann S.			Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNA-REPAIR DEFECT; PROSTATE-CANCER; CLINICAL-TRIALS; MUTANT-CELLS; GUIDELINES; MAINTENANCE; RESISTANCE; EVALUATE; DAMAGE	Background: The inhibition of poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) is a potential synthetic lethal therapeutic strategy for the treatment of cancers with specific DNA-repair defects, including those arising in carriers of a BRCA1 or BRCA2 mutation. We conducted a clinical evaluation in humans of olaparib (AZD2281), a novel, potent, orally active PARP inhibitor. Methods: This was a phase 1 trial that included the analysis of pharmacokinetic and pharmacodynamic characteristics of olaparib. Selection was aimed at having a study population enriched in carriers of a BRCA1 or BRCA2 mutation. Results: We enrolled and treated 60 patients; 22 were carriers of a BRCA1 or BRCA2 mutation and 1 had a strong family history of BRCA-associated cancer but declined to undergo mutational testing. The olaparib dose and schedule were increased from 10 mg daily for 2 of every 3 weeks to 600 mg twice daily continuously. Reversible dose-limiting toxicity was seen in one of eight patients receiving 400 mg twice daily (grade 3 mood alteration and fatigue) and two of five patients receiving 600 mg twice daily (grade 4 thrombocytopenia and grade 3 somnolence). This led us to enroll another cohort, consisting only of carriers of a BRCA1 or BRCA2 mutation, to receive olaparib at a dose of 200 mg twice daily. Other adverse effects included mild gastrointestinal symptoms. There was no obvious increase in adverse effects seen in the mutation carriers. Pharmacokinetic data indicated rapid absorption and elimination; pharmacodynamic studies confirmed PARP inhibition in surrogate samples (of peripheral-blood mononuclear cells and plucked eyebrow-hair follicles) and tumor tissue. Objective antitumor activity was reported only in mutation carriers, all of whom had ovarian, breast, or prostate cancer and had received multiple treatment regimens. Conclusions: Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer associated with the BRCA1 or BRCA2 mutation. (ClinicalTrials.gov number, NCT00516373.) N Engl J Med 2009;361:123-34.	[de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Sutton SM2 5PT, Surrey, England; [Tutt, Andrew; Wu, Peijun; Ashworth, Alan] Kings Coll London, Inst Canc Res, Breakthrough Breast Canc Res Ctr, London WC2R 2LS, England; [Tutt, Andrew; Wu, Peijun] Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England; [Wu, Peijun; Lau, Alan; O'Connor, Mark J.; Carmichael, James] KuDOS Pharmaceut, Cambridge, England; [Swaisland, Helen] AstraZeneca, Macclesfield, Cheshire, England; [Boss, David S.; Mergui-Roelvink, Marja; Schellens, Jan H. M.] Netherlands Canc Inst, Amsterdam, Netherlands; [Schellens, Jan H. M.] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; King's College London; University of London; King's College London; AstraZeneca; AstraZeneca; Netherlands Cancer Institute; Utrecht University	de Bono, JS (corresponding author), Royal Marsden NHS Fdn Trust, Inst Canc Res, Drug Dev Unit, Downs Rd, Sutton SM2 5PT, Surrey, England.	johann.de-bono@icr.ac.uk	Yap, Timothy/AAV-3573-2020	Tutt, Andrew/0000-0001-8715-2901; Lau, Alan/0000-0003-1055-9812; de Bono, Johann S/0000-0002-2034-595X	Cancer Research UK [A8363] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Breast Cancer Now		Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Brody LC, 2005, NEW ENGL J MED, V353, P949, DOI 10.1056/NEJMcibr052331; Bryant HE, 2007, NATURE, V447, P346, DOI 10.1038/nature05789; Bubley, 2007, J CLIN ONCOL, V25, P1154, DOI 10.1200/JCO.2007.11.1963; Bubley, 2000, J CLIN ONCOL, V18, P2644; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; Camidge DR, 2005, BRIT J CANCER, V92, P1837, DOI 10.1038/sj.bjc.6602558; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jackson SP, 2001, BIOCHEM SOC T, V29, P655, DOI 10.1042/BST0290655; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Rustin GJS, 2004, JNCI-J NATL CANCER I, V96, P487, DOI 10.1093/jnci/djh081; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Simon R, 1997, JNCI-J NATL CANCER I, V89, P1138, DOI 10.1093/jnci/89.15.1138; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Venkitaraman AR, 2003, NEW ENGL J MED, V348, P1917, DOI 10.1056/NEJMcibr023150; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284	33	2702	2775	11	349	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					123	134		10.1056/NEJMoa0900212	http://dx.doi.org/10.1056/NEJMoa0900212			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467OS	19553641				2022-12-28	WOS:000267748900005
J	Moustafa, A; Beszteri, B; Maier, UG; Bowler, C; Valentin, K; Bhattacharya, D				Moustafa, Ahmed; Beszteri, Bank; Maier, Uwe G.; Bowler, Chris; Valentin, Klaus; Bhattacharya, Debashish			Genomic Footprints of a Cryptic Plastid Endosymbiosis in Diatoms	SCIENCE			English	Article							NUCLEAR GENOMES; PHYLOGENY; REVEALS; GENES; CYANOBACTERIAL; ORIGINS; ENZYMES; PROTEIN; ALGAE	Diatoms and other chromalveolates are among the dominant phytoplankters in the world's oceans. Endosymbiosis was essential to the success of chromalveolates, and it appears that the ancestral plastid in this group had a red algal origin via an ancient secondary endosymbiosis. However, recent analyses have turned up a handful of nuclear genes in chromalveolates that are of green algal derivation. Using a genome-wide approach to estimate the "green" contribution to diatoms, we identified >1700 green gene transfers, constituting 16% of the diatom nuclear coding potential. These genes were probably introduced into diatoms and other chromalveolates from a cryptic endosymbiont related to prasinophyte-like green algae. Chromalveolates appear to have recruited genes from the two major existing algal groups to forge a highly successful, species-rich protist lineage.	[Moustafa, Ahmed; Bhattacharya, Debashish] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Beszteri, Bank; Valentin, Klaus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Maier, Uwe G.] Univ Marburg, Marburg, Germany; [Bowler, Chris] Ecole Normale Super, Dept Biol, CNRS, UMR8186, F-75005 Paris, France; [Bowler, Chris] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Bhattacharya, Debashish] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; [Bhattacharya, Debashish] Univ Iowa, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA	University of Iowa; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli; University of Iowa; University of Iowa	Bhattacharya, D (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	debashi-bhattacharya@uiowa.edu	Moustafa, Ahmed/AAZ-3991-2020; Beszteri, Bank M/D-1961-2010; Valentin, Klaus/G-5862-2014; Bowler, Chris/AAC-6256-2019; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Beszteri, Bank M/0000-0002-6852-1588; Valentin, Klaus/0000-0001-7401-9423; Moustafa, Ahmed/0000-0002-0111-3555; Bowler, Chris/0000-0003-3835-6187	NSF; NIH [EF 04-31117, R01ES013679]; Institutional National Research Service Award [T 32 GM98629]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098629] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DB was supported by grants from NSF and NIH EF 04-31117 and R01ES013679, respectively. AM was supported by an Institutional National Research Service Award T 32 GM98629 from NIH. UGM thanks the Deutsche Forschungsgemeinschaft grant SFB-TR1 for support. We thank T Mock for providing tiling array generated diatom transcripts and JE DeReus at the High Performance Computing Facility at the University of Iowa for technical support.	Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dismukes GC, 2008, CURR OPIN BIOTECH, V19, P235, DOI 10.1016/j.copbio.2008.05.007; Falkowski P, 2007, EVOLUTION PRIMARY PR; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; HAUBER MM, 1994, BOT ACTA, V107, P383; Ishida K, 2002, P NATL ACAD SCI USA, V99, P9294, DOI 10.1073/pnas.142091799; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; Petersen J, 2006, J MOL EVOL, V62, P143, DOI 10.1007/s00239-004-0305-3; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Reyes-Prieto A, 2007, MOL PHYLOGENET EVOL, V45, P384, DOI 10.1016/j.ympev.2007.02.026; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Round F. E., 1990, DIATOMS BIOL MORPHOL; STEINKOTTER J, 1994, J PHYCOL, V30, P340, DOI 10.1111/j.0022-3646.1994.00340.x; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Thierstein HR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P455; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	24	298	307	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1724	1726		10.1126/science.1172983	http://dx.doi.org/10.1126/science.1172983			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19556510	Green Published			2022-12-28	WOS:000267338200044
J	Rauzi, M; Lecuit, T				Rauzi, Matteo; Lecuit, Thomas			Closing in on Mechanisms of Tissue Morphogenesis	CELL			English	Editorial Material							DORSAL CLOSURE; CELL-SHAPE; FORCES; DROSOPHILA; NETWORK		[Rauzi, Matteo; Lecuit, Thomas] Univ Aix Marseille 2, IBDML, CNRS, UMR6216, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, IBDML, CNRS, UMR6216, Campus Luminy Case 907, F-13288 Marseille 09, France.	lecuit@ibdm.univ-mrs.fr		Rauzi, Matteo/0000-0002-6313-0668				Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798	9	9	9	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 26	2009	137	7					1183	1185		10.1016/j.cell.2009.06.009	http://dx.doi.org/10.1016/j.cell.2009.06.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RM	19563750	Bronze			2022-12-28	WOS:000267373400011
J	Pichevin, LE; Reynolds, BC; Ganeshram, RS; Cacho, I; Pena, L; Keefe, K; Ellam, RM				Pichevin, L. E.; Reynolds, B. C.; Ganeshram, R. S.; Cacho, I.; Pena, L.; Keefe, K.; Ellam, R. M.			Enhanced carbon pump inferred from relaxation of nutrient limitation in the glacial ocean	NATURE			English	Article							EASTERN EQUATORIAL PACIFIC; ICP-MS; FLUX; FRACTIONATION; TEMPERATURE; NITROGEN; RATIOS; OPAL	The modern Eastern Equatorial Pacific (EEP) Ocean is a large oceanic source of carbon to the atmosphere(1). Primary productivity over large areas of the EEP is limited by silicic acid and iron availability, and because of this constraint the organic carbon export to the deep ocean is unable to compensate for the outgassing of carbon dioxide that occurs through upwelling of deep waters. It has been suggested that the delivery of dust-borne iron to the glacial ocean(2,3) could have increased primary productivity and enhanced deep-sea carbon export in this region, lowering atmospheric carbon dioxide concentrations during glacial periods. Such a role for the EEP is supported by higher organic carbon burial rates documented in underlying glacial sediments(4,5), but lower opal accumulation rates cast doubts on the importance of the EEP as an oceanic region for significant glacial carbon dioxide drawdown(6,7). Here we present a new silicon isotope record that suggests the paradoxical decline in opal accumulation rate in the glacial EEP results from a decrease in the silicon to carbon uptake ratio of diatoms under conditions of increased iron availability from enhanced dust input. Consequently, our study supports the idea of an invigorated biological pump in this region during the last glacial period that could have contributed to glacial carbon dioxide drawdown. Additionally, using evidence from silicon and nitrogen isotope changes, we infer that, in contrast to the modern situation, the biological productivity in this region is not constrained by the availability of iron, silicon and nitrogen during the glacial period. We hypothesize that an invigorated biological carbon dioxide pump constrained perhaps only by phosphorus limitation was a more common occurrence in low-latitude areas of the glacial ocean.	[Pichevin, L. E.; Ganeshram, R. S.] Univ Edinburgh, Grant Inst, Sch Geosci, Edinburgh EH10 3JW, Midlothian, Scotland; [Reynolds, B. C.] ETH, IGMR, CH-8092 Zurich, Switzerland; [Cacho, I.; Pena, L.] Univ Barcelona, Fac Geol, GRC Geociencies Marines, E-08028 Barcelona, Spain; [Keefe, K.; Ellam, R. M.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland	University of Edinburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Barcelona; Scottish Universities Research & Reactor Center	Pichevin, LE (corresponding author), Univ Edinburgh, Grant Inst, Sch Geosci, W Main Rd, Edinburgh EH10 3JW, Midlothian, Scotland.	laetitia.pichevin@ed.ac.uk	Cacho, Isabel/H-4402-2013; Pena, Leopoldo/B-8140-2013; Pena, Leopoldo/A-7085-2015; Cacho, Isabel/AAX-2610-2021; Ellam, Rob M/B-7878-2009	Cacho, Isabel/0000-0002-6512-0770; Pena, Leopoldo/0000-0001-6414-6293; Pena, Leopoldo/0000-0001-6414-6293; Cacho, Isabel/0000-0002-6512-0770; Ellam, Rob M/0000-0001-8159-4864; Pichevin, Laetitia/0000-0003-2685-6926	Scottish Alliance for Geoscience Environment Society (SAGES); Natural Environment Research Council ( NERC) through a Standard NERC; Marie Curie Intra-European fellowship; ROMIAT; GRACCIE-CONSOLIDER; NERC [NE/E017738/1] Funding Source: UKRI; Natural Environment Research Council [NE/E017738/1] Funding Source: researchfish	Scottish Alliance for Geoscience Environment Society (SAGES); Natural Environment Research Council ( NERC) through a Standard NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marie Curie Intra-European fellowship(European Commission); ROMIAT; GRACCIE-CONSOLIDER; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Francois, S. Kienast, W. Geibert, E. Galbraith and G. Leduc for discussions. Funding for this project was provided by the Scottish Alliance for Geoscience Environment Society ( SAGES), the Natural Environment Research Council ( NERC) through a Standard NERC grant ( to R. S. G. and L. E. P.) and a Marie Curie Intra-European fellowship ( to L. E. P.). I. C. and L. P. acknowledge funding from the ROMIAT and GRACCIE-CONSOLIDER projects.	Altabet MA, 2001, LIMNOL OCEANOGR, V46, P368, DOI 10.4319/lo.2001.46.2.0368; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Beucher CP, 2008, GEOCHIM COSMOCHIM AC, V72, P3063, DOI 10.1016/j.gca.2008.04.021; Beucher CP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002746; Bradtmiller LI, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001282; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Ellam RM, 2007, J ANAL ATOM SPECTROM, V22, P147, DOI 10.1039/b612231k; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Francois R, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000939; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 2002, NATURE, V415, P156, DOI 10.1038/415156a; Georg RB, 2006, CHEM GEOL, V235, P95, DOI 10.1016/j.chemgeo.2006.06.006; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Kienast SS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026651; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lisitzin A. P., 1971, MICROPALAEONTOLOGY O, P173; Loubere P, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001367; LYLE M, 1988, NATURE, V335, P529, DOI 10.1038/335529a0; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; McGee D, 2007, EARTH PLANET SC LETT, V257, P215, DOI 10.1016/j.epsl.2007.02.033; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moore JK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002762; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Morley DW, 2004, J PALEOLIMNOL, V31, P391, DOI 10.1023/B:JOPL.0000021854.70714.6b; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; PEDERSEN TF, 1983, GEOLOGY, V11, P16, DOI 10.1130/0091-7613(1983)11<16:IPITEE>2.0.CO;2; Pena LD, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001620; Reynolds BC, 2006, EARTH PLANET SC LETT, V244, P431, DOI 10.1016/j.epsl.2006.02.002; Reynolds BC, 2006, J ANAL ATOM SPECTROM, V21, P266, DOI 10.1039/b515908c; Richaud M, 2007, DEEP-SEA RES PT II, V54, P762, DOI 10.1016/j.dsr2.2007.01.012; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Toggweiler JR, 1995, DAHL WS ENV, V18, P337; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595	36	77	79	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1114	U98		10.1038/nature08101	http://dx.doi.org/10.1038/nature08101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19553996	Green Accepted			2022-12-28	WOS:000267636700040
J	Pui, CH; Campana, D; Pei, DQ; Bowman, WP; Sandlund, JT; Kaste, SC; Ribeiro, RC; Rubnitz, JE; Raimondi, SC; Onciu, M; Coustan-Smith, E; Kun, LE; Jeha, S; Cheng, C; Howard, SC; Simmons, V; Bayles, A; Metzger, ML; Boyett, JM; Leung, W; Handgretinger, R; Downing, JR; Evans, WE; Relling, MV				Pui, Ching-Hon; Campana, Dario; Pei, Deqing; Bowman, W. Paul; Sandlund, John T.; Kaste, Sue C.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Raimondi, Susana C.; Onciu, Mihaela; Coustan-Smith, Elaine; Kun, Larry E.; Jeha, Sima; Cheng, Cheng; Howard, Scott C.; Simmons, Vickey; Bayles, Amy; Metzger, Monika L.; Boyett, James M.; Leung, Wing; Handgretinger, Rupert; Downing, James R.; Evans, William E.; Relling, Mary V.			Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; NERVOUS-SYSTEM RELAPSE; CHILDRENS CANCER GROUP; LOW LEUKOCYTE COUNTS; EVENT-FREE SURVIVAL; CEREBROSPINAL-FLUID; RANDOMIZED-TRIAL; LUMBAR PUNCTURE; TOTAL THERAPY; CHEMOTHERAPY	Background Prophylactic cranial irradiation has been a standard treatment in children with acute lymphoblastic leukemia (ALL) who are at high risk for central nervous system (CNS) relapse. Methods We conducted a clinical trial to test whether prophylactic cranial irradiation could be omitted from treatment in all children with newly diagnosed ALL. A total of 498 patients who could be evaluated were enrolled. Treatment intensity was based on presenting features and the level of minimal residual disease after remission-induction treatment. The duration of continuous complete remission in the 71 patients who previously would have received prophylactic cranial irradiation was compared with that of 56 historical controls who received it. Results The 5-year event-free and overall survival probabilities for all 498 patients were 85.6% (95% confidence interval [CI], 79.9 to 91.3) and 93.5% (95% CI, 89.8 to 97.2), respectively. The 5-year cumulative risk of isolated CNS relapse was 2.7% (95% CI, 1.1 to 4.3), and that of any CNS relapse (including isolated relapse and combined relapse) was 3.9% (95% CI, 1.9 to 5.9). The 71 patients had significantly longer continuous complete remission than the 56 historical controls (P = 0.04). All 11 patients with isolated CNS relapse remained in second remission for 0.4 to 5.5 years. CNS leukemia (CNS-3 status) or a traumatic lumbar puncture with blast cells at diagnosis and a high level of minimal residual disease (>= 1%) after 6 weeks of remission induction were significantly associated with poorer event-free survival. Risk factors for CNS relapse included the genetic abnormality t(1; 19)(TCF3-PBX1), any CNS involvement at diagnosis, and T-cell immunophenotype. Common adverse effects included allergic reactions to asparaginase, osteonecrosis, thrombosis, and disseminated fungal infection. Conclusions With effective risk-adjusted chemotherapy, prophylactic cranial irradiation can be safely omitted from the treatment of childhood ALL. (ClinicalTrials.gov number, NCT00137111.)	[Pui, Ching-Hon; Campana, Dario; Sandlund, John T.; Kaste, Sue C.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Coustan-Smith, Elaine; Jeha, Sima; Howard, Scott C.; Simmons, Vickey; Metzger, Monika L.; Leung, Wing; Handgretinger, Rupert] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Pui, Ching-Hon; Campana, Dario; Raimondi, Susana C.; Onciu, Mihaela; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pei, Deqing; Cheng, Cheng; Boyett, James M.] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Kaste, Sue C.; Kun, Larry E.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Evans, William E.; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pui, Ching-Hon; Campana, Dario; Sandlund, John T.; Kaste, Sue C.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Raimondi, Susana C.; Onciu, Mihaela; Kun, Larry E.; Jeha, Sima; Howard, Scott C.; Metzger, Monika L.; Leung, Wing; Downing, James R.; Evans, William E.; Relling, Mary V.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN USA; [Evans, William E.; Relling, Mary V.] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Memphis, TN USA; [Bowman, W. Paul; Bayles, Amy] Cook Childrens Med Ctr, Ft Worth, TX USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cook Children's Medical Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Evans, William E./C-2069-2012; Relling, Mary/N-5032-2018; Downing, James R./N-8102-2018; Raimondi, Susana C/N-8166-2018; Jeha, Sima C/N-8163-2018; Howard, Scott C/K-3401-2013; Pui, Ching-Hon/N-8076-2018; Kaste, Sue C/N-8165-2018; Rubnitz, Jeffrey E/N-2619-2018; Cheng, Cheng/N-8075-2018	Evans, William E./0000-0002-9333-5322; Howard, Scott C/0000-0003-2244-1686; Pui, Ching-Hon/0000-0003-0303-5658; Rubnitz, Jeffrey E/0000-0001-9885-3527; Leung, Wing Hang/0000-0002-2996-7229	National Institutes of Health [CA21765, CA60419, CA51001, CA78224, CA36401, GM61393]; American Cancer Society F. M. Kirby Clinical Research Professorship; American Lebanese Syrian Associated Charities; Enzon Pharmaceuticals; Genzyme; Sanofi-Aventis; EUSA Pharma; Enzon Pharmaceutical; NATIONAL CANCER INSTITUTE [R01CA060419, R37CA036401, R29CA051001, R01CA051001, P30CA021765, U01CA060419, R01CA078224, R01CA036401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society F. M. Kirby Clinical Research Professorship(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Enzon Pharmaceuticals; Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi-Aventis(Sanofi-Aventis); EUSA Pharma; Enzon Pharmaceutical; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health CA21765; CA60419, to Drs. Campana and Pui; and CA51001, CA78224, CA36401, and GM61393 to Drs. Relling, Pui, and Evans) and an American Cancer Society F. M. Kirby Clinical Research Professorship (to Dr. Pui); and by the American Lebanese Syrian Associated Charities. Dr. Pui reports receiving lecture fees from Enzon Pharmaceuticals; Dr. Cheng, receiving grant support from Enzon Pharmaceuticals; Dr. Jeha, receiving grant support from Genzyme, Sanofi-Aventis, and EUSA Pharma; Dr. Downing, serving as a council member with the American Society for Investigative Pathology; Dr. Relling, receiving grant support from Enzon Pharmaceutical and consulting fees from Genome Explorations; Dr. Evans, being an inventor on a patent concerning molecular diagnosis of thiopurine-S-methyltransferase deficiency (Drs. Evans and Relling and St. Jude Children's Research Hospital, receiving royalties from licensing of this patent). No other potential conflict of interest relevant to this article was reported.; We thank Julie Groff for assistance with an earlier draft of the figure; Jeana Cromer, Emily Baum, and Linda Holloway for data management; Dr. Sheila Shurtleff for molecular analysis; and our clinical and laboratory colleagues and the many patients and parents who participated in the research program.	Barredo JC, 2006, J CLIN ONCOL, V24, P3142, DOI 10.1200/JCO.2005.03.3373; BLANEY SM, 1995, J CLIN ONCOL, V13, P177, DOI 10.1200/JCO.1995.13.1.177; Bostrom BC, 2003, BLOOD, V101, P3809, DOI 10.1182/blood-2002-08-2454; Burger B, 2003, J CLIN ONCOL, V21, P184, DOI 10.1200/JCO.2003.04.096; Conter V, 1997, J CLIN ONCOL, V15, P2786, DOI 10.1200/JCO.1997.15.8.2786; Conter V, 2000, LEUKEMIA, V14, P2196, DOI 10.1038/sj.leu.2401963; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Gajjar A, 2000, BLOOD, V96, P3381; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; Hagedorn N, 2007, BLOOD, V110, P4022, DOI 10.1182/blood-2007-04-082040; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; Hill FGH, 2004, BRIT J HAEMATOL, V124, P33, DOI 10.1046/j.1365-2141.2003.04738.x; Howard SC, 2002, JAMA-J AM MED ASSOC, V288, P2001, DOI 10.1001/jama.288.16.2001; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kamps WA, 2002, LEUKEMIA, V16, P1099, DOI 10.1038/sj.leu.2402489; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; Lange BJ, 2002, BLOOD, V99, P825, DOI 10.1182/blood.V99.3.825; MAHMOUD HH, 1993, NEW ENGL J MED, V329, P314, DOI 10.1056/NEJM199307293290504; Manera R, 2000, LEUKEMIA, V14, P1354, DOI 10.1038/sj.leu.2401835; Matloub Y, 2006, BLOOD, V108, P1165, DOI 10.1182/blood-2005-12-011809; Mitchell CD, 2005, BRIT J HAEMATOL, V129, P734, DOI 10.1111/j.1365-2141.2005.05509.x; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Neale GAM, 2004, LEUKEMIA, V18, P934, DOI 10.1038/sj.leu.2403348; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Pession A, 2005, J CLIN ONCOL, V23, P7161, DOI 10.1200/JCO.2005.11.411; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; Pui CH, 2003, NEW ENGL J MED, V349, P1299; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Pulte D, 2008, JNCI-J NATL CANCER I, V100, P1301, DOI 10.1093/jnci/djn276; Relling MV, 1999, BLOOD, V93, P2817; Salzer W, 2001, CANCER CHEMOTH PHARM, V48, P235, DOI 10.1007/s002800100328; Schrappe M, 2000, BLOOD, V95, P3310; te Loo DMWM, 2006, J CLIN ONCOL, V24, P2332, DOI 10.1200/JCO.2005.03.9727; Vilmer E, 2000, LEUKEMIA, V14, P2257, DOI 10.1038/sj.leu.2401960; Waber DP, 2007, J CLIN ONCOL, V25, P4914, DOI 10.1200/JCO.2007.10.8464; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404	48	837	885	2	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2009	360	26					2730	2741		10.1056/NEJMoa0900386	http://dx.doi.org/10.1056/NEJMoa0900386			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461RC	19553647	Green Accepted			2022-12-28	WOS:000267286600007
J	Shishkin, SV; Vlassov, VV				Shishkin, Sergey V.; Vlassov, Vasiliy V.			Russia's healthcare system: in need of modernisation	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		[Shishkin, Sergey V.] State Univ Higher Sch Econ, Moscow 109028, Russia; [Vlassov, Vasiliy V.] Moscow Med Acad, Moscow, Russia	HSE University (National Research University Higher School of Economics); Sechenov First Moscow State Medical University	Shishkin, SV (corresponding author), State Univ Higher Sch Econ, Pokrovsky Blvd 11,Off E302, Moscow 109028, Russia.	shishkin@hse.ru	Vlassov, Valentin/F-4720-2013; Vlassov, Vasiliy/B-4036-2014	Vlassov, Valentin/0000-0003-2845-2992; Vlassov, Vasiliy/0000-0001-5203-549X				[Anonymous], 2008, COUNTRY PROGR REPORT; *CAR POP CTR, RUSS LONG MON SURV; CASSILETH BR, 1995, JAMA-J AM MED ASSOC, V273, P1569, DOI 10.1001/jama.273.20.1569; DANILOVA I, 1999, MMWR-MORBID MORTAL W, V48, P661; GAIDAR Y, 2007, RUSSIAN EC 2006 TREN; *GOV RUSS FED, 2008, CONC DOLG SOTS EC RA; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; *MIN HLTH SOC DEV, 2008, CONC RAZV SYST ZDRAV; SHISHKIN S, 2008, ROSSIISKOE ZDRAVOOKH; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; UNAIDS, 2008 REP GLOB AIDS E; Vishnevskiy A., 2006, ROSSIYSKOE ZDRAVOOKH; VLASSOV VV, 2008, BRIT MED J, V337, P1315; *WORLD BANK, 2007, BETT OUTC HLTH REF R; World Health Organization Regional Office for Europe, 2009, EUR HLTH ALL DAT; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	17	6	6	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 25	2009	338								b2132	10.1136/bmj.b2132	http://dx.doi.org/10.1136/bmj.b2132			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MP	19556273				2022-12-28	WOS:000267436600003
J	Neligan, A; Holdright, DR; Rugg-Gunn, FJ; Sander, JW				Neligan, A.; Holdright, D. R.; Rugg-Gunn, F. J.; Sander, J. W.			Lesson of the Week A case of mistaken mesial temporal identity	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC-ARRHYTHMIAS; EPILEPTIC-SEIZURES; MISDIAGNOSIS; ASYSTOLE		[Rugg-Gunn, F. J.; Sander, J. W.] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, London WC1N 3BG, England; [Holdright, D. R.] UCLH Heart Hosp, London W1G 8PF, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University College London Hospitals NHS Foundation Trust	Sander, JW (corresponding author), Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	lsander@ion.ucl.ac.uk	Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661; Neligan, Aidan/0000-0003-3390-5589				DIMARCO JP, 1990, ANN INTERN MED, V113, P53, DOI 10.7326/0003-4819-113-1-53; GASTAUT H, 1958, LANCET, V2, P1018; Gavris MF, 2002, J ELECTROCARDIOL, V35, P279, DOI 10.1054/jelc.2002.33763; HOWELL SJL, 1989, JNNP, V52, P797; Hunt DPJ, 2005, EMERG MED J, V22, P600, DOI 10.1136/emj.2003.007997; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Krahn Andrew D., 1997, Cardiology Clinics, V15, P313; LINZER M, 1994, AM J MED, V96, P146, DOI 10.1016/0002-9343(94)90135-X; McDade G, 1992, Seizure, V1, P7, DOI 10.1016/1059-1311(92)90047-5; MITCHELL LC, 1991, AM J EMERG MED, V9, P457, DOI 10.1016/0735-6757(91)90215-6; PACIA SV, 1994, NEUROLOGY, V44, P1408, DOI 10.1212/WNL.44.8.1408; Rocamora R, 2003, EPILEPSIA, V44, P179, DOI 10.1046/j.1528-1157.2003.15101.x; Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6; Rugg-Gunn FJ, 2001, EPILEPSY RES, V43, P193, DOI 10.1016/S0920-1211(00)00209-6; SCHOTT GD, 1977, BRIT MED J, V1, P1454, DOI 10.1136/bmj.1.6074.1454; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2	17	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2009	338								b2258	10.1136/bmj.b2258	http://dx.doi.org/10.1136/bmj.b2258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463MM	19549648				2022-12-28	WOS:000267436300001
J	Miryala, R; Neilan, R				Miryala, Radheshyam; Neilan, Ryan			Perforated Umbilical Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miryala, Radheshyam; Neilan, Ryan] Univ Texas Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Miryala, R (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.	ramiryal@utmb.edu							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					E32	E32		10.1056/NEJMicm0801211	http://dx.doi.org/10.1056/NEJMicm0801211			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19535799				2022-12-28	WOS:000267060000011
J	Reynolds, T				Reynolds, Tim			Care coordination for patients with chronic conditions did not reduce hospitalizations or Medicare costs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Queens Hosp, Burton Upon Trent, England		Reynolds, T (corresponding author), Queens Hosp, Burton Upon Trent, England.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12								10.7326/0003-4819-150-12-200906160-02014	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19528559				2022-12-28	WOS:000267164800026
J	Meyer, E; Glatzel, T				Meyer, Ernst; Glatzel, Thilo			Novel Probes for Molecular Electronics	SCIENCE			English	Editorial Material							CONDUCTANCE		[Meyer, Ernst; Glatzel, Thilo] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	University of Basel	Meyer, E (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	ernst.meyer@unibas.ch	Meyer, Ernst/L-3873-2016; Glatzel, Thilo/F-2639-2011	Meyer, Ernst/0000-0001-6385-3412; Glatzel, Thilo/0000-0002-3533-4217				[Anonymous], 2005, PHYS REV LETT; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; Bocquet F, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035410; BURKE SA, 2009, ADV MATER, V21, P1; Enevoldsen GH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236104; Glatzel T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3080614; Gross L, 2009, SCIENCE, V324, P1428, DOI 10.1126/science.1172273; Lafferentz L, 2009, SCIENCE, V323, P1193, DOI 10.1126/science.1168255; Maier S, 2008, SMALL, V4, P1115, DOI 10.1002/smll.200701259; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Repp J, 2006, SCIENCE, V312, P1196, DOI 10.1126/science.1126073; Zahl P, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1852925	12	17	17	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 12	2009	324	5933					1397	1398		10.1126/science.1175869	http://dx.doi.org/10.1126/science.1175869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19520946				2022-12-28	WOS:000266878700029
J	Fuhrer, MS; Adam, S				Fuhrer, Michael S.; Adam, Shaffique			CONDENSED-MATTER PHYSICS: Carbon conductor corrupted	NATURE			English	Editorial Material							GRAPHENE; DIFFUSION; ABSENCE		[Fuhrer, Michael S.] Univ Maryland, Ctr Nanophys & Adv Mat, Dept Phys, College Pk, MD 20742 USA; [Adam, Shaffique] Univ Maryland, Dept Phys, Condensed Matter Theory Ctr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Fuhrer, MS (corresponding author), Univ Maryland, Ctr Nanophys & Adv Mat, Dept Phys, College Pk, MD 20742 USA.	mfuhrer@umd.edu; adam1@umd.edu	Fuhrer, Michael S/E-7634-2010; Adam, Shaffique/B-3264-2008	Fuhrer, Michael S/0000-0001-6183-2773; Adam, Shaffique/0000-0002-3095-9920				Adam S, 2007, P NATL ACAD SCI USA, V104, P18392, DOI 10.1073/pnas.0704772104; Aleiner IL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236801; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bardarson JH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106801; Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Sofo JO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153401; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	10	15	15	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					38	39		10.1038/458038a	http://dx.doi.org/10.1038/458038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19553953				2022-12-28	WOS:000263836000022
J	Rondina, M				Rondina, Matthew			Oral vitamin K did not reduce bleeding in patients with excessive anticoagulation after receiving warfarin	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Utah, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rondina, M (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.				NHLBI NIH HHS [K23 HL092161] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092161] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2009	150	12							JC6-9	10.7326/0003-4819-150-12-200906160-02009	http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460CX	19648428				2022-12-28	WOS:000267164800021
